PT J
AU Brady, L
   Sadikovic, B
   Rupar, CA
   Tarnopolsky, MA
AF Brady, Lauren
   Sadikovic, Bekim
   Rupar, C. Anthony
   Tarnopolsky, Mark A.
TI Complete elimination of a pathogenic homoplasmic mtDNA mutation in one generation
SO MITOCHONDRION
LA English
DT Article
ID hereditary optic neuropathy; mitochondrial-dna mutations; leigh-syndrome; oogenesis; disease; patient; muscle
AB Mitochondrial DNA (mtDNA) mutations have been implicated in a wide variety of neurological conditions and are maternally inherited through a complex process which is not fully understood. Genetic counselling for mitochondrial conditions secondary to a mtDNA mutation can be challenging as it is not currently possible to accurately predict the mutational load/heteroplasmy of the mutation which could be passed to the offspring. In general, one expects that the higher the level of heteroplasmy the more likely that the same mtDNA mutation will be seen in the offspring. We report here a family which places a caveat on genetic counselling for mtDNA disorders. The proband is a 63 year old woman with m.14459G > A associated dystonia/spasticity/ataxia. The m.14459G > A mutation was detected at homoplasmic/near homoplasmic levels in her muscle tissue and fibroblasts, but did not appear to have been passed on to any of her offspring. To our knowledge, this is the first report of complete selection against a homoplasmic variant within maternally transmitted mtDNA. It is not clear if this novel phenomenon occurred by random chance or by another method of mitochondrial selection.
C1 [Brady, Lauren; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
   [Sadikovic, Bekim; Rupar, C. Anthony] Childrens Hlth Res Inst, London Hlth Sci Ctr, Mol Diagnost Div, Mol Genet Lab, London, ON, Canada.
   [Sadikovic, Bekim; Rupar, C. Anthony] Western Univ, Dept Pathol & Lab Med, London, ON, Canada.
   [Sadikovic, Bekim; Rupar, C. Anthony] Western Univ, Dept Pediat, London, ON, Canada.
   [Sadikovic, Bekim; Rupar, C. Anthony] Western Univ, Dept Biochem, London, ON, Canada.
   [Sadikovic, Bekim; Rupar, C. Anthony] Western Univ, Childrens Hlth Res Inst, London, ON, Canada.
C3 McMaster University; London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
CR Blakely EL, 2006, PEDIATR RES, V59, P440, DOI 10.1203/01.pdr.0000198771.78290.c4
   Degoul F, 1997, J INHERIT METAB DIS, V20, P49, DOI 10.1023/A:1005357506614
   DeVries DD, 1996, AM J HUM GENET, V58, P703
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   GÃ¶tz A, 2012, PEDIATR RES, V72, P90, DOI 10.1038/pr.2012.43
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kerkhof J, 2017, J MOL GENET, V0, P0
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Marlow FL, 2017, STEM CELL RES, V21, P178, DOI 10.1016/j.scr.2017.03.004
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Ronchi D, 2011, BMC NEUROL, V11, P0, DOI 10.1186/1471-2377-11-85
   Schenkel LC, 2016, J MOL DIAGN, V18, P657, DOI 10.1016/j.jmoldx.2016.04.002
   SHOFFNER JM, 1995, ANN NEUROL, V38, P163, DOI 10.1002/ana.410380207
   St John JC, 2004, GENETICS, V167, P897, DOI 10.1534/genetics.103.025049
   Tarnopoisky M, 2013, AM J MED GENET A, V161, P2020, DOI 10.1002/ajmg.a.36000
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   Taylor RW, 2003, J MED GENET, V40, P0, DOI 10.1136/jmg.40.7.e85
   Taylor RW, 2002, NEUROMUSCULAR DISORD, V12, P659, DOI 10.1016/S0960-8966(02)00026-3
   Tworzydlo W, 2016, CELL TISSUE RES, V366, P191, DOI 10.1007/s00441-016-2414-x
   Wallace D, 2007, EMERY RIMOINS PRINCI, V0, P0
   Weber K, 1997, AM J HUM GENET, V60, P373
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Wilding M, 2001, ZYGOTE, V9, P347, DOI 10.1017/S096719940100140X
   Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626
   Wray CD, 2013, MITOCHONDRION, V13, P656, DOI 10.1016/j.mito.2013.09.004
   Zhang YZ, 2008, DEV GROWTH DIFFER, V50, P189, DOI 10.1111/j.1440-169X.2008.00988.x
NR 29
TC 1
Z9 1
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2019
VL 45
IS 
BP 18
EP 21
DI 10.1016/j.mito.2018.01.010
PG 4
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA HO3WI
UT WOS:000460853300003
PM 29408632
DA 2024-11-01
ER

PT J
AU Kim, MJ
   Haroon, S
   Chen, GD
   Ding, DL
   Wanagat, J
   Liu, LJ
   Zhang, YP
   White, K
   Park, HJ
   Han, C
   Boyd, K
   Caicedo, I
   Evans, K
   Linser, PJ
   Tanokura, M
   Prolla, T
   Salvi, R
   Vermulst, M
   Someya, S
AF Kim, Mi-Jung
   Haroon, Suraiya
   Chen, Guang-Di
   Ding, Dalian
   Wanagat, Jonathan
   Liu, Lijie
   Zhang, Yanping
   White, Karessa
   Park, Hyo-Jin
   Han, Chul
   Boyd, Kevin
   Caicedo, Isabela
   Evans, Kaitlyn
   Linser, Paul J.
   Tanokura, Masaru
   Prolla, Tomas
   Salvi, Richard
   Vermulst, Marc
   Someya, Shinichi
TI Increased burden of mitochondrial DNA deletions and point mutations in early-onset age-related hearing loss in mitochondrial mutator mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Mitochondrial DNA mutations; Mitochondrial disease; Hearing loss; Aging
ID hair cell loss; skeletal-muscle; mtdna mutations; copy number; presbycusis; deficiency; brain; inner; abnormality; accumulation
AB Mitochondrial DNA (mtDNA) mutations are thought to have a causal role in a variety of age-related neurode-generative diseases, including age-related hearing loss (AHL). In the current study, we investigated the roles of mtDNA deletions and point mutations in AHL in mitochondrial mutator mice (Polg(mut/mut)) that were backcrossed onto CBA/CaJ mice, a well-established model of late-onset AHL. mtDNA deletions accumulated significantly with age in the inner ears of Polg(mut/mut) mice, while there were no differences in mtDNA deletion frequencies in the inner ears between 5 and 17 months old Polg(+/+)( )mice or 5 months old Polg(+/+) and Polg(mut/mut) mice. mtDNA deletions also accumulated significantly in the inner ears of CBA/CaJ mice during normal aging. In contrast, 5 months old Polg(mut/mut) mice displayed a 238-fold increase in mtDNA point mutation frequencies in the inner ears compared to age-matched Pole(+/+) mice, but there were no differences in mtDNA point mutation frequencies in the inner ears between 5 and 17 months old Polg(mut/mut )mice. Seventeen-month-old Polg(mut/mut) mice also displayed early-onset severe hearing loss associated with a significant reduction in neural output of the cochlea, while age-matched Polg(+/+) mice displayed little or no hearing impairment. Consistent with the physiological and mtDNA deletion test result, 17-month-old Polg(mut/mut) mice displayed a profound loss of spiral ganglion neurons in the cochlea. Thus, our data suggest that a higher burden of mtDNA point mutations from a young age and age-related accumulation of mtDNA deletions likely contribute to early-onset AHL in mitochondrial mutator mice.
C1 [Kim, Mi-Jung; White, Karessa; Park, Hyo-Jin; Han, Chul; Boyd, Kevin; Caicedo, Isabela; Evans, Kaitlyn; Someya, Shinichi] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32610 USA.
   [Haroon, Suraiya; Vermulst, Marc] Univ Penn, Ctr Mitochondria & Epigen Med, Philadelphia, PA 19104 USA.
   [Chen, Guang-Di; Ding, Dalian; Liu, Lijie; Salvi, Richard] SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY USA.
   [Wanagat, Jonathan] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.
   [Zhang, Yanping] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gene Express & Genotyping, Gainesville, FL 32610 USA.
   [Linser, Paul J.] Univ Florida, Whitney Lab, 9505 Ocean Shore Blvd, St Augustine, FL 32086 USA.
   [Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan.
   [Prolla, Tomas] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.
   [Salvi, Richard] Asia Univ, Dept Audiol & Speech Language Pathol, Taichung, Taiwan.
C3 State University System of Florida; University of Florida; University of Pennsylvania; State University of New York (SUNY) System; University at Buffalo, SUNY; University of California System; University of California Los Angeles; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Tokyo; University of Wisconsin System; University of Wisconsin Madison; Asia University Taiwan
RP Someya, S (corresponding author), Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32610 USA.
EM someya@ufl.edu
FU National Institutes of Health [R03 DC011840, R01 DC012552, R01 DC014437]; National Institute on Deafness and Communication Disorders [R03 DC011840, R01 DC012552, R01 DC014437]; Claude D. Pepper Older Americans Independence Centers at the University of Florida from the National Institute of Health [P30 AG028740]; Claude D. Pepper Older Americans Independence Centers at the University of Florida from the National Institute on Aging; Japan Society for the Promotion of Science (JSPS) [26253081, 23228003]; Glenn Foundation for Medical Research; National Institute on Aging [AG032873, AG055518]; UCLA Older Americans Independence Center [P30 AG028748]; Ellison Medical Foundation New Scholar Award; UCSD/UCLA Diabetes Research Center Pilot and Feasibility Grant [DK063491]; Grants-in-Aid for Scientific Research [26253081] Funding Source: KAKEN
CR Bai U, 1997, AM J OTOL, V18, P449
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Chen GD, 2014, HEARING RES, V317, P1, DOI 10.1016/j.heares.2014.08.004
   Chen GD, 2013, HEARING RES, V295, P100, DOI 10.1016/j.heares.2012.11.016
   Chen T, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-8
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Ding D, 1999, LIN CHUANG ER BI YAN HOU KE ZA ZHI, V13, P510
   Ding DL, 2016, AGING-US, V8, P730, DOI 10.18632/aging.100927
   Ding DL, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0079817
   Durrant JD, 1998, J ACOUST SOC AM, V104, P370, DOI 10.1121/1.423293
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Falah M, 2016, THER CLIN RISK MANAG, V12, P1573, DOI 10.2147/TCRM.S117491
   FischelGhodsian N, 1997, HEARING RES, V110, P147, DOI 10.1016/S0378-5955(97)00077-4
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Han C, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0180817
   Han C, 2013, MOL CELL NEUROSCI, V55, P95, DOI 10.1016/j.mcn.2012.07.004
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Jiang C, 2017, HEARING RES, V347, P28, DOI 10.1016/j.heares.2016.10.021
   Johnson KR, 2006, BRAIN RES, V1091, P79, DOI 10.1016/j.brainres.2006.02.021
   Kane KL, 2012, HEARING RES, V283, P80, DOI 10.1016/j.heares.2011.11.007
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Li-Harms X, 2015, BLOOD, V125, P162, DOI 10.1182/blood-2014-07-586396
   Markaryan A, 2008, MUTAT RES-FUND MOL M, V640, P38, DOI 10.1016/j.mrfmmm.2007.12.007
   Markaryan A, 2010, ACTA OTO-LARYNGOL, V130, P780, DOI 10.3109/00016480903397702
   Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   McKiernan SH, 2007, AM J PHYSIOL-RENAL, V292, PF1751, DOI 10.1152/ajprenal.00307.2006
   MÃ¼ller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011
   Nikoletopoulou V, 2018, TRENDS CELL BIOL, V28, P646, DOI 10.1016/j.tcb.2018.03.006
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226
   Ohlemiller KK, 2010, JARO-J ASSOC RES OTO, V11, P605, DOI 10.1007/s10162-010-0228-1
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Salvi R, 2017, FRONT NEUROSCI-SWITZ, V10, P0, DOI 10.3389/fnins.2016.00621
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   Seidman MD, 1996, LARYNGOSCOPE, V106, P777, DOI 10.1097/00005537-199606000-00021
   Sheppard AM, 2017, NEUROSCIENCE, V359, P159, DOI 10.1016/j.neuroscience.2017.07.005
   Sheppard AM, 2015, HEARING RES, V327, P1, DOI 10.1016/j.heares.2015.04.007
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Someya S, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0171159
   Spongr VP, 1997, J ACOUST SOC AM, V101, P3546, DOI 10.1121/1.418315
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang J, 1997, HEARING RES, V107, P67, DOI 10.1016/S0378-5955(97)00020-8
   White K, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-23436-w
   White K, 2017, J NEUROSCI, V37, P5770, DOI 10.1523/JNEUROSCI.0519-17.2017
   Xing GQ, 2007, CELL RES, V17, P227, DOI 10.1038/sj.cr.7310124
   Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021
   Yin S, 2007, NEUROBIOL DIS, V27, P370, DOI 10.1016/j.nbd.2007.06.006
   Zhou XM, 2006, BRAIN RES, V1091, P16, DOI 10.1016/j.brainres.2006.01.107
NR 63
TC 15
Z9 17
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD OCT 1
PY 2019
VL 125
IS 
BP 
EP 
DI 10.1016/j.exger.2019.110675
PG 12
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA IV1FD
UT WOS:000484021800012
PM 31344454
DA 2024-11-01
ER

PT J
AU Li, HZ
   Slone, J
   Fei, L
   Huang, TS
AF Li, Huanzheng
   Slone, Jesse
   Fei, Lin
   Huang, Taosheng
TI Mitochondrial DNA Variants and Common Diseases: A Mathematical Model for the Diversity of Age-Related mtDNA Mutations
SO CELLS
LA English
DT Review
DE mitochondria; mitochondrial genetics; aging; cancer; diabetes; mutation
ID copy number; huntingtons-disease; parkinsons-disease; alzheimers-disease; cardiac-muscle; d-loop; deletions; protein; metabolism; cancer
AB The mitochondrion is the only organelle in the human cell, besides the nucleus, with its own DNA (mtDNA). Since the mitochondrion is critical to the energy metabolism of the eukaryotic cell, it should be unsurprising, then, that a primary driver of cellular aging and related diseases is mtDNA instability over the life of an individual. The mutation rate of mammalian mtDNA is significantly higher than the mutation rate observed for nuclear DNA, due to the poor fidelity of DNA polymerase and the ROS-saturated environment present within the mitochondrion. In this review, we will discuss the current literature showing that mitochondrial dysfunction can contribute to age-related common diseases such as cancer, diabetes, and other commonly occurring diseases. We will then turn our attention to the likely role that mtDNA mutation plays in aging and senescence. Finally, we will use this context to develop a mathematical formula for estimating for the accumulation of somatic mtDNA mutations with age. This resulting model shows that almost 90% of non-proliferating cells would be expected to have at least 100 mutations per cell by the age of 70, and almost no cells would have fewer than 10 mutations, suggesting that mtDNA mutations may contribute significantly to many adult onset diseases.
C1 [Li, Huanzheng] Nanchang Univ, Human Aging Res Inst, Nanchang 330031, Jiangxi, Peoples R China.
   [Li, Huanzheng] Wenzhou Cent Hosp, Wenzhou Key Lab Birth Defects, Wenzhou 325000, Zhejiang, Peoples R China.
   [Slone, Jesse; Huang, Taosheng] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
   [Fei, Lin] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
C3 Nanchang University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center
RP Huang, TS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
EM oceanuniversity@126.com; jesse.slone@cchmc.org; lin.fei@cchmc.org; Taosheng.Huang@cchmc.org
CR Abudu YP, 2019, DEV CELL, V49, P509, DOI 10.1016/j.devcel.2019.03.013
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Banoei MM, 2007, CELL MOL NEUROBIOL, V27, P867, DOI 10.1007/s10571-007-9206-5
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178
   Baysal BE, 2015, ENDOCR-RELAT CANCER, V22, PT71, DOI 10.1530/ERC-15-0226
   BENDALL KE, 1995, AM J HUM GENET, V57, P248
   Bi R, 2015, NEUROBIOL AGING, V36, P0, DOI 10.1016/j.neurobiolaging.2014.10.009
   Bianconi E, 2013, ANN HUM BIOL, V40, P463, DOI 10.3109/03014460.2013.807878
   Blesa J, 2012, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2012/845618
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Cadonic C, 2016, MOL NEUROBIOL, V53, P6078, DOI 10.1007/s12035-015-9515-5
   Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537
   Choi J, 2014, MITOCHONDRION, V18, P41, DOI 10.1016/j.mito.2014.09.005
   Colijn C, 2005, J THEOR BIOL, V237, P117, DOI 10.1016/j.jtbi.2005.03.033
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coto E, 2011, NEUROGENETICS, V12, P345, DOI 10.1007/s10048-011-0295-4
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   El-Hattab AW, 2014, MITOCHONDRION, V18, P63, DOI 10.1016/j.mito.2014.07.008
   Farshbaf MJ, 2017, NEUROTOX RES, V32, P518, DOI 10.1007/s12640-017-9766-1
   Fesahat F, 2007, CELL MOL NEUROBIOL, V27, P329, DOI 10.1007/s10571-006-9126-9
   Fliedner TM, 2002, CANCER BIOTHER RADIO, V17, P405, DOI 10.1089/108497802760363204
   Foote K, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12773
   Fouquerel E, 2019, MOL CELL, V75, P117, DOI 10.1016/j.molcel.2019.04.024
   Gegg ME, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0004756
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   GÃ³mez-Serrano M, 2017, REDOX BIOL, V11, P415, DOI 10.1016/j.redox.2016.12.013
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   GrÃ¼newald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027
   Guo JH, 2011, CANCER RES, V71, P2978, DOI 10.1158/0008-5472.CAN-10-3482
   Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911
   Hong YB, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-125
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Kasraie S, 2008, CELL MOL NEUROBIOL, V28, P933, DOI 10.1007/s10571-008-9261-6
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Khalil B, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2014.581
   Kim YK, 2015, DIABETOLOGIA, V58, P771, DOI 10.1007/s00125-015-3506-y
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Krishnan KJ, 2012, NEUROBIOL AGING, V33, P2210, DOI 10.1016/j.neurobiolaging.2011.08.009
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lakshmanan LN, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12814
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200
   Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011
   Lim JA, 2015, AUTOPHAGY, V11, P385, DOI 10.1080/15548627.2015.1009779
   Liou CW, 2016, EUR J NEUROL, V23, P1289, DOI 10.1111/ene.13020
   Marin S, 2003, FEBS LETT, V554, P342, DOI 10.1016/S0014-5793(03)01185-2
   Maruszak A, 2011, J ALZHEIMERS DIS, V27, P197, DOI 10.3233/JAD-2011-110710
   Mehta P, 2009, MOVEMENT DISORD, V24, P290, DOI 10.1002/mds.22389
   Mena NP, 2015, MITOCHONDRION, V21, P92, DOI 10.1016/j.mito.2015.02.001
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Morozova KN, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0204735
   Mousavizadeh K, 2015, MITOCHONDR DNA, V26, P579, DOI 10.3109/19401736.2013.878902
   Myhill S, 2009, INT J CLIN EXP MED, V2, P1
   Naing A, 2014, J DIABETES COMPLICAT, V28, P542, DOI 10.1016/j.jdiacomp.2014.03.006
   Neuhaus JFG, 2017, NEUROENDOCRINOLOGY, V104, P72, DOI 10.1159/000444680
   Nie HR, 2016, MITOCHONDRION, V26, P104, DOI 10.1016/j.mito.2015.12.001
   Niemann J, 2017, FREE RADICAL BIO MED, V102, P174, DOI 10.1016/j.freeradbiomed.2016.11.035
   Onyango IG, 2016, AGING DIS, V7, P201, DOI 10.14336/AD.2015.1007
   OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453
   Parra V, 2014, DIABETES, V63, P75, DOI 10.2337/db13-0340
   Petersen MH, 2014, MITOCHONDRION, V17, P14, DOI 10.1016/j.mito.2014.05.001
   Poewe W, 2017, NAT REV DIS PRIMERS, V3, P0, DOI 10.1038/nrdp.2017.13
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Poovathingal SK, 2012, BIOGERONTOLOGY, V13, P557, DOI 10.1007/s10522-012-9390-7
   Purevsuren J, 2009, MOL GENET METAB, V98, P372, DOI 10.1016/j.ymgme.2009.07.011
   Rana A, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00525-4
   Reddy PH, 2004, HUM MOL GENET, V13, P1225, DOI 10.1093/hmg/ddh140
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Sanders LH, 2014, NEUROBIOL DIS, V70, P214, DOI 10.1016/j.nbd.2014.06.014
   Santoro A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012037
   Schulte Joost, 2011, CURR TRENDS NEUROL, V5, P65
   Sender R, 2016, PLOS BIOL, V14, P0, DOI 10.1371/journal.pbio.1002533
   Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013
   Shiba-Fukushima K, 2017, HUM MOL GENET, V26, P3172, DOI 10.1093/hmg/ddx201
   Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024
   Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Slone J, 2017, J MOL GENET MED, V11, P0, DOI 10.4172/1747-0862.1000258
   Slone J, 2018, J HUM GENET, V63, P1211, DOI 10.1038/s10038-018-0515-y
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Song LY, 2017, NEUROBIOL DIS, V100, P30, DOI 10.1016/j.nbd.2016.12.024
   Stadler K, 2015, CURR DIABETES REP, V15, P0, DOI 10.1007/s11892-015-0611-8
   Swerdlow RH, 2018, J ALZHEIMERS DIS, V62, P1403, DOI 10.3233/JAD-170585
   Szklarczyk R, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0439
   Tanaka N, 2010, MITOCHONDRION, V10, P32, DOI 10.1016/j.mito.2009.08.008
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Tranah GJ, 2012, J ALZHEIMERS DIS, V32, P357, DOI 10.3233/JAD-2012-120466
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Weber DD, 2018, AGING-US, V10, P164, DOI 10.18632/aging.101382
   Zhang BF, 2015, BIOMATERIALS, V61, P178, DOI 10.1016/j.biomaterials.2015.05.027
   Zhou J, 2017, AGING-US, V9, P583, DOI 10.18632/aging.101181
   Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004
NR 106
TC 61
Z9 68
U1 0
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD JUN 15
PY 2019
VL 8
IS 6
BP 
EP 
DI 10.3390/cells8060608
PG 21
WC Cell Biology
SC Cell Biology
GA II6MY
UT WOS:000475309200096
PM 31216686
DA 2024-11-01
ER

PT J
AU Gagliardi, D
   Mauri, E
   Magri, F
   Velardo, D
   Meneri, M
   Abati, E
   Brusa, R
   Faravelli, I
   Piga, D
   Ronchi, D
   Triulzi, F
   Peverelli, L
   Sciacco, M
   Bresolin, N
   Comi, GP
   Corti, S
   Govoni, A
AF Gagliardi, Delia
   Mauri, Eleonora
   Magri, Francesca
   Velardo, Daniele
   Meneri, Megi
   Abati, Elena
   Brusa, Roberta
   Faravelli, Irene
   Piga, Daniela
   Ronchi, Dario
   Triulzi, Fabio
   Peverelli, Lorenzo
   Sciacco, Monica
   Bresolin, Nereo
   Comi, Giacomo Pietro
   Corti, Stefania
   Govoni, Alessandra
TI Can Intestinal Pseudo-Obstruction Drive Recurrent Stroke-Like Episodes in Late-Onset MELAS Syndrome? A Case Report and Review of the Literature
SO FRONTIERS IN NEUROLOGY
LA English
DT Review
DE MELAS; mitochondrial disorders; intestinal pseudo-obstruction; stroke-like episodes; gastrointestinal disturbance
ID lactic-acidosis; mitochondrial myopathy; encephalopathy; involvement; features
AB Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a maternally inherited mitochondrial disorder that is most commonly caused by the m. 3243A>G mutation in the MT-TL1 mitochondrial DNA gene, resulting in impairment of mitochondrial energy metabolism. Although childhood is the typical age of onset, a small fraction (1-6%) of individuals manifest the disease after 40 years of age and usually have a less aggressive disease course. The clinicalmanifestations are variable and mainly depend on the degree of heteroplasmy in the patient's tissues and organs. They include muscle weakness, diabetes, lactic acidemia, gastrointestinal disturbances, and stroke-like episodes, which are the most commonly observed symptom. We describe the case of a 50-year-old male patient who presented with relapsing intestinal pseudo-obstruction (IPO) episodes, which led to a late diagnosis of MELAS. After diagnosis, he presented several stroke-like episodes in a short time period and developed a rapidly progressive cognitive decline, which unfortunately resulted in his death. We describe the variable clinical manifestations of MELAS syndrome in this atypical and relatively old patient, with a focus on paralytic ileus and stroke-like episodes; the first symptom may have driven the others, leading to a relentless decline. Moreover, we provide a brief revision of previous reports of IPO occurrence in MELAS patients with the m. 3243A>G mutation, and we investigate its relationship with stroke-like episodes. Our findings underscore the importance of recognizing gastrointestinal disturbance to prevent neurological comorbidities.
C1 [Gagliardi, Delia; Mauri, Eleonora; Magri, Francesca; Abati, Elena; Brusa, Roberta; Faravelli, Irene; Ronchi, Dario; Bresolin, Nereo; Comi, Giacomo Pietro; Corti, Stefania] Univ Milan, Neurosci Sect, Dept Pathophysiol & Transplantat DEPT, Dino Ferrari Ctr, Milan, Italy.
   [Velardo, Daniele; Meneri, Megi; Piga, Daniela; Bresolin, Nereo; Comi, Giacomo Pietro; Corti, Stefania; Govoni, Alessandra] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
   [Triulzi, Fabio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuroradiol Unit, Milan, Italy.
   [Peverelli, Lorenzo; Sciacco, Monica] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neurosci, Neuromuscular & Rare Dis Unit, Milan, Italy.
   [Corti, Stefania; Govoni, Alessandra] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat DEPT, Neurol Unit,Neurosci Sect,Dino Ferrari Ctr, Milan, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan
RP Corti, S (corresponding author), Univ Milan, Neurosci Sect, Dept Pathophysiol & Transplantat DEPT, Dino Ferrari Ctr, Milan, Italy.; Corti, S; Govoni, A (corresponding author), IRCCS Fdn Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.; Corti, S; Govoni, A (corresponding author), Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat DEPT, Neurol Unit,Neurosci Sect,Dino Ferrari Ctr, Milan, Italy.
EM stefania.corti@unimi.it; alessandra.govoni@policlinico.mi.it
CR Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Chang TM, 2004, PEDIATR NEUROL, V31, P374, DOI 10.1016/j.pediatrneurol.2004.05.009
   Chiyonobu T, 2008, BRAIN DEV-JPN, V30, P430, DOI 10.1016/j.braindev.2007.12.006
   Downes TJ, 2018, J CLIN GASTROENTEROL, V52, P477, DOI 10.1097/MCG.0000000000001047
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fryer RH, 2016, PEDIATR NEUROL, V56, P59, DOI 10.1016/j.pediatrneurol.2015.12.010
   GarcÃ­a-Velasco A, 2003, J INTERN MED, V253, P381, DOI 10.1046/j.1365-2796.2003.01095.x
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Iida H, 2013, J EPIDEMIOL, V23, P288, DOI 10.2188/jea.JE20120173
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Muehlenberg K, 2002, DEUT MED WOCHENSCHR, V127, P611, DOI 10.1055/s-2002-22669
   Nakae Yoshiharu, 2007, RINSHO SHINKEIGAKU, V47, P177
   Ng YS, 2016, ANN NEUROL, V80, P686, DOI 10.1002/ana.24736
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Primiano G, 2014, NEUROLOGY, V82, P1932, DOI 10.1212/WNL.0000000000000458
   Seessle J, 2012, Z GASTROENTEROL, V50, P1161, DOI 10.1055/s-0032-1313125
   Sekino Y, 2012, WORLD J GASTROENTERO, V18, P4557, DOI 10.3748/wjg.v18.i33.4557
   Suzuki J, 2018, INTERNAL MED, V57, P771, DOI 10.2169/internalmedicine.9632-17
   Suzuki J, 2017, INTERNAL MED, V56, P1089, DOI 10.2169/internalmedicine.56.7753
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Walcott BP, 2012, NEUROLOGIST, V18, P159, DOI 10.1097/NRL.0b013e318247bcd8
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 24
TC 16
Z9 16
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD JAN 31
PY 2019
VL 10
IS 
BP 
EP 
DI 10.3389/fneur.2019.00038
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HJ7HX
UT WOS:000457368100002
PM 30766507
DA 2024-11-01
ER

PT J
AU Daher, R
   Mansouri, A
   Martelli, A
   Bayart, S
   Manceau, H
   Callebaut, I
   Moulouel, B
   Gouya, L
   Puy, H
   Kannengiesser, C
   Karim, Z
AF Daher, Raed
   Mansouri, Abdellah
   Martelli, Alain
   Bayart, Sophie
   Manceau, Hana
   Callebaut, Isabelle
   Moulouel, Boualem
   Gouya, Laurent
   Puy, Herve
   Kannengiesser, Caroline
   Karim, Zoubida
TI <i>GLRX5</i> mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE GLRX5; Sideroblastic anemia; Porphyrins; Mitochondria; Heme; Iron
ID hepatic mitochondrial-dna; monothiol glutaredoxins; gene; degradation; deficiency; deletions; clusters; myopathy; complex
AB Non-syndromic microcytic congenital sideroblastic anemia (cSA) is predominantly caused by defective genes encoding for either ALAS2, the first enzyme of heme biosynthesis pathway or SLC25A38, the mitochondrial importer of glycine, an ALAS2 substrate. Herein we explored a new case of cSA with two mutations in GLRX5, a gene for which only two patients have been reported so far. The patient was a young female with biallelic compound heterozygous mutations in GLRX5 (p.Cys67Tyr and p.Met128Lys). Three-D structure analysis confirmed the involvement of Cys67 in the coordination of the [2Fe-2S] cluster and suggested a potential role of Met128 in partner interactions. The protein-level of ferrochelatase, the terminal-enzyme of heme process, was increased both in patient-derived lymphoblastoid and CD34 + cells, however, its activity was drastically decreased. The activity of ALAS2 was found altered and possibly related to a defect in the biogenesis of its cosubstrate, the succinyl-CoA. Thus, the patient exhibits both a very low ferrochelatase activity without any accumulation of porphyrins precursors in contrast to what is reported in erythropoietic protoporphyria with solely impaired ferrochelatase activity. A significant oxidative stress was evidenced by decreased reduced glutathione and aconitase activity, and increased MnSOD protein expression. This oxidative stress depleted and damaged mtDNA, decreased complex I and IV activities and depleted ATP content. Collectively, our study demonstrates the key role of GLRX5 in modulating ALAS2 and ferrochelatase activities and in maintaining mitochondrial function.
C1 [Daher, Raed; Mansouri, Abdellah; Manceau, Hana; Gouya, Laurent; Puy, Herve; Kannengiesser, Caroline; Karim, Zoubida] INSERM, U1149, CRI, Paris, France.
   [Daher, Raed; Mansouri, Abdellah; Manceau, Hana; Gouya, Laurent; Puy, Herve; Kannengiesser, Caroline; Karim, Zoubida] Univ Paris Diderot, Sorbonne Paris Cite, DHU UNITY, Site Bichat, Paris, France.
   [Daher, Raed; Manceau, Hana; Gouya, Laurent; Puy, Herve; Kannengiesser, Caroline; Karim, Zoubida] Lab Excellence GR Ex, Paris, France.
   [Martelli, Alain] Dept Translat Med & Neurogenet, Illkirch Graffenstaden, France.
   [Bayart, Sophie] CHU Rennes, Hop Sud, Dept Pediat Hematol, Rennes, France.
   [Callebaut, Isabelle] Univ Pierre & Marie Curie Paris6, Sorbonne Univ, CNRS, UMR7590,MNHN,IRD,IUC, Paris, France.
   [Daher, Raed; Moulouel, Boualem; Gouya, Laurent; Puy, Herve] Hop Louis Mourier, AP HP, CFP, Colombes, France.
   [Daher, Raed; Kannengiesser, Caroline] Hop Bichat Claude Bernard, AP HP, Dept Genet, Paris, France.
   [Martelli, Alain] Pfizer Inc, Rare Dis Res Unit, Cambridge, MA USA.
C3 Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Universite de Rennes; CHU Rennes; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Museum National d'Histoire Naturelle (MNHN); Institut de Recherche pour le Developpement (IRD); Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Bichat-Claude Bernard - APHP; Pfizer
RP Puy, H; Karim, Z (corresponding author), INSERM, U1149, CRI, Paris, France.
EM herve.puy@aphp.fr; Zoubida.karim@inserm.fr
FU INSEAM; Paris Diderot University, France; Laboratory of excellence GR-Ex, Paris, France [ANR-11-LABX-0051]; program "Investissements d'avenir " of the French National Research Agency [ANR-11-IDEX-0005-02]
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Baker PR, 2014, BRAIN, V137, P366, DOI 10.1093/brain/awt328
   Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50
   Bekri S, 2000, BLOOD, V96, P3256
   Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Camaschella C, 2008, BRIT J HAEMATOL, V143, P27, DOI 10.1111/j.1365-2141.2008.07290.x
   Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520
   Cazzola M, 2003, BLOOD, V101, P1996, DOI 10.1182/blood-2002-07-2006
   Cazzola M, 2015, HEMATOL-AM SOC HEMAT, V0, PP19, DOI 10.1182/asheducation-2015.1.19
   Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370
   Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954
   Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1
   Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359
   HOLMGREN A, 1989, J BIOL CHEM, V264, P13963
   Johansson C, 2011, BIOCHEM J, V433, P303, DOI 10.1042/BJ20101286
   Kannengiesser C, 2011, HAEMATOL-HEMATOL J, V96, P808, DOI 10.3324/haematol.2010.039164
   Karim Z, 2015, CLIN RES HEPATOL GAS, V39, P412, DOI 10.1016/j.clinre.2015.05.009
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lichtenstein DA, 2016, BLOOD, V128, P1913, DOI 10.1182/blood-2016-05-719062
   Liu G, 2016, J CELL BIOCHEM, V117, P207, DOI 10.1002/jcb.25267
   Liu G, 2014, BLOOD, V124, P2750, DOI 10.1182/blood-2014-08-598508
   Mansouri A, 1999, GASTROENTEROLOGY, V117, P181, DOI 10.1016/S0016-5085(99)70566-4
   Mansouri A, 1997, J HEPATOL, V27, P96, DOI 10.1016/S0168-8278(97)80286-3
   Marquet A, 2001, VITAM HORM, V61, P51
   Matthes T, 2006, EUR J HAEMATOL, V77, P169, DOI 10.1111/j.1600-0609.2006.00674.x
   Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n
   MÃ¼hlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446
   Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5
   Ricketts CJ, 2006, ACTA PAEDIATR, V95, P99, DOI 10.1080/08035250500323715
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Robin MA, 2005, HEPATOLOGY, V42, P1280, DOI 10.1002/hep.20949
   RodrÃ­guez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517
   Schmitz-Abe K, 2015, BLOOD, V126, P2734, DOI 10.1182/blood-2015-09-659854
   Vilella F, 2004, COMP FUNCT GENOM, V5, P328, DOI 10.1002/cfg.406
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Walter PB, 2002, P NATL ACAD SCI USA, V99, P2264, DOI 10.1073/pnas.261708798
   Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003
   Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887
   Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372
NR 40
TC 22
Z9 22
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD NOV 15
PY 2019
VL 128
IS 3
BP 342
EP 351
DI 10.1016/j.ymgme.2018.12.012
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA JY4EK
UT WOS:000504369700022
PM 30660387
DA 2024-11-01
ER

PT J
AU YalcouyÃ©, A
   Diallo, SH
   Coulibaly, T
   CissÃ©, L
   Diallo, S
   SamassÃ©kou, O
   Diarra, S
   Coulibaly, D
   Keita, M
   Guinto, CO
   Fischbeck, K
   LandourÃ©, G
AF Yalcouye, Abdoulaye
   Diallo, Seybou H.
   Coulibaly, Thomas
   Cisse, Lassana
   Diallo, Salimata
   Samassekou, Oumar
   Diarra, Salimata
   Coulibaly, Dramane
   Keita, Mohamed
   Guinto, Cheick O.
   Fischbeck, Kenneth
   Landoure, Guida
TI A novel mutation in the <i>GARS</i> gene in a Malian family with Charcot-Marie-Tooth disease
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE CMT; CMT2D; GARS; Mali; novel mutation
AB Background Charcot-Marie-Tooth (CMT) disease is a very heterogeneous neurological condition with more than 90 reported genetic entities. It is the most common inherited peripheral neuropathy; however, cases are rarely reported in sub-Saharan Africa. In addition, only few families, mostly of Caucasian ancestry, have been reported to have Charcot-Marie-Tooth disease type 2D (CMT2D) mutations. To date no case of CMT2D was reported in Africa. We present here a consanguineous family with CMT phenotype in which a novel mutation in the GARS (glycyl-tRNA synthetase) gene was identified. Methods Patients were examined thoroughly and nerve conduction studies (NCS) were performed. DNA from the proband was used for CMT gene panel testing (including 50 genes, PMP22 duplication and mtDNA). Putative mutations were verified in all available family members to check for segregation. Results Two individuals, a male and a female, were found to be affected. Symptoms started in their teenage years with muscle weakness and atrophy in hands. Later, distal involvement of the lower limbs was noticed. Patients complained of minor sensory impairment. NCS showed no response in the upper as well as the lower limbs. Genetic testing surprisingly identified a novel heterozygous missense mutation c.794C>A (p.Ser265Tyr) in the GARS gene associated with CMT2D. This variant segregated with the disease in the family and was also seen in the mother who presented no symptoms. Conclusion This is the first report of a genetically confirmed CMT2D case in Africa, expanding its genetic epidemiology. Increasing access to genetic testing may reveal more novel CMT variants or genes in the African population that could be relevant to other populations and further our understanding of their mechanism.
C1 [Yalcouye, Abdoulaye; Diallo, Seybou H.; Coulibaly, Thomas; Samassekou, Oumar; Diarra, Salimata; Keita, Mohamed; Guinto, Cheick O.; Landoure, Guida] USTTB, Fac Med & Odontostomatol, BP 1805, Bamako, Mali.
   [Diallo, Seybou H.; Diallo, Salimata] Ctr Hosp Univ Gabriel Toure, Serv Neurol, Bamako, Mali.
   [Coulibaly, Thomas; Cisse, Lassana; Guinto, Cheick O.; Landoure, Guida] Ctr Hosp Univ Point G, Serv Neurol, Bamako, Mali.
   [Diarra, Salimata; Fischbeck, Kenneth; Landoure, Guida] NINDS, Neurogenet Branch, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
   [Coulibaly, Dramane] Ctr Hosp Univ Mere Enfant Luxembourg, Serv Med, Bamako, Mali.
   [Keita, Mohamed] Ctr Hosp Univ Gabriel Toure, Serv ORL, Bamako, Mali.
C3 University of Science & Technology of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)
RP LandourÃ©, G (corresponding author), USTTB, Fac Med & Odontostomatol, BP 1805, Bamako, Mali.
EM guida@icermali.org
FU National Institutes of Neurological Disorders and Stroke, H3 Africa Initiative [U01HG007044]; National Institutes of Neurological Disorders and Stroke [NS00297]
CR Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039
   Dubourg O, 2006, NEUROLOGY, V66, P1721, DOI 10.1212/01.wnl.0000218304.02715.04
   Griffin LB, 2014, HUM MUTAT, V35, P1363, DOI 10.1002/humu.22681
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Lee HJ, 2012, J PERIPHER NERV SYST, V17, P418, DOI 10.1111/j.1529-8027.2012.00442.x
   Liao YC, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0133423
   Motley WW, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002399
   Rohkamm B, 2007, J NEUROL SCI, V263, P100, DOI 10.1016/j.jns.2007.06.047
   Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590
   Sleigh JN, 2017, P NATL ACAD SCI USA, V114, PE3324, DOI 10.1073/pnas.1614557114
NR 10
TC 10
Z9 12
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
EI 
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD JUL 15
PY 2019
VL 7
IS 7
BP 
EP 
DI 10.1002/mgg3.782
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA IJ1RC
UT WOS:000475675000021
PM 31173493
DA 2024-11-01
ER

PT J
AU Ozawa, K
   Mochizuki, K
   Manabe, Y
   Yoshikura, N
   Shimohata, T
   Nishino, I
   Goto, Y
AF Ozawa, Kenji
   Mochizuki, Kiyofumi
   Manabe, Yusuke
   Yoshikura, Nobuaki
   Shimohata, Takayoshi
   Nishino, Ichizo
   Goto, Yu-ichi
TI Retinal dystrophy associated with a single-base deletion mutation in mitochondrial DNA 3271 in patient with MELAS syndrome
SO DOCUMENTA OPHTHALMOLOGICA
LA English
DT Article
DE Mitochondrial DNA; 3271; MELAS; M; 3271delT; Retinopathy
ID stroke-like episodes; lactic-acidosis; iscev standard; encephalopathy; retinopathy; myopathy
AB PurposeMitochondrial encephalopathy with lactic acid and stroke-like episodes (MELAS) is caused by mutations in the mitochondrial DNA. Approximately 80% of MELAS patients have an A>G transition mutation at nucleotide pair 3243 in the mitochondrial DNA, m.3243A>G. There are also MELAS patients with a one-base deletion at nucleotide pair 3271 in the mitochondrial DNA, m.3271delT, but these cases are very rare. We report a case of MELAS with the m.3271delT and describe the retinal structure and electrophysiological alterations.MethodsThe retinal structure and function of a 37-year-old woman who was referred to our clinic for of nyctalopia were studied. Standard ophthalmological examinations including the medical history, measurements of the best-corrected visual acuity, intraocular pressures, and slit-lamp biomicroscopy, ophthalmoscopy, fluorescein angiography, fundus autofluorescence, spectral-domain optical coherence tomography (SD-OCT), full-field electroretinography (ERG), and multifocal electroretinography (mfERG) were performed.ResultsFundus examination showed bilateral hypopigmentary changes of the retinal pigment epithelium which extended from the posterior pole to the equator. Fluorescein angiography showed patchy hyperfluorescence due to window defects at the atrophic areas. Fundus autofluorescence demonstrated mild hyperfluorescent lesions in both eyes. SD-OCT showed that the interdigitation zone was indistinct in both eyes, and the inner nuclear layer was slightly thinner. The amplitudes of the rod, cone, and 30-Hz flicker ERGs were severely reduced, and the implicit times were prolonged. The a- and b-waves of the bright-flash mixed rod-cone ERGs were also reduced. The dark-adapted oscillatory potentials were reduced. The amplitudes of the mfERGs were severely depressed except at the fovea in both eyes.ConclusionsThese findings indicate that the RPE atrophy was wider and the rod dysfunction was more severe affected than that of previously reported MELAS cases with the m.3243A>G mutation.
C1 [Ozawa, Kenji; Mochizuki, Kiyofumi; Manabe, Yusuke] Gifu Univ, Dept Ophthalmol, Grad Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.
   [Yoshikura, Nobuaki; Shimohata, Takayoshi] Gifu Univ, Dept Neurol & Geriatr, Grad Sch Med, Gifu, Japan.
   [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurol & Psychiat, Dept Neuromuscular Res, Tokyo, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurol & Psychiat, Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Tokyo, Japan.
C3 Gifu University; Gifu University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan
RP Ozawa, K (corresponding author), Gifu Univ, Dept Ophthalmol, Grad Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.
EM kj-ozawa@umin.ac.jp
FU Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [29-4]
CR Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004
   Bellmann C, 2004, INVEST OPHTH VIS SCI, V45, P2355, DOI 10.1167/iovs.03-1090
   BRESNICK GH, 1984, ARCH OPHTHALMOL-CHIC, V102, P1307, DOI 10.1001/archopht.1984.01040031057023
   BRESNICK GH, 1987, ARCH OPHTHALMOL-CHIC, V105, P929, DOI 10.1001/archopht.1987.01060070065030
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hood DC, 2012, DOC OPHTHALMOL, V124, P1, DOI 10.1007/s10633-011-9296-8
   Hori N, 2012, DOC OPHTHALMOL, V125, P235, DOI 10.1007/s10633-012-9351-0
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Latvala T, 2002, GRAEF ARCH CLIN EXP, V240, P795, DOI 10.1007/s00417-002-0555-y
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   SAKUTA R, 1993, J NEUROL SCI, V115, P158, DOI 10.1016/0022-510X(93)90219-O
   Shinmei Y, 2007, J NEURO-OPHTHALMOL, V27, P22, DOI 10.1097/WNO.0b013e3180334cb0
   SHOFFNER JM, 1995, NEUROLOGY, V45, P286, DOI 10.1212/WNL.45.2.286
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   YONEMURA D, 1962, ARCH OPHTHALMOL-CHIC, V68, P19
NR 22
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0012-4486
EI 1573-2622
J9 DOC OPHTHALMOL
JI Doc. Ophthalmol.
PD APR 15
PY 2019
VL 138
IS 2
BP 147
EP 152
DI 10.1007/s10633-019-09673-y
PG 6
WC Ophthalmology
SC Ophthalmology
GA HP0QA
UT WOS:000461369500007
PM 30701423
DA 2024-11-01
ER

PT J
AU Ross, JM
   Coppotelli, G
   Branca, RM
   Kim, KM
   LehtiÃ¶, J
   Sinclair, DA
   Olson, L
AF Ross, Jaime M.
   Coppotelli, Giuseppe
   Branca, Rui M.
   Kim, Kyung M.
   Lehtio, Janne
   Sinclair, David A.
   Olson, Lars
TI Voluntary exercise normalizes the proteomic landscape in muscle and brain and improves the phenotype of progeroid mice
SO AGING CELL
LA English
DT Article
DE aging; exercise; mitochondria; mtDNA; PolG; proteomics
ID mitochondrial-dna mutations; neurons
AB The accumulation of mitochondrial DNA (mtDNA) mutations is a suspected driver of aging and age-related diseases, but forestalling these changes has been a major challenge. One of the best-studied models is the prematurely aging mtDNA mutator mouse, which carries a homozygous knock-in of a proofreading deficient version of the catalytic subunit of mtDNA polymerase-gamma (PolgA). We investigated how voluntary exercise affects the progression of aging phenotypes in this mouse, focusing on mitochondrial and protein homeostasis in both brain and peripheral tissues. Voluntary exercise significantly ameliorated several aspects of the premature aging phenotype, including decreased locomotor activity, alopecia, and kyphosis, but did not have major effects on the decreased lifespan of mtDNA mutator mice. Exercise also decreased the mtDNA mutation load. In-depth tissue proteomics revealed that exercise normalized the levels of about half the proteins, with the majority involved in mitochondrial function and nuclear-mitochondrial crosstalk. There was also a specific increase in the nuclear-encoded proteins needed for the tricarboxylic acid cycle and complex II, but not in mitochondrial-encoded oxidative phosphorylation proteins, as well as normalization of enzymes involved in coenzyme Q biosynthesis. Furthermore, we found tissue-specific alterations, with brain coping better as compared to muscle and with motor cortex being better protected than striatum, in response to mitochondrial dysfunction. We conclude that voluntary exercise counteracts aging in mtDNA mutator mice by counteracting protein dysregulation in muscle and brain, decreasing the mtDNA mutation burden in muscle, and delaying overt aging phenotypes.
C1 [Ross, Jaime M.; Coppotelli, Giuseppe; Olson, Lars] Karolinska Inst, Dept Neurosci, Biomed, Stockholm, Sweden.
   [Ross, Jaime M.; Coppotelli, Giuseppe; Kim, Kyung M.; Sinclair, David A.] Harvard Med Sch, Blavatn Inst, Dept Genet, Paul F Glenn Ctr Biol Aging Res, Boston, MA 02115 USA.
   [Branca, Rui M.; Lehtio, Janne] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden.
C3 Karolinska Institutet; Harvard University; Harvard Medical School; Karolinska Institutet
RP Ross, JM; Coppotelli, G (corresponding author), Karolinska Inst, Dept Neurosci, Biomed, Stockholm, Sweden.
EM Jaime.Ross@ki.se; Giuseppe_Coppotelli@hms.harvard.edu
FU National Institute on Aging [K99AG055683]; Radiumhemmets Forskningsfonder; Stiftelsen for Strategisk Forskning; Barncancerfonden; Swedish Brain Power; Hjarnfonden; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Loo och Hans Ostermans Stiftelse for Medicinsk Forskning; FP7 Ideas: European Research Council [322744]; Svenska Sallskapet for Medicinsk Forskning; Karolinska Institutet; Swedish Research Council [537-2014-6856, 2015-04622, K2012-62X-03185-42-4]; Swedish Cancer Society; Swedish Lundbeck Foundation; Glenn Foundation for Medical Research; National Institutes of Health [R37AG028730, R01DK100263]; Harvard Brain Science Initiative Bipolar Disorder Seed Grant; Swedish Research Council [2015-04622] Funding Source: Swedish Research Council
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bereczki E, 2018, BRAIN, V141, P582, DOI 10.1093/brain/awx352
   Brustovetsky N, 2003, J NEUROSCI, V23, P4858
   Carbon S, 2019, NUCLEIC ACIDS RES, V47, PD330, DOI 10.1093/nar/gky1055
   Chen YH, 2019, J NEUROCHEM, V150, P56, DOI 10.1111/jnc.14702
   Clark-Matott J, 2015, NEUROBIOL AGING, V36, P2972, DOI 10.1016/j.neurobiolaging.2015.07.020
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, PG914, DOI 10.1152/ajpgi.00402.2011
   Huang J, 2016, MEDICINE, V95, P0, DOI 10.1097/MD.0000000000003323
   Jensen J, 2011, FRONT PHYSIOL, V2, P0, DOI 10.3389/fphys.2011.00112
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kelly SA, 2016, PHYSL REP, V4, P21
   KÃ¼hl I, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.30952
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Memon Ashfaque A, 2017, BIOMOL DETECT QUANTIF, V13, P32, DOI 10.1016/j.bdq.2017.08.001
   Oliveira JMA, 2009, J BIOL CHEM, V284, P5010, DOI 10.1074/jbc.M807459200
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Reiner M, 2013, BMC PUBLIC HEALTH, V13, P0, DOI 10.1186/1471-2458-13-813
   Ross JM, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Ross JM, 2011, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/3266
   Roxas BAP, 2008, BMC BIOINFORMATICS, V9, P0, DOI 10.1186/1471-2105-9-187
   Safdar A, 2016, SKELET MUSCLE, V6, P0, DOI 10.1186/s13395-016-0075-9
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sandberg A, 2012, MOL CELL PROTEOMICS, V11, P0, DOI 10.1074/mcp.M112.016998
   Sasaki H, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep27607
   Savitski MM, 2015, MOL CELL PROTEOMICS, V14, P2394, DOI 10.1074/mcp.M114.046995
   Shabalina IG, 2017, AGING-US, V9, P315, DOI 10.18632/aging.101174
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Someya S, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0171159
   Suwa M, 2016, INT J SPORTS MED, V37, P483, DOI 10.1055/s-0042-101412
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, PD447, DOI 10.1093/nar/gku1003
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wall CE, 2015, P NATL ACAD SCI USA, V112, P8714, DOI 10.1073/pnas.1509930112
   Wang J, 2013, NUCLEIC ACIDS RES, V41, PW77, DOI 10.1093/nar/gkt439
   Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI 10.1038/NMETH.1322
NR 39
TC 21
Z9 23
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD DEC 15
PY 2019
VL 18
IS 6
BP 
EP 
DI 10.1111/acel.13029
EA SEP 2019
PG 16
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA JJ8VY
UT WOS:000485670500001
PM 31489782
DA 2024-11-01
ER

PT J
AU Maffezzini, C
   Laine, I
   Dallabona, C
   Clemente, P
   Calvo-Garrido, J
   Wibom, R
   Naess, K
   Barbaro, M
   Falk, A
   Donnini, C
   Freyer, C
   Wredenberg, A
   Wedell, A
AF Maffezzini, Camilla
   Laine, Isabelle
   Dallabona, Cristina
   Clemente, Paula
   Calvo-Garrido, Javier
   Wibom, Rolf
   Naess, Karin
   Barbaro, Michela
   Falk, Anna
   Donnini, Claudia
   Freyer, Christoph
   Wredenberg, Anna
   Wedell, Anna
TI Mutations in the mitochondrial tryptophanyl-tRNA synthetase cause growth retardation and progressive leukoencephalopathy
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE aminoacylation; mitochondria; mitochondrial tryptophanyl-tRNA synthetase; WARS2
ID biallelic mutations; lactic-acidosis; brain-stem; human es; deficiency; wars2; involvement; variants; lars2; lead
AB BackgroundMutations in mitochondrial aminoacyl tRNA synthetases form a subgroup of mitochondrial disorders often only perturbing brain function by affecting mitochondrial translation. Here we report two siblings with mitochondrial disease, due to compound heterozygous mutations in the mitochondrial tryptophanyl-tRNA synthetase (WARS2) gene, presenting with severe neurological symptoms but normal mitochondrial function in skeletal muscle biopsies and cultured skin fibroblasts. MethodsWhole exome sequencing on genomic DNA samples from both subjects and their parents identified two compound heterozygous variants c.833T>G (p.Val278Gly) and c.938A>T (p.Lys313Met) in the WARS2 gene as potential disease-causing variants. We generated patient-derived neuroepithelial stem cells and modeled the disease in yeast and Drosophila melanogaster to confirm pathogenicity. ResultsBiochemical analysis of patient-derived neuroepithelial stem cells revealed a mild combined complex I and IV defect, while modeling the disease in yeast demonstrated that the reported aminoacylation defect severely affects respiration and viability. Furthermore, silencing of wild type WARS2 in Drosophila melanogaster showed that a partial defect in aminoacylation is enough to cause lethality. ConclusionsOur results establish the identified WARS2 variants as disease-causing and highlight the benefit of including human neuronal models, when investigating mutations specifically affecting the nervous system.
C1 [Maffezzini, Camilla; Laine, Isabelle; Clemente, Paula; Calvo-Garrido, Javier; Freyer, Christoph; Wredenberg, Anna; Wedell, Anna] Karolinska Inst Lab, Max Planck Inst Biol Ageing, Stockholm, Sweden.
   [Maffezzini, Camilla; Laine, Isabelle; Clemente, Paula; Wibom, Rolf; Naess, Karin; Freyer, Christoph; Wredenberg, Anna] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.
   [Dallabona, Cristina; Donnini, Claudia] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy.
   [Calvo-Garrido, Javier; Barbaro, Michela; Wedell, Anna] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
   [Wibom, Rolf; Naess, Karin; Barbaro, Michela; Freyer, Christoph; Wredenberg, Anna; Wedell, Anna] Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden.
   [Falk, Anna] Karolinska Inst, Dept Neurosci, Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska Institutet; University of Parma; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet
RP Freyer, C; Wredenberg, A; Wedell, A (corresponding author), Karolinska Inst Lab, Max Planck Inst Biol Ageing, Stockholm, Sweden.
EM christoph.freyer@ki.se; anna.wredenberg@ki.se; anna.wedell@ki.se
FU Vetenskapsradet [2016-01082, 2016-02179, VR521-201-2571]; Hjarnfonden [FO2015-0146]; Knut och Alice Wallenbergs Stiftelse [2013.0026, 2014.0293]; Stockholms Lans Landsting [20140053, K0176-2012]; Stiftelsen for Strategisk Forskning [ICA 12-0017]; Fondazione Telethon [GGP15041]; Ragnar Soderbergs stiftelse [M77/13]; Swedish Research Council [2016-01082, 2016-02179, VR521-201-2571]; Stockholm County Council [20140053, K0176-2012]; Swedish Foundation for Strategic Research [0026, 0293]; Brain Foundation [FO2015-0146, GGP15041, M77, 13]; Telethon Foundation; Karolinska Institutet; Swedish Research Council [2016-02179, 2016-01082] Funding Source: Swedish Research Council
CR Adzhubei Ivan, 2013, CURR PROTOC HUM GENET, VChapter 7, P0, DOI 10.1002/0471142905.hg0720s76
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   Bayat V, 2012, PLOS BIOL, V10, P0, DOI 10.1371/journal.pbio.1001288
   BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609
   Burke EA, 2018, CLIN GENET, V93, P712, DOI 10.1111/cge.13172
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Falk A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0029597
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13
   Guitart T, 2013, NUCLEIC ACIDS RES, V41, P6595, DOI 10.1093/nar/gkt402
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Kele M, 2016, STEM CELL RES, V17, P474, DOI 10.1016/j.scr.2016.09.028
   Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017
   Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005
   Meiklejohn CD, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003238
   Musante L, 2017, HUM MUTAT, V38, P621, DOI 10.1002/humu.23205
   MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Perli E, 2016, HUM MOL GENET, V25, P903, DOI 10.1093/hmg/ddv619
   Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007
   Riley LG, 2016, JIMD REP, V28, P49, DOI 10.1007/8904_2015_515
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002
   Sommerville EW, 2017, JAMA NEUROL, V74, P686, DOI 10.1001/jamaneurol.2016.4357
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Stranneheim H, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-1090
   Theisen BE, 2017, AM J MED GENET A, V173, P2505, DOI 10.1002/ajmg.a.38339
   Uhlin E, 2017, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/56146
   van Berge L, 2013, BIOCHEM J, V450, P345, DOI 10.1042/BJ20121564
   Vantroys E, 2018, ORPHANET J RARE DIS, V13, P0, DOI 10.1186/s13023-018-0822-6
   WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310
   Wang Y, 2016, J BIOL CHEM, V291, P6507, DOI 10.1074/jbc.M115.700849
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
   Wortmann SB, 2017, HUM MUTAT, V38, P1786, DOI 10.1002/humu.23340
NR 40
TC 15
Z9 16
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
EI 
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD JUN 15
PY 2019
VL 7
IS 6
BP 
EP 
DI 10.1002/mgg3.654
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA IK7CE
UT WOS:000476745400006
PM 30920170
DA 2024-11-01
ER

PT J
AU Tarpey, MD
   Valencia, AP
   Jackson, KC
   Amorese, AJ
   Balestrieri, NP
   Renegar, RH
   Pratt, SJP
   Ryan, TE
   McClung, JM
   Lovering, RM
   Spangenburg, EE
AF Tarpey, Michael D.
   Valencia, Ana P.
   Jackson, Kathryn C.
   Amorese, Adam J.
   Balestrieri, Nicholas P.
   Renegar, Randall H.
   Pratt, Stephen J. P.
   Ryan, Terence E.
   McClung, Joseph M.
   Lovering, Richard M.
   Spangenburg, Espen E.
TI Induced <i>in vivo</i> knockdown of the <i>Brca1</i> gene in skeletal muscle results in skeletal muscle weakness
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Article
DE BRCA1; Skeletal muscle; kyphosis; Muscle physiology; mtDNA damage; Mitochondria
ID cancer susceptibility; oxidative stress; breast-cancer; transcriptional regulation; mitochondrial fission; dna-repair; cell-cycle; phosphorylation; mutations; expression
AB Recent evidence suggests that the breast cancer 1 early onset gene (BRCA1) influences numerous peripheral tissues, including skeletal muscle. The present study aimed to determine whether induced-loss of the breast cancer type 1 susceptibility protein (Brca1) alters skeletal muscle function. We induced genetic ablation of exon 11 in the Brca1 gene specifically in the skeletal muscle of adult mice to generate skeletal muscle-specific Brca1 homozygote knockout (Brca1KO(smi)) mice. Brca1KO(smi) exhibited kyphosis and decreased maximal isometric force in limb muscles compared to age-matched wild-type mice. Brca1KO(smi) skeletal muscle shifted toward an oxidative muscle fibre type and, in parallel, increased myofibre size and reduced capillary numbers. Unexpectedly, myofibre bundle mitochondrial respiration was reduced, whereas contraction-induced lactate production was elevated in Brca1KO(smi) muscle. Brca1KO(smi) mice accumulated mitochondrial DNA mutations and exhibited an altered mitochondrial morphology characterized by distorted and enlarged mitochondria, and these were more susceptible to swelling. In summary, skeletal muscle-specific loss of Brca1 leads to a myopathy and mitochondriopathy characterized by reductions in skeletal muscle quality and a consequent kyphosis. Given the substantial impact of BRCA1 mutations on cancer development risk in humans, a parallel loss of BRCA1 function in patient skeletal muscle cells would potentially result in implications for human health.
C1 [Tarpey, Michael D.; Amorese, Adam J.; Balestrieri, Nicholas P.; Ryan, Terence E.; McClung, Joseph M.; Spangenburg, Espen E.] East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27858 USA.
   [McClung, Joseph M.; Spangenburg, Espen E.] East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA.
   [Valencia, Ana P.; Jackson, Kathryn C.] Univ Maryland, Dept Kinesiol, Sch Publ Hlth, College Pk, MD 20742 USA.
   [Renegar, Randall H.] East Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27858 USA.
   [Pratt, Stephen J. P.; Lovering, Richard M.] Univ Maryland, Sch Med, Dept Orthoped, Baltimore, MD 21201 USA.
C3 University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University System of Maryland; University of Maryland College Park; University of North Carolina; East Carolina University; University System of Maryland; University of Maryland Baltimore
RP Spangenburg, EE (corresponding author), East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA.
EM spangenburge14@ecu.edu
FU National Institutes of Health [R01AR06660, R21AR059913, R01HL25695, R01AR059179, R21AR067872, F32HL129632]
CR [Anonymous], 2018, TISSUE EXPRESSION BR, V0, P0
   Arun B, 2015, INT J ONCOL, V47, P262, DOI 10.3892/ijo.2015.3003
   Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119
   Barton ER, 2008, MEASURING ISOMETRIC, V0, P1
   Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166
   Clark SL, 2012, COMPUT STRUCT BIOTEC, V1, P0, DOI 10.5936/csbj.201204005
   Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895
   Cousineau I, 2007, CELL CYCLE, V6, P962, DOI 10.4161/cc.6.8.4105
   Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010
   desVries RLA, 2012, AUTOPHAGY, V8, P699
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   Dulic A, 2001, BIOCHEMISTRY-US, V40, P5906, DOI 10.1021/bi002701e
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Freemont PS, 2000, CURR BIOL, V10, PR84, DOI 10.1016/S0960-9822(00)00287-6
   Godet Ines, 2017, INTEGR CANCER SCI THER, V4, P0, DOI 10.15761/ICST.1000228
   Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337
   Gouspillou G, 2018, J PHYSIOL-LONDON, V596, P2565, DOI 10.1113/JP275604
   Hennessy BTJ, 2010, J CLIN ONCOL, V28, P3570, DOI 10.1200/JCO.2009.27.2997
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Iyer SR, 2016, METHODS MOL BIOL, V1460, P293, DOI 10.1007/978-1-4939-3810-0_20
   Jackson KC, 2018, FASEB J, V32, P3070, DOI 10.1096/fj.201700464R
   Jackson KC, 2014, J LIPID RES, V55, P668, DOI 10.1194/jlr.M043851
   Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002
   Kim SS, 2004, MOL CELL BIOL, V24, P9498, DOI 10.1128/MCB.24.21.9498-9507.2004
   Konishi H, 2011, P NATL ACAD SCI USA, V108, P17773, DOI 10.1073/pnas.1110969108
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lark DS, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00332
   Lee WK, 2005, AM J PHYSIOL-CELL PH, V289, PC656, DOI 10.1152/ajpcell.00049.2005
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   Liu YL, 2002, BREAST CANCER RES, V4, P9, DOI 10.1186/bcr417
   Lovren F, 2014, J THORAC CARDIOV SUR, V147, P1946, DOI 10.1016/j.jtcvs.2013.09.060
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915
   Maniccia AW, 2009, J CELL PHYSIOL, V219, P634, DOI 10.1002/jcp.21708
   Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877
   Mehrgou Amir, 2016, MED J ISLAM REPUB IRAN, V30, P369
   Metter EJ, 2002, J GERONTOL A-BIOL, V57, PB359, DOI 10.1093/gerona/57.10.B359
   MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954
   Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200
   Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114
   Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200
   ORourke AR, 2018, FEBS J, V285, P481, DOI 10.1111/febs.14367
   Ortega FJ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0033233
   Otis JS, 2004, J APPL PHYSIOL, V96, P584, DOI 10.1152/japplphysiol.00724.2003
   Palmer CS, 2013, J BIOL CHEM, V288, P27584, DOI 10.1074/jbc.M113.479873
   Privat M, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0102438
   Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181
   Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398
   Ryan TE, 2016, DIABETES, V65, P2553, DOI 10.2337/db16-0387
   Saha T, 2010, J BIOL CHEM, V285, P19092, DOI 10.1074/jbc.M110.104430
   Saha T, 2009, FEBS LETT, V583, P1535, DOI 10.1016/j.febslet.2009.04.005
   Salem AF, 2012, CELL CYCLE, V11, P4167, DOI 10.4161/cc.22316
   Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Schmidt CA, 2017, J VASC SURG, V65, P1504, DOI 10.1016/j.jvs.2016.04.041
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Shukla PC, 2011, NAT COMMUN, V2, P0, DOI 10.1038/ncomms1601
   Silver DP, 2012, CANCER DISCOV, V2, P679, DOI 10.1158/2159-8290.CD-12-0221
   Singh KK, 2013, J THORAC CARDIOV SUR, V146, P949, DOI 10.1016/j.jtcvs.2012.12.064
   Spangenburg EE, 2008, J PHYSIOL-LONDON, V586, P283, DOI 10.1113/jphysiol.2007.141507
   Suberbielle E, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9897
   Szabo CI, 1996, HUM MOL GENET, V5, P1289, DOI 10.1093/hmg/5.9.1289
   Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   Wang Y, 2000, GENE DEV, V14, P927
   Williams RS, 2005, BIOCHEM CELL BIOL, V83, P721, DOI 10.1139/O05-153
   Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x
   Yoshikawa K, 1999, CLIN CANCER RES, V5, P1249
   Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753
NR 72
TC 10
Z9 12
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD FEB 1
PY 2019
VL 597
IS 3
BP 869
EP 887
DI 10.1113/JP276863
PG 19
WC Neurosciences; Physiology
SC Neurosciences & Neurology; Physiology
GA HJ8UJ
UT WOS:000457475300022
PM 30556208
DA 2024-11-01
ER

PT J
AU Daniels, EG
   Alders, M
   Lezzerini, M
   McDonald, A
   Peters, M
   Kuijpers, TW
   Lakeman, P
   Houtkooper, RH
   MacInnes, AW
AF Daniels, Eileen G.
   Alders, Marielle
   Lezzerini, Marco
   McDonald, Andrew
   Peters, Marjolein
   Kuijpers, Taco W.
   Lakeman, Phillis
   Houtkooper, Riekelt H.
   MacInnes, Alyson W.
TI A uniparental isodisomy event introducing homozygous pathogenic variants drives a multisystem metabolic disorder
SO COLD SPRING HARBOR MOLECULAR CASE STUDIES
LA English
DT Article
ID sideroblastic anemia-mlasa; mitochondrial myopathy; lactic-acidosis; missense mutation; p53; disomy; phosphofructokinase; susceptibility; cells; gene
AB Uniparental isodisomy (UPiD) is a rare genetic event that occurs when two identical copies of a single chromosome are inherited from one parent. Here we report a patient with a severe, multisystem metabolic disorder who inherited two copies of Chromosome 12 from her father. He was a heterozygous carrier of a variant in the muscle-specific enzyme 6-phosphofructokinase (PFKM) gene and of a truncating variant in the pseudouridine synthase 1 (PUS1) gene (both on Chromosome 12), resulting in a homozygous state of these mutations in his daughter. The PFKM gene functions in glycolysis and is linked to Tarui syndrome. The PUS1 gene functions in mitochondrial tRNA processing and is linked to myopathy, lactic acidosis, and sideroblastic anemia (MLASA). Analysis of human dermal fibroblasts, which do not express PFKM, revealed a loss of PUS1 mRNA and PUS1 protein only in the patient cells compared to healthy controls. The patient cells also revealed a reduction of the mitochondrial-encoded protein MTCO1, whereas levels of the nuclear-encoded SDHA remained unchanged, suggesting a specific impairment of mitochondrial translation. Further destabilization of these cells is suggested by the altered levels of BAX, BCL-2, and TP53 proteins, alterations that become augmented upon exposure of the cells to DNA damage. The results illustrate the efficacy of UPiD events to reveal rare pathogenic variants in human disease and demonstrate how these events can lead to cellular destabilization.
C1 [Daniels, Eileen G.; Lezzerini, Marco; McDonald, Andrew; Houtkooper, Riekelt H.; MacInnes, Alyson W.] Univ Amsterdam, Emma Childrens Hosp, Amsterdam Gastroenterol & Metab, Lab Genet Metab Dis,Amsterdam UMC, NL-1105 AZ Amsterdam, Netherlands.
   [Alders, Marielle; Lakeman, Phillis] Univ Amsterdam, Emma Childrens Hosp, Amsterdam UMC, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands.
   [Peters, Marjolein] Univ Amsterdam, Emma Childrens Hosp, Amsterdam UMC, Dept Pediat Hematol, NL-1105 AZ Amsterdam, Netherlands.
   [Kuijpers, Taco W.] Univ Amsterdam, Emma Childrens Hosp, Amsterdam UMC, Dept Pediat Hematol Immunol & Infect Dis, NL-1105 AZ Amsterdam, Netherlands.
   [MacInnes, Alyson W.] Philips Res, Dept Precis Diagnost, NL-5656 AE Eindhoven, Netherlands.
C3 University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Emma Children's Hospital; Emma Children's Hospital; University of Amsterdam; Philips; Philips Research
RP MacInnes, AW (corresponding author), Univ Amsterdam, Emma Childrens Hosp, Amsterdam Gastroenterol & Metab, Lab Genet Metab Dis,Amsterdam UMC, NL-1105 AZ Amsterdam, Netherlands.; MacInnes, AW (corresponding author), Philips Res, Dept Precis Diagnost, NL-5656 AE Eindhoven, Netherlands.
EM alyson.macinnes@philips.com
FU European Research Council (ERC) [638290]; Vidi grant from ZonMw [91715305]; Velux Stiftung [1063]; E-Rare-2, ERA-Net for Research on Rare Diseases ZonMw in the Netherlands [40-44000-98-1008]
CR Badhai J, 2009, BBA-MOL BASIS DIS, V1792, P1036, DOI 10.1016/j.bbadis.2009.08.002
   Balbeur S, 2016, CLIN CASE REP, V4, P265, DOI 10.1002/ccr3.501
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Campagnoli MF, 2008, HUM MUTAT, V29, P911, DOI 10.1002/humu.20752
   Cao M, 2016, NEUROGENETICS, V17, P65, DOI 10.1007/s10048-015-0465-x
   Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368
   Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290
   Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Fleming MD, 2011, HEMATOL-AM SOC HEMAT, V0, PP525, DOI 10.1182/asheducation-2011.1.525
   Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137
   INBAL A, 1995, AM J MED GENET, V55, P372, DOI 10.1002/ajmg.1320550325
   Kasapkara CS, 2017, TURK J HEMATOL, V34, P376, DOI 10.4274/tjh.2017.0231
   King DA, 2014, GENOME RES, V24, P673, DOI 10.1101/gr.160465.113
   Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883
   Liehr T, 2019, CASES UNIPARENTAL DI, V0, P0
   Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014
   Metodiev MD, 2015, EUR J HUM GENET, V23, P880, DOI 10.1038/ejhg.2014.192
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Pereboeva L, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0076473
   Perkins G, 2009, EXP NEUROL, V218, P183, DOI 10.1016/j.expneurol.2009.05.021
   RABEN N, 1995, HUM MUTAT, V6, P1, DOI 10.1002/humu.1380060102
   Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x
   Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Robinson WP, 2000, BIOESSAYS, V22, P452
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tesarova M, 2019, PEDIATR BLOOD CANCER, V66, P0, DOI 10.1002/pbc.27591
   Ulirsch JC, 2018, AM J HUM GENET, V103, P930, DOI 10.1016/j.ajhg.2018.10.027
   Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005
   VORA S, 1983, ISOZYMES-CURR T BIOL, V11, P3
   Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
   Zhou LY, 2008, J CELL SCI, V121, P2186, DOI 10.1242/jcs.024703
   Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987
NR 39
TC 2
Z9 2
U1 0
U2 2
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 2373-2873
EI 
J9 CSH MOL CASE STUD
JI Cold Spring Harb. Mol. Case Stud.
PD DEC 15
PY 2019
VL 5
IS 6
BP 
EP 
DI 10.1101/mcs.a004457
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA KJ8TM
UT WOS:000512328600007
PM 31653659
DA 2024-11-01
ER

PT J
AU Bardanzellu, F
   Pintus, MC
   Fanos, V
   Marcialis, MA
AF Bardanzellu, Flaminia
   Pintus, Maria Cristina
   Fanos, Vassilios
   Marcialis, Maria Antonietta
TI Once we were bacteria ... mitochondria to infinity and beyond
SO JOURNAL OF PEDIATRIC AND NEONATAL INDIVIDUALIZED MEDICINE
LA English
DT Review
DE Mitochondria; microbiota; mitobiota; stem cells; tunneling nanotubes
ID dna molecules; copy number; cell; methylation; health; life; restriction; replication; dysfunction; obesity
AB Mitochondria, cytoplasmic organelles originated from endosymbiotic bacteria, can be metaphorically described using "Janus bifrons" image, due to their involvement in life, providing cellular energy and resulting essential even for stem cells, but playing a key role also in cell death. Mitochondria own a maternally inherited genome and are the site of aerobic respiration; they can produce proteins, nucleotides, lipids, steroids and heme and result involved in iron homeostasis. Moreover, mitochondria can generate free radicals, break down waste products and represent the primary source of cellular heat. The size and shape of mitochondria depend on the intracellular metabolic status, from tubular presentation to a blob form in case of irreversible damage. Each mitochondrion carries different sets of DNA; when one set accumulates mutations, it can be replaced by another. It has been widely demonstrated that mitochondrial disorders are involved in many pathologies, including autism, multiple endocrinopathies, diabetes, Alzheimer's disease, ataxia, Barth's syndrome, myopathy, and even aging and cancer. Human population is characterized by different mitochondrial DNA haplogroups reflecting the mutations accumulated and useful to characterize genetic diversity. The mitochondrial role also results relevant in pregnancy, providing information about maternal-fetal dyad in physiological and in pathological conditions. Recent evidence suggests that an intriguing bidirectional inter-talk exists between microbiota and mitochondria, influencing cellular homeostasis and metabolism. A recently demonstrated mitochondrial property is the possibility to be transferred from a donor cell to a recipient cell, through a system of tunneling nanotubes. Recently, a promising integrated approach involving omics sophisticate technologies has been applied in mitochondrial pathophysiology. This is still at an early stage, and further studies will clarify such complex genotype-phenotype relationships. In conclusion, mitochondria are not simple energetic organelles but represent dynamic structures communicating with the cell nucleus and even with other cells, influencing metabolism and their targets' functions. More detailed knowledge of their involvement in disease, even though a combined omics approach, could represent a chance for new therapies.
C1 [Bardanzellu, Flaminia] AOU, Neonatal Pathol & Neonatal Sect, Neonatal Intens Care Unit, Cagliari, Italy.
   [Bardanzellu, Flaminia] Univ Cagliari, Cagliari, Italy.
C3 University of Cagliari
RP Bardanzellu, F (corresponding author), AOU, Neonatal Pathol & Neonatal Sect, Neonatal Intens Care Unit, Cagliari, Italy.; Bardanzellu, F (corresponding author), Univ Cagliari, Cagliari, Italy.
EM bardanzellu.flaminia@virgilio.it
CR Ahmad T, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2012.213
   Alexeyev M, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012641
   Altmann R, 1890, DIE ELEMENTARORGANISMEN UND IHRE BEZIEHUNGEN ZU DEN ZELLEN, V0, P145
   Anelli GM, 2017, J MATERN FETAL NEON, V0, P2388
   [Anonymous], 2018, HUM EVOL, V0, P0
   Austefjord Magnus Wiger, 2014, COMMUN INTEGR BIOL, V7, Pe27934, DOI 10.4161/cib.27934
   Bajpai P, 2018, MITOCHONDRION, V39, P20, DOI 10.1016/j.mito.2017.08.008
   Benda C, 1898, ARCH ANAT PHYSIOL, V73, P393
   Berridge MV, 2017, CLIN EXP PHARMACOL P, V44, P15, DOI 10.1111/1440-1681.12764
   Blanch M, 2016, AM J PATHOL, V186, P385, DOI 10.1016/j.ajpath.2015.10.004
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Cao X, 2012, MOL MED REP, V6, P426, DOI 10.3892/mmr.2012.913
   Cavelier L, 2000, EXP CELL RES, V259, P79, DOI 10.1006/excr.2000.4949
   Chiaratti MR, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0130631
   Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188
   ChrÃ©tien D, 2018, PLOS BIOL, V16, P0, DOI 10.1371/journal.pbio.2003992
   Clark A, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.00319
   Colleoni F, 2010, AM J OBSTET GYNECOL, V203, P0, DOI 10.1016/j.ajog.2010.05.027
   Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101
   Fattuoni C, 2018, PLACENTA, V61, P89, DOI 10.1016/j.placenta.2017.11.014
   Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947
   Franco-Obregon A, 2017, MSYSTEMS, V9, P2
   Gruber J, 2017, CELL, V169, P1168, DOI 10.1016/j.cell.2017.05.048
   Hastie R, 2014, PLACENTA, V35, P673, DOI 10.1016/j.placenta.2014.06.368
   Hirose M, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-15377-7
   Hsu YC, 2016, SEMIN CELL DEV BIOL, V52, P119, DOI 10.1016/j.semcdb.2016.02.011
   Ito K, 2016, ANNU REV CELL DEV BI, V32, P399, DOI 10.1146/annurev-cellbio-111315-125134
   Janssen BG, 2015, EPIGENETICS-US, V10, P536, DOI 10.1080/15592294.2015.1048412
   Lamb R, 2015, ONCOTARGET, V6, P4569, DOI 10.18632/oncotarget.3174
   Lane N, 2015, VITAL QUESTION WHY I, V0, P0
   Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024
   Lee WTY, 2015, ANN NY ACAD SCI, V1350, P95, DOI 10.1111/nyas.12873
   Lees JG, 2017, STEM CELLS INT, V2017, P0, DOI 10.1155/2017/2874283
   Lezi E, 2012, ADV EXP MED BIOL, V942, P269, DOI 10.1007/978-94-007-2869-1_12
   Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651
   Ma J, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-257
   MandÃ² C, 2014, AM J PHYSIOL-ENDOC M, V306, PE404, DOI 10.1152/ajpendo.00426.2013
   MandÃ² C, 2016, STEM CELL TRANSL MED, V5, P451, DOI 10.5966/sctm.2015-0155
   Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270
   Marcialis MA, 2016, J PEDIATR NEONATAL I, V5, P0, DOI 10.7363/050215
   Martijn J, 2018, NATURE, V557, P101, DOI 10.1038/s41586-018-0059-5
   Mayeur S, 2013, AM J PHYSIOL-ENDOC M, V304, PE14, DOI 10.1152/ajpendo.00332.2012
   Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704
   Myatt L, 2016, SEMIN REPROD MED, V34, P42, DOI 10.1055/s-0035-1570027
   NASS S, 1963, J CELL BIOL, V19, P613, DOI 10.1083/jcb.19.3.613
   Novielli C, 2017, PLACENTA, V55, P63, DOI 10.1016/j.placenta.2017.05.008
   ORourke B, 2005, PHYSIOLOGY, V20, P303, DOI 10.1152/physiol.00020.2005
   Palmfeldt J, 2017, MITOCHONDRION, V33, P2, DOI 10.1016/j.mito.2016.07.006
   Palmieri L, 2010, BBA-BIOENERGETICS, V1797, P1130, DOI 10.1016/j.bbabio.2010.04.018
   Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006
   Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021
   Retzius G, 1890, BIOL UNTERSUCH, V1, P51
   Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Saint-Georges-Chaumet Y, 2015, CELL MOL BIOL, V61, P121
   Saint-Georges-Chaumet Y, 2016, PATHOG DIS, V74, P0, DOI 10.1093/femspd/ftv096
   Sathananthan A H, 2000, HUM REPROD, V15 Suppl 2, P148
   Shahan ST, 2017, ENG APPL SCI THESES, V2017, P228
   SIEKEVITZ P, 1957, SCI AM, V197, P131, DOI 10.1038/scientificamerican0757-131
   Srinivasan S, 2017, BBA-BIOENERGETICS, V1858, P602, DOI 10.1016/j.bbabio.2017.01.004
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Varum S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0020914
   Viale A, 2015, CANCER RES, V75, P3687, DOI 10.1158/0008-5472.CAN-15-0491
   Vignais ML, 2017, STEM CELLS INT, V2017, P0, DOI 10.1155/2017/6917941
   Vincent AE, 2017, TRENDS CELL BIOL, V27, P797, DOI 10.1016/j.tcb.2017.08.009
   Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002
   Wang Z, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep07949
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhang HB, 2018, DEVELOPMENT, V145, P0, DOI 10.1242/dev.143420
   Zorov DB, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1017, DOI 10.1134/S0006297914100046
   Zorov DB, 2012, BIOCHEMISTRY-MOSCOW+, V77, P742, DOI 10.1134/S0006297912070073
NR 76
TC 0
Z9 0
U1 0
U2 8
PU HYGEIA PRESS CORRIDORI MARINELLA
PI QUARTU SANT ELENA
PA VIA MONTECATINI 53, QUARTU SANT ELENA, CA09045, ITALY
SN 2281-0692
EI 
J9 J PEDIATR NEONATAL I
JI J. Pediatr. Neonatal Individ. Med.
PD APR 15
PY 2019
VL 8
IS 1
BP 
EP 
DI 10.7363/080106
PG 13
WC Pediatrics
SC Pediatrics
GA HZ4AT
UT WOS:000468790200021
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Melichart-Kotig, M
   Woehrer, A
AF Finsterer, Josef
   Melichart-Kotig, Madleine
   Woehrer, Adelheid
TI Mitochondrial disorder mimicking rheumatoid disease
SO ZEITSCHRIFT FUR RHEUMATOLOGIE
LA English
DT Article
DE MtDNA; Mitochondrion; Neuromuscular; Myopathy; Arthralgia; Pituitary insufficiency
ID congenital myasthenic syndrm; molecular characterization; mutations; skin
AB Objective Mitochondrial disorders (MIDs) may manifest phenotypically with a plethora of clinical features, but polyarthralgia and cutaneous lesions are still infrequently reported and recognized as phenotypic manifestations of a MID. Case report The patient is a 27-year-old Caucasian female with a history of preterm birth, symptomatic myopathy, and polyarthralgia since infancy, followed by multiple endocrinopathies including pituitary insufficiency, cardiac conduction defects, nephrolithiasis, aseptic chronic pancreatitis and sialadenitis, anemia, hyperlipidemia, and dysmorphic features. The patient reported to have profited from hydrocortisone and long-term chloroquine, but hardly from long-term immunosuppression with various immunosuppressants. The diagnosis MID was established upon the multiorgan nature of the disease, presence of core clinical features of a MID, and a muscle biopsy indicative of a mitochondrial defect. The family history was positive for mitochondrial features in the mother and grandmother from the mother's side. Conclusion Seronegative and non-destructive polyarthralgia and unexplained cutaneous features mimicking cutaneous lupus should be considered as a phenotypic feature of a multisystem MID (mitochondrial multiorgan disorder syndrome, MIMODS). Mitochondrial metabolic defects may trigger secondary immune reactions. Core clinical features of a non-specific MID with infantile onset include symptomatic myopathy, endocrine abnormalities, cardiac conduction defects, dysmorphism, hyperlipidemia, anemia, and nephrolithiasis.
C1 [Finsterer, Josef] Vet Univ Vienna, Messerli Inst, Krankenanstalt Rudolfstiftung, Vienna, Austria.
   [Melichart-Kotig, Madleine] Krankenanstalt Rudolfstiftung Wien, Med Dept, Vienna, Austria.
   [Woehrer, Adelheid] Med Univ Vienna, Neurol Inst, Vienna, Austria.
C3 University of Veterinary Medicine Vienna; Rudolfstiftung Hospital; Rudolfstiftung Hospital; Medical University of Vienna
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Alvarez-Garcia O, 2017, ARTHRITIS RHEUMATOL, V69, P1418, DOI 10.1002/art.40104
   Azuma Y, 2015, NEUROMUSCULAR DISORD, V25, P60, DOI 10.1016/j.nmd.2014.09.002
   Boulton SJ, 2015, EXP DERMATOL, V24, P12, DOI 10.1111/exd.12597
   Finsterer J, 2017, ACTA NEUROL BELG, V117, P969, DOI 10.1007/s13760-017-0821-8
   Finsterer J, 2015, PEDIATR NEUROL, V53, P301, DOI 10.1016/j.pediatrneurol.2015.03.005
   Harty LC, 2012, ANN RHEUM DIS, V71, P582, DOI 10.1136/annrheumdis-2011-200245
   Mihaylova V, 2010, J NEUROL NEUROSUR PS, V81, P973, DOI 10.1136/jnnp.2009.177816
   MÃ¼ller JS, 2006, NEUROMUSCULAR DISORD, V16, P661, DOI 10.1016/j.nmd.2006.05.068
   Natera-de Benito D, 2017, NEUROMUSCULAR DISORD, V27, P1087, DOI 10.1016/j.nmd.2017.08.003
   Shen XM, 2016, HUM MUTAT, V37, P1051, DOI 10.1002/humu.23043
   Soto-Hermida A, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0112735
   Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393
NR 12
TC 7
Z9 7
U1 0
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-1855
EI 1435-1250
J9 Z RHEUMATOL
JI Z. Rheumatol.
PD NOV 15
PY 2019
VL 78
IS 9
BP 875
EP 880
DI 10.1007/s00393-018-0551-1
PG 6
WC Rheumatology
SC Rheumatology
GA JJ3GJ
UT WOS:000494049400010
PM 30291434
DA 2024-11-01
ER

PT J
AU GonzÃ¡lez-del Angel, A
   Bisciglia, M
   Vargas-CaÃ±as, S
   Fernandez-Valverde, F
   Kazakova, E
   Escobar, RE
   Romero, NB
   Jarder, C
   Rucheton, B
   Stojkovic, T
   Malfatti, E
AF Gonzalez-del Angel, Ariadna
   Bisciglia, Michela
   Vargas-Canas, Steven
   Fernandez-Valverde, Francisca
   Kazakova, Ekaterina
   Elena Escobar, Rosa
   Romero, Norma B.
   Jarder, Claude
   Rucheton, Benoit
   Stojkovic, Tanya
   Malfatti, Edoardo
TI Novel Phenotypes and Cardiac Involvement Associated With DNA2 Genetic Variants
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE mitochondrial disease; early onset myopathy; DNA2; cardiomyopathy; velopharyngeal weakness; rhabdomyolysis
ID muscle mitochondrial-dna; myopathy; spectrum; nuclear
AB Objectives: To report two novel DNA2 gene mutations causing early onset myopathy with cardiac involvement and late onset mitochondriopathy with rhabdomyolysis. Methods: We performed detailed clinical, muscle histopathology and molecular studies including mitochondrial gene NGS analysis in two patients (Patient 1 and 2), a mother and her son, belonging to a Mexican family, and a third sporadic French patient. Results: Patient 1 and 2 presented with an early onsetmyopathy associated with ptosis, velopharyngeal weakness, and cardiac involvement. Patient 3 presented rhabdomyolysis unmasking amitochondrial disease characterized by a sensorineural hearing loss, ptosis, and lipomas. Muscle biopsies performed in all patients showed variable mitochondrial alterations. Patient 3 hadmultiplemtDNA deletion in hismuscle. Genetic studies revealed a novel heterozygous frameshift mutation in DNA2 gene (c.2346delT p.Phe782Leufs*3) in P1 and P2, and a novel heterozygous missense mutation in DNA2 gene (c.578T>C p.Leu193Ser) in the P3. Conclusions: To date only few AD cases presenting either missense or truncating DNA2 variants have been reported. None of them presented with a cardiac involvement or rhabdomyolysis. Here we enlarge the genetic and phenotypic spectrum of DNA2-related mitochondrial disorders.
C1 [Gonzalez-del Angel, Ariadna] Inst Nacl Pediat, Dept Genet Humana, Lab Biol Mol, Mexico City, DF, Mexico.
   [Bisciglia, Michela; Romero, Norma B.; Stojkovic, Tanya] GHU La Pitie Saipetriere, AP HP, Inst Myol, Paris, France.
   [Vargas-Canas, Steven; Fernandez-Valverde, Francisca; Romero, Norma B.] Inst Nacl Neurol & Neurochirurg, Mexico City, DF, Mexico.
   [Vargas-Canas, Steven; Fernandez-Valverde, Francisca; Romero, Norma B.] Inst Nacl Neurol & Neurocirug, Lab Patol Expt, Mexico City, DF, Mexico.
   [Kazakova, Ekaterina; Romero, Norma B.] Cedimemm Ctr Diagnost Metab Energet & Med Mitocon, Mexico City, DF, Mexico.
   [Elena Escobar, Rosa; Romero, Norma B.] INR, Unit Muscle Dystrophies, Mexico City, DF, Mexico.
   [Romero, Norma B.] Sorbonne Univ, Ctr Reference Malad Neuromusculaires Nord Est Ile, Ctr Rech, GHU Pitie Salpetriere,INSERM, Paris, France.
   [Jarder, Claude; Rucheton, Benoit] GHU Pitie Salpetriere, AP HP, UF Cardiogenet & Myogenet, Serv Biochim Metabol, Paris, France.
   [Malfatti, Edoardo] CHU Raymond Poincare, Ctr Reference Malad Neuromusculaire Paris Nord, Serv Neurol Med, Garches, France.
   [Malfatti, Edoardo] Univ Versailles St Quentin En Yvelines, UFR Sci Sante Simone Veil, Handicap Neuromusculaire Physiol Biotherapie & Ph, UVSQ,INSERM,U1179, Versailles, France.
C3 Assistance Publique Hopitaux Paris (APHP); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Universite Paris Saclay; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Malfatti, E (corresponding author), CHU Raymond Poincare, Ctr Reference Malad Neuromusculaire Paris Nord, Serv Neurol Med, Garches, France.; Malfatti, E (corresponding author), Univ Versailles St Quentin En Yvelines, UFR Sci Sante Simone Veil, Handicap Neuromusculaire Physiol Biotherapie & Ph, UVSQ,INSERM,U1179, Versailles, France.
EM edoardo.malfatti@gmail.com
CR Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Andalib S, 2017, EXPERT REV MOL MED, V19, P0, DOI 10.1017/erm.2017.5
   Baker SK, 2008, CAN J NEUROL SCI, V35, P94, DOI 10.1017/S0317167100007630
   Budd ME, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0004267
   Buja LM, 2013, TEX HEART I J, V40, P221
   Chae JH, 2015, J MED GENET, V52, P208, DOI 10.1136/jmedgenet-2014-102819
   Ding L, 2015, INT J MOL SCI, V16, P10870, DOI 10.3390/ijms160510870
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Hirano M, 2001, CURR OPIN CARDIOL, V16, P201, DOI 10.1097/00001573-200105000-00008
   Khetarpal P, 2016, MOL GENET GENOMICS, V291, P1, DOI 10.1007/s00438-015-1110-y
   Mohassel P, 2013, CURR OPIN RHEUMATOL, V25, P747, DOI 10.1097/01.bor.0000434673.85515.89
   Phowthongkum P, 2017, NEUROMUSCULAR DISORD, V27, P616, DOI 10.1016/j.nmd.2017.03.013
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   StÃ¶llberger C, 2019, EXPERT REV CARDIOVAS, V17, P95, DOI 10.1080/14779072.2019.1561280
   Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023
   Ye L, 1997, AM J MED GENET, V68, P494, DOI 10.1002/(SICI)1096-8628(19970211)68:4<494::AID-AJMG30>3.0.CO;2-L
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 19
TC 7
Z9 7
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD OCT 4
PY 2019
VL 10
IS 
BP 
EP 
DI 10.3389/fneur.2019.01049
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA JO5ZZ
UT WOS:000497657800001
PM 31636600
DA 2024-11-01
ER

PT J
AU Espinoza-Derout, J
   Hasan, KM
   Shao, XSM
   Jordan, MC
   Sims, C
   Lee, DL
   Sinha, S
   Simmons, Z
   Mtume, N
   Liu, YJ
   Roos, KP
   Sinha-Hikim, AP
   Friedman, TC
AF Espinoza-Derout, Jorge
   Hasan, Kamrul M.
   Shao, Xuesi M.
   Jordan, Maria C.
   Sims, Carl
   Lee, Desean L.
   Sinha, Satyesh
   Simmons, Zena
   Mtume, Norma
   Liu, Yanjun
   Roos, Kenneth P.
   Sinha-Hikim, Amiya P.
   Friedman, Theodore C.
TI Chronic intermittent electronic cigarette exposure induces cardiac dysfunction and atherosclerosis in apolipoprotein-E knockout mice
SO AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
LA English
DT Article
DE atherosclerosis; cardiomyopathy; cardiovascular disease; inflammation; myocardial biology
ID high-fat diet; oxidative stress; heart-failure; mitochondrial dysfunction; cardiovascular toxicity; myocardial-infarction; nicotine implications; circadian clock; skeletal-muscle; expression
AB Electronic cigarettes (e-cigarettes), also known as electronic nicotine delivery systems, are a popular alternative to conventional nicotine cigarettes, both among smokers and those who have never smoked. In spite of the widespread use of e-cigarettes and the proposed detrimental cardiac and atherosclerotic effects of nicotine, the effects of e-cigarettes on these systems are not known. In this study, we investigated the cardiovascular and cardiac effects of e-cigarettes with and without nicotine in apolipoprotein-E knockout (ApoE(-/-)) mice. We developed an e-cigarette exposure model that delivers nicotine in a manner similar to that of human e-cigarettes users. Using commercially available e-cigarettes, bluCig PLUS, ApoE(-/-) mice were exposed to saline, e-cigarette without nicotine [e-cigarette (0%)], and e-cigarette with 2.4% nicotine [e-cigarette (2.4%)] aerosol for 12 wk. Echocardiographic data show that mice treated with e-cigarette (2.4%) had decreased left ventricular fractional shortening and ejection fraction compared with e-cigarette (0%) and saline. Ventricular transcriptomic analysis revealed changes in genes associated with metabolism, circadian rhythm, and inflammation in e-cigarette (2.4%)-treated ApoE(-/-) mice. Transmission electron microscopy revealed that cardiomyocytes of mice treated with e-cigarette (2.4%) exhibited ultrastructural abnormalities indicative of cardiomyopathy. Additionally, we observed increased oxidative stress and mitochondrial DNA mutations in mice treated with e-cigarette (2.4%). ApoE(-/-) mice on e-cigarette (2.4%) had also increased atherosclerotic lesions compared with saline aerosol-treated mice. These results demonstrate adverse effects of e-cigarettes on cardiac function in mice. NEW & NOTEWORTHY The present study is the first to show that mice exposed to nicotine electronic cigarettes (e-cigarettes) have decreased cardiac fractional shortening and ejection fraction in comparison with controls. RNA-seq analysis reveals a proinflammatory phenotype induced by e-cigarettes with nicotine. We also found increased atherosclerosis in the aortic root of mice treated with e-cigarettes with nicotine. Our results show that e-cigarettes with nicotine lead to detrimental effects on the heart that should serve as a warning to e-cigarette users and agencies that regulate them.
C1 [Espinoza-Derout, Jorge; Hasan, Kamrul M.; Shao, Xuesi M.; Sims, Carl; Lee, Desean L.; Sinha, Satyesh; Simmons, Zena; Mtume, Norma; Liu, Yanjun; Sinha-Hikim, Amiya P.; Friedman, Theodore C.] Charles R Drew Univ Med & Sci, Dept Internal Med, Div Endocrinol Metab & Mol Med, Los Angeles, CA 90059 USA.
   [Shao, Xuesi M.; Jordan, Maria C.; Sinha, Satyesh; Liu, Yanjun; Roos, Kenneth P.; Sinha-Hikim, Amiya P.; Friedman, Theodore C.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
C3 Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA
RP Espinoza-Derout, J (corresponding author), Charles R Drew Univ Med & Sci, 1731 E 120th St LSRNE Bldg,Rm N220, Los Angeles, CA 90059 USA.
EM jorgeespinozaderout@cdrewu.edu
FU Diversity-Promoting Institution Drug Abuse Research Program [R24DA017298]; National Institutes of Health (NIH) [5U54MD007598]; California Tobacco-Related Disease Research Program Grant [251P003]; NIH [SC1-DK-104821]; National Institute on Minority Health and Health Disparities Grant [S21-MD000103]
CR Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726
   Akoumianakis I, 2017, CARDIOVASC RES, V113, P999, DOI 10.1093/cvr/cvx111
   Alzahrani T, 2018, AM J PREV MED, V55, P455, DOI 10.1016/j.amepre.2018.05.004
   Antoniewicz L, 2016, ATHEROSCLEROSIS, V255, P179, DOI 10.1016/j.atherosclerosis.2016.09.064
   Baglione Julie, 2006, V129, V0, P83
   Ballinger SW, 1996, CANCER RES, V56, P5692
   Barrera-Vilarmau S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021413
   Benowitz NL, 2017, NAT REV CARDIOL, V14, P447, DOI 10.1038/nrcardio.2017.36
   Benowitz NL, 2016, TRENDS CARDIOVAS MED, V26, P515, DOI 10.1016/j.tcm.2016.03.001
   Benowitz NL, 1997, J AM COLL CARDIOL, V29, P1422, DOI 10.1016/S0735-1097(97)00079-X
   Benowitz NL, 1997, BRIT J CLIN PHARMACO, V43, P259, DOI 10.1111/j.1365-2125.1997.00566.x
   Bhatnagar A, 2014, CIRCULATION, V130, P1418, DOI 10.1161/CIR.0000000000000107
   Bitzer ZT, 2018, CHEM RES TOXICOL, V31, P4, DOI 10.1021/acs.chemrestox.7b00116
   Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09
   Bonney S, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0071493
   Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011
   Chong CR, 2017, CARDIOVASC RES, V113, P422, DOI 10.1093/cvr/cvx018
   Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151
   Colombo ES, 2013, CARDIOVASC TOXICOL, V13, P364, DOI 10.1007/s12012-013-9217-z
   Daniele G, 2014, DIABETES, V63, P2812, DOI 10.2337/db13-1130
   Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957
   Fowler PA, 2014, HUM REPROD, V29, P1471, DOI 10.1093/humrep/deu117
   Friedman TC, 2012, ENDOCRINOLOGY, V153, P5809, DOI 10.1210/en.2012-1750
   Ge F, 2012, J OBES, V2012, P0, DOI 10.1155/2012/205648
   Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693
   Ghosh A, 2017, J BIOMED SCI, V24, P0, DOI 10.1186/s12929-017-0357-5
   Glantz SA, 2018, ANNU REV PUBL HEALTH, V39, P215, DOI 10.1146/annurev-publhealth-040617-013757
   GonÃ§alves N, 2016, AM J PHYSIOL-HEART C, V310, PH655, DOI 10.1152/ajpheart.00684.2015
   Gooley JJ, 2014, J GENET GENOMICS, V41, P231, DOI 10.1016/j.jgg.2014.04.001
   Hajek P, 2019, NEW ENGL J MED, V380, P629, DOI 10.1056/NEJMoa1808779
   Herder C, 2017, HEART, V103, P63, DOI 10.1136/heartjnl-2015-309181
   Herst PM, 2017, FRONT ENDOCRINOL, V8, P0, DOI 10.3389/fendo.2017.00296
   Hirabara SM, 2010, J CELL PHYSIOL, V222, P187, DOI 10.1002/jcp.21936
   Ho E, 2013, REDOX BIOL, V1, P483, DOI 10.1016/j.redox.2013.07.006
   Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519
   Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3
   Husari A, 2016, NICOTINE TOB RES, V18, P613, DOI 10.1093/ntr/ntv169
   Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686
   Jacob P, 2011, J CHROMATOGR B, V879, P267, DOI 10.1016/j.jchromb.2010.12.012
   Koskivirta I, 2010, J BIOL CHEM, V285, P24487, DOI 10.1074/jbc.M110.136820
   Kristjansson AL, 2017, SUBST ABUS, V38, P473, DOI 10.1080/08897077.2017.1343218
   La Carrubba S, 2013, J CARDIOVASC ECHOGR, V23, P96, DOI 10.4103/2211-4122.127410
   Langmead B, 2012, NAT METHODS, V9, P357, DOI 10.1038/NMETH.1923
   Lee J, 2011, ATHEROSCLEROSIS, V215, P281, DOI 10.1016/j.atherosclerosis.2011.01.003
   Lee SR, 2017, FRONT BIOSCI-LANDMRK, V22, P1177, DOI 10.2741/4541
   Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x
   Lerner CA, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0116732
   Li B, 2011, BMC BIOINFORMATICS, V12, P0, DOI 10.1186/1471-2105-12-323
   Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067
   Lo Sasso G, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0901-1
   Lukyanenko V, 2009, INT J BIOCHEM CELL B, V41, P1957, DOI 10.1016/j.biocel.2009.03.011
   Madrigal-Matute J, 2015, CARDIOVASC RES, V108, P139, DOI 10.1093/cvr/cvv204
   Mak KM, 2016, ANAT REC, V299, P613, DOI 10.1002/ar.23330
   Mandl A, 2011, CIRCULATION, V124, P31, DOI 10.1161/CIRCULATIONAHA.110.988303
   Mangubat M, 2012, J ENDOCRINOL, V212, P317, DOI 10.1530/JOE-11-0350
   Miedema MD, 2014, AM J CARDIOL, V114, P843, DOI 10.1016/j.amjcard.2014.06.012
   Mitchell T, 2013, AM J PHYSIOL-ENDOC M, V305, PE585, DOI 10.1152/ajpendo.00093.2013
   Miyazaki M, 2009, AM J PHYSIOL-CELL PH, V296, PC583, DOI 10.1152/ajpcell.00464.2008
   MORTON LF, 1982, ATHEROSCLEROSIS, V42, P41, DOI 10.1016/0021-9150(82)90124-1
   Nelluri B, 2016, FUTUR CARDIOL, V12, P167, DOI 10.2217/fca.15.83
   Nojiri H, 2006, J BIOL CHEM, V281, P33789, DOI 10.1074/jbc.M602118200
   OECD, 2009, SER PEST, V39, P1
   Olfert IM, 2018, J APPL PHYSIOL, V124, P573, DOI 10.1152/japplphysiol.00713.2017
   Patenge N, 2017, METHODS MOL BIOL, V1644, P159, DOI 10.1007/978-1-4939-7187-9_14
   Pendse AA, 2009, J LIPID RES, V50, PS178, DOI 10.1194/jlr.R800070-JLR200
   Rapti K, 2017, FREE RADICAL BIO MED, V110, P206, DOI 10.1016/j.freeradbiomed.2017.06.010
   Redmann M, 2018, REDOX BIOL, V17, P59, DOI 10.1016/j.redox.2018.04.005
   Ren MY, 2012, MOL BIOL REP, V39, P9971, DOI 10.1007/s11033-012-1867-6
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Roos KP, 2007, J CARD FAIL, V13, P318, DOI 10.1016/j.cardfail.2007.01.004
   SchÃ¶nfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029
   Schroeder J, 2016, IMPLEMENT SCI, V11, P0
   Shao XSM, 2018, J APPL PHYSIOL, V125, P1555, DOI 10.1152/japplphysiol.00357.2018
   Shao XSM, 2013, NICOTINE TOB RES, V15, P1248, DOI 10.1093/ntr/nts261
   Sinha-Hikim I, 2017, CELL TISSUE RES, V368, P159, DOI 10.1007/s00441-016-2536-1
   Sinha-Hikim I, 2014, ENDOCRINOLOGY, V155, P865, DOI 10.1210/en.2013-1795
   Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719
   Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114
   United States Environmental Protection Agency (USEPA), 1998, HLTH EFF TEST GUID O, V0, P0
   Wang C, 2017, ARTERIOSCL THROM VAS, V37, P53, DOI 10.1161/ATVBAHA.116.307264
   Wang ZY, 2017, MEDIAT INFLAMM, V2017, P0, DOI 10.1155/2017/3102737
   Wu Y, 2015, NAT MED, V21, P373, DOI 10.1038/nm.3826
   Young ME, 2002, J MOL CELL CARDIOL, V34, P223, DOI 10.1006/jmcc.2001.1504
   Zaragoza C, 2011, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2011/497841
NR 84
TC 68
Z9 76
U1 0
U2 23
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6135
EI 1522-1539
J9 AM J PHYSIOL-HEART C
JI Am. J. Physiol.-Heart Circul. Physiol.
PD AUG 15
PY 2019
VL 317
IS 2
BP H445
EP H459
DI 10.1152/ajpheart.00738.2018
PG 15
WC Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology; Physiology
GA IX4PV
UT WOS:000485669000020
PM 31172811
DA 2024-11-01
ER

PT J
AU Lopez-Gomez, C
   Hewan, H
   Sierra, C
   Akman, HO
   Sanchez-Quintero, MJ
   Juanola-Falgarona, M
   Tadesse, S
   Tanji, K
   Konofagou, EE
   Hirano, M
AF Lopez-Gomez, Carlos
   Hewan, Henly
   Sierra, Carlos
   Akman, Hasan O.
   Sanchez-Quintero, Maria J.
   Juanola-Falgarona, Marti
   Tadesse, Saba
   Tanji, Kurenai
   Konofagou, Elisa E.
   Hirano, Michio
TI Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency
SO EBIOMEDICINE
LA English
DT Article
DE Thymidine kinase 2; TK2; mtDNA depletion syndrome; Nucleoside; Deoxycytidine; Thymidine
ID mitochondrial-dna depletion; thymidine kinase; functional-characterization; focused ultrasound; mutations; pools; deoxycytidine; expression; mechanism; delivery
AB Background: TK2 is a nuclear gene encoding the mitochondrial matrix protein thymidine kinase 2 (TK2), a critical enzyme in the mitochondrial nucleotide salvage pathway. Deficiency of TK2 activity causes mitochondrial DNA (mtDNA) depletion, which in humans manifests predominantly as a mitochondria myopathy with onset typically in infancy and childhood. We previously showed that oral treatment of the Tk2 H126N knock-in mouse model (Tk2(-/-)) with the TK2 substrates, deoxycytidine (dCtd) and thymidine (dThd), delayed disease onset and prolonged median survival by 3-fold. Nevertheless, dCtd + dThd treated Tk2(-/-) mice showed mtDNA depletion in brain as early as postnatal day 13 and in virtually all other tissues at age 29 days. Methods: To enhance mechanistic understanding and efficacy of dCtd dThd therapy, we studied the bioavailability of dCtd and dThd in various tissues as well as levels of the cytosolic enzymes, TK1 and dCK that convert the deoxynucleosides into dCMP and dTMP. Findings: Parenteral treatment relative to oral treatment produced higher levels of dCtd and dThd and improved mtDNA levels in liver and heart, but did not ameliorate molecular defects in brain or prolong survival. Downregulation of TK1 correlated with temporal- and tissue-specificity of response to dCtd + dThd. Finally, we observed in human infant and adult muscle expression of TK1 and dCK, which account for the long-term efficacy to dCtd + dThd therapy in TK2 defident patients. Interpretations: These data indicate that the cytosolic pyrimidine salvage pathway enzymes TK1 and dCK are critical for therapeutic efficacy of deoxynucleoside therapy for Tk2 deficiency. (C) 2019 The Authors. Published by Elsevier B.V.
C1 [Lopez-Gomez, Carlos; Hewan, Henly; Akman, Hasan O.; Sanchez-Quintero, Maria J.; Juanola-Falgarona, Marti; Tadesse, Saba; Hirano, Michio] Columbia Univ, Dept Neurol, H Houston Merritt Neuromuscular Res Ctr, Med Ctr, New York, NY 10032 USA.
   [Sierra, Carlos; Konofagou, Elisa E.] Columbia Univ, Dept Biomed Engn Ultrasound & Elast, Imaging Lab, New York, NY USA.
   [Konofagou, Elisa E.] Columbia Univ, Dept Radiol, New York, NY USA.
   [Tanji, Kurenai] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA.
C3 Columbia University; Columbia University; Columbia University; Columbia University
RP Hirano, M (corresponding author), Columbia Univ, Med Ctr, 630 West 168th St,P&S 4-423, New York, NY 10032 USA.
EM mh29@columbia.edu
FU NIH [P01 HD32062]; Arturo Estopinan TK2 Research Fund; Nicholas Nunno Foundation; JDM Fund for Mitochondrial Research; Shuman Mitochondrial Disease Fund; Marriott Mitochondrial Disease Clinic Research Fund (MMDCRF) from the J. Willard and Alice S. Marriott Foundation; NIH from NICHD [R01 HD057543, R01 HD056103]; Office of Dietary Supplements; NINDS [U54 NS078059]; NICHD
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   BÃ©hin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   Blazquez-Bermejo C, 2019, AGE RELATED ME UNPUB, V0, P0
   CÃ¡mara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Choi JJ, 2007, PHYS MED BIOL, V52, P5509, DOI 10.1088/0031-9155/52/18/004
   Choi JJ, 2007, ULTRASOUND MED BIOL, V33, P95, DOI 10.1016/j.ultrasmedbio.2006.07.018
   Choi JJ, 2011, P NATL ACAD SCI USA, V108, P16539, DOI 10.1073/pnas.1105116108
   Choi JJ, 2008, ULTRASONIC IMAGING, V30, P189, DOI 10.1177/016173460803000304
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   DomÃ­nguez-GonzÃ¡lez C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   DomÃ­nguez-GonzÃ¡lez C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103
   Feshitan JA, 2009, J COLLOID INTERF SCI, V329, P316, DOI 10.1016/j.jcis.2008.09.066
   Franzolin E, 2012, EXP CELL RES, V318, P2226, DOI 10.1016/j.yexcr.2012.05.028
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Hodzic J, 2011, NUCLEOS NUCLEOT NUCL, V30, P1214, DOI 10.1080/15257770.2011.629271
   Huang WY, 2017, PROTEIN CELL, V8, P284, DOI 10.1007/s13238-016-0350-x
   Konofagou EE, 2012, CURR PHARM BIOTECHNO, V13, P1332
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   LÃ³pez LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   MartÃ­ R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   MartÃ­ R, 2012, METHODS MOL BIOL, V837, P135, DOI 10.1007/978-1-61779-504-6_9
   MartÃ­ R, 2012, METHODS MOL BIOL, V837, P121, DOI 10.1007/978-1-61779-504-6_8
   Munch-Petersen B, 2010, NUCLEOS NUCLEOT NUCL, V29, P363, DOI 10.1080/15257771003729591
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Rehan S, 2015, PROTEIN EXPRES PURIF, V114, P99, DOI 10.1016/j.pep.2015.07.003
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sierra C, 2017, J CEREBR BLOOD F MET, V37, P1236, DOI 10.1177/0271678X16652630
   Tung YS, 2011, J ACOUST SOC AM, V130, P3059, DOI 10.1121/1.3646905
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
   Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007
NR 38
TC 16
Z9 16
U1 1
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2352-3964
EI 
J9 EBIOMEDICINE
JI EBioMedicine
PD AUG 15
PY 2019
VL 46
IS 
BP 356
EP 367
DI 10.1016/j.ebiom.2019.07.037
PG 12
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA IY7RE
UT WOS:000486592000045
PM 31383553
DA 2024-11-01
ER

PT J
AU Boggan, RM
   Lim, A
   Taylor, RW
   McFarland, R
   Pickett, SJ
AF Boggan, Roisin M.
   Lim, Albert
   Taylor, Robert W.
   McFarland, Robert
   Pickett, Sarah J.
TI Resolving complexity in mitochondrial disease: Towards precision medicine
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Review
DE Mitochondrial disease; Complex disease; m.3243A > G; Heterogeneity; Precision medicine; MELAS
ID stroke-like episodes; transfer rnaleu(uur) gene; greater-than g; lactic-acidosis; point mutation; dna mutations; hearing-loss; m.3243a-greater-than-g mutation; a3243g mutation; mtdna mutation
AB Mitochondrial diseases, caused by mutations in either the nuclear or mitochondrial genomes (mtDNA), are the most common form of inherited neurometabolic disorders. They are remarkably heterogeneous, both in their clinical presentation and genetic etiology, presenting challenges for diagnosis, clinical management and elucidation of molecular mechanism. The multifaceted nature of these diseases, compounded by the unique characteristics of mitochondrial genetics, cement their space in the field of complex disease. In this review we examine the m.3243A > G variant, one of the most prevalent mitochondrial DNA mutations, using it as an exemplar to demonstrate the challenges presented by these complex disorders. Disease caused by m.3243A > G is one of the most phenotypically diverse of all mitochondrial diseases; we outline known causes of this heterogeneity including mtDNA heteroplasmy, mtDNA copy number and nuclear genetic factors. We consider the impact that this has in the clinic, discussing the personalized management of common manifestations attributed to this pathogenic mtDNA variant, including hearing impairment, diabetes mellitus, myopathy, cardiac disease, stroke-like episodes and gastrointestinal disturbances. Future research into this complex disorder must account for this heterogeneity, benefitting from the use of large patient cohorts to build upon current clinical expertise. Through multi-disciplinary collaboration, the complexities of this mitochondrial disease can be addressed with the variety of diagnostic, prognostic, and treatment approaches that are moulded to best fit the needs of each individual patient.
C1 [Boggan, Roisin M.; Lim, Albert; Taylor, Robert W.; McFarland, Robert; Pickett, Sarah J.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP McFarland, R (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.mcfarland@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Wellcome Career Re-entry Fellowship [204709/Z/16/Z]; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children
CR Abate M, 2020, SEMIN CELL DEV BIOL, V98, P139, DOI 10.1016/j.semcdb.2019.05.022
   Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Apabhai S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022294
   Aurangzeb Sidra, 2014, PRACT NEUROL, V14, P432, DOI 10.1136/practneurol-2014-000853
   Bates MGD, 2013, INT J CARDIOL, V168, P3599, DOI 10.1016/j.ijcard.2013.05.062
   Bates MGD, 2013, EUR HEART J-CARD IMG, V14, P650, DOI 10.1093/ehjci/jes226
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Boal RL, 2019, J CLIN ENDOCR METAB, V104, P2057, DOI 10.1210/jc.2018-00957
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Cao X, 2012, MOL MED REP, V6, P426, DOI 10.3892/mmr.2012.913
   Chin J, 2014, MITOCHONDRION, V17, P34, DOI 10.1016/j.mito.2014.05.005
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   Chistiakov DA, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/238463
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Conley KE, 2007, CURR OPIN CLIN NUTR, V10, P688, DOI 10.1097/MCO.0b013e3282f0dbfb
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   de Laat P, 2015, NETH J MED, V73, P30
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Deschauer M, 2001, ARCH NEUROL-CHICAGO, V58, P1885, DOI 10.1001/archneur.58.11.1885
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Doynova MD, 2016, MITOCHONDRION, V30, P187, DOI 10.1016/j.mito.2016.08.003
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   Egeberg M, 2006, PALGRAVE STUD EUR UN, V0, P66
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Flierl A, 1997, PATHOPHYSIOLOGY MELA, V0, P0
   Frederiksen AL, 2009, J CLIN ENDOCR METAB, V94, P2872, DOI 10.1210/jc.2009-0235
   Gagliardi D, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00038
   Gill T, 2013, J BIOL CHEM, V288, P26246, DOI 10.1074/jbc.M113.476895
   Giordano L, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.364
   Gorman GS, 2018, LANCET, V392, P1191, DOI 10.1016/S0140-6736(18)31868-3
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   Hattersley AT, 2017, DIABETOLOGIA, V60, P769, DOI 10.1007/s00125-017-4226-2
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Horan MP, 2014, HUM GENET, V133, P435, DOI 10.1007/s00439-013-1402-4
   Horan MP, 2013, EUR J HUM GENET, V21, P1335, DOI 10.1038/ejhg.2013.75
   HUTCHISOCA, 1974, NATURE, V251, P536, DOI 10.1038/251536a0
   Hwang J M, 1996, KOREAN J OPHTHALMOL, V10, P122
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Iwanicka-Pronicka K, 2015, MED SCI MONITOR, V21, P694, DOI 10.12659/MSM.890965
   Janssen GMC, 1999, J BIOL CHEM, V274, P29744, DOI 10.1074/jbc.274.42.29744
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kaipparettu BA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0061747
   Karaa A, 2019, MOL GENET METAB, V127, P122, DOI 10.1016/j.ymgme.2019.05.012
   KÃ¤rppÃ¤ M, 2004, J NEUROL, V251, P556, DOI 10.1007/s00415-004-0363-x
   KÃ¤rppÃ¤ M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Kastaniotis AJ, 2017, BBA-MOL CELL BIOL L, V1862, P39, DOI 10.1016/j.bbalip.2016.08.011
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2011, NATURAL HIST MELAS A, V0, PP32062, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Koene S, 2018, J INHERIT METAB DIS, V41, P1267, DOI 10.1007/s10545-018-0229-5
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Kullar PJ, 2016, BRAIN, V139, PE33, DOI 10.1093/brain/aww051
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lax NZ, 2016, NEUROPATH APPL NEURO, V42, P180, DOI 10.1111/nan.12238
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   Liu H, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067146
   Lodi R, 2004, BBA-BIOENERGETICS, V1657, P146, DOI 10.1016/j.bbabio.2004.05.003
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Lutz-Bonengel S, 2019, P NATL ACAD SCI USA, V116, P1821, DOI 10.1073/pnas.1820533116
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Maeda K, 2016, CLIN PHENOTYPE SEGRE, V73, P0, DOI 10.1001/jamaneurol.2016.0886
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, P0, DOI 10.1136/jnnp.2007.122648
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Majamaa-Voltti Kirsi, 2002, BMC CARDIOVASC DISORD, V2, P12
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MARON BJ, 1979, CIRCULATION, V60, P685, DOI 10.1161/01.CIR.60.3.685
   McBride HM, 2006, CURR BIOL, V16, PR551, DOI 10.1016/j.cub.2006.06.054
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Moggio Maurizio, 2014, ACTA MYOL, V33, P86
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   MORGANHUGHES JA, 1994, CURR OPIN NEUROL, V7, P457, DOI 10.1097/00019052-199410000-00014
   Nadol JB, 2001, INT J PEDIATR OTORHI, V61, P1, DOI 10.1016/S0165-5876(01)00546-8
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Newkirk JE, 1997, DIABETIC MED, V14, P457, DOI 10.1002/(SICI)1096-9136(199706)14:6<457::AID-DIA372>3.3.CO;2-N
   Ng YS, 2016, ANN NEUROL, V80, P686, DOI 10.1002/ana.24736
   Nguyen T, 2019, INT J PEDIATR OTORHI, V120, P15, DOI 10.1016/j.ijporl.2019.02.002
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Ott J, 2015, NAT REV GENET, V16, P275, DOI 10.1038/nrg3908
   Ozawa M, 1998, J NEUROL SCI, V159, P170, DOI 10.1016/S0022-510X(98)00152-X
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Phoenix C, 2006, NEUROMUSCULAR DISORD, V16, P814, DOI 10.1016/j.nmd.2006.08.006
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Pickett SJ, 2019, NEW ENGL J MED, V380, P1971, DOI 10.1056/NEJMc1808565
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sadun AA, 2013, CLIN EXP OPHTHALMOL, V41, P702, DOI 10.1111/ceo.12086
   Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Scarpelli M, 2017, APPL CLIN GENET, V10, P21, DOI 10.2147/TACG.S94267
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shaikh S, 2001, AM J OPHTHALMOL, V131, P143, DOI 10.1016/S0002-9394(00)00716-9
   Shirani J, 2000, J AM COLL CARDIOL, V35, P36, DOI 10.1016/S0735-1097(99)00492-1
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Suzuki J, 2018, INTERNAL MED, V57, P771, DOI 10.2169/internalmedicine.9632-17
   Suzuki J, 2017, INTERNAL MED, V56, P1089, DOI 10.2169/internalmedicine.56.7753
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Tsao K, 1999, BRIT J OPHTHALMOL, V83, P577, DOI 10.1136/bjo.83.5.577
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
   Uimonen S, 2001, HUM GENET, V108, P284, DOI 10.1007/s004390100475
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Veitia RA, 2018, HUM MOL GENET, V27, P1565, DOI 10.1093/hmg/ddy063
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322
   Vrettou CS, 2013, INTENS CARE MED, V39, P1148, DOI 10.1007/s00134-013-2884-1
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006
   Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626
   Xia CY, 2016, CHINESE MED J-PEKING, V129, P1945, DOI 10.4103/0366-6999.187845
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Zhang Z, 2018, J NEUROL SCI, V385, P151, DOI 10.1016/j.jns.2017.12.033
NR 161
TC 23
Z9 27
U1 0
U2 16
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD SEP-OCT 15
PY 2019
VL 128
IS 1-2
BP 19
EP 29
DI 10.1016/j.ymgme.2019.09.003
PG 11
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA JU0SN
UT WOS:000501389600004
PM 31648942
DA 2024-11-01
ER

PT J
AU Rovelli, V
   Manzoni, F
   Viau, K
   Pasquali, M
   Longo, N
AF Rovelli, Valentina
   Manzoni, Francesca
   Viau, Krista
   Pasquali, Marzia
   Longo, Nicola
TI Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Very long chain AcylCoA dehydrogenase (VLCAD) deficiency; Fatty acid oxidation; Newborn screening; Outcome; Carnitine; CK
ID fatty-acid oxidation; ventricular septal-defect; vlcad-deficiency; mutation analysis; inborn-errors; newborn; mitochondrial; disorders; carnitine; coenzyme
AB Background: Very-Long-Chain Acyl-CoA Dehydrogenase (VLCAD) deficiency is a disorder of fatty acid oxidation included in the recommended uniform newborn screening (NBS) panel in the USA. It can have variable clinical severity and there is limited information on the natural history of this condition, clinical presentation according to genotype and effectiveness of newborn screening. Methods: Retrospective data (growth parameters, morbidity, biochemical and genetic testing results) were collected from patients with VLCAD deficiency, to evaluate biochemical and clinical outcomes. Descriptive statistics was used for qualitative variables, while linear regression analysis was used to correlate continuous variables. Results: VLCAD deficiency (screened by measuring elevated levels of C14:1-carnitine in blood spots) was more frequent in Utah than the national average (1:27,617 versus 1:63,481) in the first ten years of screening. Twenty-six patients had a confirmed diagnosis of VLCAD deficiency using DNA testing or functional studies. The c.848T > C (p.V283A) variant in the ACADVL gene was the most frequent in our population. Novel variants (c.623-21A > G (IVS7-21A > G); c.1052C > T (p.T351I); c.1183-7A > G (IVS11-7A > G); c.1281G > C (p.W427C); c.1923G > C (p.L641F); c.1924G > A (p.V642M)) were identified in this study, with their pathogenicity remaining unclear in most cases. C14:1-carnitine levels decreased with age and significantly correlated with CK levels as index of muscle involvement. There were no cases of HELLP syndrome nor liver disease during pregnancies in the mothers of VLCAD patients. None of our patients developed cardiac involvement after birth and all patients had normal growth parameters while on treatment. Clinical manifestations were related to concomitant infections and altered biochemical parameters. Discussion: VLCAD deficiency can be identified by neonatal screening. Most patients compliant with therapy normalized biochemical parameters and had no major clinical manifestations. Complications were completely prevented with a relatively low number of pre-emptive ER visits or hospital admissions. It remains unclear whether neonatal screening is now identifying less severely affected patient or if complications will arise as subjects become older. Observation beyond puberty is necessary to fully understand the impact of VLCAD deficiency on morbidity in patients with VLCAD deficiency.
C1 [Rovelli, Valentina; Manzoni, Francesca; Viau, Krista; Pasquali, Marzia; Longo, Nicola] Univ Utah, Div Med Genet Pediat, Salt Lake City, UT 84108 USA.
   [Rovelli, Valentina] Univ Milan, San Paolo Hosp, Clin Dept Pediat, Milan, Italy.
   [Manzoni, Francesca] Univ Milan, San Paolo Hosp, Clin Dept Neuropsychiat, Milan, Italy.
   [Viau, Krista] Boston Childrens Hosp, Boston, MA USA.
   [Pasquali, Marzia; Longo, Nicola] ARUP Labs, Salt Lake City, UT USA.
   [Pasquali, Marzia; Longo, Nicola] Univ Utah, Dept Pathol, Salt Lake City, UT USA.
C3 Utah System of Higher Education; University of Utah; San Paolo-Polo Universitaria Hospital; University of Milan; San Paolo-Polo Universitaria Hospital; University of Milan; Harvard University; Boston Children's Hospital; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah
RP Longo, N (corresponding author), Univ Utah, Div Med Genet, Dept Pediat, 295 Chipeta Way, Salt Lake City, UT 84108 USA.
EM Nicola.Longo@hsc.utah.edu
CR Andresen BS, 1996, HUM MOL GENET, V5, P461, DOI 10.1093/hmg/5.4.461
   Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261
   AOYAMA T, 1995, AM J HUM GENET, V57, P273
   AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368
   Arnold GL, 2009, MOL GENET METAB, V96, P85, DOI 10.1016/j.ymgme.2008.09.008
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   BERTRAND C, 1993, BIOCHIM BIOPHYS ACTA, V1180, P327, DOI 10.1016/0925-4439(93)90058-9
   Boneh A, 2006, MOL GENET METAB, V88, P166, DOI 10.1016/j.ymgme.2005.12.012
   Bonnet D, 1999, CIRCULATION, V100, P2248, DOI 10.1161/01.CIR.100.22.2248
   BrownHarrison MC, 1996, BIOCHEM MOL MED, V58, P59, DOI 10.1006/bmme.1996.0033
   Costa CG, 1998, J INHERIT METAB DIS, V21, P391, DOI 10.1023/A:1005354624735
   Costa CG, 1997, J LIPID RES, V38, P173
   Coughlin CR, 2010, J INHERIT METAB DIS, V33, PS129, DOI 10.1007/s10545-009-9041-6
   Cox GF, 1998, J PEDIATR-US, V133, P247, DOI 10.1016/S0022-3476(98)70228-8
   Cox KB, 2009, LAB INVEST, V89, P1348, DOI 10.1038/labinvest.2009.86
   Diekman EF, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0147818
   Diekman EF, 2015, GENET MED, V17, P989, DOI 10.1038/gim.2015.22
   Diekman EF, 2014, J INHERIT METAB DIS, V37, P405, DOI 10.1007/s10545-013-9666-3
   Gillingham MB, 2006, MOL GENET METAB, V89, P58, DOI 10.1016/j.ymgme.2006.06.004
   Gillingham MB, 2017, J INHERIT METAB DIS, V40, P831, DOI 10.1007/s10545-017-0085-8
   Goetzman ES, 2007, MOL GENET METAB, V91, P138, DOI 10.1016/j.ymgme.2007.01.013
   Gregersen N, 2004, EUR J BIOCHEM, V271, P470, DOI 10.1046/j.1432-1033.2003.03949.x
   Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174
   HALE DE, 1990, PROG CLIN BIOL RES, V321, P303
   Hall PL, 2014, MOL GENET METAB, V113, P274, DOI 10.1016/j.ymgme.2014.10.007
   Hoffmann L, 2012, J INHERIT METAB DIS, V35, P269, DOI 10.1007/s10545-011-9391-8
   Liebig M, 2006, PEDIATRICS, V118, P1065, DOI 10.1542/peds.2006-0666
   Lindner M, 2010, J INHERIT METAB DIS, V33, P521, DOI 10.1007/s10545-010-9076-8
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Lund AM, 2010, J INHERIT METAB DIS, V33, P495, DOI 10.1007/s10545-009-9000-2
   Marsden D, 2001, EUR J PEDIATR, V160, P599, DOI 10.1007/s004310100808
   Mathur A, 1999, CIRCULATION, V99, P1337, DOI 10.1161/01.CIR.99.10.1337
   McHugh DMS, 2011, GENET MED, V13, P230, DOI 10.1097/GIM.0b013e31820d5e67
   Merinero B, 1999, J INHERIT METAB DIS, V22, P802, DOI 10.1023/A:1005553907216
   Merritt JL, 2014, MOL GENET METAB, V111, P484, DOI 10.1016/j.ymgme.2014.01.009
   Miller MJ, 2015, MOL GENET METAB, V116, P139, DOI 10.1016/j.ymgme.2015.08.011
   MILLINGTON DS, 1990, J INHERIT METAB DIS, V13, P321, DOI 10.1007/BF01799385
   Oey NA, 2006, J INHERIT METAB DIS, V29, P71, DOI 10.1007/s10545-006-0199-x
   Orii KO, 1995, BIOCHEM BIOPH RES CO, V217, P987, DOI 10.1006/bbrc.1995.2867
   Parini R, 1998, EUR J PEDIATR, V157, P992, DOI 10.1007/s004310050984
   Pena LDM, 2016, MOL GENET METAB, V118, P272, DOI 10.1016/j.ymgme.2016.05.007
   Rakheja D, 2002, PLACENTA, V23, P447, DOI 10.1053/plac.2002.0808
   ROGUIN N, 1995, J AM COLL CARDIOL, V26, P1545, DOI 10.1016/0735-1097(95)00358-4
   Ryder B, 2016, J INHERIT METAB DIS, V39, P409, DOI 10.1007/s10545-015-9911-z
   Sahai I, 2011, J PEDIATR-US, V158, P172, DOI 10.1016/j.jpeds.2010.09.026
   Sands AJ, 1999, ARCH DIS CHILD-FETAL, V81, PF61, DOI 10.1136/fn.81.1.F61
   Schymik I, 2006, J PEDIATR-US, V149, P128, DOI 10.1016/j.jpeds.2006.02.037
   Solis JO, 2002, J AM DIET ASSOC, V102, P1800, DOI 10.1016/S0002-8223(02)90386-X
   Souri M, 1996, AM J HUM GENET, V58, P97
   Spiekerkoetter U, 2005, PEDIATR RES, V57, P760, DOI 10.1203/01.PDR.0000157915.26049.47
   Spiekerkoetter U, 2004, EUR J CLIN INVEST, V34, P191, DOI 10.1111/j.1365-2362.2004.01308.x
   Spiekerkoetter U, 2012, JIMD REP, V6, P113, DOI 10.1007/8904_2012_129
   Spiekerkoetter U, 2003, J PEDIATR-US, V143, P335, DOI 10.1067/S0022-3476(03)00292-0
   Spiekerkoetter U, 2007, J INHERIT METAB DIS, V30, P405, DOI 10.1007/s10545-007-0548-4
   Spiekerkoetter U, 2009, J INHERIT METAB DIS, V32, P498, DOI 10.1007/s10545-009-1126-8
   Spiekerkoetter U, 2008, MOL GENET METAB, V94, P428, DOI 10.1016/j.ymgme.2008.04.002
   Spiekerkoetter U, 2010, J INHERIT METAB DIS, V33, P539, DOI 10.1007/s10545-010-9121-7
   SpiekerkÃ¶tter U, 2000, ACTA PAEDIATR, V89, P492, DOI 10.1080/080352500750028267
   Therrell BL, 2014, MOL GENET METAB, V113, P14, DOI 10.1016/j.ymgme.2014.07.009
   Tucci S, 2017, J INHERIT METAB DIS, V40, P317, DOI 10.1007/s10545-017-0016-8
   Vockley J, 2015, MOL GENET METAB, V116, P53, DOI 10.1016/j.ymgme.2015.06.006
   Wanders RJA, 2016, FRONT CELL DEV BIOL, V3, P0, DOI 10.3389/fcell.2015.00083
   Winter SC, 2003, J INHERIT METAB DIS, V26, P171, DOI 10.1023/A:1024433100257
   Wood JC, 2001, PEDIATRICS, V108, P0, DOI 10.1542/peds.108.1.e19
   YAMAGUCHI S, 1993, PEDIATR RES, V34, P111, DOI 10.1203/00006450-199307000-00025
NR 65
TC 21
Z9 27
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD MAY 15
PY 2019
VL 127
IS 1
BP 64
EP 73
DI 10.1016/j.ymgme.2019.04.001
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA ID5SD
UT WOS:000471735400009
PM 31031081
DA 2024-11-01
ER

PT J
AU Lee, JH
   Kim, MJ
   Park, SH
   Chae, JH
   Shin, K
AF Lee, Jae Hyun
   Kim, Min Jung
   Park, Sung-Hye
   Chae, Jong-Hee
   Shin, Kichul
TI Case study of an inborn error manifested in the elderly: A woman with adult-onset mitochondrial disease mimicking systemic vasculitis
SO INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
LA English
DT Article
DE Fanconi syndrome; MELAS; mitochondrial myopathy
ID stroke-like episodes; lactic-acidosis; melas; encephalopathy; myopathy
AB Mitochondrial diseases are a group of disorders presenting mainly during infancy due to pathological dysfunction of the mitochondrial respiratory chain. We report a case of mitochondrial disease in an elderly woman complaining of generalized myalgia. A 69-year-old woman was admitted due to fatigue, general weakness, and a drowsy mental status. A brain magnetic resonance imaging (MRI) demonstrated multifocal lesions of increased T2 signal intensity, and laboratory findings were consistent with Fanconi syndrome. During her hospital course, she developed seizures, stress-induced cardiomyopathy, and respiratory failure. A muscle biopsy demonstrated ragged-red fibers in the muscle tissues seen in mitochondrial myopathy. We confirmed an 8 kb deletion in her mitochondrial DNA. Following treatment with l-carnitine, coenzyme Q10, and supportive measures, brain lesions on MRI scans disappeared, and the general symptoms gradually improved.
C1 [Lee, Jae Hyun] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea.
   [Kim, Min Jung] Seoul Natl Univ, Seoul Natl Univ Hosp, Div Rheumatol, Coll Med, Seoul, South Korea.
   [Park, Sung-Hye] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Pathol, Coll Med, Seoul, South Korea.
   [Chae, Jong-Hee] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Coll Med, Seoul, South Korea.
   [Shin, Kichul] Seoul Metropolitan Govt Seoul Natl Univ, Div Rheumatol, Boramae Med Ctr, Seoul, South Korea.
C3 Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital
RP Shin, K (corresponding author), Seoul Metropolitan Govt Seoul Natl Univ, Div Rheumatol, Boramae Med Ctr, Seoul, South Korea.
EM kideb1@snu.ac.kr
CR Abdullah Mishal, 2012, J MED CASE REP, V6, P55, DOI 10.1186/1752-1947-6-55
   Cohen BH, 2013, NEUROTHERAPEUTICS, V10, P227, DOI 10.1007/s13311-013-0188-3
   DeSouza RA, 2004, SOUTH MED J, V97, P528, DOI 10.1097/00007611-200405000-00023
   Enns GM, 2014, J CHILD NEUROL, V29, P1235, DOI 10.1177/0883073814538509
   FERNANDEZSOLA J, 1992, POSTGRAD MED J, V68, P212, DOI 10.1136/pgmj.68.797.212
   Finsterer J, 2009, FORTSCHR NEUROL PSYC, V77, P631, DOI 10.1055/s-0028-1109759
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060
   MANCIAS P, 1995, PHARMACOTHERAPY, V15, P528
   Muravchick S, 2008, ADV DRUG DELIVER REV, V60, P1553, DOI 10.1016/j.addr.2008.03.019
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Villanova M, 1999, MUSCLE NERVE, V22, P289, DOI 10.1002/(SICI)1097-4598(199902)22:2<289::AID-MUS26>3.0.CO;2-O
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 14
TC 5
Z9 5
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1756-1841
EI 1756-185X
J9 INT J RHEUM DIS
JI Int. J. Rheum. Dis.
PD JUN 15
PY 2019
VL 22
IS 6
BP 1152
EP 1156
DI 10.1111/1756-185X.13575
PG 5
WC Rheumatology
SC Rheumatology
GA II8OC
UT WOS:000475450300027
PM 30968563
DA 2024-11-01
ER

PT J
AU Dong, HL
   Ma, Y
   Li, QF
   Du, YC
   Yang, L
   Chen, S
   Wu, ZY
AF Dong, Hai-Lin
   Ma, Yin
   Li, Quan-Fu
   Du, Yi-Chu
   Yang, Lu
   Chen, Sheng
   Wu, Zhi-Ying
TI Genetic and clinical features of Chinese patients with mitochondrial ataxia identified by targeted next-generation sequencing
SO CNS NEUROSCIENCE & THERAPEUTICS
LA English
DT Article
DE ataxia; Chinese; mitochondria; targeted next-generation sequencing
ID progressive external ophthalmoplegia; onset spinocerebellar ataxia; transfer-rna; leigh-syndrome; dna; mutations; variants; disease; common; classification
AB Aim To characterize the mutations in mitochondrial DNA (mtDNA) and mitochondrion-related nuclear genes (nDNA), and clinical features in Chinese patients with mitochondrial ataxia. Methods Targeted next-generation sequencing (NGS) technology was performed to screen the whole mtDNA sequence and nDNA genes in a cohort of 33 unrelated ataxia patients. Results A total of 5 pedigrees were finally genetically diagnosed as mitochondrial ataxia, with 3 pathogenic mutations (m.8344A>G, m.9176T>C, and m.9185T>C), one likely pathogenic mutation (m.3995A>G) in mtDNA, and one pathogenic mutation (c.1159_1162dupAAGT, p.Ser388Terfs) in PDHA1. The prevalence of mitochondrial ataxia in our patient cohort is 15.2%. In addition, all 4 patients with mtDNA mutations experienced symptoms of ataxia with age at onset ranging from 12 to 39 years (21 +/- 12.2) and developed extrapyramidal symptoms during the disease course. One male patient with pyruvate dehydrogenase deficiency showed an acute intermittent ataxia phenotype. Conclusions Our results implicate that mitochondrial ataxia might not be as rare in Chinese as previously assumed. This study firstly defines the mutations of mitochondrial ataxia in a Chinese population by targeted NGS, which broadens the clinical spectrum of mtDNA mutations and highlights the importance of screening mtDNA and nDNA mutations among undefined ataxia patients.
C1 [Dong, Hai-Lin; Ma, Yin; Li, Quan-Fu; Du, Yi-Chu; Yang, Lu; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Dept Neurol, Hangzhou, Zhejiang, Peoples R China.
   [Dong, Hai-Lin; Ma, Yin; Li, Quan-Fu; Du, Yi-Chu; Yang, Lu; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Res Ctr Neurol, Hangzhou, Zhejiang, Peoples R China.
   [Dong, Hai-Lin; Ma, Yin; Li, Quan-Fu; Du, Yi-Chu; Yang, Lu; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Key Lab Med Neurobiol Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.
   [Chen, Sheng] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China.
C3 Zhejiang University; Zhejiang University; Zhejiang University; Fudan University
RP Wu, ZY (corresponding author), Zhejiang Univ, Sch Med, Dept Neurol, Hangzhou, Zhejiang, Peoples R China.; Wu, ZY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Res Ctr Neurol, Hangzhou, Zhejiang, Peoples R China.
EM zhiyingwu@zju.edu.cn
FU National Natural Science Foundation [81125009]; research foundation for distinguished scholar of Zhejiang University [188020-193810101/089]
CR Alsemari A, 2016, CLIN CASE REP, V4, P111, DOI 10.1002/ccr3.435
   Bargiela David, 2015, CEREBELLUM ATAXIAS, V2, P16, DOI 10.1186/s40673-015-0035-x
   Castellana S, 2015, HUM MUTAT, V36, PE2413, DOI 10.1002/humu.22720
   Chen B, 2008, AM J MED GENET A, V146A, P1248, DOI 10.1002/ajmg.a.32285
   Chen S, 2016, CNS NEUROSCI THER, V22, P38, DOI 10.1111/cns.12443
   DeBrosse SD, 2012, MOL GENET METAB, V107, P394, DOI 10.1016/j.ymgme.2012.09.001
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Dong Y, 2015, PARKINSONISM RELAT D, V21, P398, DOI 10.1016/j.parkreldis.2015.01.006
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P543, DOI 10.1017/S0317167100008027
   Gamba J, 2012, J NEUROL SCI, V320, P131, DOI 10.1016/j.jns.2012.05.037
   Gan SR, 2010, BMC MED GENET, V11, P0, DOI 10.1186/1471-2350-11-47
   Gerards M, 2016, MOL GENET METAB, V117, P300, DOI 10.1016/j.ymgme.2015.12.004
   Goodship JA, 2002, J MED GENET, V39, P221, DOI 10.1136/jmg.39.3.221
   Hadjivassiliou M, 2017, J NEUROL NEUROSUR PS, V88, P301, DOI 10.1136/jnnp-2016-314863
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   HATTORI Y, 1994, J NEUROL SCI, V125, P50, DOI 10.1016/0022-510X(94)90241-0
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Klockgether T, 2010, LANCET NEUROL, V9, P94, DOI 10.1016/S1474-4422(09)70305-9
   Lee YC, 2007, J NEUROL SCI, V254, P65, DOI 10.1016/j.jns.2007.01.005
   Li HF, 2017, NEUROBIOL AGING, V49, P0, DOI 10.1016/j.neurobiolaging.2016.09.018
   Li LX, 2017, HUM MUTAT, V38, P1569, DOI 10.1002/humu.23309
   Lin J, 2014, MITOCHONDR DNA, V25, P56, DOI 10.3109/19401736.2013.779259
   Liu ZJ, 2017, CLIN GENET, V92, P267, DOI 10.1111/cge.13015
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Makino M, 1998, NEUROMUSCULAR DISORD, V8, P149, DOI 10.1016/S0960-8966(98)00017-0
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   NAITO E, 1994, HUM MOL GENET, V3, P1193, DOI 10.1093/hmg/3.7.1193
   Niroula A, 2016, NUCLEIC ACIDS RES, V44, P2020, DOI 10.1093/nar/gkw046
   Okura T, 2003, HUM GENET, V113, P432, DOI 10.1007/s00439-003-0983-8
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   Piccoli C, 2008, J MED GENET, V45, P596, DOI 10.1136/jmg.2008.058628
   Pulkes T, 2012, J NEUROL NEUROSUR PS, V83, P857, DOI 10.1136/jnnp-2012-302959
   Qin YW, 2014, J AM HEART ASSOC, V3, P0, DOI 10.1161/JAHA.113.000437
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Saitoh S, 1998, J CHILD NEUROL, V13, P573, DOI 10.1177/088307389801301109
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Sun YM, 2016, CLIN GENET, V90, P305, DOI 10.1111/cge.12808
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Synofzik M, 2012, EUR J NEUROL, V19, Pe114, DOI 10.1111/j.1468-1331.2012.03812.x
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   Wang J, 2012, GENET MED, V14, P620, DOI 10.1038/gim.2012.4
   Wei YL, 2009, CLIN EXP PHARMACOL P, V36, P933, DOI 10.1111/j.1440-1681.2009.05183.x
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 49
TC 6
Z9 6
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1755-5930
EI 1755-5949
J9 CNS NEUROSCI THER
JI CNS Neurosci. Ther.
PD JAN 15
PY 2019
VL 25
IS 1
BP 21
EP 29
DI 10.1111/cns.12972
PG 9
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA HE8GS
UT WOS:000453684300003
PM 29756269
DA 2024-11-01
ER

PT J
AU Paramasiyam, A
   Venkatapathi, C
   Sandeep, G
   Meena, AK
   Uppin, MS
   Mohapatra, S
   Pitceathly, RDS
   Thangaraj, K
AF Paramasiyam, Arumugam
   Venkatapathi, Challa
   Sandeep, Gampa
   Meena, Angamuthu K.
   Uppin, Megha S.
   Mohapatra, Swati
   Pitceathly, Robert D. S.
   Thangaraj, Kumarasamy
TI Homozygous R627W mutations in <i>POLG</i> cause mitochondrial DNA depletion leading to encephalopathy, seizures and stroke-like episodes
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial disease; POLG; Encephalopathy; Seizures; Status epilepticus; Stroke-like episode; mtDNA
ID progressive external ophthalmoplegia; polymerase gamma; read alignment; consequence; phenotype; spectrum
AB Mutations in the mitochondrial DNA maintenance gene POLG (DNA Polymerase Gamma, Catalytic Subunit), encoding mitochondrial DNA polymerase gamma (pol gamma), are associated with an extremely broad phenotypic spectrum. We identified homozygous POLG c.1879C > T; p.R627W mutations in two siblings from a consanguineous South Asian family following targeted resequencing of 75 nuclear-encoded mitochondrial genes. Both patients presented with encephalopathy, seizures and stroke-like episodes, and mitochondrial DNA depletion was confirmed in the proband's muscle tissue. Subsequent Sanger sequencing of POLG in a further 275 unrelated probands with genetically unconfirmed mitochondrial disease revealed a third unrelated proband with a similar phenotype harboring homozygous c.1879C > T; p.R627W mutations and a fourth patient, with a milder clinical disorder, harboring compound heterozygous POLG c.1879C > T; p.R627W and c.2341G > A; p.A781T mutations. Given endogamous practices in the Indian subcontinent, homozygous POLG c.1879C > T; p.R627W mutations should be excluded in South Asian patients presenting with encephalopathy, seizures and stroke-like episodes.
C1 [Paramasiyam, Arumugam; Venkatapathi, Challa; Mohapatra, Swati; Thangaraj, Kumarasamy] Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, India.
   [Paramasiyam, Arumugam] Saveetha Univ, Saveetha Inst Med & Tech Sci SIMMS, Saveetha Dent Coll & Hosp, BRULAC DRC, Chennai, Tamil Nadu, India.
   [Sandeep, Gampa] Bhimavaram Hosp, Dept Neurol, Bhimavaram, India.
   [Meena, Angamuthu K.] Nizams Inst Med Sci, Dept Neurol, Hyderabad, India.
   [Uppin, Megha S.] Nizams Inst Med Sci, Dept Pathol, Hyderabad, India.
   [Pitceathly, Robert D. S.] Inst Neurol, MRC Ctr Neuromuscular Dis, UCL Queen Sq, London, England.
   [Pitceathly, Robert D. S.] Natl Hosp Neurol & Neurosurg, London, England.
   [Pitceathly, Robert D. S.] UCL, Dept Neuromuscular Dis, Inst Neurol, Queen Sq, London, England.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Saveetha Institute of Medical & Technical Science; Saveetha Dental College & Hospital; Nizam's Institute of Medical Sciences; Nizam's Institute of Medical Sciences; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London
RP Thangaraj, K (corresponding author), Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, India.
EM thangs@ccmb.res.in
FU NCP project from the Council of Scientific and Industrial Research (CSIR), Government of India [MLP0117, GAP0517]; Science and Engineering Research Board (SERB), Government of India [GAP0517, PDF/2016/000881]; Medical Research Council Clinician Scientist Fellowship [MR/S002065/1]; MRC [MR/S002065/1] Funding Source: UKRI
CR Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Boengler K, 2011, BBA-MOL CELL RES, V1813, P1286, DOI 10.1016/j.bbamcr.2011.01.009
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chinnery PF, 1993, SOURCE GENEREVIEWS, V0, P0
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI 10.1093/bioinformatics/btp100
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Meyer LR, 2013, NUCLEIC ACIDS RES, V41, PD64, DOI 10.1093/nar/gks1048
   Nakatsuka N, 2017, NAT GENET, V49, P1403, DOI 10.1038/ng.3917
   Nolte KW, 2013, NEUROPATHOLOGY, V33, P59, DOI 10.1111/j.1440-1789.2012.01317.x
   Paramasivam A, 2016, MITOCHONDRION, V26, P81, DOI 10.1016/j.mito.2015.12.006
   Pitceathly RDS, 2013, J NEUROL NEUROSUR PS, V84, P107, DOI 10.1136/jnnp-2012-303232
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Thangaraj K, 2002, J ANDROL, V23, P815
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
NR 21
TC 8
Z9 8
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP 15
PY 2019
VL 48
IS 
BP 78
EP 83
DI 10.1016/j.mito.2019.08.003
PG 6
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA JA3YX
UT WOS:000487766600009
PM 31425757
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Laccone, F
AF Finsterer, Josef
   Laccone, Franco
TI Autosomal dominant optic atrophy plus due to the novel OPA1 variant c.1463G&gt;C
SO METABOLIC BRAIN DISEASE
LA English
DT Article
DE Optic atrophy; Retinal ganglion cells; Migraine; Hypoacusis; Mutation; Multiple mtDNA deletions
ID mutations
AB OPA1 variants most frequently manifest phenotypically with pure autosomal dominant optic atrophy (ADOA) or with ADOA plus. The most frequent abnormalities in ADOA plus in addition to the optic nerve affection include hypoacusis, migraine, myopathy, and neuropathy. Hypertelorism and atrophy of the acoustic nerve have not been reported. The patient is a 48yo Caucasian female with slowly progressive, visual impairment since childhood, bilateral hypoacusis since age 10y, and classical migraine since age 20y. The family history was positive for diabetes (father, mother) and visual impairment (daughter). Clinical examination revealed hypertelorism, visual impairment, hypoacusis, tinnitus, weakness for elbow flexion and finger straddling, and generally reduced tendon reflexes. MRI of the cerebrum was non-informative but hypoplasia of the acoustic nerve bilaterally was described. Visually-evoked potentials revealed markedly prolonged P100-latencies bilaterally. Acoustically-evoked potentials were distorted with poor reproducibility and prolonged latencies. Muscle biopsy revealed reduced activities of complexes I, II, and IV. Genetic work-up revealed the novel variant c.1463G>C in the OPA1 gene. This case provides novel information regarding the genotype of ADOA plus. The novel OPA1 variant c.1463G>C not only manifests with visual impairment, hypoacusis, migraine, and myopathy, but also with hypertelorisms and acoustic nerve atrophy.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Messerli Inst, Postfach 20, A-1180 Vienna, Austria.
   [Laccone, Franco] Med Univ Vienna, Inst Med Genet, Wahringer Str 10, A-1090 Vienna, Austria.
C3 Rudolfstiftung Hospital; Medical University of Vienna
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Messerli Inst, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de; franco.laccone@meduniwien.ac.at
CR Ahmad KE, 2015, J NEUROL, V262, P2323, DOI 10.1007/s00415-015-7849-6
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200
   Finsterer J, 2018, MITOCHONDRION, V42, P1, DOI 10.1016/j.mito.2017.10.003
   Gerber S, 2017, BRAIN, V140, P2586, DOI 10.1093/brain/awx219
   Ham M, 2019, MITOCHONDRION, V46, P262, DOI 10.1016/j.mito.2018.07.006
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Li HJ, 2018, OPHTHALMIC GENET, V39, P569, DOI 10.1080/13816810.2018.1466337
   Liskova P, 2013, ACTA OPHTHALMOL, V91, PE225, DOI 10.1111/aos.12038
   Nasca A, 2017, ORPHANET J RARE DIS, V12, P0, DOI 10.1186/s13023-017-0641-1
   Pretegiani E, 2017, J NEUROL SCI, V382, P29, DOI 10.1016/j.jns.2017.09.018
   Santarelli R, 2015, BRAIN, V138, P563, DOI 10.1093/brain/awu378
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 16
TC 1
Z9 1
U1 1
U2 1
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0885-7490
EI 1573-7365
J9 METAB BRAIN DIS
JI Metab. Brain Dis.
PD AUG 15
PY 2019
VL 34
IS 4
BP 1023
EP 1027
DI 10.1007/s11011-019-00425-0
PG 5
WC Endocrinology & Metabolism; Neurosciences
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA IJ1ZL
UT WOS:000475697800007
PM 31152339
DA 2024-11-01
ER

PT J
AU Sinnecker, T
   Andelova, M
   Mayr, M
   RÃ¼egg, S
   Sinnreich, M
   Hench, J
   Frank, S
   Schaller, A
   Stippich, C
   Wuerfel, J
   Bonati, LH
AF Sinnecker, Tim
   Andelova, Michaela
   Mayr, Michael
   Ruegg, Stephan
   Sinnreich, Michael
   Hench, Juergen
   Frank, Stephan
   Schaller, Andre
   Stippich, Christoph
   Wuerfel, Jens
   Bonati, Leo H.
TI Diagnosis of adult-onset MELAS syndrome in a 63-year-old patient with suspected recurrent strokes - a case report
SO BMC NEUROLOGY
LA English
DT Article
DE MELAS; Stroke-like episodes; Recurrent ischemic strokes; MRI
ID lactic-acidosis; mitochondrial-myopathy; episodes melas; encephalopathy; encephalomyopathy; diffusion; disorders; serial
AB BackgroundMitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) is a mitochondrial cytopathy caused by mutations in mitochondrial DNA. Clinical manifestation is typically before the age of 40.Case presentationWe present the case of a 63-year-old female in whom the symptoms of MELAS were initially misdiagnosed as episodes of recurrent ischemic strokes. Brain imaging including MRI, clinical and laboratory findings that lent cues to the diagnosis of MELAS are discussed. In addition, MRI findings in MELAS in comparison to imaging mimics of MELAS are presented.ConclusionsThis case underscores the importance of considering MELAS as a potential cause of recurrent stroke-like events if imaging findings are untypical for cerebral infarction, even among middle-aged patients with vascular risk factors.
C1 [Sinnecker, Tim; Andelova, Michaela; Ruegg, Stephan; Sinnreich, Michael; Bonati, Leo H.] Univ Hosp, Dept Med, Neurol Clin & Policlin, Petersgraben 4, CH-4031 Basel, Switzerland.
   [Sinnecker, Tim; Andelova, Michaela; Ruegg, Stephan; Sinnreich, Michael; Bonati, Leo H.] Univ Hosp, Dept Clin Res, Neurol Clin & Policlin, Petersgraben 4, CH-4031 Basel, Switzerland.
   [Sinnecker, Tim; Andelova, Michaela; Ruegg, Stephan; Sinnreich, Michael; Bonati, Leo H.] Univ Hosp, Dept Biomed Engn, Neurol Clin & Policlin, Petersgraben 4, CH-4031 Basel, Switzerland.
   [Sinnecker, Tim; Andelova, Michaela; Mayr, Michael; Ruegg, Stephan; Sinnreich, Michael; Hench, Juergen; Frank, Stephan; Stippich, Christoph; Bonati, Leo H.] Univ Basel, Petersgraben 4, CH-4031 Basel, Switzerland.
   [Sinnecker, Tim; Wuerfel, Jens] Med Imaging Anal Ctr AG, Basel, Switzerland.
   [Mayr, Michael] Univ Hosp, Dept Internal Med, Basel, Switzerland.
   [Hench, Juergen; Frank, Stephan] Univ Hosp, Inst Pathol, Div Neuropathol, Basel, Switzerland.
   [Schaller, Andre] Univ Bern, Bern Univ Hosp, Inselspital, Div Human Genet,Dept Pediat, Bern, Switzerland.
   [Stippich, Christoph] Univ Hosp, Dept Radiol, Basel, Switzerland.
C3 University of Basel; University of Bern; University Hospital of Bern
RP Bonati, LH (corresponding author), Univ Hosp, Dept Med, Neurol Clin & Policlin, Petersgraben 4, CH-4031 Basel, Switzerland.; Bonati, LH (corresponding author), Univ Hosp, Dept Clin Res, Neurol Clin & Policlin, Petersgraben 4, CH-4031 Basel, Switzerland.; Bonati, LH (corresponding author), Univ Hosp, Dept Biomed Engn, Neurol Clin & Policlin, Petersgraben 4, CH-4031 Basel, Switzerland.; Bonati, LH (corresponding author), Univ Basel, Petersgraben 4, CH-4031 Basel, Switzerland.
EM Tim.Sinnecker@usb.ch; Leo.Bonati@usb.ch
CR Adam G, 2018, INSIGHTS IMAGING, V0, P0
   Aurangzeb Sidra, 2014, PRACT NEUROL, V14, P432, DOI 10.1136/practneurol-2014-000853
   Brady E, 2018, CLIN IMAG, V47, P80, DOI 10.1016/j.clinimag.2017.08.008
   CRIMMINS D, 1993, J NEUROL NEUROSUR PS, V56, P900, DOI 10.1136/jnnp.56.8.900
   Devine MJ, 2018, NAT REV NEUROSCI, V19, P63, DOI 10.1038/nrn.2017.170
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Fang GL, 2018, CLIN INTERV AGING, V13, P2421, DOI 10.2147/CIA.S186636
   Farrar MA, 2010, PEDIATRICS, V126, PE734, DOI 10.1542/peds.2009-2930
   Geberhiwot T, 2006, NEW ENGL J MED, V354, P1096
   Gieraerts C, 2013, J COMPUT ASSIST TOMO, V37, P279, DOI 10.1097/RCT.0b013e3182811170
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Kimata KG, 1998, ARCH NEUROL-CHICAGO, V55, P722, DOI 10.1001/archneur.55.5.722
   Kisanuki YY, 2006, ARCH NEUROL-CHICAGO, V63, P1200, DOI 10.1001/archneur.63.8.1200
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Kubota H, 2005, J CHILD NEUROL, V20, P116, DOI 10.1177/08830738050200020601
   Kung NH, 2016, JAMA NEUROL, V73, P880, DOI 10.1001/jamaneurol.2016.1336
   Li JY, 2007, J FORMOS MED ASSOC, V106, P528, DOI 10.1016/S0929-6646(07)60003-5
   Lyoubi-Idrissi A, 2017, STROKE, V48, P1408, DOI 10.1161/STROKEAHA.116.015724
   Malhotra K, 2016, CURR PAIN HEADACHE R, V20, P0, DOI 10.1007/s11916-016-0583-7
   Marques-Matos C, 2016, JAMA NEUROL, V73, P604, DOI 10.1001/jamaneurol.2015.5061
   MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Narita Hiroyuki, 2004, NO TO SHINKEI, V56, P345
   Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Sharfstein SR, 1999, ARCH NEUROL-CHICAGO, V56, P241, DOI 10.1001/archneur.56.2.241
   Sheerin F, 2008, CLIN RADIOL, V63, P1245, DOI 10.1016/j.crad.2007.12.018
   Testai FD, 2010, ARCH NEUROL-CHICAGO, V67, P19, DOI 10.1001/archneurol.2009.309
   Tzoulis C, 2009, STROKE, V40, PE15, DOI 10.1161/STROKEAHA.108.523118
   Wang XY, 2003, NEURORADIOLOGY, V45, P640, DOI 10.1007/s00234-003-1029-6
   Wattjes MP, 2013, MULT SCLER J, V19, P1826, DOI 10.1177/1352458513510224
   Xu WXZ, 2018, J COMPUT ASSIST TOMO, V42, P510, DOI 10.1097/RCT.0000000000000712
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
NR 37
TC 17
Z9 17
U1 1
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2377
EI 
J9 BMC NEUROL
JI BMC Neurol.
PD MAY 8
PY 2019
VL 19
IS 
BP 
EP 
DI 10.1186/s12883-019-1306-6
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA HX7ML
UT WOS:000467589100003
PM 31068171
DA 2024-11-01
ER

PT J
AU Lu, JQ
   Mubaraki, A
   Yan, CZ
   Provias, J
   Tarnopolsky, MA
AF Lu, Jian-Qiang
   Mubaraki, Adnan
   Yan, Chuanzhu
   Provias, John
   Tarnopolsky, Mark A.
TI Neurogenic Muscle Biopsy Findings Are Common in Mitochondrial Myopathy
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Denervation atrophy; Fiber type grouping; Mitochondrial disease; Mitochondrial myopathy; Neurogenic features; Neuropathy; Type 2 fiber predominance
ID peripheral neuropathy; neuromuscular system; denervated muscle; skeletal-muscle; dna; generation; abnormality; involvement; disorders; mutations
AB Mitochondrial diseases (MIDs) involve peripheral nerves and skeletal muscle, but the prevalence of mitochondrial neuropathy is still unclear. Mitochondrial neuropathy has been found to correlate with muscle weakness that may be due to myopathic and/or neurogenic myopathy in patients with MIDs. We examined vastus lateralis muscle biopsies of 58 consecutive patients with mitochondrial myopathy (MM), compared with 204 consecutive non-MM patients. Muscle fiber denervation atrophy was found in 39/58 (67%) of MM patients, significantly more than 41/204 (20%) of non-MM patients and 20/58 (34%) of clinically diagnosed neuropathy. Fiber type grouping was noted in 15/58 (26%) of MM patients, significantly more than 15/204 (7%) of non-MM patients. Type 2 fiber predominance (T2FP) was identified in 7/58 (12%) of MM patients, significantly more than 1/204 (0.5%) of non-MM patients. After dividing patients into age groups, muscle fiber denervation atrophy was significantly more in MM patients aged >50 years than MM patients aged <= 50 years, without differences from all MM patients; there were no differences in fiber type grouping or T2FP between the 2 age groups. Finally, electron microscopy demonstrated MM ultrastructural changes in the neuromuscular junctions. Our findings suggest that a neurogenic component in MM is common.
C1 [Lu, Jian-Qiang; Provias, John] McMaster Univ, Dept Pathol & Mol Med Neuropathol, Hamilton, ON, Canada.
   [Mubaraki, Adnan; Tarnopolsky, Mark A.] McMaster Univ, Dept Med Neurol, Hamilton, ON, Canada.
   [Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada.
   [Yan, Chuanzhu] Shandong Univ, Neuromuscular Ctr, Qilu Hosp, Jinan, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Mitochondrial Med Lab, Qilu Hosp, Jinan, Shandong, Peoples R China.
C3 McMaster University; McMaster University; McMaster University; Shandong University; Shandong University
RP Lu, JQ (corresponding author), McMaster Univ, Hamilton Gen Hosp, 237 Barton St, Hamilton, ON L8L 2X2, Canada.
EM luj85@mcmaster.ca
CR [Anonymous], 2013, MUSCLE BIOPSY PRACTI, V0, P0
   Areti A, 2016, CURR NEUROPHARMACOL, V14, P593, DOI 10.2174/1570159X14666151126215358
   Chu CC, 1997, EUR NEUROL, V37, P110, DOI 10.1159/000117420
   Cormio A, 2005, NEUROBIOL AGING, V26, P655, DOI 10.1016/j.neurobiolaging.2004.06.014
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DING R, 1982, BRAIN RES, V253, P47, DOI 10.1016/0006-8993(82)90672-2
   EISENBERG HA, 1994, J APPL PHYSIOL, V76, P859, DOI 10.1152/jappl.1994.76.2.859
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   Finsterer J, 2005, CLIN NEUROL NEUROSUR, V107, P181, DOI 10.1016/j.clineuro.2004.07.001
   Finsterer J, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7020016
   Finsterer J, 2016, NEUROMUSCULAR DISORD, V26, P548, DOI 10.1016/j.nmd.2016.06.006
   Flippo KH, 2017, J CELL SCI, V130, P671, DOI 10.1242/jcs.171017
   Gehrig SM, 2016, ORPHANET J RARE DIS, V11, P0, DOI 10.1186/s13023-016-0488-x
   Girlanda P, 1999, CLIN NEUROPHYSIOL, V110, P1284, DOI 10.1016/S1388-2457(98)00041-8
   Haas RH, 2014, SEMIN NEUROL, V34, P321, DOI 10.1055/s-0034-1386770
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kerkhof J, 2017, J MOL DIAGN, V19, P905, DOI 10.1016/j.jmoldx.2017.07.004
   KRENDEL DA, 1987, MUSCLE NERVE, V10, P299, DOI 10.1002/mus.880100404
   Lu JQ, 2016, J NEUROL SCI, V360, P84, DOI 10.1016/j.jns.2015.11.053
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Mancuso M, 2012, NEUROL SCI, V33, P449, DOI 10.1007/s10072-011-0703-4
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Mitchell WK, 2012, FRONT PHYSIOL, V3, P0, DOI 10.3389/fphys.2012.00260
   Mosole S, 2014, J NEUROPATH EXP NEUR, V73, P284, DOI 10.1097/NEN.0000000000000032
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pollock N, 2017, FREE RADICAL BIO MED, V112, P84, DOI 10.1016/j.freeradbiomed.2017.07.017
   Rygiel KA, 2016, J PHYSIOL-LONDON, V594, P4499, DOI 10.1113/JP271212
   Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850
   Schenkel LC, 2016, J MOL DIAGN, V18, P657, DOI 10.1016/j.jmoldx.2016.04.002
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   van Stralen KJ, 2010, NEPHRON CLIN PRACT, V116, PC143, DOI 10.1159/000315883
   Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215
   Venhoff N, 2012, ARTHRITIS RES THER, V14, P0, DOI 10.1186/ar4076
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   WICKS KL, 1991, AM J PHYSIOL, V260, PC841, DOI 10.1152/ajpcell.1991.260.4.C841
   YOSHINAGA H, 1993, J CHILD NEUROL, V8, P129, DOI 10.1177/088307389300800204
NR 39
TC 10
Z9 10
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUN 15
PY 2019
VL 78
IS 6
BP 508
EP 514
DI 10.1093/jnen/nlz029
PG 7
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA IF0ZD
UT WOS:000472806000005
PM 31100146
DA 2024-11-01
ER

PT J
AU Felhi, R
   Sfaihi, L
   Charif, M
   Desquiret-Dumas, V
   Bris, C
   GoudenÃ¨ge, D
   Ammar-Keskes, L
   Hachicha, M
   Bonneau, D
   Procaccio, V
   Reynier, P
   Amati-Bonneau, P
   Lenaers, G
   Fakhfakh, F
AF Felhi, Rahma
   Sfaihi, Lamia
   Charif, Majida
   Desquiret-Dumas, Valerie
   Bris, Celine
   Goudenege, David
   Ammar-Keskes, Leila
   Hachicha, Mongia
   Bonneau, Dominique
   Procaccio, Vincent
   Reynier, Pascal
   Amati-Bonneau, Patrizia
   Lenaers, Guy
   Fakhfakh, Faiza
TI Next generation sequencing in family with MNGIE syndrome associated to optic atrophy: Novel homozygous POLG mutation in the C-terminal sub-domain leading to mtDNA depletion
SO CLINICA CHIMICA ACTA
LA English
DT Article
DE MNGIE; POLG; OPA1; mtDNA depletion; Pathogenic variants
ID neurogastrointestinal encephalomyopathy mngie; mitochondrial-dna; disease; variants; patient; server
AB Introduction: Mitochondrial diseases are a group of disorders caused mainly by the impairment of the mitochondrial oxidative phosphorylation process, due to mutations either in the mitochondrial or nuclear genome. Among them, the mitochondrial neuro-gastrointestinal encephalo-myopathy (MNGIE) syndrome affects adolescents or young adults, and is mostly caused by TYMP mutations encoding a cytosolic thymidine phosphorylase (TP). Patients and methods: The present study reports the molecular investigation by next-generation re-sequencing of 281 nuclear genes, encoding mitochondrial proteins, of consanguineous family including two individuals with MNGIE syndrome associated to optic atrophy. Bioinformatic analysis was also performed in addition to mtDNA deletion screening and mtDNA copy number quantification in blood of the two patients which were carried out by solf clipping program and qPCR respectively. Results: Next-generation re-sequencing revealed a novel homozygous c.2391G > T POLG mutation (p.M797I) co-occurring with the hypomorphic c.1311A > G OPA1 variant (p.I437M). Analysis of the mitochondrial genome in the two patients disclosed mtDNA depletion in blood, but no deletion. Bio-informatics investigations supported the pathogenicity of the novel POW mutation that is located in the C-terminal subdomain and might change POLG 3D structure, stability and function. Conclusion: The novel homozygous p.M797I POLG mutation is responsible for MNGIE combined to optic atrophy and mtDNA depletion in the two patients.
C1 [Felhi, Rahma; Fakhfakh, Faiza] Univ Sfax, Fac Sci Sfax, Mol & Funct Genet Lab, Route Soukra Km 3, Sfax, Tunisia.
   [Charif, Majida; Desquiret-Dumas, Valerie; Bris, Celine; Goudenege, David; Bonneau, Dominique; Procaccio, Vincent; Reynier, Pascal; Amati-Bonneau, Patrizia; Lenaers, Guy] Angers Univ, Inst MitoVasc, MitoLab Team, UMR CNRS 6015,INSERM U1083, Angers, France.
   [Sfaihi, Lamia; Hachicha, Mongia] Univ Hosp Hedi Chaker, Dept Pediat, Sfax, Tunisia.
   [Ammar-Keskes, Leila] Univ Sfax, Fac Med Sfax, Human Mol Genet Lab, Sfax, Tunisia.
   [Desquiret-Dumas, Valerie; Bris, Celine; Goudenege, David; Bonneau, Dominique; Procaccio, Vincent; Reynier, Pascal; Amati-Bonneau, Patrizia] Univ Hosp Angers, Dept Biochem & Genet, Angers, France.
C3 Universite de Sfax; Faculty of Sciences Sfax; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Sfax; Hopital Habib Bourguiba; Hopital Hedi Chaker; Universite de Sfax; Universite d'Angers; Centre Hospitalier Universitaire d'Angers
RP Felhi, R; Fakhfakh, F (corresponding author), Univ Sfax, Fac Sci Sfax, Mol & Funct Genet Lab, Route Soukra Km 3, Sfax, Tunisia.
EM Rahma.90felhi@gmail.com; Faiza.fakfakh02@gmail.com
FU Ministry of Higher Education and Scientific Research in Tunisia, University of Sfax; Institut National de la Sante et de la Recherche Medicate (INSERM), France; Centre National de la Recherche Scientifique (CNRS), France; Universite d'Angers, France; University Hospital of Angers, France; Region Pays de Loire, France; Angers Loire Metropole, France
CR Adzhubei Ivan, 2013, CURR PROTOC HUM GENET, VChapter 7, P0, DOI 10.1002/0471142905.hg0720s76
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Baris Z, 2010, EUR J PEDIATR, V169, P1375, DOI 10.1007/s00431-010-1237-0
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Bonifert T, 2014, BRAIN, V137, P2164, DOI 10.1093/brain/awu165
   Bonneau D, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu184
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101
   Chiaratti MR, 2011, MITOCHONDRION, V11, P820, DOI 10.1016/j.mito.2010.11.004
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   De Baets G, 2012, NUCLEIC ACIDS RES, V40, PD935, DOI 10.1093/nar/gkr996
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Demaria F, 2016, J ADOLESCENT HEALTH, V59, P729, DOI 10.1016/j.jadohealth.2016.08.012
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Ferreira M, 2011, NEUROMUSCULAR DISORD, V21, P483, DOI 10.1016/j.nmd.2011.03.011
   Foury F, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027847
   Montiel-Sosa JF, 2013, MITOCHONDR DNA, V24, P420, DOI 10.3109/19401736.2012.760550
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   KÃ¤llberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2
   Kasiviswanathan R, 2011, MITOCHONDRION, V11, P929, DOI 10.1016/j.mito.2011.08.003
   Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006
   Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, PD980, DOI 10.1093/nar/gkt1113
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Milone M, 2011, ARCH NEUROL-CHICAGO, V68, P806, DOI 10.1001/archneurol.2011.124
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Nurminen A, 2017, BBA CLIN, V7, P147, DOI 10.1016/j.bbacli.2017.04.001
   Prasun P, 2014, J NEUROL, V261, P1818, DOI 10.1007/s00415-014-7428-2
   Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036
   Schimpf S, 2008, HUM MUTAT, V29, P106, DOI 10.1002/humu.20607
   Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Venegas V, 2011, CURR PROTOC HUM GENE, V0, P19
   Wei Z, 2011, NUCLEIC ACIDS RES, V39, P0, DOI 10.1093/nar/gkr599
   Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918
   Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105
NR 48
TC 13
Z9 14
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0009-8981
EI 1873-3492
J9 CLIN CHIM ACTA
JI Clin. Chim. Acta
PD JAN 15
PY 2019
VL 488
IS 
BP 104
EP 110
DI 10.1016/j.cca.2018.11.003
PG 7
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA HI9EK
UT WOS:000456757900015
PM 30395865
DA 2024-11-01
ER

PT J
AU ForsstrÃ¶m, S
   Jackson, CB
   Carroll, CJ
   Kuronen, M
   Pirinen, E
   Pradhan, S
   Marmyleva, A
   Auranen, M
   Kleine, IM
   Khan, NA
   Roivainen, A
   MarjamÃ¤ki, P
   LiljenbÃ¤ck, H
   Wang, LY
   Battersby, BJ
   Richter, U
   Velagapudi, V
   Nikkanen, J
   Euro, L
   Suomalainen, A
AF Forsstrom, Saara
   Jackson, Christopher B.
   Carroll, Christopher J.
   Kuronen, Mervi
   Pirinen, Eija
   Pradhan, Swagat
   Marmyleva, Anastasiia
   Auranen, Mari
   Kleine, Iida-Marja
   Khan, Nahid A.
   Roivainen, Anne
   Marjamaki, Paivi
   Liljenback, Heidi
   Wang, Liya
   Battersby, Brendan J.
   Richter, Uwe
   Velagapudi, Vidya
   Nikkanen, Joni
   Euro, Liliya
   Suomalainen, Anu
TI Fibroblast Growth Factor 21 Drives Dynamics of Local and Systemic Stress Responses in Mitochondrial Myopathy with mtDNA Deletions
SO CELL METABOLISM
LA English
DT Article
ID multiple deletions; metabolic-activity; dna deletions; beta-klotho; ppar-alpha; muscle; fgf21; opa1; activation; deficiency
AB Mitochondrial dysfunction elicits stress responses that safeguard cellular homeostasis against metabolic insults. Mitochondrial integrated stress response (ISRmt) is a major response to mitochondrial (mt)DNA expression stress (mtDNA maintenance, translation defects), but the knowledge of dynamics or interdependence of components is lacking. We report that in mitochondrial myopathy, ISRmt progresses in temporal stages and development from early to chronic and is regulated by autocrine and endocrine effects of FGF21, a metabolic hormone with pleiotropic effects. Initial disease signs induce transcriptional ISRmt (ATF5, mitochondria) one-carbon cycle, FGF21, and GDF15). The local progression to 2nd metabolic ISRmt stage (ATF3, ATF4, glucose uptake, serine biosynthesis, and transsulfuration) is FGF21 dependent. Mitochondria! unfolded protein response marks the 3rd ISRmt stage of failing tissue. Systemically, FGF21 drives weight loss and glucose preference, and modifies metabolism and respiratory chain deficiency in a specific hippocampal brain region. Our evidence indicates that FGF21 is a local and systemic messenger of mtDNA stress in mice and humans with mitochondrial disease.
C1 [Forsstrom, Saara; Jackson, Christopher B.; Carroll, Christopher J.; Kuronen, Mervi; Pradhan, Swagat; Marmyleva, Anastasiia; Kleine, Iida-Marja; Khan, Nahid A.; Nikkanen, Joni; Euro, Liliya; Suomalainen, Anu] Univ Helsinki, Fac Med, Stem Cells & Metab Res Program, FIN-00290 Helsinki, Finland.
   [Carroll, Christopher J.] St Georges Univ London, Mol & Clin Sci Res Inst, London SW17 0RE, England.
   [Pirinen, Eija] Univ Helsinki, Fac Med, Clin & Mol Metab Res Program, FIN-00290 Helsinki, Finland.
   [Auranen, Mari; Suomalainen, Anu] Helsinki Univ Cent Hosp, Dept Neurosci, Helsinki 00290, Finland.
   [Roivainen, Anne; Marjamaki, Paivi; Liljenback, Heidi] Univ Turku, Turku PET Ctr, FIN-20520 Turku, Finland.
   [Roivainen, Anne; Liljenback, Heidi] Univ Turku, Inst Biomed, Turku Ctr Dis Modeling, FIN-20520 Turku, Finland.
   [Wang, Liya] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, S-75007 Uppsala, Sweden.
   [Battersby, Brendan J.; Richter, Uwe] Univ Helsinki, Inst Biotechnol, Helsinki 00790, Finland.
   [Velagapudi, Vidya] Univ Helsinki, HiLIFE, Inst Mol Med Finland FIMM, Metabol Unit, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Neurosci Ctr, FIN-00290 Helsinki, Finland.
C3 University of Helsinki; City St Georges, University of London; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; Swedish University of Agricultural Sciences; University of Helsinki; University of Helsinki; University of Helsinki
RP Suomalainen, A (corresponding author), Univ Helsinki, Fac Med, Stem Cells & Metab Res Program, FIN-00290 Helsinki, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Cent Hosp, Dept Neurosci, Helsinki 00290, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Neurosci Ctr, FIN-00290 Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
FU Academy of Finland; European Research Council; Sigrid Juselius Foundation; Swiss National Science Foundation; Novartis Foundation for Medical-Biological Research; Helsinki Biomedical Graduate Program; Maud Kuistila Memorial Foundation; Oskar Oflund Foundation; Waldemar von Frenkell's Foundation; Biomedicum Helsinki Foundation
CR Agnew T, 2018, CELL REP, V25, P3315, DOI 10.1016/j.celrep.2018.11.080
   Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Ahola-ErkkilÃ¤ S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Bao XR, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10575
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   French JB, 2016, SCIENCE, V351, P733, DOI 10.1126/science.aac6054
   Gardner BM, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a013169
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Keipert S, 2014, AM J PHYSIOL-ENDOC M, V306, PE469, DOI 10.1152/ajpendo.00330.2013
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359
   KÃ¼hl I, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.30952
   Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200
   Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186
   MartÃ­ R, 2012, METHODS MOL BIOL, V837, P135, DOI 10.1007/978-1-61779-504-6_9
   Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012
   Nandania J, 2018, METABOLITES, V8, P0, DOI 10.3390/metabo8030044
   Nandania J, 2018, J CHROMATOGR B, V1092, P168, DOI 10.1016/j.jchromb.2018.06.008
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Ost M, 2016, MOL METAB, V5, P79, DOI 10.1016/j.molmet.2015.11.002
   Ost M, 2015, FASEB J, V29, P1314, DOI 10.1096/fj.14-261503
   Pereira RO, 2017, EMBO J, V36, P2126, DOI 10.15252/embj.201696179
   Potthoff MJ, 2017, NAT REV ENDOCRINOL, V13, P74, DOI 10.1038/nrendo.2016.206
   Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106
   Pulliam DA, 2014, BIOCHEM J, V462, P359, DOI 10.1042/BJ20140291
   QuirÃ³s PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Richter U, 2019, LIFE SCI ALLIANCE, V2, P0, DOI 10.26508/lsa.201800219
   Richter U, 2015, J CELL BIOL, V211, P373, DOI 10.1083/jcb.201504062
   Richter U, 2013, CURR BIOL, V23, P535, DOI 10.1016/j.cub.2013.02.019
   Rygiel KA, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09906
   Seiferling D, 2016, EMBO REP, V17, P953, DOI 10.15252/embr.201642077
   Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042
   Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392
   Zhang J, 2014, MOL CELL, V56, P205, DOI 10.1016/j.molcel.2014.08.018
   Zhang Q, 2018, CELL, V174, P870, DOI 10.1016/j.cell.2018.06.029
   Zhang Z, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069282
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
NR 59
TC 152
Z9 158
U1 1
U2 23
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD DEC 3
PY 2019
VL 30
IS 6
BP 1040
EP +
DI 10.1016/j.cmet.2019.013.019
PG 22
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA JT2BD
UT WOS:000500800300007
PM 31523008
DA 2024-11-01
ER

PT J
AU Tabassum, R
   Jeong, NY
AF Tabassum, Rubaiya
   Jeong, Na Young
TI Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases
SO INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
LA English
DT Review
DE central nervous system; hydrogen sulphide; mitochondrial dysfunction; neurodegenerative diseases; oxidative stress
ID cystathionine gamma-lyase; superoxide-dismutase; parkinsons-disease; alzheimers-disease; skeletal-muscle; mouse model; dna-damage; apoptosis; cysteine; mitochondria
AB Oxidative phosphorylation is a source of energy production by which many cells satisfy their energy requirements. Endogenous reactive oxygen species (ROS) are by-products of oxidative phosphorylation. ROS are formed due to the inefficiency of oxidative phosphorylation, and lead to oxidative stress that affects mitochondrial metabolism. Chronic oxidative stress contributes to the onset of neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS). The immediate consequences of oxidative stress include lipid peroxidation, protein oxidation, and mitochondrial deoxyribonucleic acid (mtDNA) mutation, which induce neuronal cell death. Mitochondrial binding of amyloid-beta (A beta) protein has been identified as a contributing factor in AD. In PD and HD, respectively, a-synuclein (alpha-syn) and huntingtin (Htt) gene mutations have been reported to exacerbate the effects of oxidative stress. Similarly, abnormalities in mitochondrial dynamics and the respiratory chain occur in ALS due to dysregulation of mitochondrial complexes II and IV. However, oxidative stress-induced dysfunctions in neurodegenerative diseases can be mitigated by the antioxidant function of hydrogen sulfide (H2S), which also acts through the potassium (K-ATP/K+) ion channel and calcium (Ca2+) ion channels to increase glutathione (GSH) levels. The pharmacological activity of H2S is exerted by both inorganic and organic compounds. GSH, glutathione peroxidase (Gpx), and superoxide dismutase (SOD) neutralize H2O2-induced oxidative damage in mitochondria. The main purpose of this review is to discuss specific causes and effects of mitochondrial oxidative stress in neurodegenerative diseases, and how these are impacted by the antioxidant functions of H2S to support the development of advancements in neurodegenerative disease treatment.
C1 [Tabassum, Rubaiya; Jeong, Na Young] Dong A Univ, Coll Med, Dept Anat & Cell Biol, 32 Daesingongwon Ro, Busan 49201, South Korea.
   [Tabassum, Rubaiya; Jeong, Na Young] Dong A Univ, Grad Sch, Dept Med, 32 Daesingongwon Ro, Busan 49201, South Korea.
C3 Dong A University; Dong A University
RP Jeong, NY (corresponding author), Dong A Univ, Coll Med, Dept Anat & Cell Biol, 32 Daesingongwon Ro, Busan 49201, South Korea.
EM jnyjjy@dau.ac.kr
FU Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korea government (MSIT) [2018R1A2B6001123]
CR Ahmad W, 2017, J BIOMED SCI, V24, P0, DOI 10.1186/s12929-017-0379-z
   Andrich J, 2004, MOVEMENT DISORD, V19, P226, DOI 10.1002/mds.10629
   Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3
   Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018
   Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330
   Battin EE, 2009, CELL BIOCHEM BIOPHYS, V55, P1, DOI 10.1007/s12013-009-9054-7
   BEYER WF, 1987, BIOCHEMISTRY-US, V26, P1251, DOI 10.1021/bi00379a008
   Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613
   Blesa J, 2015, FRONT NEUROANAT, V9, P0, DOI 10.3389/fnana.2015.00091
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   Cao X, 2019, ANTIOXID REDOX SIGN, V31, P1, DOI 10.1089/ars.2017.7058
   Cardoso SA, 2004, NEUROCHEM INT, V45, P693, DOI 10.1016/j.neuint.2004.03.003
   Chang CC, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/9015765
   Chiang SC, 2017, SCI ADV, V3, P0, DOI 10.1126/sciadv.1602506
   Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200
   Chung CHY, 2007, BIOCHEMISTRY-US, V46, P3262, DOI 10.1021/bi061888s
   Dalmasso G, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0168198
   Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje
   Essawy SS, 2017, ARCH MED SCI, V13, P659, DOI 10.5114/aoms.2017.67284
   Fahn S, 2004, NEW ENGL J MED, V351, P2498
   Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030
   Forgione MA, 2002, AM J PHYSIOL-HEART C, V282, PH1255, DOI 10.1152/ajpheart.00598.2001
   Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999
   Gao C, 2017, INT J MOL MED, V0, P242
   Gao J, 2017, ANTIOXIDANTS-BASEL, V6, P0, DOI 10.3390/antiox6020025
   Gella A, 2009, CELL ADHES MIGR, V3, P88, DOI 10.4161/cam.3.1.7402
   Georgieva E, 2017, ANTICANCER RES, V37, P5373, DOI 10.21873/anticanres.11963
   Giulia N, 2017, CURR TOP MED CHEM, V17, P3062, DOI 10.2174/1568026617666170607114232
   Giuliani D, 2013, NEUROBIOL LEARN MEM, V104, P82, DOI 10.1016/j.nlm.2013.05.006
   Guin D, 2017, BMC MED GENOMICS, V10, P0, DOI 10.1186/s12920-017-0291-0
   Hassan E, 2019, LIFE SCI, V226, P193, DOI 10.1016/j.lfs.2019.04.020
   Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x
   Hodgson N, 2013, J ALZHEIMERS DIS, V36, P197, DOI 10.3233/JAD-130101
   HÃ¶hn A, 2017, REDOX BIOL, V11, P482, DOI 10.1016/j.redox.2016.12.001
   Huguenard JR, 1998, TRENDS NEUROSCI, V21, P451, DOI 10.1016/S0166-2236(98)01331-9
   Ighodaro OM, 2018, ALEX J MED, V54, P287, DOI 10.1016/j.ajme.2017.09.001
   Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664
   Kasarskis EJ, 2009, AMYOTROPH LATERAL SC, V10, P35, DOI 10.1080/17482960802351029
   Kashfi K, 2013, BIOCHEM PHARMACOL, V85, P689, DOI 10.1016/j.bcp.2012.10.019
   Kitaoka Y, 2016, PHYSIOL REP, V4, P0, DOI 10.14814/phy2.13064
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Predmore BL, 2012, ANTIOXID REDOX SIGN, V17, P119, DOI 10.1089/ars.2012.4612
   Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505
   Li XY, 2012, BIOCHEM BIOPH RES CO, V421, P727, DOI 10.1016/j.bbrc.2012.04.070
   Lu HY, 2013, FRONT AGING NEUROSCI, V5, P0, DOI 10.3389/fnagi.2013.00085
   Luthi-Carter R, 2003, CLIN NEUROSCI RES, V3, P165, DOI 10.1016/S1566-2772(03)00059-8
   Manoharan S, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/8590578
   Mikami Y, 2013, BIOCHEM BIOPH RES CO, V431, P131, DOI 10.1016/j.bbrc.2013.01.010
   Mikhed Y, 2015, INT J MOL SCI, V16, P15918, DOI 10.3390/ijms160715918
   Morroni F, 2018, J AGR FOOD CHEM, V66, P856, DOI 10.1021/acs.jafc.7b04641
   Muid KA, 2014, BIOCHEM BIOPH RES CO, V444, P260, DOI 10.1016/j.bbrc.2014.01.056
   Munaron L, 2013, CELL CALCIUM, V53, P77, DOI 10.1016/j.ceca.2012.07.001
   Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje
   Narasimhan M, 2014, FREE RADICAL BIO MED, V71, P402, DOI 10.1016/j.freeradbiomed.2014.02.023
   Obeid R, 2009, CLIN CHEM, V55, P1852, DOI 10.1373/clinchem.2009.125021
   Oheim M, 2006, CELL CALCIUM, V40, P423, DOI 10.1016/j.ceca.2006.08.007
   Olson KR, 2013, CLIN CHEM LAB MED, V51, P623, DOI 10.1515/cclm-2012-0551
   Pan LL, 2012, INT J CARDIOL, V155, P327, DOI 10.1016/j.ijcard.2011.12.059
   Paul BD, 2018, BIOCHEM PHARMACOL, V149, P101, DOI 10.1016/j.bcp.2017.11.019
   Paul BD, 2014, NATURE, V509, P96, DOI 10.1038/nature13136
   Perron NR, 2008, INORG CHEM, V47, P6153, DOI 10.1021/ic7022727
   Pratt AJ, 2012, DEGENER NEUROL NEURO, V2, P1, DOI 10.2147/DNND.S19803
   Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016
   Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805
   Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010
   Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j
   Sestito S, 2017, FRONT CHEM, V5, P0, DOI 10.3389/fchem.2017.00072
   Shah SZA, 2017, FRONT AGING NEUROSCI, V9, P0, DOI 10.3389/fnagi.2017.00120
   Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI 10.1089/ars.2008.2253
   Shin JY, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050496
   Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008
   Tarozzi A, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/415078
   Tiiman A, 2013, NEUROCHEM INT, V62, P367, DOI 10.1016/j.neuint.2013.01.023
   Vandini E, 2019, PHARMACOLOGY, V103, P50, DOI 10.1159/000494113
   Veeranki OL, 2013, BRIT J NUTR, V109, P25, DOI 10.1017/S0007114512000657
   Vieira GDT, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0175222
   Walewska A, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19103227
   Wang Q, 2010, ANTIOXID REDOX SIGN, V12, P1155, DOI 10.1089/ars.2009.2947
   Wu B, 2017, EXP NEUROL, V293, P83, DOI 10.1016/j.expneurol.2017.03.020
   Xie ZZ, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/6043038
   Zhelev Z, 2013, ACS CHEM NEUROSCI, V4, P1439, DOI 10.1021/cn400159h
   Zoccolella Stefano, 2006, CURRENT VASCULAR PHARMACOLOGY, V4, P237, DOI 10.2174/157016106777698414
NR 83
TC 89
Z9 95
U1 1
U2 27
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-1907
EI 
J9 INT J MED SCI
JI Int. J. Med. Sci.
PD JUN 15
PY 2019
VL 16
IS 10
BP 1386
EP 1396
DI 10.7150/ijms.36516
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA IZ7KO
UT WOS:000487272400010
PM 31692944
DA 2024-11-01
ER

PT J
AU Hou, Y
   Xie, ZY
   Zhao, XT
   Yuan, Y
   Dou, P
   Wang, ZX
AF Hou, Yue
   Xie, Zhiying
   Zhao, Xutong
   Yuan, Yun
   Dou, Pan
   Wang, Zhaoxia
TI Appendicular skeletal muscle mass: A more sensitive biomarker of disease severity than BMI in adults with mitochondrial diseases
SO PLOS ONE
LA English
DT Article
ID bioelectrical-impedance analysis; body-composition; abnormal growth; dna deletion; sarcopenia; fat; capacity; myopathy; age; manifestations
AB The study aimed to evaluate the body composition of patients with mitochondrial diseases (MD) and correlate it with disease severity. Overall, 89 patients (age. 18 years) with MD were recruited, including 49 with chronic progressive external ophthalmoplegia (CPEO) and 40 with mitochondrial encephalomyopathy with lactate acidosis and stroke-like episodes (MELAS). Body composition, including fat mass index (FMI), fat-free mass index (FFMI), skeletal muscle mass index (SMI), and appendicular skeletal muscle mass index (ASMI), were examined using multifrequency bioelectric impedance analysis. Clinical assessments, including muscle strength, usual gait speed, and disease severity determined by the Newcastle Mitochondrial Disease Adult Scale score (NMDAS), were performed. The comparisons between patients group and age-and gender-matched healthy controls, as well as the correlations between anthropometric measurements, body composition, and disease severity were analyzed. Height, weight, body mass index (BMI), FFMI, SMI, and ASMI were significantly lower in patients with MD than in healthy controls. Notably, low muscle mass was noted in 69.7% (62/89) of MD patients, with 22 patients also presenting with compromised physical performance as indicated by decreased gait speed, resulting in 24.7% satisfied the sarcopenia diagnostic criteria. Disease severity was more negatively correlated with ASMI than it was with height, weight, and BMI. Subgroup analysis showed that in the MELAS subgroup, disease severity was negatively correlated with height, weight, and ASMI; whereas in the CPEO subgroup, it was only negatively correlated with ASMI and SMI. Additionally, ASMI was positively associated with muscle strength. Altogether, compared with BMI, ASMI is a more sensitive biomarker predicting disease severity of MD, both in MELAS and CPEO patients.
C1 [Hou, Yue; Xie, Zhiying; Zhao, Xutong; Yuan, Yun; Wang, Zhaoxia] Peking Univ, Hosp 1, Dept Neurol, Beijing, Peoples R China.
   [Dou, Pan] Peking Univ, Hosp 1, Dept Clin Nutr, Beijing, Peoples R China.
C3 Peking University; Peking University
RP Wang, ZX (corresponding author), Peking Univ, Hosp 1, Dept Neurol, Beijing, Peoples R China.; Dou, P (corresponding author), Peking Univ, Hosp 1, Dept Clin Nutr, Beijing, Peoples R China.
EM doupan@pkufh.cn; drwangzx@163.com
FU Ministry of Science and Technology of China [2011ZX09307-001-07]; Beijing Municipal Science and Technology Commission [Z151100003915126]
CR Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   BÃ©ghin L, 2016, CLIN NUTR, V35, P1414, DOI 10.1016/j.clnu.2016.03.015
   Boal RL, 2018, J CLIN ENDOCRINOL ME, V10, P0
   Bovenschen HJ, 2006, DIGEST DIS SCI, V51, P1509, DOI 10.1007/s10620-006-9120-6
   Brioche T, 2016, MOL ASPECTS MED, V50, P56, DOI 10.1016/j.mam.2016.04.006
   BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307
   Canapari CA, 2015, PEDIATR PULM, V50, P63, DOI 10.1002/ppul.23004
   Castro-Gago M, 2010, ACTA PAEDIATR, V99, P796, DOI 10.1111/j.1651-2227.2010.01738.x
   Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025
   Chien MY, 2008, J AM GERIATR SOC, V56, P1710, DOI 10.1111/j.1532-5415.2008.01854.x
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Dasarathy S, 2016, J HEPATOL, V65, P1232, DOI 10.1016/j.jhep.2016.07.040
   Davidson ZE, 2009, J HUM NUTR DIET, V22, P383, DOI 10.1111/j.1365-277X.2009.00979.x
   de Laat P, 2015, NETH J MED, V73, P30
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Finsterer J, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7020016
   Ge Yu-Xing, 2017, ENEUROLOGICALSCI, V6, P16, DOI 10.1016/j.ensci.2016.11.005
   Gimenes AC, 2015, BRAZ J MED BIOL RES, V48, P354, DOI 10.1590/1414-431X20143467
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Gueugneau M, 2015, J GERONTOL A-BIOL, V70, P566, DOI 10.1093/gerona/glu086
   Han SS, 2010, J AM GERIATR SOC, V58, P312, DOI 10.1111/j.1532-5415.2009.02672.x
   Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kulich KR, 2008, HEALTH QUAL LIFE OUT, V6, P0, DOI 10.1186/1477-7525-6-12
   Kyle UG, 2015, EUR J CLIN NUTR, V69, P1298, DOI 10.1038/ejcn.2015.86
   Leng YL, 2015, MITOCHONDR DNA, V26, P208, DOI 10.3109/19401736.2014.905860
   Ling CHY, 2011, CLIN NUTR, V30, P610, DOI 10.1016/j.clnu.2011.04.001
   Maetzler W, 2015, NERVENARZT, V86, P420, DOI 10.1007/s00115-014-4181-9
   Mathur S, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00104
   Matsuzaki M, 2002, NEUROPEDIATRICS, V33, P271, DOI 10.1055/s-2002-36742
   Matusik E, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8020071
   Molnar MJ, 2018, HAND CLINIC, V145, P147, DOI 10.1016/B978-0-12-802395-2.00010-9
   Morava E, 2006, J INHERIT METAB DIS, V29, P589, DOI 10.1007/s10545-006-0227-x
   Oh SW, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0084052
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   Pestronk A, 2017, MUSCLE NERVE, V56, P122, DOI 10.1002/mus.25442
   Rahman S, 2013, J INHERIT METAB DIS, V36, P659, DOI 10.1007/s10545-013-9614-2
   Ranasinghe C, 2013, BMC PUBLIC HEALTH, V13, P0, DOI 10.1186/1471-2458-13-797
   Rider LG, 2010, ARTHRIT CARE RES, V62, P465, DOI 10.1002/acr.20035
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Romanello V, 2016, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00422
   Sato E, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep36618
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Shah VO, 2009, GENET MED, V11, P147, DOI 10.1097/GIM.0b013e31819307a2
   Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V55, PE9, DOI 10.1016/j.archger.2012.06.015
   Thrift AP, 2014, J CLIN GASTROENTEROL, V48, P218, DOI 10.1097/MCG.0b013e31829ae98c
   Widen EM, 2014, OBES SURG, V24, P847, DOI 10.1007/s11695-014-1182-5
   Wolny S, 2009, ACTA PAEDIATR, V98, P553, DOI 10.1111/j.1651-2227.2008.01148.x
   Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a
   Yu M, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0175343
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zhao DH, 2013, CLIN NEUROL NEUROSUR, V115, P1490, DOI 10.1016/j.clineuro.2012.11.011
NR 58
TC 15
Z9 16
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD JUL 25
PY 2019
VL 14
IS 7
BP 
EP 
DI 10.1371/journal.pone.0219628
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW4VN
UT WOS:000484977900021
PM 31344055
DA 2024-11-01
ER

PT J
AU Souza, PVS
   Bortholin, T
   Teixeira, CAC
   Seneor, DD
   Marin, VDGB
   Dias, RB
   Farias, IB
   Badia, BML
   Silva, LHL
   Pinto, WBVR
   Oliveira, ASB
   DiMauro, S
AF Souza, P. V. S.
   Bortholin, Thiago
   Castro Teixeira, Carlos Alberto
   Seneor, Daniel Delgado
   Barrios Marin, Vitor Dias Gomes
   Dias, Renan Braido
   Farias, Igor Braga
   Badia, B. M. L.
   Libardi Silva, Luiz Henrique
   Pinto, W. B. V. R.
   Bulle Oliveira, Acary Souza
   DiMauro, Salvatore
TI Leigh syndrome caused by mitochondrial DNA-maintenance defects revealed by whole exome sequencing
SO MITOCHONDRION
LA English
DT Article
DE Leigh syndrome; Mitochondrial disorders; Mitochondrial DNA maintenance; Whole exome sequencing
ID progressive external ophthalmoplegia; chinese patients; mutations; disease; depletion; deletions; dominant
AB Leigh syndrome represents a complex inherited neurometabolic and neurodegenerative disorder associated with different clinical, genetic and neuroimaging findings in the context of bilateral symmetrical lesions involving the brainstem and basal ganglia. Heterogeneous neurological manifestations such as spasticity, cerebellar ataxia, dystonia, choreoathetosis and parkinsonism are associated with multisystemic and ophthalmological abnormalities due to > 75 different monogenic causes. Here, we describe the clinical and genetic features of a Brazilian cohort of patients with Leigh Syndrome in which muscle biopsy analysis showed mitochondrial DNA defects and determine the utility of whole exome sequencing for a final genetic diagnostic in this cohort.
C1 [Souza, P. V. S.; Bortholin, Thiago; Castro Teixeira, Carlos Alberto; Seneor, Daniel Delgado; Barrios Marin, Vitor Dias Gomes; Dias, Renan Braido; Farias, Igor Braga; Badia, B. M. L.; Libardi Silva, Luiz Henrique; Pinto, W. B. V. R.; Bulle Oliveira, Acary Souza] Fed Univ Scio Paulo UNIFESP, Div Neuromuscular Dis, Dept Neurol, Dept Neurosurg, Rua Estado Israel 899, BR-04022002 Sao Paulo, SP, Brazil.
   [DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA.
C3 Universidade Federal de Sao Paulo (UNIFESP); Columbia University
RP Souza, PVS (corresponding author), Fed Univ Scio Paulo UNIFESP, Div Neuromuscular Dis, Dept Neurol, Dept Neurosurg, Rua Estado Israel 899, BR-04022002 Sao Paulo, SP, Brazil.
EM paulo.sgobbi@unifesp.br
CR Adzhubei Ivan, 2013, CURR PROTOC HUM GENET, VChapter 7, P0, DOI 10.1002/0471142905.hg0720s76
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bugiardini E, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000168
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Del Bo R, 2008, NEUROLOGY, V71, P1959, DOI 10.1212/01.wnl.0000327095.32005.a4
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Gerards M, 2016, MOL GENET METAB, V117, P300, DOI 10.1016/j.ymgme.2015.12.004
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   Leigh PN, 2015, J NEUROL NEUROSUR PS, V86, P363, DOI 10.1136/jnnp-2012-304601
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   McKelvie P, 2012, J CLIN NEUROSCI, V19, P195, DOI 10.1016/j.jocn.2011.09.009
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Paul R, 1996, TRENDS GENET, V12, P131
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176
   Sadat R, 2016, MOL GENET METAB, V118, P28, DOI 10.1016/j.ymgme.2016.03.004
   Santel A, 2001, J CELL SCI, V114, P867
   Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
   de Souza PVS, 2017, CEREBELLUM, V16, P525, DOI 10.1007/s12311-016-0803-z
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001
   Yang YL, 2006, CHINESE MED J-PEKING, V119, P373, DOI 10.1097/00029330-200603010-00004
   Zhang Y, 2007, J INHERIT METAB DIS, V30, P265, DOI 10.1007/s10545-006-0481-y
NR 41
TC 3
Z9 3
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV 15
PY 2019
VL 49
IS 
BP 25
EP 34
DI 10.1016/j.mito.2019.06.008
PG 10
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA JX2AW
UT WOS:000503545000004
PM 31271879
DA 2024-11-01
ER

PT J
AU Vecoli, C
   Borghini, A
   Pulignani, S
   Mercuri, A
   Turchi, S
   Picano, E
   Andreassi, MG
AF Vecoli, Cecilia
   Borghini, Andrea
   Pulignani, Silvia
   Mercuri, Antonella
   Turchi, Stefano
   Picano, Eugenio
   Andreassi, Maria Grazia
TI Independent and Combined Effects of Telomere Shortening and mtDNA<SUP>4977</SUP> Deletion on Long-term Outcomes of Patients with Coronary Artery Disease
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE major adverse cardiac events; all-cause mortality; leucocyte telomere length; mtDNA(4977) common deletion; coronary artery disease
ID mitochondrial-dna damage; 4977 bp deletion; prognostic value; length; heart; atherosclerosis; association; dysfunction; cancer; muscle
AB Aging is one of the main risk factors for cardiovascular disease, resulting in a progressive organ and cell decline. This study evaluated a possible joint impact of two emerging hallmarks of aging, leucocyte telomere length (LTL) and common mitochondrial DNA deletion (mtDNA(4977)), on major adverse cardiovascular events (MACEs) and all-cause mortality in patients with coronary artery disease (CAD). We studied 770 patients (673 males, 64.8 +/- 8.3 years) with known or suspected stable CAD. LTL and mtDNA(4977) deletion were assessed in peripheral blood using qRT-PCR. During a median follow-up of 5.4 +/- 1.2 years, MACEs were 140 while 86 deaths were recorded. After adjustments for confounding risk factors, short LTLs and high mtDNA(4977) deletion levels acted independently as predictors of MACEs (HR: 2.2, 95% CI: 1.2-3.9, p = 0.01 and HR: 1.7, 95% CI: 1.1-2.9, p = 0.04; respectively) and all-cause mortality events (HR: 2.1, 95% CI: 1.1-4.6, p = 0.04 and HR: 2.3, 95% CI: 1.1-4.9, p = 0.02; respectively). Patients with both short LTLs and high mtDNA(4977) deletion levels had an increased risk for MACEs (HR: 4.3; 95% CI: 1.9-9.6; p = 0.0006) and all-cause mortality (HR: 6.0; 95% CI: 2.0-18.4; p = 0.001). The addition of mtDNA(4977) deletion to a clinical reference model was associated with a significant net reclassification improvement (NRI = 0.18, p = 0.01). Short LTL and high mtDNA(4977) deletion showed independent and joint predictive value on adverse cardiovascular outcomes and all-cause mortality in patients with CAD. These findings strongly support the importance of evaluating biomarkers of physiological/biological age, which can predict disease risk and mortality more accurately than chronological age.
C1 [Vecoli, Cecilia; Borghini, Andrea; Pulignani, Silvia; Mercuri, Antonella; Turchi, Stefano; Picano, Eugenio; Andreassi, Maria Grazia] CNR, Inst Clin Physiol, Via Moruzzi 1, I-56124 Pisa, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)
RP Vecoli, C; Andreassi, MG (corresponding author), CNR, Inst Clin Physiol, Via Moruzzi 1, I-56124 Pisa, Italy.
EM vecoli@ifc.cnr.it; aborghini@ifc.cnr.it; pulignani@ifc.cnr.it; mercuri@ifc.cnr.it; turchi@ifc.cnr.it; picano@ifc.cnr.it; mariagrazia.andreassi@ifc.cnr.it
FU National Research Council (CNR) grant Progetto di Interesse "Invecchiamento"
CR Ait-Aissa K, 2016, PHARMACOL RES, V111, P422, DOI 10.1016/j.phrs.2016.07.003
   Andreassi MG, 2015, JACC-CARDIOVASC INTE, V8, P616, DOI 10.1016/j.jcin.2014.12.233
   Andreassi MG, 2012, ATHEROSCLEROSIS, V223, P409, DOI 10.1016/j.atherosclerosis.2012.05.029
   [Anonymous], 2017, AM J EPIDEMIOL, V0, P0, DOI DOI 10.1093/aje/kww210
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373
   Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   DMello MJJ, 2015, CIRC-CARDIOVASC GENE, V8, P82, DOI 10.1161/CIRCGENETICS.113.000485
   Fajemiroye JO, 2018, BIOMED RES INT, V2018, P0, DOI 10.1155/2018/7156435
   Fang EF, 2016, NAT REV MOL CELL BIO, V17, P308, DOI 10.1038/nrm.2016.14
   Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049
   Fetterman JL, 2016, CARDIOVASC DIABETOL, V15, P0, DOI 10.1186/s12933-016-0372-y
   Fyhrquist F, 2013, NAT REV CARDIOL, V10, P274, DOI 10.1038/nrcardio.2013.30
   Goglin SE, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0160748
   Gonzalez-Ebsen AC, 2017, FRONT BIOSCI-LANDMRK, V22, P117, DOI 10.2741/4475
   Hammadah M, 2017, CIRC RES, V120, P1130, DOI 10.1161/CIRCRESAHA.116.309421
   Haycock PC, 2014, BMJ-BRIT MED J, V349, P0, DOI 10.1136/bmj.g4227
   JylhÃ¤vÃ¤ J, 2017, EBIOMEDICINE, V21, P29, DOI 10.1016/j.ebiom.2017.03.046
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x
   Lowsky DJ, 2014, J GERONTOL A-BIOL, V69, P640, DOI 10.1093/gerona/glt162
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Moslehi J, 2012, CIRC RES, V110, P1226, DOI 10.1161/CIRCRESAHA.111.246868
   Murphy MP, 2018, NAT REV DRUG DISCOV, V17, P865, DOI 10.1038/nrd.2018.174
   North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876
   OSullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848
   Pallis AG, 2014, J GERIATR ONCOL, V5, P204, DOI 10.1016/j.jgo.2013.09.001
   Paneni F, 2017, J AM COLL CARDIOL, V69, P1952, DOI 10.1016/j.jacc.2017.01.064
   Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929
   Perez-Rivera JA, 2014, AM J CARDIOL, V113, P418, DOI 10.1016/j.amjcard.2013.10.009
   Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sobenin IA, 2015, GERONTOLOGY, V61, P343, DOI 10.1159/000368923
   Vecoli C, 2018, ATHEROSCLEROSIS, V276, P91, DOI 10.1016/j.atherosclerosis.2018.07.015
   Vecoli C, 2016, INT J CARDIOL, V204, P17, DOI 10.1016/j.ijcard.2015.11.133
   Wang Y, 2017, ARTERIOSCL THROM VAS, V37, PE99, DOI 10.1161/ATVBAHA.117.309580
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu E, 2012, CARDIOVASC RES, V95, P173, DOI 10.1093/cvr/cvs111
NR 40
TC 15
Z9 16
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD NOV 15
PY 2019
VL 20
IS 21
BP 
EP 
DI 10.3390/ijms20215508
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA JQ4VU
UT WOS:000498946100266
PM 31694204
DA 2024-11-01
ER

PT J
AU Bhatt, PS
   Tzoulis, C
   Balafkan, N
   Miletic, H
   Tran, GTT
   Sanaker, PS
   Bindoff, LA
AF Bhatt, Padmanabh S.
   Tzoulis, Charalampos
   Balafkan, Novin
   Miletic, Hrvoje
   Gia Tuong Thi Tran
   Sanaker, Petter Schandl
   Bindoff, Laurence A.
TI Mitochondrial DNA depletion in sporadic inclusion body myositis
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Sporadic inclusion body myositis; Mitochondrial DNA depletion; Mitochondrial DNA deletion; Necrotising myopathy
ID deletions; abnormality; pathogenesis; diagnosis; muscle
AB Sporadic inclusion body myositis (sIBM) is a late onset disorder of unkown aetiology. Mitochondrial changes such as cytochrome oxidase deficient fibres are a well recognised feature and mitochondrial DNA (mtDNA) deletions have also been reported, but not consistently. Since mtDNA deletions are not present in all cases, we investigated whether other types of mtDNA abnormality were responsible for the mitochondrial changes. We studied 9 patients with sIBM. To control for fibre loss or replacement with inflammatory cells, we compared sIBM patients with necrotising myopathy (n = 4) as well as with healthy controls. Qualitative anlysis for mtDNA deletions and quantitative measurement of mtDNA copy number showed that muscle from patients with sIBM contained on average 67% less mtDNA than healthy controls (P=0.001). The level of mtDNA was also significantly depleted in sIBM when compared to necrotising myopathy. No significant difference in copy number was seen in patients with necrotising myopathy compared to controls. Deletions of mtDNA were present in 4 patients with sIBM, but not all. Our findings suggest that mtDNA depletion is a more consistent finding in sIBM, and one that may be implicated in the pathogenesis of the disease. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Bhatt, Padmanabh S.; Tzoulis, Charalampos; Sanaker, Petter Schandl; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Tzoulis, Charalampos; Balafkan, Novin; Gia Tuong Thi Tran; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med K1, Pb 7804, N-5020 Bergen, Norway.
   [Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway.
   [Miletic, Hrvoje] Univ Bergen, Dept Biomed, Pb 7804, N-5020 Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen
RP Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
CR Askanas V, 2015, BBA-MOL BASIS DIS, V1852, P633, DOI 10.1016/j.bbadis.201409.005
   Campbell GR, 2013, NEUROPATH APPL NEURO, V39, P377, DOI 10.1111/j.1365-2990.2012.01290.x
   CatalÃ¡n-GarcÃ­a M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Dalakas MC, 2006, NAT CLIN PRACT NEURO, V2, P437, DOI 10.1038/ncpneuro0261
   Dobloug C, 2012, CLIN EXP RHEUMATOL, V30, P838
   DÃ¶lle C, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-19745-9
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   Johnson Liam G, 2009, J CLIN NEUROMUSCUL DIS, V10, P178, DOI 10.1097/CND.0b013e3181a23c86
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Molberg O, 2016, CURR OPIN RHEUMATOL, V28, P657, DOI 10.1097/BOR.0000000000000327
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Needham M, 2016, CLIN NEUROPHYSIOL, V127, P1764, DOI 10.1016/j.clinph.2015.12.011
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
NR 21
TC 9
Z9 10
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD MAR 15
PY 2019
VL 29
IS 3
BP 242
EP 246
DI 10.1016/j.nmd.2019.02.001
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HS7ZK
UT WOS:000464087600008
PM 30850168
DA 2024-11-01
ER

PT J
AU Hsieh, PC
   Wang, CC
   Tsai, CL
   Yeh, YM
   Lee, YS
   Wu, YR
AF Hsieh, Pei-Chen
   Wang, Chun-Chieh
   Tsai, Chia-Lung
   Yeh, Yuan-Ming
   Lee, Yun Shien
   Wu, Yih-Ru
TI <i>POLG</i> R964C and <i>GBA</i> L444P mutations in familial Parkinson's disease: Case report and literature review
SO BRAIN AND BEHAVIOR
LA English
DT Review
DE GBA; missense substitution; next-generation sequencing; Parkinson's disease; POLG
ID dna-polymerase-gamma; glucocerebrosidase mutations; variants; genetics; onset; degeneration; toxicity
AB Polymerase gamma (POLG) is an enzyme responsible for the replication and repair of mitochondrial DNA. Mutations in POLG may cause variable clinical manifestations, including parkinsonism, epilepsy, cerebellar ataxia, neuropathy, and progressive external ophthalmoplegia. However, mutations of this gene are rare in patients with typical Parkinson's disease (PD). We report a man (current age: 59 years) without any underlying disease presenting with right-hand tremor at the age of 39 years, followed by slow movement, rigidity, and postural instability. He developed motor fluctuation and levodopa-induced dyskinesia 8 years later. At the age of 58 years, cognitive decline and visual hallucination ensued; he was institutionalized thereafter. We used multiplex ligation-dependent probe amplification, which demonstrated no large deletions or duplications of relevant PD genes. Next, targeted sequencing panel covering 51 genes causative for PD was applied for the proband; it revealed a heterozygous missense substitution R964C in POLG and a heterozygous missense substitution L444P in GBA. The patient's father, who had been diagnosed as having PD and type 2 diabetes mellitus at the age of 70 years, demonstrated identical mutations. This is the first report of familial PD combined with POLG R964C and GBA L444P mutations. Two pathogenic gene mutations potentially cause double hit in pathological neurodegeneration. This finding extends our understanding of the PD genotype-phenotype correlation.
C1 [Hsieh, Pei-Chen; Wang, Chun-Chieh; Wu, Yih-Ru] Chang Gung Mem Hosp, Dept Neurol, Linkou Med Ctr, Taoyuan, Taiwan.
   [Tsai, Chia-Lung; Yeh, Yuan-Ming] Chang Gung Mem Hosp, Genom Med Core Lab, Taoyuan, Taiwan.
   [Lee, Yun Shien] Ming Chuan Univ, Dept Biotechnol, Taoyuan, Taiwan.
   [Wu, Yih-Ru] Chang Gung Univ, Coll Med, Dept Neurol, Taoyuan, Taiwan.
C3 Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Ming Chuan University; Chang Gung University
RP Wu, YR (corresponding author), Chang Gung Mem Hosp, Dept Neurol, Linkou Med Ctr, Taoyuan, Taiwan.
EM yihruwu@cgmh.org.tw
FU Chang Gung Memorial Hospital [CMRPG3H0311, CMRPG3G3H0312]
CR Bahassi E, 2014, MUTAGENESIS, V29, P303, DOI 10.1093/mutage/geu031
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   Cady J, 2015, ANN NEUROL, V77, P100, DOI 10.1002/ana.24306
   Calabrese VP, 2007, NEUROLOGY, V69, P223, DOI 10.1212/01.wnl.0000271777.50910.73
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chen B, 2018, CLIMACTERIC, V21, P467, DOI 10.1080/13697137.2018.1467891
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de la Mata M, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep10903
   Delgado-Alvarado M, 2015, J NEUROL SCI, V350, P93, DOI 10.1016/j.jns.2015.02.011
   Deng H, 2018, AGEING RES REV, V42, P72, DOI 10.1016/j.arr.2017.12.007
   Gaare JJ, 2018, MOVEMENT DISORD, V33, P1591, DOI 10.1002/mds.64
   Gegg ME, 2016, NEUROBIOL DIS, V90, P43, DOI 10.1016/j.nbd.2015.09.006
   Giri M, 2016, CLIN INTERV AGING, V11, P665, DOI 10.2147/CIA.S105769
   Jeuken J, 2006, J MOL DIAGN, V8, P433, DOI 10.2353/jmoldx.2006.060012
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Li HY, 2019, AUTOPHAGY, V15, P113, DOI 10.1080/15548627.2018.1509818
   Lill CM, 2016, MOL CELL PROBE, V30, P386, DOI 10.1016/j.mcp.2016.11.001
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Mehta SH, 2016, PARKINSONISM RELAT D, V30, P83, DOI 10.1016/j.parkreldis.2016.06.013
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Mukai M, 2013, PARKINSONISM RELAT D, V19, P821, DOI 10.1016/j.parkreldis.2013.04.011
   Murgai AA, 2018, MOVEMENT DISORD, V33, P1368, DOI 10.1002/mds.27394
   ORegan G, 2017, J PARKINSON DIS, V7, P411, DOI 10.3233/JPD-171092
   Puschmann A, 2017, CURR NEUROL NEUROSCI, V17, P0, DOI 10.1007/s11910-017-0780-8
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Schapira AHV, 2011, PARKINSONS DIS-US, V2011, P0, DOI 10.4061/2011/159160
   Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
   YlÃ¶nen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
NR 35
TC 19
Z9 19
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 2162-3279
EI 
J9 BRAIN BEHAV
JI Brain Behav.
PD MAY 15
PY 2019
VL 9
IS 5
BP 
EP 
DI 10.1002/brb3.1281
PG 7
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA ID0BQ
UT WOS:000471349100016
PM 30941926
DA 2024-11-01
ER

PT J
AU Montano, V
   Simoncini, C
   CalÃ¬, CL
   Legati, A
   Siciliano, G
   Mancuso, M
AF Montano, V.
   Simoncini, C.
   Cali, Cassi L.
   Legati, A.
   Siciliano, G.
   Mancuso, M.
TI CPEO and Mitochondrial Myopathy in a Patient with <i>DGUOK</i> Compound Heterozygous Pathogenetic Variant and mtDNA Multiple Deletions
SO CASE REPORTS IN NEUROLOGICAL MEDICINE
LA English
DT Article
ID dna depletion; optic atrophy; molecular-features; mutations; instability; gene
AB The classic features of deoxyguanosine kinase (DGUOK) deficiency are infantile onset hepatic failure with nystagmus and hypotonia; mitochondrial DNA studies on affected tissue reveal mitochondrial DNA depletion. Later, it has been shown that the mutations in the same gene may present with adult-onset mitochondrial myopathy and mitochondrial DNA multiple deletions in skeletal muscle. Here we report the case of a 42-year-old Italian woman presenting with a chronic progressive external ophthalmoplegia and myopathy with mtDNA multiple deletions and the compound heterozygous c.462T>A (p.Asn154Lys) and c.707+2T>G pathogenic variants in DGUOK.
C1 [Montano, V.; Simoncini, C.; Siciliano, G.; Mancuso, M.] Univ Pisa, Dept Clin & Expt Med, Neurol Clin, Pisa, Italy.
   [Cali, Cassi L.] Univ Pisa, Dept Hand Surg & Reconstruct Microsurg, Pisa, Italy.
   [Legati, A.] Fdn IRCCS Ist Neurol C Besta, Unit Med Genet & Neurogenet, Milan, Italy.
C3 University of Pisa; University of Pisa; Fondazione IRCCS Istituto Neurologico Carlo Besta
RP Mancuso, M (corresponding author), Univ Pisa, Dept Clin & Expt Med, Neurol Clin, Pisa, Italy.
EM v.montano89@gmail.com; costanza.simoncini85@gmail.com; lorenzo.cali.cassi@gmail.com; Andrea.Legati@istituto-besta.it; g.siciliano@med.unipi.it; mancusomichelangelo@gmail.com
FU Telethon Grant [GUP09004]; Telethon-MITOCON Grant [GSP16001]
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Caporali L, 2018, BRAIN, V141, P0, DOI 10.1093/brain/awx301
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Nogueira C, 2014, ITAL J PEDIATR, V40, P0, DOI 10.1186/1824-7288-40-34
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Vilarinho S, 2016, HEPATOLOGY, V63, P1977, DOI 10.1002/hep.28499
   Yu-Wai-Man P, 2012, BRAIN, V135, P9, DOI 10.1093/brain/awr352
NR 16
TC 4
Z9 4
U1 0
U2 3
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-6668
EI 2090-6676
J9 CASE REP NEUROL MED
JI Case Rep. Neurol. Med.
PD JUN 15
PY 2019
VL 2019
IS 
BP 
EP 
DI 10.1155/2019/5918632
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA HP3ZE
UT WOS:000461615400001
PM 30956829
DA 2024-11-01
ER

PT J
AU Hahn, A
   Zuryn, S
AF Hahn, Anne
   Zuryn, Steven
TI The Cellular Mitochondrial Genome Landscape in Diesease
SO TRENDS IN CELL BIOLOGY
LA English
DT Review
ID oxygen species production; dna mutations; skeletal-muscle; mtdna mutations; in-vivo; oxidative-phosphorylation; genetic bottleneck; clonal expansion; ros production; narp mutation
AB Mitochondrial genome (mitochondrial DNA, mtDNA) lesions that unbalance bioenergetic and oxidative outputs are an important cause of human disease. A major impediment in our understanding of the pathophysiology of mitochondrial disorders is the complexity with which mtDNA mutations are spatiotemporally distributed and managed within individual cells, tissues, and organs. Unlike the comparatively static nuclear genome, accumulating evidence highlights the variability, dynamism, and modifiability of the mtDNA nucleotide sequence between individual cells overtime. In this review, we summarize and discuss the impact of mtDNA defects on disease within the context of a mosaic and shifting mutational landscape.
C1 [Hahn, Anne; Zuryn, Steven] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia.
C3 University of Queensland
RP Zuryn, S (corresponding author), Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia.
EM s.zuryn@uq.edu.au
FU University of Queensland International Scholarship; Stafford Fox Senior Research Fellowship; NHMRC [1128381]; National Health and Medical Research Council of Australia [1128381] Funding Source: NHMRC
CR Ahier A, 2018, NAT CELL BIOL, V20, P352, DOI 10.1038/s41556-017-0023-x
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Arnold RS, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/239257
   AurÃ© K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Bagwan N, 2018, CELL REP, V23, P3685, DOI 10.1016/j.celrep.2018.05.080
   Ballana E, 2006, BIOCHEM BIOPH RES CO, V341, P950, DOI 10.1016/j.bbrc.2006.01.049
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   BARRELL BG, 1979, NATURE, V282, P189, DOI 10.1038/282189a0
   Barshad G, 2018, TRENDS GENET, V34, P682, DOI 10.1016/j.tig.2018.05.009
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, P NATL ACAD SCI USA, V105, P16496, DOI 10.1073/pnas.0802779105
   Berendzen KM, 2016, CELL, V166, P1553, DOI 10.1016/j.cell.2016.08.042
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Berridge MV, 2016, CURR OPIN GENET DEV, V38, P75, DOI 10.1016/j.gde.2016.04.003
   Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burgstaller JP, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04797-2
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020
   Burr SP, 2018, DEV GROWTH DIFFER, V60, P21, DOI 10.1111/dgd.12420
   Cadet J, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012559
   Carelli V, 2015, INT J BIOCHEM CELL B, V63, P21, DOI 10.1016/j.biocel.2015.01.023
   Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Cornelissen T, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.35878
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cruz-BermÃºdez A, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0146816
   Cruz-BermÃºdez A, 2015, ONCOTARGET, V6, P13628, DOI 10.18632/oncotarget.3698
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532
   Degoul F, 1995, J INHERIT METAB DIS, V18, P682, DOI 10.1007/BF02436757
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   FernÃ¡ndez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8
   Formosa LE, 2018, NAT CELL BIOL, V20, P511, DOI 10.1038/s41556-018-0098-z
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   GarcÃ­a JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   GarcÃ­a-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   GAREY JR, 1989, J MOL EVOL, V28, P374, DOI 10.1007/BF02603072
   Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI 10.1038/nchembio.2287
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   GIULIVI C, 1995, ARCH BIOCHEM BIOPHYS, V316, P909, DOI 10.1006/abbi.1995.1122
   Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466
   Gonzalo R, 2005, FEBS LETT, V579, P6909, DOI 10.1016/j.febslet.2005.11.034
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003082
   Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006
   Haag S, 2016, EMBO J, V35, P2104, DOI 10.15252/embj.201694885
   HAGINOYA K, 1990, ACTA NEUROPATHOL, V80, P642, DOI 10.1007/BF00307633
   HÃ¤mÃ¤lÃ¤inen RH, 2015, CELL REP, V11, P1614, DOI 10.1016/j.celrep.2015.05.009
   Harper JW, 2018, NAT REV MOL CELL BIO, V19, P93, DOI 10.1038/nrm.2017.129
   Hatakeyama H, 2017, AM J PATHOL, V187, P110, DOI 10.1016/j.ajpath.2016.09.003
   Hatakeyama H, 2015, ACTA NEUROPATHOL COM, V3, P0, DOI 10.1186/s40478-015-0227-x
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Higuchi R, 2013, CURR BIOL, V23, P2417, DOI 10.1016/j.cub.2013.10.022
   Hopkins JF, 2018, GASTROENTEROLOGY, V154, P1620, DOI 10.1053/j.gastro.2018.01.029
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   Huang CC, 1999, ACTA NEUROL SCAND, V99, P125, DOI 10.1111/j.1600-0404.1999.tb00670.x
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Jena NR, 2012, J BIOSCIENCES, V37, P503, DOI 10.1007/s12038-012-9218-2
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jiang CB, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0109984
   Johnston IG, 2016, AM J HUM GENET, V99, P1150, DOI 10.1016/j.ajhg.2016.09.016
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Kandul NP, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13100
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Kolesar JE, 2014, FREE RADICAL BIO MED, V75, P241, DOI 10.1016/j.freeradbiomed.2014.07.038
   Kolesnikov AA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1424, DOI 10.1134/S0006297912130020
   Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221
   Kretzschmar C, 2016, ONCOTARGET, V7, P74460, DOI 10.18632/oncotarget.11952
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kulawiec M, 2009, CANCER BIOL THER, V8, P1378, DOI 10.4161/cbt.8.14.8751
   Lehtinen SK, 2000, GENETICS, V154, P363
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li HY, 2018, BIOCHEM BIOPH RES CO, V495, P574, DOI 10.1016/j.bbrc.2017.11.061
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Li W, 2015, MOL CELL BIOCHEM, V408, P171, DOI 10.1007/s11010-015-2493-0
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Liu YQ, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-03303-w
   Liu Z, 2014, J MED GENET, V51, P176, DOI 10.1136/jmedgenet-2013-101818
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   MACINO G, 1979, P NATL ACAD SCI USA, V76, P3784, DOI 10.1073/pnas.76.8.3784
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Marchington DR, 2006, EUR J HUM GENET, V14, P816, DOI 10.1038/sj.ejhg.5201618
   Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Morris J, 2017, CELL REP, V21, P2706, DOI 10.1016/j.celrep.2017.11.031
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Neupane J, 2015, CELL REP, V13, P1304, DOI 10.1016/j.celrep.2015.10.019
   Niemann J, 2017, FREE RADICAL BIO MED, V102, P174, DOI 10.1016/j.freeradbiomed.2016.11.035
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   NONAKA I, 1992, CURR OPIN NEUROL NEU, V5, P622
   OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003
   Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818
   Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Pryde KR, 2016, J CELL BIOL, V213, P163, DOI 10.1083/jcb.201509003
   Radzvilavicius AL, 2016, PLOS BIOL, V14, P0, DOI 10.1371/journal.pbio.2000410
   Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027
   Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9
   Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Sazonova MA, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/825468
   Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151
   Schull S, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.62
   SHADEL GS, 1993, J BIOL CHEM, V268, P16083
   Shao LW, 2016, CELL RES, V26, P1182, DOI 10.1038/cr.2016.118
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Shen J, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-017-0145-x
   Shokolenko Inna N, 2014, WORLD J EXP MED, V4, P46
   Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110
   Singh RK, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06571
   SkoczÃ©n N, 2018, BBA-BIOENERGETICS, V1859, P602, DOI 10.1016/j.bbabio.2018.05.009
   SOONG NW, 1992, NAT GENET, V2, P318
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Sun WY, 2009, CLIN CANCER RES, V15, P476, DOI 10.1158/1078-0432.CCR-08-0930
   Szczepanowska K, 2017, ESSAYS BIOCHEM, V61, P325, DOI 10.1042/EBC20160090
   Tam ZY, 2015, PLOS COMPUT BIOL, V11, P0, DOI 10.1371/journal.pcbi.1004183
   Torralba D, 2016, FRONT CELL DEV BIOL, V4, P0, DOI 10.3389/fcell.2016.00107
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van Gisbergen MW, 2015, MUTAT RES-REV MUTAT, V764, P16, DOI 10.1016/j.mrrev.2015.01.001
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811
   WEISIGER RA, 1973, J BIOL CHEM, V248, P4793
   Weiss H, 2012, ENDOCRINOLOGY, V153, P4666, DOI 10.1210/en.2012-1296
   Williams SL, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003990
   Wilton PR, 2018, GENETICS, V208, P1261, DOI 10.1534/genetics.118.300711
   Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Xue L, 2016, MITOCHONDRION, V30, P208, DOI 10.1016/j.mito.2016.08.008
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yu JL, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114650
   Yuan Y, 2015, BMC CANCER, V15, P0, DOI 10.1186/s12885-015-1349-z
   Zhang Q, 2018, CELL, V174, P870, DOI 10.1016/j.cell.2018.06.029
   Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317
NR 171
TC 55
Z9 61
U1 0
U2 38
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0962-8924
EI 1879-3088
J9 TRENDS CELL BIOL
JI Trends Cell Biol.
PD MAR 15
PY 2019
VL 29
IS 3
BP 227
EP 240
DI 10.1016/j.tcb.2018.11.004
PG 14
WC Cell Biology
SC Cell Biology
GA HL4NM
UT WOS:000458698800004
PM 30509558
DA 2024-11-01
ER

PT J
AU Inoue, M
   Uchino, S
   Iida, A
   Noguchi, S
   Hayashi, S
   Takahashi, T
   Fujii, K
   Komaki, H
   Takeshita, E
   Nonaka, I
   Okada, Y
   Yoshizawa, T
   Van Lommel, L
   Schuit, F
   Goto, Y
   Mimaki, M
   Nishino, I
AF Inoue, Michio
   Uchino, Shumpei
   Iida, Aritoshi
   Noguchi, Satoru
   Hayashi, Shinichiro
   Takahashi, Tsutomu
   Fujii, Katsunori
   Komaki, Hirofumi
   Takeshita, Eri
   Nonaka, Ikuya
   Okada, Yukinori
   Yoshizawa, Takuya
   Van Lommel, Leentje
   Schuit, Frans
   Goto, Yu-ichi
   Mimaki, Masakazu
   Nishino, Ichizo
TI <i>COX6A2</i> variants cause a muscle-specific cytochrome <i>c</i> oxidase deficiency
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID mitochondrial-dna depletion; subunit; mutations; myopathy; complexes; genes
AB Objective Cytochrome c oxidase (COX) deficiency is a major mitochondrial respiratory chain defect that has vast genetic and phenotypic heterogeneity. This study aims to identify novel causative genes of COX deficiency with only striated muscle-specific symptoms. Methods Whole exome sequencing was performed in 2 unrelated individuals who were diagnosed with congenital myopathy and presented COX deficiency in muscle pathology. We assessed the COX6A2 variants using measurements of enzymatic activities and assembly of mitochondrial respiratory chain complexes in the samples from the patients and knockout mice. Results Both patients presented muscle weakness and hypotonia in 4 limbs along with facial muscle weakness. One patient had cardiomyopathy. Neither patient exhibited involvement from other organs. Whole exome sequencing identified biallelic missense variants in COX6A2, which is expressed only in the skeletal muscle and heart. The variants detected were homozygous c.117C > A (p.Ser39Arg) and compound heterozygous c.117C > A (p.Ser39Arg) and c.127T > C (p.Cys43Arg). We found specific reductions in complex IV activities in the skeletal muscle of both individuals. Assembly of complex IV and its supercomplex formation were impaired in the muscle. Interpretation This study indicates that biallelic variants in COX6A2 cause a striated muscle-specific form of COX deficiency. ANN NEUROL 2019;86:193-202
C1 [Inoue, Michio; Noguchi, Satoru; Hayashi, Shinichiro; Nonaka, Ikuya; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.
   [Inoue, Michio] Univ Yamanashi, Integrated Grad Sch Med Engn & Agr Sci, Yamanashi, Japan.
   [Inoue, Michio; Iida, Aritoshi; Noguchi, Satoru; Hayashi, Shinichiro; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Tokyo, Japan.
   [Uchino, Shumpei; Komaki, Hirofumi; Takeshita, Eri; Goto, Yu-ichi; Mimaki, Masakazu] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Uchino, Shumpei; Mimaki, Masakazu] Teikyo Univ, Dept Pediat, Sch Med, Tokyo, Japan.
   [Takahashi, Tsutomu] Saiseikai Utsunomiya Hosp, Dept Pediat, Utsunomiya, Tochigi, Japan.
   [Fujii, Katsunori] Chiba Univ, Dept Pediat, Grad Sch Med, Chiba, Japan.
   [Komaki, Hirofumi; Takeshita, Eri; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Natl Ctr Hosp, Tokyo, Japan.
   [Okada, Yukinori] Osaka Univ, Dept Stat Genet, Grad Sch Med, Osaka, Japan.
   [Yoshizawa, Takuya] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Japan.
   [Van Lommel, Leentje; Schuit, Frans] Katholieke Univ Leuven, Fac Med, Dept Cellular & Mol Med, Leuven, Belgium.
C3 National Center for Neurology & Psychiatry - Japan; University of Yamanashi; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Teikyo University; Chiba University; National Center for Neurology & Psychiatry - Japan; Osaka University; Ritsumeikan University; KU Leuven
RP Noguchi, S (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.
EM noguchi@ncnp.go.jp
FU Grants-in-Aid for Scientific Research [16K09999] Funding Source: KAKEN
CR BÃ©hin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   BONNE G, 1993, EUR J BIOCHEM, V217, P1099, DOI 10.1111/j.1432-1033.1993.tb18342.x
   Cogliati S, 2016, NATURE, V539, P579, DOI 10.1038/nature20157
   DiMauro S, 2012, ADV EXP MED BIOL, V748, P341, DOI 10.1007/978-1-4614-3573-0_14
   Endo Y, 2015, HUM MOL GENET, V24, P637, DOI 10.1093/hmg/ddu477
   Giordano C, 2010, ARCH NEUROL-CHICAGO, V67, P1144, DOI 10.1001/archneurol.2010.200
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Inoue M, 2018, HUM GENOME VAR, V5, P0, DOI 10.1038/s41439-018-0009-7
   KIM K, 1995, BIOCHEM J, V306, P353, DOI 10.1042/bj3060353
   Ma YY, 2011, J CHILD NEUROL, V26, P974, DOI 10.1177/0883073811399905
   Malicdan MCV, 2009, METHOD ENZYMOL, V453, P379, DOI 10.1016/S0076-6879(08)04019-6
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   Noguchi S, 2017, EBIOMEDICINE, V15, P193, DOI 10.1016/j.ebiom.2016.12.011
   Okada Y, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0087645
   Okada Y, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03274-0
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Quintens R, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0056719
   Radford NB, 2002, AM J PHYSIOL-HEART C, V282, PH726, DOI 10.1152/ajpheart.00308.2001
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   SCHLERF A, 1988, EMBO J, V7, P2387, DOI 10.1002/j.1460-2075.1988.tb03083.x
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   TAANMAN JW, 1992, BIOCHIM BIOPHYS ACTA, V1139, P155, DOI 10.1016/0925-4439(92)90095-5
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Trounce I A, 1996, METHODS ENZYMOL, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136
   von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957
NR 31
TC 18
Z9 22
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD AUG 15
PY 2019
VL 86
IS 2
BP 193
EP 202
DI 10.1002/ana.25517
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA IJ1PL
UT WOS:000475670500005
PM 31155743
DA 2024-11-01
ER

PT J
AU Chumarina, M
   Russ, K
   Azevedo, C
   Heuer, A
   Pihl, M
   Collin, A
   Frostner, EÃ
   Elmer, E
   Hyttel, P
   Cappelletti, G
   Zini, M
   Goldwurm, S
   Roybon, L
AF Chumarina, Margarita
   Russ, Kaspar
   Azevedo, Carla
   Heuer, Andreas
   Pihl, Maria
   Collin, Anna
   Frostner, Eleonor Asander
   Elmer, Eskil
   Hyttel, Poul
   Cappelletti, Graziella
   Zini, Michela
   Goldwurm, Stefano
   Roybon, Laurent
TI Cellular alterations identified in pluripotent stem cell-derived midbrain spheroids generated from a female patient with progressive external ophthalmoplegia and parkinsonism who carries a novel variation (p.Q811R) in the POLG1 gene
SO ACTA NEUROPATHOLOGICA COMMUNICATIONS
LA English
DT Article
DE Parkinson's disease; POLG1; iPSCs; Midbrain spheroids; Proteomics; MAO-B; Glycolysis; Alpha-synuclein
ID mitochondrial transcription factor; dna-polymerase-gamma; monoamine-oxidase b; alpha-synuclein; substantia-nigra; lysosomal dysfunction; lactate-dehydrogenase; mouse model; dopamine; disease
AB Variations in the POLG1 gene encoding the catalytic subunit of the mitochondrial DNA polymerase gamma, have recently been associated with Parkinson's disease (PD), especially in patients diagnosed with progressive external ophthalmoplegia (PEO). However, the majority of the studies reporting this association mainly focused on the genetic identification of the variation in POLG1 in PD patient primary cells, and determination of mitochondrial DNA copy number, providing little information about the cellular alterations existing in patient brain cells, in particular dopaminergic neurons. Therefore, through the use of induced pluripotent stem cells (iPSCs), we assessed cellular alterations in novel p.Q811R POLG1 (POLG1(Q811R)) variant midbrain dopaminergic neuron-containing spheroids (MDNS) from a female patient who developed early-onset PD, and compared them to cultures derived from a healthy control of the same gender. Both POLG1 variant and control MDNS contained functional midbrain regionalized TH/FOXA2-positive dopaminergic neurons, capable of releasing dopamine. Western blot analysis identified the presence of high molecular weight oligomeric alpha-synuclein in POLG1(Q811R) MDNS compared to control cultures. In order to assess POLG1(Q811R)-related cellular alterations within the MDNS, we applied mass-spectrometry based quantitative proteomic analysis. In total, 6749 proteins were identified, with 61 significantly differentially expressed between POLG1(Q811R) and control samples. Pro- and anti-inflammatory signaling and pathways involved in energy metabolism were altered. Notably, increased glycolysis in POLG1(Q811R) MDNS was suggested by the increase in PFKM and LDHA levels and confirmed using functional analysis of glycolytic rate and oxygen consumption levels. Our results validate the use of iPSCs to assess cellular alterations in relation to PD pathogenesis, in a unique PD patient carrying a novel p.Q811R variation in POLG1, and identify several altered pathways that may be relevant to PD pathogenesis.
C1 [Chumarina, Margarita; Russ, Kaspar; Azevedo, Carla; Roybon, Laurent] Lund Univ, Dept Expt Med Sci, Cell Stem Cell Lab CNS Dis Modeling, S-22184 Lund, Sweden.
   [Chumarina, Margarita; Russ, Kaspar; Azevedo, Carla; Roybon, Laurent] Lund Univ, MultiPk, S-22184 Lund, Sweden.
   [Chumarina, Margarita; Russ, Kaspar; Azevedo, Carla; Roybon, Laurent] Lund Univ, Lund Stem Cell Ctr, S-22184 Lund, Sweden.
   [Heuer, Andreas] Lund Univ, Dept Expt Med Sci, Behav Neurosci Lab, S-22184 Lund, Sweden.
   [Pihl, Maria; Hyttel, Poul] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, DK-1870 Copenhagen, Denmark.
   [Collin, Anna] Dept Clin Genet & Pathol, Div Lab Med, Off Med Serv, Lund, Sweden.
   [Frostner, Eleonor Asander; Elmer, Eskil] Lund Univ, Dept Clin Sci Lund, Mitochondrial Med, S-22184 Lund, Sweden.
   [Cappelletti, Graziella] Univ Milan, Dept Biosci, Via Celoria 26, I-20133 Milan, Italy.
   [Cappelletti, Graziella] Univ Milan, Ctr Excellence Neurodegenerat Dis, Via Balzaretti, I-20133 Milan, Italy.
   [Zini, Michela; Goldwurm, Stefano] ASST Pini CTO, Parkinson Inst, Via Bignami 1, I-20126 Milan, Italy.
C3 Lund University; Lund University; Lund University; Lund University; University of Copenhagen; Lund University; University of Milan; University of Milan
RP Roybon, L (corresponding author), Lund Univ, Dept Expt Med Sci, Cell Stem Cell Lab CNS Dis Modeling, S-22184 Lund, Sweden.; Roybon, L (corresponding author), Lund Univ, MultiPk, S-22184 Lund, Sweden.; Roybon, L (corresponding author), Lund Univ, Lund Stem Cell Ctr, S-22184 Lund, Sweden.
EM laurent.roybon@med.lu.se
FU Holger Crafoord Foundation; Thelma Zoegas Foundation; Shaking Generation Foundation; Ake Wibergs Foundation; Magnus Bergvalls Foundation; Greta och Johan Kocks Foundation; Swedish Research Council [VR-2015-03684, VR 2016-01789]; Brainstem - Stem Cell Center for Excellence in Neurology - Innovation Fund Denmark; Lund University; Olav Thon Foundation; donations for science, medicine and technology at Fysiografen in Lund; Vinnova [2016-01789] Funding Source: Vinnova; Swedish Research Council [2016-01789, 2015-03684] Funding Source: Swedish Research Council
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Agnihotri S, 2016, CANCER RES, V76, P4708, DOI 10.1158/0008-5472.CAN-15-3079
   Ahmad AS, 2016, J NEUROL NEUROSCI, V7, P88, DOI 10.21767/2171-6625.100088
   Aldrin-Kirk P, 2018, NEUROBIOL DIS, V109, P148, DOI 10.1016/j.nbd.2017.10.010
   Allocati N, 2018, ONCOGENESIS, V7, P0, DOI 10.1038/s41389-017-0025-3
   Bachstetter AD, 2010, AGING DIS, V1, P199
   BÃ©langer M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016
   Bellinger FP, 2011, MOL NEURODEGENER, V6, P0, DOI 10.1186/1750-1326-6-8
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Bogetofte H, 2019, FRONT CELL NEUROSCI, V13, P0, DOI 10.3389/fncel.2019.00297
   Booth HDE, 2017, TRENDS NEUROSCI, V40, P358, DOI 10.1016/j.tins.2017.04.001
   Burbulla LF, 2017, SCIENCE, V357, P1255, DOI 10.1126/science.aam9080
   Cai R, 2019, J CLIN INVEST, V129, P4539, DOI 10.1172/JCI129987
   Chung SY, 2016, STEM CELL REP, V7, P664, DOI 10.1016/j.stemcr.2016.08.012
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   DÃ¶lle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170
   Feng YB, 2018, CANCER MED-US, V7, P6124, DOI 10.1002/cam4.1820
   Finberg JPM, 2016, FRONT PHARMACOL, V7, P0, DOI 10.3389/fphar.2016.00340
   Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hansmannel F, 2010, J ALZHEIMERS DIS, V21, P1013, DOI 10.3233/JAD-2010-100630
   Harris RA, 2016, J NEUROSCI, V36, P1871, DOI 10.1523/JNEUROSCI.3131-15.2016
   Hoffman AF, 1998, J NEUROCHEM, V70, P179
   Holmqvist S, 2016, NPJ PARKINSONS DIS, V2, P0, DOI 10.1038/npjparkd.2016.9
   Holmqvist S, 2015, STEM CELL RES, V15, P203, DOI 10.1016/j.scr.2015.05.014
   Hong CT, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25344
   Hu QS, 2016, TRANSL NEURODEGENER, V5, P0, DOI 10.1186/s40035-016-0060-6
   Jha SK, 2015, INT J MOL CELL MED, V4, P67
   Jiang HB, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms1669
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3
   Kaludercic N, 2014, ANTIOXID REDOX SIGN, V20, P267, DOI 10.1089/ars.2012.4616
   Kang SS, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201798878
   Kim JM, 2006, DNA RES, V13, P275, DOI 10.1093/dnares/dsl016
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Liu P, 2014, NEUROBIOL AGING, V35, P1992, DOI 10.1016/j.neurobiolaging.2014.03.013
   Del Rey NLG, 2018, FRONT NEUROANAT, V12, P0, DOI 10.3389/fnana.2018.00113
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mazzulli JR, 2016, P NATL ACAD SCI USA, V113, P1931, DOI 10.1073/pnas.1520335113
   Mehta SH, 2016, PARKINSONISM RELAT D, V30, P83, DOI 10.1016/j.parkreldis.2016.06.013
   MÃ¼ller-Nedebock AC, 2019, NEUROCHEM INT, V129, P0, DOI 10.1016/j.neuint.2019.104495
   MuÃ±oz P, 2012, PARKINSONS DIS-US, V2012, P0, DOI 10.1155/2012/920953
   Newington JT, 2012, J BIOL CHEM, V287, P37245, DOI 10.1074/jbc.M112.366195
   NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8
   Park JS, 2018, CURR NEUROL NEUROSCI, V18, P0, DOI 10.1007/s11910-018-0829-3
   Peng KG, 2017, MOL NEUROBIOL, V54, P3783, DOI 10.1007/s12035-016-9944-9
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   RENIS M, 1977, PHARMACOLOGY, V15, P392, DOI 10.1159/000136715
   Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107
   Roussa E, 2004, CELL TISSUE RES, V318, P23, DOI 10.1007/s00441-004-0916-4
   Ryu EJ, 2005, NEUROBIOL DIS, V18, P54, DOI 10.1016/j.nbd.2004.08.016
   Santacatterina F, 2018, FREE RADICAL BIO MED, V126, P235, DOI 10.1016/j.freeradbiomed.2018.08.020
   Santos D, 2015, MOL NEUROBIOL, V52, P573, DOI 10.1007/s12035-014-8893-4
   Sato K, 2011, J NEUROL, V258, P1327, DOI 10.1007/s00415-011-5936-x
   Segura-Aguilar J, 2014, J NEUROCHEM, V129, P898, DOI 10.1111/jnc.12686
   SeguraAguilar J, 1997, J BIOL CHEM, V272, P5727, DOI 10.1074/jbc.272.9.5727
   SEGURAAGUILAR J, 1989, CHEM-BIOL INTERACT, V72, P309, DOI 10.1016/0009-2797(89)90006-9
   Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035
   Smith AM, 2018, MOVEMENT DISORD, V33, P1580, DOI 10.1002/mds.104
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Sturza A, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/8954201
   Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869
   Tong JC, 2017, BRAIN, V140, P2460, DOI 10.1093/brain/awx172
   Tong JC, 2015, NEUROBIOL DIS, V82, P243, DOI 10.1016/j.nbd.2015.06.010
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje
   Woodard CM, 2014, CELL REP, V9, P1173, DOI 10.1016/j.celrep.2014.10.023
   Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883
   Youdim MBH, 2006, BRIT J PHARMACOL, V147, PS287, DOI 10.1038/sj.bjp.0706464
   Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108
   Zhang M, 2018, J NEUROPATH EXP NEUR, V77, P1163, DOI 10.1093/jnen/nly102
   Zhang XD, 2016, ELIFE, V5, P0, DOI 10.7754/eLife.13374
   Zucca FA, 2017, PROG NEUROBIOL, V155, P96, DOI 10.1016/j.pneurobio.2015.09.012
NR 82
TC 21
Z9 21
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2051-5960
EI 
J9 ACTA NEUROPATHOL COM
JI Acta Neuropathol. Commun.
PD DEC 16
PY 2019
VL 7
IS 1
BP 
EP 
DI 10.1186/s40478-019-0863-7
PG 19
WC Neurosciences
SC Neurosciences & Neurology
GA KF9UI
UT WOS:000509587600001
PM 31843010
DA 2024-11-01
ER

PT J
AU Keatley, K
   Stromei-Cleroux, S
   Wiltshire, T
   Rajala, N
   Burton, G
   Holt, WV
   Littlewood, DTJ
   Briscoe, AG
   Jung, J
   Ashkan, K
   Heales, SJ
   Pilkington, GJ
   Meunier, B
   McGeehan, JE
   Hargreaves, IP
   McGeehan, RE
AF Keatley, Kathleen
   Stromei-Cleroux, Samuel
   Wiltshire, Tammy
   Rajala, Nina
   Burton, Gary
   Holt, William V.
   Littlewood, D. Timothy J.
   Briscoe, Andrew G.
   Jung, Josephine
   Ashkan, Keyoumars
   Heales, Simon J.
   Pilkington, Geoffrey J.
   Meunier, Brigitte
   McGeehan, John E.
   Hargreaves, Iain P.
   McGeehan, Rhiannon E.
TI Integrated Approach Reveals Role of Mitochondrial Germ-Line Mutation F18L in Respiratory Chain, Oxidative Alterations, Drug Sensitivity, and Patient Prognosis in Glioblastoma
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE glioblastoma; mtDNA; mutation; mitochondria; OXPHOS; ROS; CoQ10; prognosis; clomipramine
ID skeletal-muscle; coenzyme q(10); cytochrome-c; glioma; phosphorylation; identification; expression; variants; disease; genes
AB Glioblastoma is the most common and malignant primary brain tumour in adults, with a dismal prognosis. This is partly due to considerable inter- and intra-tumour heterogeneity. Changes in the cellular energy-producing mitochondrial respiratory chain complex (MRC) activities are a hallmark of glioblastoma relative to the normal brain, and associate with differential survival outcomes. Targeting MRC complexes with drugs can also facilitate anti-glioblastoma activity. Whether mutations in the mitochondrial DNA (mtDNA) that encode several components of the MRC contribute to these phenomena remains underexplored. We identified a germ-line mtDNA mutation (m. 14798T > C), enriched in glioblastoma relative to healthy controls, that causes an amino acid substitution F18L within the core mtDNA-encoded cytochrome b subunit of MRC complex III. F18L is predicted to alter corresponding complex III activity, and sensitivity to complex III-targeting drugs. This could in turn alter reactive oxygen species (ROS) production, cell behaviour and, consequently, patient outcomes. Here we show that, despite a heterogeneous mitochondrial background in adult glioblastoma patient biopsy-derived cell cultures, the F18L substitution associates with alterations in individual MRC complex activities, in particular a 75% increase in MRC complex II_III activity, and a 34% reduction in CoQ10, the natural substrate for MRC complex III, levels. Downstream characterisation of an F18L-carrier revealed an 87% increase in intra-cellular ROS, an altered cellular distribution of mitochondrial-specific ROS, and a 64% increased sensitivity to clomipramine, a repurposed MRC complex III-targeting drug. In patients, F18L-carriers that received the current standard of care treatment had a poorer prognosis than non-carriers (373 days vs. 415 days, respectively). Single germ-line mitochondrial mutations could predispose individuals to differential prognoses, and sensitivity to mitochondrial targeted drugs. Thus, F18L, which is present in blood could serve as a useful non-invasive biomarker for the stratification of patients into prognostically relevant groups, one of which requires a lower dose of clomipramine to achieve clinical effect, thus minimising side-effects.
C1 [Keatley, Kathleen; Stromei-Cleroux, Samuel; Rajala, Nina; Pilkington, Geoffrey J.; McGeehan, Rhiannon E.] Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biol & Biomed Sci, Brain Tumour Res Ctr, Portsmouth PO1 2DT, Hants, England.
   [Wiltshire, Tammy; McGeehan, John E.] Univ Portsmouth, Sch Biol Sci, Inst Biol & Biomed Sci, Ctr Enzyme Innovat, Portsmouth PO1 2DY, Hants, England.
   [Burton, Gary] Univ Portsmouth, Inst Cosmol & Gravitat, Portsmouth PO1 3FX, Hants, England.
   [Holt, William V.] Univ Sheffield, Acad Unit Reprod & Dev Med, Sheffield S10 2SF, S Yorkshire, England.
   [Littlewood, D. Timothy J.; Briscoe, Andrew G.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England.
   [Briscoe, Andrew G.] Nat Hist Museum, Core Res Labs, London SW7 5BD, England.
   [Jung, Josephine; Ashkan, Keyoumars] Kings Coll Hosp London, Dept Neurosurg, London SE5 9RS, England.
   [Heales, Simon J.; Hargreaves, Iain P.] Natl Hosp Neurol, Neurometab Unit, London WC1N 3BG, England.
   [Heales, Simon J.] Great Ormond St Hosp Children NHS Fdn Trust, Dept Chem Pathol, London WC1N 3JH, England.
   [Heales, Simon J.] UCL Great Ormond St Inst Child Hlth, London WC1N 1EH, England.
   [Meunier, Brigitte] Inst Integrat Biol Cell, F-91190 Gif Sur Yvette, France.
   [Hargreaves, Iain P.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England.
C3 University of Portsmouth; University of Portsmouth; University of Portsmouth; University of Sheffield; Natural History Museum London; Natural History Museum London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Universite Paris Saclay; Liverpool John Moores University
RP McGeehan, RE (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biol & Biomed Sci, Brain Tumour Res Ctr, Portsmouth PO1 2DT, Hants, England.; Hargreaves, IP (corresponding author), Natl Hosp Neurol, Neurometab Unit, London WC1N 3BG, England.; Hargreaves, IP (corresponding author), Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England.
EM i.hargreaves@ucl.ac.uk; Rhiannon.mcgeehan@port.ac.uk
FU Headcase Cancer Trust; Ministry of Education, higher education and research of Quebec (Bourses pour courts sejours d'etudes universitaires)
CR Al-Mehdi AB, 2012, SCI SIGNAL, V5, P0, DOI 10.1126/scisignal.2002712
   Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   Daley E, 2005, BIOCHEM BIOPH RES CO, V328, P623, DOI 10.1016/j.bbrc.2005.01.028
   DeHaan C, 2004, MOL CANCER, V3, P0, DOI 10.1186/1476-4598-3-19
   Deighton RF, 2014, J NEURO-ONCOL, V118, P247, DOI 10.1007/s11060-014-1430-5
   Del Bufalo D, 2001, J CELL BIOCHEM, V83, P473, DOI 10.1002/jcb.1245
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Dubrow R, 2013, NEURO-ONCOLOGY, V15, P1750, DOI 10.1093/neuonc/not122
   Dudek Henryk, 2004, WIAD LEK, V57, P16
   Duncan AJ, 2005, CLIN CHEM, V51, P2380, DOI 10.1373/clinchem.2005.054643
   Enriquez JA, 2014, MOL SYNDROMOL, V5, P119, DOI 10.1159/000363364
   Feichtinger RG, 2014, GLIA, V62, P514, DOI 10.1002/glia.22621
   Griguer CE, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0061035
   Hargreaves I P, 2014, INT J BIOCHEM CELL BIOL, V49, P105, DOI 10.1016/j.biocel.2014.01.020
   Hargreaves IP, 2002, J INHERIT METAB DIS, V25, P7, DOI 10.1023/A:1015104910239
   Higgins SC, 2010, ANTICANCER RES, V30, P391
   Hopkins JF, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00377-y
   Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112
   King AL, 2016, REDOX BIOL, V9, P188, DOI 10.1016/j.redox.2016.08.005
   Kohsaka S, 2013, CANCER LETT, V331, P68, DOI 10.1016/j.canlet.2012.12.005
   Landis CJ, 2018, BBA-REV CANCER, V1869, P175, DOI 10.1016/j.bbcan.2018.01.004
   Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573
   Lee HC, 2004, INT J MOL MED, V13, P883
   Levkovitz Y, 2005, J MOL NEUROSCI, V27, P29, DOI 10.1385/JMN:27:1:029
   Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lloyd RE, 2015, NEURO-ONCOLOGY, V17, P942, DOI 10.1093/neuonc/nov020
   Lowe TM, 2016, NUCLEIC ACIDS RES, V44, PW54, DOI 10.1093/nar/gkw413
   Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012
   Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580
   Montero R, 2013, MITOCHONDRION, V13, P337, DOI 10.1016/j.mito.2013.04.001
   Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551
   Oksanen J, 2010, **DATA OBJECT**, V0, P0
   Oliva CR, 2017, ONCOTARGET, V8, P37568, DOI 10.18632/oncotarget.17247
   Oliva CR, 2015, ONCOTARGET, V6, P4330, DOI 10.18632/oncotarget.3015
   Oliva CR, 2010, J BIOL CHEM, V285, P39759, DOI 10.1074/jbc.M110.147504
   Ordys BB, 2010, MOL NEUROBIOL, V42, P64, DOI 10.1007/s12035-010-8133-5
   Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087
   Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019
   Pilkington GJ, 2008, SEMIN CANCER BIOL, V18, P226, DOI 10.1016/j.semcancer.2007.12.006
   Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036
   Selak MA, 2000, PEDIATR NEUROL, V23, P54, DOI 10.1016/S0887-8994(00)00145-4
   Shchors K, 2015, CANCER CELL, V28, P0, DOI 10.1016/j.ccell.2015.08.012
   Shwetha SD, 2016, PATHOL RES PRACT, V212, P17, DOI 10.1016/j.prp.2015.11.002
   Song Z, 2016, HUM MUTAT, V37, P933, DOI 10.1002/humu.23024
   Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020
   Walker AJ, 2011, BRIT J CANCER, V104, P193, DOI 10.1038/sj.bjc.6605996
   Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001
   Wharton DC, 1967, METHODS ENZYMOL, V10, P245, DOI 10.1016/0076-6879(67)10048-7
   Yeung KY, 2014, ACTA NEUROPATHOL COM, V2, P0, DOI 10.1186/2051-5960-2-1
NR 57
TC 8
Z9 8
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
EI 
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL 1
PY 2019
VL 20
IS 13
BP 
EP 
DI 10.3390/ijms20133364
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA IL1EG
UT WOS:000477041100248
PM 31323957
DA 2024-11-01
ER

PT J
AU Baek, MS
   Kim, SH
   Lee, YM
AF Baek, Min-Seong
   Kim, Se Hoon
   Lee, Young-Mock
TI The Usefulness of Muscle Biopsy in Initial Diagnostic Evaluation of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes
SO YONSEI MEDICAL JOURNAL
LA English
DT Article
DE MELAS; muscle biopsy; genetic diagnosis; morphological diagnosis
ID clinical-features; melas; mutation; encephalopathy; disease; prevalence; management; phenotype; myopathy; cohort
AB Purpose: The disease entity mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is characterized by an early onset of stroke-like episodes. MELAS is the most dominant subtype of mitochondrial disease. Molecular genetic testing is important in the diagnosis of MELAS. The mitochondrial DNA (mtDNA) 3243A>G mutation is found in 80% of MELAS patients. Nevertheless, molecular analysis alone may be insufficient to diagnose MELAS because of mtDNA heteroplasmy. This study aimed to evaluate whether muscle biopsy is useful in MELAS patients as an initial diagnostic evaluation method. Materials and Methods: The medical records of patients who were diagnosed with MELAS at the Department of Pediatrics of Gangnam Severance Hospital between January 2006 and January 2017 were reviewed. The study population included 12 patients. They were divided into two subgroups according to whether the results of muscle pathology were in accordance with mitochondrial diseases. Clinical variables, diagnostic evaluations, and clinical outcomes were compared between the two groups. Results: Of the 12 patients, seven were muscle pathology-positive for mitochondrial disease. No statistically significant difference in clinical data was observed between the groups that were muscle pathology-positive and muscle pathology-negative for mtDNA 3243A>G mutation. Additionally, the patients with weakness as the initial symptom were all muscle pathology-positive. Conclusion: The usefulness of muscle biopsy appears to be limited to an initial confirmative diagnostic evaluation of MELAS. Muscle biopsy can provide some information in MELAS patients with weakness not confirmed by genetic testing.
C1 [Baek, Min-Seong; Lee, Young-Mock] Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea.
   [Kim, Se Hoon] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System
RP Lee, YM (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Pediat, 211 Eonju Ro, Seoul 06273, South Korea.
EM ymleemd@yuhs.ac
FU Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C0673]
CR El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, V0, PS107
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Joyce NC, 2012, PHYS MED REH CLIN N, V23, P609, DOI 10.1016/j.pmr.2012.06.006
   Kisler JE, 2010, DEV MED CHILD NEUROL, V52, P422, DOI 10.1111/j.1469-8749.2009.03605.x
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Lorenzoni PJ, 2009, ARQ NEURO-PSIQUIAT, V67, P668, DOI 10.1590/S0004-282X2009000400018
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Parsons T, 2010, ARCH NEUROL-CHICAGO, V67, P976, DOI 10.1001/archneurol.2010.174
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 22
TC 5
Z9 6
U1 0
U2 5
PU YONSEI UNIV COLL MEDICINE
PI SEOUL
PA 50-1 YONSEI-RO, SEODAEMUN-GU, SEOUL 120-752, SOUTH KOREA
SN 0513-5796
EI 1976-2437
J9 YONSEI MED J
JI Yonsei Med. J.
PD JAN 15
PY 2019
VL 60
IS 1
BP 98
EP 105
DI 10.3349/ymj.2019.60.1.98
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA HE3FA
UT WOS:000453236500012
PM 30554496
DA 2024-11-01
ER

PT J
AU Ronchi, D
   Liu, CW
   Caporali, L
   Piga, D
   Li, HZ
   Tagliavini, F
   Valentino, ML
   Ferro, MT
   Bini, P
   Zheng, L
   Carelli, V
   Shen, BH
   Comi, GP
AF Ronchi, Dario
   Liu, Changwei
   Caporali, Leonardo
   Piga, Daniela
   Li, Hongzhi
   Tagliavini, Francesca
   Valentino, Maria Lucia
   Ferro, Maria Teresa
   Bini, Paola
   Zheng, Li
   Carelli, Valerio
   Shen, Binghui
   Comi, Giacomo Pietro
TI Novel mutations in DNA2 associated with myopathy and mtDNA instability
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID mitochondrial; replication; nuclease/helicase; maintenance
AB The maintenance of mitochondrial DNA (mtDNA) relies on proteins encoded by nuclear genes. Mutations in their coding sequences result in heterogenous clinical presentations featuring mtDNA instability in affected tissues. DNA2 is a multi-catalytic protein involved in the removal of single strand DNA during mtDNA replication or Long Patch Base Excision Repair pathway. We have previously described DNA2 mutations in adult patients affected with familial and sporadic forms of mitochondrial myopathy. Here we describe four novel probands presenting with limb weakness associated with novel DNA2 molecular defects. Biochemical assays were established to investigate the functional effects of these variants.
C1 [Ronchi, Dario; Piga, Daniela] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
   [Ronchi, Dario; Comi, Giacomo Pietro] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Liu, Changwei; Li, Hongzhi; Zheng, Li; Shen, Binghui] Beckman Res Inst City Hope, Dept Canc Genet & Epigenet, 1500 East Duarte Rd, Duarte, CA 91010 USA.
   [Caporali, Leonardo; Tagliavini, Francesca; Valentino, Maria Lucia; Carelli, Valerio] UOC Clin Neurol, Ist Sci Neurol Bologna, Bologna, Italy.
   [Valentino, Maria Lucia; Carelli, Valerio] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie DIBINEM, Bologna, Italy.
   [Ferro, Maria Teresa] Osped Maggiore Crema, Neurol Unit, Crema, Italy.
   [Bini, Paola] Natl Neurol Inst, IRCCS C Mondino Fdn, Pavia, Italy.
   [Comi, Giacomo Pietro] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neurosci, Neuromuscular & Rare Dis Unit, I-20122 Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; City of Hope; Beckman Research Institute of City of Hope; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; Fondazione IRCCS Istituto Neurologico Carlo Besta; IRCCS Fondazione Casimiro Mondino; IRCCS Ca Granda Ospedale Maggiore Policlinico
RP Shen, BH (corresponding author), Beckman Res Inst City Hope, Dept Canc Genet & Epigenet, 1500 East Duarte Rd, Duarte, CA 91010 USA.; Carelli, V (corresponding author), UOC Clin Neurol, Ist Sci Neurol Bologna, Bologna, Italy.; Carelli, V (corresponding author), Univ Bologna, Dipartimento Sci Biomed & Neuromotorie DIBINEM, Bologna, Italy.; Comi, GP (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Neurosci Sect, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Via Francesco Sforza 35, I-20122 Milan, Italy.
EM valerio.carelli@unibo.it; bshen@coh.org; giacomo.comi@unimi.it
FU Fondazione Cariplo [2014-1010]; Italian Telethon [GSP16001]; Italian Ministry of Health;  [R01CA085344]
CR Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Akhmedov AT, 2015, MOL CELL BIOCHEM, V409, P283, DOI 10.1007/s11010-015-2532-x
   Chae JH, 2015, J MED GENET, V52, P208, DOI 10.1136/jmedgenet-2014-102819
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Jia PP, 2017, DNA REPAIR, V59, P9, DOI 10.1016/j.dnarep.2017.09.001
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Li ZK, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201796729
   Miller AS, 2017, GENE DEV, V31, P503, DOI 10.1101/gad.295659.116
   Peng G, 2012, CANCER RES, V72, P2802, DOI 10.1158/0008-5472.CAN-11-3152
   Phowthongkum P, 2017, NEUROMUSCULAR DISORD, V27, P616, DOI 10.1016/j.nmd.2017.03.013
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 15
TC 11
Z9 11
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
EI 
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD SEP 15
PY 2019
VL 6
IS 9
BP 1893
EP 1899
DI 10.1002/acn3.50888
EA SEP 2019
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA JA5LI
UT WOS:000484834100001
PM 31478350
DA 2024-11-01
ER

PT J
AU Tonska, K
AF Tonska, Katarzyna
TI Instability of Human Mitochondrial DNA, Nuclear Genes and Diseases
SO HANDBOOK OF MITOCHONDRIAL DYSFUNCTION
LA English
DT Article; Book Chapter
ID progressive external ophthalmoplegia; impair mtdna replication; thymidine kinase; mpv17 encodes; optic atrophy; mutations; deletions; twinkle; accumulation; polymerase
C1 [Tonska, Katarzyna] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Warsaw, Poland.
C3 University of Warsaw
RP Tonska, K (corresponding author), Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Warsaw, Poland.
FU Polish National Science Center [2014/15/B/NZ5/00434]
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083
   Barshad G, 2018, TRENDS GENET, V34, P682, DOI 10.1016/j.tig.2018.05.009
   Bartsakoulia M, 2018, HUM MOL GENET, V27, P1186, DOI 10.1093/hmg/ddy033
   Benbrik E, 1997, J NEUROL SCI, V149, P19, DOI 10.1016/S0022-510X(97)05376-8
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bradshaw E, 2012, FEBS LETT, V586, P1245, DOI 10.1016/j.febslet.2012.03.046
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Elson JL, 2010, GENET MED, V12, P313, DOI 10.1097/GIM.0b013e3181da76e3
   Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   GarcÃ­a-GÃ³mez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   GarcÃ­a-Sobrino T, 2017, NEUROMUSCULAR DISORD, V27, P667, DOI 10.1016/j.nmd.2017.01.008
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   GrÃ¼newald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Hillen HS, 2017, CELL, V171, P1082, DOI 10.1016/j.cell.2017.09.035
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a012971
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Hoyle JC, 2015, APPL CLIN GENET, V8, P235, DOI 10.2147/TACG.S69969
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   HyvÃ¤rinen AK, 2011, MOL BIOL REP, V38, P1321, DOI 10.1007/s11033-010-0233-9
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Kanfer G, 2016, BIOCHEM SOC T, V44, P510, DOI 10.1042/BST20150274
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Keen BA, 2014, NUCLEIC ACIDS RES, V42, P12102, DOI 10.1093/nar/gku879
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2012, NEUROBIOL AGING, V33, P2210, DOI 10.1016/j.neurobiolaging.2011.08.009
   KÃ¼hl I, 2016, SCI ADV, V2, P0, DOI 10.1126/sciadv.1600963
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Li JL, 2015, INVEST OPHTH VIS SCI, V56, P1181, DOI 10.1167/iovs.14-16072
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Melov S, 1999, NEUROBIOL AGING, V20, P565, DOI 10.1016/S0197-4580(99)00092-5
   Namba K, 2016, OTOL NEUROTOL, V37, P394, DOI 10.1097/MAO.0000000000000978
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Phillips NR, 2014, ALZHEIMERS DEMENT, V10, P393, DOI 10.1016/j.jalz.2013.04.508
   Piekutowska-Abramczuk D, 2019, MITOCHONDRION, V47, P179, DOI 10.1016/j.mito.2018.11.004
   PohjoismÃ¤ki JLO, 2018, BIOESSAYS, V40, P0, DOI 10.1002/bies.201800102
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   ROBBERSODL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Ryu SW, 2010, CELL MOL LIFE SCI, V67, P2839, DOI 10.1007/s00018-010-0365-z
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Sasaki T, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-10843-8
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-016-0404-6
   Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Zhang LL, 2017, ADV EXP MED BIOL, V1038, P85, DOI 10.1007/978-981-10-6674-0_7
   Zhao FX, 2013, HUM GENET, V132, P913, DOI 10.1007/s00439-013-1303-6
NR 88
TC 0
Z9 0
U1 0
U2 0
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
SN 
EI 
J9 
PD JUN 15
PY 2019
VL 0
IS 
BP 39
EP 54
DI 
PG 16
WC Cell Biology; Genetics & Heredity; Pathology
SC Cell Biology; Genetics & Heredity; Pathology
GA BQ1CL
UT WOS:000575159400005
DA 2024-11-01
ER

PT J
AU Fekete, B
   PentelÃ©nyi, K
   Rudas, G
   GÃ¡l, A
   Grosz, Z
   IllÃ©s, A
   Idris, J
   Csukly, G
   Domonkos, A
   Molnar, MJ
AF Fekete, Balint
   Pentelenyi, Klara
   Rudas, Gabor
   Gal, Aniko
   Grosz, Zoltan
   Illes, Anett
   Idris, Jimoh
   Csukly, Gabor
   Domonkos, Andor
   Molnar, Maria Judit
TI Broadening the phenotype of the <i>TWNK</i> gene associated Perrault syndrome
SO BMC MEDICAL GENETICS
LA English
DT Article
DE Perrault syndrome; TWNK; Hyperintense cerebellar signal; Spastic ataxia
ID twinkle; mutations; helicase; spectrum
AB Background: Perrault syndrome is a genetically heterogenous, very rare disease, characterized clinically by sensorineural hearing loss, ovarian dysfunction and neurological symptoms. We present the case of a 33 years old female patient with TWNK-associated Perrault syndrome. The TWNK gene is coding the mitochondrial protein Twinkle and currently there are only two reports characterizing the phenotype of TWNK-associated Perrault syndrome. None of these publications reported about special brain MRI alterations and neuropathological changes in the muscle and peripheral nerves. Case presentation: Our patients with TWNK-dependent Perrault syndrome had severe bilateral hypoacusis, severe ataxia, polyneuropathy, lower limb spastic paraparesis with pyramidal signs, and gonadal dysgenesis. Psychiatric symptoms such as depression and paranoia were present as well. Brain MRI observed progressive cerebellar hyperintensive signs associated with cerebellar, medulla oblongata and cervical spinal cord atrophy. Light microscopy of the muscle biopsy detected severe neurogenic lesions. COX staining was centrally reduced in many muscle fibers. Both muscle and sural nerve electron microscopy detected slightly enlarged mitochondria with abnormal cristae surrounded by lipid vacuoles. In the sural nerve, dystrophic axons had focally uncompacted myelin lamellae present. Genetic investigation revealed multiple mtDNA deletion and compound heterozygous mutations of the TWNK gene (c.1196 A > G, c.1358 G > A). Conclusion: This study demonstrates that TWNK associated Perrault syndrome has a much broader phenotype as originally published. The coexistence of severe hypoacusis, spastic limb weakness, ataxia, polyneuropathy, gonadal dysgensia, hyperintense signals in the cerebellum and the presence of the mtDNA multiple deletion could indicate the impairment of the TWNK gene. This is the first report about pyramidal tract involvement and cerebellar MRI alteration associated with TWNK-related Perrault syndrome.
C1 [Fekete, Balint; Pentelenyi, Klara; Gal, Aniko; Grosz, Zoltan; Illes, Anett; Idris, Jimoh; Molnar, Maria Judit] Semmelweis Univ, Inst Genom Med & Rare Disorders, 26 Ulloi Rd, H-1085 Budapest, Hungary.
   [Rudas, Gabor] Semmelweis Univ, MR Res Ctr, Budapest, Hungary.
   [Csukly, Gabor] Semmelweis Univ, Dept Psychiat & Psychotherapy, Budapest, Hungary.
   [Domonkos, Andor] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary.
C3 Semmelweis University; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; Hungarian Research Network; HUN-REN Institute of Experimental Medicine
RP Fekete, B (corresponding author), Semmelweis Univ, Inst Genom Med & Rare Disorders, 26 Ulloi Rd, H-1085 Budapest, Hungary.
EM Fba8713@gmail.com
FU Hungarian Brain Project [KTIA_NAP_2017-1.2.1-NKP-2017-00002]
CR Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918
   Chatzispyrou IA, 2017, HUM MOL GENET, V26, P2541, DOI 10.1093/hmg/ddx152
   Demain LAM, 2017, CLIN GENET, V91, P302, DOI 10.1111/cge.12776
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Faridi R, 2017, CLIN GENET, V91, P328, DOI 10.1111/cge.12867
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Jenkinson EM, 2012, J NEUROL, V259, P974, DOI 10.1007/s00415-011-6285-5
   Lieber DS, 2014, BMC MED GENET, V15, P0, DOI 10.1186/1471-2350-15-30
   LÃ¶nnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Oldak M, 2017, J TRANSL MED, V15, P0, DOI 10.1186/s12967-017-1129-4
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
NR 15
TC 14
Z9 13
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2350
J9 BMC MED GENET
JI BMC Med. Genet.
PD DEC 18
PY 2019
VL 20
IS 1
BP 
EP 
DI 10.1186/s12881-019-0934-4
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA KI8NU
UT WOS:000511615500001
PM 31852434
DA 2024-11-01
ER

PT J
AU Papadimas, GK
   Kokkinis, C
   Xirou, S
   Chrysanthou, M
   Kararizou, E
   Papadopoulos, C
AF Papadimas, George K.
   Kokkinis, Charalampos
   Xirou, Sophia
   Chrysanthou, Margarita
   Kararizou, Evangelia
   Papadopoulos, Constantinos
TI Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature
SO RHEUMATOLOGY INTERNATIONAL
LA English
DT Review
DE Polymyositis; Mitochondria; mtDNA; Inclusion body myositis
ID dna deletions; hypothyroid myopathy; muscle-fibers
AB Polymyositis with mitochondrial pathology (PM-Mito) is a rare form of idiopathic inflammatory myopathy with no definite diagnostic criteria and similarities to both PM and sporadic inclusion body myositis (s-IBM). The aim of this study is to address the dilemma of whether PM-Mito is a subtype of inflammatory myopathy or represents a disease falling into the spectrum of s-IBM. Herein, we report four female patients diagnosed with PM-Mito, highlighting their rather atypical clinical and histopathological characteristics that seem to indicate a diagnosis away from s-IBM. Muscle weakness was rather proximal and symmetrical and lacked the selective pattern observed in s-IBM. Patients had large-scale deletions in mtDNA, reflecting the mitochondrial component in the pathology of the disease. Conclusively, our study adds to the limited data in the literature on whether PM-Mito is a distinct form of myositis or represents a prodromal stage of s-IBM. Although the latter seems to be supported by a substantial body of evidence, there are, however, important differences, such as the different patterns of muscle weakness, and the good response to treatment observed in some patients. Larger-scale studies are certainly needed to clarify pathogenesis and clinical characteristics of PM-Mito patients, especially in therapeutic and prognostic terms.
C1 [Papadimas, George K.; Xirou, Sophia; Chrysanthou, Margarita; Kararizou, Evangelia; Papadopoulos, Constantinos] Univ Athens, Eginit Hosp, Sch Med, Dept Neurol 1, 74 Vas Sophias Ave, Athens 11528, Greece.
   [Kokkinis, Charalampos] Univ Athens, St Sofias Childrens Hosp, Sch Med, Dept Med Genet, Athens, Greece.
C3 Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens
RP Papadimas, GK (corresponding author), Univ Athens, Eginit Hosp, Sch Med, Dept Neurol 1, 74 Vas Sophias Ave, Athens 11528, Greece.
EM gkpapad@yahoo.gr; haris.kokkinis@gmail.com; sopxir@hotmail.com; margarita.chrysanthou@gmail.com; ekarariz@med.uoa.gr; constantinospapadopoulos@yahoo.com
CR Amato Anthony A, 2013, CONTINUUM (MINNEAP MINN), V19, P1615, DOI 10.1212/01.CON.0000440662.26427.bd
   Blume G, 1997, BRAIN, V120, P39, DOI 10.1093/brain/120.1.39
   Brady S, 2014, BMJ OPEN, V4, P0, DOI 10.1136/bmjopen-2013-004552
   Brady S, 2013, J NEUROL NEUROSUR PS, V84, P1240, DOI 10.1136/jnnp-2013-305690
   Chariot P, 1996, ACTA NEUROPATHOL, V91, P530, DOI 10.1007/s004010050462
   Delalande S, 2004, MEDICINE, V83, P280, DOI 10.1097/01.md.0000141099.53742.16
   Fauchais AL, 2010, AUTOIMMUN REV, V9, P595, DOI 10.1016/j.autrev.2010.05.004
   Finsterer J, 1999, HORM RES, V52, P205, DOI 10.1159/000023462
   FLORENCE JM, 1992, PHYS THER, V72, P115, DOI 10.1093/ptj/72.2.115
   Gallay L, 2016, REV NEUROL-FRANCE, V172, P581, DOI 10.1016/j.neurol.2016.07.016
   Greenberg Steven A, 2016, CONTINUUM (MINNEAP MINN), V22, P1871
   GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504
   Hiniker A, 2013, ACTA NEUROPATHOL COM, V1, P0, DOI 10.1186/2051-5960-1-29
   Lamperti C, 2009, ACTA MYOL, V28, P2
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Lundberg IE, 2018, NAT REV RHEUMATOL, V14, P269, DOI 10.1038/nrrheum.2018.41
   Mastaglia FL, 2015, J CLIN NEUROSCI, V22, P6, DOI 10.1016/j.jocn.2014.09.012
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Modi G, 2000, J NEUROL SCI, V175, P28, DOI 10.1016/S0022-510X(00)00266-5
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Oh TH, 2007, MAYO CLIN PROC, V82, P441, DOI 10.4065/82.4.441
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Rojana-udomsart A, 2011, CLIN NEUROL NEUROSUR, V113, P559, DOI 10.1016/j.clineuro.2011.03.016
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Siepmann T, 2013, ANN DIAGN PATHOL, V17, P183, DOI 10.1016/j.anndiagpath.2012.10.004
   Simon JP, 2016, FRONT IMMUNOL, V7, P0, DOI 10.3389/fimmu.2016.00234
   Temiz P, 2009, J NEUROL SCI, V278, P25, DOI 10.1016/j.jns.2008.11.010
   Varadhachary AS, 2010, CURR OPIN RHEUMATOL, V22, P651, DOI 10.1097/BOR.0b013e32833f108a
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
NR 32
TC 9
Z9 11
U1 0
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0172-8172
EI 1437-160X
J9 RHEUMATOL INT
JI Rheumatol. Int.
PD AUG 15
PY 2019
VL 39
IS 8
BP 1459
EP 1466
DI 10.1007/s00296-019-04314-8
PG 8
WC Rheumatology
SC Rheumatology
GA IF6LI
UT WOS:000473191800019
PM 31055642
DA 2024-11-01
ER

PT J
AU Shree, R
   Mehta, S
   Goyal, MK
   Gaspar, BL
   Lal, V
AF Shree, Ritu
   Mehta, Sahil
   Goyal, Manoj K.
   Gaspar, Balan L.
   Lal, Vivek
TI Muscle Biopsy: A Boon for Diagnosis of Mitochondrial Parkinsonism in Developing Countries
SO ANNALS OF INDIAN ACADEMY OF NEUROLOGY
LA English
DT Article
DE Dystonia; mitochondria; muscle biopsy; Parkinsonism
ID movement-disorders; mutation; ophthalmoplegia; neuropathy; myopathy; disease
AB Mitochondrial dysfunction plays an important role in the pathogenesis of Parkinson's disease. Primary genetic abnormalities in the mitochondrial DNA or nuclear DNA can cause parkinsonism. Mitochondrial parkinsonism presents with classical features of parkinsonism along with multisystem involvement. Genetic analysis is essential in reaching the diagnosis which is not always possible, especially in developing countries. Muscle biopsy can be a boon in this setting as exemplified in our report of two siblings where a diagnosis of mitochondrial parkinsonism was made on the basis of muscle biopsy.
C1 [Shree, Ritu; Mehta, Sahil; Goyal, Manoj K.; Lal, Vivek] Postgrad Inst Med Educ & Res, Dept Neurol, Chandigarh, India.
   [Gaspar, Balan L.] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh, India.
C3 Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh
RP Mehta, S (corresponding author), Postgrad Inst Med Educ & Res, Dept Neurol, Chandigarh, India.
EM mehtasahilpgi@gmail.com
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Casali C, 2001, NEUROLOGY, V56, P802, DOI 10.1212/WNL.56.6.802
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Dermaut B, 2010, J NEUROL NEUROSUR PS, V81, P90, DOI 10.1136/jnnp.2008.157354
   Gautier CA, 2014, REV NEUROL-FRANCE, V170, P339, DOI 10.1016/j.neurol.2013.06.003
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   Moustris Andreas, 2011, HANDB CLIN NEUROL, V100, P173, DOI 10.1016/B978-0-444-52014-2.00010-0
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Thobois S, 1997, REV NEUROL, V153, P595
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Tranchant C, 2016, REV NEUROL-FRANCE, V172, P524, DOI 10.1016/j.neurol.2016.07.003
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
NR 16
TC 0
Z9 0
U1 0
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0972-2327
EI 1998-3549
J9 ANN INDIAN ACAD NEUR
JI Ann. Indian Acad. Neurol.
PD APR-JUN 15
PY 2019
VL 22
IS 2
BP 228
EP 230
DI 10.4103/aian.AIAN_436_17
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA HS9DL
UT WOS:000464167900023
PM 31007443
DA 2024-11-01
ER

PT J
AU Spangenberg, L
   GraÃ±a, M
   Mansilla, S
   Martinez, J
   TapiÃ©, A
   Greif, G
   Montano, N
   Vaglio, A
   GuecaimburÃº, R
   Robello, C
   Castro, L
   Quijano, C
   Raggio, V
   Naya, H
AF Spangenberg, Lucia
   Grana, Martin
   Mansilla, Santiago
   Martinez, Jennyfer
   Tapie, Alejandra
   Greif, Gonzalo
   Montano, Nelida
   Vaglio, Alicia
   Guecaimburu, Rosario
   Robello, Carlos
   Castro, Laura
   Quijano, Celia
   Raggio, Victor
   Naya, Hugo
TI Deep sequencing discovery of causal mtDNA mutations in a patient with unspecific neurological disease
SO MITOCHONDRION
LA English
DT Article
DE Deep sequencing; Neurological disorders; mitDNA; Causative mutation; 9017C; 9010A
ID mitochondrial-dna; skeletal-muscle; high penetrance; human brain; heteroplasmy; variants; decline; web
AB Mitochondrial diseases (MD) are a group of diseases that can be caused by either mutations in the mitochondrial genome or nuclear DNA. MD may be difficult to diagnose since very often they are highly heterogeneous and with overlapping phenotypes. Molecular genomics approaches, especially NGS have helped in this sense. In this study we have sequenced the mitochondrial genome of a girl with an unspecific neurological disorder and her mother. The later, while neurologically unaffected, suffers from a myopathy without clear cause. We were able to detect two non-synonymous mutations in the MT-ATP6 gene, which we propose are strong candidates for causative agents. 9017C as the main candidate present at high heteroplasmy frequency in the patient (83,2%) and moderate in the mother (45,4%) while it has a low frequency in the general population. It might act alone or in conjunction with 9010A as an accessory mutation. Evolutionary analysis showed that both mutations were located in a critical position in the F-0 a subunit, from F-0-F-1 ATPase. Functional studies showed that carriers of those mutations in comparison to an unaffected individual (father) presented a decrease in the basal and ATP dependent oxygen consumption rate and a decrease in the maximum respiration rate.
C1 [Spangenberg, Lucia; Grana, Martin; Naya, Hugo] Inst Pasteur Montevideo, Unidad Bioinformat, Montevideo, Uruguay.
   [Tapie, Alejandra; Guecaimburu, Rosario; Raggio, Victor] UDELAR, Dept Genet, Fac Med, Montevideo, Uruguay.
   [Mansilla, Santiago; Martinez, Jennyfer; Castro, Laura; Quijano, Celia] UDELAR, Dept Bioquim, Fac Med, Montevideo, Uruguay.
   [Montano, Nelida; Vaglio, Alicia] Inst Med Genet, Montevideo, Uruguay.
   [Mansilla, Santiago; Martinez, Jennyfer; Castro, Laura; Quijano, Celia] Ctr Free Rad & Biomed Res CEINBIO, Montevideo, Uruguay.
   [Naya, Hugo] UDELAR, Dept Prod Anim & Pasturas, Fac Agron, Montevideo, Uruguay.
   [Greif, Gonzalo; Robello, Carlos] Inst Pasteur Montevideo, Unidad Biol Mol, Montevideo, Uruguay.
C3 Pasteur Network; Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Pasteur Network; Institut Pasteur de Montevideo
RP Naya, H (corresponding author), Inst Pasteur Montevideo, Bioinformat Unit, Mataojo 2020, Montevideo 11400, Uruguay.
EM naya@pasteur.edu.uy
FU FOCEM (MERCOSUR Structural Convergence Fund) [COF 03/11]; Inter-American Development Bank [ATN/KK-14584]; INNOVA-Uruguay; Espacio Interdisciplinario - Centros, UDELAR 2015; CSIC grupos I + D [767]; CSIC I + D [280]
CR Adzhubei I, 2013, CURR PROTOC HUM S76, V0, P76
   Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI 10.1042/BSE0520023
   Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Blein S, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0136192
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   Calabrese C, 2014, BIOINFORMATICS, V30, P3115, DOI 10.1093/bioinformatics/btu483
   Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen N, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep37404
   Chinnery P, 2000, MITOCHONDRIAL DISORD, V0, P1
   Finn RD, 2015, NUCLEIC ACIDS RES, V43, PW30, DOI 10.1093/nar/gkv397
   Hamosh A, 2000, HUM MUTAT, V15, P57, DOI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G
   Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95
   Ji YC, 2016, INVEST OPHTH VIS SCI, V57, P2377, DOI 10.1167/iovs.16-19243
   Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kramer PA, 2014, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/51301
   Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, PD980, DOI 10.1093/nar/gkt1113
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Povalko N, 2005, MITOCHONDRION, V5, P194, DOI 10.1016/j.mito.2005.03.003
   Quijano C, 2016, REDOX BIOL, V8, P28, DOI 10.1016/j.redox.2015.11.010
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Stavropoulos DJ, 2016, NPJ GENOM MED, V1, P0, DOI 10.1038/npjgenmed.2015.12
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Zhou AN, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.10180
   2013, 1900, V12, V0, PP812, DOI 10.1111/GBB.12089
   2016, 1900, V28, V0, PP54, DOI 10.1016/J.MITO.2016.03.006
NR 42
TC 6
Z9 7
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAY 15
PY 2019
VL 46
IS 
BP 337
EP 344
DI 10.1016/j.mito.2018.09.004
PG 8
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA HX8NY
UT WOS:000467663800043
PM 30227252
DA 2024-11-01
ER

PT J
AU Endres, D
   SÃ¼ss, P
   Maier, SJ
   Friedel, E
   Nickel, K
   Ziegler, C
   Fiebich, BL
   Glocker, FX
   Stock, F
   Eggers, K
   Lange, T
   Dacko, M
   Venhoff, N
   Erny, D
   Doostkam, S
   Komlosi, K
   Domschke, K
   van Elst, LT
AF Endres, Dominique
   Suess, Patrick
   Maier, Simon J.
   Friedel, Evelyn
   Nickel, Kathrin
   Ziegler, Christiane
   Fiebich, Bernd L.
   Glocker, Franz X.
   Stock, Friedrich
   Eggers, Karl
   Lange, Thomas
   Dacko, Michael
   Venhoff, Nils
   Erny, Daniel
   Doostkam, Soroush
   Komlosi, Katalin
   Domschke, Katharina
   van Elst, Ludger Tebartz
TI New Variant of MELAS Syndrome With Executive Dysfunction, Heteroplasmic Point Mutation in the <i>MT-ND4</i> Gene (m.12015T>C; p.Leu419Pro) and Comorbid Polyglandular Autoimmune Syndrome Type 2
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE MELAS; mitochondrial disease; polyglandular autoimmune syndrome; ND4 gene; dysexecutive syndrome
ID endocrine disorders; mitochondrial; lactate; disease
AB Background: Mitochondrial diseases are caused by dysfunctions in mitochondrial metabolic pathways. MELAS syndrome is one of the most frequent mitochondrial disorders; it is characterized by encephalopathy, myopathy, lactic acidosis, and stroke-like episodes. Typically, it is associated with a point mutation with an adenine-to-guanine transition at position 3243 of the mitochondrial DNA (mtDNA; m.3243A>G) in the mitochondrially encoded tRNA leucine 1 (MT-TL1) gene. Other point mutations are possible and the association with polyglandular autoimmune syndrome type 2 has not yet been described. Case presentation: We present the case of a 25-year-old female patient with dysexecutive syndrome, muscular fatigue, and continuous headache. Half a year ago, she fought an infection-triggered Addison crisis. As the disease progressed, she had two epileptic seizures and stroke-like episodes with hemiparesis on the right side. Cerebral magnetic resonance imaging showed a substance defect of the parieto-occipital left side exceeding the vascular territories with a lactate peak. The lactate ischemia test was clearly positive, and a muscle biopsy showed single cytochrome c oxidase-negative muscle fibers. Genetic testing of blood mtDNA revealed a heteroplasmic base exchange mutation in the mitochondrially encoded NADH: ubiquinone oxidoreductase core subunit 4 (MT-ND4) gene (m.12015T>C; p.Leu419Pro; heteroplasmy level in blood 12%, in muscle tissue: 15%). The patient suffered from comorbid autoimmune polyglandular syndrome type 2 with Hashimoto's thyroiditis, Addison's disease, and autoimmune gastritis. In addition, we found increased anti-glutamic acid decarboxylase 65, anti-partial cell, anti-intrinsic factor, and anti-nuclear antibodies. Conclusion: We present an atypical case of MELAS syndrome with predominant symptoms of a dysexecutive syndrome, two stroke-like episodes, and fast-onset fatigue. The symptoms were associated with a not yet described base and aminoacid exchange mutation in the MT-ND4 gene (m.12015T>C to p.Leu419Pro). The resulting changed protein complex in our patient is part of the respiratory chain multicomplex I and might be the reason for the mitochondriopathy. However, different simulations for pathogenetic relevance are contradictory and rather speak for a benign variant. To our knowledge this case report is the first reporting MELAS syndrome with comorbid polyglandular autoimmune syndrome type 2. Screening for autoimmune alterations in those patients is important to prevent damage to end organs.
C1 [Endres, Dominique; Suess, Patrick; Maier, Simon J.; Friedel, Evelyn; Nickel, Kathrin; van Elst, Ludger Tebartz] Univ Freiburg, Fac Med, Med Ctr, Sect Expt Neuropsychiat,Dept Psychiat & Psychothe, Freiburg, Germany.
   [Endres, Dominique; Suess, Patrick; Maier, Simon J.; Friedel, Evelyn; Nickel, Kathrin; Ziegler, Christiane; Fiebich, Bernd L.; Domschke, Katharina; van Elst, Ludger Tebartz] Univ Freiburg, Fac Med, Med Ctr, Dept Psychiat & Psychotherapy, Freiburg, Germany.
   [Glocker, Franz X.] Univ Freiburg, Fac Med, Med Ctr, Dept Neurol, Freiburg, Germany.
   [Stock, Friedrich] Univ Hosp Muenster, Inst Human Genet, Munster, Germany.
   [Eggers, Karl] Univ Freiburg, Fac Med, Med Ctr, Dept Neuroradiol, Freiburg, Germany.
   [Lange, Thomas; Dacko, Michael] Univ Freiburg, Fac Med, Med Ctr, Dept Radiol,Med Phys, Freiburg, Germany.
   [Venhoff, Nils] Univ Freiburg, Fac Med, Med Ctr, Dept Rheumatol & Clin Immunol, Freiburg, Germany.
   [Erny, Daniel; Doostkam, Soroush] Univ Freiburg, Fac Med, Med Ctr, Inst Neuropathol, Freiburg, Germany.
   [Erny, Daniel] Univ Freiburg, Fac Med, Berta Ottenstein Programme, Freiburg, Germany.
   [Komlosi, Katalin] Univ Freiburg, Fac Med, Med Ctr, Inst Human Genet, Freiburg, Germany.
C3 University of Freiburg; University of Freiburg; University of Freiburg; University of Munster; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg
RP Endres, D (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Sect Expt Neuropsychiat,Dept Psychiat & Psychothe, Freiburg, Germany.; Endres, D (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Psychiat & Psychotherapy, Freiburg, Germany.
EM dominique.endres@uniklinik-Freiburg.de
FU German Research Foundation (DFG); University of Freiburg
CR Afroze B, 2014, BRAIN DEV-JPN, V36, P924, DOI 10.1016/j.braindev.2013.12.009
   Al-Gadi IS, 2018, J ENDOCR SOC, V2, P361, DOI 10.1210/js.2017-00434
   BEHAR KL, 1994, MAGNET RESON MED, V32, P294, DOI 10.1002/mrm.1910320304
   Brabant G, 2002, DTSCH ARZTEBL INT, V99, P1428
   Cutolo M, 2014, AUTOIMMUN REV, V13, P85, DOI 10.1016/j.autrev.2013.07.006
   de Castro CSA, 2013, NMR BIOMED, V26, P1213, DOI 10.1002/nbm.2937
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Finsterer J, 1998, J NEUROL SCI, V159, P176, DOI 10.1016/S0022-510X(98)00170-1
   Kornblum C, 2012, MITOCHONDRIALE ERKRA, V0, P0
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J
   Nieves-Moreno M, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0180450
   OGrady Michael J, 2015, BMJ CASE REP, V2015, P0, DOI 10.1136/bcr-2014-208514
   Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612
   PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Seidowsky A, 2013, CLIN NEPHROL, V80, P456, DOI 10.5414/CN107063
   Tarnopolsky MA, 1998, MUSCLE NERVE, V21, P25, DOI 10.1002/(SICI)1097-4598(199801)21:1<25::AID-MUS4>3.0.CO;2-I
   Velankar S, 2016, NUCLEIC ACIDS RES, V44, PD385, DOI 10.1093/nar/gkv1047
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 22
TC 7
Z9 7
U1 0
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
EI 
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAR 21
PY 2019
VL 10
IS 
BP 
EP 
DI 10.3389/fimmu.2019.00412
PG 11
WC Immunology
SC Immunology
GA HP7GM
UT WOS:000461855800001
PM 30949164
DA 2024-11-01
ER

PT J
AU Lin, TK
   Chen, SD
   Chuang, YC
   Lan, MY
   Chuang, JH
   Wang, PW
   Hsu, TY
   Wang, FS
   Tsai, MH
   Huang, ST
   Wang, XW
   Tsai, PC
   Lin, HY
   Liou, CW
AF Lin, Tsu-Kung
   Chen, Shang-Der
   Chuang, Yao-Chung
   Lan, Min-Yu
   Chuang, Jiin-Haur
   Wang, Pei-Wen
   Hsu, Te-Yao
   Wang, Feng-Sheng
   Tsai, Meng-Han
   Huang, Sheng-Teng
   Wang, Xiao-Wen
   Tsai, Po-Chin
   Lin, Hung-Yu
   Liou, Chia-Wei
TI Mitochondrial Transfer of Wharton's Jelly Mesenchymal Stem Cells Eliminates Mutation Burden and Rescues Mitochondrial Bioenergetics in Rotenone-Stressed MELAS Fibroblasts
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
AB Wharton's jelly mesenchymal stem cells (WJMSCs) transfer healthy mitochondria to cells harboring a mitochondrial DNA (mtDNA) defect. Mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is one of the major subgroups of mitochondrial diseases, caused by the mt.3243A>G point mutation in the mitochondrial tRNALeu((UUR)) gene. The specific aim of the study is to investigate whether WJMSCs exert therapeutic effect for mitochondrial dysfunction in cells of MELAS patient through donating healthy mitochondria. We herein demonstrate that WJMSCs transfer healthy mitochondria into rotenone-stressed fibroblasts of a MELAS patient, thereby eliminating mutation burden and rescuing mitochondria! functions. In the coculture system in vitro study, WJMSCs transferred healthy mitochondria to rotenone-stressed MELAS fibroblasts. By inhibiting actin polymerization to block tunneling nanotubes (TNTs), the WJMSC-conducted mitochondria! transfer was abrogated. After mitochondrial transfer, the mt.3243A>G mutation burden of MELAS fibroblasts was reduced to an undetectable level, with long-term retention. Sequencing results confirmed that the transferred mitochondria were donated from WJMSCs. Furthermore, mitochondrial transfer of WJMSCs to MELAS fibroblasts improves mitochondria! functions and cellular performance, including protein translation of respiratory complexes, ROS overexpression, mitochondrial membrane potential, mitochondrial morphology and bioenergetics, cell proliferation, mitochondrion-dependent viability, and apoptotic resistance. This study demonstrates that WJMSCs exert bioenergetic therapeutic effects through mitochondrial transfer. This finding paves the way for the development of innovative treatments for MELAS and other mitochondrial diseases.
C1 [Lin, Tsu-Kung; Chen, Shang-Der; Chuang, Yao-Chung; Lan, Min-Yu; Tsai, Meng-Han; Wang, Xiao-Wen; Tsai, Po-Chin; Liou, Chia-Wei] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung 833, Taiwan.
   [Lin, Tsu-Kung; Chen, Shang-Der; Chuang, Yao-Chung; Lan, Min-Yu; Chuang, Jiin-Haur; Wang, Pei-Wen; Hsu, Te-Yao; Wang, Feng-Sheng; Tsai, Meng-Han; Wang, Xiao-Wen; Tsai, Po-Chin; Lin, Hung-Yu; Liou, Chia-Wei] Chang Gung Univ, Coll Med, Kaohsiung 833, Taiwan.
   [Lin, Tsu-Kung; Chuang, Jiin-Haur; Wang, Pei-Wen; Wang, Feng-Sheng; Wang, Xiao-Wen; Tsai, Po-Chin; Lin, Hung-Yu] Kaohsiung Chang Gung Mem Hosp, Mitochondrial Res Unit, Kaohsiung 833, Taiwan.
   [Lin, Tsu-Kung] Kaohsiung Chang Gung Mem Hosp, Ctr Parkinsons Dis, Kaohsiung 833, Taiwan.
   [Chuang, Jiin-Haur; Lin, Hung-Yu] Kaohsiung Chang Gung Mem Hosp, Dept Pediat Surg, Kaohsiung 833, Taiwan.
   [Wang, Pei-Wen] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung 833, Taiwan.
   [Hsu, Te-Yao; Liou, Chia-Wei] Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung 833, Taiwan.
   [Wang, Feng-Sheng; Liou, Chia-Wei] Chang Gung Univ, Core Lab Phen & Diagnost, Coll Med, Kaohsiung, Taiwan.
   [Wang, Feng-Sheng] Chang Gung Univ, Dept Med Res, Coll Med, Kaohsiung, Taiwan.
   [Huang, Sheng-Teng] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan.
C3 Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; China Medical University Taiwan; China Medical University Hospital - Taiwan
RP Liou, CW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung 833, Taiwan.; Lin, HY; Liou, CW (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung 833, Taiwan.; Lin, HY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Mitochondrial Res Unit, Kaohsiung 833, Taiwan.; Lin, HY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat Surg, Kaohsiung 833, Taiwan.; Liou, CW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung 833, Taiwan.; Liou, CW (corresponding author), Chang Gung Univ, Core Lab Phen & Diagnost, Coll Med, Kaohsiung, Taiwan.
EM linhungyu700218@gmail.com; cwliou@ms22.hinet.net
FU Chang Gung Memorial Hospital [CORPG8F1021-2, CMRPG8E0291-3, CMRPG8H0191, CMRPG8I0231]; Ministry of Science and Technology, Taiwan [105-2314-B-182A-010, 106-2314-B-182A-057-MY3]
CR Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030
   Arutyunyan I, 2016, STEM CELLS INT, V2016, P0, DOI 10.1155/2016/6901286
   Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019
   Chen MY, 2009, EXP HEMATOL, V37, P629, DOI 10.1016/j.exphem.2009.02.003
   Chuang YC, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/5691215
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9
   Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943
   Fong CY, 2011, STEM CELL REV REP, V7, P1, DOI 10.1007/s12015-010-9166-x
   Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946
   Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606
   Gropman AL, 2001, PEDIATR NEUROL, V1, P185, DOI 10.1007/S11910-001-0015-9
   HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0
   Hsu YC, 2016, SEMIN CELL DEV BIOL, V52, P119, DOI 10.1016/j.semcdb.2016.02.011
   ICHIKI T, 1988, ANN NEUROL, V23, P287, DOI 10.1002/ana.410230312
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014
   KOBAYASHI M, 1987, J PEDIATR-US, V110, P223, DOI 10.1016/S0022-3476(87)80158-0
   Li XY, 2014, INT J MOL MED, V34, P695, DOI 10.3892/ijmm.2014.1821
   Lin HY, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/7514383
   Lin HY, 2015, MITOCHONDRION, V22, P31, DOI 10.1016/j.mito.2015.02.006
   LIOU C, 2002, ACTA NEUROL SCAND, V90, P354
   Otera H, 2012, INT J CELL BIOL, V2012, P821676, DOI 10.1155/2012/821676
   Peng JY, 2011, PLOS COMPUT BIOL, V7, P0, DOI 10.1371/journal.pcbi.1002212
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028
   Tafrechi RSJ, 2005, MUTAT RES-FUND MOL M, V578, P43, DOI 10.1016/j.mrfmmm.2005.02.002
   Tang BL, 2016, CELLS-BASEL, V5, P0, DOI 10.3390/cells5010001
   Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312
   Torralba D, 2016, FRONT CELL DEV BIOL, V4, P0, DOI 10.3389/fcell.2016.00107
   Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211
   Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820
   Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
NR 39
TC 27
Z9 28
U1 0
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD JUN 15
PY 2019
VL 2019
IS 
BP 
EP 
DI 10.1155/2019/9537504
PG 17
WC Cell Biology
SC Cell Biology
GA IB3RZ
UT WOS:000470186000001
PM 31249652
DA 2024-11-01
ER

PT J
AU Meira, B
   Roque, R
   Pinto, M
   Caetano, A
AF Meira, Bruna
   Roque, Rafael
   Pinto, Miguel
   Caetano, Andre
TI Late-onset presentation of POLG1-associated mitochondrial disease
SO BMJ CASE REPORTS
LA English
DT Article
DE neuromuscular disease; muscle disease; neuro genetics; neuroopthalmology; parkinson's disease
AB Mutations in the nuclear POLG1 gene compromise the integrity of mitochondrial DNA and show great allelic and clinical heterogeneity. Among adult POLG1-associated mitochondrial disease, the main clinical feature is chronic progressive external ophthalmoplegia. Other related clinical manifestations are sensory or cerebellar ataxia, peripheral neuropathy, myopathy or extrapyramidal symptoms. We report the case of a 72-year-old man who presented with a late onset sensory neuronopathy, chronic progressive external ophthalmoplegia, gait ataxia and parkinsonism. Genetic studies showed a compound heterozygosity of known pathogenic mutations in the POLG1 gene (variant T252I/P587L in cis configuration in allele 1 and variant R807C in allele 2). Late life presentation highlights that mitochondrial disorders should be considered regardless of age of onset of symptoms.
C1 [Meira, Bruna; Pinto, Miguel; Caetano, Andre] Ctr Hosp Lisboa Ocidental EPE, Neurol Dept, Lisbon, Portugal.
   [Roque, Rafael] Ctr Hosp Lisboa Norte EPE, Neurol Dept, Neuropathol Unit, Lisbon, Portugal.
C3 Centro Hospitalar de Lisboa Ocidental, EPE; Centro Hospitalar de Lisboa Ocidental, EPE
RP Meira, B (corresponding author), Ctr Hosp Lisboa Ocidental EPE, Neurol Dept, Lisbon, Portugal.
EM bmeira.rmm@gmail.com
CR Brais Bernard, 2011, HANDB CLIN NEUROL, V101, P181, DOI 10.1016/B978-0-08-045031-5.00014-1
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Gago MF, 2006, NEUROMUSCULAR DISORD, V16, P507, DOI 10.1016/j.nmd.2006.05.016
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Lovan Alyson, 2013, BMJ CASE REP, V2013, P0, DOI 10.1136/bcr-2013-010343
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Tchikviladze M, 2015, J NEUROL NEUROSUR PS, V86, P646, DOI 10.1136/jnnp-2013-306799
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
NR 15
TC 4
Z9 4
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 
EI 1757-790X
J9 BMJ CASE REP
JI BMJ Case Rep.
PD JUN 15
PY 2019
VL 12
IS 3
BP 
EP 
DI 10.1136/bcr-2018-228482
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA VK1LQ
UT WOS:000661378700154
PM 30936349
DA 2024-11-01
ER

PT J
AU Zhou, NW
   Tang, L
   Jiang, YY
   Qin, SM
   Cui, J
   Wang, YN
   Zhu, WQ
   Zhao, WP
   Pan, CZ
   Shu, XH
AF Zhou, Nianwei
   Tang, Lu
   Jiang, Yingying
   Qin, Shengmei
   Cui, Jie
   Wang, Yanan
   Zhu, Wenqing
   Zhao, Weipeng
   Pan, Cuizhen
   Shu, Xianhong
TI Whole-exome sequencing reveals a novel mutation of <i>MT</i>-<i>ND5</i> gene in a mitochondrial cardiomyopathy pedigree: Patients who show biventricular hypertrophy, hyperlactacidemia, pulmonary hypertension, and decreased exercise tolerance
SO ANATOLIAN JOURNAL OF CARDIOLOGY
LA English
DT Article
DE MT-ND5; whole-exome sequencing; cardiomyopathy; pulmonary hypertension
ID stroke-like episodes; leigh-syndrome; complex-i; missense mutation; lactic-acidosis; nd5 gene; melas; dna
AB Objective: The aim of the present study was to determine whether pathogenic mutations were present in families with mitochondrial cardiomyopathy that presented during adolescence. Methods: The proband was a 21-year-old man who presented clinically with palpitations, chest tightness, pulmonary hypertension, and limited exercise tolerance. Cardiac magnetic resonance imaging studies showed biventricular cardiac hypertrophy. We determine whether pathogenic mutations were present by whole-exome sequencing (WES) in families. Results: Screening of the family using tandem mass spectrometry showed elevated lactic acid levels, glutaric aciduria, a mildly increased glutarylca rnitine-to-octanoylcarnitine ratio, and normal blood alpha-glucosidase, which was consistent with a respiratory chain complex 1 metabolic disorder. We identified a novel mutation of MT-ND5, c.1315A>G (p.Thr439Ala). Skeletal muscle biopsy histology showed predominantly ragged red fibers and few ragged blue fibers, which was consistent with mitochondrial myopathy. Conclusion: In the present study, we identified a novel mutation of MT-ND5, c.1315A>G (p.Thr439Ala), in a family pedigree using WES.
C1 [Zhou, Nianwei; Tang, Lu; Jiang, Yingying; Wang, Yanan; Zhao, Weipeng; Pan, Cuizhen; Shu, Xianhong] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai Inst Med Imaging,Dept Echocardiog, Shanghai, Peoples R China.
   [Qin, Shengmei; Cui, Jie; Zhu, Wenqing] Fudan Univ, Zhongshan Hosp, Shanghai Inst Med Imaging, Shanghai Inst Cardiovasc Dis,Dept Cardiol, Shanghai, Peoples R China.
C3 Fudan University; Fudan University
RP Shu, XH (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai Inst Med Imaging,Dept Echocardiog, Shanghai, Peoples R China.
EM shu.xianhong@zs-hospital.sh.cn
FU National Science Foundation of China [81200170]; Science and Technology Committee Foundation of Shanghai [17411954400]
CR Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Brecht M, 2015, JIMD REP, V19, P95, DOI 10.1007/8904_2014_375
   Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Crimi M, 2003, NEUROLOGY, V60, P1857, DOI 10.1212/01.WNL.0000066048.72780.69
   Curry JL, 2012, SEMIN CUTAN MED SURG, V31, P267, DOI 10.1016/j.sder.2012.07.007
   Kingsmore SF, 2012, GENOME MED, V4, P0, DOI 10.1186/gm324
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   Li WW, 2015, INT J CLIN EXP PATHO, V8, P7022
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Monlleo-Neila L, 2013, J CHILD NEUROL, V28, P1531, DOI 10.1177/0883073812460580
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Petersen BS, 2017, BMC GENET, V18, P0, DOI 10.1186/s12863-017-0479-5
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Roncarati R, 2013, EUR J HUM GENET, V21, P1105, DOI 10.1038/ejhg.2013.16
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Sazonova MA, 2016, CURR PHARM DESIGN, V22, P390, DOI 10.2174/1381612822666151112152335
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
NR 21
TC 5
Z9 5
U1 0
U2 3
PU TURKISH SOC CARDIOLOGY
PI BAHCELIEVLER
PA COBANCESME SANAYI CAD NO 11, NISH ISTANBUL A BLOK KAT 8 NO 47-48, YENIBOSNA, BAHCELIEVLER, ISTANBUL 34196, TURKEY
SN 2149-2263
EI 2149-2271
J9 ANATOL J CARDIOL
JI Anat. J. Cardiol.
PD JAN 15
PY 2019
VL 21
IS 1
BP 18
EP 24
DI 10.14744/AnatolJCardiol.2018.53258
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HQ3XW
UT WOS:000462344800005
PM 30587702
DA 2024-11-01
ER

PT J
AU Pinti, MV
   Fink, GK
   Hathaway, QA
   Durr, AJ
   Kunovac, A
   Hollander, JM
AF Pinti, Mark V.
   Fink, Garrett K.
   Hathaway, Quincy A.
   Durr, Andrya J.
   Kunovac, Amina
   Hollander, John M.
TI Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Review
DE diabetes mellitus; mitochondria dysfunction
ID hepatic insulin-resistance; nonalcoholic fatty liver; skeletal-muscle mitochondria; activated protein-kinase; electron-transport chain; visceral adipose-tissue; membrane mam integrity; long noncoding rnas; goto-kakizaki rats; beta-cell function
AB Type 2 diabetes mellitus (T2DM) is a systemic disease characterized by hyperglycemia, hyperlipidemia, and organismic insulin resistance. This pathological shift in both circulating fuel levels and energy substrate utilization by central and peripheral tissues contributes to mitochondrial dysfunction across organ systems. The mitochondrion lies at the intersection of critical cellular pathways such as energy substrate metabolism, reactive oxygen species (ROS) generation, and apoptosis. It is the disequilibrium of these processes in T2DM that results in downstream deficits in vital functions, including hepatocyte metabolism, cardiac output, skeletal muscle contraction, beta-cell insulin production, and neuronal health. Although mitochondria are known to be susceptible to a variety of genetic and environmental insults, the accumulation of mitochondrial DNA (mtDNA) mutations and mtDNA copy number depletion is helping to explain the prevalence of mitochondrial-related diseases such as T2DM. Recent work has uncovered novel mitochondrial biology implicated in disease progressions such as mtDNA heteroplasmy, noncoding RNA (ncRNA), epigenetic modification of the mitochondrial genome, and epitranscriptomic regulation of the mtDNA-encoded mitochondrial transcriptome. The goal of this review is to highlight mitochondrial dysfunction observed throughout major organ systems in the context of T2DM and to present new ideas for future research directions based on novel experimental and technological innovations in mitochondrial biology. Finally, the field of mitochondria-targeted therapeutics is discussed, with an emphasis on novel therapeutic strategies to restore mitochondrial homeostasis in the setting of T2DM.
C1 [Pinti, Mark V.; Fink, Garrett K.; Hathaway, Quincy A.; Durr, Andrya J.; Kunovac, Amina; Hollander, John M.] West Virginia Univ, Sch Med, Div Exercise Physiol, POB 9227 1 Med Ctr Dr, Morgantown, WV 26506 USA.
   [Pinti, Mark V.; Hathaway, Quincy A.; Durr, Andrya J.; Kunovac, Amina; Hollander, John M.] West Virginia Univ, Sch Med, Mitochondria Metab & Bioenerget Working Grp, Morgantown, WV USA.
   [Pinti, Mark V.] West Virginia Univ, Sch Pharm, Morgantown, WV USA.
   [Hathaway, Quincy A.] West Virginia Univ, Sch Med, Toxicol Working Grp, Morgantown, WV USA.
C3 West Virginia University; West Virginia University; West Virginia University; West Virginia University
RP Hollander, JM (corresponding author), West Virginia Univ, Sch Med, Div Exercise Physiol, POB 9227 1 Med Ctr Dr, Morgantown, WV 26506 USA.
EM jhollander@hsc.wvu.edu
FU Community Foundation for the Ohio Valley Whipkey Trust [R01-HL-128485, AHA-17PRE33660333, DGE-1144676]
CR Akude E, 2011, DIABETES, V60, P288, DOI 10.2337/db10-0818
   Anderson EJ, 2011, AM J PHYSIOL-HEART C, V300, PH118, DOI 10.1152/ajpheart.00932.2010
   Anderson EJ, 2009, J AM COLL CARDIOL, V54, P1891, DOI 10.1016/j.jacc.2009.07.031
   Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048
   Andrzejewski S, 2014, CANCER METAB, V2, P0, DOI 10.1186/2049-3002-2-12
   Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9
   Angermueller C, 2016, NAT METHODS, V13, P229, DOI 10.1038/nmeth.3728
   ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790
   Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735
   Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230
   Bajpeyi S, 2011, J CLIN ENDOCR METAB, V96, P1160, DOI 10.1210/jc.2010-1621
   Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225
   Balducci S, 2006, J DIABETES COMPLICAT, V20, P216, DOI 10.1016/j.jdiacomp.2005.07.005
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Baseler WA, 2011, AM J PHYSIOL-REG I, V300, PR186, DOI 10.1152/ajpregu.00423.2010
   Beaudoin MS, 2014, J PHYSIOL-LONDON, V592, P2519, DOI 10.1113/jphysiol.2013.270538
   Bianchessi V, 2015, J MOL CELL CARDIOL, V81, P62, DOI 10.1016/j.yjmcc.2015.01.012
   Bloem CJ, 2008, J CLIN ENDOCR METAB, V93, P387, DOI 10.1210/jc.2007-1734
   Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje
   Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601
   Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281
   Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620
   Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052
   Bugger H, 2009, DIABETES, V58, P1986, DOI 10.2337/db09-0259
   Carvalho C, 2015, BBA-MOL BASIS DIS, V1852, P1665, DOI 10.1016/j.bbadis.2015.05.001
   Cassidy S, 2016, DIABETOLOGIA, V59, P56, DOI 10.1007/s00125-015-3741-2
   Chattopadhyay M, 2015, MOL CELL BIOCHEM, V399, P95, DOI 10.1007/s11010-014-2236-7
   Chattopadhyay M, 2011, METABOLISM, V60, P1702, DOI 10.1016/j.metabol.2011.04.015
   Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692
   Cheng JT, 2006, DIABETES, V55, P819, DOI 10.2337/diabetes.55.03.06.db05-0934
   Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049
   Cho YE, 2013, AM J PHYSIOL-CELL PH, V305, PC1033, DOI 10.1152/ajpcell.00234.2013
   Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2
   Chowdhury SKR, 2012, BRAIN, V135, P1751, DOI 10.1093/brain/aws097
   Clark MB, 2015, NAT METHODS, V12, P339, DOI 10.1038/NMETH.3321
   Clark SJ, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03149-4
   Cohen ND, 2008, DIABETES RES CLIN PR, V79, P405, DOI 10.1016/j.diabres.2007.09.020
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Covian R, 2014, BBA-BIOENERGETICS, V1837, P1913, DOI 10.1016/j.bbabio.2014.08.006
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x
   Croston TL, 2014, AM J PHYSIOL-HEART C, V307, PH54, DOI 10.1152/ajpheart.00845.2013
   Dabkowski ER, 2010, AM J PHYSIOL-HEART C, V299, PH529, DOI 10.1152/ajpheart.00267.2010
   Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421
   Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   De Feyter HM, 2008, EUR J ENDOCRINOL, V158, P643, DOI 10.1530/EJE-07-0756
   DlaskovÃ¡ A, 2010, BBA-BIOENERGETICS, V1797, P1327, DOI 10.1016/j.bbabio.2010.02.003
   Donath MY, 2005, DIABETES, V54, PS108, DOI 10.2337/diabetes.54.suppl_2.S108
   Dzitoyeva S, 2012, NEUROBIOL AGING, V33, P2881, DOI 10.1016/j.neurobiolaging.2012.02.006
   Edwards JL, 2010, DIABETOLOGIA, V53, P160, DOI 10.1007/s00125-009-1553-y
   Escribano-Lopez I, 2016, REDOX BIOL, V10, P200, DOI 10.1016/j.redox.2016.10.017
   Feder J, 2009, BMC MED GENET, V10, P0, DOI 10.1186/1471-2350-10-60
   Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008
   Fritz T, 2006, DIABETES-METAB RES, V22, P492, DOI 10.1002/dmrr.656
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039
   Ghosh S, 2014, MITOCHONDRION, V18, P58, DOI 10.1016/j.mito.2014.07.007
   Glancy B, 2017, CELL REP, V19, P487, DOI 10.1016/j.celrep.2017.03.063
   Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614
   Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983
   GORDON ES, 1960, AM J CLIN NUTR, V8, P740, DOI 10.1093/ajcn/8.5.740
   Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001
   Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441
   Hey-Mogensen M, 2010, DIABETOLOGIA, V53, P1976, DOI 10.1007/s00125-010-1813-x
   Hinder LM, 2013, J ENDOCRINOL, V216, P1, DOI 10.1530/JOE-12-0356
   Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200
   HolmstrÃ¶m MH, 2012, AM J PHYSIOL-ENDOC M, V302, PE731, DOI 10.1152/ajpendo.00159.2011
   Hu YJ, 2016, GENOME BIOL, V17, P0, DOI 10.1186/s13059-016-0950-z
   Hwang JH, 2007, AM J PHYSIOL-ENDOC M, V293, PE1663, DOI 10.1152/ajpendo.00590.2006
   IDF, 2017, GLOB PICT DIAB FACT, V8th, P0
   Imai Y, 2018, PHARMACOL RES PERSPE, V6, P0, DOI 10.1002/prp2.393
   Jagannathan R, 2015, CIRC-CARDIOVASC GENE, V8, P785, DOI 10.1161/CIRCGENETICS.115.001067
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kalichman MW, 1998, ACTA NEUROPATHOL, V95, P47, DOI 10.1007/s004010050764
   Kamalden TA, 2017, ANTIOXID REDOX SIGN, V27, P913, DOI 10.1089/ars.2016.6844
   Kanazawa A, 2002, AM J PHYSIOL-ENDOC M, V282, PE778, DOI 10.1152/ajpendo.00255.2001
   KELLEY DE, 1994, J CLIN INVEST, V94, P2349, DOI 10.1172/JCI117600
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kizhakekuttu TJ, 2012, ARTERIOSCL THROM VAS, V32, P2531, DOI 10.1161/ATVBAHA.112.256024
   Koka S, 2014, AM J PHYSIOL-HEART C, V306, PH1558, DOI 10.1152/ajpheart.00865.2013
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044
   Koska J, 2008, AM J CLIN NUTR, V87, P295, DOI 10.1093/ajcn/87.2.295
   Kotronen A, 2008, DIABETOLOGIA, V51, P130, DOI 10.1007/s00125-007-0867-x
   Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021
   Krebs M, 2005, DIABETES OBES METAB, V7, P621, DOI 10.1111/j.1463-1326.2004.00439.x
   KROTKIEWSKI M, 1985, DIABETOLOGIA, V28, P881, DOI 10.1007/BF00703130
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Laye MJ, 2009, J PHYSIOL-LONDON, V587, P3729, DOI 10.1113/jphysiol.2009.172601
   LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878
   Li XY, 2017, MOL CELL, V68, P993, DOI 10.1016/j.molcel.2017.10.019
   Liao WQ, 2008, TOHOKU J EXP MED, V215, P377, DOI 10.1620/tjem.215.377
   Lim JH, 2009, CELL SIGNAL, V21, P169, DOI 10.1016/j.cellsig.2008.10.004
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   LindstrÃ¶m J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725
   Liou CW, 2007, J CLIN ENDOCR METAB, V92, P235, DOI 10.1210/jc.2006-0653
   Liou CW, 2012, DIABETES, V61, P2642, DOI 10.2337/db11-1369
   Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011
   Liu BJ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep23421
   Lokk K, 2014, GENOME BIOL, V15, P0, DOI 10.1186/gb-2014-15-4-r54
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Mariappan N, 2010, CARDIOVASC RES, V85, P473, DOI 10.1093/cvr/cvp305
   Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016
   Matilainen O, 2017, TRENDS CELL BIOL, V27, P453, DOI 10.1016/j.tcb.2017.02.004
   Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366
   Meex RCR, 2010, DIABETES, V59, P572, DOI 10.2337/db09-1322
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   Mittelbrunn M, 2011, NAT COMMUN, V2, P0, DOI 10.1038/ncomms1285
   Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981
   Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4
   Montaigne D, 2014, CIRCULATION, V130, P554, DOI 10.1161/CIRCULATIONAHA.113.008476
   Montgomery MK, 2015, ENDOCR CONNECT, V4, P0, DOI 10.1530/EC-14-0092
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Moreira PI, 2003, DIABETES, V52, P1449, DOI 10.2337/diabetes.52.6.1449
   Moreira PI, 2005, EXP NEUROL, V196, P112, DOI 10.1016/j.expneurol.2005.07.012
   Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371
   Nakamura H, 2014, CIRC-HEART FAIL, V7, P383, DOI 10.1161/HHF.0000000000000001
   Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006
   Nieuwoudt S, 2017, AM J PHYSIOL-ENDOC M, V313, PE314, DOI 10.1152/ajpendo.00407.2016
   Nile DL, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0115433
   Nilsson E, 2014, DIABETES, V63, P2962, DOI 10.2337/db13-1459
   Noh JH, 2016, GENE DEV, V30, P1224, DOI 10.1101/gad.276022.115
   Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868
   Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z
   Patel KD, 2016, BBA-BIOENERGETICS, V1857, P1284, DOI 10.1016/j.bbabio.2016.02.014
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107
   Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256
   Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012
   Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478
   Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603
   Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198
   Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111
   Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108
   Raza H, 2015, CELL PHYSIOL BIOCHEM, V35, P1241, DOI 10.1159/000373947
   Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030
   Rector RS, 2010, AM J PHYSIOL-ENDOC M, V298, PE1179, DOI 10.1152/ajpendo.00703.2009
   Rieusset J, 2016, DIABETOLOGIA, V59, P614, DOI 10.1007/s00125-015-3829-8
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, PE49, DOI 10.1152/ajpendo.00317.2009
   Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533
   Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190
   Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135
   Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013
   Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105
   Safra M, 2017, NATURE, V551, P251, DOI 10.1038/nature24456
   Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2
   Saker PJ, 1997, DIABETIC MED, V14, P42, DOI 10.1002/(SICI)1096-9136(199701)14:1<42::AID-DIA295>3.0.CO;2-T
   Santos MS, 2001, DIABETES-METAB RES, V17, P223, DOI 10.1002/dmrr.200
   Santos RX, 2014, MOL CELL BIOCHEM, V394, P13, DOI 10.1007/s11010-014-2076-5
   Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076
   Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1
   Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506
   Shepherd DL, 2018, J MOL CELL CARDIOL, V119, P104, DOI 10.1016/j.yjmcc.2018.04.016
   Shepherd DL, 2017, J MOL CELL CARDIOL, V110, P15, DOI 10.1016/j.yjmcc.2017.06.012
   Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498
   Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108
   Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642
   Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194
   Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2
   Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927
   Sorrentino V, 2018, ANNU REV PHARMACOL, V58, P353, DOI 10.1146/annurev-pharmtox-010716-104908
   Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913
   Sun XY, 2016, FEBS LETT, V590, P3510, DOI 10.1002/1873-3468.12440
   Szabo L, 2016, NAT REV GENET, V17, P679, DOI 10.1038/nrg.2016.114
   Szendroedi J, 2009, HEPATOLOGY, V50, P1079, DOI 10.1002/hep.23093
   Tang DL, 2006, DIABETES RES CLIN PR, V73, P77, DOI 10.1016/j.diabres.2005.12.001
   Targher G, 2013, J CLIN ENDOCR METAB, V98, P483, DOI 10.1210/jc.2012-3093
   Tawata M, 1998, DIABETES, V47, P276, DOI 10.2337/diab.47.2.276
   Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269
   Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20
   Tocchetti CG, 2012, DIABETES, V61, P3094, DOI 10.2337/db12-0072
   Toledo FGS, 2007, DIABETES, V56, P2142, DOI 10.2337/db07-0141
   Tolman KG, 2007, DIABETES CARE, V30, P734, DOI 10.2337/dc06-1539
   Tubbs E, 2018, DIABETES, V67, P636, DOI 10.2337/db17-0316
   Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   van der Wijst MGP, 2015, TRENDS GENET, V31, P353, DOI 10.1016/j.tig.2015.03.009
   van Tienen FHJ, 2012, J CLIN ENDOCR METAB, V97, P3261, DOI 10.1210/jc.2011-3454
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vial G, 2010, ACTA BIOCHIM POL, V57, P389
   Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003
   Vincent AM, 2010, ACTA NEUROPATHOL, V120, P477, DOI 10.1007/s00401-010-0697-7
   Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503
   Wang CH, 2017, J BIOMED SCI, V24, P0, DOI 10.1186/s12929-017-0375-3
   Wang D, 2001, EXP CLIN ENDOCR DIAB, V109, P361, DOI 10.1055/s-2001-17407
   Wang QL, 2017, DIABETES, V66, P193, DOI 10.2337/db16-0915
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Ward MS, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-10209-0
   Williams M, 2018, FRONT ENDOCRINOL, V9, P0, DOI 10.3389/fendo.2018.00211
   Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047
   Xiao L, 2017, REDOX BIOL, V11, P297, DOI 10.1016/j.redox.2016.12.022
   Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004
   Yang SQ, 2000, ARCH BIOCHEM BIOPHYS, V378, P259, DOI 10.1006/abbi.2000.1829
   Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336
   Ye Z, 2013, DIABETOLOGIA, V56, P1907, DOI 10.1007/s00125-013-2945-6
   Yokota T, 2009, AM J PHYSIOL-HEART C, V297, PH1069, DOI 10.1152/ajpheart.00267.2009
   Yu P, 2004, CHINESE MED J-PEKING, V117, P985
   Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103
   Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104
   Zhong S, 2000, J CLIN PATHOL, V53, P466, DOI 10.1136/jcp.53.6.466
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
   Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433
   Zoppini G, 2006, NUTR METAB CARDIOVAS, V16, P543, DOI 10.1016/j.numecd.2005.09.004
NR 213
TC 242
Z9 256
U1 2
U2 99
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD FEB 15
PY 2019
VL 316
IS 2
BP E268
EP E285
DI 10.1152/ajpendo.00314.2018
PG 18
WC Endocrinology & Metabolism; Physiology
SC Endocrinology & Metabolism; Physiology
GA HK7RQ
UT WOS:000458187400013
PM 30601700
DA 2024-11-01
ER

PT J
AU Filosto, M
   Piccinelli, SC
   Lamperti, C
   Mongini, T
   Servidei, S
   Musumeci, O
   Tonin, P
   Santorelli, FM
   Simoncini, C
   Primiano, G
   Vercelli, L
   Rubegni, A
   Galvagni, A
   Moggio, M
   Comi, GP
   Carelli, V
   Toscano, A
   Padovani, A
   Siciliano, G
   Mancuso, M
AF Filosto, Massimiliano
   Piccinelli, Stefano Cotti
   Lamperti, Costanza
   Mongini, Tiziana
   Servidei, Serenella
   Musumeci, Olimpia
   Tonin, Paola
   Santorelli, Filippo Maria
   Simoncini, Costanza
   Primiano, Guido
   Vercelli, Liliana
   Rubegni, Anna
   Galvagni, Anna
   Moggio, Maurizio
   Comi, Giacomo Pietro
   Carelli, Valerio
   Toscano, Antonio
   Padovani, Alessandro
   Siciliano, Gabriele
   Mancuso, Michelangelo
TI Muscle pain in mitochondrial diseases: a picture from the Italian network
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Mitochondrial diseases; Muscle pain; Myalgia; cPEO; Mitochondrial myopathy
ID exercise intolerance; mutations; cohort
AB Muscle pain may be part of many neuromuscular disorders including myopathies, peripheral neuropathies and lower motor neuron diseases. Although it has been reported also in mitochondrial diseases (MD), no extensive studies in this group of diseases have been performed so far. We reviewed clinical data from 1398 patients affected with mitochondrial diseases listed in the database of the Nation-wide Italian Collaborative Network of Mitochondrial Diseases, to assess muscle pain and its features. Muscle pain was present in 164 patients (11.7%). It was commonly observed in subjects with chronic progressive external ophthalmoplegia (cPEO) and with primary myopathy without cPEO, but alsoalthough less frequentlyin multisystem phenotypes such as MELAS, MERFF, Kearns Sayre syndrome, NARP, MNGIE and Leigh syndrome. Patients mainly complain of diffuse exercise-related muscle pain, but focal/multifocal and at rest myalgia were often also reported. Muscle pain was more commonly detected in patients with mitochondrial DNA mutations (67.8%) than with nuclear DNA changes (32.2%). Only 34% of the patients showed a good response to drug therapy. Interestingly, patients with nuclear DNA mutations tend to have a better therapeutic response than patients with mtDNA mutations. Muscle pain is present in a significant number of patients with MD, being one of the most common symptoms. Although patients with a myopathic phenotype are more prone to develop muscle pain, this is also observed in patients with a multi system involvement, representing an important and disabling symptom having poor response to current therapy.
C1 [Filosto, Massimiliano; Piccinelli, Stefano Cotti; Galvagni, Anna; Padovani, Alessandro] ASST Spedali Civili, Neurol Unit, Ctr Neuromuscular Dis, Brescia, Italy.
   [Filosto, Massimiliano; Piccinelli, Stefano Cotti; Galvagni, Anna; Padovani, Alessandro] Univ Brescia, Brescia, Italy.
   [Lamperti, Costanza] Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, Milan, Italy.
   [Mongini, Tiziana; Vercelli, Liliana] Univ Torino, Dept Neurosci Rita Levi Montalcini, Turin, Italy.
   [Servidei, Serenella; Primiano, Guido] Univ Cattolica Sacro Cuore, Ist Neurol, Fdn Policlin Univ A Gemelli IRCCS, UOC Neurofisiopatol, Rome, Italy.
   [Musumeci, Olimpia; Toscano, Antonio] Univ Messina, Dept Clin & Expt Med, UOC Neurol & Malattie Neuromuscolari, Messina, Italy.
   [Tonin, Paola] Univ Verona, Neurol Clin, Verona, Italy.
   [Santorelli, Filippo Maria; Rubegni, Anna] IRCCS Fdn Stella Maris, Mol Med Unit, Pisa, Italy.
   [Simoncini, Costanza; Siciliano, Gabriele; Mancuso, Michelangelo] Univ Pisa, Neurol Clin, Pisa, Italy.
   [Moggio, Maurizio] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Dept Neurosci, Neuromuscular & Rare Dis Unit, Milan, Italy.
   [Comi, Giacomo Pietro] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Neurol Unit,Neurosci Sect,Dino Ferrari Ctr, Milan, Italy.
   [Carelli, Valerio] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy.
C3 Hospital Spedali Civili Brescia; University of Brescia; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Turin; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Messina; University of Verona; IRCCS Fondazione Stella Maris; University of Pisa; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); AUSL di Bologna
RP Filosto, M (corresponding author), ASST Spedali Civili, Neurol Unit, Ctr Neuromuscular Dis, Brescia, Italy.; Filosto, M (corresponding author), Univ Brescia, Brescia, Italy.
EM massimiliano.filosto@unibs.it
FU Telethon [GUP09004, GSP16001]; patients' association MITOCON
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Apostolopoulou M, 2015, EUR J CLIN INVEST, V45, P745, DOI 10.1111/eci.12461
   Camerino GM, 2017, FRONT PHARMACOL, V8, P0, DOI 10.3389/fphar.2017.00500
   Czell D, 2012, BMJ CASE REP, V0, P0
   Deschauer M, 1999, NEUROMUSCULAR DISORD, V9, P305, DOI 10.1016/S0960-8966(99)00019-X
   du Souich P, 2017, PHARMACOL THERAPEUT, V175, P1, DOI 10.1016/j.pharmthera.2017.02.029
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Filosto M, 2007, NEUROLOGY, V68, P181, DOI 10.1212/01.wnl.0000252252.29532.cc
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grafakou O, 2003, J INHERIT METAB DIS, V26, P593, DOI 10.1023/A:1025960300710
   Jensen MP, 2005, ARCH PHYS MED REHAB, V86, P1155, DOI 10.1016/j.apmr.2004.11.028
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Mancuso M, 2014, MOVEMENT DISORD, V29, P722, DOI 10.1002/mds.25839
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Pulkes T, 2005, NEUROLOGY, V64, P1091, DOI 10.1212/01.WNL.0000154471.33156.55
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   van de Glind G, 2007, EUR J PAEDIATR NEURO, V11, P243, DOI 10.1016/j.ejpn.2007.01.004
NR 19
TC 8
Z9 8
U1 0
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD APR 15
PY 2019
VL 266
IS 4
BP 953
EP 959
DI 10.1007/s00415-019-09219-x
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA HS6GQ
UT WOS:000463969200017
PM 30710167
DA 2024-11-01
ER

PT J
AU McManus, MJ
   Picard, M
   Chen, HW
   De Haas, HJ
   Potluri, P
   Leipzig, J
   Towheed, A
   Angelin, A
   Sengupta, P
   Morrow, RM
   Kauffman, BA
   Vermulst, M
   Narula, J
   Wallace, DC
AF McManus, Meagan J.
   Picard, Martin
   Chen, Hsiao-Wen
   De Haas, Hans J.
   Potluri, Prasanth
   Leipzig, Jeremy
   Towheed, Atif
   Angelin, Alessia
   Sengupta, Partho
   Morrow, Ryan M.
   Kauffman, Brett A.
   Vermulst, Marc
   Narula, Jagat
   Wallace, Douglas C.
TI Mitochondrial DNA Variation Dictates Expressivity and Progression of Nuclear DNA Mutations Causing Cardiomyopathy
SO CELL METABOLISM
LA English
DT Article
ID adenine-nucleotide translocator; optic atrophy 1; atp synthase; permeability transition; myocardial mechanics; skeletal-muscle; mouse model; cristae; deficiency; gene
AB Nuclear-encoded mutations causing metabolic and degenerative diseases have highly variable expressivity. Patients sharing the homozygous mutation (c.523delC) in the adenine nucleotide translocator 1 gene (SLC25A4, ANT1) develop cardiomyopathy that varies from slowly progressive to fulminant. This variability correlates with the mitochondrial DNA (mtDNA) lineage. To confirm that mtDNA variants can modulate the expressivity of nuclear DNA (nDNA)-encoded diseases, we combined in mice the nDNA Slc25a4(-/-) null mutation with a homoplasmic mtDNA ND6(P25L) or COIV421A variant. The ND6(P25L) variant significantly increased the severity of cardiomyopathy while the COIV421A variant was phenotypically neutral. The adverse Slc25a4(-/-) and ND6(P25L) combination was associated with impaired mitochondrial complex I activity, increased oxidative damage, decreased l-Opa1, altered mitochondrial morphology, sensitization of the mitochondrial permeability transition pore, augmented somatic mtDNA mutation levels, and shortened lifespan. The strikingly different phenotypic effects of these mild mtDNA variants demonstrate that mtDNA can be an important modulator of autosomal disease.
C1 [McManus, Meagan J.; Picard, Martin; Chen, Hsiao-Wen; Potluri, Prasanth; Leipzig, Jeremy; Towheed, Atif; Angelin, Alessia; Morrow, Ryan M.; Vermulst, Marc; Wallace, Douglas C.] Childrens Hosp Philadelphia, Ctr Mitochondria & Epigen Med, Colket Translat Res Bldg,Room 6060, Philadelphia, PA 19104 USA.
   [McManus, Meagan J.; Picard, Martin; Chen, Hsiao-Wen; Potluri, Prasanth; Leipzig, Jeremy; Towheed, Atif; Angelin, Alessia; Morrow, Ryan M.; Vermulst, Marc; Wallace, Douglas C.] Univ Penn, Colket Translat Res Bldg,Room 6060, Philadelphia, PA 19104 USA.
   [Picard, Martin] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY 10032 USA.
   [Picard, Martin] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
   [De Haas, Hans J.; Sengupta, Partho; Narula, Jagat] Mt Sinai Hosp, Dept Med, New York, NY 10029 USA.
   [Kauffman, Brett A.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15261 USA.
   [Wallace, Douglas C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Sengupta, Partho] West Virginia Univ, Sch Med, Div Cardiol, WVU Heart & Vasc Inst, Morgantown, WV 26506 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; West Virginia University
RP Wallace, DC (corresponding author), Childrens Hosp Philadelphia, Ctr Mitochondria & Epigen Med, Colket Translat Res Bldg,Room 6060, Philadelphia, PA 19104 USA.; Wallace, DC (corresponding author), Univ Penn, Colket Translat Res Bldg,Room 6060, Philadelphia, PA 19104 USA.; Wallace, DC (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
EM wallaced1@email.chop.edu
FU NIH [5R01-NS021328-30, 1R01MH10859201A1, 1R01MN110185-01A1, RO1NS41850, R01OD010944-05]; DOD [PR150585]
CR AcÃ­n-PÃ©rez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021
   Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0
   Arbustini E, 1998, HEART, V80, P548, DOI 10.1136/hrt.80.6.548
   Aronow BJ, 2001, PHYSIOL GENOMICS, V6, P19, DOI 10.1152/physiolgenomics.2001.6.1.19
   Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493
   Biering-Sorensen T, 2017, CIRC-CARDIOVASC IMAG, V10, P0, DOI 10.1161/CIRCIMAGING.116.005521
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890
   Burke MA, 2016, JCI INSIGHT, V1, P0, DOI 10.1172/jci.insight.86898
   Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989
   Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen L, 2012, J AM HEART ASSOC, V1, P0, DOI 10.1161/JAHA.112.003012
   Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008
   Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909
   Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016
   Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109
   Duckles SP, 2006, MOL INTERV, V6, P26, DOI 10.1124/mi.6.1.6
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Eichner LJ, 2011, MITOCHONDRION, V11, P544, DOI 10.1016/j.mito.2011.03.121
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358
   Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015
   Glytsou C, 2016, CELL REP, V17, P3024, DOI 10.1016/j.celrep.2016.11.049
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Gray JJ, 2013, BRAIN RES, V1494, P28, DOI 10.1016/j.brainres.2012.12.001
   Houtkooper RH, 2011, SCI REP-UK, V1, P0, DOI 10.1038/srep00134
   Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034
   Jang JY, 2008, BMC CANCER, V8, P0, DOI 10.1186/1471-2407-8-160
   Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109
   Ji YC, 2014, J HUM GENET, V59, P134, DOI 10.1038/jhg.2013.134
   Kim A, 2010, MAMM GENOME, V21, P534, DOI 10.1007/s00335-010-9299-x
   Kokoszka JE, 2016, BBA-BIOENERGETICS, V1857, P1203, DOI 10.1016/j.bbabio.2016.03.026
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   McManus MJ, 2014, MOL CELL NEUROSCI, V63, P13, DOI 10.1016/j.mcn.2014.09.002
   Mofarrahi M, 2013, AUTOPHAGY, V9, P1604, DOI 10.4161/auto.25955
   Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114
   Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652
   Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Narula N, 2011, JACC-CARDIOVASC IMAG, V4, P1, DOI 10.1016/j.jcmg.2010.06.018
   Navarro SJ, 2012, G3-GENES GENOM GENET, V2, P99, DOI 10.1534/g3.111.000778
   Norton M, 2014, SCI SIGNAL, V7, P0, DOI 10.1126/scisignal.2004374
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   Picard M, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7259
   Porter GA, 2011, PROG PEDIATR CARDIOL, V31, P75, DOI 10.1016/j.ppedcard.2011.02.002
   Ramonet D, 2013, CELL DEATH DIFFER, V20, P77, DOI 10.1038/cdd.2012.95
   ScialÃ² F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x
   Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z
   van der Westhuizen FH, 2010, J INHERIT METAB DIS, V33, PS55, DOI 10.1007/s10545-009-9020-y
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   Wallace DC, 2013, PHILOS T R SOC B, V368, P0, DOI 10.1098/rstb.2012.0267
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021
   Yadava N, 2002, J BIOL CHEM, V277, P21221, DOI 10.1074/jbc.M202016200
   Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104
   Zamora M, 2004, J BIOL CHEM, V279, P38415, DOI 10.1074/jbc.M404928200
   Zamora M, 2004, FEBS LETT, V563, P155, DOI 10.1016/S0014-5793(04)00293-5
   Zaragoza MV, 2011, EUR J HUM GENET, V19, P200, DOI 10.1038/ejhg.2010.169
   Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001
NR 72
TC 46
Z9 49
U1 1
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD JAN 8
PY 2019
VL 29
IS 1
BP 78
EP +
DI 10.1016/j.cmet.2018.08.002
PG 18
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA HG6KK
UT WOS:000455090100012
PM 30174309
DA 2024-11-01
ER

PT J
AU Nimmo, GAM
   Venkatesh, S
   Pandey, AK
   Marshall, CR
   Hazrati, LN
   Blaser, S
   Ahmed, S
   Cameron, J
   Singh, K
   Ray, PN
   Suzuki, CK
   Yoon, G
AF Nimmo, Graeme A. M.
   Venkatesh, Sundararajan
   Pandey, Ashutosh K.
   Marshall, Christian R.
   Hazrati, Lili-Naz
   Blaser, Susan
   Ahmed, Sohnee
   Cameron, Jessie
   Singh, Kamalendra
   Ray, Peter N.
   Suzuki, Carolyn K.
   Yoon, Grace
TI Bi-allelic mutations of <i>LONP1</i> encoding the mitochondrial LonP1 protease cause pyruvate dehydrogenase deficiency and profound neurodegeneration with progressive cerebellar atrophy
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID codas syndrome; skeletal anomaly; oxidase subunits; dna-binding; phosphorylation; accumulation; degradation; expression; proteins; defects
AB LonP1 is crucial for maintaining mitochondrial proteostasis and mitigating cell stress. We identified a novel homozygous missense LONP1 variant, c.2282 C > T, (p.Pro761Leu), by whole-exome and Sanger sequencing in two siblings born to healthy consanguineous parents. Both siblings presented with stepwise regression during infancy, profound hypotonia and muscle weakness, severe intellectual disability and progressive cerebellar atrophy on brain imaging. Muscle biopsy revealed the absence of ragged-red fibers, however, scattered cytochrome c oxidase-negative staining and electron dense mitochondrial inclusions were observed. Primary cultured fibroblasts from the siblings showed normal levels of mtDNA and mitochondrial transcripts, and normal activities of oxidative phosphorylation complexes I through V. Interestingly, fibroblasts of both siblings showed glucose-repressed oxygen consumption compared to their mother, whereas galactose and palmitic acid utilization were similar. Notably, the siblings' fibroblasts had reduced pyruvate dehydrogenase (PDH) activity and elevated intracellular lactate: pyruvate ratios, whereas plasma ratios were normal. We demonstrated that in the siblings' fibroblasts, PDH dysfunction was caused by increased levels of the phosphorylated E1 alpha subunit of PDH, which inhibits enzyme activity. Blocking E1 alpha phosphorylation activated PDH and reduced intracellular lactate concentrations. In addition, overexpressing wild-type LonP1 in the siblings' fibroblasts down-regulated phosphoE1 alpha. Furthermore, in vitro studies demonstrated that purified LonP1-P761L failed to degrade phosphorylated E1 alpha, in contrast to wild-type LonP1. We propose a novel mechanism whereby homozygous expression of the LonP1-P761L variant leads to PDH deficiency and energy metabolism dysfunction, which promotes severe neurologic impairment and neurodegeneration.
C1 [Nimmo, Graeme A. M.; Ahmed, Sohnee; Yoon, Grace] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Dept Paediat, Toronto, ON M5G 1X8, Canada.
   [Venkatesh, Sundararajan; Pandey, Ashutosh K.; Suzuki, Carolyn K.] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA.
   [Marshall, Christian R.; Cameron, Jessie; Ray, Peter N.] Univ Toronto, Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada.
   [Marshall, Christian R.; Ray, Peter N.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada.
   [Hazrati, Lili-Naz] Univ Toronto, Hosp Sick Children, Div Neuropathol, Toronto, ON M5G 1X8, Canada.
   [Blaser, Susan] Univ Toronto, Hosp Sick Children, Div Paediat Neuroradiol, Toronto, ON M5G 1X8, Canada.
   [Singh, Kamalendra] Univ Missouri, Christopher Bond Life Sci Ctr, Mol Microbiol & Immunol, Sch Med, Columbia, MO 65211 USA.
   [Singh, Kamalendra] Karolinska Inst, Div Clin Microbiol, Dept Lab Med, SE-17176 Stockholm, Sweden.
   [Ray, Peter N.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X8, Canada.
   [Yoon, Grace] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Neurol, Toronto, ON M5G 1X8, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids); Rutgers University System; Rutgers University Newark; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences; University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Missouri System; University of Missouri Columbia; Karolinska Institutet; University of Toronto; University of Toronto; Hospital for Sick Children (SickKids)
RP Yoon, G (corresponding author), Hosp Sick Children, Div Clin & Metab Genet, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Suzuki, CK (corresponding author), Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, 225 Warren St,E450S, Newark, NJ 07103 USA.
EM carolyn.suzuki@njms.rutgers.edu; grace.yoon@utoronto.ca
FU University of Toronto McLaughlin Centre: Next Generation Diagnostics: Advancing the Clinical Application of Genomic Analysis [MC-2012-13A]; National Institutes of Health [1R21HD008391601]
CR Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   BROWN GK, 1988, EUR J PEDIATR, V147, P10, DOI 10.1007/BF00442603
   Cameron JM, 2009, HUM GENET, V125, P319, DOI 10.1007/s00439-009-0629-6
   Crewe C, 2017, J BIOL CHEM, V292, P305, DOI 10.1074/jbc.M116.754127
   DEALMEIDA JCC, 1995, AM J MED GENET, V55, P19, DOI 10.1002/ajmg.1320550107
   Dikoglu E, 2015, AM J MED GENET A, V167, P1501, DOI 10.1002/ajmg.a.37029
   Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047
   Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458
   Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103
   Innes AM, 2001, AM J MED GENET, V102, P44, DOI 10.1002/1096-8628(20010722)102:1<44::AID-AJMG1410>3.0.CO;2-7
   Inui T, 2017, J HUM GENET, V62, P653, DOI 10.1038/jhg.2017.11
   Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010
   Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122
   Khan AO, 2018, J AAPOS, V22, P229, DOI 10.1016/j.jaapos.2017.10.012
   Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200
   Lu B, 2003, GENE, V306, P45, DOI 10.1016/S0378-1119(03)00403-7
   Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023
   Maj MC, 2005, J CLIN ENDOCR METAB, V90, P4101, DOI 10.1210/jc.2005-0123
   Marlin S, 2010, AM J MED GENET A, V152A, P1510, DOI 10.1002/ajmg.a.33242
   Ngo JK, 2011, J GERONTOL A-BIOL, V66, P1178, DOI 10.1093/gerona/glr145
   Patel KP, 2012, MOL GENET METAB, V106, P384, DOI 10.1016/j.ymgme.2012.03.016
   Peter B, 2018, HUM MOL GENET, V27, P1743, DOI 10.1093/hmg/ddy080
   QuirÃ³s PM, 2014, CELL REP, V8, P541, DOI 10.1016/j.celrep.2014.06.018
   Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040
   ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5
   Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623
   Sepuri NBV, 2017, BBA-BIOENERGETICS, V1858, P519, DOI 10.1016/j.bbabio.2017.04.003
   SHEBIB SM, 1991, AM J MED GENET, V40, P88, DOI 10.1002/ajmg.1320400118
   SHEU KFR, 1981, J CLIN INVEST, V67, P1463, DOI 10.1172/JCI110176
   Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003
   SUZUKI CK, 1994, SCIENCE, V264, P891, DOI 10.1126/science.8178144
   Tian Q, 2011, J BIOL CHEM, V286, P26424, DOI 10.1074/jbc.M110.215772
   UTTER MF, 1963, J BIOL CHEM, V238, P2603
   van Dyck L, 1998, GENE DEV, V12, P1515, DOI 10.1101/gad.12.10.1515
   Venkatesh S, 2012, BBA-MOL CELL RES, V1823, P56, DOI 10.1016/j.bbamcr.2011.11.003
NR 36
TC 26
Z9 26
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN 15
PY 2019
VL 28
IS 2
BP 290
EP 306
DI 10.1093/hmg/ddy351
PG 17
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA HP8MW
UT WOS:000461947100010
PM 30304514
DA 2024-11-01
ER

PT J
AU Haraux, F
   LombÃ¨s, A
AF Haraux, Francis
   Lombes, Anne
TI Kinetic analysis of ATP hydrolysis by complex V in four murine tissues: Towards an assay suitable for clinical diagnosis
SO PLOS ONE
LA English
DT Article
ID synthase deficiency; inhibitor protein; mitochondrial-dna; mutations; if1; identification; specificity; gene
AB Background ATP synthase, the mitochondrial complex V, plays a major role in bioenergetics and its defects lead to severe diseases. Lack of a consensual protocol for the assay of complex V activity probably explains the under-representation of complex V defect among mitochondrial diseases. The aim of this work was to elaborate a fast, simple and reliable method to check the maximal complex V capacity in samples relevant to clinical diagnosis. Methods Using homogenates from four different murine organs, we tested the use of dodecylmaltoside, stability of the activity, linearity with protein amount, sensitivity to oligomycin and to exogenous inhibitory factor 1 (IF1), influence of freezing, and impact of mitochondrial purification. Results We obtained organ-dependent, reproducible and stable complex V specific activities, similar with fresh and frozen organs. Similar inhibition by oligomycin and exogenous IF1 demonstrated tight coupling between F-1 and F-0 domains. The Michaelis constant for MgATP had close values for all organs, in the 150-220 mu M range. Complex V catalytic turnover rate, as measured in preparations solubilized in detergent using immunotitration and activity measurements, was more than three times higher in extracts from brain or muscle than in extracts from heart or liver. This tissue specificity suggested post-translational modifications. Concomitant measurement of respiratory activities showed only slightly different complex II/complex V ratio in the four organs. In contrast, complex I/complex V ratio differed in brain as compared to the three other organs because of a high complex I activity in brain. Mitochondria purification preserved these ratios, except for brain where selective degradation of complex I occurred. Therefore, mitochondrial purification could introduce a biased enzymatic evaluation. Conclusion Altogether, this work demonstrates that a reliable assay of complex V activity is perfectly possible with very small samples from frozen biopsies, which was confirmed using control and deficient human muscles.
C1 [Haraux, Francis] CEA, I2BC, Gif Sur Yvette, France.
   [Haraux, Francis] CNRS, UMR 9198, Gif Sur Yvette, France.
   [Haraux, Francis] Univ Paris Saclay, Univ Paris Sud, Gif Sur Yvette, France.
   [Lombes, Anne] INSERM, Unite U1016, Inst Cochin, Paris, France.
   [Lombes, Anne] CNRS, UMR 8104, Paris, France.
   [Lombes, Anne] Univ Paris 05, Paris, France.
C3 Universite Paris Saclay; CEA; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Paris Saclay; Universite Paris Cite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Paris Cite; Universite Paris Cite
RP LombÃ¨s, A (corresponding author), INSERM, Unite U1016, Inst Cochin, Paris, France.; LombÃ¨s, A (corresponding author), CNRS, UMR 8104, Paris, France.; LombÃ¨s, A (corresponding author), Univ Paris 05, Paris, France.
EM anne.lombes@inserm.fr
FU Fondation pour la Recherche Medicale (FRM) [DPM20121125550]; AFM Telethon [16416]; French Infrastructure for Integrated Structural Biology (FRISBI)
CR Andrianaivomananjaona T, 2011, BBA-BIOENERGETICS, V1807, P197, DOI 10.1016/j.bbabio.2010.10.002
   Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Augereau O, 2005, CELL MOL LIFE SCI, V62, P1478, DOI 10.1007/s00018-005-5005-7
   AurÃ© K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Barca E, 2018, HUM MOL GENET, V27, P3305, DOI 10.1093/hmg/ddy231
   Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034
   CabezÃ³n E, 2002, J BIOL CHEM, V277, P41334, DOI 10.1074/jbc.M207169200
   CizkovÃ¡ A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Dautant A, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.00329
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Vazquez-Memije ME, 2009, J CELL BIOCHEM, V106, P878, DOI 10.1002/jcb.22055
   Franko A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082392
   Giorgio V, 2010, J BIOENERG BIOMEMBR, V42, P117, DOI 10.1007/s10863-010-9270-2
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Green DW, 2000, BBA-BIOENERGETICS, V1458, P343, DOI 10.1016/S0005-2728(00)00085-2
   Hatefi Y, 1967, METHODS ENZYMOL, V10, P235
   JAULT JM, 1993, J BIOL CHEM, V268, P1558
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   LombÃ¨s A, 2014, BIOCHIMIE, V100, P171, DOI 10.1016/j.biochi.2013.08.012
   MATSUNOYAGI A, 1988, BIOCHEMISTRY-US, V27, P335, DOI 10.1021/bi00401a050
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   OlÃ¡hovÃ¡ M, 2018, AM J HUM GENET, V102, P494, DOI 10.1016/j.ajhg.2018.01.020
   PecinovÃ¡ A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   PULLMAN ME, 1963, J BIOL CHEM, V238, P3762
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schmitt S, 2013, ANAL BIOCHEM, V443, P66, DOI 10.1016/j.ab.2013.08.007
   Shibata T, 2015, BIOCHEM BIOPH RES CO, V463, P563, DOI 10.1016/j.bbrc.2015.05.095
   Sikorska M, 2009, MUSCLE NERVE, V40, P381, DOI 10.1002/mus.21355
   Song JY, 2018, P NATL ACAD SCI USA, V115, P2850, DOI 10.1073/pnas.1801697115
   Thompson K, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809060
   vanRaaij MJ, 1996, BIOCHEMISTRY-US, V35, P15618, DOI 10.1021/bi960628f
   Vantourout P, 2010, WORLD J GASTROENTERO, V16, P5925, DOI 10.3748/wjg.v16.i47.5925
   Venard R, 2003, BIOCHEMISTRY-US, V42, P7626, DOI 10.1021/bi034394t
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   ZIEGLER D, 1967, METHOD ENZYMOL, V10, P231
NR 40
TC 12
Z9 12
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD AUG 28
PY 2019
VL 14
IS 8
BP 
EP 
DI 10.1371/journal.pone.0221886
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW5XV
UT WOS:000485052300062
PM 31461494
DA 2024-11-01
ER

PT J
AU Campbell, GR
   Mahad, DJ
AF Campbell, Graham R.
   Mahad, Don J.
TI A Method to Detect Cytochrome <i>c</i> Oxidase Activity and Mitochondrial Proteins in Oligodendrocytes
SO OLIGODENDROCYTES: Methods and Protocols
LA English
DT Article; Book Chapter
DE Mitochondria; Cytochrome c oxidase; Neurodegeneration; Immunohistochemistry and histochemistry
ID dna mutations; muscle-fibers; mechanisms
AB Cytochrome c oxidase or mitochondrial respiratory chain complex IV is where over 90% of oxygen is consumed. The relationship between complex IV activity and mitochondrial proteins, which provides a guide to understanding the mechanisms in primary mitochondrial disorders, has been determined by histochemistry (complex IV activity) and immunohistochemistry in serial sections. In the central nervous system (CNS), mitochondrial activity and immunoreactivity have been determined in populations of cells in serial sections as capturing cells in more than one section is difficult. In this report, we describe a method to determine complex IV activity in relation to mitochondrial proteins at a single-cell level in the CNS. We performed complex IV histochemistry and immunohistochemistry consecutively in snap-frozen sections. Although the product of complex IV histochemistry reduces the sensitivity of standard immunohistochemistry (secondary antibody and ABC method), the biotin-free Menapath polymer detection system enables mitochondrial proteins to be detected following complex IV histochemistry. The co-occurring chromogens may then be separately visualized and analyzed using multispectral imaging. Our technique is applicable for exploring mitochondrial defects within single cells, including oligodendrocytes, in a variety of CNS disorders and animal models of those diseases.
C1 [Campbell, Graham R.; Mahad, Don J.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.
C3 University of Edinburgh
RP Campbell, GR (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.
CR Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DIMLICH RVW, 1990, BRAIN RES, V516, P181, DOI 10.1016/0006-8993(90)90917-Z
   Elfering SL, 2004, AM J PHYSIOL-HEART C, V286, PH22, DOI 10.1152/ajpheart.00766.2003
   Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86
   FÃ¼nfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   HEVNER RF, 1995, NEUROSCIENCE, V65, P313, DOI 10.1016/0306-4522(94)00514-6
   JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106
   JOHNSON MA, 1988, J NEUROL SCI, V87, P75, DOI 10.1016/0022-510X(88)90056-1
   KEILIN D, 1945, BIOCHEM J, V39, P289, DOI 10.1042/bj0390289
   Mahad DJ, 2009, J NEUROSCI METH, V184, P310, DOI 10.1016/j.jneumeth.2009.08.020
   Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954
   Mansfield James R, 2008, CURR PROTOC MOL BIOL, VChapter 14, P0, DOI 10.1002/0471142727.mb1419s84
   Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160
   Pye D, 2006, NUCLEIC ACIDS RES, V34, P0, DOI 10.1093/nar/gkl516
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Taanman JW, 2001, BIOCHEM SOC T, V29, P446, DOI 10.1042/BST0290446
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Tanji K, 2000, BRAIN PATHOL, V10, P422
   Tanji K, 2008, METHODS, V46, P274, DOI 10.1016/j.ymeth.2008.09.027
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
NR 27
TC 3
Z9 3
U1 0
U2 3
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
EI 1940-6029
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PD JUN 15
PY 2019
VL 1936
IS 
BP 333
EP 342
DI 10.1007/978-1-4939-9072-6_19
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Cell Biology; Neurosciences
SC Biochemistry & Molecular Biology; Cell Biology; Neurosciences & Neurology
GA BS0ET
UT WOS:000681408800020
PM 30820908
DA 2024-11-01
ER

PT J
AU VÃ¡zquez-Justes, D
   CarreÃ±o-Gago, L
   GarcÃ­a-Arum, E
   Traveset, A
   Montoya, J
   Ruiz-Pesini, E
   LÃ³pez, R
   Brieva, L
AF Vazquez-Justes, Daniel
   Carreno-Gago, Lidia
   Garcia-Arum, Elena
   Traveset, Alicia
   Montoya, Julio
   Ruiz-Pesini, Eduardo
   Lopez, Ricard
   Brieva, Luis
TI Mitochondrial m.13513G&gt;A Point Mutation in ND5 in a 16-Year-Old Man with Leber Hereditary Optic Neuropathy Detected by Next-Generation Sequencing
SO JOURNAL OF PEDIATRIC GENETICS
LA English
DT Article
DE Leber hereditary optic neuropathy; whole genome sequencing; next-generation sequencing
ID dna g13513a mutation; leigh-syndrome
AB This article reports a Leber hereditary optic neuropathy (LHON) case associated for the first time with mitochondrial m.13513G>A mutation. We present a 16-year-old man who complained of subacute, painless, visual loss. Ocular examination showed optic nerve atrophy, papillary pseudoedema, and optic disc pallor. Extraocular manifestations included hypertrophic myocardiopathy and myopathy. Initial genetic analysis excluded the three most common LHON mutations. Sanger sequencing of the whole mitochondrial deoxyribonucleic acid showed no mutation. Next-generation sequencing (NGS) revealed m.13513G>A mutation in the NADH dehydrogenase (ND5) subunit gene ( MT-ND5 ). The m.13513G>A mutation has never been associated with LHON phenotype without Leigh/mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes features. NGS techniques should be considered when this diagnosis is strongly suspected.
C1 [Vazquez-Justes, Daniel; Brieva, Luis] Hosp Arnau Vilanova, Dept Neurol, Lleida, Spain.
   [Carreno-Gago, Lidia; Garcia-Arum, Elena] Univ Autonoma Barcelona, Inst Recerca VHIR, Hosp Univ Vall dHebron, Dept Patol Mitocondrial & Neuromuscular, Barcelona, Spain.
   [Carreno-Gago, Lidia; Garcia-Arum, Elena] ISCIII, CIBERER, Barcelona, Spain.
   [Garcia-Arum, Elena] Hosp Univ Vall dHebron, Area Genet Clin & Mol, Barcelona, Spain.
   [Traveset, Alicia] Hosp Arnau Vilanova, Dept Ophthalmol, Lleida, Spain.
   [Montoya, Julio; Ruiz-Pesini, Eduardo] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, CIBERER, IISAragon, Zaragoza, Spain.
   [Lopez, Ricard] Hosp Arnau Vilanova, Lab Clin ICS, Unitat Citogenet, Lleida, Spain.
C3 University Hospital Arnau de Vilanova; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari Vall d'Hebron; University Hospital Arnau de Vilanova; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Zaragoza; University Hospital Arnau de Vilanova
RP VÃ¡zquez-Justes, D (corresponding author), Arnau Vilanova Univ Hosp, Dept Neurol, Rovira Roure 80, Lleida, Spain.
EM danivazkez@gmail.com
FU Instituto de Salud Carlos III; Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon [B33]; European Union
CR Blok MJ, 2007, J MED GENET, V44, P0, DOI 10.1136/jmg.2006.045716
   Brecht M, 2015, JIMD REP, V19, P95, DOI 10.1007/8904_2014_375
   Duan MQ, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23020323
   ChacÃ³n-Camacho OF, 2017, GAC MED MEX, V153, P276
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   Monlleo-Neila L, 2013, J CHILD NEUROL, V28, P1531, DOI 10.1177/0883073812460580
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   UEMURA A, 1987, BRIT J OPHTHALMOL, V71, P531, DOI 10.1136/bjo.71.7.531
   van Karnebeek CDM, 2011, DEV MED CHILD NEUROL, V53, P565, DOI 10.1111/j.1469-8749.2010.03907.x
   Vasta V, 2009, GENOME MED, V1, P0, DOI 10.1186/gm100
   Wang ZX, 2010, NEUROPATHOLOGY, V30, P606, DOI 10.1111/j.1440-1789.2010.01115.x
NR 15
TC 7
Z9 7
U1 0
U2 5
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 2146-4596
EI 2146-460X
J9 J PEDIATR GENET
JI J. Pediatr. Genet.
PD DEC 15
PY 2019
VL 8
IS 4
BP 231
EP 234
DI 10.1055/s-0039-1691812
PG 4
WC Pediatrics
SC Pediatrics
GA JJ8BP
UT WOS:000494377800010
PM 31687263
DA 2024-11-01
ER

PT J
AU Tarnopolsky, M
   Brady, L
   MacNeil, L
AF Tarnopolsky, Mark
   Brady, Lauren
   MacNeil, Lauren
TI Myasthenia graves-like symptoms associated with rare mitochondrial mutation (m.5728T &gt; C)
SO MITOCHONDRION
LA English
DT Article
ID exercise; dna
AB We report here on a patient who presented with myasthenia gravis type symptoms (fatigable ptosis, increased jitter on single fiber EMG, and a thymic mass) who was subsequently diagnosed with a mitochondrial myopathy. Sequencing of the mitochondrial genome (mtDNA) identified a transition variant in the tRNA asparagine gene (MT-TN) (m.5728T > C) at in 41% of mtDNA molecules in muscle tissue. The variant was not detectable in blood. The m.5728T > C variant has been reported previously in a ten year old male with global developmental delays, failure to thrive, ataxia, weakness, cognitive regression, seizures, and glomerulosclerosis. The variant was seen in 97% of mtDNA molecules in muscle and 50% in blood. This case report supports the pathogenicity of the m.5728T > C and helps to establish the phenotypic spectrum of this condition at a lower heteroplasmy.
C1 [Tarnopolsky, Mark; Brady, Lauren] McMaser Univ, Med Ctr, Dept Pediat Neuromuscular & Neurometab Disorders, Hamilton, ON L8N 3Z5, Canada.
   [MacNeil, Lauren] Hosp Sick Children, Dept Pediat Lab Med, Div Clin Biochem, Toronto, ON M5G 2L3, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids)
RP Tarnopolsky, M (corresponding author), McMaser Univ, Med Ctr, Dept Pediat Neuromuscular & Neurometab Disorders, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
CR Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Cruz-Martinez A, 2004, ELECTROMYOGR CLIN NEUROPHYSIOL, V44, P35
   Girlanda P, 1999, CLIN NEUROPHYSIOL, V110, P1284, DOI 10.1016/S1388-2457(98)00041-8
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   McKenzie S, 2000, AM J PHYSIOL-ENDOC M, V278, PE580, DOI 10.1152/ajpendo.2000.278.4.E580
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   UKACHOKE C, 1994, CAN J NEUROL SCI, V21, P125, DOI 10.1017/S0317167100049040
NR 9
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2019
VL 47
IS 
BP 139
EP 140
DI 10.1016/j.mito.2019.04.003
PG 2
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA II9VD
UT WOS:000475547200016
PM 31026515
DA 2024-11-01
ER

PT J
AU Siva, MA
   Mahalakshmi, R
   Bhakta-Guha, D
   Guha, G
AF Siva, M. Aravintha
   Mahalakshmi, R.
   Bhakta-Guha, Dipita
   Guha, Gunjan
TI Gene therapy for the mitochondrial genome: Purging mutations, pacifying ailments
SO MITOCHONDRION
LA English
DT Review
DE Mitochondrial diseases; Mystondria; mtDNA mutations; Gene therapy
ID hereditary optic neuropathy; messenger-rna localization; maternally inherited cardiomyopathy; liposome-based carrier; dna mutations; oxidative stress; leigh-syndrome; mtdna heteroplasmy; skeletal-muscle; mito-porter
AB In the recent years, the reported cases of mitochondrial disorders have reached a colossal number. These disorders spawn a sundry of pathological conditions, which lead to pernicious symptoms and even fatality. Due to the unpredictable etiologies, mitochondrial diseases are putatively referred to as "mystondria" (mysterious diseases of mitochondria). Although present-day research has greatly improved our understanding of mitochondrial disorders, effective therapeutic interventions are still at the precursory stage. The conundrum becomes further complicated because these pathologies might occur due to either mitochondrial DNA (mtDNA) mutations or due to mutations in the nuclear DNA (nDNA), or both. While correcting nDNA mutations by using gene therapy (replacement of defective genes by delivering wild-type (WT) ones into the host cell, or silencing a dominant mutant allele that is pathogenic) has emerged as a promising strategy to address some mitochondrial diseases, the complications in correcting the defects of mtDNA in order to renovate mitochondrial functions have remained a steep challenge. In this review, we focus specifically on the selective gene therapy strategies that have demonstrated prospects in targeting the pathological mutations in the mitochondrial genome, thereby treating mitochondrial ailments.
C1 [Siva, M. Aravintha; Mahalakshmi, R.; Bhakta-Guha, Dipita; Guha, Gunjan] SASTRA Univ, Sch Chem & Bio Technol, Cellular Dyshomeostasis Lab CDHL, Thanjavur 613401, Tamil Nadu, India.
C3 Shanmugha Arts, Science, Technology & Research Academy (SASTRA)
RP Bhakta-Guha, D; Guha, G (corresponding author), SASTRA Univ, SCBT, CDHL, Thanjavur 613401, Tamil Nadu, India.
EM dipitaguha@scbt.sastra.edu; gunjanguha@scbt.sastra.edu
CR Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   [Anonymous], 1900, DOI 10.1016/J.YEXCR.2014.03.012, V0, P0
   [Anonymous], 1900, DOI 10.1016/J.MITO.2015.10.008, V0, P0
   Asayama S, 2015, PHARMACEUTICS, V7, P224, DOI 10.3390/pharmaceutics7030224
   AurÃ© K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bacman SR, 2012, GENE THER, V19, P1101, DOI 10.1038/gt.2011.196
   Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Birch-Machin MA, 2016, BRIT J DERMATOL, V175, P26, DOI 10.1111/bjd.14906
   Bonnardel J, 2019, IMMUNITY, V0, P0, DOI DOI 10.1016/j.immuni.2019.08.017
   Bonnet C, 2007, REJUV RES, V10, P127, DOI 10.1089/rej.2006.0526
   Bonnet Crystel, 2007, JOURNAL DE LA SOCIETE DE BIOLOGIE, V201, P69, DOI 10.1051/jbio:2007008
   Boominathan A, 2016, NUCLEIC ACIDS RES, V44, P9342, DOI 10.1093/nar/gkw756
   Camus MF, 2012, CURR BIOL, V22, P1717, DOI 10.1016/j.cub.2012.07.018
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Chadderton N, 2013, EUR J HUM GENET, V21, P62, DOI 10.1038/ejhg.2012.112
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chin RM, 2018, CELL REP, V22, P2818, DOI 10.1016/j.celrep.2018.02.059
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11168, DOI 10.1073/pnas.91.23.11168
   Choong C-J, 2015, EXPERT OPIN BIOL TH, V0, PP1, DOI 10.1517/14712598.2016
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   Cwerman-Thibault H, 2015, MOL THER-METH CLIN D, V2, P0, DOI 10.1038/mtm.2015.3
   DSouza GGM, 2005, MITOCHONDRION, V5, P352, DOI 10.1016/j.mito.2005.07.001
   Das P, 2010, J SCI RES, V3, P177, DOI 10.3329/jsr.v3i1.5078
   Davis Ryan L, 2018, HANDB CLIN NEUROL, V147, P125, DOI 10.1016/B978-0-444-63233-3.00010-5
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   De Praeter C, 2015, EUR J PEDIATR, V174, P267, DOI 10.1007/s00431-014-2370-y
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dipchand AI, 2001, PEDIATR CARDIOL, V22, P14, DOI 10.1007/s002460010145
   Doyle SR, 2008, HUM GENE THER, V19, P1335, DOI 10.1089/hum.2008.090
   Dunn DA, 2012, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2012/541245
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Faridi U, 2016, OMICS, V20, P53, DOI 10.1089/omi.2015.0118
   Feuer WJ, 2016, OPHTHALMOLOGY, V123, P558, DOI 10.1016/j.ophtha.2015.10.025
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Fogleman S, 2016, AM J STEM CELLS, V5, P39
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299
   Gerards M, 2016, MOL GENET METAB, V117, P300, DOI 10.1016/j.ymgme.2015.12.004
   Gibson SAJ, 2012, STEM CELL RES THER, V3, P0, DOI 10.1186/scrt102
   Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698
   GÃ³mez-Tatay L, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6030025
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Heller A, 2012, EUR J PHARM BIOPHARM, V82, P1, DOI 10.1016/j.ejpb.2012.05.014
   Herold MJ, 2002, J IMMUNOL, V168, P3902, DOI 10.4049/jimmunol.168.8.3902
   HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465
   Hoptasz M, 2014, NEUROL NEUROCHIR POL, V48, P150, DOI 10.1016/j.pjnns.2013.12.007
   Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264
   Ishikawa T, 2018, J CONTROL RELEASE, V274, P109, DOI 10.1016/j.jconrel.2018.02.005
   Iyer S, 2012, HUM GENE THER, V23, P647, DOI 10.1089/hum.2011.177
   Jacobs HT, 2003, HUM MOL GENET, V12, PR293, DOI 10.1093/hmg/ddg285
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Joseph LC, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0145750
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Kagawa Y, 1997, GENE THER, V4, P6, DOI 10.1038/sj.gt.3300347
   Kaltimbacher V, 2006, RNA, V12, P1408, DOI 10.1261/rna.18206
   Kambe Y, 2016, J MOL NEUROSCI, V59, P106, DOI 10.1007/s12031-015-0710-7
   Kamimura K, 2015, PHARMACEUTICS, V7, P213, DOI 10.3390/pharmaceutics7030213
   Kanabus M, 2014, BRIT J PHARMACOL, V171, P1798, DOI 10.1111/bph.12456
   Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287
   Kaurola P, 2016, BBA-BIOMEMBRANES, V1858, P2116, DOI 10.1016/j.bbamem.2016.06.016
   Khan SM, 2004, J BIOENERG BIOMEMBR, V36, P387, DOI 10.1023/B:JOBB.0000041773.20072.9e
   Kim JY, 2002, ANN NEUROL, V51, P630, DOI 10.1002/ana.10177
   Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156
   Koilkonda RD, 2010, ARCH OPHTHALMOL-CHIC, V128, P876, DOI 10.1001/archophthalmol.2010.135
   Kwiecien S, 2014, J PHYSIOL PHARMACOL, V65, P613
   Kyriakouli DS, 2008, GENE THER, V15, P1017, DOI 10.1038/gt.2008.91
   KytÃ¶vuori L, 2016, J NEUROL, V263, P2188, DOI 10.1007/s00415-016-8249-2
   Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343
   Leslie N, 2016, HUM PATHOL, V49, P27, DOI 10.1016/j.humpath.2015.09.039
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lyrawati D, 2011, PHARM RES-DORDR, V28, P2848, DOI 10.1007/s11095-011-0544-0
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Mangiafico RA, 2004, INT J CLIN PHARM RES, V24, P15
   Marella M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0025910
   Marella M, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011472
   Martikainen MH, 2013, MITOCHONDRION, V13, P83, DOI 10.1016/j.mito.2013.01.012
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   Mkaouar-Rebai E, 2011, J CHILD NEUROL, V26, P12, DOI 10.1177/0883073810371227
   Mkaouar-Rebai E, 2009, MOL GENET METAB, V97, P179, DOI 10.1016/j.ymgme.2009.03.003
   Moggio Maurizio, 2014, ACTA MYOL, V33, P86
   Montgomery MK, 2015, ENDOCR CONNECT, V4, P0, DOI 10.1530/EC-14-0092
   Moon HE, 2015, EXP NEUROBIOL, V24, P103, DOI 10.5607/en.2015.24.2.103
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Nagata K, 2014, J CONTROL RELEASE, V183, P27, DOI 10.1016/j.jconrel.2014.03.021
   NAGLEY P, 1988, P NATL ACAD SCI USA, V85, P2091, DOI 10.1073/pnas.85.7.2091
   National Organization for Rare Disorders, 2016, LEIGH SYNDR, V0, P0
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Niazi AK, 2013, MITOCHONDRION, V13, P548, DOI 10.1016/j.mito.2012.05.004
   Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081
   Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010
   Palomo GM, 2015, BRAIN RES, V1607, P36, DOI 10.1016/j.brainres.2014.09.065
   Papworth M, 2006, GENE, V366, P27, DOI 10.1016/j.gene.2005.09.011
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945
   Quijano C, 2016, REDOX BIOL, V8, P28, DOI 10.1016/j.redox.2015.11.010
   Rahman S, 1993, GENEREVIEWS, V0, P0
   Rahman S, 2015, J INHERIT METAB DIS, V38, P641, DOI 10.1007/s10545-015-9855-3
   Ramalingam S, 2011, J MOL BIOL, V405, P630, DOI 10.1016/j.jmb.2010.10.043
   Rat Genome Database, 2017, LEIGH SYNDR DUE MIT, V0, P0
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Santorelli FM, 1999, AM J HUM GENET, V64, P295, DOI 10.1086/302188
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003
   Selosse MA, 2011, TRENDS MICROBIOL, V19, P255, DOI 10.1016/j.tim.2011.04.001
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107
   Singh KK, 2015, MITOCHONDRION, V24, P0
   Singh KK, 2013, MITOCHONDRIAL DNA MU, V0, P0
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   Spruijt L, 2007, ARCH NEUROL-CHICAGO, V64, P890, DOI 10.1001/archneur.64.6.890
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Steele HE, 2017, BRAIN, V140, P2530, DOI 10.1093/brain/awx168
   Sundaram C, 2011, J CLIN NEUROSCI, V18, P535, DOI 10.1016/j.jocn.2010.06.014
   Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212
   Thajeb Peterus, 2006, TAIWAN J OBSTET GYNECOL, V45, P201
   Thambisetty M, 2004, EXPERT REV MOL DIAGN, V4, P631, DOI 10.1586/14737159.4.5.631
   Thomas RR, 2011, MITOCHONDRION, V11, P108, DOI 10.1016/j.mito.2010.08.004
   Thorburn DR, 1993, GENEREVIEWS, V0, P0
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271
   Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Vaidya B, 2009, CURR GENE THER, V9, P475, DOI 10.2174/156652309790031102
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Van Trappen PO, 2007, GYNECOL ONCOL, V104, P129, DOI 10.1016/j.ygyno.2006.07.010
   Verdile G, 2015, INFLAMMATION OXIDATI, V0, P0, DOI DOI 10.1155/2015/105828 ID 105828.
   Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wan X, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep21587
   Wang YG, 2016, WORLD J GASTROENTERO, V22, P326, DOI 10.3748/wjg.v22.i1.326
   Weber-Lotfi F, 2015, BBA-MOL CELL RES, V1853, P3165, DOI 10.1016/j.bbamcr.2015.09.011
   Weissig V, 2004, MOL THER, V9, P0
   Weissig V, 2000, DRUG DELIV, V7, P1, DOI 10.1080/107175400266722
   Weissig V, 2001, J DRUG TARGET, V9, P1
   Weissig Volkmar, 2015, METHODS MOL BIOL, V1265, P1, DOI 10.1007/978-1-4939-2288-8_1
   Wernick RI, 2016, FRONT GENET, V7, P0, DOI 10.3389/fgene.2016.00051
   WESTARP ME, 1992, EUR NEUROL, V32, P206, DOI 10.1159/000116823
   Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013
   Wyman TB, 1997, BIOCHEMISTRY-US, V36, P3008, DOI 10.1021/bi9618474
   Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002
   Yamada Y, 2007, MITOCHONDRION, V7, P63, DOI 10.1016/j.mito.2006.12.003
   Yamada Y, 2017, BIOMATERIALS, V136, P56, DOI 10.1016/j.biomaterials.2017.05.016
   Yamada Yuma, 2015, METHODS MOL BIOL, V1265, P123, DOI 10.1007/978-1-4939-2288-8_10
   Yamada Y, 2014, YAKUGAKU ZASSHI, V134, P1143, DOI 10.1248/yakushi.14-00191
   Yamada Y, 2012, BIOMATERIALS, V33, P1589, DOI 10.1016/j.biomaterials.2011.10.082
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Yang Ai-fen, 2011, ZHONGHUA YIXUE YICHUANXUE ZAZHI, V28, P165, DOI 10.3760/cma.j.issn.1003-9406.2011.02.010
   Yang S, 2016, EBIOMEDICINE, V10, P258, DOI 10.1016/j.ebiom.2016.07.002
   Yao X, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0139416
   Yasuzaki Y, 2015, MOL PHARMACEUT, V12, P4311, DOI 10.1021/acs.molpharmaceut.5b00511
   Yasuzaki Y, 2013, J CONTROL RELEASE, V172, P805, DOI 10.1016/j.jconrel.2013.09.029
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yu H, 2015, P NATL ACAD SCI USA, V112, PE5689, DOI 10.1073/pnas.1506129112
   Yu H, 2012, P NATL ACAD SCI USA, V109, PE1238, DOI 10.1073/pnas.1119577109
   Yu-Wai-Man P, 1993, GENEREVIEWS, V0, P0
   Yu-Wai-Man P, 2016, BRIT J OPHTHALMOL, V100, P1322, DOI 10.1136/bjophthalmol-2015-308329
   Zhao LJ, 2016, PHYTOMEDICINE, V23, P114, DOI 10.1016/j.phymed.2015.12.019
   Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001
   Zhu XY, 2009, ACTA BIOCH BIOPH SIN, V41, P179, DOI 10.1093/abbs/gmn021
   Zsurka G, 2010, NEUROLOGY, V74, P507, DOI 10.1212/WNL.0b013e3181cef7ab
   Zupancic S, 2014, MOL PHARMACEUT, V11, P2334, DOI 10.1021/mp500003q
   2013, 1900, V493, V0, PP627, DOI 10.1038/NATURE11647
   2015, 1900, V6, V0, PP372, DOI 10.1016/J.REDOX.2015.08.016
   2009, 1900, V9, V0, PP196, DOI 10.1016/J.MITO.2009.01.012
   2009, 1900, V20, V0, PP897, DOI 10.1089/HUM.2009.023
   2014, 1900, V113, V0, PP207, DOI 10.1016/J.YMGME.2014.06.004
   2007, 1900, V7, V0, PP45, DOI 10.1016/J.MITO.2006.11.025
   2010, 1900, V51, V0, PP451, DOI 10.1002/EM.20570
   2013, 1900, V15, V0, P141
NR 195
TC 9
Z9 10
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAY 15
PY 2019
VL 46
IS 
BP 195
EP 208
DI 10.1016/j.mito.2018.06.002
PG 14
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA HX8NY
UT WOS:000467663800024
PM 29890303
DA 2024-11-01
ER

PT J
AU Tesarova, M
   Vondrackova, A
   Stufkova, H
   Veprekova, L
   Stranecky, V
   Berankova, K
   Hansikova, H
   Magner, M
   Galoova, N
   Honzik, T
   Vodickova, E
   Stary, J
   Zeman, J
AF Tesarova, Marketa
   Vondrackova, Alzbeta
   Stufkova, Hana
   Veprekova, Lenka
   Stranecky, Viktor
   Berankova, Kamila
   Hansikova, Hana
   Magner, Martin
   Galoova, Natalia
   Honzik, Tomas
   Vodickova, Elena
   Stary, Jan
   Zeman, Jiri
TI Sideroblastic anemia associated with multisystem mitochondrial disorders
SO PEDIATRIC BLOOD & CANCER
LA English
DT Article
DE mitochondrial disorders; MLASA; mtDNA; Pearson syndrome; ring sideroblasts; sideroblastic anemia
ID lactic-acidosis; transfer-rna; muscle mitochondria; mutations; erythropoietin; myopathy; gene; spectrum; single; pathophysiology
AB Background Sideroblastic anemia represents a heterogeneous group of inherited or acquired diseases with disrupted erythroblast iron utilization, ineffective erythropoiesis, and variable systemic iron overload. In a cohort of 421 patients with multisystem mitochondrial diseases, refractory anemia was found in 8 children. Results Five children had sideroblastic anemia with increased numbers of ring sideroblasts >15%. Two of the children had a fatal course of MLASA1 syndrome (mitochondrial myopathy, lactic acidosis, and sideroblastic anemia [SA]) due to a homozygous, 6-kb deletion in the PUS1 gene, part of the six-member family of pseudouridine synthases (pseudouridylases). Large homozygous deletions represent a novel cause of presumed PUS1-loss-of-function phenotype. The other three children with SA had Pearson syndrome (PS) due to mtDNA deletions of 4 to 8 kb; two of these children showed early onset of PS and died due to repeated sepsis; the other child had later onset of PS and survived as the hematological parameters normalized and the disease transitioned to Kearns-Sayre syndrome. In addition, anemia without ring sideroblasts was found in three other patients with mitochondrial disorders, including two children with later onset of PS and one child with failure to thrive, microcephaly, developmental delay, hypertrophic cardiomyopathy, and renal tubular acidosis due to the heterozygous mutations c.610A>G (p.Asn204Asp) and c.674C>T (p.Pro225Leu) in the COX10 gene encoding the cytochrome c oxidase assembly factor. Conclusions Sideroblastic anemia was found in fewer than 1.2% of patients with multisystem mitochondrial disease, and it was usually associated with an unfavorable prognosis.
C1 [Tesarova, Marketa; Vondrackova, Alzbeta; Stufkova, Hana; Veprekova, Lenka; Stranecky, Viktor; Berankova, Kamila; Hansikova, Hana; Magner, Martin; Honzik, Tomas; Zeman, Jiri] Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Tesarova, Marketa; Vondrackova, Alzbeta; Stufkova, Hana; Veprekova, Lenka; Stranecky, Viktor; Berankova, Kamila; Hansikova, Hana; Magner, Martin; Honzik, Tomas; Zeman, Jiri] Gen Univ Hosp, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Galoova, Natalia] Childrens Univ Hosp, Dept Paediat Oncol & Haematol, Kosice, Slovakia.
   [Vodickova, Elena] Motol Univ Hosp, Dept Haematol, Prague, Czech Republic.
   [Stary, Jan] Charles Univ Prague, Fac Med 2, Dept Paediat Haematol & Oncol, Prague, Czech Republic.
   [Stary, Jan] Motol Univ Hosp, Prague, Czech Republic.
C3 Charles University Prague; General University Hospital Prague; Motol University Hospital; Motol University Hospital; Charles University Prague; Motol University Hospital
RP Zeman, J (corresponding author), Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.; Zeman, J (corresponding author), Gen Univ Hosp, Ke Karlovu 2, Prague 12808 2, Czech Republic.
EM jzem@lf1.cuni.cz
FU Ministerstvo Zdravotnictvi Ceske Republiky [AZV 17-30965A, RVOVFN 64165]; Univerzita Karlova v Praze [Progres Q26/LF1, UNCE 204064]; Grantova Agentura Ceske Republiky [GACR 14-36804G]
CR Ahlqvist KJ, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7494
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Bader-Meunier B, 1999, PEDIATR RES, V46, P158, DOI 10.1203/00006450-199908000-00005
   Benderro GF, 2013, ADV EXP MED BIOL, V765, P9, DOI 10.1007/978-1-4614-4989-8_2
   Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244
   BÃ¶hm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Bottomley SS, 2014, HEMATOL ONCOL CLIN N, V28, P653, DOI 10.1016/j.hoc.2014.04.008
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Che RC, 2014, AM J PHYSIOL-RENAL, V306, PF367, DOI 10.1152/ajprenal.00571.2013
   Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003
   Coenen MJH, 2004, ANN NEUROL, V56, P560, DOI 10.1002/ana.20229
   Czudnochowski N, 2013, J MOL BIOL, V425, P3875, DOI 10.1016/j.jmb.2013.05.014
   Diaz GA, 1999, NAT GENET, V22, P309, DOI 10.1038/10385
   Farruggia P, 2016, JIMD REP, V26, P37, DOI 10.1007/8904_2015_470
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001
   Fujiwara T, 2013, PEDIATR INT, V55, P675, DOI 10.1111/ped.12217
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009
   Henkel A, 2013, SEMIN LIVER DIS, V33, P321, DOI 10.1055/s-0033-1358522
   Honzik T, 2008, EARLY HUM DEV, V84, P269, DOI 10.1016/j.earlhumdev.2006.07.008
   INBAL A, 1995, AM J MED GENET, V55, P372, DOI 10.1002/ajmg.1320550325
   Kimura S, 2015, BBA-MOL CELL RES, V1853, P1272, DOI 10.1016/j.bbamcr.2014.12.010
   Klug L, 2014, FEMS YEAST RES, V14, P369, DOI 10.1111/1567-1364.12141
   Lichtenstein DA, 2016, BLOOD, V128, P1913, DOI 10.1182/blood-2016-05-719062
   LÃ¶nnberg M, 2013, J PHARMACEUT BIOMED, V81-82, P187, DOI 10.1016/j.jpba.2013.04.009
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, PD986, DOI 10.1093/nar/gkt958
   MAKINEN MW, 1968, ARCH BIOCHEM BIOPHYS, V126, P75, DOI 10.1016/0003-9861(68)90561-4
   Malcovati L, 2016, BRIT J HAEMATOL, V174, P847, DOI 10.1111/bjh.14215
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Maxwell PH, 1997, KIDNEY INT, V51, P393, DOI 10.1038/ki.1997.52
   Mazurova S, 2017, CARDIOL YOUNG, V27, P936, DOI 10.1017/S1047951116001876
   Nagai T, 2014, BIOCHEM BIOPH RES CO, V449, P222, DOI 10.1016/j.bbrc.2014.05.014
   OToole JF, 2014, INT J NEPHROL RENOV, V7, P57, DOI 10.2147/IJNRD.S37887
   Patnaik MM, 2017, AM J HEMATOL, V92, P297, DOI 10.1002/ajh.24637
   Pitceathly RDS, 2013, JAMA NEUROL, V70, P1556, DOI 10.1001/jamaneurol.2013.3242
   Rickwood D, 1987, MITOCHONDRIA PRACTIC, V0, P3
   Riley LG, 2016, JIMD REP, V28, P49, DOI 10.1007/8904_2015_515
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112
   Schmitz-Abe K, 2015, BLOOD, V126, P2734, DOI 10.1182/blood-2015-09-659854
   Sibert BS, 2008, RNA, V14, P1895, DOI 10.1261/rna.984508
   Stiburek L, 2005, BIOCHEM J, V392, P625, DOI 10.1042/BJ20050807
   SubirÃ³s N, 2012, THER ADV NEUROL DISO, V5, P161, DOI 10.1177/1756285611434926
   Suzuki N, 2011, MOL CELL BIOL, V31, P3896, DOI 10.1128/MCB.05463-11
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   Wiseman DH, 2013, BLOOD, V122, P112, DOI 10.1182/blood-2012-08-439083
   Yun S, 2015, CRIT REV ONCOL HEMAT, V95, P12, DOI 10.1016/j.critrevonc.2015.02.006
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
NR 56
TC 16
Z9 17
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-5009
EI 1545-5017
J9 PEDIATR BLOOD CANCER
JI Pediatr. Blood Cancer
PD APR 15
PY 2019
VL 66
IS 4
BP 
EP 
DI 10.1002/pbc.27591
PG 8
WC Oncology; Hematology; Pediatrics
SC Oncology; Hematology; Pediatrics
GA HM4RZ
UT WOS:000459463300020
PM 30588737
DA 2024-11-01
ER

PT J
AU Yan, CJ
   Duanmu, XY
   Zeng, L
   Liu, B
   Song, ZY
AF Yan, Chaojun
   Duanmu, Xiaoying
   Zeng, Ling
   Liu, Bing
   Song, Zhiyin
TI Mitochondrial DNA: Distribution, Mutations, and Elimination
SO CELLS
LA English
DT Review
DE mitochondria; mtDNA; mitophagy; mtDNA distribution; mitochondrial dynamics
ID dynamin-related protein; cytochrome-c release; paternal mitochondria; contact site; selective degradation; maternal inheritance; myoclonic epilepsy; oxidative stress; skeletal-muscle; mtdna mutations
AB Mitochondrion harbors its own DNA (mtDNA), which encodes many critical proteins for the assembly and activity of mitochondrial respiratory complexes. mtDNA is packed by many proteins to form a nucleoid that uniformly distributes within the mitochondrial matrix, which is essential for mitochondrial functions. Defects or mutations of mtDNA result in a range of diseases. Damaged mtDNA could be eliminated by mitophagy, and all paternal mtDNA are degraded by endonuclease G or mitophagy during fertilization. In this review, we describe the role and mechanism of mtDNA distribution and elimination. In particular, we focus on the regulation of paternal mtDNA elimination in the process of fertilization.
C1 [Yan, Chaojun; Duanmu, Xiaoying; Zeng, Ling; Liu, Bing; Song, Zhiyin] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China.
C3 Wuhan University
RP Song, ZY (corresponding author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China.
EM ycj114@whu.edu.cn; duanmu@whu.edu.cn; zengling368@whu.edu.cn; bingbingliu@whu.edu.cn; songzy@whu.edu.cn
FU National Natural Science Foundation of China [31671393, 91854107]; Fundamental Research Funds for the Central Universities [2042017kf0197, 2042017kf0242]
CR Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Arakaki N, 2006, BIOL PHARM BULL, V29, P1962, DOI 10.1248/bpb.29.1962
   Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chan DC, 2012, DEV CELL, V22, P469, DOI 10.1016/j.devcel.2012.02.008
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021
   Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DeLuca SZ, 2012, DEV CELL, V22, P660, DOI 10.1016/j.devcel.2011.12.021
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Ding CL, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep16064
   Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Finkel T, 2009, P NATL ACAD SCI USA, V106, P11825, DOI 10.1073/pnas.0906430106
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Fujimoto M, 2012, BIOCHEM BIOPH RES CO, V417, P635, DOI 10.1016/j.bbrc.2011.12.022
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gerhold JM, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15292
   Gilkerson R, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011080
   GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   HOWELL N, 1991, AM J HUM GENET, V49, P939
   Hubstenberger A, 2010, J BIOENERG BIOMEMBR, V42, P143, DOI 10.1007/s10863-010-9269-8
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Itoh K, 2013, MOL BIOL CELL, V24, P1842, DOI 10.1091/mbc.E13-03-0125
   Jayashankar V, 2014, CURR OPIN CELL BIOL, V26, P34, DOI 10.1016/j.ceb.2013.09.002
   Jian FL, 2018, CELL REP, V23, P2989, DOI 10.1016/j.celrep.2018.05.015
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Kandul NP, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13100
   Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111
   Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132
   Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360
   Kozjak-Pavlovic V, 2017, CELL TISSUE RES, V367, P83, DOI 10.1007/s00441-016-2433-7
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lewis SC, 2016, SCIENCE, V353, P0, DOI 10.1126/science.aaf5549
   Li H, 2016, CELL DEATH DIFFER, V23, P380, DOI 10.1038/cdd.2015.102
   Li Z, 2016, MITOCHONDRIAL MECH D, V0, P49
   Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Murley A, 2013, ELIFE, V2, P0, DOI 10.7554/eLife.00422
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Nicholls TJ, 2018, TRENDS BIOCHEM SCI, V43, P869, DOI 10.1016/j.tibs.2018.08.007
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Osman C, 2015, P NATL ACAD SCI USA, V112, PE947, DOI 10.1073/pnas.1501737112
   Parone PA, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003257
   Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608
   Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320
   Peeva V, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04131-w
   Peralta S, 2018, J CELL SCI, V131, P0, DOI 10.1242/jcs.217075
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Renken C, 2002, J STRUCT BIOL, V138, P137, DOI 10.1016/S1047-8477(02)00012-6
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   Riley JS, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201899238
   Sastri M, 2017, J CELL SCI, V130, P3248, DOI 10.1242/jcs.201400
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Sato M, 2012, AUTOPHAGY, V8, P424, DOI 10.4161/auto.19243
   Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333
   SbisÃ  E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6
   Schorr S, 2018, SEMIN CELL DEV BIOL, V76, P191, DOI 10.1016/j.semcdb.2017.09.021
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052
   Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Song WH, 2016, P NATL ACAD SCI USA, V113, PE5261, DOI 10.1073/pnas.1605844113
   Song WH, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/981867
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Stefano GB, 2016, BIOMED REP, V4, P259, DOI 10.3892/br.2016.590
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Sutovsky P, 2004, REPROD BIOMED ONLINE, V8, P24, DOI 10.1016/S1472-6483(10)60495-6
   Sutovsky P, 2003, BIOL REPROD, V68, P1793, DOI 10.1095/biolreprod.102.012799
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Thompson WE, 2003, BIOL REPROD, V69, P254, DOI 10.1095/biolreprod.102.010975
   van der Laan M, 2016, CURR OPIN CELL BIOL, V41, P33, DOI 10.1016/j.ceb.2016.03.013
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang XD, 1999, SCIENTIST, V13, P16
   Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108
   Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042
   Yamamoto H, 2002, MOL BIOL CELL, V13, P0
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Yu ZS, 2017, CURR BIOL, V27, P1033, DOI 10.1016/j.cub.2017.02.014
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhou QH, 2016, SCIENCE, V353, P394, DOI 10.1126/science.aaf4777
   ZÃ¼chner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 121
TC 159
Z9 179
U1 8
U2 71
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD APR 15
PY 2019
VL 8
IS 4
BP 
EP 
DI 10.3390/cells8040379
PG 15
WC Cell Biology
SC Cell Biology
GA HX3PN
UT WOS:000467304300093
PM 31027297
DA 2024-11-01
ER

PT J
AU GoudenÃ¨ge, D
   Bris, C
   Hoffmann, V
   Desquiret-Dumas, V
   Jardel, C
   Rucheton, B
   Bannwarth, S
   Paquis-Flucklinger, V
   Lebre, AS
   Colin, E
   Amati-Bonneau, P
   Bonneau, D
   Reynier, P
   Lenaers, G
   Procaccio, V
AF Goudenege, David
   Bris, Celine
   Hoffmann, Virginie
   Desquiret-Dumas, Valerie
   Jardel, Claude
   Rucheton, Benoit
   Bannwarth, Sylvie
   Paquis-Flucklinger, Veronique
   Lebre, Anne Sophie
   Colin, Estelle
   Amati-Bonneau, Patrizia
   Bonneau, Dominique
   Reynier, Pascal
   Lenaers, Guy
   Procaccio, Vincent
TI eKLIPse: a sensitive tool for the detection and quantification of mitochondrial DNA deletions from next-generation sequencing data
SO GENETICS IN MEDICINE
LA English
DT Article
DE mitochondrial diseases; mitochondrial genome; mtDNA deletions; next-generation sequencing; soft clipping
ID mutations; phenotype; genotype; information; muscle; pcr
AB Purpose: Accurate detection of mitochondrial DNA (mtDNA) alterations is essential for the diagnosis of mitochondrial diseases. The development of high-throughput sequencing technologies has enhanced the detection sensitivity of mtDNA pathogenic variants, but the detection of mtDNA rearrangements, especially multiple deletions, is still poorly processed. Here, we present eKLIPse, a sensitive and specific tool allowing the detection and quantification of large mtDNA rearrangements from single and paired-end sequencing data. Methods: The methodology was first validated using a set of simulated data to assess the detection sensitivity and specificity, and second with a series of sequencing data from mitochondrial disease patients carrying either single or multiple deletions, related to pathogenic variants in nuclear genes involved in mtDNA maintenance. Results: eKLIPse provides the precise breakpoint positions and the cumulated percentage of mtDNA rearrangements at a given gene location with a detection sensitivity lower than 0.5% mutant. eKLIPse software is available either as a script to be integrated in a bioinformatics pipeline, or as user-friendly graphical interface to visualize the results through a Circos representation (https://github.com/dooguypapua/eKLIPse). Conclusion: Thus, eKLIPse represents a useful resource to study the causes and consequences of mtDNA rearrangements, for further genotype/phenotype correlations in mitochondrial disorders.
C1 [Goudenege, David; Bris, Celine; Hoffmann, Virginie; Desquiret-Dumas, Valerie; Colin, Estelle; Amati-Bonneau, Patrizia; Bonneau, Dominique; Reynier, Pascal; Lenaers, Guy; Procaccio, Vincent] Angers Univ, MitoVasc Inst, MitoLab, UMR CNRS 6015,INSERM U1083, Angers, France.
   [Goudenege, David; Bris, Celine; Desquiret-Dumas, Valerie; Colin, Estelle; Amati-Bonneau, Patrizia; Bonneau, Dominique; Reynier, Pascal; Procaccio, Vincent] Angers Hosp, Biochem & Genet Dept, Angers, France.
   [Jardel, Claude; Rucheton, Benoit] GHU Pitie Salpetriere, AP HP, Biochem Dept, Paris, France.
   [Jardel, Claude; Rucheton, Benoit] GHU Pitie Salpetriere, AP HP, Genet Ctr, Paris, France.
   [Bannwarth, Sylvie; Paquis-Flucklinger, Veronique] Univ Cote dAzur, IRCAN, CNRS, INSERM,CHU Nice, Nice, France.
   [Lebre, Anne Sophie] CHU Reims, Pole Biol, Serv Genet, Hop Maison Blanche, Reims, France.
C3 Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Cote d'Azur; Universite de Reims Champagne-Ardenne; CHU de Reims
RP Procaccio, V (corresponding author), Angers Univ, MitoVasc Inst, MitoLab, UMR CNRS 6015,INSERM U1083, Angers, France.; Procaccio, V (corresponding author), Angers Hosp, Biochem & Genet Dept, Angers, France.
EM ViProcaccio@chu-angers.fr
FU Association contre les Maladies Mitochondriales; University and Hospital of Angers
CR BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Belmonte FR, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25186
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1821-7
   Boucret L, 2017, HUM REPROD, V32, P2101, DOI 10.1093/humrep/dex268
   Caboche S, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-264
   Camacho C, 2009, BMC BIOINFORMATICS, V10, P0, DOI 10.1186/1471-2105-10-421
   Damas J, 2014, NUCLEIC ACIDS RES, V42, PD1261, DOI 10.1093/nar/gkt982
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Grady JP, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114462
   Guo Y, 2013, BIOINFORMATICS, V29, P1210, DOI 10.1093/bioinformatics/btt118
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465
   Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   MORAES CT, 1995, MUSCLE NERVE, V0, PS150
   Pirooznia M, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00138
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Sadikovic B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015687
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Seneca S, 2015, EUR J HUM GENET, V23, P41, DOI 10.1038/ejhg.2014.49
   SPELBRINK JN, 1994, HUM MOL GENET, V3, P1989, DOI 10.1093/hmg/3.11.1989
   Suzuki S, 2011, BMC BIOINFORMATICS, V12, P0, DOI 10.1186/1471-2105-12-S14-S7
   Tonska K, 2012, GENE, V506, P161, DOI 10.1016/j.gene.2012.06.081
   Vancampenhout K, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0112950
   Wallace D, 2013, EMERY AND RIMOINS PRINCIPLES AND PRACTICE OF MEDICAL GENETICS, V0, P1
   Wong LJC, 2013, NEUROTHERAPEUTICS, V10, P262, DOI 10.1007/s13311-012-0170-5
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Wu Yinghua, 2013, FRONTIERS IN GENETICS, V4, P157, DOI 10.3389/fgene.2013.00157
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
NR 37
TC 35
Z9 35
U1 0
U2 8
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1098-3600
EI 1530-0366
J9 GENET MED
JI Genet. Med.
PD JUN 15
PY 2019
VL 21
IS 6
BP 1407
EP 1416
DI 10.1038/s41436-018-0350-8
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA IB2DN
UT WOS:000470079700020
PM 30393377
DA 2024-11-01
ER

PT J
AU Schoonen, M
   Smuts, I
   Louw, R
   Elson, JL
   van Dyk, E
   Jonck, LM
   Rodenburg, RJT
   van der Westhuizen, FH
AF Schoonen, Maryke
   Smuts, Izelle
   Louw, Roan
   Elson, Joanna L.
   van Dyk, Etresia
   Jonck, Lindi-Maryn
   Rodenburg, Richard J. T.
   van der Westhuizen, Francois H.
TI Panel-Based Nuclear and Mitochondrial Next-Generation Sequencing Outcomes of an Ethnically Diverse Pediatric Patient Cohort with Mitochondrial Disease
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Article
ID coa dehydrogenase-deficiency; molecular-mechanisms; diagnostic-criteria; mutations; dna; variants; protein; gene; pathogenicity; muscle
AB Mitochondrial disease (MD) is a group of rare inherited disorders with clinical heterogeneous phenotypes. Recent advances in next-generation sequencing (NGS) allow for rapid genetic diagnostics in patients who experience MD, resulting in significant strides in determining its etiology. This, however, has not been the case in many patient populations. We report on a molecular diagnostic study using mitochondrial DNA and targeted nuclear DNA (nDNA) NGS of an extensive cohort of predominantly sub-Saharan African pediatric patients with clinical and biochemically defined MD. Patients in this novel cohort presented mostly with muscle involvement (73%). Of the original 212 patients, a muscle respiratory chain deficiency was identified in 127 cases. Genetic analyses were conducted for these 127 cases based on biochemical deficiencies, for both mitochondrial (n = 123) and nDNA using panel-based NGS (n = 86). As a pilot investigation, whole-exome sequencing was performed in a subset of African patients (n = 8). These analyses resulted in the identification of a previously reported pathogenic mitochondrial DNA variant and seven pathogenic or likely pathogenic nDNA variants (ETFDH, SURF1, COQ6, RYR1, STAC3, ALAS2, and TRIOBP), most of which were identified via whole-exome sequencing. This study contributes to knowledge of MD etiology in an understudied, ethnically diverse population; highlights inconsistencies in genotype-phenotype correlations; and proposes future directions for diagnostic approaches in such patient populations.
C1 [Schoonen, Maryke; Louw, Roan; Elson, Joanna L.; van Dyk, Etresia; Jonck, Lindi-Maryn; van der Westhuizen, Francois H.] North West Univ, Fac Nat & Agr Sci, Human Metabol, Potchefstroom, South Africa.
   [Smuts, Izelle] Univ Pretoria, Steve Biko Acad Hosp, Dept Paediat & Child Hlth, Pretoria, South Africa.
   [Elson, Joanna L.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.
   [Rodenburg, Richard J. T.] Radboudumc Amalia Childrens Hosp, Radboud Ctr Mitochondrial Med, Dept Pediat, Nijmegen, Netherlands.
C3 North West University - South Africa; University of Pretoria; Newcastle University - UK
RP van der Westhuizen, FH (corresponding author), North West Univ, Human Metabol, Potchefstroom Campus,Private Bag X6001, ZA-2520 Potchefstroom, South Africa.
EM francois.vanderwesthuizen@nwu.ac.za
FU Medical Research Council of South Africa
CR AlcÃ¡zar-Fabra M, 2018, ESSAYS BIOCHEM, V62, P377, DOI 10.1042/EBC20170107
   Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   [Anonymous], 1993, GENEREVIEWS(), V0, P0
   Bayona-Bafaluy MP, 2011, BBA-BIOENERGETICS, V1807, P643, DOI 10.1016/j.bbabio.2010.08.004
   Benson DA, 2012, NUCLEIC ACIDS RES, V41, P0
   Blackburn PR, 2017, MOL GENET GENOM MED, V5, P295, DOI 10.1002/mgg3.280
   BROWN MD, 1992, FASEB J, V6, P2791, DOI 10.1096/fasebj.6.10.1634041
   Cavadas B, 2015, HUM MUTAT, V36, P1100, DOI 10.1002/humu.22849
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Ernst C, 2018, BMC MED GENOMICS, V11, P0, DOI 10.1186/s12920-018-0353-y
   Gamba J, 2012, J NEUROL SCI, V320, P131, DOI 10.1016/j.jns.2012.05.037
   Gaspar R, 2015, NEURODEGENER DIS, V15, P70, DOI 10.1159/000380766
   GÃ¶rlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horstick EJ, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2952
   Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, PD840, DOI 10.1093/nar/gkw971
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Louw R, 2018, MOL GENET METAB, V125, P38, DOI 10.1016/j.ymgme.2018.02.015
   Martins RG, 2013, ENDOCR-RELAT CANCER, V20, PL23, DOI 10.1530/ERC-12-0399
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McLaren W, 2016, GENOME BIOL, V17, P0, DOI 10.1186/s13059-016-0974-4
   Meldau S, 2018, CLIN GENET, V93, P1093, DOI 10.1111/cge.13208
   Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   Neto OA, 2015, GENET MOL BIOL, V38, P147, DOI 10.1590/S1415-4757382220140238
   Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Ni Y, 2008, AM J HUM GENET, V83, P261, DOI 10.1016/j.ajhg.2008.07.011
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Paila U, 2013, PLOS COMPUT BIOL, V9, P0, DOI 10.1371/journal.pcbi.1003153
   Plaitakis A, 2010, EUR J HUM GENET, V18, P336, DOI 10.1038/ejhg.2009.179
   Plutino M, 2018, BMC MED GENET, V19, P0, DOI 10.1186/s12881-018-0568-y
   Punetha Jaya, 2016, J NEUROMUSCUL DIS, V3, P209
   Reinecke CJ, 2012, METABOLOMICS, V8, P264, DOI 10.1007/s11306-011-0309-0
   Riazuddin S, 2006, AM J HUM GENET, V78, P137, DOI 10.1086/499164
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Santorelli FM, 1997, NEUROMUSCULAR DISORD, V7, P156, DOI 10.1016/S0960-8966(97)00444-6
   Shahin H, 2006, AM J HUM GENET, V78, P144, DOI 10.1086/499495
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Smuts I, 2010, J INHERIT METAB DIS, V33, PS95, DOI 10.1007/s10545-009-9031-8
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Tanigawa J, 2012, BRAIN DEV-JPN, V34, P861, DOI 10.1016/j.braindev.2012.02.007
   To-Figueras J, 2011, BLOOD, V118, P1443, DOI 10.1182/blood-2011-03-342873
   van der Walt EM, 2012, EUR J HUM GENET, V20, P650, DOI 10.1038/ejhg.2011.262
   van der Watt G, 2010, MOL GENET METAB, V101, P178, DOI 10.1016/j.ymgme.2010.07.018
   van der Westhuizen FH, 2015, HUM MUTAT, V36, P569, DOI 10.1002/humu.22789
   van der Westhuizena FH, 2018, J NEUROL SCI, V384, P121, DOI 10.1016/j.jns.2017.11.012
   van Oven M, 2015, FORENS SCI INT-GEN S, V5, PE392, DOI 10.1016/j.fsigss.2015.09.155
   Venter L, 2015, METABOLOMICS, V11, P111, DOI 10.1007/s11306-014-0675-5
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Watanabe H, 2000, HUM MUTAT, V15, P430, DOI 10.1002/(SICI)1098-1004(200005)15:5<430::AID-HUMU4>3.3.CO;2-T
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, PW64, DOI 10.1093/nar/gkw247
   Wilmshurst JM, 2010, ANN NEUROL, V68, P717, DOI 10.1002/ana.22119
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Zhao FX, 2009, BIOCHEM BIOPH RES CO, V389, P466, DOI 10.1016/j.bbrc.2009.08.168
   Zhou H, 2007, BRAIN, V130, P2024, DOI 10.1093/brain/awm096
NR 73
TC 11
Z9 11
U1 2
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD MAY 15
PY 2019
VL 21
IS 3
BP 503
EP 513
DI 10.1016/j.jmoldx.2019.02.002
PG 11
WC Pathology
SC Pathology
GA HX4FL
UT WOS:000467350300014
PM 30872186
DA 2024-11-01
ER

PT J
AU Newell, C
   Khan, A
   Sinasac, D
   Shoffner, J
   Friederich, MW
   Van Hove, JLK
   Hume, S
   Shearer, J
   Sosova, I
AF Newell, Christopher
   Khan, Aneal
   Sinasac, David
   Shoffner, John
   Friederich, Marisa W.
   Van Hove, Johan L. K.
   Hume, Stacey
   Shearer, Jane
   Sosova, Iveta
TI Hybrid gel electrophoresis using skin fibroblasts to aid in diagnosing mitochondrial disease
SO NEUROLOGY-GENETICS
LA English
DT Article
ID blue native electrophoresis; membrane-protein complexes; oxidative-phosphorylation; mutations; subcomplexes; disorders; pathology
AB Objective We developed a novel, hybrid method combining both blue-native (BN-PAGE) and clear-native (CN-PAGE) polyacrylamide gel electrophoresis, termed BCN-PAGE, to perform in-gel activity stains on the mitochondrial electron transport chain (ETC) complexes in skin fibroblasts. Methods Four patients aged 46-65 years were seen in the Metabolic Clinic at Alberta Children's Hospital and investigated for mitochondrial disease and had BN-PAGE or CN-PAGE on skeletal muscle that showed incomplete assembly of complex V (CV) in each patient. Long-range PCR performed on muscle-extracted DNA identified 4 unique mitochondrial DNA (mtDNA) deletions spanning the ATP6 gene of CV. We developed a BCN-PAGE method in skin fibroblasts taken from the patients at the same time and compared the findings with those in skeletal muscle. Results In all 4 cases, BCN-PAGE in skin fibroblasts confirmed the abnormal CV activity found from muscle biopsy, suggesting that the mtDNA deletions involving ATP6 were most likely germline mutations that are associated with a clinical phenotype of mitochondrial disease. Conclusions The BCN-PAGE method in skin fibroblasts has a potential to be a less-invasive tool compared with muscle biopsy to screen patients for abnormalities in CV and other mitochondrial ETC complexes.
C1 [Newell, Christopher; Khan, Aneal; Sinasac, David; Shoffner, John] Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp Res Inst, Dept Med Genet, Calgary, AB, Canada.
   [Khan, Aneal] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada.
   [Friederich, Marisa W.; Van Hove, Johan L. K.] Univ Colorado, Sect Clin Genet & Metab, Dept Pediat, Boulder, CO 80309 USA.
   [Hume, Stacey] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.
   [Shearer, Jane] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.
   [Sosova, Iveta] Univ Alberta, Dept Lab Med, Edmonton, AB, Canada.
   [Sosova, Iveta] Univ Alberta, Dept Pathol, Edmonton, AB, Canada.
C3 University of Calgary; University of Calgary; University of Colorado System; University of Colorado Boulder; University of Alberta; University of Calgary; University of Alberta; University of Alberta
RP Khan, A (corresponding author), Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp Res Inst, Dept Med Genet, Calgary, AB, Canada.
EM khaa@ucalgary.ca
FU Alberta Children's Hospital Research Foundation (ACHRF); MitoCanada; Alberta Innovates-Health Solutions MD/PhD Studentship; Alberta Children's Hospital Research Institute (ACHRI) Clinical Research Fellowship
CR Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   CEUTERICK C, 1984, J NEUROL SCI, V65, P179, DOI 10.1016/0022-510X(84)90082-0
   Chatfield KC, 2015, MITOCHONDRION, V21, P1, DOI 10.1016/j.mito.2014.12.005
   Chretien D, 2003, J INHERIT METAB DIS, V26, P189, DOI 10.1023/A:1024437201166
   Coughlin CR, 2015, J MED GENET, V52, P532, DOI 10.1136/jmedgenet-2015-103049
   da Cunha ES, 2011, ANAL BIOCHEM, V418, P158, DOI 10.1016/j.ab.2011.06.044
   Desjardins CA, 2008, GENOME BIOL, V9, P0, DOI 10.1186/gb-2008-9-12-r183
   Diaz Francisca, 2009, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1904s63
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Dimmock DP, 2017, PEDIATR CLIN N AM, V64, P161, DOI 10.1016/j.pcl.2016.08.011
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Fiala GJ, 2011, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/2164
   Friederich MW, 2016, HUM MOL GENET, V26, P0
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Kramer KA, 2005, CLIN CHEM, V51, P2110, DOI 10.1373/clinchem.2005.050146
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022
   Newell C, 2018, MOL GENET METAB, V125, P332, DOI 10.1016/j.ymgme.2018.10.002
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Roels F, 2009, BMC CLIN PATHOL, V9, P0, DOI 10.1186/1472-6890-9-4
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Shoffner JM, 2000, NEUROL CLIN, V18, P105, DOI 10.1016/S0733-8619(05)70180-8
   Shukolyukov SA, 2011, CELL TISSUE BIOL, V5, P311, DOI 10.1134/S1990519X11030126
   Smet J, 2011, J INHERIT METAB DIS, V34, P741, DOI 10.1007/s10545-011-9315-7
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Baquedano MS, 2013, J CLIN ENDOCR METAB, V98, PE153, DOI 10.1210/jc.2012-2865
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Stephenson EJ, 2014, BBA-GEN SUBJECTS, V1840, P1285, DOI 10.1016/j.bbagen.2013.12.004
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   Tucci A, 2014, J NEUROL NEUROSUR PS, V85, P486, DOI 10.1136/jnnp-2013-306387
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Vangipuram M, 1900, PE3779, V0, P0
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Williams SL, 2001, LAB INVEST, V81, P1069, DOI 10.1038/labinvest.3780319
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
NR 45
TC 5
Z9 6
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
EI 
J9 NEUROL-GENET
JI Neurol.-Genet.
PD JUN 15
PY 2019
VL 5
IS 3
BP 
EP 
DI 10.1212/NXG.0000000000000336
PG 8
WC Genetics & Heredity; Clinical Neurology
SC Genetics & Heredity; Neurosciences & Neurology
GA IR8BW
UT WOS:000481667200012
PM 31192304
DA 2024-11-01
ER

PT J
AU Fukuda, M
   Nagao, Y
AF Fukuda, Mai
   Nagao, Yoshiro
TI Dynamic derangement in amino acid profile during and after a stroke-like episode in adult-onset mitochondrial disease: a case report
SO JOURNAL OF MEDICAL CASE REPORTS
LA English
DT Article
DE Maternally inherited diabetes and deafness; Mitochondrial myopathy; encephalopathy; lactic acidosis; and stroke-like episodes; Growth differentiation factor-15; Arginine; Citrulline; Aspartic acid; Taurine; Case report
ID nitric-oxide production; diabetes-mellitus; l-arginine; melas syndrome; mutation; diagnosis; patient; gene; encephalopathy; management
AB Background Maternally inherited diabetes and deafness, and mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes are examples of mitochondrial diseases that are relatively common in the adult population. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes are assumed to be associated with decreases in arginine and citrulline. Biomarkers, such as growth differentiation factor-15, were developed to assist in the diagnosis of mitochondrial diseases. Case presentation A 55-year-old Japanese man, an insulin user, presented after a loss of consciousness. A laboratory test showed diabetic ketoacidosis. He and his mother had severe hearing difficulty. Bilateral lesions on magnetic resonance imaging, the presence of seizure, and an elevated ratio of lactate to pyruvate, altogether suggested a diagnosis of mitochondrial disease. Mitochondrial DNA in our patient's peripheral blood was positive with a 3243A>G mutation, which is the most frequent cause of maternally inherited diabetes and deafness, and mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. As a result, maternally inherited diabetes and deafness/mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes was diagnosed. We measured growth differentiation factor-15 and multiple amino acids in his blood, longitudinally during and after the stroke-like episode. Growth differentiation factor-15 was increased to an immeasurably high level on the day of the stroke-like episode. Although his diabetes improved with an increased dose of insulin, the growth differentiation factor-15 level gradually increased, suggesting that his mitochondrial insufficiency did not improve. Multiple amino acid species, including arginine, citrulline, and taurine, showed a decreased level on the day of the episode and a sharp increase the next day. In contrast, the level of aspartic acid increased to an extremely high level on the day of the episode, and decreased gradually thereafter. Conclusions Growth differentiation factor-15 can be used not only for the diagnosis of mitochondrial disease, but as an indicator of its acute exacerbation. A stroke-like episode of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes reflects a drastic derangement of multiple amino acids. The involvement of aspartic acid in the episodes should be explored in future studies.
C1 [Fukuda, Mai; Nagao, Yoshiro] Hidaka Tokushukai Hosp, 1-10-27 Shizunai Kose Cho, Shin Hidaka, Hokkaido 0560005, Japan.
   [Nagao, Yoshiro] Fukuoka Tokushukai Hosp, 4-5 Sugukita, Kasuga, Fukuoka 8160864, Japan.
RP Nagao, Y (corresponding author), Fukuoka Tokushukai Hosp, 4-5 Sugukita, Kasuga, Fukuoka 8160864, Japan.
EM in_the_pacific214@yahoo.co.jp
CR Abdullah Mishal, 2012, J MED CASE REP, V6, P55, DOI 10.1186/1752-1947-6-55
   Abu-Amero Khaled K, 2009, J MED CASE REP, V3, P77, DOI 10.1186/1752-1947-3-77
   Cai Stephen S, 2016, RADIOL CASE REP, V11, P425
   El-Hattab AW, 2016, MOL GENET METAB, V117, P407, DOI 10.1016/j.ymgme.2016.01.010
   El-Hattab AW, 2012, MOL GENET METAB, V105, P607, DOI 10.1016/j.ymgme.2012.01.016
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   KADOWAKI H, 1993, LANCET, V341, P893, DOI 10.1016/0140-6736(93)93101-6
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2012, BIOCH BIOPHYS ACTA, V608, P614
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Kolb SJ, 2003, J NEUROL SCI, V216, P11, DOI 10.1016/S0022-510X(03)00218-1
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Murakami T, 2016, TOHOKU J EXP MED, V239, P89, DOI 10.1620/tjem.239.89
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Nakamura S, 2000, DIABETES METAB, V26, P407
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Okuno Y, 2013, METABOLISM, V62, P1470, DOI 10.1016/j.metabol.2013.05.022
   Omata T, 2016, J NEUROL SCI, V360, P57, DOI 10.1016/j.jns.2015.11.043
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   Saisho Y, 2011, ENDOCR J, V58, P315, DOI 10.1507/endocrj.K10E-399
   Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65
   Tetsuka Syuichi, 2017, J CLIN MED RES, V9, P812, DOI 10.14740/jocmr3122w
   The Japanse Society of Mitochondrial Research and Medicine, 2017, MIT DIS MAN MAN 2017, V0, P0
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Wang ZP, 2016, FOLIA NEUROPATHOL, V54, P66, DOI 10.5114/fn.2016.58917
   Yatsuga S, 2012, BIOCH BIOPHYS ACTA, V619, P624
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
NR 36
TC 3
Z9 3
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1752-1947
J9 J MED CASE REP
JI J. Med. Case Rep.
PD OCT 21
PY 2019
VL 13
IS 1
BP 
EP 
DI 10.1186/s13256-019-2255-9
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA WD3GG
UT WOS:000704833000001
PM 31630688
DA 2024-11-01
ER

PT J
AU Tarnopolsky, MA
   Sundaram, ANE
   Provias, J
   Brady, L
   Sadikovic, B
AF Tarnopolsky, Mark A.
   Sundaram, Arun N. E.
   Provias, John
   Brady, Lauren
   Sadikovic, Bekim
TI CPEO - Like mitochondrial myopathy associated with m.8340G &gt; A mutation
SO MITOCHONDRION
LA English
DT Article
ID ragged-red fibers; myoclonic epilepsy; muscle; merrf; mtdna; 3243a-greater-than-g; dysfunction; deafness; disease
AB Two patients with an m.8340G > A mitochondrial DNA variant have been reported with one patient showing ptosis, ophthalmoparesis and myopathy at 53% heteroplasmy and another with pigmentary retinopathy, cataracts and sensory neural deafness and slightly higher heteroplasmy (65%). Here we report that higher muscle mutant heteroplasmy (93%) for m.8340G > A is associated with ptosis, ophthalmoparesis and mitochondrial myopathy, thus confirming the initial phenotypic association and showing that heteroplasmy per se does not explain the phenotypic spectrum of disease associated with the m.8340G > A mutation.
C1 [Tarnopolsky, Mark A.; Brady, Lauren] McMaster Univ, Dept Pediat, Hamilton, ON, Canada.
   [Sundaram, Arun N. E.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada.
   [Provias, John] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.
   [Sadikovic, Bekim] Childrens Hlth Res Inst, London Hlth Sci Ctr, Mol Genet Lab, Mol Diagnost Div, London, ON, Canada.
C3 McMaster University; University of Toronto; Sunnybrook Research Institute; Sunnybrook Health Science Center; McMaster University; London Health Sciences Centre
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Med Ctr, Pediat & Med, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
CR Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   Crane JD, 2013, J GERONTOL A-BIOL, V68, P631, DOI 10.1093/gerona/gls237
   Devries MC, 2013, J CLIN ENDOCR METAB, V98, P4852, DOI 10.1210/jc.2013-2044
   Gill JS, 2017, BRIT J OPHTHALMOL, V101, P1298, DOI 10.1136/bjophthalmol-2017-310370
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HOLME E, 1993, AM J HUM GENET, V52, P551
   Howell N, 2003, AM J MED GENET A, V119A, P147, DOI 10.1002/ajmg.a.20135
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2014, NEUROMUSCULAR DISORD, V24, P162, DOI 10.1016/j.nmd.2013.08.004
   KÃ¤rppÃ¤ M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Kerkhof J, 2017, J MOL DIAGN, V19, P905, DOI 10.1016/j.jmoldx.2017.07.004
   LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Macmillan C, 1998, NEUROLOGY, V50, P417, DOI 10.1212/WNL.50.2.417
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   2016, 1900, V18, V0, PP657, DOI 10.1016/J.JMOLDX.2016.04.002
NR 25
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAY 15
PY 2019
VL 46
IS 
BP 69
EP 72
DI 10.1016/j.mito.2018.02.008
PG 4
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA HX8NY
UT WOS:000467663800009
PM 29501485
DA 2024-11-01
ER

PT J
AU Fervenza, FC
   Gavrilova, RH
   Nasr, SH
   Irazabal, MV
   Nath, KA
AF Fervenza, Fernando C.
   Gavrilova, Ralitza H.
   Nasr, Samih H.
   Irazabal, Maria, V
   Nath, Karl A.
TI CKD Due to a Novel Mitochondrial DNA Mutation: A Case Report
SO AMERICAN JOURNAL OF KIDNEY DISEASES
LA English
DT Article
ID cox-i gene; kidney; disease; proteinuria; nuclear
AB In human kidney disease, mitochondrial ultrastructural damage has long been recognized. Although the extent to which such mitochondrial changes contribute to human kidney disease is uncertain, experimental studies clearly demonstrate that mitochondrial damage can instigate pathogenetic processes that drive ongoing kidney disease. Clinical credence for this experimentally based hypothesis is provided by the development of kidney disease in patients with primary mitochondrial disorders. In this regard, substantial interest surrounds the occurrence of kidney disease in primary mitochondrial cytopathies, a heterogeneous group of conditions in which mutations in mitochondrial DNA (mtDNA) or nuclear DNA impair the functionality of components of the mitochondrial respiratory chain. We describe a novel mtDNA mutation in a patient who developed chronic kidney disease. The patient exhibited mitochondrial abnormalities in both muscle and kidney, chronic tubulointerstitial changes, and recurrent episodes of rhabdomyolysis. We outline mechanisms that may underlie the occurrence of chronic kidney disease in the setting of this novel mtDNA mutation. We also underscore the need to consider in relevant kidney diseases the presence of an underlying mitochondrial cytopathy because the latter more commonly exists than is generally recognized.
C1 [Fervenza, Fernando C.; Irazabal, Maria, V; Nath, Karl A.] Mayo Clin, Div Nephrol & Hypertens, Coll Med, Rochester, MN 55905 USA.
   [Gavrilova, Ralitza H.] Mayo Clin, Dept Clin Genom, Coll Med, Rochester, MN 55905 USA.
   [Gavrilova, Ralitza H.] Mayo Clin, Dept Neurol, Coll Med, Rochester, MN 55905 USA.
   [Nasr, Samih H.] Mayo Clin, Dept Lab Med & Pathol, Coll Med, Rochester, MN 55905 USA.
C3 Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic
RP Nath, KA (corresponding author), Mayo Clin, Guggenheim 542,200 First St SW, Rochester, MN 55905 USA.
EM nath.karl@mayo.edu
FU National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [R01-47060]
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034
   Jaksch M, 1998, J MED GENET, V35, P895, DOI 10.1136/jmg.35.11.895
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Kobayashi A, 2010, AM J SURG PATHOL, V34, P262, DOI 10.1097/PAS.0b013e3181cb4ed3
   Lucioli S, 2006, NEUROGENETICS, V7, P51, DOI 10.1007/s10048-005-0015-z
   MartÃ­n-HernÃ¡ndez E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   Nasr SH, 2003, AM J KIDNEY DIS, V41, P259, DOI 10.1053/ajkd.2003.50068
   Nath KA, 2000, KIDNEY INT, V57, P2423, DOI 10.1046/j.1523-1755.2000.00101.x
   Nath KA, 1998, KIDNEY INT, V53, P100, DOI 10.1046/j.1523-1755.1998.00731.x
   NATH KA, 1992, AM J KIDNEY DIS, V20, P1
   Nath KA, 2000, AM J MED, V109, P665, DOI 10.1016/S0002-9343(00)00612-4
   Niaudet P, 1997, KIDNEY INT, V51, P1000, DOI 10.1038/ki.1997.140
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Rudnicki M, 2016, AM J KIDNEY DIS, V68, P949, DOI 10.1053/j.ajkd.2016.06.027
   SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181
   Szeto HH, 2017, J AM SOC NEPHROL, V28, P2856, DOI 10.1681/ASN.2017030247
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Wallace DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/pnas.94.26.14900
NR 21
TC 6
Z9 7
U1 0
U2 4
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0272-6386
EI 1523-6838
J9 AM J KIDNEY DIS
JI Am. J. Kidney Dis.
PD FEB 15
PY 2019
VL 73
IS 2
BP 273
EP 277
DI 10.1053/j.ajkd.2018.06.032
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA HI2YV
UT WOS:000456314000016
PM 30309714
DA 2024-11-01
ER

PT J
AU Fujii, T
   Takase, K
   Honda, H
   Kawamura, N
   Yamasaki, R
   Urata, M
   Uchiumi, T
   Iwaki, T
   Kira, J
AF Fujii, Takayuki
   Takase, Kei-ichiro
   Honda, Hiroyuki
   Kawamura, Nobutoshi
   Yamasaki, Ryo
   Urata, Michiyo
   Uchiumi, Takeshi
   Iwaki, Toru
   Kira, Jun-ichi
TI Toxic myopathy with multiple deletions in mitochondrial DNA associated with long-term use of oral anti-viral drugs for hepatitis B: A case study
SO NEUROPATHOLOGY
LA English
DT Article
DE anti-hepatitis B drugs; common deletion; mitochondrial DNA; mitochondrial myopathy; oxidative damage
ID ragged-red fibers; skeletal-muscle; cytopathy; therapy
AB Oral nucleoside analogs (NAs) reduce hepatitis B virus (HBV) replication by inhibiting HBV DNA polymerase. However, NAs can also affect human mitochondrial DNA (mtDNA) polymerase, which can lead to mtDNA depletion (quantitative abnormality). Indeed, several mitochondrial myopathy cases have been reported in which a reduced mtDNA copy number was induced by oral NAs for hepatitis B. Herein, we report a case of toxic myopathy with multiple mtDNA deletions (qualitative abnormality) associated with long-term use of NAs for hepatitis B. A 68-year-old woman, who underwent long-term treatment with lamivudine and adefovir for chronic hepatitis B, developed proximal muscle weakness in the four extremities. Neurological examination showed mild proximal muscle weakness and atrophy in the four extremities. Upon admission to our hospital, her blood lactate/pyruvate ratio during an aerobic exercise test was elevated. Myogenic patterns were observed in lower limb muscles on electromyographic examination. Muscle magnetic resonance imaging revealed diffuse atrophy of proximal muscles in the four extremities with no signal changes. A biopsy from the biceps brachii muscle showed an abnormally large variation in fiber size, scattered muscle fibers with decreased cytochrome c oxidase activity, and ragged-red fibers. Analysis of mtDNA from skeletal muscle revealed no decrease in copy number but increased incidence of multiple deletions, including a deletion of 4977 base pairs (known as the common deletion) reflecting oxidative stress-induced mtDNA damage. This case study indicates that long-term oral antiviral therapy for hepatitis B can induce chronic oxidative damage to mtDNA resulting in qualitative mtDNA abnormalities and toxic myopathy.
C1 [Fujii, Takayuki; Takase, Kei-ichiro; Kawamura, Nobutoshi; Yamasaki, Ryo; Kira, Jun-ichi] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka, Fukuoka, Japan.
   [Honda, Hiroyuki; Iwaki, Toru] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neuropathol, Fukuoka, Fukuoka, Japan.
   [Urata, Michiyo; Uchiumi, Takeshi] Kyushu Univ Hosp, Dept Clin Chem & Lab Med, Fukuoka, Fukuoka, Japan.
C3 Kyushu University; Kyushu University; Kyushu University
RP Kira, J (corresponding author), Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol,Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.
EM kira@neuro.med.kyushu-u.ac.jp
FU Grants-in-Aid for Scientific Research [20K20470] Funding Source: KAKEN
CR Capasso M, 2006, NEUROLOGY, V67, P1467, DOI 10.1212/01.wnl.0000240078.47020.5e
   Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559
   Cohen BH, 2001, CLEV CLIN J MED, V68, P625, DOI 10.3949/ccjm.68.7.625
   EGGER J, 1981, ARCH DIS CHILD, V56, P741, DOI 10.1136/adc.56.10.741
   Fodale V, 2005, ANAESTHESIA, V60, P806, DOI 10.1111/j.1365-2044.2005.04208.x
   Fung J, 2014, J GASTROEN HEPATOL, V29, P428, DOI 10.1111/jgh.12499
   Kayaaslan B, 2017, WORLD J HEPATOL, V9, P227, DOI 10.4254/wjh.v9.i5.227
   Lal A, 2016, JCI INSIGHT, V1, P0, DOI 10.1172/jci.insight.88150
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   LÃ³pez-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Mannion AF, 1997, J ORTHOPAED RES, V15, P881, DOI 10.1002/jor.1100150614
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Muqit MMK, 2008, J NEUROL NEUROSUR PS, V79, P68, DOI 10.1136/jnnp.2006.112250
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Scruggs ER, 2008, PHARMACOLOGY, V82, P83, DOI 10.1159/000134943
   Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023
   SWASH M, 1978, J NEUROL SCI, V38, P347, DOI 10.1016/0022-510X(78)90141-7
   Tanji N, 2001, HUM PATHOL, V32, P734, DOI 10.1053/hupa.2001.25586
   Xu HL, 2014, J CLIN PATHOL, V67, P999, DOI 10.1136/jclinpath-2013-202069
NR 20
TC 4
Z9 4
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0919-6544
EI 1440-1789
J9 NEUROPATHOLOGY
JI Neuropathology
PD APR 15
PY 2019
VL 39
IS 2
BP 162
EP 167
DI 10.1111/neup.12548
PG 6
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA HR3LR
UT WOS:000463039500013
PM 30847961
DA 2024-11-01
ER

PT J
AU Balasubramaniam, S
   Christodoulou, J
   Rahman, S
AF Balasubramaniam, Shanti
   Christodoulou, John
   Rahman, Shamima
TI Disorders of riboflavin metabolism
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Review
DE riboflavin metabolism; riboflavin transport; flavocoenzyme; flavoprotein; flavoproteome; FAD synthase deficiency; FLAD1 mutations; riboflavin responsive disorders
ID acyl-coa dehydrogenase; mitochondrial myopathy; acad9 mutations; multiple; identification; deficiency; phenotype; transporter; patient
AB Riboflavin (vitamin B2), a water-soluble vitamin, is an essential nutrient in higher organisms as it is not endogenously synthesised, with requirements being met principally by dietary intake. Tissue-specific transporter proteins direct riboflavin to the intracellular machinery responsible for the biosynthesis of the flavocoenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). These flavocoenzymes play a vital role in ensuring the functionality of a multitude of flavoproteins involved in bioenergetics, redox homeostasis, DNA repair, chromatin remodelling, protein folding, apoptosis, and other physiologically relevant processes. Hence, it is not surprising that the impairment of flavin homeostasis in humans may lead to multisystem dysfunction including neuromuscular disorders, anaemia, abnormal fetal development, and cardiovascular disease. In this review, we provide an overview of riboflavin absorption, transport, and metabolism. We then focus on the clinical and biochemical features associated with biallelic FLAD1 mutations leading to FAD synthase deficiency, the only known primary defect in flavocoenzyme synthesis, in addition to providing an overview of clinical disorders associated with nutritional deficiency of riboflavin and primary defects of riboflavin transport. Finally, we give a brief overview of disorders of the cellular flavoproteome. Because riboflavin therapy may be beneficial in a number of primary or secondary disorders of the cellular flavoproteome, early recognition and prompt management of these disorders is imperative.
C1 [Balasubramaniam, Shanti] Childrens Hosp Westmead, Western Sydney Genet Program, Sydney, NSW, Australia.
   [Balasubramaniam, Shanti] Childrens Hosp Westmead, Kids Res Inst, Sydney, NSW, Australia.
   [Balasubramaniam, Shanti; Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Genet Med, Sydney, NSW, Australia.
   [Balasubramaniam, Shanti; Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia.
   [Christodoulou, John] Murdoch Childrens Res Inst, Brain & Mitochondrial Res Grp, Melbourne, Vic, Australia.
   [Christodoulou, John] Univ Melbourne, Melbourne Med Sch, Dept Paediat, Melbourne, Vic, Australia.
   [Rahman, Shamima] UCL Great Ormond St Inst Child Hlth, Mitochondrial Res Grp, 30 Guilford St, London WC1N 1EH, England.
   [Rahman, Shamima] Great Ormond St Hosp NHS Fdn Trust, Metab Unit, London, England.
C3 University of Sydney; NSW Health; The Children's Hospital at Westmead; NSW Health; The Children's Hospital at Westmead; University of Sydney; University of Sydney; University of Sydney; Murdoch Children's Research Institute; University of Melbourne; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust
RP Rahman, S (corresponding author), UCL Great Ormond St Inst Child Hlth, Mitochondrial Res Grp, 30 Guilford St, London WC1N 1EH, England.
EM shamima.rahman@ucl.ac.uk
FU Lily Foundation; NIHR Great Ormond Street Hospital Biomedical Research Centre; Great Ormond Street Hospital Children's Charity; State Government of Victoria's Operational Infrastructure Support Program
CR Auranen M, 2017, NEUROMUSCULAR DISORD, V27, P581, DOI 10.1016/j.nmd.2017.03.003
   Barile M, 2016, J INHERIT METAB DIS, V39, P545, DOI 10.1007/s10545-016-9950-0
   Bosch AM, 2011, J INHERIT METAB DIS, V34, P159, DOI 10.1007/s10545-010-9242-z
   Brizio C, 2006, BIOCHEM BIOPH RES CO, V344, P1008, DOI 10.1016/j.bbrc.2006.04.003
   Buehler BA, 2011, J EVID-BASED INTEGR, V16, P88, DOI 10.1177/1533210110392943
   Carrozzo R, 2014, MITOCHONDRION, V18, P49, DOI 10.1016/j.mito.2014.09.006
   CHASTAIN JL, 1987, AM J CLIN NUTR, V46, P830, DOI 10.1093/ajcn/46.5.830
   Collet M, 2016, EUR J HUM GENET, V24, P1112, DOI 10.1038/ejhg.2015.264
   De Meirleir LJ, 2016, INBORN METABOLIC DIS, V0, P194
   Dewulf JP, 2016, MOL GENET METAB, V118, P185, DOI 10.1016/j.ymgme.2016.05.005
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Giancaspero TA, 2015, FRONT CHEM, V3, P0, DOI 10.3389/fchem.2015.00030
   Giancaspero TA, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/101286
   Giancaspero TA, 2013, J BIOL CHEM, V288, P29069, DOI 10.1074/jbc.M113.500066
   Green P, 2010, AM J HUM GENET, V86, P485, DOI 10.1016/j.ajhg.2010.02.006
   GrÃ¼nert SC, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0117-5
   Heimer G, 2018, EUR J PAEDIATR NEURO, V22, P93, DOI 10.1016/j.ejpn.2017.09.004
   Hellebrekers DM, 2017, EUR J HUM GENET, V25, P886, DOI 10.1038/ejhg.2017.62
   Henriques BJ, 2013, B VITAMINS FOLATE CH, V0, P0
   Ho G, 2011, HUM MUTAT, V32, PE1976, DOI 10.1002/humu.21399
   Hustad S, 2002, CLIN CHEM, V48, P1571
   Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010
   Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x
   Karthikeyan S, 2003, STRUCTURE, V11, P265, DOI 10.1016/S0969-2126(03)00024-8
   Kennedy DO, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8020068
   Leone P, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23010116
   LEVY G, 1966, J PHARM SCI-US, V55, P285, DOI 10.1002/jps.2600550305
   Lienhart WD, 2013, ARCH BIOCHEM BIOPHYS, V535, P150, DOI 10.1016/j.abb.2013.02.015
   Marashly ET, 2017, FRONT NEUROL, V8, P0, DOI 10.3389/fneur.2017.00333
   MCCORMICK DB, 1989, PHYSIOL REV, V69, P1170, DOI 10.1152/physrev.1989.69.4.1170
   Mosegaard S, 2017, MOL GENET METAB, V122, P182, DOI 10.1016/j.ymgme.2017.10.014
   Nouws J, 2014, HUM MOL GENET, V23, P1311, DOI 10.1093/hmg/ddt521
   OCallaghan B, 2019, J INHERIT METAB DIS, V0, P0
   Ogle RF, 1997, J PEDIATR-US, V130, P138, DOI 10.1016/S0022-3476(97)70323-8
   Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135
   Olsen RKJ, 2016, AM J HUM GENET, V98, P1130, DOI 10.1016/j.ajhg.2016.04.006
   Olsen RKJ, 2003, HUM MUTAT, V22, P12, DOI 10.1002/humu.10226
   Pinto JT, 2016, ADV NUTR, V7, P973, DOI 10.3945/an.116.012716
   Powers HJ, 2003, AM J CLIN NUTR, V77, P1352
   Quinonez SC, 2013, PEDIATR NEUROL, V48, P67, DOI 10.1016/j.pediatrneurol.2012.09.013
   Repp BM, 2018, ORPHANET J RARE DIS, V13, P0, DOI 10.1186/s13023-018-0784-8
   Rinaldi C, 2012, AM J HUM GENET, V91, P1095, DOI 10.1016/j.ajhg.2012.10.008
   Ryder B, 2019, JIMD REP, V45, P37, DOI 10.1007/8904_2018_139
   Schiff M, 2016, NEW ENGL J MED, V374, P795, DOI 10.1056/NEJMc1513610
   Smedts HPM, 2008, EUR J NUTR, V47, P357, DOI 10.1007/s00394-008-0735-6
   Smith LD, 2017, CLIN ASPECTS LAB DET, V2, P361, DOI 10.1016/B978-0-12-802896-4.00011-0
   Spaan AN, 2005, MOL GENET METAB, V86, P441, DOI 10.1016/j.ymgme.2005.07.014
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Titus SA, 2000, J BIOL CHEM, V275, P36811, DOI 10.1074/jbc.M005163200
   Torchetti EM, 2011, FEBS J, V278, P4435, DOI 10.1111/j.1742-4658.2011.08368.x
   Torchetti EM, 2010, MITOCHONDRION, V10, P263, DOI 10.1016/j.mito.2009.12.149
   Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206
   Yildiz Y, 2018, NEUROMUSCULAR DISORD, V28, P787, DOI 10.1016/j.nmd.2018.05.009
   Yonezawa A, 2013, MOL ASPECTS MED, V34, P693, DOI 10.1016/j.mam.2012.07.014
   Zempleni J, 1996, AM J CLIN NUTR, V63, P54, DOI 10.1093/ajcn/63.1.54
NR 56
TC 84
Z9 94
U1 5
U2 74
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD JUL 15
PY 2019
VL 42
IS 4
BP 608
EP 619
DI 10.1002/jimd.12058
PG 12
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA JD9WH
UT WOS:000490338400004
PM 30680745
DA 2024-11-01
ER

PT J
AU Abrigo, J
   Simon, F
   Cabrera, D
   Vilos, C
   Cabello-Verrugio, C
AF Abrigo, Johanna
   Simon, Felipe
   Cabrera, Daniel
   Vilos, Cristian
   Cabello-Verrugio, Claudio
TI Mitochondrial Dysfunction in Skeletal Muscle Pathologies
SO CURRENT PROTEIN & PEPTIDE SCIENCE
LA English
DT Review
DE Mitochondria; ROS; skeletal muscle; atrophy; dystrophy; ATP production
ID ubiquitin-proteasome system; dna-deletion mutations; duchenne muscular-dystrophy; protein-degradation; oxidative stress; huntingtons-disease; insulin-resistance; permeability transition; lactate production; molecular-basis
AB Several molecular mechanisms are involved in the regulation of skeletal Muscle function. Among them, mitochondrial activity can be identified. The mitochondria is an important and essential organelle in the skeletal muscle that is involved in metabolic regulation and ATP production, which are two key elements of muscle contractibility and plasticity. Thus, in this review, we present the critical and recent antecedents regarding the mechanisms through which mitochondrial dysfunction can be involved in the generation and development of skeletal muscle pathologies, its contribution to detrimental functioning in skeletal muscle and its crosstalk with other typical signaling pathways related to muscle diseases. In addition, an update on the development of new strategies with therapeutic potential to inhibit the deleterious impact of mitochondrial dysfunction in skeletal muscle is discussed.
C1 [Abrigo, Johanna; Cabello-Verrugio, Claudio] Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Lab Muscle Pathol Fragil & Aging, Santiago 8370186, Chile.
   [Abrigo, Johanna; Simon, Felipe; Cabello-Verrugio, Claudio] Millennium Inst Immunol & Immunotherapy, Santiago, Chile.
   [Abrigo, Johanna; Vilos, Cristian; Cabello-Verrugio, Claudio] Univ Santiago Chile, Ctr Dev Nanosci & Nanotechnol CEDENNA, Santiago, Chile.
   [Simon, Felipe] Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Lab Integrat Physiopathol, Santiago, Chile.
   [Cabrera, Daniel] Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Santiago, Chile.
   [Cabrera, Daniel] Univ Bernardo O Higgins, Fac Salud, Dept Ciencias Quim & Biol, Santiago, Chile.
   [Vilos, Cristian] Univ Talca, Sch Med, Ctr Med Res, Lab Nanomed & Targeted Delivery, Talca, Chile.
C3 Universidad Andres Bello; Universidad de Santiago de Chile; Universidad Andres Bello; Pontificia Universidad Catolica de Chile; Universidad  Bernardo O'Higgins; Universidad de Talca
RP Cabello-Verrugio, C (corresponding author), Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Lab Muscle Pathol Fragil & Aging, Santiago 8370186, Chile.
EM claudio.cabello@unab.cl
FU National Fund for Science & Technology Development [FONDECYT 1161646, 1161288, 1161438, 11171001]; Millennium Institute on Immunology and Immunotherapy [P09-016-F]; Programa de Cooperacion Cientifica ECOS-CONICYT [C16S02]; Center for Aging and Regeneration [CARE PFB12/2007]; BASAL Grant CEDENNA [FB0807]; H2020-MSCA-RISE-2016 [734801 MAG-NAMED]; Nucleus-UNAB [DI 36-18/N]; Conicyt [21161353]
CR AgustÃ­ AGN, 2002, AM J RESP CRIT CARE, V166, P485, DOI 10.1164/rccm.2108013
   Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001
   Asami Y, 2018, INT J MED SCI, V15, P628, DOI 10.7150/ijms.22723
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barreiro E, 2018, J THORAC DIS, V10, PS1415, DOI 10.21037/jtd.2018.04.168
   Bialek P, 2011, PHYSIOL GENOMICS, V43, P1075, DOI 10.1152/physiolgenomics.00247.2010
   Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011
   Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389
   Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, PE907, DOI 10.1152/ajpendo.00380.2013
   Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601
   Bragoszewski P, 2013, MOL CELL BIOL, V33, P2136, DOI 10.1128/MCB.01579-12
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092
   Bronstad E, 2012, EUR RESPIR J, V40, P1130, DOI 10.1183/09031936.00193411
   Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, PC817, DOI 10.1152/ajpcell.00139.2004
   Brown JL, 2017, J CACHEXIA SARCOPENI, V8, P926, DOI 10.1002/jcsm.12232
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Busse ME, 2008, J NEUROL, V255, P1534, DOI 10.1007/s00415-008-0964-x
   Campos F, 2018, PFLUG ARCH EUR J PHY, V470, P1503, DOI 10.1007/s00424-018-2167-3
   CantÃ³ C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Chakrabarty S, 2018, MITOCHONDRION, V43, P25, DOI 10.1016/j.mito.2018.06.006
   Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243
   Cheema N, 2015, AGING CELL, V14, P1085, DOI 10.1111/acel.12399
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Ciammola A, 2006, CELL DEATH DIFFER, V13, P2068, DOI 10.1038/sj.cdd.4401967
   Ciammola A, 2011, MOVEMENT DISORD, V26, P130, DOI 10.1002/mds.23258
   Cole MA, 2002, NEUROMUSCULAR DISORD, V12, P247, DOI 10.1016/S0960-8966(01)00278-4
   Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Damas F, 2018, EUR J APPL PHYSIOL, V118, P485, DOI 10.1007/s00421-017-3792-9
   Dasarathy S, 2016, CURR OPIN GASTROEN, V32, P159, DOI 10.1097/MOG.0000000000000261
   De Palma C, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00188
   Debashree B, 2018, J NEUROCHEM, V145, P323, DOI 10.1111/jnc.14318
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dhanapal Raghu, 2011, J ORAL MAXILLOFAC PATHOL, V15, P257, DOI 10.4103/0973-029X.86670
   Di Meo S, 2017, J ENDOCRINOL, V233, PR15, DOI 10.1530/JOE-16-0598
   Dirks A, 2002, AM J PHYSIOL-REG I, V282, PR519, DOI 10.1152/ajpregu.00458.2001
   Dirks AJ, 2005, SPORTS MED, V35, P473, DOI 10.2165/00007256-200535060-00002
   Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002
   Doehner W, 2015, ESC HEART FAIL, V2, P85, DOI 10.1002/ehf2.12035
   DrÃ¶ge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Dumas JF, 2009, DIABETES METAB, V35, P159, DOI 10.1016/j.diabet.2009.02.002
   DUNN JF, 1991, J NEUROL SCI, V103, P226, DOI 10.1016/0022-510X(91)90168-7
   Dupont-Versteegden EE, 2005, EXP GERONTOL, V40, P473, DOI 10.1016/j.exger.2005.04.003
   Ebner N, 2015, ESC HEART FAIL, V2, P58, DOI 10.1002/ehf2.12033
   Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81
   Fanzani A, 2012, J CACHEXIA SARCOPENI, V3, P163, DOI 10.1007/s13539-012-0074-6
   Favero G, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20030765
   Fealy CE, 2018, TRANSL RES, V202, P69, DOI 10.1016/j.trsl.2018.07.011
   Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030
   Frontera WR, 2012, PHYS MED REH CLIN N, V23, P201, DOI 10.1016/j.pmr.2011.11.012
   Gallegly JC, 2004, J APPL PHYSIOL, V97, P1082, DOI 10.1152/japplphysiol.00006.2004
   Gammage PA, 2018, METHODS MOL BIOL, V1867, P43, DOI 10.1007/978-1-4939-8799-3_4
   Gammage PA, 2016, METHODS MOL BIOL, V1351, P145, DOI 10.1007/978-1-4939-3040-1_11
   Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005
   Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906
   Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247
   Guido C, 2012, ONCOTARGET, V3, P798, DOI 10.18632/oncotarget.574
   Guillot M, 2014, J VASC SURG, V60, P1043, DOI 10.1016/j.jvs.2013.07.100
   Guo YT, 2013, AM J RESP CRIT CARE, V188, P1313, DOI 10.1164/rccm.201304-0732OC
   GUSELLA JF, 1993, ARCH NEUROL-CHICAGO, V50, P1157, DOI 10.1001/archneur.1993.00540110037003
   Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4
   Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137
   Hornikx M, 2012, RESP RES, V13, P0, DOI 10.1186/1465-9921-13-84
   Hou YJ, 2016, AM J PHYSIOL-RENAL, V310, PF547, DOI 10.1152/ajprenal.00574.2014
   Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838
   Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, PC834, DOI 10.1152/ajpcell.00579.2003
   Jangamreddy JR, 2012, HEPAT MON, V12, P0, DOI 10.5812/hepatmon.6159
   Kanabus M, 2014, BRIT J PHARMACOL, V171, P1798, DOI 10.1111/bph.12456
   Karam C, 2017, SKELET MUSCLE, V7, P0, DOI 10.1186/s13395-017-0123-0
   Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001
   Laporte C, 2007, CELL DEATH DIFFER, V14, P266, DOI 10.1038/sj.cdd.4401994
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083
   LEE CM, 1994, MECH AGEING DEV, V75, P69, DOI 10.1016/0047-6374(94)90029-9
   Lee IH, 2013, CURR OPIN CELL BIOL, V25, P724, DOI 10.1016/j.ceb.2013.07.002
   Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1
   Lehmann G, 2016, BIOCHEM BIOPH RES CO, V473, P80, DOI 10.1016/j.bbrc.2016.03.055
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Liu J, 2016, MOL PHARMACEUT, V13, P73, DOI 10.1021/acs.molpharmaceut.5b00516
   Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13
   Lodi R, 2000, ANN NEUROL, V48, P72
   Lokireddy S, 2012, AM J PHYSIOL-CELL PH, V303, PC512, DOI 10.1152/ajpcell.00402.2011
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186
   Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001
   Marzetti E, 2017, EXP GERONTOL, V87, P92, DOI 10.1016/j.exger.2016.10.003
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008
   McLean JB, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00503
   Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200
   Miljkovic N, 2015, ANN REHABIL MED-ARM, V39, P155, DOI 10.5535/arm.2015.39.2.155
   Mishra N, 2010, BIOCHEM BIOPH RES CO, V395, P17, DOI 10.1016/j.bbrc.2010.03.093
   Mofarrahi M, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0047265
   Muller FL, 2007, AM J PHYSIOL-REG I, V293, PR1159, DOI 10.1152/ajpregu.00767.2006
   Murton AJ, 2008, BBA-MOL BASIS DIS, V1782, P730, DOI 10.1016/j.bbadis.2008.10.011
   Naimi AI, 2011, CLIN PHYSIOL FUNCT I, V31, P124, DOI 10.1111/j.1475-097X.2010.00988.x
   Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799
   Nathan J, 2010, THORAX, V65, P97, DOI 10.1136/thx.2009.120824
   Neutzner Albert, 2007, NOVARTIS FOUND SYMP, V287, P4
   OLeary MF, 2013, AM J PHYSIOL-CELL PH, V304, PC422, DOI 10.1152/ajpcell.00240.2012
   OLeary MFN, 2012, AM J PHYSIOL-CELL PH, V303, PC447, DOI 10.1152/ajpcell.00451.2011
   OLeary MFN, 2009, AUTOPHAGY, V5, P230, DOI 10.4161/auto.5.2.7391
   Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54
   Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884
   Pejznochova M, 2010, MITOCHONDRION, V10, P321, DOI 10.1016/j.mito.2010.01.006
   Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415
   Perry BD, 2016, EXERC IMMUNOL REV, V22, P94
   Picard M, 2008, AM J RESP CRIT CARE, V178, P1040, DOI 10.1164/rccm.200807-1005OC
   Pistilli EE, 2006, J GERONTOL A-BIOL, V61, P245, DOI 10.1093/gerona/61.3.245
   Powers SK, 2012, AM J PHYSIOL-ENDOC M, V303, PE31, DOI 10.1152/ajpendo.00609.2011
   Puente-Maestu L, 2009, EUR RESPIR J, V33, P1045, DOI 10.1183/09031936.00112408
   Qi YB, 2016, J CELL BIOL, V215, P621, DOI 10.1083/jcb.201609019
   Rabinovich RA, 2007, EUR RESPIR J, V29, P643, DOI 10.1183/09031936.00086306
   Rahman M, 2014, ANTIOXID REDOX SIGN, V20, P443, DOI 10.1089/ars.2013.5410
   Reddy PH, 2014, DRUG DISCOV TODAY, V19, P951, DOI 10.1016/j.drudis.2014.03.020
   Reiter RJ, 2002, ANN NY ACAD SCI, V959, P238, DOI 10.1111/j.1749-6632.2002.tb02096.x
   Remels AH, 2008, EUR RESPIR J, V31, P502, DOI 10.1183/09031936.00068207
   Remels AHV, 2010, FASEB J, V24, P5052, DOI 10.1096/fj.09-150714
   ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6
   Romanello V, 2013, J MOL CELL CARDIOL, V55, P64, DOI 10.1016/j.yjmcc.2012.08.001
   Romanello V, 2010, CURR HYPERTENS REP, V12, P433, DOI 10.1007/s11906-010-0157-8
   Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60
   Roos MR, 1997, MUSCLE NERVE, V20, P679
   Rybalka E, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0115763
   Saft C, 2005, MOVEMENT DISORD, V20, P674, DOI 10.1002/mds.20373
   Sakellariou GK, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep33944
   Salazar-Roa M, 2017, TRENDS CELL BIOL, V27, P69, DOI 10.1016/j.tcb.2016.08.009
   Sandri M, 2001, J NEUROPATH EXP NEUR, V60, P302, DOI 10.1093/jnen/60.3.302
   Sandri M, 1997, J NEUROPATH EXP NEUR, V56, P45, DOI 10.1097/00005072-199701000-00005
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006
   Schrauwen P, 2006, J CLIN ENDOCR METAB, V91, P1520, DOI 10.1210/jc.2005-1572
   Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189
   Spendiff S, 2016, J PHYSIOL-LONDON, V594, P7361, DOI 10.1113/JP272487
   Sreekumar R, 2007, INDIAN J MED RES, V125, P399
   Stowe DF, 2006, AM J PHYSIOL-HEART C, V290, PH434, DOI 10.1152/ajpheart.00763.2005
   Taivassalo T, 2016, CHEST, V149, P1302, DOI 10.1016/j.chest.2015.11.021
   Takagi D, 2017, GERIATR GERONTOL INT, V17, P402, DOI 10.1111/ggi.12728
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509
   Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348
   Tews DS, 1996, NEUROMUSCULAR DISORD, V6, P265, DOI 10.1016/0960-8966(96)00018-1
   Thomas DA, 2007, J AM SOC NEPHROL, V18, P213, DOI 10.1681/ASN.2006080825
   Tryon LD, 2014, INTEGR MED RES, V3, P161, DOI 10.1016/j.imr.2014.09.001
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Vainshtein A, 2015, AM J PHYSIOL-CELL PH, V308, PC710, DOI 10.1152/ajpcell.00380.2014
   Vainshtein A, 2015, SKELET MUSCLE, V5, P0, DOI 10.1186/s13395-015-0033-y
   VanderVeen BN, 2017, OXID MED CELL LONGEV, V2017, P1, DOI 10.1155/2017/3292087
   Vinciguerra M, 2010, ADV EXP MED BIOL, V694, P211
   Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604
   von Haehling S, 2017, NAT REV CARDIOL, V14, P323, DOI 10.1038/nrcardio.2017.51
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang X, 2008, J NEUROSCI, V28, P9473, DOI 10.1523/JNEUROSCI.1867-08.2008
   Wang X, 2011, J NEUROSCI, V31, P14496, DOI 10.1523/JNEUROSCI.3059-11.2011
   Wasilewski M, 2009, TRENDS ENDOCRIN MET, V20, P287, DOI 10.1016/j.tem.2009.03.007
   Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548
   Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261
   White JP, 2012, SKELET MUSCLE, V2, P0, DOI 10.1186/2044-5040-2-14
   Wu J, 2015, MOL NEUROBIOL, V52, P783, DOI 10.1007/s12035-014-8918-z
   Xiao YJ, 2018, PHARMACOL RES, V138, P25, DOI 10.1016/j.phrs.2018.09.008
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zhang YL, 2013, ORG GEOCHEM, V55, P26, DOI 10.1016/j.orggeochem.2012.11.007
   Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004
   Zielonka D, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00380
   Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107
   ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857
NR 176
TC 57
Z9 64
U1 3
U2 32
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1389-2037
EI 1875-5550
J9 CURR PROTEIN PEPT SC
JI Curr. Protein Pept. Sci.
PD JUN 15
PY 2019
VL 20
IS 6
BP 536
EP 546
DI 10.2174/1389203720666190402100902
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA HY7RH
UT WOS:000468333200005
PM 30947668
DA 2024-11-01
ER

PT J
AU Pichaud, N
   BÃ©rubÃ©, R
   CÃ´tÃ©, G
   Belzile, C
   Dufresne, F
   Morrows, G
   Tanguays, RM
   Rands, DM
   Blier, PU
AF Pichaud, Nicolas
   Berube, Roxanne
   Cote, Genevieve
   Belzile, Claude
   Dufresne, France
   Morrows, Genevieve
   Tanguays, Robert M.
   Rands, David M.
   Blier, Pierre U.
TI Age Dependent Dysfunction of Mitochondrial and ROS Metabolism Induced by Mitonuclear Mismatch
SO FRONTIERS IN GENETICS
LA English
DT Article
DE aging; Drosophila; mitochondrial respiration; mitonuclear incompatibility; reactive oxygen species; replication; tRNA
ID permeabilized muscle-fibers; xenomitochondrial cybrids; drosophila-simulans; thermal sensitivity; dna replication; biogenesis; mitophagy; disease; fitness; populations
AB Mitochondrial and nuclear genomes have to coevolve to ensure the proper functioning of the different mitochondrial complexes that are assembled from peptides encoded by both genomes. Mismatch between these genomes is believed to be strongly selected against due to the consequent impairments of mitochondrial functions and induction of oxidative stress. Here, we used a Drosophila model harboring an incompatibility between a mitochondrial tRNA(t)(yr) and its nuclear-encoded mitochondrial tyrosine synthetase to assess the cellular mechanisms affected by this incompatibility and to test the relative contribution of mitonuclear interactions and aging on the expression of impaired phenotypes. Our results show that the mitochondrial tRNA mutation caused a decrease in mitochondrial oxygen consumption in the incompatible nuclear background but no effect with the compatible nuclear background. Mitochondrial DNA copy number increased in the incompatible genotype but that increase failed to rescue mitochondrial functions. The flies harboring mismatch between nuclear and mitochondrial genomes had almost three times the relative mtDNA copy number and fifty percent higher rate of hydrogen peroxide production compared to other genome combinations at 25 days of age. We also found that aging exacerbated the mitochondrial dysfunctions. Our results reveal the tight interactions linking mitonuclear mismatch to mitochondrial dysfunction, mitochondrial DNA regulation, ROS production and aging.
C1 [Pichaud, Nicolas] Univ Moncton, Lab Comparat Biochem & Physiol, Dept Chem & Biochem, Moncton, NB, Canada.
   [Berube, Roxanne; Cote, Genevieve; Blier, Pierre U.] Univ Quebec Rimouski, Lab Physiol Anim Integrat, Dept Biol, Rimouski, PQ, Canada.
   [Belzile, Claude] Univ Quebec Rimouski, Inst Sci Mer Rimouski, Rimouski, PQ, Canada.
   [Dufresne, France] Univ Quebec Rimouski, Lab Ecol Mol, Dept Biol, Rimouski, PQ, Canada.
   [Morrows, Genevieve; Tanguays, Robert M.] Univ Laval, Lab Genet Cellulaire & Dev, Dept Biol Mol Biochim Med & Pathol, Quebec City, PQ, Canada.
   [Rands, David M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.
C3 University of Moncton; University of Quebec; Universite du Quebec a Rimouski; University of Quebec; Universite du Quebec a Rimouski; University of Quebec; Universite du Quebec a Rimouski; Laval University; Brown University
RP Pichaud, N (corresponding author), Univ Moncton, Lab Comparat Biochem & Physiol, Dept Chem & Biochem, Moncton, NB, Canada.; Blier, PU (corresponding author), Univ Quebec Rimouski, Lab Physiol Anim Integrat, Dept Biol, Rimouski, PQ, Canada.
EM Nicolas.pichaud@umoncton.ca; Pierre_blier@uqar.ca
FU Natural Sciences and Engineering Research Council of Canada [RGPIN 2017-05-100, RGPIN 155926-2011]; Fonds de Recherche du Quebec - Nature et Technologies Quebec team Grant [166783]; CIHR grant
CR Andreyev AY, 2015, BIOCHEMISTRY-MOSCOW+, V80, P517, DOI 10.1134/S0006297915050028
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Ballard JWO, 2014, FUNCT ECOL, V28, P218, DOI 10.1111/1365-2435.12177
   Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210
   Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Buchanan JL, 2018, INTEGR COMP BIOL, V58, P591, DOI 10.1093/icb/icy078
   Burton RS, 2007, GENE, V403, P53, DOI 10.1016/j.gene.2007.07.026
   Camus MF, 2012, CURR BIOL, V22, P1717, DOI 10.1016/j.cub.2012.07.018
   Chandra A, 2016, HUM MOL GENET, V25, P2269, DOI 10.1093/hmg/ddw095
   Correa CC, 2012, MITOCHONDRION, V12, P459, DOI 10.1016/j.mito.2012.06.005
   CotÃ¡n D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Dobler R, 2014, J EVOLUTION BIOL, V27, P2021, DOI 10.1111/jeb.12468
   Ellison CK, 2008, EVOLUTION, V62, P631, DOI 10.1111/j.1558-5646.2007.00305.x
   Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002
   Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Holmbeck MA, 2015, DIS MODEL MECH, V8, P843, DOI 10.1242/dmm.019323
   Horan MP, 2013, EUR J HUM GENET, V21, P1335, DOI 10.1038/ejhg.2013.75
   Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263
   Innocenti P, 2011, SCIENCE, V332, P845, DOI 10.1126/science.1201157
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Lane N, 2011, BIOESSAYS, V33, P860, DOI 10.1002/bies.201100051
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010
   Lemieux H, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-02789-8
   LÃ³pez-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   McDonald AE, 2018, COMP BIOCHEM PHYS B, V224, P185, DOI 10.1016/j.cbpb.2017.11.006
   McKenzie M, 2003, MOL BIOL EVOL, V20, P1117, DOI 10.1093/molbev/msg132
   Meiklejohn CD, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003238
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Montooth KL, 2010, EVOLUTION, V64, P3364, DOI 10.1111/j.1558-5646.2010.01077.x
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Moreno-Loshuertos R, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1001379
   Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322
   MrÃ¡cek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014
   Orr AL, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0089938
   Osada N, 2012, MOL BIOL EVOL, V29, P337, DOI 10.1093/molbev/msr211
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Pichaud N, 2013, MITOCHONDRION, V13, P817, DOI 10.1016/j.mito.2013.05.008
   Pichaud N, 2012, EVOLUTION, V66, P3189, DOI 10.1111/j.1558-5646.2012.01683.x
   Pichaud N, 2011, AM J PHYSIOL-REG I, V301, PR48, DOI 10.1152/ajpregu.00542.2010
   Pichaud N, 2010, J EXP BIOL, V213, P1665, DOI 10.1242/jeb.040261
   Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004
   Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003
   Rand DM, 2001, ANNU REV ECOL SYST, V32, P415, DOI 10.1146/annurev.ecolsys.32.081501.114109
   Sackton TB, 2003, EVOLUTION, V57, P2315
   Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001
   Simard CJ, 2018, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/57376
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wolff JN, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0443
   Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011
   Zhang CY, 2017, DEVELOPMENT, V144, P2490, DOI 10.1242/dev.151951
   Zhu CT, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004354
NR 61
TC 37
Z9 39
U1 0
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD FEB 20
PY 2019
VL 10
IS 
BP 
EP 
DI 10.3389/fgene.2019.00130
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA HM0XR
UT WOS:000459171500001
PM 30842791
DA 2024-11-01
ER

PT J
AU Fragoso, CAV
   Manini, TM
   Kairalla, JA
   Buford, TW
   Hsu, FC
   Gill, TM
   Kritchevsky, SB
   McDermott, MM
   Sanders, JL
   Cummings, SR
   Tranah, GJ
AF Fragoso, Carlos A. Vaz
   Manini, Todd M.
   Kairalla, John A.
   Buford, Thomas W.
   Hsu, Fang-Chi
   Gill, Thomas M.
   Kritchevsky, Stephen B.
   McDermott, Mary M.
   Sanders, Jason L.
   Cummings, Steven R.
   Tranah, Gregory J.
TI Mitochondrial DNA variants and pulmonary function in older persons
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Mitochondrial DNA; Pulmonary function; Aging
ID genome-wide association; life-style interventions; lung-function; sequence variation; respiratory impairment; disease; performance; risk; age; independence
AB Background: We provide the first examination of mitochondrial DNA (mtDNA) variants and pulmonary function in older persons. Methods: Cross-sectional associations between mtDNA variants and pulmonary function were evaluated as a combined p-values meta-analysis, using data from two independent cohorts of older persons. The latter included white and black participants, aged >= 70 years, from the Lifestyle Interventions and Independence for Elders study (LIFE) (N = 1247) and the Health, Aging and Body Composition study (Health ABC) (N = 731), respectively. Pulmonary function included the forced expiratory volume in one-second as a Z-score (FEV1z) and the maximal inspiratory pressure (MIP) in cm of water. Results: In black participants, significant associations were found between mtDNA variants and MIP: m.7146A > G, COI (p = 3E-5); m.7389T > C, COI (p = 2E-4); m.15301G > A, CYB (p = 9E-5); m.16265A > G, HV1 (p = 9E-5); meta-analytical p-values < 0.0002. Importantly, these mtDNA variants were unique to black participants and were not present in white participants. Moreover, in black participants, aggregate genetic effects on MIP were observed across mutations in oxidative phosphorylation complex IV (p = 0.004), complex V (p = 0.0007), and hypervariable (p = 0.003) regions. The individual and aggregate variant results were significant after adjustment for multiple comparisons. Otherwise, no significant associations were detected for MIP in whites or for FEV1z in whites or blacks. Conclusions: We have shown that mtDNA variants of African origin are cross-sectionally associated with MIP, a measure of respiratory muscle strength. Thus, our results establish the rationale for longitudinal studies to evaluate whether mtDNA variants of African origin identify those at risk of subsequently developing a respiratory muscle impairment (lower MIP values).
C1 [Fragoso, Carlos A. Vaz; Gill, Thomas M.] Yale Sch Med, Dept Med, New Haven, CT USA.
   [Fragoso, Carlos A. Vaz] Vet Affairs Connecticut Healthcare Syst, Dept Med, West Haven, CT USA.
   [Manini, Todd M.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA.
   [Kairalla, John A.] Univ Florida, Dept Biostat, Gainesville, FL USA.
   [Buford, Thomas W.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.
   [Hsu, Fang-Chi] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA.
   [Kritchevsky, Stephen B.] Wake Forest Sch Med, Sticht Ctr Hlth Aging & Absheimers Prevent, Winston Salem, NC USA.
   [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Sanders, Jason L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.
   [Cummings, Steven R.; Tranah, Gregory J.] Calif Pacific Med Ctr Res Inst, San Francisco, CA USA.
C3 Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham; Wake Forest University; Wake Forest University; Northwestern University; Feinberg School of Medicine; Harvard University; Massachusetts General Hospital; California Pacific Medical Center; California Pacific Medical Center Research Institute
RP Fragoso, CAV (corresponding author), 950 Campbell Ave, West Haven, CT 06516 USA.
EM carlos.fragoso@yale.edu
FU National Institutes of Health (NIH), National Institute on Aging [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; National Institutes of Health [R01-AG028050, R03-AG032498, R01-NR012459, Z01A6000932, R01-HL121023]; Research and Education Leadership Committee of the CPMC Foundation; L. K. Whittier Foundation; Academic Leadership Award from the National Institute on Aging [K07AG043587]; Yale Claude D. Pepper Older Americans Independence Center [P30AG21342]
CR Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Donati A, 2001, J GERONTOL A-BIOL, V56, PB288, DOI 10.1093/gerona/56.7.B288
   ENRIGHT PL, 1994, CHEST, V106, P827, DOI 10.1378/chest.106.3.827
   Evangelou E, 2014, ANN RHEUM DIS, V73, P2130, DOI 10.1136/annrheumdis-2012-203114
   Fielding RA, 2011, J GERONTOL A-BIOL, V66, P1226, DOI 10.1093/gerona/glr123
   Fragoso CAV, 2012, AM J MED, V125, P79, DOI 10.1016/j.amjmed.2011.06.024
   Giorgi EE, 2016, CANCER EPIDEM BIOMAR, V25, P1001, DOI 10.1158/1055-9965.EPI-16-0111
   GÃ¶gele M, 2012, AM J EPIDEMIOL, V175, P739, DOI 10.1093/aje/kwr385
   GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074
   Ioannidis JPA, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000841
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Katzman SM, 2015, J GERONTOL A-BIOL, V70, P1400, DOI 10.1093/gerona/glu175
   Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290
   Lam ET, 2012, CANCER RES, V72, P686, DOI 10.1158/0008-5472.CAN-11-1682
   LANGSTON JW, 1983, NEW ENGL J MED, V309, P310
   Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200
   MCCLEARN GE, 1994, J GERONTOL, V49, PM264, DOI 10.1093/geronj/49.6.M264
   Miura S, 2013, AM J PHYSIOL-ENDOC M, V305, PE213, DOI 10.1152/ajpendo.00114.2013
   Nam HS, 2017, BIOMARK MED, V11, P475, DOI 10.2217/bmm-2016-0373
   Nguyen TT, 2009, ANN HUM GENET, V73, P638, DOI 10.1111/j.1469-1809.2009.00544.x
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Ong BA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0072899
   Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205
   Picard M, 2015, J APPL PHYSIOL, V118, P1161, DOI 10.1152/japplphysiol.00873.2014
   Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109
   Prakash YS, 2017, CHEST, V152, P618, DOI 10.1016/j.chest.2017.03.020
   Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312
   RAMSAY RR, 1986, J BIOL CHEM, V261, P7585
   Rejeski WJ, 2005, CONTEMP CLIN TRIALS, V26, P141, DOI 10.1016/j.cct.2004.12.005
   Sachs MC, 2009, RESP CARE, V54, P1321
   Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240
   Suissa S, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000474
   Tang WB, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0100776
   Tranah GJ, 2015, NEUROLOGY, V85, P325, DOI 10.1212/WNL.0000000000001744
   Tranah GJ, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2013.05.023
   Tranah GJ, 2012, BBA-BIOENERGETICS, V1817, P1691, DOI 10.1016/j.bbabio.2012.05.012
   Tranah GJ, 2011, MITOCHONDRION, V11, P855, DOI 10.1016/j.mito.2011.04.005
   Tseng CC, 2018, ARTHRITIS RES THER, V20, P0, DOI 10.1186/s13075-018-1637-5
   van der Palen J, 2004, THORAX, V59, P1063, DOI 10.1136/thx.2004.021915
   Vaz Fragoso CA, 2012, J GERONTOL A-BIOL, V67, P264, DOI 10.1093/gerona/glr198
   Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x
   Wain LV, 2017, NAT GENET, V49, P416, DOI 10.1038/ng.3787
   Wallace DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/pnas.94.26.14900
   Wallace DC, 2010, P NATL ACAD SCI USA, V107, P8947, DOI 10.1073/pnas.0914635107
   Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340
   Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029
   Yao TC, 2014, J ALLERGY CLIN IMMUN, V133, P248, DOI 10.1016/j.jaci.2013.06.018
   Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191
NR 56
TC 4
Z9 4
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN 15
PY 2019
VL 115
IS 
BP 96
EP 103
DI 10.1016/j.exger.2018.11.023
PG 8
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA HG8BZ
UT WOS:000455223100011
PM 30508565
DA 2024-11-01
ER

PT J
AU Yao, YF
   Li, H
   Da, XW
   He, ZH
   Tang, B
   Li, Y
   Hu, CQ
   Xu, CQ
   Chen, QY
   Wang, QK
AF Yao, Yufeng
   Li, Hui
   Da, Xinwen
   He, Zuhan
   Tang, Bo
   Li, Yong
   Hu, Changqing
   Xu, Chengqi
   Chen, Qiuyun
   Wang, Qing K.
TI SUMOylation of Vps34 by SUMO1 promotes phenotypic switching of vascular smooth muscle cells by activating autophagy in pulmonary arterial hypertension
SO PULMONARY PHARMACOLOGY & THERAPEUTICS
LA English
DT Article
DE Vps34; Berlin-1; Atg14
ID dna-damage; mitochondrial morphology; induced proliferation; cellular senescence; hypoxia; ubiquitin; expression; inhibition; fission; pathogenesis
AB Introduction: Pulmonary arterial hypertension (PAH) is a life-threatening disease without effective therapies. PAH is associated with a progressive increase in pulmonary vascular resistance and irreversible pulmonary vascular remodeling. SUMO1 (small ubiquitin-related modifier 1) can bind to target proteins and lead to protein SUMOylation, an important post-translational modification with a key role in many diseases. However, the contribution of SUMO1 to PAH remains to be fully characterized. Methods: In this study, we explored the role of SUMO1 in the dedifferentiation of vascular smooth muscle cells (VSMCs) involved in hypoxia-induced pulmonary vascular remodeling and PAH in vivo and in vitro. Results: In a mouse model of hypoxic PAH, SUMO1 expression was significantly increased, which was associated with activation of autophagy (increased LC3b and decreased p62), dedifferentiation of pulmonary arterial VSMCs (reduced alpha-SMA, SM22 and SM-MHC), and pulmonary vascular remodeling. Similar results were obtained in a MCT-induced PAH model. Overexpression of SUMO1 significantly increased VSMCs proliferation, migration, hypoxia-induced VSMCs dedifferentiation, and autophagy, but these effects were abolished by inhibition of autophagy by 3-MA in aortic VSMCs. Furthermore, SUMO1 knockdown reversed hypoxia-induced proliferation and migration of PASMCs. Mechanistically, SUMO1 promotes Vps34 SUMOylation and the assembly of the Beclin-l-Vps34-Atg14 complex, thereby inducing autophagy, whereas Vps34 mutation K840R reduces Vps34 SUMOylation and inhibits VSMCs dedifferentiation. Discussion: Our data uncovers an important role of SUMO1 in VSMCs proliferation, migration, autophagy, and phenotypic switching (dedifferentiation) involved in pulmonary vascular remodeling and PAH. Targeting of the SUMO1-Vps34-autophagy signaling axis may be exploited to develop therapeutic strategies to treat PAH.
C1 [Yao, Yufeng; Li, Hui; Da, Xinwen; He, Zuhan; Tang, Bo; Li, Yong; Hu, Changqing; Xu, Chengqi; Wang, Qing K.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan, Hubei, Peoples R China.
   [Yao, Yufeng; Li, Hui; Da, Xinwen; He, Zuhan; Tang, Bo; Li, Yong; Hu, Changqing; Xu, Chengqi; Wang, Qing K.] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan, Hubei, Peoples R China.
   [Chen, Qiuyun; Wang, Qing K.] Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44195 USA.
   [Chen, Qiuyun; Wang, Qing K.] Case Western Reserve Univ, Dept Mol Med, CCLCM, Cleveland, OH 44195 USA.
   [Wang, Qing K.] Case Western Reserve Univ, Dept Genet & Genome Sci, Sch Med, Cleveland, OH 44106 USA.
C3 Huazhong University of Science & Technology; Huazhong University of Science & Technology; Cleveland Clinic Foundation; University System of Ohio; Case Western Reserve University; University System of Ohio; Case Western Reserve University
RP Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan, Hubei, Peoples R China.; Chen, QY (corresponding author), Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44195 USA.
EM cheng3@ccf.org; qkwang@hust.edu.cn
FU National Natural Science Foundation of China [81630002, 31430047, 91439129]; Hubei Province Natural Science Program Innovative Team grant [2017CFA014]; China Postdoctoral Science Foundation [2017M622409]; Certificate of China Postdoctoral Science Foundation fund [2018T110754]
CR Araya J, 2013, AM J PHYSIOL-LUNG C, V304, PL56, DOI 10.1152/ajplung.00213.2012
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Atkins K, 2016, CLIN SCI, V130, P1861, DOI 10.1042/CS20160030
   Boucherat O, 2018, AM J RESP CRIT CARE, V198, P90, DOI 10.1164/rccm.201708-1751OC
   Brun S, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0178925
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chang YJ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep22147
   Chen KH, 2018, CIRCULATION, V138, P287, DOI 10.1161/CIRCULATIONAHA.117.031258
   Da Silva-Ferrada E, 2016, INT J BIOCHEM CELL B, V79, P443, DOI 10.1016/j.biocel.2016.09.015
   Erzurum S, 2010, AM J RESP CRIT CARE, V182, P1554, DOI 10.1164/rccm.201006-0869WS
   Federici C, 2015, AM J RESP CRIT CARE, V192, P219, DOI 10.1164/rccm.201411-2128OC
   Fish JE, 2007, J BIOL CHEM, V282, P15652, DOI 10.1074/jbc.M608318200
   Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604
   Grillari J, 2010, ADV EXP MED BIOL, V694, P172
   Guignabert C, 2017, SEMIN RESP CRIT CARE, V38, P571, DOI 10.1055/s-0037-1606214
   Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004
   Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478
   Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200
   HISLOP A, 1976, BRIT J EXP PATHOL, V57, P542
   Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0
   Hou X, 2017, BIOCHEM BIOPH RES CO, V494, P446, DOI 10.1016/j.bbrc.2017.10.103
   Hu JL, 2018, MOL MED REP, V17, P1690, DOI 10.3892/mmr.2017.8037
   Huang YF, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005393
   Ivanschitz L, 2015, P NATL ACAD SCI USA, V112, P14278, DOI 10.1073/pnas.1507540112
   Iwata K, 2014, ARTERIOSCL THROM VAS, V34, P110, DOI 10.1161/ATVBAHA.113.302107
   Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017
   Jiang YL, 2015, INT J MOL MED, V36, P271, DOI 10.3892/ijmm.2015.2209
   Jones SA, 2013, IMMUNOL CELL BIOL, V91, P250, DOI 10.1038/icb.2012.82
   KAY JM, 1967, THORAX, V22, P176, DOI 10.1136/thx.22.2.176
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Kuwano K, 2016, RESPIR INVESTIG, V54, P397, DOI 10.1016/j.resinv.2016.03.010
   Lee SJ, 2011, AM J RESP CRIT CARE, V183, P649, DOI 10.1164/rccm.201005-0746OC
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Li LZ, 2017, EUR J PHARMACOL, V813, P84, DOI 10.1016/j.ejphar.2017.07.038
   Li XW, 2012, EUR J PHARMACOL, V679, P117, DOI 10.1016/j.ejphar.2012.01.015
   Liu XM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0063680
   Long L, 2013, CIRC RES, V112, P1159, DOI 10.1161/CIRCRESAHA.111.300483
   Lu QL, 2016, PLOS BIOL, V14, P0, DOI 10.1371/journal.pbio.1002529
   Lu QL, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0046998
   Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207
   MORRELL NW, 1995, AM J PHYSIOL-HEART C, V269, PH1186, DOI 10.1152/ajpheart.1995.269.4.H1186
   OWENS GK, 1995, PHYSIOL REV, V75, P487
   Patel AS, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0041394
   Paulin R, 2014, CELL METAB, V20, P827, DOI 10.1016/j.cmet.2014.08.011
   Provencher S, 2018, CIRC RES, V122, P1021, DOI 10.1161/CIRCRESAHA.117.312579
   Ranchoux B, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17060990
   Ryter SW, 2013, MOL CELLS, V36, P7, DOI 10.1007/s10059-013-0140-8
   Ryter Stefan W, 2010, EXPERT REV RESPIR MED, V4, P573, DOI 10.1586/ers.10.61
   Ryter SW, 2009, AUTOPHAGY, V5, P235, DOI 10.4161/auto.5.2.7495
   Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X
   Santel A, 2001, J CELL SCI, V114, P867
   Sarangi P, 2014, NUCLEIC ACIDS RES, V42, P6393, DOI 10.1093/nar/gku300
   Schultz K, 2006, AM J PHYSIOL-HEART C, V290, PH2528, DOI 10.1152/ajpheart.01077.2005
   Seeler JS, 2017, NAT REV CANCER, V17, P184, DOI 10.1038/nrc.2016.143
   Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079
   Shao RJ, 2004, ENDOCRINOLOGY, V145, P384, DOI 10.1210/en.2003-0527
   Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f
   Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0
   Tang Jin-long, 2012, CHINESE JOURNAL OF PATHOLOGY, V41, P573, DOI 10.3760/cma.j.issn.0529-5807.2012.08.018
   Teng BY, 2016, PHYSIOL REP, V4, P0, DOI 10.14814/phy2.12818
   Wang ZF, 2017, MUTAT RES-FUND MOL M, V803, P56, DOI 10.1016/j.mrfmmm.2017.07.001
   Wauchope OR, 2018, NUCLEIC ACIDS RES, V46, P3458, DOI 10.1093/nar/gky089
   Yang YF, 2017, OPEN BIOL, V7, P0, DOI 10.1098/rsob.170167
   Yang YH, 2013, P NATL ACAD SCI USA, V110, P6841, DOI 10.1073/pnas.1217692110
   Yao YF, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00171-w
   Yao YF, 2017, J AM HEART ASSOC, V6, P0, DOI 10.1161/JAHA.117.005889
   Ye J, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep34034
   Yi B, 2012, GENE, V492, P354, DOI 10.1016/j.gene.2011.11.010
   Zhu B, 2017, BIOPHYS RES COMMUN, V0, P2125
   Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418
NR 70
TC 28
Z9 30
U1 1
U2 22
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1094-5539
EI 
J9 PULM PHARMACOL THER
JI Pulm. Pharmacol. Ther.
PD APR 15
PY 2019
VL 55
IS 
BP 38
EP 49
DI 10.1016/j.pupt.2019.01.007
PG 12
WC Pharmacology & Pharmacy; Respiratory System
SC Pharmacology & Pharmacy; Respiratory System
GA HQ4ZE
UT WOS:000462419000006
PM 30703554
DA 2024-11-01
ER

PT J
AU Fu, XL
   Zhou, XX
   Shi, Z
   Zheng, WC
AF Fu, Xiao-Li
   Zhou, Xiang-Xue
   Shi, Zhu
   Zheng, Wei-Cheng
TI Adult-onset mitochondrial encephalopathy in association with the <i>MT-ND3</i> T10158C mutation exhibits unique characteristics: A case report
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Article
DE Mitochondrial disease; Stroke-like episode; Magnetic resonance; diagnosis; Case report
AB BACKGROUND Mitochondrial diseases are a heterogenous group of multisystemic disorders caused by genetic mutations affecting mitochondrial oxidation function. Brain involvement is commonly found in most cases but rarely as the unique clinical manifestation. Since the knowledge of its clinical manifestation combined with genetic testing is important for preventing misdiagnosis and delay in treatment, we report here how we diagnosed and managed a very unusual case of mitochondrial encephalopathy. CASE SUMMARY We report a 52-year-old woman with recurrent stroke-like episodes carrying the m.10158T>C mutation in the MT-ND3 gene, which is also responsible for fatal infant-onset Leigh syndrome. Despite the common mutation, the present case featured a distinct clinical and neuroimaging manifestation from Leigh syndrome. This patient presented with sudden onset of right-sided hemiparesis and hemilateral sensory disturbance accompanied by a left temporal duster-like headache and later developed epilepsy during hospitalization, with no other sips suggestive of myopa thy, lactate acidosis, or other systemic symptoms. Brain magnetic resonance imaging revealed variable lesions involving multiple cortical and subcortical regions. Furthermore, a negative genetic test obtained from peripheral blood delayed the diagnosis of mitochondrial disease, which was eventually established through second-generation DNA sequencing using biopsied muscle. CONCLUSION Based on this report, we suggest that clinicians pursue proper genetic testing for patients when the clinical phenotype is suggestive of mitochondrial diseases.
C1 [Fu, Xiao-Li; Shi, Zhu; Zheng, Wei-Cheng] Dongguan Peoples Hosp, Dept Neurol, 2 Wandaolu South Ave, Dongguan 523059, Guangdong, Peoples R China.
   [Zhou, Xiang-Xue] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China.
C3 Sun Yat Sen University
RP Shi, Z (corresponding author), Dongguan Peoples Hosp, Dept Neurol, 2 Wandaolu South Ave, Dongguan 523059, Guangdong, Peoples R China.
EM sound_shi@126.com
FU Socioeconomic Development Project of Dongguan Science and Technology Bureau [2016108101002]
CR Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   El-Mewafy ZMH, 2018, POL J RADIOL, V83, PE215, DOI 10.5114/pjr.2018.76024
   Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200
   Grier J, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000230
   Mezuki S, 2017, BMC NEUROL, V17, P0, DOI 10.1186/s12883-017-1001-4
   Mukai M, 2017, INTERNAL MED, V56, P95, DOI 10.2169/internalmedicine.56.7301
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 8
TC 5
Z9 5
U1 0
U2 5
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 2307-8960
EI 
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD MAY 6
PY 2019
VL 7
IS 9
BP 1066
EP 1072
DI 10.12998/wjcc.v7.i9.1066
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA HW9FA
UT WOS:000466994900008
PM 31123680
DA 2024-11-01
ER

PT J
AU Mani, S
   Rao, SN
   Kumar, MVK
AF Mani, Shalini
   Rao, S. Narasimha
   Kumar, M. V. Kranthi
TI Genetic heterogeneity of mitochondrial genome in thiamine deficient Leigh syndrome patients
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Leigh syndrome; Thiamine deficiency; Mitochondrial genome; Complex I; Complex IV
ID hereditary optic neuropathy; cytochrome-c-oxidase; sequence-analysis; complex-i; phylogenetic analysis; parkinsons-disease; multiple-sclerosis; chinese family; skeletal-muscle; mtdna mutations
AB In our previously published study, we cared for 165 thiamine deficient Leigh syndrome (LS) patients who presented in acute life threatening conditions with severe neurological abnormalities. However the molecular basis for this atypical phenotype was not explored. This study is an effort to undermine the possible molecular defects in mitochondria of those patients and put-forth an explanation towards this clinical presentation. Protein coding genes of mitochondrial (mt) DNA were sequenced in total 165 LS patients and 94 age matched controls. To understand their pathogenic significance, nucleotide variations were also studied using various insilico tools. Histochemical and electron microscopic analysis was also done in tissue samples obtained from 23 patients. We observed a very high level of genetic heterogeneity across the mt DNA of all these patients. In the concordance of published literature we also observed a large number of variations in ND5 gene (hot spot for LS). We also observed a total 13 nucleotide variations across COX genes, which is otherwise not common in LS. As per insilico analysis, many of these variations were suggested to be pathogenic. Histochemical and electron microscopic studies also suggested the defects in the mitochondria of these patients. As these patients were thiamine deficient, hence we propose that genetic defects and thiamine deficiency may together severely affect the ATP level of these patients, leading to acute and life threatening clinical presentation. Present study has opened up many avenues for further research towards understanding the genetic basis and possible role of thiamine deficiency in LS patients.
C1 [Mani, Shalini] Jaypee Inst Informat Technol, Ctr Emerging Dis, Dept Biotechnol, Noida 201301, India.
   [Mani, Shalini; Kumar, M. V. Kranthi] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.
   [Rao, S. Narasimha] Niloufer Hosp Women & Children, Govt Inst Child Hlth, Red Hills, Hyderabad, India.
C3 Jaypee Institute of Information Technology (JIIT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)
RP Mani, S (corresponding author), Jaypee Inst Informat Technol, Ctr Emerging Dis, Dept Biotechnol, Noida 201301, India.
EM shalini.mani@jiit.ac.in
FU CSIR, Govt of India; CCMB Hyderabad
CR Andalib S, 2017, REV NEUROL-FRANCE, V173, P164, DOI 10.1016/j.neurol.2017.02.002
   Andalib S, 2017, EXPERT REV MOL MED, V19, P0, DOI 10.1017/erm.2017.5
   Andalib S, 2016, ACTA NEUROL BELG, V116, P439, DOI 10.1007/s13760-016-0675-5
   Andalib S, 2015, J NEUROL SCI, V356, P55, DOI 10.1016/j.jns.2015.04.050
   Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y
   Bi R, 2012, MOL VIS, V18, P3087
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   BUTTERWORTH RF, 1989, ALCOHOL ALCOHOLISM, V24, P271, DOI 10.1093/oxfordjournals.alcalc.a044913
   Chi CS, 2015, PEDIATR NEONATOL, V56, P7, DOI 10.1016/j.pedneo.2014.03.009
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   Di Rocco M, 2000, EUR J PAEDIATR NEUROL, V4, P115, DOI 10.1053/ejpn.2000.0278
   Dombi E, 2016, NEUROLOGY, V86, P1921, DOI 10.1212/WNL.0000000000002688
   Emperador S, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00061
   Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1
   Finnila Saara, 2001, MUTATION RESEARCH, V458, P31, DOI 10.1016/S1383-5726(01)00012-7
   GENGE A, 1995, NEUROMUSCULAR DISORD, V5, P139, DOI 10.1016/0960-8966(94)00039-C
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   HAYAKAWA M, 1993, MOL CELL BIOCHEM, V119, P95, DOI 10.1007/BF00926859
   Horvath J, 2002, J INHERIT METAB DIS, V25, P323, DOI 10.1023/A:1016518811940
   HorvÃ¡th R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529
   Imanishi H, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0023401
   Janssen GMC, 2006, EXP CLIN ENDOCR DIAB, V114, P168, DOI 10.1055/s-2006-924066
   JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   KYRIAKIDES T, 1993, MUSCLE NERVE, V16, P418, DOI 10.1002/mus.880160413
   Lehmann D, 2018, J INBORN ERRORS META, V6, P1
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6
   Lissens W, 1996, HUM MUTAT, V7, P46, DOI 10.1002/(SICI)1098-1004(1996)7:1<46::AID-HUMU6>3.3.CO;2-2
   LÃ³pez LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Mannan AASR, 2004, INDIAN JOURNAL OF PEDIATRICS, V71, P1029, DOI 10.1007/BF02828121
   MANZ HJ, 1980, VIRCHOWS ARCH A, V386, P1, DOI 10.1007/BF00432641
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   Naito E, 1997, J INHERIT METAB DIS, V20, P539, DOI 10.1023/A:1005305614374
   Nardone R, 2013, SCI WORLD J, V0, P0, DOI DOI 10.1155/2013/309143
   Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566
   Otaegui D, 2004, NEUROSCI LETT, V370, P171, DOI 10.1016/j.neulet.2004.08.012
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V177, P518, DOI 10.1016/0006-291X(91)92014-B
   Pandit L, 2007, ANN INDIAN ACAD NEUROL., V10, P55, DOI 10.4103/0972-2327.31488
   Pant I, 2015, ANN INDIAN ACAD NEUR, V18, P398, DOI 10.4103/0972-2327.165455
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Povalko N, 2005, MITOCHONDRION, V5, P194, DOI 10.1016/j.mito.2005.03.003
   Pradhan S, 1997, NEUROL INDIA, V45, P177
   Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D
   Qian YP, 2005, BIOCHEM BIOPH RES CO, V332, P614, DOI 10.1016/j.bbrc.2005.05.003
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rai PK, 2015, BRIT MED BULL, V116, P5, DOI 10.1093/bmb/ldv046
   Rao SN, 2008, J TROP PEDIATRICS, V54, P328, DOI 10.1093/tropej/fmn031
   REID FM, 1994, HUM MOL GENET, V3, P1435
   Rinninella E, 2018, EUR REV MED PHARMACO, V22, P4288, DOI 10.26355/eurrev_201807_15425
   RodrÃ­guez-Ballesteros M, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2006.042440
   Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHWARTZKOPFF B, 1991, VIRCHOWS ARCH A, V419, P63, DOI 10.1007/BF01600154
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Simon DK, 2003, NEUROGENETICS, V4, P199, DOI 10.1007/s10048-003-0150-3
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   TIRANTI V, 1995, HUM MOL GENET, V4, P2017, DOI 10.1093/hmg/4.11.2017
   Vincent AE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30610
   Wallace DC, 1992, AMERICAN JOURNAL OF HUMAN GENETICS, V51, P0
   Zhang J, 2015, EUR J HUM GENET, V23, P86, DOI 10.1038/ejhg.2014.52
   Zhao FX, 2009, BIOCHEM BIOPH RES CO, V389, P466, DOI 10.1016/j.bbrc.2009.08.168
   Zhou XT, 2012, INVEST OPHTH VIS SCI, V53, P4586, DOI 10.1167/iovs.11-9109
   Zhou XT, 2010, MOL GENET METAB, V100, P379, DOI 10.1016/j.ymgme.2010.04.013
NR 70
TC 8
Z9 8
U1 0
U2 20
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD SEP 15
PY 2019
VL 404
IS 
BP 91
EP 100
DI 10.1016/j.jns.2019.07.007
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA IU5PM
UT WOS:000483639800020
PM 31352295
DA 2024-11-01
ER

PT J
AU Sujkowski, A
   Spierer, AN
   Rajagopalan, T
   Bazzell, B
   Safdar, M
   Imsirovic, D
   Arking, R
   Rand, DM
   Wessells, R
AF Sujkowski, Alyson
   Spierer, Adam N.
   Rajagopalan, Thiviya
   Bazzell, Brian
   Safdar, Maryam
   Imsirovic, Dinko
   Arking, Robert
   Rand, David M.
   Wessells, Robert
TI Mito-nuclear interactions modify <i>Drosophila</i> exercise performance
SO MITOCHONDRION
LA English
DT Article
DE Drosophila; Exercise; Mitochondrial; Nuclear; Interaction
ID extended longevity phenotypes; skeletal-muscle; endurance exercise; gene-expression; heart function; mitochondrial; dysfunction; epistasis; diet; incompatibility
AB Endurance exercise has received increasing attention as a broadly preventative measure against age-related disease and dysfunction. Improvement of mitochondrial quality by enhancement of mitochondrial turnover is thought to be among the important molecular mechanisms underpinning the benefits of exercise. Interactions between the mitochondrial and nuclear genomes are important components of the genetic basis for variation in longevity, fitness and the incidence of disease. Here, we examine the effects of replacing the mitochondrial genome (mtDNA) of several Drosophila strains with mtDNA from other strains, or from closely related species, on exercise performance. We find that mitochondria from flies selected for longevity increase the performance of flies from a parental strain. We also find evidence that mitochondria from other strains or species alter exercise performance, with examples of both beneficial and deleterious effects. These findings suggest that both the mitochondrial and nuclear genomes, as well as interactions between the two, contribute significantly to exercise capacity.
C1 [Sujkowski, Alyson; Rajagopalan, Thiviya; Bazzell, Brian; Safdar, Maryam; Imsirovic, Dinko; Wessells, Robert] Wayne State Univ, Dept Physiol, Detroit, MI 48202 USA.
   [Spierer, Adam N.; Rand, David M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.
   [Arking, Robert] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.
C3 Wayne State University; Brown University; Wayne State University
RP Wessells, R (corresponding author), Wayne State Univ, Dept Physiol, Detroit, MI 48202 USA.
EM rwessell@med.wayne.edu
FU NIH/NIA; NIH/NIGMS [1RO1AG059683-02, 5R21AG055712-02, 2R01GM067862, 1R01AG027849]; MDRC Pilot Award
CR Arking R, 1996, EXP GERONTOL, V31, P623, DOI 10.1016/S0531-5565(96)00096-4
   Arking R, 2002, AGEING RES REV, V1, P209, DOI 10.1016/S1568-1637(01)00010-1
   Arking R, 2001, ANN NY ACAD SCI, V928, P157
   ARKING R, 1987, EXP GERONTOL, V22, P199, DOI 10.1016/0531-5565(87)90040-4
   Bo H, 2010, ANN NY ACAD SCI, V1201, P121, DOI 10.1111/j.1749-6632.2010.05618.x
   Booth FW, 2015, PROG MOL BIOL TRANSL, V135, P129, DOI 10.1016/bs.pmbts.2015.07.016
   BostrÃ¶m PA, 2013, IUBMB LIFE, V65, P845, DOI 10.1002/iub.1209
   Bouchard C, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0037887
   Britton S L, 2001, EXERC SPORT SCI REV, V29, P7
   Cassilhas RC, 2016, CELL MOL LIFE SCI, V73, P975, DOI 10.1007/s00018-015-2102-0
   Chan SL, 2010, AGEING RES REV, V9, P20, DOI 10.1016/j.arr.2009.09.006
   Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001
   Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140
   Damschroder D, 2018, BIO-PROTOCOL, V8, P0, DOI 10.21769/BioProtoc.3037
   Diop SB, 2015, CELL REP, V10, P1572, DOI 10.1016/j.celrep.2015.02.022
   Ferreira JCB, 2010, EXP BIOL MED, V235, P497, DOI 10.1258/ebm.2009.009165
   Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005
   Hoekstra LA, 2013, GENETICS, V195, P1129, DOI 10.1534/genetics.113.154914
   Irrcher I, 2003, SPORTS MED, V33, P783, DOI 10.2165/00007256-200333110-00001
   Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004
   Koch LG, 2012, TRENDS CARDIOVAS MED, V22, P29, DOI 10.1016/j.tcm.2012.06.007
   Laker RC, 2014, J BIOL CHEM, V289, P12005, DOI 10.1074/jbc.M113.530527
   Laker RC, 2014, DIABETES, V63, P1605, DOI 10.2337/db13-1614
   Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449
   Laranjeiro R, 2017, BMC BIOL, V15, P0, DOI 10.1186/s12915-017-0368-4
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Li L, 2011, BASIC RES CARDIOL, V106, P1221, DOI 10.1007/s00395-011-0213-9
   Liang QR, 2016, J MOL CELL CARDIOL, V95, P57, DOI 10.1016/j.yjmcc.2015.12.025
   Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486
   Matsakas A, 2010, J MUSCLE RES CELL M, V31, P111, DOI 10.1007/s10974-010-9214-9
   Mendez S, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0164706
   Montooth KL, 2010, EVOLUTION, V64, P3364, DOI 10.1111/j.1558-5646.2010.01077.x
   MorÃ¡n M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009
   Mossman JA, 2017, MOL BIOL EVOL, V34, P447, DOI 10.1093/molbev/msw246
   Mossman JA, 2016, GENETICS, V203, P463, DOI 10.1534/genetics.116.187286
   Ort T, 2007, PHYSIOL GENOMICS, V29, P302, DOI 10.1152/physiolgenomics.00257.2006
   Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021
   Piazza N, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005886
   Piazza N, 2009, BIOGERONTOLOGY, V10, P637, DOI 10.1007/s10522-008-9210-2
   Powers SK, 2014, FREE RADICAL RES, V48, P43, DOI 10.3109/10715762.2013.825371
   Puthucheary Z, 2011, SPORTS MED, V41, P845, DOI 10.2165/11593200-000000000-00000
   Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003
   Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013
   Restif C, 2014, PLOS COMPUT BIOL, V10, P0, DOI 10.1371/journal.pcbi.1003702
   RStudio Team, 2016, RSTUDIO TEAM, V0, P0
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Soh JW, 2007, MECH AGEING DEV, V128, P581, DOI 10.1016/j.mad.2007.08.004
   Sujkowski A, 2015, AGING-US, V7, P535, DOI 10.18632/aging.100789
   Sujkowski A, 2012, AGING CELL, V11, P921, DOI 10.1111/j.1474-9726.2012.00864.x
   Teran-Garcia M, 2005, AM J PHYSIOL-ENDOC M, V288, PE1168, DOI 10.1152/ajpendo.00467.2004
   Thomas RJ, 2017, BRIT J SPORT MED, V51, P0, DOI 10.1136/bjsports-2016-096343
   Tinkerhess Martin J, 2012, J VIS EXP, V0, P0, DOI DOI 10.3791/3786
   Tinkerhess MJ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031633
   Tranah GJ, 2011, AGEING RES REV, V10, P238, DOI 10.1016/j.arr.2010.06.003
   Venditti P, 2013, MITOCHONDRION, V13, P71, DOI 10.1016/j.mito.2013.01.008
   Vigelso Andreas, 2014, INT J PHYSIOL PATHOPHYSIOL PHARMACOL, V6, P84
   Wessel RJ, 2004, BIOTECHNIQUES, V37, P58, DOI 10.2144/04371ST01
   Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476
   Xiong XQ, 2015, BBA-MOL BASIS DIS, V1852, P1867, DOI 10.1016/j.bbadis.2015.06.017
   Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599
   Zanuso S, 2017, BRIT J SPORT MED, V51, P1533, DOI 10.1136/bjsports-2016-096724
   Zhang CY, 2017, DEVELOPMENT, V144, P2490, DOI 10.1242/dev.151951
   Zhu CT, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004354
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
NR 64
TC 12
Z9 14
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2019
VL 47
IS 
BP 188
EP 205
DI 10.1016/j.mito.2018.11.005
PG 18
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA II9VD
UT WOS:000475547200021
PM 30408593
DA 2024-11-01
ER

PT J
AU Young, MJ
   Jayaprakash, AD
   Young, CKJ
AF Young, Matthew J.
   Jayaprakash, Anitha D.
   Young, Carolyn K. J.
TI Analysis of Mitochondrial DNA Polymorphisms in the Human Cell Lines HepaRG and SJCRH30
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE human mitochondrial DNA (mtDNA); mtDNA homoplasmy; mtDNA heteroplasmy; cancer-derived cell lines; next-generation sequencing; Mseek; HepaRG; hepatocarcinoma; SJCRH30; rhabdomyosarcoma
ID mutations; heteroplasmy; variants; disease; muscle; polg2
AB The mitochondrial DNA (mtDNA) sequences of two commonly used human cell lines, HepaRG and SJCRH30, were determined. HepaRG originates from a liver tumor obtained from a patient with hepatocarcinoma and hepatitis C while SJCRH30 originates from a rhabdomyosarcoma patient tumor. In comparison to the revised Cambridge Reference Sequence, HepaRG and SJCRH30 mtDNA each contain 14 nucleotide variations. In addition to an insertion of a cytosine at position 315 (315insC), the mtDNA sequences from both cell types share six common polymorphisms. Heteroplasmic variants were identified in both cell types and included the identification of the 315insC mtDNA variant at 42 and 75% heteroplasmy in HepaRG and SJCRH30, respectively. Additionally, a novel heteroplasmic G13633A substitution in the HepaRG ND5 gene was detected at 33%. Previously reported cancer-associated mtDNA variants T195C and T16519C were identified in SJCRH30, both at homoplasmy (100%), while HepaRG mtDNA harbors a known prostate cancer-associated T6253C substitution at near homoplasmy, 95%. Based on our sequencing analysis, HepaRG mtDNA is predicted to lie within haplogroup branch H15a1 while SJCRH30 mtDNA is predicted to localize to H27c. The catalog of polymorphisms and heteroplasmy reported here should prove useful for future investigations of mtDNA maintenance in HepaRG and SJCRH30 cell lines.
C1 [Young, Matthew J.; Young, Carolyn K. J.] Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.
   [Jayaprakash, Anitha D.] Girihlet Inc, Oakland, CA 94609 USA.
C3 Southern Illinois University System; Southern Illinois University
RP Young, MJ (corresponding author), Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.
EM matthew.young@siu.edu
FU National Institute of Environmental Health Sciences Pathway to Independence Award [5R00ES022638-04]; SIU School of Medicine
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759
   Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554
   Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Civitarese AE, 2010, CELL METAB, V11, P412, DOI 10.1016/j.cmet.2010.04.004
   Collins DW, 2016, MOL VIS, V22, P454
   Ebner S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027192
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Herrnstadt C, 2002, MUTAT RES-FUND MOL M, V501, P19, DOI 10.1016/S0027-5107(01)00304-9
   Heupink TH, 2016, P NATL ACAD SCI USA, V113, P6892, DOI 10.1073/pnas.1521066113
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Jayaprakash AD, 2015, NUCLEIC ACIDS RES, V43, P2177, DOI 10.1093/nar/gkv052
   Kamalian L, 2018, TOXICOL IN VITRO, V53, P136, DOI 10.1016/j.tiv.2018.08.001
   Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109
   Le Guillou D, 2018, J PHARMACOL EXP THER, V365, P711, DOI 10.1124/jpet.117.246751
   Lott MT, 2013, CURR PROTOC BIOINF, V44, P1231, DOI 10.1002/0471250953.BI0123S44
   MODRICH P, 1987, ANNU REV BIOCHEM, V56, P435, DOI 10.1146/annurev.biochem.56.1.435
   Morino K, 2012, DIABETES, V61, P877, DOI 10.2337/db11-1391
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Ohnstad HO, 2011, BMC CANCER, V11, P0, DOI 10.1186/1471-2407-11-211
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Reva B, 2011, NUCLEIC ACIDS RES, V39, PE118, DOI 10.1093/nar/gkr407
   ROBERTS WM, 1989, CANCER RES, V49, P5407
   Rollins B, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0004913
   Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200
   Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109
   Singh B, 2017, SEMIN CANCER BIOL, V47, P1, DOI 10.1016/j.semcancer.2017.05.004
   Singh KK, 2017, SEMIN CANCER BIOL, V47, PIV, DOI 10.1016/j.semcancer.2017.10.013
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   Uphoff CC, 2002, IN VITRO CELL DEV-AN, V38, P79
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wallace KB, 2014, J CHILD NEUROL, V29, P1241, DOI 10.1177/0883073814538510
   Wheeler Joel H, 2019, CURR PROTOC TOXICOL, V80, Pe75, DOI 10.1002/cptx.75
   Young CKJ, 2019, CELL CYCLE, V18, P476, DOI 10.1080/15384101.2019.1578133
   Young MJ, 2017, FRONT MOL BIOSCI, V4, P0, DOI 10.3389/fmolb.2017.00074
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
NR 45
TC 4
Z9 5
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL 1
PY 2019
VL 20
IS 13
BP 
EP 
DI 10.3390/ijms20133245
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA IL1EG
UT WOS:000477041100132
PM 31269646
DA 2024-11-01
ER

PT J
AU Yang, X
   Zhang, RY
   Nakahira, K
   Gu, ZL
AF Yang, Xuan
   Zhang, Ruoyu
   Nakahira, Kiichi
   Gu, Zhenglong
TI Mitochondrial DNA Mutation, Diseases, and Nutrient-Regulated Mitophagy
SO ANNUAL REVIEW OF NUTRITION, VOL 39, 2019
LA English
DT Review; Book Chapter
DE mitochondria; mtDNA; heteroplasmy; mitophagy; nutrients
ID endoplasmic-reticulum stress; oxidative stress; pink1/parkin-mediated mitophagy; superoxide-dismutase; manganese chloride; parkinsons-disease; induced apoptosis; skeletal-muscle; sting pathway; life-span
AB A wide spectrum of human diseases, including cancer, neurodegenerative diseases, and metabolic disorders, have been shown to be associated with mitochondrial dysfunction through multiple molecular mechanisms. Mitochondria are particularly susceptible to nutrient deficiencies, and nutritional intervention is an essential way to maintain mitochondrial homeostasis. Recent advances in genetic manipulation and next-generation sequencing reveal the crucial roles of mitochondrial DNA (mtDNA) in various pathophysiological conditions. Mitophagy, a term coined to describe autophagy that targets dysfunctional mitochondria, has emerged as an important cellular process to maintain mitochondrial homeostasis and has been shown to be regulated by various nutrients and nutritional stresses. Given the high prevalence of mtDNA mutations in humans and their impact on mitochondrial function, it is important to investigate the mechanisms that regulate mtDNA mutation. Here, we discuss mitochondrial genetics and mtDNA mutations and their implications for human diseases. We also examine the role of mitophagy as a therapeutic target, highlighting how nutrients may eliminate mtDNA mutations through mitophagy.
C1 [Yang, Xuan; Zhang, Ruoyu; Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Nakahira, Kiichi] Weill Cornell Med, Joan & Sanford I Weill Dept Med, Div Pulm & Crit Care Med, New York, NY 10065 USA.
C3 Cornell University; Cornell University; Weill Cornell Medicine
RP Yang, X (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
EM xy394@cornell.edu; rz253@cornell.edu; kin2007@med.cornell.edu; zg27@cornell.edu
FU NIGMS NIH HHS [R01 GM117190] Funding Source: Medline
CR Anding AL, 2018, CURR BIOL, V28, P287, DOI 10.1016/j.cub.2017.11.064
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Baek SH, 2017, J NEUROSCI, V37, P5099, DOI 10.1523/JNEUROSCI.2385-16.2017
   Ban T, 2017, NAT CELL BIOL, V19, P856, DOI 10.1038/ncb3560
   Band M, 2009, FASEB J, V23, P2327, DOI 10.1096/fj.08-122978
   Bargiela D, 2019, NEUROSCI LETT, V710, P0, DOI 10.1016/j.neulet.2017.06.051
   Bargiela D, 2018, TRENDS ENDOCRIN MET, V29, P249, DOI 10.1016/j.tem.2018.02.002
   Bartolome F, 2017, SCI REP, V7, P1
   Basit F, 2017, CELL DEATH DIS, V8, P0, DOI 10.1038/cddis.2017.133
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780
   Berridge MJ, 2017, J PHYSIOL-LONDON, V595, P6825, DOI 10.1113/JP274887
   Bhujabal Z, 2017, EMBO REP, V18, P947, DOI 10.15252/embr.201643147
   Bian XY, 2018, FREE RADICAL RES, V52, P80, DOI 10.1080/10715762.2017.1414949
   Bin-Umer MA, 2014, P NATL ACAD SCI USA, V111, P11798, DOI 10.1073/pnas.1403145111
   Boilard E, 2016, NAT REV RHEUMATOL, V12, P195, DOI 10.1038/nrrheum.2016.24
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Boyle KA, 2018, J BIOL CHEM, V293, P14891, DOI 10.1074/jbc.RA117.001469
   Brenner SR, 2010, NEUROLOGY, V74, P182, DOI 10.1212/WNL.0b013e3181c77678
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623
   Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558
   Chen XC, 2009, HEPATOLOGY, V49, P1554, DOI 10.1002/hep.22811
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Colombo B, 2014, NEUROL SCI, V35, PS141, DOI 10.1007/s10072-014-1755-z
   Cornelius N, 2014, HUM MOL GENET, V23, P4285, DOI 10.1093/hmg/ddu146
   Correia-Melo C, 2017, NAT PROTOC, V12, P0, DOI 10.1038/nprot.2016.159
   Das DN, 2017, FREE RADICAL BIO MED, V112, P452, DOI 10.1016/j.freeradbiomed.2017.08.020
   Dawson TM, 2010, MOVEMENT DISORD, V25, PS32, DOI 10.1002/mds.22798
   de Vries RLA, 2012, AUTOPHAGY, V8, P699, DOI 10.4161/auto.19470
   Depeint F, 2006, CHEM-BIOL INTERACT, V163, P94, DOI 10.1016/j.cbi.2006.04.014
   Dietrich LEP, 2006, CURR BIOL, V16, PR395, DOI 10.1016/j.cub.2006.05.017
   Dudek J, 2017, FRONT CELL DEV BIOL, V5, P0, DOI 10.3389/fcell.2017.00090
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Ezerina D, 2018, CELL CHEM BIOL, V25, P447, DOI 10.1016/j.chembiol.2018.01.011
   Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026
   Fiesel FC, 2017, ONCOTARGET, V8, P106233, DOI 10.18632/oncotarget.22287
   Filadi R, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-017-0023-6
   Filichia E, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep32656
   Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9
   Fu M, 2013, MOL BIOL CELL, V24, P1153, DOI 10.1091/mbc.E12-08-0607
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017
   Garcia-MuÃ±oz C, 2014, CRIT REV FOOD SCI, V54, P1584, DOI 10.1080/10408398.2011.644643
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Ghosh SS, 1996, AM J HUM GENET, V58, P325
   Giardina G, 2015, FEBS J, V282, P1225, DOI 10.1111/febs.13211
   GimÃ©nez-Cassina A, 2015, TRENDS ENDOCRIN MET, V26, P165, DOI 10.1016/j.tem.2015.02.004
   Gong GH, 2015, SCIENCE, V350, P0, DOI 10.1126/science.aad2459
   Greaves LC, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003082
   Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204
   Hamacher-Brady A, 2016, CELL MOL LIFE SCI, V73, P775, DOI 10.1007/s00018-015-2087-8
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a012971
   Hsu TC, 2010, FOOD CHEM, V119, P62, DOI 10.1016/j.foodchem.2009.05.088
   Huang F, 2009, FREE RADICAL BIO MED, V46, P1186, DOI 10.1016/j.freeradbiomed.2009.01.026
   Hyland K, 2009, NEUROLOGY, V72, P0
   Ishihara M, 2013, AM J PHYSIOL-RENAL, V305, PF495, DOI 10.1152/ajprenal.00642.2012
   Jain A, 2015, J BIOL CHEM, V290, P14945, DOI 10.1074/jbc.M115.656116
   Jensen KS, 2011, EMBO J, V30, P4554, DOI 10.1038/emboj.2011.323
   Jian FL, 2018, CELL REP, V23, P2989, DOI 10.1016/j.celrep.2018.05.015
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Jin X, 2018, NEUROPSYCH DIS TREAT, V14, P3159, DOI 10.2147/NDT.S186209
   JONES CW, 1978, BIOCHIM BIOPHYS ACTA, V526, P369, DOI 10.1016/0005-2744(78)90128-6
   Jong CJ, 2015, AMINO ACIDS, V47, P2609, DOI 10.1007/s00726-015-2053-7
   Jong CJ, 2012, AMINO ACIDS, V42, P2223, DOI 10.1007/s00726-011-0962-7
   Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658
   Kameyama K, 2017, INT J NANOMED, V12, P3433, DOI 10.2147/IJN.S133482
   Kang HT, 2009, AGING CELL, V8, P426, DOI 10.1111/j.1474-9726.2009.00487.x
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Ke Z, 2013, ANN NUTR METAB, V63, P555
   Keene D, 2014, BMJ-BRIT MED J, V349, P0, DOI 10.1136/bmj.g4379
   KIESSLING KH, 1962, EXP CELL RES, V26, P198, DOI 10.1016/0014-4827(62)90215-X
   Kogot-Levin A, 2014, BIOCHIMIE, V100, P88, DOI 10.1016/j.biochi.2013.07.027
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lee HN, 2018, FRONT NEUROL, V9, P0, DOI 10.3389/fneur.2018.00621
   Lee JJ, 2018, J CELL BIOL, V217, P1613, DOI 10.1083/jcb.201801044
   Lee S, 2018, INT J MED SCI, V15, P1083, DOI 10.7150/ijms.26314
   Lee S, 2009, AM J PHYSIOL-HEART C, V297, PH569, DOI 10.1152/ajpheart.00293.2009
   Lee YJ, 2017, AUTOPHAGY, V13, P1615, DOI 10.1080/15548627.2017.1339845
   Li J, 2015, AUTOPHAGY, V11, P1216, DOI 10.1080/15548627.2015.1017180
   Li MT, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-018-0984-0
   Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139
   Li Y, 2017, BIOCHEM BIOPH RES CO, V484, P118, DOI 10.1016/j.bbrc.2017.01.061
   Liu L, 2014, CELL RES, V24, P787, DOI 10.1038/cr.2014.75
   Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422
   Liu SY, 2012, APOPTOSIS, V17, P1156, DOI 10.1007/s10495-012-0758-6
   Luz AL, 2017, TOXICOLOGY, V387, P81, DOI 10.1016/j.tox.2017.05.018
   Ma SP, 2016, ANTIOXID REDOX SIGN, V24, P486, DOI 10.1089/ars.2015.6336
   MacVicar TDB, 2015, INT J MOL SCI, V16, P13356, DOI 10.3390/ijms160613356
   Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788
   Marin JJG, 2013, FREE RADICAL BIO MED, V61, P218, DOI 10.1016/j.freeradbiomed.2013.04.002
   Matilainen O, 2017, TRENDS CELL BIOL, V27, P453, DOI 10.1016/j.tcb.2017.02.004
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039
   Meng X, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9040367
   Menzies KJ, 2013, J BIOL CHEM, V288, P6968, DOI 10.1074/jbc.M112.431155
   Mirica SN, 2013, CAN J PHYSIOL PHARM, V91, P108, DOI 10.1139/cjpp-2012-0216
   Mitsuhashi S, 2011, AUTOPHAGY, V7, P1559, DOI 10.4161/auto.7.12.17925
   Murakawa T, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8527
   Murphy E, 2007, ANNU REV PHYSIOL, V69, P51, DOI 10.1146/annurev.physiol.69.031905.163645
   Murphy MP, 2015, CELL METAB, V22, P363, DOI 10.1016/j.cmet.2015.08.012
   Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Norenberg MD, 2004, J BIOENERG BIOMEMBR, V36, P303, DOI 10.1023/B:JOBB.0000041758.20071.19
   Ohtake F, 2018, P NATL ACAD SCI USA, V115, PE1401, DOI 10.1073/pnas.1716673115
   Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013
   Ongan D, 2017, PAK J MED SCI, V33, P417, DOI 10.12669/pjms.332.11838
   Onodera R, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep04417
   Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2
   Palikaras K, 2017, PHARMACOL THERAPEUT, V178, P157, DOI 10.1016/j.pharmthera.2017.04.005
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Paul BT, 2017, EXPERT REV HEMATOL, V10, P65, DOI 10.1080/17474086.2016.1268047
   Peng TI, 2012, J PINEAL RES, V52, P93, DOI 10.1111/j.1600-079X.2011.00923.x
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Pichiah PBT, 2011, MED HYPOTHESES, V77, P677, DOI 10.1016/j.mehy.2011.07.014
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778
   Powell JM, 2008, J DAIRY SCI, V91, P857, DOI 10.3168/jds.2007-0588
   Qi YM, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep24700
   Requejo-Aguilar R, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5514
   Ricca C, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19061672
   Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107
   Rimessi A, 2013, AUTOPHAGY, V9, P1677, DOI 10.4161/auto.24795
   Robb EL, 2017, BIOCHEM BIOPH RES CO, V485, P249, DOI 10.1016/j.bbrc.2017.02.102
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Roth JA, 2009, NEUROMOL MED, V11, P281, DOI 10.1007/s12017-009-8088-8
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Ryan T, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03241-9
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005
   Sauve AA, 2012, CURR OPIN CHEM BIOL, V16, P535, DOI 10.1016/j.cbpa.2012.10.003
   Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002
   Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059
   Schipper HM, 2004, AGEING RES REV, V3, P265, DOI 10.1016/j.arr.2004.02.001
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Seibenhener ML, 2013, BBA-MOL CELL RES, V1833, P452, DOI 10.1016/j.bbamcr.2012.11.004
   Sekine S, 2018, BMC BIOL, V16, P0, DOI 10.1186/s12915-017-0470-7
   Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059
   Shaik A, 2016, CELL CYCLE, V15, P1805, DOI 10.1080/15384101.2016.1181876
   Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9
   Song DM, 2017, METALLOMICS, V9, P1251, DOI 10.1039/c7mt00085e
   Song SB, 2017, MOL CELLS, V40, P503, DOI 10.14348/molcells.2017.0081
   Springer MZ, 2016, J PATHOL, V240, P253, DOI 10.1002/path.4774
   Steward CG, 2010, PRENATAL DIAG, V30, P970, DOI 10.1002/pd.2599
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stover PJ, 2009, J NUTR, V139, P2402, DOI 10.3945/jn.109.113670
   Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, PE1339, DOI 10.1152/ajpendo.00487.2005
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Tatar M, 2016, CELL, V165, P1052, DOI 10.1016/j.cell.2016.05.021
   Thakur N, 2016, HUM HEALT HANDB, V12, P353, DOI 10.3920/978-90-8686-822-3_21
   Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039
   Thomas RL, 2013, CIRC J, V77, P2449, DOI 10.1253/circj.CJ-13-0835
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Varga NA, 2018, BEHAV BRAIN FUNCT, V14, P0, DOI 10.1186/s12993-018-0135-x
   Vazquez-Martin A, 2016, AGING-US, V8, P1330, DOI 10.18632/aging.100976
   Villa E, 2018, TRENDS CELL BIOL, V28, P882, DOI 10.1016/j.tcb.2018.07.004
   Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wang H, 2011, J PINEAL RES, V50, P418, DOI 10.1111/j.1600-079X.2011.00860.x
   Wang H, 2018, TOXICOL LETT, V282, P100, DOI 10.1016/j.toxlet.2017.10.021
   Wang X, 2017, TOXICOL APPL PHARM, V320, P26, DOI 10.1016/j.taap.2017.02.009
   Wang YQ, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1006391
   Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125
   Wei X, 2014, TOXICOL MECH METHOD, V24, P504, DOI 10.3109/15376516.2014.943444
   Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042
   WEISIGER RA, 1973, J BIOL CHEM, V248, P4793
   Wu J, 2016, EXP CELL RES, V341, P42, DOI 10.1016/j.yexcr.2016.01.014
   Wu SP, 2015, GUT, V64, P1082, DOI 10.1136/gutjnl-2014-307436
   Xiao B, 2017, CELL DEATH DIS, V8, P0, DOI 10.1038/cddis.2017.463
   Xiao B, 2017, J BIOL CHEM, V292, P16697, DOI 10.1074/jbc.M117.787739
   Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999
   Xue Y, 2017, J BIOL CHEM, V292, P13197, DOI 10.1074/jbc.M117.784249
   Yamada T, 2018, CELL METAB, V28, P588, DOI 10.1016/j.cmet.2018.06.014
   Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Yuan Y, 2017, AUTOPHAGY, V13, P1754, DOI 10.1080/15548627.2017.1357792
   Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108
   Zhang HT, 2016, TOXICOL IN VITRO, V34, P212, DOI 10.1016/j.tiv.2016.04.006
   Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16
   Zhang SR, 2004, TOXICOL IN VITRO, V18, P71, DOI 10.1016/j.tiv.2003.09.002
   Zhang TM, 2016, J BIOL CHEM, V291, P21616, DOI 10.1074/jbc.M116.733410
   Zhang WL, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.21407
   Zhang XN, 2014, AUTOPHAGY, V10, P1801, DOI 10.4161/auto.32136
   Zhang Y, 2013, J MEMBRANE BIOL, V246, P365, DOI 10.1007/s00232-013-9540-0
   Zhou HB, 2017, MICRO NANO TECHNOL, V0, PP1, DOI 10.1016/B978-0-32-346240-2.00001-7
   Zhou XL, 2014, J OVARIAN RES, V7, P0, DOI 10.1186/s13048-014-0097-z
   Zhu LY, 2010, CELL RES, V20, P676, DOI 10.1038/cr.2010.46
NR 197
TC 18
Z9 20
U1 2
U2 45
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0199-9885
EI 1545-4312
J9 ANNU REV NUTR
JI Annu. Rev. Nutr.
PD JUN 15
PY 2019
VL 39
IS 
BP 201
EP 226
DI 10.1146/annurev-nutr-082018-124643
PG 26
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA BN4PC
UT WOS:000482643700009
PM 31433742
DA 2024-11-01
ER

PT J
AU Pan, XL
   Wang, LJ
   Fei, GQ
   Dong, JH
   Zhong, CJ
   Lu, JH
   Jin, LR
AF Pan, Xiaoli
   Wang, Lijun
   Fei, Guoqiang
   Dong, Jihong
   Zhong, Chunjiu
   Lu, Jiahong
   Jin, Lirong
TI Acute Respiratory Failure Is the Initial Manifestation in the Adult-Onset A3243G tRNALeu mtDNA Mutation: A Case Report and the Literature Review
SO FRONTIERS IN NEUROLOGY
LA English
DT Review
DE mitochondrial myopathy; A3243G mutation; respiratory failure; mtDNA; sedative drug
ID isolated mitochondrial myopathy; patient; diagnosis; insufficiency; phenotypes
AB Isolated mitochondrial myopathy refers to the condition of mitochondria' disorders that primarily affect the skeletal muscle system. Here we report on a case of a patient who presented with acute respiratory failure as the initial and predominant clinical manifestation after using anesthetic drugs. The diagnosis of mitochondrial myopathy was made by histochemical findings of ragged red fibers with a modified Gomori trichrome Stain in the skeletal muscle biopsy and the genetic detection of an A3243G point mutation in the tRNALeu (UUR) gene of mitochondrial DNA (mtDNA) in a peripheral blood specimen. The patient revealed a benign clinical outcome with ventilator assistance and a cocktail treatment. Further, we performed a literature review on patients with respiratory failure as the early and predominant manifestation in adult-onset isolated mitochondrial myopathy. Eleven cases in nine studies (including our case) have been reported, and five of whom underwent DNA analysis all harbored the A3243G mutation in the tRNA(Leu) gene of the mtDNA. Use of sedative drugs tends to induce acute respiratory failure in such cases.
C1 [Pan, Xiaoli; Wang, Lijun; Fei, Guoqiang; Dong, Jihong; Zhong, Chunjiu; Jin, Lirong] Fudan Univ, Zhongshan Hosp, Dept Neurol, Shanghai, Peoples R China.
   [Pan, Xiaoli; Wang, Lijun; Fei, Guoqiang; Dong, Jihong; Zhong, Chunjiu; Jin, Lirong] Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China.
   [Wang, Lijun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai, Peoples R China.
   [Wang, Lijun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Coinnovat Ctr Neurodegenerat, Shanghai, Peoples R China.
   [Lu, Jiahong] Fudan Univ, Huashan Hosp, Dept Neurd, Shanghai, Peoples R China.
C3 Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University
RP Jin, LR (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Neurol, Shanghai, Peoples R China.; Jin, LR (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China.; Lu, JH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurd, Shanghai, Peoples R China.
EM lujiahong@yahoo.com; jinlr99@163.com
FU National Natural Science Foundation of China [91332201]; National Natural Science Foundation for Young Scientists of China [81600930]
CR Amornvit Jakkrit, 2014, JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, V97, P467
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   BAROHN RJ, 1990, NEUROLOGY, V40, P103, DOI 10.1212/WNL.40.1.103
   BENNETT DA, 1988, CLIN NEUROPHARMACOL, V11, P303, DOI 10.1097/00002826-198808000-00002
   CARROLL JE, 1976, NEUROLOGY, V26, P140, DOI 10.1212/WNL.26.2.140
   Chang KC, 2002, HONG KONG MEDICAL JOURNAL, V8, P137
   CROS D, 1992, CHEST, V101, P824, DOI 10.1378/chest.101.3.824
   DiMauro S, 2005, CURR OPIN NEUROL, V18, P538, DOI 10.1097/01.wco.0000179761.63486.1a
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   [é­å GUO Jun], 2010, åäº¬å»å­¦ BEIJING MEDICAL JOURNAL, V32, P86
   KAMAKURA K, 1995, J NEUROL, V242, P253, DOI 10.1007/BF00919602
   KIM G W, 1991, YONSEI MEDICAL JOURNAL, V32, P184
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317
   Leshinsky-Silver E, 2008, EUR J PAEDIATR NEURO, V12, P309, DOI 10.1016/j.ejpn.2007.09.005
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Naddaf E, 2017, MUSCLE NERVE, V56, P881, DOI 10.1002/mus.25602
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   OBrien A, 1998, EUR RESPIR J, V12, P742, DOI 10.1183/09031936.98.12030742
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Scheffler IE, 2001, MITOCHONDRION, V1, P3, DOI 10.1016/S1567-7249(00)00002-7
   Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854
   Spinazzola A, 2004, NEUROMUSCULAR DISORD, V14, P815, DOI 10.1016/j.nmd.2004.09.002
   Suomalainen A, 2011, J INHERIT METAB DIS, V34, P277, DOI 10.1007/s10545-010-9222-3
   Yang CC, 1998, J FORMOS MED ASSOC, V97, P715
NR 25
TC 9
Z9 10
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD JUL 18
PY 2019
VL 10
IS 
BP 
EP 
DI 10.3389/fneur.2019.00780
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA IJ5EJ
UT WOS:000475925300001
PM 31379729
DA 2024-11-01
ER

PT J
AU Genin, EC
   Hounoum, BM
   Bannwarth, S
   Fragaki, K
   Lacas-Gervais, S
   Mauri-Crouzet, A
   Lespinasse, F
   Neveu, J
   Ropert, B
   AugÃ©, G
   Cochaud, C
   Lefebvre-Omar, C
   Bigou, S
   Chiot, A
   Mochel, F
   BoillÃ©e, S
   Lobsiger, CS
   Bohl, D
   Ricci, JE
   Paquis-Flucklinger, V
AF Genin, Emmanuelle C.
   Hounoum, Blandine Madji
   Bannwarth, Sylvie
   Fragaki, Konstantina
   Lacas-Gervais, Sandra
   Mauri-Crouzet, Alessandra
   Lespinasse, Francoise
   Neveu, Julien
   Ropert, Baptiste
   Auge, Gaelle
   Cochaud, Charlotte
   Lefebvre-Omar, Cynthia
   Bigou, Stephanie
   Chiot, Aude
   Mochel, Fanny
   Boillee, Severine
   Lobsiger, Christian S.
   Bohl, Delphine
   Ricci, Jean-Ehrland
   Paquis-Flucklinger, Veronique
TI Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10<SUP>S59L/+</SUP> mouse
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE CHCHD10; Mitochondrial disorder; ALS; Mouse model; iPSC
ID amyotrophic-lateral-sclerosis; chchd10 mutations; acetylcholine-receptors; phosphorylation; pathogenesis; system; gene
AB Recently, we provided genetic basis showing that mitochondrial dysfunction can trigger motor neuron degeneration, through identification of CHCHD10 encoding a mitochondrial protein. We reported patients, carrying the p.Ser59Leu heterozygous mutation in CHCHD10, from a large family with a mitochondrial myopathy associated with motor neuron disease (MND). Rapidly, our group and others reported CHCHD10 mutations in amyotrophic lateral sclerosis (ALS), frontotemporal dementia-ALS and other neurodegenerative diseases. Here, we generated knock-in (KI) mice, carrying the p.Ser59Leu mutation, that mimic the mitochondrial myopathy with mtDNA instability displayed by the patients from our original family. Before 14months of age, all KI mice developed a fatal mitochondrial cardiomyopathy associated with enhanced mitophagy. CHCHD10(S59L/+) mice also displayed neuromuscular junction (NMJ) and motor neuron degeneration with hyper-fragmentation of the motor end plate and moderate but significant motor neuron loss in lumbar spinal cord at the end stage of the disease. At this stage, we observed TDP-43 cytoplasmic aggregates in spinal neurons. We also showed that motor neurons differentiated from human iPSC carrying the p.Ser59Leu mutation were much more sensitive to Staurosporine or glutamate-induced caspase activation than control cells. These data confirm that mitochondrial deficiency associated with CHCHD10 mutations can be at the origin of MND. CHCHD10 is highly expressed in the NMJ post-synaptic part. Importantly, the fragmentation of the motor end plate was associated with abnormal CHCHD10 expression that was also observed closed to NMJs which were morphologically normal. Furthermore, we found OXPHOS deficiency in muscle of CHCHD10(S59L/+) mice at 3months of age in the absence of neuron loss in spinal cord. Our data show that the pathological effects of the p.Ser59Leu mutation target muscle prior to NMJ and motor neurons. They likely lead to OXPHOS deficiency, loss of cristae junctions and destabilization of internal membrane structure within mitochondria at motor end plate of NMJ, impairing neurotransmission. These data are in favor with a key role for muscle in MND associated with CHCHD10 mutations.
C1 [Genin, Emmanuelle C.; Bannwarth, Sylvie; Fragaki, Konstantina; Mauri-Crouzet, Alessandra; Lespinasse, Francoise; Neveu, Julien; Ropert, Baptiste; Auge, Gaelle; Cochaud, Charlotte; Paquis-Flucklinger, Veronique] Univ Cote Azur, CHU Nice, Sch Med, Inserm,U1081,CNRS,UMR7284,IRCAN, 28 Av Valombrose, F-06107 Nice 2, France.
   [Hounoum, Blandine Madji; Ricci, Jean-Ehrland] Univ Cote Azur, C3M, INSERM, U1065, Nice, France.
   [Lacas-Gervais, Sandra] Univ Cote Azur, Ctr Commun Microscopie Appl, Nice, France.
   [Lefebvre-Omar, Cynthia; Bigou, Stephanie; Chiot, Aude; Mochel, Fanny; Boillee, Severine; Lobsiger, Christian S.; Bohl, Delphine] Sorbonne Univ, Inst Cerveau & Moelle Epiniere, ICM, Inserm,U1127,CNRS,UMR7225, F-75013 Paris, France.
   [Mochel, Fanny] La Pitie Salpetriere Univ Hosp, AP HP, Dept Genet, Paris, France.
   [Mochel, Fanny] La Pitie Salpetriere Univ Hosp, AP HP, Reference Ctr Adult Neurometab Dis, Paris, France.
C3 Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP
RP Paquis-Flucklinger, V (corresponding author), Univ Cote Azur, CHU Nice, Sch Med, Inserm,U1081,CNRS,UMR7284,IRCAN, 28 Av Valombrose, F-06107 Nice 2, France.
EM paquis@unice.fr
FU ANR (Agence Nationale de la Recherche) [ANR-16-CE16-0024-01]; AFM-Telethon (Association Francaise contre les Myopathies) [20947]; Fondation Maladies Rares; program "Investissements d'avenir" [ANR-11-INBS-0011-NeurATRIS];  [ANR-10-LABX-73]; Agence Nationale de la Recherche (ANR) [ANR-16-CE16-0024] Funding Source: Agence Nationale de la Recherche (ANR)
CR Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x
   Auranen M, 2015, NEUROL-GENET, V1, P0, DOI 10.1212/NXG.0000000000000003
   Bannwarth S, 2016, MITOCHONDRION, V30, P126, DOI 10.1016/j.mito.2016.02.005
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Blasco H, 2014, CURR MED CHEM, V21, P3551, DOI 10.2174/0929867321666140916120118
   Bloch-Gallego E, 2015, CELL MOL LIFE SCI, V72, P1029, DOI 10.1007/s00018-014-1768-z
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cozzolino M, 2015, FRONT CELL NEUROSCI, V9, P0, DOI 10.3389/fncel.2015.00031
   Dadon-Nachum M, 2011, J MOL NEUROSCI, V43, P470, DOI 10.1007/s12031-010-9467-1
   Desport JC, 2001, AM J CLIN NUTR, V74, P328
   Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002
   Dupuis L, 2004, NEURODEGENER DIS, V1, P245, DOI 10.1159/000085063
   Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6
   Dupuis L, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005390
   Genin EC, 2018, NEUROBIOL DIS, V119, P159, DOI 10.1016/j.nbd.2018.07.027
   Genin EC, 2016, EMBO MOL MED, V8, P58, DOI 10.15252/emmm.201505496
   Gorman GS, 2018, LANCET, V392, P1191, DOI 10.1016/S0140-6736(18)31868-3
   Guo W, 2017, NAT COMMUN, V0, P0
   Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005
   Huang MLH, 2013, AM J PATHOL, V183, P745, DOI 10.1016/j.ajpath.2013.05.032
   Johnson JO, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu265
   Jones RA, 2016, OPEN BIOL, V6, P0, DOI 10.1098/rsob.160240
   Lehmer C, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708558
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049
   Mesci P, 2015, BRAIN, V138, P53, DOI 10.1093/brain/awu312
   MÃ¼ller K, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu227
   MusarÃ² A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839
   Palma E, 2016, P NATL ACAD SCI USA, V113, P3060, DOI 10.1073/pnas.1600251113
   Palma E, 2011, P NATL ACAD SCI USA, V108, P20184, DOI 10.1073/pnas.1117975108
   PenttilÃ¤ S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319
   Philips Thomas, 2015, CURR PROTOC PHARMACOL, V69, P0, DOI 10.1002/0471141755.ph0567s69
   Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613
   Rocha MC, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0073846
   Ronchi D, 2015, BRAIN, V138, PE372, DOI 10.1093/brain/awu384
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SALMON MA, 1971, LANCET, V2, P290
   Smith EF, 2017, NEUROSCI LETT, V0, P0
   Tong MM, 2016, CURR OPIN GENET DEV, V38, P8, DOI 10.1016/j.gde.2016.02.006
   Van den Bosch L, 2006, BBA-MOL BASIS DIS, V1762, P1068, DOI 10.1016/j.bbadis.2006.05.002
   Villa E, 2017, CELL REP, V20, P2846, DOI 10.1016/j.celrep.2017.08.087
   Willadt S, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep24849
   Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4
   Woo JAA, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15558
   Yaplito-Lee J, 2007, J PEDIATR-US, V150, P407, DOI 10.1016/j.jpeds.2006.12.047
   Yuan X, 2016, DRUG DES DEV THER, V10, P2729, DOI 10.2147/DDDT.S111253
NR 46
TC 57
Z9 62
U1 0
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD JUL 15
PY 2019
VL 138
IS 1
BP 123
EP 145
DI 10.1007/s00401-019-01988-z
PG 23
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA ID5IA
UT WOS:000471708700007
PM 30874923
DA 2024-11-01
ER

PT J
AU Rahman, S
   Copeland, WC
AF Rahman, Shamima
   Copeland, William C.
TI <i>POLG</i>-related disorders and their neurological manifestations
SO NATURE REVIEWS NEUROLOGY
LA English
DT Review
ID dna-polymerase-gamma; acute liver-failure; encephalomyopathy (mngie)-like phenotype; mitochondrial point mutations; refractory status epilepticus; impair mtdna replication; onset alpers-syndrome; disease mutations; w748s mutation; decanoic acid
AB The POLG gene encodes the mitochondrial DNA polymerase that is responsible for replication of the mitochondrial genome. Mutations in POLG can cause early childhood mitochondrial DNA (mtDNA) depletion syndromes or later-onset syndromes arising from mtDNA deletions. POLG mutations are the most common cause of inherited mitochondrial disorders, with as many as 2% of the population carrying these mutations. POLG-related disorders comprise a continuum of overlapping phenotypes with onset from infancy to late adulthood. The six leading disorders caused by POLG mutations are Alpers-Huttenlocher syndrome, which is one of the most severe phenotypes; childhood myocerebrohepatopathy spectrum, which presents within the first 3 years of life; myoclonic epilepsy myopathy sensory ataxia; ataxia neuropathy spectrum; autosomal recessive progressive external ophthalmoplegia; and autosomal dominant progressive external ophthalmoplegia. This Review describes the clinical features, pathophysiology, natural history and treatment of POLG-related disorders, focusing particularly on the neurological manifestations of these conditions.
C1 [Rahman, Shamima] UCL Great Ormond St Inst Child Hlth, Mitochondrial Res Grp, London, England.
   [Rahman, Shamima] Great Ormond St Hosp Children NHS Fdn Trust, Metab Unit, London, England.
   [Copeland, William C.] NIEHS, Mitochondrial DNA Replicat Grp, Genome Integr & Struct Biol Lab, NIH, Durham, NC 27709 USA.
C3 University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Mitochondrial DNA Replicat Grp, Genome Integr & Struct Biol Lab, NIH, Durham, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [ES 065078, ES 065080]; Great Ormond Street Hospital Children's Charity Research Leadership Award [V1260]; Lily Foundation; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London, UK; MRC [G0200335] Funding Source: UKRI
CR Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Ahola-ErkkilÃ¤ S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   BELL EA, 1992, ANN PHARMACOTHER, V26, P18, DOI 10.1177/106002809202600104
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bugiardini E, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000149
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chang P, 2016, BRAIN, V139, P431, DOI 10.1093/brain/awv325
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Craig K, 2007, BRAIN, V130, P0, DOI 10.1093/brain/awm009
   Dagan T, 2002, MITOCHONDRION, V1, P397, DOI 10.1016/S1567-7249(02)00003-X
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   DeBalsi KL, 2017, J BIOL CHEM, V292, P4198, DOI 10.1074/jbc.M116.773341
   Delarue A, 2000, PEDIATR TRANSPLANT, V4, P67, DOI 10.1034/j.1399-3046.2000.00090.x
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Dhamija R, 2011, NEUROLOGY, V76, PE22, DOI 10.1212/WNL.0b013e31820a0d39
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   Di Meo I, 2012, EMBO MOL MED, V4, P1008, DOI 10.1002/emmm.201201433
   Duncan AJ, 2012, HUM REPROD, V27, P2243, DOI 10.1093/humrep/des130
   Echaniz-Laguna A, 2010, ARCH NEUROL-CHICAGO, V67, P1140, DOI 10.1001/archneurol.2010.219
   Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   GATTERMANN N, 1995, LEUKEMIA, V9, P1704
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Harris MO, 2010, ARCH NEUROL-CHICAGO, V67, P493, DOI 10.1001/archneurol.2010.36
   Hasselmann O, 2010, MOL GENET METAB, V99, P58, DOI 10.1016/j.ymgme.2009.08.005
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Hikmat O, 2017, J INHERIT METAB DIS, V40, P861, DOI 10.1007/s10545-017-0084-9
   Hinnell C, 2012, MOVEMENT DISORD, V27, P162, DOI 10.1002/mds.23960
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hughes SD, 2014, J NEUROCHEM, V129, P426, DOI 10.1111/jnc.12646
   Hynynen J, 2014, LIVER TRANSPLANT, V20, P1402, DOI 10.1002/lt.23965
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Johansen KK, 2008, MOVEMENT DISORD, V23, P1624, DOI 10.1002/mds.22178
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kanabus M, 2016, J INHERIT METAB DIS, V39, P415, DOI 10.1007/s10545-016-9930-4
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kayihan N, 2000, PEDIATR TRANSPLANT, V4, P211, DOI 10.1034/j.1399-3046.2000.00115.x
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Khan A, 2012, J CHILD NEUROL, V27, P636, DOI 10.1177/0883073811423973
   Kirschenbaum D, 2018, NEUROPATH APPL NEURO, V44, P639, DOI 10.1111/nan.12429
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kremer LS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15824
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2001, LAB INVEST, V81, P777, DOI 10.1038/labinvest.3780288
   Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Lupashko S, 2011, CHILD NERV SYST, V27, P1321, DOI 10.1007/s00381-011-1495-9
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   Martikainen MH, 2012, EPILEPTIC DISORD, V14, P438, DOI 10.1684/epd.2012.0543
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   McKiernan P, 2016, J PEDIATR GASTR NUTR, V63, P592, DOI 10.1097/MPG.0000000000001345
   McKiernan P, 2014, LIVER TRANSPLANT, V20, P1287, DOI 10.1002/lt.23988
   Menezes MP, 2016, MITOCHONDRION, V30, P162, DOI 10.1016/j.mito.2016.07.014
   Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mindikoglu AL, 2011, J PEDIATR-US, V158, P802, DOI 10.1016/j.jpeds.2010.10.033
   Nadanaciva S, 2011, CURR PHARM DESIGN, V17, P2100, DOI 10.2174/138161211796904795
   Naviaux RK, 2005, ANN NEUROL, V58, P491, DOI 10.1002/ana.20544
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nicastro N, 2016, CEREBELLUM, V15, P829, DOI 10.1007/s12311-015-0749-6
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nikkanen J, 2018, EMBO MOL MED, V10, P13, DOI 10.15252/emmm.201707993
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nurminen A, 2017, BBA CLIN, V7, P147, DOI 10.1016/j.bbacli.2017.04.001
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Palin EJH, 2012, J NEUROL SCI, V315, P160, DOI 10.1016/j.jns.2011.11.028
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pitayu L, 2016, HUM MOL GENET, V25, P715, DOI 10.1093/hmg/ddv509
   Pitceathly RDS, 2013, J NEUROL NEUROSUR PS, V84, P107, DOI 10.1136/jnnp-2012-303232
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Prasun P, 2014, J NEUROL, V261, P1818, DOI 10.1007/s00415-014-7428-2
   PrÃ¼ss H, 2008, EPILEPSY RES, V82, P219, DOI 10.1016/j.eplepsyres.2008.08.005
   Rahman S, 2013, J INHERIT METAB DIS, V36, P659, DOI 10.1007/s10545-013-9614-2
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Rajakulendran S, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0145500
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Schicks J, 2010, MOVEMENT DISORD, V25, P2678, DOI 10.1002/mds.23286
   Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiegler J, 2011, NEUROPEDIATRICS, V42, P194, DOI 10.1055/s-0031-1287812
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Staufner C, 2016, J INHERIT METAB DIS, V39, P3, DOI 10.1007/s10545-015-9896-7
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1
   Synofzik M, 2010, MOVEMENT DISORD, V25, P2472, DOI 10.1002/mds.23307
   Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Thomson MA, 2000, TRANSPLANT P, V32, P200, DOI 10.1016/S0041-1345(99)00936-7
   Torres-Torronteras J, 2011, GENE THER, V18, P795, DOI 10.1038/gt.2011.24
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2016, MITOCHONDRION, V28, P33, DOI 10.1016/j.mito.2016.03.003
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115
   van Baalen A, 2017, NEUROPEDIATRICS, V48, P5, DOI 10.1055/s-0036-1597271
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Visser NA, 2010, NEUROLOGY, V74, P1231, DOI 10.1212/WNL.0b013e3181d90005
   Visser NA, 2011, J NEUROL, V258, P218, DOI 10.1007/s00415-010-5721-2
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Woodbridge P, 2013, INTERN MED J, V43, P150, DOI 10.1111/j.1445-5994.2012.02847.x
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Young MJ, 2017, FRONT MOL BIOSCI, V4, P0, DOI 10.3389/fmolb.2017.00074
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 171
TC 210
Z9 220
U1 2
U2 33
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-4758
EI 1759-4766
J9 NAT REV NEUROL
JI Nat. Rev. Neurol.
PD JAN 15
PY 2019
VL 15
IS 1
BP 40
EP 52
DI 10.1038/s41582-018-0101-0
PG 13
WC Clinical Neurology
SC Neurosciences & Neurology
GA HG3AJ
UT WOS:000454841000011
PM 30451971
DA 2024-11-01
ER

PT J
AU Zierz, CM
   Baty, K
   Blakely, EL
   Hopton, S
   Falkous, G
   Schaefer, AM
   Hadjivassiliou, M
   Sarrigiannis, PG
   Ng, YS
   Taylor, RW
AF Zierz, Charlotte M.
   Baty, Karen
   Blakely, Emma L.
   Hopton, Sila
   Falkous, Gavin
   Schaefer, Andrew M.
   Hadjivassiliou, Marios
   Sarrigiannis, Ptolemaios G.
   Ng, Yi Shiau
   Taylor, Robert W.
TI A Novel Pathogenic Variant in MT-CO2 Causes an Isolated Mitochondrial Complex IV Deficiency and Late-Onset Cerebellar Ataxia
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE isolated COX deficiency; cerebellar ataxia; mitochondrial DNA; single fibre segregation studies; heteroplasmy
ID cytochrome-c-oxidase; subunit-ii; consensus statement; mutation; diagnosis; disease; algorithm; codon; assay; gene
AB Both nuclear and mitochondrial DNA defects can cause isolated cytochrome c oxidase (COX; complex IV) deficiency, leading to the development of the mitochondrial disease. We report a 52-year-old female patient who presented with a late-onset, progressive cerebellar ataxia, tremor and axonal neuropathy. No family history of neurological disorder was reported. Although her muscle biopsy demonstrated a significant COX deficiency, there was no clinical and electromyographical evidence of myopathy. Electrophysiological studies identified low frequency sinusoidal postural tremor at 3 Hz, corroborating the clinical finding of cerebellar dysfunction. Complete sequencing of the mitochondrial DNA genome in muscle identified a novel MT-CO2 variant, m.8163A>G predicting p.(Tyr193Cys). We present several lines of evidence, in proving the pathogenicity of this heteroplasmic mitochondrial DNA variant, as the cause of her clinical presentation. Our findings serve as an important reminder that full mitochondrial DNA analysis should be included in the diagnostic pipeline for investigating individuals with spinocerebellar ataxia.
C1 [Zierz, Charlotte M.; Baty, Karen; Blakely, Emma L.; Hopton, Sila; Falkous, Gavin; Schaefer, Andrew M.; Ng, Yi Shiau; Taylor, Robert W.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Baty, Karen; Blakely, Emma L.; Hopton, Sila; Falkous, Gavin; Taylor, Robert W.] Newcastle Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Schaefer, Andrew M.; Ng, Yi Shiau] Newcastle Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Hadjivassiliou, Marios; Sarrigiannis, Ptolemaios G.] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Acad Directorate Neurosci, Sheffield S10 2JF, S Yorkshire, England.
   [Sarrigiannis, Ptolemaios G.] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Clin Neurophysiol, Sheffield S10 2JF, S Yorkshire, England.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Sheffield; University of Sheffield
RP Ng, YS (corresponding author), Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Ng, YS (corresponding author), Newcastle Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
EM CharlotteZierz@web.de; karen.baty@nuth.nhs.uk; emma.watson@nuth.nhs.uk; sila.hopton@ncl.ac.uk; gavin.falkous@nuth.nhs.uk; andrew.schaefer@nuth.nhs.uk; m.hadjivassiliou@sheffield.ac.uk; p.sarrigiannis@sheffield.ac.uk; yi.ng@ncl.ac.uk; robert.taylor@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Newcastle University Centre for Ageing and Vitality - (Biotechnology and Biological Sciences Research Council); Newcastle University Centre for Ageing and Vitality - (Medical Research Council) [L016354]; UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; NIHR Clinical Lectureship in Neurology [CL-2016-01-003]
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bargiela David, 2015, CEREBELLUM ATAXIAS, V2, P16, DOI 10.1186/s40673-015-0035-x
   Bhatia KP, 2018, MOVEMENT DISORD, V33, P75, DOI 10.1002/mds.27121
   Cassim F, 2006, NEUROPHYSIOL CLIN, V36, P281, DOI 10.1016/j.neucli.2006.10.001
   Caviness JN, 2004, LANCET NEUROL, V3, P598, DOI 10.1016/S1474-4422(04)00880-4
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   Cruccu G, 2008, CLIN NEUROPHYSIOL, V119, P1705, DOI 10.1016/j.clinph.2008.03.016
   Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303
   Fogel BL, 2014, JAMA NEUROL, V71, P1237, DOI 10.1001/jamaneurol.2014.1944
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Hadjivassiliou M, 2017, J NEUROL NEUROSUR PS, V88, P301, DOI 10.1136/jnnp-2016-314863
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Mallaret M, 2016, J NEUROL, V263, P1314, DOI 10.1007/s00415-016-8112-5
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   OlÃ¡hovÃ¡ M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Poole OV, 2019, MITOCHONDRION, V47, P294, DOI 10.1016/j.mito.2019.02.004
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Renaud M, 2017, ANN NEUROL, V82, P892, DOI 10.1002/ana.25084
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   Shibasaki H, 2005, MUSCLE NERVE, V31, P157, DOI 10.1002/mus.20234
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Tranchant C, 2016, REV NEUROL-FRANCE, V172, P524, DOI 10.1016/j.neurol.2016.07.003
   Uusimaa J, 2003, PEDIATRICS, V111, P0, DOI 10.1542/peds.111.3.e262
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   von Kleist-Retzow JC, 1999, BBA-MOL BASIS DIS, V1455, P35, DOI 10.1016/S0925-4439(99)00050-2
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
   Zhadanov SI, 2006, J HUM GENET, V51, P161, DOI 10.1007/s10038-005-0340-y
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 34
TC 10
Z9 10
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD JUN 15
PY 2019
VL 8
IS 6
BP 
EP 
DI 10.3390/jcm8060789
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA II7CG
UT WOS:000475349300033
PM 31167410
DA 2024-11-01
ER

PT J
AU Schlapakow, E
   Peeva, V
   Zsurka, G
   Jeub, M
   Wabbels, B
   Kornblum, C
   Kunz, WS
AF Schlapakow, Elena
   Peeva, Viktoriya
   Zsurka, Gabor
   Jeub, Monika
   Wabbels, Bettina
   Kornblum, Cornelia
   Kunz, Wolfram S.
TI Distinct segregation of the pathogenic m.5667G>A mitochondrial tRNA<SUP>Asn</SUP> mutation in extraocular and skeletal muscle in chronic progressive external ophthalmoplegia
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Chronic progressive external ophthalmoplegia (CPEO); mt-tRNA(Asn); Single muscle fiber; Heteroplasmy; mtDNA copy number
ID dna mutations; point mutations; gene; myopathy; deletions; patient
AB Chronic progressive external ophthalmoplegia (CPEO) is a frequent clinical manifestation of disorders caused by pathogenic mitochondrial DNA mutations. However, for diagnostic purposes skeletal muscle tissue is used, since extraocular muscle tissue is usually not available for work-up. In the present study we aimed to identify causative factors that are responsible for extraocular muscle to be primarily affected in CPEO. We performed comparative histochemical and molecular genetic analyses of extraocular muscle and skeletal muscle single fibers in a case of isolated CPEO caused by the heteroplasmic m.5667G>A mutation in the mitochondrial tRNA(Asn) gene (MT-TN). Histochemical analyses revealed higher proportion of cytochrome c oxidase deficient fibers in extraocular muscle (41%) compared to skeletal muscle (10%). However, genetic analyses of single fibers revealed no significant difference either in the mutation loads between extraocular muscle and skeletal muscle cytochrome c oxidase deficient single fibers (extraocular muscle 86%+/- 4.6%; skeletal muscle 87.8%+/- 5.7%, p = 0.246) nor in the mutation threshold (extraocular muscle 74%+/- 3%; skeletal muscle 74%+/- 4%). We hypothesize that higher proportion of cytochrome c oxidase deficient fibers in extraocular muscle compared to skeletal muscle might be due to facilitated segregation of the m.5667G>A mutation into extraocular muscle, which may explain the preferential ocular manifestation and clinically isolated CPEO. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Schlapakow, Elena; Jeub, Monika; Kornblum, Cornelia] Univ Hosp Bonn, Dept Neurol, Bonn, Germany.
   [Peeva, Viktoriya; Zsurka, Gabor; Kunz, Wolfram S.] Univ Bonn, Inst Expt Epileptol & Cognit Res, Div Neurochem, Sigmund Freud Str 25, D-53105 Bonn, Germany.
   [Zsurka, Gabor; Kunz, Wolfram S.] Univ Bonn, Dept Epileptol, Bonn, Germany.
   [Schlapakow, Elena; Kornblum, Cornelia] Univ Hosp Bonn, Ctr Rare Dis, Bonn, Germany.
   [Wabbels, Bettina] Univ Bonn, Dept Ophthalmol, Bonn, Germany.
C3 University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of Bonn
RP Kunz, WS (corresponding author), Univ Bonn, Inst Expt Epileptol & Cognit Res, Div Neurochem, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM wolfram.kunz@ukbonn.de
FU Deutsche Forschungsgemeinschaft [KU 911/21-2, ZS 99/3-2]; BONFOR
CR [Anonymous], 2013, MUSCLE BIOPSY PRACTI, V0, P0
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Bohnsack BL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1030, DOI 10.1001/archophthalmol.2011.75
   Bruno C, 2011, BIOCHEM BIOPH RES CO, V412, P518, DOI 10.1016/j.bbrc.2011.06.155
   Coulbault L, 2005, BIOCHEM BIOPH RES CO, V329, P1152, DOI 10.1016/j.bbrc.2005.02.083
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   PinÃ³s T, 2013, NEUROMUSCULAR DISORD, V23, P330, DOI 10.1016/j.nmd.2013.01.001
   PORTER JD, 1995, SURV OPHTHALMOL, V39, P451, DOI 10.1016/S0039-6257(05)80055-4
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Ronchi D, 2012, EUR J HUM GENET, V20, P357, DOI 10.1038/ejhg.2011.238
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485
   Spinazzola A, 2004, NEUROMUSCULAR DISORD, V14, P815, DOI 10.1016/j.nmd.2004.09.002
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Vives-Bauza C, 2003, J INHERIT METAB DIS, V26, P507, DOI 10.1023/A:1025133629685
   Wiedemann FR, 2000, ANAL BIOCHEM, V279, P55, DOI 10.1006/abio.1999.4434
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Yu CY, 2005, NEUROMUSCULAR DISORD, V15, P17, DOI 10.1016/j.nmd.2004.10.002
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   Zierz S, 2014, MUSKELERKRANKUNGEN, V0, P274
   Zsurka G, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2004.022566
   Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d
NR 32
TC 8
Z9 8
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD MAY 15
PY 2019
VL 29
IS 5
BP 358
EP 367
DI 10.1016/j.nmd.2019.02.009
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ID5RT
UT WOS:000471734400003
PM 30962064
DA 2024-11-01
ER

PT J
AU Musumeci, O
   Barca, E
   Lamperti, C
   Servidei, S
   Comi, GP
   Moggio, M
   Mongini, T
   Siciliano, G
   Filosto, M
   Pegoraro, E
   Primiano, G
   Ronchi, D
   Vercelli, L
   Orsucci, D
   Bello, L
   Zeviani, M
   Mancuso, M
   Toscano, A
AF Musumeci, Olimpia
   Barca, Emanuele
   Lamperti, Costanza
   Servidei, Serenella
   Comi, Giacomo Pietro
   Moggio, Maurizio
   Mongini, Tiziana
   Siciliano, Gabriele
   Filosto, Massimiliano
   Pegoraro, Elena
   Primiano, Guido
   Ronchi, Dario
   Vercelli, Liliana
   Orsucci, Daniele
   Bello, Luca
   Zeviani, Massimo
   Mancuso, Michelangelo
   Toscano, Antonio
TI Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial Patients
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE multiple symmetrical lipomatosis; MERRF; mitochondrial myopathy; madelung's disease; brown fat
ID multiple symmetric lipomatosis; dysfunction; neuropathy; mutation
AB Lipomas have often been associated with mtDNA mutations and were mainly observed in patients with mutation in mitochondrial tRNAlysine which is also the most frequent mutation associated with MERRF. Up to date, no systematic studies have been developed in order to assess the incidence of lipomas in large cohorts of mitochondrial patients.The aim of this study is to analyze the incidence and characteristics of lipomas among an Italian cohort of patients with mitochondrial diseases. A retrospective, database-based study (Nation-wide Italian Collaborative Network of Mitochondrial Diseases) of patients with lipomas was performed. A total of 22 (1.7%) patients with lipomas have been identified among the 1,300 mitochondrial patients, enrolled in the Italian database. In about 18% multiple systemic lipomatosis (MSL) was the only clinical manifestation; 54% of patients showed a classical MERRF syndrome. Myopathy, alone or in association with other symptoms, was found in 27% of patients. Lactate was elevated in all the 12 patients in which was measured. Muscle biopsy was available in 18/22 patients: in all of them mitochondrial abnormalities were present. Eighty six percent had mutations in mtDNA coding for tRNA lysine. In most of patients, lipomas were localized along the cervical-cranial-thoracic region. In 68% of the patients were distributed symmetrically. Only two patients had lipomas in a single anatomical site (1 in right arm and 1 in gluteus maximum). MSL is often overlooked by clinicians in patients with mitochondrial diseases where the clinical picture could be dominated by a severe multi-systemic involvement. Our data confirmed that MSL is a rare sign of mitochondrial disease with a strong association between multiple lipomas and lysine tRNA mutations. MSL could be considered, even if rare, a red flag for mitochondrial disorders, even in patients with an apparently isolated MSL.
C1 [Musumeci, Olimpia; Toscano, Antonio] Univ Messina, Dept Clin & Expt Med, UOC Neurol & Malattie Neuromuscolari, Messina, Italy.
   [Barca, Emanuele] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA.
   [Lamperti, Costanza] Fdn Carlo Besta Inst Neurol IRCCS, UO Med Genet & Neurogenet, Milan, Italy.
   [Servidei, Serenella; Primiano, Guido] Fdn Policlin Univ A Gemelli IRCCS, UOC Neurofisiopatol, Ist Neurol Univ Cattolica Sacro Cuore, Rome, Italy.
   [Comi, Giacomo Pietro; Ronchi, Dario] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat,Neurosci Sect,Ne, Milan, Italy.
   [Moggio, Maurizio] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Dept Neurosci, Neuromuscular & Rare Dis Unit, Milan, Italy.
   [Mongini, Tiziana; Vercelli, Liliana] Univ Torino, Dept Neurosci Rita Levi Montalcini, Turin, Italy.
   [Siciliano, Gabriele; Orsucci, Daniele; Mancuso, Michelangelo] Univ Pisa, Neurol Inst, Dept Clin & Expt Med, Pisa, Italy.
   [Filosto, Massimiliano] ASST Spedali Civili, Unit Neurol, Ctr Neuromuscular Dis, Brescia, Italy.
   [Filosto, Massimiliano] Univ Brescia, Brescia, Italy.
   [Pegoraro, Elena; Bello, Luca] Univ Padua, Dept Neurosci, Padua, Italy.
   [Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge, England.
C3 University of Messina; Columbia University; Fondazione IRCCS Istituto Neurologico Carlo Besta; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Turin; University of Pisa; Hospital Spedali Civili Brescia; University of Brescia; University of Padua
RP Musumeci, O (corresponding author), Univ Messina, Dept Clin & Expt Med, UOC Neurol & Malattie Neuromuscolari, Messina, Italy.
EM omusumeci@unime.it
FU Telethon Grant [GUP09004]; Telethon MITOCON Grant [GSP16001]; MRC [MC_UU_00015/5, MC_UP_1002/1, MC_EX_MR/P007031/1] Funding Source: UKRI
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   BERKOVIC SF, 1991, ANN NEUROL, V29, P566, DOI 10.1002/ana.410290519
   Brodie BC, 1846, LECTURES ILLUSTRATIVE OF VARIOUS SUBJECTS IN PATHOLOGY AND SURGERY. M, V0, P275
   CarriÃ¨re A, 2014, DIABETES, V63, P3253, DOI 10.2337/db13-1885
   Chong P Siao Tick, 2003, J CLIN NEUROMUSCUL DIS, V5, P1, DOI 10.1097/00131402-200309000-00001
   Coin A, 2000, J CLIN NEUROMUSCUL DIS, V1, P124, DOI 10.1097/00131402-200003000-00002
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Enzi G, 2002, INT J OBESITY, V26, P253, DOI 10.1038/sj.ijo.0801867
   ENZI G, 1985, MEDICINE, V64, P388, DOI 10.1097/00005792-198511000-00003
   GÃ¡mez J, 1998, NEUROLOGY, V51, P258, DOI 10.1212/WNL.51.1.258
   Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007
   KLOPSTOCK T, 1994, NEUROLOGY, V44, P862, DOI 10.1212/WNL.44.5.862
   Launois PE, 1898, B SOC M D H P PARIS, V1, P298
   Madelung OW, 1888, ARCH KLIN CHIR, V37, P106
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Naumann M, 1997, MUSCLE NERVE, V20, P833, DOI 10.1002/(SICI)1097-4598(199707)20:7<833::AID-MUS7>3.0.CO;2-8
   Sawyer SL, 2015, HUM MOL GENET, V24, P5109, DOI 10.1093/hmg/ddv229
   Schoffer K, 2006, MUSCLE NERVE, V33, P142, DOI 10.1002/mus.20406
   VilÃ  MR, 2000, BIOCHEM BIOPH RES CO, V278, P800, DOI 10.1006/bbrc.2000.3828
   Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546
NR 20
TC 22
Z9 24
U1 0
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD FEB 27
PY 2019
VL 10
IS 
BP 
EP 
DI 10.3389/fneur.2019.00160
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HM9FO
UT WOS:000459788500001
PM 30873109
DA 2024-11-01
ER

PT J
AU de Laat, P
   Rodenburg, RJ
   Smeitink, JAM
   Janssen, MCH
AF de Laat, Paul
   Rodenburg, Richard J.
   Smeitink, Jan A. M.
   Janssen, Mirian C. H.
TI Intra-patient variability of heteroplasmy levels in urinary epithelial cells in carriers of the m.3243A>G mutation
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE heteroplasmy; m.3243A>G; maternally inherited diabetes deafness; mitochondrial medicine; mitochondrial myopathy; encephalopathy; lactic acidosis and stroke-like episodes; NMDAS; outcome measures
ID transfer rnaleu(uur) gene; lactic-acidosis; mitochondrial myopathy; melas; a3243g; encephalopathy; epidemiology; prevalence; episodes
AB Background The mitochondrial DNA m.3243A>G mutation is one the most prevalent mutation causing mitochondrial disease in adult patients. Several cohort studies have used heteroplasmy levels in urinary epithelial cells (UEC) to correlate the genotype of the patients to the clinical severity. However, the interpretation of these data is hampered by a lack of knowledge on the intra-patient variability of the heteroplasmy levels. The goal of this study was to determine the day-to-day variation of the heteroplasmy levels in UEC. Methods Fifteen carriers of the m.3243A>G mutation collected five urine samples in a 14-day window. Heteroplasmy levels of the m.3243A>G mutation were determined in these samples. Data from the national cohort study, including Newcastle Mitochondrial Disease Adult Scale scores and clinical diagnosis, were used. Results In the samples of six patients, heteroplasmy levels were within a 5% margin. In the samples collected from five patients, the margin was >20%. Conclusion Heteroplasmy levels of UEC in carriers of the m.3243A>G mutation have a significant day-to-day variation. The interpretation of a correlation between heteroplasmy levels in urine and disease severity is therefore not reliable. Therefore, heteroplasmy levels in UEC should not be used as a prognostic biomarker in these patients.
C1 [de Laat, Paul; Rodenburg, Richard J.; Smeitink, Jan A. M.; Janssen, Mirian C. H.] Radboudumc Amalia Childrens Hosp, Radboud Ctr Mitochondrial Med, Dept Pediat, Nijmegen, Netherlands.
   [Janssen, Mirian C. H.] Radboudumc, Radboud Ctr Mitochondrial Med, Dept Internal Med, Nijmegen, Netherlands.
C3 Radboud University Nijmegen
RP Janssen, MCH (corresponding author), Radboudumc Amalia Childrenshosp, Radboud Ctr Mitochondrial Med, Nijmegen, Netherlands.
EM paul.delaat@radboudumc.nl
FU ZonMW Priority Medicines [113302003]; Stichting Energy4All
CR Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   desLaat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   desLaat P, 2015, NETH J MED, V73, P30
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Liu CH, 2012, J FORMOS MED ASSOC, V111, P489, DOI 10.1016/j.jfma.2011.06.014
   LÃ¶wik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marotta R, 2009, J CLIN NEUROSCI, V16, P1223, DOI 10.1016/j.jocn.2008.11.012
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   SCHUMANN GB, 1981, ACTA CYTOL, V25, P147
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 24
TC 9
Z9 9
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
EI 
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD FEB 15
PY 2019
VL 7
IS 2
BP 
EP 
DI 10.1002/mgg3.523
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA HN0ZM
UT WOS:000459916900014
PM 30516030
DA 2024-11-01
ER

PT J
AU Duran, J
   Martinez, A
   Adler, E
AF Duran, Jason
   Martinez, Armando
   Adler, Eric
TI Cardiovascular Manifestations of Mitochondrial Disease
SO BIOLOGY-BASEL
LA English
DT Review
DE mitochondrial; genetic mutations; cardiovascular disease; heart failure; cardiomyopathy
ID hereditary optic neuropathy; cytochrome-c-oxidase; stem-cell transplantation; parkinson-white-syndrome; neurogastrointestinal encephalomyopathy mngie; linked cardioskeletal myopathy; left-ventricular myocardium; neurogenic muscle weakness; lethal metabolic-disorder; fetal-growth-retardation
AB Genetic mitochondrial cardiomyopathies are uncommon causes of heart failure that may not be seen by most physicians. However, the prevalence of mitochondrial DNA mutations and somatic mutations affecting mitochondrial function are more common than previously thought. In this review, the pathogenesis of genetic mitochondrial disorders causing cardiovascular disease is reviewed. Treatment options are presently limited to mostly symptomatic support, but preclinical research is starting to reveal novel approaches that may lead to better and more targeted therapies in the future. With better understanding and clinician education, we hope to improve clinician recognition and diagnosis of these rare disorders in order to improve ongoing care of patients with these diseases and advance research towards discovering new therapeutic strategies to help treat these diseases.
C1 [Duran, Jason; Martinez, Armando; Adler, Eric] Univ Calif San Diego, Med Ctr, Dept Cardiol, La Jolla, CA 92037 USA.
C3 University of California System; University of California San Diego
RP Adler, E (corresponding author), Univ Calif San Diego, Med Ctr, Dept Cardiol, La Jolla, CA 92037 USA.
EM jaduran@ucsd.edu; arm021@ucsd.edu; eradler@ucsd.edu
CR Abbas Afroze, 2008, EXPERT REV CARDIOVASC THER, V6, P1135, DOI 10.1586/14779072.6.8.1135
   Achilli A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0042242
   ADES LC, 1993, AM J MED GENET, V45, P327, DOI 10.1002/ajmg.1320450309
   Aggarwal P, 2001, HUM HERED, V51, P114, DOI 10.1159/000022950
   Akaike M, 1997, CLIN CARDIOL, V20, P239, DOI 10.1002/clc.4960200310
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   AurÃ© K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Azevedo O, 2010, CARDIOLOGY, V115, P71, DOI 10.1159/000252811
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barboni P, 2006, INVEST OPHTH VIS SCI, V47, P5303, DOI 10.1167/iovs.06-0520
   BARDOSI A, 1987, ACTA NEUROPATHOL, V74, P248, DOI 10.1007/BF00688189
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Battisti C, 2004, J NEUROL NEUROSUR PS, V75, P1731, DOI 10.1136/jnnp.2003.024372
   Bax BE, 2013, NEUROLOGY, V81, P1269, DOI 10.1212/WNL.0b013e3182a6cb4b
   Bell DSH, 2003, DIABETES CARE, V26, P2949, DOI 10.2337/diacare.26.10.2949
   BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   Blanco-Grau A, 2013, GENES BRAIN BEHAV, V12, P812, DOI 10.1111/gbb.12089
   Bleyl SB, 1997, AM J HUM GENET, V61, P868, DOI 10.1086/514879
   Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   BOLHUIS PA, 1991, AM J HUM GENET, V48, P481
   Bonfante E, 2016, PEDIATR RADIOL, V46, P443, DOI 10.1007/s00247-015-3523-5
   Brady AN, 2006, PRENATAL DIAG, V26, P462, DOI 10.1002/pd.1438
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2011, BRAIN, V134, P0, DOI 10.1093/brain/awr180
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, PC137, DOI 10.1152/ajpcell.00270.2006
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   Claeys KG, 2016, MUSCLE NERVE, V54, P328, DOI 10.1002/mus.25125
   Clarke SLN, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-23
   Crippa BL, 2015, AM J MED GENET A, V167, P621, DOI 10.1002/ajmg.a.36939
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   DAdamo P, 1997, AM J HUM GENET, V61, P862, DOI 10.1086/514886
   Dai DF, 2014, AGING CELL, V13, P529, DOI 10.1111/acel.12203
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   de la Barca JMC, 2016, BRAIN, V139, P2864, DOI 10.1093/brain/aww222
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Drinkard BE, 2010, ARCH PHYS MED REHAB, V91, P1044, DOI 10.1016/j.apmr.2010.04.007
   Duncan JG, 2011, BBA-MOL CELL RES, V1813, P1351, DOI 10.1016/j.bbamcr.2011.01.014
   Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066
   Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El-Hattab AW, 2016, MOL GENET METAB, V117, P407, DOI 10.1016/j.ymgme.2016.01.010
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   El-Hattab AW, 2013, META GENE, V1, P8, DOI 10.1016/j.mgene.2013.09.001
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   FANG W, 1994, MUSCLE NERVE, V17, P52, DOI 10.1002/mus.880170107
   Farruggia P, 2016, JIMD REP, V26, P37, DOI 10.1007/8904_2015_470
   Fellman V, 2002, BLOOD CELL MOL DIS, V29, P444, DOI 10.1006/bcmd.2002.0582
   Fellman V, 1998, LANCET, V351, P490, DOI 10.1016/S0140-6736(97)09272-6
   Fellman V, 2008, J HUM GENET, V53, P554, DOI 10.1007/s10038-008-0284-0
   Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Filosto M, 2012, J NEUROL, V259, P2699, DOI 10.1007/s00415-012-6572-9
   Finsterer J, 2004, ACTA CARDIOL, V59, P187, DOI 10.2143/AC.59.2.2005175
   Finsterer J, 2002, CARDIOVASC PATHOL, V11, P146, DOI 10.1016/S1054-8807(01)00087-4
   Finsterer J, 2018, J INT MED RES, V46, P2054, DOI 10.1177/0300060518765846
   FRYER A, 1994, ARCH DIS CHILD, V71, P419, DOI 10.1136/adc.71.5.419
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Funalot B, 2002, ANN NEUROL, V52, P374, DOI 10.1002/ana.10299
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Ganetzky RD, 2018, MOL GENET METAB, V123, P301, DOI 10.1016/j.ymgme.2018.01.010
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gaspard GJ, 2015, CHEM PHYS LIPIDS, V193, P1, DOI 10.1016/j.chemphyslip.2015.09.005
   Gerards M, 2013, BRAIN, V136, P882, DOI 10.1093/brain/awt013
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Giraudet S, 2011, BRIT J OPHTHALMOL, V95, P887, DOI 10.1136/bjo.2009.161539
   Gobu P, 2011, INDIAN PACING ELECTROPHYSIOL J, V10, P547
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Guy J, 2017, OPHTHALMOLOGY, V124, P1621, DOI 10.1016/j.ophtha.2017.05.016
   Guy J, 2009, INVEST OPHTH VIS SCI, V50, P4205, DOI 10.1167/iovs.08-3214
   Hadzsiev K, 2010, NEUROMOL MED, V12, P277, DOI 10.1007/s12017-010-8115-9
   Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9
   Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   HAMBY RI, 1974, JAMA-J AM MED ASSOC, V229, P1749, DOI 10.1001/jama.229.13.1749
   HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hirano M, 2001, CURR OPIN CARDIOL, V16, P201, DOI 10.1097/00001573-200105000-00008
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   HUOPONEN K, 1991, AM J HUM GENET, V48, P1147
   Jefferies JL, 2013, AM J MED GENET C, V163, P198, DOI 10.1002/ajmg.c.31372
   Jensen MK, 2012, CIRCULATION, V125, P1591, DOI 10.1161/CIRCULATIONAHA.112.095364
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Kara B, 2012, MOL GENET METAB, V107, P389, DOI 10.1016/j.ymgme.2012.06.013
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121
   KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6
   Khan NA, 2017, INVEST OPHTH VIS SCI, V58, P3923, DOI 10.1167/iovs.16-20695
   Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010
   Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001
   Koilkonda RD, 2014, JAMA OPHTHALMOL, V132, P409, DOI 10.1001/jamaophthalmol.2013.7630
   Kotarsky H, 2010, MITOCHONDRION, V10, P497, DOI 10.1016/j.mito.2010.05.009
   Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kulik W, 2008, CLIN CHEM, V54, P371, DOI 10.1373/clinchem.2007.095711
   Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730
   Lane N, 2011, SCIENCE, V334, P184, DOI 10.1126/science.1214012
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   Lee WS, 2013, J PEDIATR-US, V163, P942, DOI 10.1016/j.jpeds.2013.05.036
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lesnefsky EJ, 2017, ANNU REV PHARMACOL, V57, P535, DOI 10.1146/annurev-pharmtox-010715-103335
   Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Lien LM, 2001, ACTA NEUROL SCAND, V103, P159, DOI 10.1034/j.1600-0404.2001.103003159.x
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   LÃ³pez-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Lott MT, 2013, CURR PROTOC BIOINF, V44, P1231, DOI 10.1002/0471250953.BI0123S44
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Majamaa-Voltti Kirsi, 2002, BMC CARDIOVASC DISORD, V2, P12
   Majander A, 2017, BRIT J OPHTHALMOL, V101, P1505, DOI 10.1136/bjophthalmol-2016-310072
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mariotti C, 2003, NEUROLOGY, V60, P1676, DOI 10.1212/01.WNL.0000055872.50364.FC
   Mascialino B, 2012, EUR J OPHTHALMOL, V22, P461, DOI 10.5301/ejo.5000055
   Mashima Y, 2000, J NEURO-OPHTHALMOL, V20, P166, DOI 10.1097/00041327-200020030-00006
   Mashima Y, 1996, CLIN GENET, V50, P535
   MASHIMA Y, 1992, LANCET, V340, P368, DOI 10.1016/0140-6736(92)91442-B
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   MEIRE FM, 1995, OPHTHALMIC GENET, V16, P119, DOI 10.3109/13816819509059971
   Meyers Deborah E, 2013, TEX HEART INST J, V40, P635
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Meyerson C, 2015, CLIN OPHTHALMOL, V9, P1165, DOI 10.2147/OPTH.S62021
   Momiyama Y, 2002, DIABETES CARE, V25, P2308, DOI 10.2337/diacare.25.12.2308
   Mordel P, 2017, BIOCHEM BIOPH RES CO, V494, P133, DOI 10.1016/j.bbrc.2017.10.066
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Moslemi AR, 2003, NEUROLOGY, V61, P991, DOI 10.1212/01.WNL.0000082391.98672.0A
   Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Narbonne H, 2004, DIABETES METAB, V30, P61, DOI 10.1016/S1262-3636(07)70090-3
   NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   NIKOSKELAINEN EK, 1994, LANCET, V344, P857, DOI 10.1016/S0140-6736(94)92830-4
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   ORTIZ RG, 1992, AM J OPHTHALMOL, V113, P561, DOI 10.1016/S0002-9394(14)74730-0
   OZAWA M, 1995, NEUROMUSCULAR DISORD, V5, P483, DOI 10.1016/0960-8966(95)00009-C
   PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PÃ©quignot MO, 2001, HUM MUTAT, V17, P374, DOI 10.1002/humu.1112.abs
   Perez F, 2009, CLIN NEUROL NEUROSUR, V111, P83, DOI 10.1016/j.clineuro.2008.06.021
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Pignatelli RH, 2003, CIRCULATION, V108, P2672, DOI 10.1161/01.CIR.0000100664.10777.B8
   Pisano A, 2015, HUM MOL GENET, V24, P6921, DOI 10.1093/hmg/ddv396
   Porto FBO, 2001, AM J OPHTHALMOL, V132, P935, DOI 10.1016/S0002-9394(01)01187-4
   POULTON J, 1991, AM J HUM GENET, V48, P649
   Poyau A, 2000, HUM GENET, V106, P194, DOI 10.1007/s004390051028
   Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010
   Puomila A, 2007, EUR J HUM GENET, V15, P1079, DOI 10.1038/sj.ejhg.5201828
   Puri Aniket, 2012, INDIAN HEART J, V64, P515, DOI 10.1016/j.ihj.2012.07.010
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rajendran J, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17111824
   Rapola J, 2002, PEDIATR PATHOL MOL M, V21, P183, DOI 10.1080/15227950252852087
   REGAN TJ, 1977, J CLIN INVEST, V60, P885, DOI 10.1172/JCI108843
   Remes AM, 2005, NEUROLOGY, V64, P976, DOI 10.1212/01.WNL.0000154518.31302.ED
   Rigaud C, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-70
   RIORDANEVA P, 1995, J MED GENET, V32, P81, DOI 10.1136/jmg.32.2.81
   Robberecht K, 2010, OPHTHALMIC GENET, V31, P240, DOI 10.3109/13816810.2010.520297
   Roberts AE, 2012, AM J MED GENET A, V158A, P2726, DOI 10.1002/ajmg.a.35609
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   RÃ¶eben B, 2017, ORPHANET J RARE DIS, V12, P0, DOI 10.1186/s13023-017-0687-0
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4
   Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   Sadun AA, 2012, ARCH NEUROL-CHICAGO, V69, P331, DOI 10.1001/archneurol.2011.2972
   Salles JE, 2006, DIABETES RES CLIN PR, V72, P100, DOI 10.1016/j.diabres.2005.09.005
   Santorelli FM, 1996, NEUROLOGY, V47, P1320, DOI 10.1212/WNL.47.5.1320
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   Scarpelli M, 2013, NEURORADIOL J, V26, P520, DOI 10.1177/197140091302600505
   Schultz JC, 2009, MAYO CLIN PROC, V84, P1001, DOI 10.4065/84.11.1001
   Sciacco M, 2003, J NEUROL, V250, P1498, DOI 10.1007/s00415-003-0246-6
   Serdaroglu E, 2016, TURKISH J PEDIATR, V58, P658, DOI 10.24953/turkjped.2016.06.013
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   Sonam K, 2014, BRAIN DEV-JPN, V36, P807, DOI 10.1016/j.braindev.2013.10.012
   Spencer CT, 2006, PEDIATRICS, V118, PE337, DOI 10.1542/peds.2005-2667
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Steriade C, 2014, PEDIATR NEUROL, V50, P498, DOI 10.1016/j.pediatrneurol.2014.01.009
   Steward CG, 2010, PRENATAL DIAG, V30, P970, DOI 10.1002/pd.2599
   Steward CG, 2019, CURR OPIN HEMATOL, V26, P6, DOI 10.1097/MOH.0000000000000472
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Tabebi M, 2017, J DIABETES COMPLICAT, V31, P253, DOI 10.1016/j.jdiacomp.2016.06.028
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Tocchi A, 2015, BBA-BIOENERGETICS, V1847, P1424, DOI 10.1016/j.bbabio.2015.07.009
   Torres-Torronteras J, 2016, HUM GENE THER, V27, P656, DOI 10.1089/hum.2015.160
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023
   Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236
   Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193
   Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200
   van Beynum I, 2012, JIMD REP, V2, P7, DOI 10.1007/8904_2011_32
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VisapÃ¤Ã¤ I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Wang Jing, 2015, CLIN NUTR RES, V4, P132, DOI 10.7762/cnr.2015.4.2.132
   Wang Shi-Bing, 2008, PEDIATRICS AND NEONATOLOGY, V49, P145, DOI 10.1016/S1875-9572(08)60030-3
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yang S, 2016, EBIOMEDICINE, V10, P258, DOI 10.1016/j.ebiom.2016.07.002
   Yang YL, 2006, CHINESE MED J-PEKING, V119, P373, DOI 10.1097/00029330-200603010-00004
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang J, 2015, INT J CLIN EXP PATHO, V8, P13411
   Zhu J, 2017, J DIABETES COMPLICAT, V31, P1354, DOI 10.1016/j.jdiacomp.2017.04.001
NR 253
TC 22
Z9 25
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2079-7737
J9 BIOLOGY-BASEL
JI Biology-Basel
PD JUN 15
PY 2019
VL 8
IS 2
BP 
EP 
DI 10.3390/biology8020034
PG 27
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA II6FD
UT WOS:000475287600015
PM 31083569
DA 2024-11-01
ER

PT J
AU Danda, S
   Thomas, BM
   Paramasivam, G
   Thomas, R
   Mathew, J
   Danda, D
AF Danda, Sumita
   Thomas, Blessy Mariam
   Paramasivam, G.
   Thomas, Raji
   Mathew, John
   Danda, Debashish
TI A descriptive pilot study of mitochondrial mutations & clinical phenotype in fibromyalgia syndrome
SO INDIAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Article
DE DNA deletions; fibromyalgia; genetic; Indian; long-range polymerise chain reaction; mitochondrial mutations; vitamin D
AB Background & objectives: Fibromyalgia syndrome (FMS) is one of the most common chronic pain conditions of unknown aetiology. Mitochondria! dysfunction has been reported in FMS with some studies reporting the presence of mitochondria! mutation namely A3243G, which also causes mitochondria! encephalomyopathy, lactic acidosis and stroke-like episodes. This pilot study was conducted to assess this mutation and also detect large deletions in mitochondrial DNA (mtDNA) in patients with FMS. Methods: Thirty female patients with FMS participated and 30 matched controls were included. Genomic DNA was subjected to polymerise chain reaction (PCR) amplification using specific primers followed by restriction digestion with Apal enzyme to detect the specific A3243G mtDNA mutation. Long-range PCR was done in two sets to detect the large deletions in the mtDNA. Biochemical parameters including thyroid-stimulating hormone and vitamin D levels were also looked at. Results: None of the patients were found to carry the common mutation or large deletions. Low vitamin D level w as a common finding. Hypothyroidism was found in a few patients. Interpretation & conclusions: Although the common mutation or large mtDNA deletions were not detected in blood mtDNA in the FMS patients, mutations in the muscle and sequence variation in mtDNA remained a possibility. Future studies in both blood and muscle tissue including mtDNA sequencing are warranted in such patients to determine if a subset of FMS patients have mitochondrial myopathy.
C1 [Danda, Sumita; Thomas, Blessy Mariam; Paramasivam, G.] Christian Med Coll & Hosp, Dept Med Genet, Vellore, Tamil Nadu, India.
   [Thomas, Raji] Christian Med Coll & Hosp, Dept Phys Med & Rehabil, Vellore, Tamil Nadu, India.
   [Mathew, John; Danda, Debashish] Christian Med Coll & Hosp, Dept Clin Immunol & Rheumatol, Vellore 632004, Tamil Nadu, India.
C3 Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore
RP Danda, D (corresponding author), Christian Med Coll & Hosp, Dept Clin Immunol & Rheumatol, Vellore 632004, Tamil Nadu, India.
EM debashisdandacmc@hotmail.com
FU Lady Tata foundation for Research, Mumbai
CR Abdullah Mishal, 2012, J MED CASE REP, V6, P55, DOI 10.1186/1752-1947-6-55
   Bandelt HJ, 2014, J HUM GENET, V59, P66, DOI 10.1038/jhg.2013.120
   Bhatty SA, 2010, J PAK MED ASSOC, V60, P949
   Castro-Marrero J, 2015, ANTIOXID REDOX SIGN, V22, P679, DOI 10.1089/ars.2014.6181
   Cordero MD, 2016, J MED GENET, V53, P113, DOI 10.1136/jmedgenet-2015-103392
   Cordero MD, 2013, ANTIOXID REDOX SIGN, V18, P800, DOI 10.1089/ars.2012.4892
   Cordero MD, 2011, REUMATOL CLIN, V7, P281, DOI 10.1016/j.reuma.2010.12.007
   Cordero MD, 2010, ARTHRITIS RES THER, V12, P0, DOI 10.1186/ar2918
   DeSouza RA, 2004, SOUTH MED J, V97, P528, DOI 10.1097/00007611-200405000-00023
   Dogru A, 2017, EURASIAN J MED, V49, P113, DOI 10.5152/eurasianjmed.2017.16283
   Ohkubo K, 2001, CLIN CHEM, V47, P1641
   Sprott H, 2004, ANN RHEUM DIS, V63, P245, DOI 10.1136/ard.2002.004762
   Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   2011, 1900, V11, V0, PP623, DOI 10.1016/J.MITO.2011.03.122
NR 15
TC 3
Z9 3
U1 0
U2 5
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0971-5916
EI 
J9 INDIAN J MED RES
JI Indian J. Med. Res.
PD JAN 15
PY 2019
VL 149
IS 1
BP 47
EP 50
DI 10.4103/ijmr.IJMR_1977_16
PG 4
WC Immunology; Medicine, General & Internal; Medicine, Research & Experimental
SC Immunology; General & Internal Medicine; Research & Experimental Medicine
GA HV2MR
UT WOS:000465825200008
PM 31115374
DA 2024-11-01
ER

PT J
AU Roos, S
   Sofou, K
   Hedberg-Oldfors, C
   Kollberg, G
   Lindgren, U
   Thomsen, C
   Tulinius, M
   Oldfors, A
AF Roos, Sara
   Sofou, Kalliopi
   Hedberg-Oldfors, Carola
   Kollberg, Gittan
   Lindgren, Ulrika
   Thomsen, Christer
   Tulinius, Mar
   Oldfors, Anders
TI Mitochondrial complex IV deficiency caused by a novel frameshift variant in <i>MT-CO2</i> associated with myopathy and perturbed acylcarnitine profile
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID cytochrome-c-oxidase; subunit-ii; mutation; gene
AB Mitochondrial myopathies are a heterogeneous group of disorders associated with a wide range of clinical phenotypes. We present a 16-year-old girl with a history of exercise intolerance since childhood. Acylcarnitine species suggestive of multiple acyl-CoA dehydrogenase deficiency were found in serum, however genetic analysis did not reveal variants in genes associated with this disorder. Biochemical analyses of skeletal muscle mitochondria revealed an isolated and extremely low activity of cytochrome c oxidase (COX). This finding was confirmed by enzyme histochemistry, which demonstrated an almost complete absence of fibers with normal COX activity. Whole-exome sequencing revealed a single base-pair deletion (m.8088delT) in MT-CO2, which encodes subunit 2 of COX, resulting in a premature stop codon. Restriction fragment length polymorphism-analysis confirmed mtDNA heteroplasmy with high mutant load in skeletal muscle, the only clinically affected tissue, but low levels in other investigated tissues. Single muscle fiber analysis showed segregation of the mutant genotype with respiratory chain dysfunction. Immuno-histochemical studies indicated that the truncating variant in COX2 has an inhibitory effect on the assembly of the COX holoenzyme.
C1 [Roos, Sara; Hedberg-Oldfors, Carola; Lindgren, Ulrika; Thomsen, Christer; Oldfors, Anders] Univ Gothenburg, Dept Pathol & Genet, Gothenburg, Sweden.
   [Roos, Sara; Hedberg-Oldfors, Carola; Lindgren, Ulrika; Thomsen, Christer; Oldfors, Anders] Univ Gothenburg, Inst Biomed, Gothenburg, Sweden.
   [Sofou, Kalliopi] Sahlgrens Univ Hosp, Dept Pediat, Queen Silvia Childrens Hosp, Gothenburg, Sweden.
   [Kollberg, Gittan] Univ Gothenburg, Inst Biomed, Dept Clin Chem, Gothenburg, Sweden.
   [Tulinius, Mar] Univ Gothenburg, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden.
C3 University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; Queen Silvia Children's Hospital; University of Gothenburg; University of Gothenburg
RP Roos, S (corresponding author), Univ Gothenburg, Dept Pathol & Genet, Gothenburg, Sweden.; Roos, S (corresponding author), Univ Gothenburg, Inst Biomed, Gothenburg, Sweden.
EM sara.roos@gu.se
FU Swedish Research Council [2012-2014]
CR Abdulhag UN, 2015, EUR J HUM GENET, V23, P159, DOI 10.1038/ejhg.2014.85
   Campos Y, 2001, ANN NEUROL, V50, P409, DOI 10.1002/ana.1141
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P1, DOI 10.1177/000271623618500112
   Hallmann K, 2016, BRAIN, V139, P338, DOI 10.1093/brain/awv357
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   HorvÃ¡th R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Roos S, 2014, NEUROMUSCULAR DISORD, V24, P713, DOI 10.1016/j.nmd.2014.05.009
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   Uusimaa J, 2003, PEDIATRICS, V111, P0, DOI 10.1542/peds.111.3.e262
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   Wajner M, 2016, BIOSCIENCE REP, V36, P0, DOI 10.1042/BSR20150240
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
NR 19
TC 15
Z9 18
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD FEB 15
PY 2019
VL 27
IS 2
BP 331
EP 335
DI 10.1038/s41431-018-0286-0
PG 5
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA HH8LP
UT WOS:000455983900019
PM 30315213
DA 2024-11-01
ER

PT J
AU Heighton, JN
   Brady, LI
   Sadikovic, B
   Bulman, DE
   Tarnopolsky, MA
AF Heighton, Julia N.
   Brady, Lauren I.
   Sadikovic, Bekim
   Bulman, Dennis E.
   Tarnopolsky, Mark A.
TI Genotypes of chronic progressive external ophthalmoplegia in a large adult-onset cohort
SO MITOCHONDRION
LA English
DT Article
DE Chronic Progressive External Ophthalmoplegia; mtDNA deletion; POLG; WFS1; Sensorineural hearing loss
ID mitochondrial-dna deletions; autosomal-dominant; mutations; disease; single; gene; wfs1
AB Chronic progressive external ophthalmoplegia (CPEO) is a common presentation of mitochondrial disease. We performed a retrospective evaluation of the molecular genetic testing and genotype-phenotype correlations in a large cohort of adult-onset CPEO patients (N = 111). One hundred percent of patients tested had at least one mitochondrial DNA (mtDNA) deletion. Genetic testing of nuclear genes encoding mitochondrial proteins identified pathogenic/likely pathogenic variants likely to be associated with CPEO in 7.6% of patients. As expected, the nuclear gene most associated with DNA variation was POLG. A single likely pathogenic mitochondrial DNA variant (m.12278T > C) was identified in two unrelated patients. No significant differences were noted in the clinical phenotypes of patients with pathogenic or likely pathogenic nuclear variants in comparison to those with negative nuclear gene testing. Analysis of deletion size and heteroplasmy in muscle-derived mtDNA showed significant correlations with age of symptom onset but not disease severity (number of canonical CPEO features). Results suggest that smaller mtDNA deletions (p = 0.0127, r(2) = 0.1201) and higher heteroplasmy of single mtDNA deletions (p = 0.0112, r(2) = 0.2483) are associated with an earlier age of onset in CPEO patients.
C1 [Heighton, Julia N.; Brady, Lauren I.; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada.
   [Sadikovic, Bekim] Western Univ, Dept Pathol & Lab Med, London, ON, Canada.
   [Bulman, Dennis E.] Childrens Hosp Eastern Ontario, Newborn Screening Ontario, Ottawa, ON, Canada.
   [Bulman, Dennis E.] Childrens Hosp Eastern Ontario, CHEO Res Inst, Ottawa, ON, Canada.
   [Sadikovic, Bekim] London Hlth Sci Ctr, Mol Genet Lab, Mol Diagnost Div, London, ON, Canada.
C3 McMaster University; Western University (University of Western Ontario); University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; London Health Sciences Centre
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON, Canada.
EM tarnopol@mcmaster.ca
FU Canadian Institute for Health Research grant [143325]
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Barrientos A, 1996, J CLIN INVEST, V97, P1570, DOI 10.1172/JCI118581
   Belmonte FR, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25186
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Cruz S, 2017, MUSCLE NERVE, V56, P868, DOI 10.1002/mus.25593
   Cryns K, 2003, HUM MUTAT, V22, P275, DOI 10.1002/humu.10258
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Huang Taosheng, 2011, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1908s71
   Kerkhof J, 2017, J MOL DIAGN, V19, P905, DOI 10.1016/j.jmoldx.2017.07.004
   Kraytsberg Y, 2009, METHODS MOL BIOL, V554, P329, DOI 10.1007/978-1-59745-521-3_21
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee Andrew G, 2002, CURR NEUROL NEUROSCI REP, V2, P413, DOI 10.1007/s11910-002-0067-5
   LÃ³pez-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Lott MT, 2013, CURR PROTOC BIOINFOR, V44, P0
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Park KP, 2011, J CLIN NEUROL, V7, P25, DOI 10.3988/jcn.2011.7.1.25
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Sadikovic B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015687
   Schenkel LC, 2016, J MOL DIAGN, V18, P657, DOI 10.1016/j.jmoldx.2016.04.002
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Sotiriou E, 2009, NEUROMUSCULAR DISORD, V19, P297, DOI 10.1016/j.nmd.2009.01.014
   Van den Ouweland JMW, 2003, J MOL DIAGN, V5, P88, DOI 10.1016/S1525-1578(10)60457-6
   YAMAMOTO M, 1991, NEUROLOGY, V41, P1822, DOI 10.1212/WNL.41.11.1822
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 32
TC 14
Z9 14
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV 15
PY 2019
VL 49
IS 
BP 227
EP 231
DI 10.1016/j.mito.2019.09.002
PG 5
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA JX2AW
UT WOS:000503545000025
PM 31521625
DA 2024-11-01
ER

PT J
AU Suzuki-Hatano, S
   Sriramvenugopal, M
   Ramanathan, M
   Soustek, M
   Byrne, BJ
   Cade, WT
   Kang, PB
   Pacak, CA
AF Suzuki-Hatano, Silveli
   Sriramvenugopal, Mughil
   Ramanathan, Manash
   Soustek, Meghan
   Byrne, Barry J.
   Cade, W. Todd
   Kang, Peter B.
   Pacak, Christina A.
TI Increased mtDNA Abundance and Improved Function in Human Barth Syndrome Patient Fibroblasts Following AAV-<i>TAZ</i> Gene Delivery
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Barth syndrome; mitochondrial disease; mtDNA copy numbers; gene therapy; AAV; TMEM65; fibroblasts
ID young-adults; mitochondrial; cardiolipin; deficiency; lead
AB Barth syndrome (BTHS) is a rare, X-linked, mitochondrial disorder caused by mutations in the gene encoding tafazzin. BTHS results in cardiomyopathy, muscle fatigue, and neutropenia in patients. Tafazzin is responsible for remodeling cardiolipin, a key structural lipid of the inner mitochondrial membrane. As symptoms can vary in severity amongst BTHS patients, we sought to compare mtDNA copy numbers, mitochondrial fragmentation, and functional parameters between primary dermal BTHS fibroblasts isolated from patients with two different mutations in the TAZ locus. To confirm cause-effect relationships and further support the development of gene therapy for BTHS, we also characterized the BTHS cells following adeno-associated virus (AAV)-TAZ transduction. Our data show that, in response to AAV-TAZ transduction, these remarkably dynamic organelles show recovery of mtDNA copy numbers, mitochondrial structure, and mitochondrial function, providing additional evidence to support the therapeutic potential of AAV-mediated gene delivery for BTHS. This study also demonstrates the direct relationship between healthy mitochondrial membrane structure and maintenance of proper levels of mtDNA copy numbers.
C1 [Suzuki-Hatano, Silveli; Sriramvenugopal, Mughil; Ramanathan, Manash; Soustek, Meghan; Byrne, Barry J.; Kang, Peter B.; Pacak, Christina A.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32610 USA.
   [Soustek, Meghan; Byrne, Barry J.; Kang, Peter B.; Pacak, Christina A.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.
   [Cade, W. Todd] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO 63110 USA.
C3 State University System of Florida; University of Florida; State University System of Florida; University of Florida; Washington University (WUSTL)
RP Pacak, CA (corresponding author), Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32610 USA.; Pacak, CA (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.
EM pacakc@peds.ufl.edu
FU Barth Syndrome Foundation: Association Barth France; Will McCurdy Fund for the Advancement of Therapies for Barth Syndrome [AGR DTD 03-06-2015]; Barth Syndrome Foundation: Barth Syndrome Foundation of Canada [AGR DTD 7-14-2017]; American Heart Association-Scientist Development Grant [17SDG33410467]; Children's Miracle Network: UF Pediatrics Pilot Project; National Institutes of Health [R01 HL136759-01A1, R01 HL107406-01A1]; American Heart Association (AHA) [17SDG33410467] Funding Source: American Heart Association (AHA)
CR Bashir A, 2017, PHYSIOL REP, V5, P0, DOI 10.14814/phy2.13130
   Bowron A, 2015, J INHERIT METAB DIS, V38, P279, DOI 10.1007/s10545-014-9747-y
   Cade WT, 2017, JIMD REP, V32, P15, DOI 10.1007/8904_2016_553
   Cade WT, 2013, J INHERIT METAB DIS, V36, P91, DOI 10.1007/s10545-012-9486-x
   Cade WT, 2019, J INHERIT METAB DIS, V42, P480, DOI 10.1002/jimd.12094
   Cade WT, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0197776
   Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886
   Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009
   Huang J, 2016, MEDICINE, V95, P0, DOI 10.1097/MD.0000000000003323
   Johnson-Cadwell LI, 2007, J NEUROCHEM, V101, P1619, DOI 10.1111/j.1471-4159.2007.04516.x
   Kuijpers TW, 2004, BLOOD, V103, P3915, DOI 10.1182/blood-2003-11-3940
   Li MX, 2010, HUM GENE THER, V21, P1527, DOI 10.1089/hum.2010.005
   Nazli A, 2017, EUR J HUM GENET, V25, P744, DOI 10.1038/ejhg.2017.20
   Neuwald AF, 1997, CURR BIOL, V7, P0
   Nishimura N, 2014, PEERJ, V2, P0, DOI 10.7717/peerj.349
   Saini-Chohan HK, 2009, J LIPID RES, V50, P1600, DOI 10.1194/jlr.M800561-JLR200
   Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002
   Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015
   Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200
   Schnepp BC, 2003, J VIROL, V77, P3495, DOI 10.1128/JVI.77.6.3495-3504.2003
   Sharma P, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9391
   Spencer CT, 2006, PEDIATRICS, V118, PE337, DOI 10.1542/peds.2005-2667
   Spencer CT, 2011, AM J PHYSIOL-HEART C, V301, PH2122, DOI 10.1152/ajpheart.00479.2010
   Suzuki-Hatano S, 2019, HUM GENE THER, V30, P139, DOI 10.1089/hum.2018.020
   Suzuki-Hatano S, 2019, MOL THER-METH CLIN D, V13, P167, DOI 10.1016/j.omtm.2019.01.007
   Taggart K, 2017, BIORESEARCH OPEN ACC, V6, P182, DOI 10.1089/biores.2017.0023
   Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200
   Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545
   Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200
   Yue P, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0206003
   Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105
NR 31
TC 8
Z9 8
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL 2
PY 2019
VL 20
IS 14
BP 
EP 
DI 10.3390/ijms20143416
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA IQ0OB
UT WOS:000480449300040
PM 31336787
DA 2024-11-01
ER

PT J
AU BlÃ¡zquez-Bermejo, C
   Molina-Granada, D
   Vila-JuliÃ , F
   JimÃ©nez-Heis, D
   Zhou, XS
   Torres-Torronteras, J
   Karlsson, A
   MartÃ­, R
   CÃ¡mara, Y
AF Blazquez-Bermejo, Cora
   Molina-Granada, David
   Vila-Julia, Ferran
   Jimenez-Heis, Daniel
   Zhou, Xiaoshan
   Torres-Torronteras, Javier
   Karlsson, Anna
   Marti, Ramon
   Camara, Yolanda
TI Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice
SO EBIOMEDICINE
LA English
DT Article
DE TK2; Deoxynucleoside therapy; mtDNA depletion; Encephalomyopathy; Thymidine; Deoxycytidine
ID mitochondrial-dna; substrate-specificity; pools; expression; mutations; onset
AB Background: Thymidine kinase 2 (TK2) catalyses the phosphorylation of deoxythymidine (dThd) and deoxycytidine (dCtd) within mitochondria. TK2 deficiency leads to mtDNA depletion or accumulation of multiple deletions. In patients, TK2 mutations typically manifest as a rapidly progressive myopathy with infantile onset, leading to respiratory insufficiency and encephalopathy in the most severe clinical presentations. TK2-deficient mice develop the most severe form of the disease and die at average postnatal day 16. dThd+dCtd administration delayed disease progression and expanded lifespan of a knockin murine model of the disease. Methods: We daily administered TK2 knockout mice (Tk2(KO)) from postnatal day 4 with equimolar doses of dThd+dCtd, dTMP+dCMP, dThd alone or dCtd alone. We monitored body weight and survival and studied different variables at 12 or 29 days of age. We determined metabolite levels in plasma and target tissues, mtDNA copy number in tissues, and the expression and activities of enzymes with a relevant role in mitochondrial dNTP anabolism or catabolism. Findings: dThd+dCtd treatment extended average lifespan of Tk2(KO) mice from 16 to 34 days, attenuated growth retardation, and rescued mtDNA depletion in skeletal muscle and other target tissues of 12-day-old mice, except in brain. However, the treatment was ineffective in 29-day-old mice that still died prematurely. Bioavailability of dThd and dCtd markedly decreased during mouse development. Activity of enzymes catabolizing dThd and dCtd increased with age in small intestine. Conversely, the activity of the anabolic enzymes decreased in target tissues during mouse development. We also found that administration of dThd alone had the same impact on survival to that of dThd+dCtd, whereas dCtd alone had no influence on lifespan. Interpretation: dThd+dCtd treatment recruits alternative cytosolic salvage pathways for dNTP synthesis, suggesting that this therapy would be of benefit for any Tk2 mutation. dThd accounts for the therapeutic effect of the combined treatment in mice. During the first weeks after birth, mice experience marked tissue-specific metabolic regulations and ontogenetic changes in dNTP metabolism-related enzymes that limit therapeutic efficacy to early developmental stages. (C) 2019 The Authors. Published by Elsevier B.V.
C1 [Blazquez-Bermejo, Cora; Molina-Granada, David; Vila-Julia, Ferran; Jimenez-Heis, Daniel; Torres-Torronteras, Javier; Marti, Ramon; Camara, Yolanda] Univ Autonoma Barcelona, Res Grp Neuromuscular & Mitochondrial Disorders, Vall dHebron Inst Recerca, Barcelona, Spain.
   [Blazquez-Bermejo, Cora; Molina-Granada, David; Vila-Julia, Ferran; Torres-Torronteras, Javier; Marti, Ramon; Camara, Yolanda] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain.
   [Zhou, Xiaoshan; Karlsson, Anna] Karolinska Inst, Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, S-14186 Stockholm, Sweden.
C3 Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Instituto de Salud Carlos III; Karolinska Institutet; Karolinska University Hospital
RP CÃ¡mara, Y (corresponding author), Hosp Univ Vall dHebron, Lab Patol Neuromuscular & Mitocondrial, Inst Recerca, CIBERER, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.
EM yolanda.camara@vhir.org
FU SpanishMinistry of Industry, Economy and Competitiveness [BFU2014-52618-R, SAF2017-87506-R]; Spanish Instituto de Salud Carlos III [PI15/00465, PMP 15/00025]; ERDF; Fundacion Inocente, Inocente; AFMTelethon [19,965]; Generalitat de Catalunya (PERIS program) [SLT002/16/00370]
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   CÃ¡mara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   DomÃ­nguez-GonzÃ¡lez C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   ELKOUNI MH, 1993, CANCER RES, V53, P3687
   FANUCCHI MP, 1986, BIOCHEM PHARMACOL, V35, P1199, DOI 10.1016/0006-2952(86)90160-7
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   GÃ¶tz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hu CM, 2007, J BIOMED SCI, V14, P491, DOI 10.1007/s11373-007-9175-1
   Ke PY, 2007, FASEB J, V21, P1276, DOI 10.1096/fj.06-7272com
   Krishnan S, 2014, J BIOL CHEM, V289, P0, DOI 10.1074/jbc.M114.588921
   LÃ³pez LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Lopez-Gomez C, 2019, BIOAVAILABILIT UNPUB, V0, P0
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   MartÃ­ R, 2012, METHODS MOL BIOL, V837, P121, DOI 10.1007/978-1-61779-504-6_8
   Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev
   Pastor-Anglada M, 2018, COMPR PHYSIOL, V8, P1003, DOI 10.1002/cphy.c170039
   Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002
   Redzic Zoran B, 2010, CEREBROSPINAL FLUID RES, V7, P2, DOI 10.1186/1743-8454-7-2
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029
   Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SPECTOR R, 1984, FED PROC, V43, P196
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Walker UA, 2006, ANTIVIR THER, V11, P25
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   Young JD, 2016, BIOCHEM SOC T, V44, P869, DOI 10.1042/BST20160038
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
   Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4
NR 35
TC 20
Z9 21
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2352-3964
EI 
J9 EBIOMEDICINE
JI EBioMedicine
PD AUG 15
PY 2019
VL 46
IS 
BP 342
EP 355
DI 10.1016/j.ebiom.2019.07.042
PG 14
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA IY7RE
UT WOS:000486592000044
PM 31351931
DA 2024-11-01
ER

PT J
AU Singh, RK
   Saini, SK
   Prakasam, G
   Kalairasan, P
   Bamezai, RNK
AF Singh, Rajnish Kumar
   Saini, Sunil Kumar
   Prakasam, Gopinath
   Kalairasan, Ponnuusamy
   Bamezai, Rameshwar N. K.
TI Role of ectopically expressed mtDNA encoded cytochrome c oxidase subunit I (MT-COI) in tumorigenesis
SO MITOCHONDRION
LA English
DT Article
ID mitochondrial-dna mutations; leigh-syndrome; nd5 mutation; common-cause; complex-i; cancer; gene; breast; myopathy; model
AB Somatic mutations within mitochondrial DNA (mtDNA) encoded cytochrome c oxidase subunit I (MT-CO1 or MT-COI) are frequent in various cancer types. In addition, perturbation from orchestrated expression of mitochondrial DNA encoded genes is also associated with complex disorders, including cancer. Since codon bias and the mitochondrial translation system restricts functional characterization of over-expressed wild type or mutant mitochondrial DNA encoded genes, the codon optimization and artificial synthesis of entire MT-CO1 allowed us to over-express the wild type and one of its deleterious mutants into the mitochondria of the transfected cells. Ectopically expressed MT-CO1 was observed to efficiently express and localized to mitochondria but showed high level of aggregation under denaturing condition. Over-expression of wild type or mutant variant of MT-CO1 promoted anchorage dependent and independent proliferation potential in in-vitro experiments and introduced the cancer cell metabolic phenotype of high glucose uptake and lactate release. Reactive oxygen species generated in cells over-expressing MT-CO1 variants acted as key effectors mediating differential expression of apoptosis and DNA damage pathway related genes. High ROS generated also down-regulated the expression of global regulators of gene expression, DNMT3A and DNMT3B. The down-regulated expression of DNMTs co-related with differential methylation of the CpG islands in the promoter region of a select set of studied genes, in a manner to promote pro-cancerous phenotype. Apart from assigning the mechanistic role to the MT-CO1 variants and their perturbed expression in cancer development, the present study provides novel insights into the functional role of somatic mutations within MT-CO1 promoting cancer phenotype.
C1 [Singh, Rajnish Kumar; Saini, Sunil Kumar; Prakasam, Gopinath; Kalairasan, Ponnuusamy; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Iife Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.
   [Singh, Rajnish Kumar] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Kalairasan, Ponnuusamy] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi, India.
C3 Jawaharlal Nehru University, New Delhi; University of Pennsylvania; Jawaharlal Nehru University, New Delhi
RP Bamezai, RNK (corresponding author), Jawaharlal Nehru Univ, Sch Iife Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.
EM rajnishsbt2005@gmail.com; bamezai@mail.jnu.ac.in
FU Council of Scientific and Industrial Research (CSIR), Govt. of India; University grant commission (UGC), Govt. of India
CR ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   DAurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141
   Darvishi K, 2007, CANCER LETT, V249, P249, DOI 10.1016/j.canlet.2006.09.005
   Das TK, 1998, BIOCHEMISTRY-US, V37, P14471, DOI 10.1021/bi981500w
   Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532
   Dhar SS, 2013, OPEN BIOL, V3, P0, DOI 10.1098/rsob.120176
   Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05
   Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013
   Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338
   Gao S, 2018, MITOCHONDRION, V38, P41, DOI 10.1016/j.mito.2017.08.002
   Gochhait S, 2008, INT J CANCER, V123, P2580, DOI 10.1002/ijc.23817
   HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010
   Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109
   Leadsham JE, 2013, CELL METAB, V18, P279, DOI 10.1016/j.cmet.2013.07.005
   Lee I, 2012, J PHYSIOL-LONDON, V590, P5231, DOI 10.1113/jphysiol.2012.239707
   Lenaz G, 2009, INT J BIOCHEM CELL B, V41, P1750, DOI 10.1016/j.biocel.2009.04.003
   Liu XL, 2011, OPHTHALMOLOGY, V118, P978, DOI 10.1016/j.ophtha.2010.09.003
   Lloyd RE, 2015, NEURO-ONCOLOGY, V17, P942, DOI 10.1093/neuonc/nov020
   Lloyd RE, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069003
   LOVE B, 1970, J BIOL CHEM, V245, P6664
   Massie R, 2012, J NEUROL SCI, V319, P158, DOI 10.1016/j.jns.2012.05.003
   Mayorov V, 2005, ANN NEUROL, V58, P807, DOI 10.1002/ana.20669
   Moilanen JS, 2003, MOL BIOL EVOL, V20, P1195, DOI 10.1093/molbev/msg121
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Pal R, 2010, MOL CANCER, V9, P0, DOI 10.1186/1476-4598-9-303
   Parrella P, 2001, CANCER RES, V61, P7623
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Petruzzella V, 2003, NEUROLOGY, V61, P1017, DOI 10.1212/01.WNL.0000080363.10902.E9
   Ramos A, 2011, ELECTROPHORESIS, V32, P782, DOI 10.1002/elps.201000583
   Ray AM, 2009, PROSTATE, V69, P956, DOI 10.1002/pros.20943
   Saini SK, 2018, MITOCHONDRION, V43, P30, DOI 10.1016/j.mito.2018.04.005
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Shen LJ, 2011, J CANCER RES CLIN, V137, P669, DOI 10.1007/s00432-010-0912-x
   Singer VL, 1999, MUTAT RES-GEN TOX EN, V439, P37, DOI 10.1016/S1383-5718(98)00172-7
   Singh RK, 2017, MITOCHONDRION, V35, P35, DOI 10.1016/j.mito.2017.05.001
   Singh RK, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06571
   Skonieczna K, 2018, HUM MUTAT, V39, P691, DOI 10.1002/humu.23402
   Sun WY, 2009, CLIN CANCER RES, V15, P476, DOI 10.1158/1078-0432.CCR-08-0930
   Tabebi M, 2015, BIOCHEM BIOPH RES CO, V459, P353, DOI 10.1016/j.bbrc.2015.01.151
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Wilkins HM, 2014, REDOX BIOL, V2, P619, DOI 10.1016/j.redox.2014.03.006
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yin PH, 2010, MITOCHONDRION, V10, P174, DOI 10.1016/j.mito.2009.12.147
   Zambelli F, 2018, STEM CELL REP, V11, P102, DOI 10.1016/j.stemcr.2018.05.007
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
   Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104
NR 48
TC 15
Z9 16
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV 15
PY 2019
VL 49
IS 
BP 56
EP 65
DI 10.1016/j.mito.2019.07.002
PG 10
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA JX2AW
UT WOS:000503545000007
PM 31299394
DA 2024-11-01
ER

PT J
AU Ohsawa, Y
   Hagiwara, H
   Nishimatsu, SI
   Hirakawa, A
   Kamimura, N
   Ohtsubo, H
   Fukai, Y
   Murakami, T
   Koga, Y
   Goto, YI
   Ohta, S
   Sunada, Y
   Onoue, H
   Kaida, K
   Sato, K
   Uchiyama, T
   Ueda, A
   Mutoh, T
   Nakamura, M
   Nishida, K
   Funakawa, I
   Ogawa, A
   Nakata, R
   Shiraishi, H
   Tsujino, A
   Takahashi, T
   Matsumoto, M
AF Ohsawa, Yutaka
   Hagiwara, Hiroki
   Nishimatsu, Shin-ichiro
   Hirakawa, Akihiro
   Kamimura, Naomi
   Ohtsubo, Hideaki
   Fukai, Yuta
   Murakami, Tatsufumi
   Koga, Yasutoshi
   Goto, Yu-ichi
   Ohta, Shigeo
   Sunada, Yoshihide
   Onoue, H.
   Kaida, K.
   Sato, K.
   Uchiyama, T.
   Ueda, A.
   Mutoh, T.
   Nakamura, M.
   Nishida, K.
   Funakawa, I.
   Ogawa, A.
   Nakata, R.
   Shiraishi, H.
   Tsujino, A.
   Takahashi, T.
   Matsumoto, M.
TI Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Article
ID wobble modification deficiency; transfer rnaleu(uur) gene; mitochondrial myopathy; lactic-acidosis; transfer-rna; modification defect; encephalopathy; mutation
AB Objective The aim of this study was to evaluate the efficacy and safety of high-dose taurine supplementation for prevention of stroke-like episodes of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes), a rare genetic disorder caused by point mutations in the mitochondrial DNA that lead to a taurine modification defect at the first anticodon nucleotide of mitochondrial tRNA(Leu(UUR)), resulting in failure to decode codons accurately. Methods After the nationwide survey of MELAS, we conducted a multicentre, open-label, phase III trial in which 10 patients with recurrent stroke-like episodes received high-dose taurine (9 g or 12 g per day) for 52 weeks. The primary endpoint was the complete prevention of stroke-like episodes during the evaluation period. The taurine modification rate of mitochondrial tRNA(Leu(UUR)) was measured before and after the trial. Results The proportion of patients who reached the primary endpoint (100% responder rate) was 60% (95% CI 26.2% to 87.8%). The 50% responder rate, that is, the number of patients achieving a 50% or greater reduction in frequency of stroke-like episodes, was 80% (95% CI 44.4% to 97.5%). Taurine reduced the annual relapse rate of stroke-like episodes from 2.22 to 0.72 (P=0.001). Five patients showed a significant increase in the taurine modification of mitochondrial tRNA(Leu(UUR)) from peripheral blood leukocytes (P<0.05). No severe adverse events were associated with taurine. Conclusions The current study demonstrates that oral taurine supplementation can effectively reduce the recurrence of stroke-like episodes and increase taurine modification in mitochondrial tRNA(Leu(UUR)) in MELAS.
C1 [Ohsawa, Yutaka; Ohtsubo, Hideaki; Fukai, Yuta; Murakami, Tatsufumi; Sunada, Yoshihide] Kawasaki Med Sch, Dept Neurol, Kurashiki, Okayama 7010192, Japan.
   [Hagiwara, Hiroki] Teikyo Univ Sci, Dept Med Sci, Adachi Ku, Tokyo, Japan.
   [Nishimatsu, Shin-ichiro] Kawasaki Med Sch, Dept Nat Sci, Kurashiki, Okayama, Japan.
   [Hirakawa, Akihiro] Nagoya Univ Hosp, Stat Anal Sect, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan.
   [Hirakawa, Akihiro] Univ Tokyo, Dept Biostat & Bioinformat, Grad Sch Med, Tokyo, Japan.
   [Kamimura, Naomi; Ohta, Shigeo] Nippon Med Sch, Grad Sch Med, Dept Biochem & Cell Biol, Tokyo, Japan.
   [Koga, Yasutoshi] Kurume Univ, Grad Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan.
   [Ohta, Shigeo] Juntendo Univ, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo, Japan.
   [Onoue, H.; Kaida, K.] Natl Def Med Coll Hosp, Tokyo, Japan.
   [Sato, K.; Uchiyama, T.] Seirei Hamamatsu Gen Hosp, Shizuoka, Japan.
   [Ueda, A.; Mutoh, T.] Fujita Hlth Univ Sch Hosp, Toyoake, Aichi, Japan.
   [Nakamura, M.] Natl Hosp Org Kyoto Med Ctr, Kyoto, Japan.
   [Nishida, K.; Funakawa, I.] Natl Hosp Org Hyogo Chuo Natl Hosp, Kobe, Hyogo, Japan.
   [Ogawa, A.] Fukuoka Univ, Chikushi Hosp, Fukuoka, Fukuoka, Japan.
   [Nakata, R.; Shiraishi, H.; Tsujino, A.] Nagasaki Univ Hosp, Nagasaki, Japan.
   [Takahashi, T.; Matsumoto, M.] Hiroshima Univ Hosp, Hiroshima, Japan.
C3 Kawasaki Medical School; Kawasaki Medical School; Nagoya University; University of Tokyo; Nippon Medical School; Kurume University; National Center for Neurology & Psychiatry - Japan; Juntendo University; Fukuoka University; Nagasaki University; Hiroshima University
RP Sunada, Y (corresponding author), Kawasaki Med Sch, Dept Neurol, Kurashiki, Okayama 7010192, Japan.
EM ysunada@med.kawasaki-m.ac.jp
FU Research on Rare and Intractable Diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan [H24-Nanchitou(Nan)-Ippan-068]; Japan Agency for Medical Research and Development (AMED) [JP15ek0109093h0001, JP16ek0109093h0002, JP17ek0109093h0003]
CR Chinnery P F, 2003, NEUROMUSCUL DISORD, V13, P757, DOI 10.1016/S0960-8966(03)00097-X
   CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0
   DiMauro S, 1993, GENEREVIEWS R, V0, P0
   Fakruddin M, 2018, CELL REP, V22, P482, DOI 10.1016/j.celrep.2017.12.051
   Torres AG, 2014, TRENDS MOL MED, V20, P306, DOI 10.1016/j.molmed.2014.01.008
   Glover EI, 2010, MUSCLE NERVE, V42, P739, DOI 10.1002/mus.21758
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rikimaru M, 2012, INTERNAL MED, V51, P3351, DOI 10.2169/internalmedicine.51.7529
   Schaffer S, 2016, AMINO ACIDS, V48, P549, DOI 10.1007/s00726-015-2110-2
   Stacpoole PW, 2011, MITOCHONDRION, V11, P679, DOI 10.1016/j.mito.2011.05.002
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 27
TC 69
Z9 74
U1 1
U2 14
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 1468-330X
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD MAY 15
PY 2019
VL 90
IS 5
BP 529
EP 536
DI 10.1136/jnnp-2018-317964
PG 8
WC Clinical Neurology; Psychiatry; Surgery
SC Neurosciences & Neurology; Psychiatry; Surgery
GA IC6XR
UT WOS:000471116400008
PM 29666206
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Pharmacotherapeutic management of epilepsy in MERRF syndrome
SO EXPERT OPINION ON PHARMACOTHERAPY
LA English
DT Review
DE MERRF syndrome; m; 8344A>G; seizures; antiepileptic drugs; gene; mitochondrial disorder; epilepsy
ID ragged-red fibers; merrf/melas overlap syndrome; stroke-like episodes; myoclonic-astatic epilepsy; transfer-rna lys; mitochondrial-dna; a8344g mutation; g8363a mutation; patient; phenotype
AB Introduction: Epilepsy is a prominent feature of myoclonic epilepsy with ragged-red fibers (MERRF)-syndrome. The most frequent seizure type is myoclonic seizures, of which the treatment is challenging and empiric. Areas covered: Herein, the author summarises and discusses previous and recent findings of antiepileptic drug (AED) treatment in MERRF-syndrome. Expert opinion: MERRF-syndrome is a predominantly maternally inherited, multisystem mitochondrial disorder caused by pathogenic variants predominantly of the mitochondrial DNA (mtDNA). Canonical clinical features of MERRF include myoclonus, epilepsy, ataxia, and myopathy. Additionally, other manifestations in the CNS, peripheral nerves, eyes, ears, heart, gastrointestinal tract, and endocrine organs may occur (MERRF-plus). Today, MERRF is considered rather as myoclonic ataxia than as myoclonic epilepsy. Genotypically, MERRF is due to mutations in 13 mtDNA-located genes and 1 nDNA-located gene. According to the modified Smith-score, the strongest gene-disease relationship exists for MT-TK, MT-TL1, and POLG1. Epilepsy is the second most frequent phenotypic feature of MERRF. Seizure-types associated with MERRF include focal myoclonic, focal clonic, and focal atonic seizures, generalized myoclonic, tonic-clonic, atonic, and myoclonic-atonic seizures, or typical absences. Treatment of myoclonic epilepsy relies on expert judgments recommending levetiracetam, together with clonazepam, or topiramate, zonisamide, or piracetam in monotherapy as the first line AEDs.
C1 [Finsterer, Josef] Messerli Inst, Krankenanstalt Rudolfstiftung, Postfach 20, A-1180 Vienna, Austria.
C3 Rudolfstiftung Hospital
RP Finsterer, J (corresponding author), Messerli Inst, Krankenanstalt Rudolfstiftung, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Abou-Khalil Bassel, 2008, NEUROPSYCHIATR DIS TREAT, V4, P507
   Afra P, 2012, SEIZURE-EUR J EPILEP, V21, P202, DOI 10.1016/j.seizure.2011.12.010
   Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Arenas J, 1999, NEUROLOGY, V52, P377, DOI 10.1212/WNL.52.2.377
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   Ban R, 2018, CHINESE MED J-PEKING, V131, P1569, DOI 10.4103/0366-6999.235120
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Biancheri R, 2010, AJNR AM J NEURORADIOL, V31, PE78, DOI 10.3174/ajnr.A2182
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Bindu PS, 2018, CLIN NEUROL NEUROSUR, V164, P182, DOI 10.1016/j.clineuro.2017.12.010
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   CALABRESI PA, 1994, MUSCLE NERVE, V17, P943, DOI 10.1002/mus.880170815
   Campos Y, 1996, MUSCLE NERVE, V19, P187, DOI 10.1002/(SICI)1097-4598(199602)19:2<187::AID-MUS10>3.0.CO;2-S
   CarrÃ© F, 2019, EUR ANN OTORHINOLARY, V136, P113, DOI 10.1016/j.anorl.2018.10.015
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Caviness JN, 2014, NEUROTHERAPEUTICS, V11, P188, DOI 10.1007/s13311-013-0216-3
   Chandra SR, 2015, J POSTGRAD MED, V61, P200, DOI 10.4103/0022-3859.150905
   CHEN RS, 1993, ACTA NEUROL SCAND, V87, P494
   Chen ST, 2008, J CHILD NEUROL, V23, P1447, DOI 10.1177/0883073808318541
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   COQUET M, 1993, NEUROMUSCULAR DISORD, V3, P593, DOI 10.1016/0960-8966(93)90122-Z
   Crest C, 2004, NEUROLOGY, V62, P640, DOI 10.1212/01.WNL.0000110193.78872.DD
   De la Mata M, 2012, NEUROTHERAPEUTICS, V9, P446, DOI 10.1007/s13311-012-0103-3
   OCallaghan MD, 2012, NEUROGENETICS, V13, P245, DOI 10.1007/s10048-012-0322-0
   Delgado-Escueta AV, 2001, AM J MED GENET, V106, P129, DOI 10.1002/ajmg.1575
   DiMauro S, 2002, ADV NEUROL, V89, P217
   DiMauro S, 2003, GENEREVIEWS, V0, P0
   Herrero-MartÃ­n MD, 2010, J NEUROL NEUROSUR PS, V81, P471, DOI 10.1136/jnnp.2009.173831
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   Erdocia-GoÃ±i A, 2018, REV NEUROLOGIA, V66, P268, DOI 10.33588/rn.6608.2017503
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   Fan PC, 2014, J FORMOS MED ASSOC, V113, P258, DOI 10.1016/j.jfma.2013.02.008
   FANG W, 1994, MUSCLE NERVE, V17, P52, DOI 10.1002/mus.880170107
   Fedi M, 2001, ARCH NEUROL-CHICAGO, V58, P781, DOI 10.1001/archneur.58.5.781
   Finsterer J, 2013, ACTA NEUROL SCAND, V128, P141, DOI 10.1111/ane.12122
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Finsterer J, 2017, IRAN J NEUROL, V16, P45
   Finsterer J, 2017, SEIZURE-EUR J EPILEP, V50, P166, DOI 10.1016/j.seizure.2017.06.010
   Finsterer J, 2016, EUR J PAEDIATR NEURO, V20, P824, DOI 10.1016/j.ejpn.2016.08.002
   Finsterer J, 2016, J NEUROL, V263, P586, DOI 10.1007/s00415-016-8028-0
   Finsterer J, 2012, SEIZURE-EUR J EPILEP, V21, P316, DOI 10.1016/j.seizure.2012.03.003
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Florian A, 2015, J CARDIOVASC MAGN R, V17, P0, DOI 10.1186/s12968-015-0145-x
   Frye RE, 2015, EPILEPSY BEHAV, V47, P147, DOI 10.1016/j.yebeh.2014.08.134
   Fukuhara Nobuyoshi, 2008, BRAIN AND NERVE (TOKYO), V60, P53
   Gilson Robert Christopher, 2018, JAAD CASE REP, V4, P822, DOI 10.1016/j.jdcr.2018.05.004
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Ito S, 2008, AM J NEURORADIOL, V29, P392, DOI 10.3174/ajnr.A0865
   Iwanga K, 1992, RINSHO SHINKEIGAKU, V32, P870
   Kilaru S, 2007, EPILEPSIA, V48, P1703, DOI 10.1111/j.1528-1167.2007.01186.x
   Kobayashi J, 2010, INTERNAL MED, V49, P479, DOI 10.2169/internalmedicine.49.2996
   Koubeissi MZ, 2009, NEUROLOGY, V72, P858, DOI 10.1212/01.wnl.0000343959.15205.52
   Lamperti C, 2016, EPILEPTIC DISORD, V18, P0
   Levy A, 2016, CURR TREAT OPTION NE, V18, P0, DOI 10.1007/s11940-016-0404-7
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Mancuso M, 2006, J NEUROL SCI, V243, P97, DOI 10.1016/j.jns.2005.11.021
   Mancuso M, 2014, MOVEMENT DISORD, V29, P722, DOI 10.1002/mds.25839
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Mantoan L, 2011, CURR TREAT OPTION NE, V13, P355, DOI 10.1007/s11940-011-0131-z
   MartÃ­n-JimÃ©nez R, 2012, MITOCHONDRION, V12, P288, DOI 10.1016/j.mito.2011.10.004
   Michelucci R, 2016, EPILEPTIC DISORD, V18, PS145, DOI 10.1684/epd.2016.0861
   Miyaue N, 2018, INTERNAL MED, V57, P3439, DOI 10.2169/internalmedicine.1210-18
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Monden Y, 2013, BRAIN DEV-JPN, V35, P582, DOI 10.1016/j.braindev.2012.08.006
   Mongini T, 2002, CLIN NEUROPATHOL, V21, P72
   Morales-LÃ³pez RA, 2019, UROL CASE REP, V22, P21, DOI 10.1016/j.eucr.2018.10.006
   Najjar RP, 2019, J NEURO-OPHTHALMOL, V39, P18, DOI 10.1097/WNO.0000000000000690
   Nakamura M, 2010, J MED GENET, V47, P659, DOI 10.1136/jmg.2009.072058
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nomura T, 1993, RINSHO SHINKEIGAKU, V33, P1198
   Orcesi S, 2006, J CHILD NEUROL, V21, P79, DOI 10.1177/08830738060210010901
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Park SY, 2017, FRONT NEUROL, V8, P0, DOI 10.3389/fneur.2017.00520
   Peng Y, 2003, MOVEMENT DISORD, V18, P716, DOI 10.1002/mds.10428
   PRANZATELLI MR, 1995, EPILEPSIA, V36, P783, DOI 10.1111/j.1528-1157.1995.tb01615.x
   Santamarina E, 2015, EPILEPSY BEHAV CASE, V4, P56, DOI 10.1016/j.ebcr.2015.06.007
   Scalais E, 2013, EUR J PAEDIATR NEURO, V17, P625, DOI 10.1016/j.ejpn.2013.05.013
   Shen CZ, 2018, FRONT NEUROL, V9, P0, DOI 10.3389/fneur.2018.00724
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shtilbans A, 2000, J CHILD NEUROL, V15, P759, DOI 10.1177/088307380001501109
   SILVA MTG, 1987, NEUROPEDIATRICS, V18, P200, DOI 10.1055/s-2008-1052480
   Sinha S, 2007, EPILEPSY RES, V74, P55, DOI 10.1016/j.eplepsyres.2006.12.003
   Sitburana Oraporn, 2001, JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, V84, P1051
   Sort R, 2013, EUR J PAEDIATR NEURO, V17, P531, DOI 10.1016/j.ejpn.2013.05.001
   Steele HE, 2015, SEMIN NEUROL, V35, P300, DOI 10.1055/s-0035-1552624
   Su LJ, 2018, CHINESE MED J-PEKING, V131, P2433, DOI 10.4103/0366-6999.243568
   Suzuki Y, 1997, DIABETES CARE, V20, P1138, DOI 10.2337/diacare.20.7.1138
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   Taylor D, 2013, CASE REP NEUROL MED, V2013, P0, DOI 10.1155/2013/125672
   Toyono M, 2001, NEUROMUSCULAR DISORD, V11, P300, DOI 10.1016/S0960-8966(00)00176-0
   TSAIRIS P, 1973, NEUROLOGY, V23, P408
   Vallance HD, 2004, PEDIATR CARDIOL, V25, P538, DOI 10.1007/s00246-003-0446-y
   van de Glind G, 2007, EUR J PAEDIATR NEURO, V11, P243, DOI 10.1016/j.ejpn.2007.01.004
   Vastagh I, 2011, IDEGGYOGY SZEMLE, V64, P399
   Verma A, 1996, NEUROLOGY, V46, P1334, DOI 10.1212/WNL.46.5.1334
   Vilela H, 2005, PEDIATR ANESTH, V15, P77, DOI 10.1111/j.1460-9592.2005.01384.x
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   von StÃ¼lpnagel C, 2012, EUR J PAEDIATR NEURO, V16, P459, DOI 10.1016/j.ejpn.2011.12.012
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wang YL, 1999, AM J HEMATOL, V60, P83, DOI 10.1002/(SICI)1096-8652(199901)60:1<83::AID-AJH19>3.0.CO;2-N
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Yang Hecheng, 2014, PEDIATR NEUROL, V51, Pe19, DOI 10.1016/j.pediatrneurol.2014.08.020
   Zaganas I, 2009, J NEUROL, V256, P271, DOI 10.1007/s00415-009-0921-3
   Zhao Juan, 2012, ZHONGHUA YI XUE ZA ZHI, V92, P2835
   Zhao Man-man, 2015, BEIJING DA XUE XUE BAO YI XUE BAN, V47, P1034
   Zsurka G, 2013, SEIZURE-EUR J EPILEP, V22, P483, DOI 10.1016/j.seizure.2013.03.003
   Zupanc ML, 2010, PEDIATR NEUROL, V42, P396, DOI 10.1016/j.pediatrneurol.2010.02.013
NR 113
TC 6
Z9 8
U1 0
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1465-6566
EI 1744-7666
J9 EXPERT OPIN PHARMACO
JI Expert Opin. Pharmacother.
PD JUL 3
PY 2019
VL 20
IS 10
BP 1289
EP 1297
DI 10.1080/14656566.2019.1609941
EA APR 2019
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA IG0ZA
UT WOS:000470379300001
PM 31063406
DA 2024-11-01
ER

PT J
AU Kim, J
   Daadi, MM
AF Kim, Jeffrey
   Daadi, Marcel M.
TI Non-cell autonomous mechanism of Parkinson's disease pathology caused by G2019S LRRK2 mutation in Ashkenazi Jewish patient: Single cell analysis
SO BRAIN RESEARCH
LA English
DT Review
DE Induced pluripotent stem cells; Neural stem cells; Single cell technologies; Mitochondrial function; Non-cell autonomous pathology; Parkinson's disease
ID mitochondrial complex-i; kinase 2 lrrk2; diagnostic-criteria; skeletal-muscle; early endosm; gene; neurons; expression; phosphorylation; differentiation
AB Parkinson's disease (PD) is the second most prevalent neurodegenerative disease, characterized by the loss of the midbrain dopaminergic neurons, which leads to impaired motor and cognitive functions. PD is predominantly an idiopathic disease, however about 5% of cases are linked to hereditary mutations. The most common mutation in both familial and sporadic PD is the G2019S mutation of leucine-rich repeat kinase 2 (LRRK2) with high prevalence in Ashkenazi Jewish patients and in North African Berber and Arab patients. It is still not fully understood how this mutation leads to PD pathology. In this study, we derived induced pluripotent stem cells (iPSCs) from an Ashkenazi Jewish patient with G2019S LRRK2 mutation to isolate self-renewable multipotent neural stem cells (NSCs) and to model this form of PD in vitro. To investigate the cellular diversity and disease pathology in the NSCs, we used single cell RNA-seq transcriptomic profiling. The evidence suggests there are three subpopulations within the NSCs: a committed neuronal population, intermediate stage population and undifferentiated stage population. Unbiased single-cell transcriptomic analysis revealed differential expression and dysregulation of genes involved in PD pathology. The significantly affected genes were involved in mitochondrial function, DNA repair, protein degradation, oxidative stress, lysosome biogenesis, ubiquitination, endosome function, autophagy and mitochondrial quality control. The results suggest that G2019S LRRK2 mutation may affect multiple cell types in a non-cell autonomous mechanism of PD pathology and that unbiased single-cell transcriptomics holds promise for personalized medicine.
C1 [Kim, Jeffrey; Daadi, Marcel M.] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, POB 760549, San Antonio, TX 78245 USA.
   [Kim, Jeffrey; Daadi, Marcel M.] Dept Cell Syst & Anat, San Antonio, TX USA.
   [Kim, Jeffrey; Daadi, Marcel M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol, San Antonio, TX 78229 USA.
C3 Texas Biomedical Research Institute; University of Texas System; University of Texas Health Science Center at San Antonio
RP Daadi, MM (corresponding author), Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, POB 760549, San Antonio, TX 78245 USA.
EM mdaadi@txbiomed.org
FU Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; Perry & Ruby Stevens Charitable Foundation; Marmion Family Fund; Worth Family Fund; NIH [P51 OD011133, R56 AG059284]
CR Araki M, 2002, NEUROSCI RES, V44, P379, DOI 10.1016/S0168-0102(02)00156-6
   Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007
   Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111
   Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805
   Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Borgs L, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep33377
   Boulet A, 2017, J BIOL CHEM, V0, P1
   Braak H, 1995, J NEURAL TRANSM-SUPP, V0, P15
   Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d
   Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71
   Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935
   Cooper P, 2012, INT J EMOT EDUC, V4, P1
   Daadi MM, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001644
   Daadi MM, 2019, METHODS MOL BIOL, V1919, P1, DOI 10.1007/978-1-4939-9007-8_1
   Daadi MM, 1999, J NEUROSCI, V19, P4484
   DÃ¤chsel JC, 2010, ARCH NEUROL-CHICAGO, V67, P542, DOI 10.1001/archneurol.2010.79
   de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9
   Dulken BW, 2017, CELL REP, V18, P777, DOI 10.1016/j.celrep.2016.12.060
   Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507
   Fung HC, 2006, MOVEMENT DISORD, V21, P880, DOI 10.1002/mds.20814
   Gandhi PN, 2009, J NEUROSCI RES, V87, P1283, DOI 10.1002/jnr.21949
   Gao F, 2015, HUM MOL GENET, V24, P2528, DOI 10.1093/hmg/ddv017
   Garcia-Miralles M, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0118947
   Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33
   Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1
   Greggio E, 2006, NEUROBIOL DIS, V0, P0
   Hanagasi HA, 2005, INT J NEUROSCI, V115, P479, DOI 10.1080/00207450590523017
   Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0
   Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181
   Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080
   Ida M, 2004, NEUROSCI RES, V50, P199, DOI 10.1016/j.neures.2004.06.018
   Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163
   Isosomppi J, 2002, HUM MOL GENET, V11, P885, DOI 10.1093/hmg/11.8.885
   Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209
   Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045
   JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935
   Kalinderi K, 2007, EUR J NEUROL, V14, P1088, DOI 10.1111/j.1468-1331.2007.01867.x
   Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289
   Kim J, 2019, METHODS MOL BIOL, V1919, P145, DOI 10.1007/978-1-4939-9007-8_11
   Kim J, 2019, METHODS MOL BIOL, V1919, P129, DOI 10.1007/978-1-4939-9007-8_10
   Klein C, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a008888
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540
   Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006
   LuzÃ³n-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151
   MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008
   Marras C, 2016, MOVEMENT DISORD, V31, P1192, DOI 10.1002/mds.26614
   Marrone L, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0192497
   Migheli R, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0077198
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Noureddine MA, 2005, MOVEMENT DISORD, V20, P1299, DOI 10.1002/mds.20573
   Ohnishi T, 2017, SCIENTIFIC REPORTS, V7, P1
   Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509
   PaisÃ¡n-RuÃ­z C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318
   Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009
   Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324
   Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x
   Porcelli V, 2014, J BIOL CHEM, V289, P13374, DOI 10.1074/jbc.M114.547448
   Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098
   Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445
   SÃ¡nchez-DanÃ©s A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215
   Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576
   Sandor C, 2017, HUM MOL GENET, V26, P552, DOI 10.1093/hmg/ddw412
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104
   Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066
   Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003
   Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015
   Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776
   Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Tan EK, 2005, NEUROSCI LETT, V384, P327, DOI 10.1016/j.neulet.2005.04.103
   Tan EK, 2007, MOVEMENT DISORD, V22, P105, DOI 10.1002/mds.21206
   Tang FC, 2009, NAT METHODS, V6, P377, DOI 10.1038/NMETH.1315
   Tomiyama H, 2006, MOVEMENT DISORD, V21, P1102, DOI 10.1002/mds.20886
   West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102
   Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008
   Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X
   Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, PD754, DOI 10.1093/nar/gkx1098
   Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727
   Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005
NR 88
TC 7
Z9 8
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0006-8993
EI 1872-6240
J9 BRAIN RES
JI Brain Res.
PD NOV 1
PY 2019
VL 1722
IS 
BP 
EP 
DI 10.1016/j.brainres.2019.146342
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA JF3QF
UT WOS:000491301400024
PM 31330122
DA 2024-11-01
ER

PT J
AU DomÃ­nguez-GonzÃ¡lez, C
   HernÃ¡ndez-LaÃ­n, A
   Rivas, E
   HernÃ¡ndez-Voth, A
   CatalÃ¡n, JS
   FernÃ¡ndez-TorrÃ³n, R
   Fuiza-Luces, C
   GarcÃ­a, JG
   MorÃ­s, G
   OlivÃ©, M
   Miralles, F
   DÃ­az-Manera, J
   Caballero, C
   MÃ©ndez-Ferrer, B
   MartÃ­, R
   Arumi, EG
   Badosa, MC
   Esteban, J
   Jimenez-Mallebrera, C
   Encinar, AB
   Arenas, J
   Hirano, M
   Martin, MA
   Paradas, C
AF Dominguez-Gonzalez, Cristina
   Hernandez-Lain, Aurelio
   Rivas, Eloy
   Hernandez-Voth, Ana
   Catalan, Javier Sayas
   Fernandez-Torron, Roberto
   Fuiza-Luces, Carmen
   Garcia Garcia, Jorge
   Moris, German
   Olive, Montse
   Miralles, Frances
   Diaz-Manera, Jordi
   Caballero, Candela
   Mendez-Ferrer, Bosco
   Marti, Ramon
   Garcia Arumi, Elena
   Carmen Badosa, Maria
   Esteban, Jesus
   Jimenez-Mallebrera, Cecilia
   Blazquez Encinar, Alberto
   Arenas, Joaquin
   Hirano, Michio
   Angel Martin, Miguel
   Paradas, Carmen
TI Late-onset thymidine kinase 2 deficiency: a review of 18 cases
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Review
DE TK2 deficiency; Mitochondrial myopathy; Multiple deletions
ID mitochondrial; mutations
AB BackgroundTK2 gene encodes for mitochondrial thymidine kinase, which phosphorylates the pyrimidine nucleosides thymidine and deoxycytidine. Recessive mutations in the TK2 gene are responsible for the myopathic form' of the mitochondrial depletion/multiple deletions syndrome, with a wide spectrum of severity.MethodsWe describe 18 patients with mitochondrial myopathy due to mutations in the TK2 gene with absence of clinical symptoms until the age of 12.ResultsThe mean age of onset was 31years. The first symptom was muscle limb weakness in 10/18, eyelid ptosis in 6/18, and respiratory insufficiency in 2/18. All patients developed variable muscle weakness during the evolution of the disease. Half of patients presented difficulty in swallowing. All patients showed evidence of respiratory muscle weakness, with need for non-invasive Mechanical Ventilation in 12/18. Four patients had deceased, all of them due to respiratory insufficiency. We identified common radiological features in muscle magnetic resonance, where the most severely affected muscles were the gluteus maximus, semitendinosus and sartorius. On muscle biopsies typical signs of mitochondrial dysfunction were associated with dystrophic changes. All mutations identified were previously reported, being the most frequent the in-frame deletion p.Lys202del. All cases showed multiple mtDNA deletions but mtDNA depletion was present only in two patients.ConclusionsThe late-onset is the less frequent form of presentation of the TK2 deficiency and its natural history is not well known. Patients with late onset TK2 deficiency have a consistent and recognizable clinical phenotype and a poor prognosis, due to the high risk of early and progressive respiratory insufficiency.
C1 [Dominguez-Gonzalez, Cristina; Esteban, Jesus] 12 Octubre Hosp, Neurol Dept, Neuromuscular Disorders Unit, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina; Fuiza-Luces, Carmen; Esteban, Jesus; Blazquez Encinar, Alberto; Arenas, Joaquin; Angel Martin, Miguel] 12 Octubre Hosp, Res Inst I 12, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina; Fuiza-Luces, Carmen; Diaz-Manera, Jordi; Marti, Ramon; Garcia Arumi, Elena; Esteban, Jesus; Jimenez-Mallebrera, Cecilia; Blazquez Encinar, Alberto; Arenas, Joaquin; Angel Martin, Miguel] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain.
   [Hernandez-Lain, Aurelio] 12 Octubre Hosp, Pathol Dept, Neuromuscular Disorders Unit, Neuropathol, Madrid, Spain.
   [Rivas, Eloy] Univ Seville, Hosp Univ Virgen del Rocio, Pathol Anat Dept,CSIC, Neuromuscular Disorders Unit,Inst Biomed Sevilla, Seville, Spain.
   [Hernandez-Voth, Ana; Catalan, Javier Sayas] 12 Octubre Hosp, Neumol Dept, Neuromuscular Disorders Unit, Madrid, Spain.
   [Fernandez-Torron, Roberto] Hosp Donostia, Neuromuscular Disorders Unit, Neurol Dept, San Sebastian, Spain.
   [Fuiza-Luces, Carmen; Blazquez Encinar, Alberto; Arenas, Joaquin; Angel Martin, Miguel] Hosp 12 Octubre I 12, Res Inst, Mitochondrial & Neuromuscular Dis Lab, Madrid, Spain.
   [Garcia Garcia, Jorge] Hosp Albacete, Neurol Dept, Albacete, Spain.
   [Moris, German] Hosp Cent Asturias, Neurol Dept, Neuromuscular Disorders Unit, Oviedo, Spain.
   [Olive, Montse] Hosp Bellvitge Princeps Espanya, IDIBELL, Neuromuscular Disorders Unit, Pathol Anat Dept, Barcelona, Spain.
   [Miralles, Frances] Hosp Univ Son Espases, Neurol Dept, Neuromuscular Disorders Unit, Palma De Mallorca, Spain.
   [Diaz-Manera, Jordi] Hosp Santa Creu & Sant Pau, Neurol Dept, Neuromuscular Disorders Unit, Barcelona, Spain.
   [Caballero, Candela] Univ Seville, Inst Biomed Sevilla, Resp Dept, Hosp Univ Virgen del Rocio,CSIC,CIBERES, Seville, Spain.
   [Mendez-Ferrer, Bosco] Hosp Virgen del Rocio, Rehabil Dept, Seville, Spain.
   [Garcia Arumi, Elena] Univ Autonoma Barcelona, ValldHebron Res Inst, Res Grp Neuromuscular & Mitochondrial Dis, Barcelona, Spain.
   [Marti, Ramon; Carmen Badosa, Maria; Jimenez-Mallebrera, Cecilia] Hosp St Joan de Deu, Inst Recerca St Joan de Deu, Neurol Dept, Neuromuscular Unit, Barcelona, Spain.
   [Hirano, Michio] Columbia Univ, Med Ctr, H Houston Merritt Ctr, Dept Neurol, New York, NY USA.
   [Paradas, Carmen] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Neurol Dept,Neuromuscular Disorders Unit,Inst Bio, Avd Manuel Siurot S-N, Seville 41013, Spain.
   [Paradas, Carmen] Biomed Network Res Ctr Neurodegenerat Dis CIBERNE, Madrid, Spain.
C3 Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; University of Barcelona; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitario 12 de Octubre; University Hospital Donostia; Hospital Universitario 12 de Octubre; Central University Hospital Asturias; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Universitari Son Espases; Hospital of Santa Creu i Sant Pau; Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Autonomous University of Barcelona; University of Barcelona; Columbia University; Consejo Superior de Investigaciones Cientificas (CSIC); Virgen del Rocio University Hospital; University of Sevilla
RP Paradas, C (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Neurol Dept,Neuromuscular Disorders Unit,Inst Bio, Avd Manuel Siurot S-N, Seville 41013, Spain.; Paradas, C (corresponding author), Biomed Network Res Ctr Neurodegenerat Dis CIBERNE, Madrid, Spain.
EM cparadas@us.es
FU Plan Nacional de I + D + I [PI16-01843, PI16/00579, CP09/00011]; Instituto de Salud Carlos III (ISCIII), Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria [PI16-01843, PI16/00579, CP09/00011]; European Regional Development Fund (FEDER a way to achieve Europe); Spanish ISCIII [PI 15/00431]; ISCIII [PMP15/00025]
CR Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c
   CÃ¡mara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   CÃ¡mara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Carbonell-Corvilloa P, 2018, NEUROMUSCULAR DISORD, V28, P828, DOI 10.1016/j.nmd.2018.07.006
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   FernÃ¡ndez J, 2000, MED CLIN-BARCELONA, V114, P121, DOI 10.1016/S0025-7753(00)71216-4
   Fischer D, 2008, NEUROLOGY, V71, P758, DOI 10.1212/01.wnl.0000324927.28817.9b
   Fiuza-Luces C, 2018, MED SCI SPORT EXER, V50, P1142, DOI 10.1249/MSS.0000000000001546
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Hedermann G, 2018, NEUROMUSCULAR DISORD, V28, P408, DOI 10.1016/j.nmd.2018.02.008
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   MartÃ­ R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   OlivÃ© M, 2011, NEUROMUSCULAR DISORD, V21, P533, DOI 10.1016/j.nmd.2011.05.002
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tordjman M, 2018, EUR RADIOL, V28, P5293, DOI 10.1007/s00330-018-5472-5
   Trucco F, 2018, J INT MED RES, V46, P1153, DOI 10.1177/0300060517728857
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
NR 29
TC 30
Z9 32
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1750-1172
EI 
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD MAY 6
PY 2019
VL 14
IS 
BP 
EP 
DI 10.1186/s13023-019-1071-z
PG 10
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA HX3DG
UT WOS:000467271200001
PM 31060578
DA 2024-11-01
ER

PT J
AU Vissing, CR
   Duno, M
   Wibrand, F
   Christensen, M
   Vissing, J
AF Vissing, Christoffer Rasmus
   Duno, Morten
   Wibrand, Flemming
   Christensen, Mette
   Vissing, John
TI Hydroxylated Long-Chain Acylcarnitines are Biomarkers of Mitochondrial Myopathy
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID acid beta-oxidation; skeletal-muscle; exercise intolerance; respiratory-chain; quantitative-analysis; insulin-resistance; mcad deficiency; blood spots; mutation; plasma
AB Context: Plasma acylcarnitines are biomarkers of beta-oxidation and are useful in diagnosing several inborn errors of metabolism but have never been investigated systematically in patients with mitochondrial myopathy. Objective: We hypothesized that acylcarnitines can also be biomarkers of mitochondrial myopathy and sought to investigate the prevalence and pattern of elevated acylcarnitines. Design: This was a prospective cohort study of patients with confirmed mitochondrial myopathy followed at Copenhagen Neuromuscular Center, Rigshospitalet, Copenhagen, Denmark. Patients: We included 35 patients (44 +/- 15 years, 15 women) with mitochondrial myopathy caused by single, large-scale deletions of mitochondrial DNA (n = 17), pathogenic variants in mitochondrial transfer RNA (n = 13), or in proteins of the respiratory chain complexes (n = 5). Concentrations of 35 acylcarnitines were measured using ultra-HPLC and tandem massspectrometry. Findings were compared with muscle mutation load in all patients and to respiratory chain activity in 26 patients. Main Outcome Measures: Prevalence of elevated concentrations of acylcarnitines related to acylcoenzyme A (CoA) dehydrogenases in patients with mitochondrial myopathy and relation to genotypes/phenotypes. Results: In total, 27 (77%) patients had elevated concentrations of acylcarnitines related to acyl-CoA dehydrogenases. Elevated concentrations of seven acylcarnitine species were more common in patients compared with a control cohort of >900 individuals, and a specific pattern involving hydroxylated long-chain acylcarnitines occurred in 22 (63%) patients. Severity of derangements was correlated with muscle mutation load and genotypes/phenotypes. Conclusion: In conclusion, elevated concentrations of acylcarnitines is common in patients with mitochondrial myopathy and shows a specific pattern affecting hydroxylated long-chain acylcarnitines, which can have implications for future diagnostic workup of patients.
C1 [Vissing, Christoffer Rasmus; Vissing, John] Univ Copenhagen, Rigshosp, Copenhagen Neuromuscular Ctr, Dept Neurol, DK-2100 Copenhagen, Denmark.
   [Duno, Morten; Wibrand, Flemming; Christensen, Mette] Univ Copenhagen, Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark.
C3 Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen
RP Vissing, CR (corresponding author), Univ Copenhagen, Copenhagen Neuromuscular Ctr, Dept Neurol, Rigshosp,Sect 3342, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM Christoffer.rasmus.vissing@regionh.dk
CR Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754
   Aguer C, 2015, FASEB J, V29, P336, DOI 10.1096/fj.14-255901
   Bak AM, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0200817
   Born AP, 2015, EUR J PAEDIATR NEURO, V19, P69, DOI 10.1016/j.ejpn.2014.10.006
   Chace DH, 1997, CLIN CHEM, V43, P2106
   Costa CCG, 1999, PEDIATR RES, V46, P440, DOI 10.1203/00006450-199910000-00013
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   Eaton S, 1996, BIOCHEM J, V319, P633, DOI 10.1042/bj3190633
   Frye RE, 2013, TRANSL PSYCHIAT, V3, P0, DOI 10.1038/tp.2012.143
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jeppesen TD, 2009, ARCH NEUROL-CHICAGO, V66, P365, DOI 10.1001/archneurol.2009.24
   Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013
   KUTTIS J, 1968, ARCH BIOCHEM BIOPHYS, V126, P634, DOI 10.1016/0003-9861(68)90450-5
   Lipina C, 2013, DIABETES, V62, P3426, DOI 10.2337/db13-0264
   LUNDBAEK K, 1948, YALE J BIOL MED, V20, P533
   Makrecka M, 2014, MOL CELL BIOCHEM, V395, P1, DOI 10.1007/s11010-014-2106-3
   Nada MA, 1996, PRENATAL DIAG, V16, P117, DOI 10.1002/(SICI)1097-0223(199602)16:2<117::AID-PD820>3.0.CO;2-Z
   Ostergaard E, 2015, J MED GENET, V52, P203, DOI 10.1136/jmedgenet-2014-102914
   Rafiq J, 2016, JIMD REP, V25, P65, DOI 10.1007/8904_2015_459
   Rebouche CJ, 2004, ANN NY ACAD SCI, V1033, P30, DOI 10.1196/annals.1320.003
   Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000
   Rinaldo P, 2008, GENET MED, V10, P151, DOI 10.1097/GIM.0b013e3181614289
   Roos S, 2019, EUR J HUM GENET, V27, P331, DOI 10.1038/s41431-018-0286-0
   Rue N, 2014, J CLIN ENDOCR METAB, V99, P3757, DOI 10.1210/jc.2014-1831
   Schooneman MG, 2014, BBA-MOL CELL BIOL L, V1841, P987, DOI 10.1016/j.bbalip.2014.04.001
   Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sim KG, 2002, METABOLISM, V51, P366, DOI 10.1053/meta.2002.30521
   Soldath P, 2017, BMC MUSCULOSKEL DIS, V18, P0, DOI 10.1186/s12891-017-1781-0
   Suomalainen A, 2000, MOL BIOTECHNOL, V15, P123, DOI 10.1385/MB:15:2:123
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tonazzi A, 2015, MINI-REV MED CHEM, V15, P396, DOI 10.2174/138955751505150408142032
   Turpin SM, 2009, J PHYSIOL-LONDON, V587, P1593, DOI 10.1113/jphysiol.2008.166033
   van Eunen K, 2013, PLOS COMPUT BIOL, V9, P0, DOI 10.1371/journal.pcbi.1003186
   Van Hove JLK, 2000, J INHERIT METAB DIS, V23, P571, DOI 10.1023/A:1005673828469
   VANHOVE JLK, 1993, AM J HUM GENET, V52, P958
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Vissing J, 1996, ANN NEUROL, V40, P655, DOI 10.1002/ana.410400416
   WATMOUGH NJ, 1990, J CLIN INVEST, V85, P177, DOI 10.1172/JCI114409
   Wibrand F, 2010, MUSCLE NERVE, V41, P607, DOI 10.1002/mus.21541
   Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225
NR 44
TC 17
Z9 17
U1 0
U2 8
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0021-972X
EI 1945-7197
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD DEC 15
PY 2019
VL 104
IS 12
BP 5968
EP 5976
DI 10.1210/jc.2019-00721
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA KE0FQ
UT WOS:000508237600032
PM 31294795
DA 2024-11-01
ER

PT J
AU DiMauro, S
AF DiMauro, Salvatore
TI A Brief History of Mitochondrial Pathologies
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE mitochondrial pathologies; mtDNA mutations; mendelian and maternal inheritance
ID onset spinocerebellar ataxia; multiple deletions; dna-damage; mutations; gene; mtdna; depletion; family; deficiency; myopathy
AB The history of "mitochondrial pathologies", namely genetic pathologies affecting mitochondrial metabolism because of mutations in nuclear DNA-encoded genes for proteins active inside mitochondria or mutations in mitochondrial DNA-encoded genes, began in 1988. In that year, two different groups of researchers discovered, respectively, large-scale single deletions of mitochondrial DNA (mtDNA) in muscle biopsies from patients with "mitochondrial myopathies" and a point mutation in the mtDNA gene for subunit 4 of NADH dehydrogenase (MTND4), associated with maternally inherited Leber's hereditary optic neuropathy (LHON). Henceforth, a novel conceptual "mitochondrial genetics", separate from mendelian genetics, arose, based on three features of mtDNA: (1) polyplasmy; (2) maternal inheritance; and (3) mitotic segregation. Diagnosis of mtDNA-related diseases became possible through genetic analysis and experimental approaches involving histochemical staining of muscle or brain sections, single-fiber polymerase chain reaction (PCR) of mtDNA, and the creation of patient-derived "cybrid" (cytoplasmic hybrid) immortal fibroblast cell lines. The availability of the above-mentioned techniques along with the novel sensitivity of clinicians to such disorders led to the characterization of a constantly growing number of pathologies. Here is traced a brief historical perspective on the discovery of autonomous pathogenic mtDNA mutations and on the related mendelian pathology altering mtDNA integrity.
C1 [DiMauro, Salvatore] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
C3 Columbia University
RP DiMauro, S (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.
EM sd12@cumc.columbia.edu
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006
   Borthwick Gillian M, 2006, ANN NEUROL, V59, P570, DOI 10.1002/ana.20758
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2017, J CHILD NEUROL, V32, P246, DOI 10.1177/0883073816666221
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hong DJ, 2010, MUSCLE NERVE, V41, P92, DOI 10.1002/mus.21439
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5
   Paradas C, 2013, JAMA NEUROL, V70, P1425, DOI 10.1001/jamaneurol.2013.3185
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Pons R, 1996, PEDIATR NEUROL, V15, P153, DOI 10.1016/0887-8994(96)00118-X
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Sazonova MA, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9090499
   Sazonova MA, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/6934394
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Takata A, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-9-r92
   Tanji K, 2007, METHOD CELL BIOL, V80, P135, DOI 10.1016/S0091-679X(06)80006-3
   TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209
   Uryga A, 2016, ANNU REV PHYSIOL, V78, P45, DOI 10.1146/annurev-physiol-021115-105127
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   Varma H, 2016, EUR J MED GENET, V59, P540, DOI 10.1016/j.ejmg.2016.08.012
   Volobueva A, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9080377
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yu EPK, 2016, FREE RADICAL BIO MED, V100, P223, DOI 10.1016/j.freeradbiomed.2016.06.011
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 54
TC 14
Z9 16
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD NOV 15
PY 2019
VL 20
IS 22
BP 
EP 
DI 10.3390/ijms20225643
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA JW0YW
UT WOS:000502786800125
PM 31718067
DA 2024-11-01
ER

PT J
AU Jou, C
   Ortigoza-Escobar, JD
   Ocallaghan, MM
   Nascimento, A
   Darling, A
   Pias-Peleteiro, L
   Perez-DueÃ±as, B
   Pineda, M
   Codina, A
   Arjona, C
   Armstrong, J
   Palau, F
   Ribes, A
   Gort, L
   Tort, F
   Navas, P
   Ruiz-Pesini, E
   Emperador, S
   Lopez-Gallardo, E
   Bayona-Bafaluy, P
   Montero, R
   Jimenez-Mallebrera, C
   Garcia-Cazorla, A
   Montoya, J
   Yubero, D
   Artuch, R
AF Jou, Cristina
   Ortigoza-Escobar, Juan D.
   Ocallaghan, Maria M.
   Nascimento, Andres
   Darling, Alejandra
   Pias-Peleteiro, Leticia
   Perez-Duenas, Belen
   Pineda, Mercedes
   Codina, Anna
   Arjona, Cesar
   Armstrong, Judith
   Palau, Francesc
   Ribes, Antonia
   Gort, Laura
   Tort, Frederic
   Navas, Placido
   Ruiz-Pesini, Eduardo
   Emperador, Sonia
   Lopez-Gallardo, Ester
   Bayona-Bafaluy, Pilar
   Montero, Raquel
   Jimenez-Mallebrera, Cecilia
   Garcia-Cazorla, Angels
   Montoya, Julio
   Yubero, Delia
   Artuch, Rafael
TI Muscle Involvement in a Large Cohort of Pediatric Patients with Genetic Diagnosis of Mitochondrial Disease
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE mitochondrial diseases; myopathy; pediatric patients; biochemical markers; muscle histopathology; next generation sequencing
ID respiratory-chain disorders; deficiency; mutations; genome
AB Mitochondrial diseases (MD) are a group of genetic and acquired disorders which present significant diagnostic challenges. Here we report the disease characteristics of a large cohort of pediatric MD patients (n = 95) with a definitive genetic diagnosis, giving special emphasis on clinical muscle involvement, biochemical and histopathological features. Of the whole cohort, 51 patients harbored mutations in nuclear DNA (nDNA) genes and 44 patients had mutations in mitochondrial DNA (mtDNA) genes. The nDNA patients were more likely to have a reduction in muscle fiber succinate dehydrogenase (SDH) stains and in SDH-positive blood vessels, while a higher frequency of mtDNA patients had ragged red (RRF) and blue fibers. The presence of positive histopathological features was associated with ophthalmoplegia, myopathic facies, weakness and exercise intolerance. In 17 patients younger than two years of age, RRF and blue fibers were observed only in one case, six cases presented cytochrome c oxidase (COX) reduction/COX-fibers, SDH reduction was observed in five and all except one presented SDH-positive blood vessels. In conclusion, muscle involvement was a frequent finding in our series of MD patients, especially in those harboring mutations in mtDNA genes.
C1 [Jou, Cristina; Ortigoza-Escobar, Juan D.; Ocallaghan, Maria M.; Nascimento, Andres; Darling, Alejandra; Pias-Peleteiro, Leticia; Perez-Duenas, Belen; Pineda, Mercedes; Codina, Anna; Arjona, Cesar; Armstrong, Judith; Palau, Francesc; Montero, Raquel; Jimenez-Mallebrera, Cecilia; Garcia-Cazorla, Angels; Yubero, Delia; Artuch, Rafael] Inst Recerca St Joan de Deu, Clin Biochem Dept, Esplugues 08950, Spain.
   [Jou, Cristina; Ortigoza-Escobar, Juan D.; Ocallaghan, Maria M.; Nascimento, Andres; Darling, Alejandra; Pias-Peleteiro, Leticia; Perez-Duenas, Belen; Pineda, Mercedes; Codina, Anna; Arjona, Cesar; Armstrong, Judith; Palau, Francesc; Montero, Raquel; Jimenez-Mallebrera, Cecilia; Garcia-Cazorla, Angels; Yubero, Delia; Artuch, Rafael] Inst Recerca St Joan de Deu, Pathol Dept, Esplugues 08950, Spain.
   [Jou, Cristina; Ortigoza-Escobar, Juan D.; Ocallaghan, Maria M.; Nascimento, Andres; Darling, Alejandra; Pias-Peleteiro, Leticia; Perez-Duenas, Belen; Pineda, Mercedes; Codina, Anna; Arjona, Cesar; Armstrong, Judith; Palau, Francesc; Montero, Raquel; Jimenez-Mallebrera, Cecilia; Garcia-Cazorla, Angels; Yubero, Delia; Artuch, Rafael] Inst Recerca St Joan de Deu, Paediat Neurol Dept, Esplugues 08950, Spain.
   [Jou, Cristina; Ortigoza-Escobar, Juan D.; Ocallaghan, Maria M.; Nascimento, Andres; Darling, Alejandra; Pias-Peleteiro, Leticia; Perez-Duenas, Belen; Pineda, Mercedes; Codina, Anna; Arjona, Cesar; Armstrong, Judith; Palau, Francesc; Montero, Raquel; Jimenez-Mallebrera, Cecilia; Garcia-Cazorla, Angels; Yubero, Delia; Artuch, Rafael] Inst Recerca St Joan de Deu, Mol Med Dept, Esplugues 08950, Spain.
   [Jou, Cristina; Ortigoza-Escobar, Juan D.; Ocallaghan, Maria M.; Nascimento, Andres; Darling, Alejandra; Pias-Peleteiro, Leticia; Perez-Duenas, Belen; Pineda, Mercedes; Codina, Anna; Arjona, Cesar; Armstrong, Judith; Palau, Francesc; Montero, Raquel; Jimenez-Mallebrera, Cecilia; Garcia-Cazorla, Angels; Yubero, Delia; Artuch, Rafael] CIBERER ISCIII, Esplugues 08950, Spain.
   [Ribes, Antonia; Gort, Laura; Tort, Frederic] Hosp Clin Barcelona, IDIBAPS, CIBERER ISCIII, Seccio Errors Congenits Metab IBC,Serv Bioquim &, Barcelona 08028, Spain.
   [Navas, Placido] Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain.
   [Navas, Placido] CIBERER ISCIII, Seville 41013, Spain.
   [Ruiz-Pesini, Eduardo; Emperador, Sonia; Lopez-Gallardo, Ester; Bayona-Bafaluy, Pilar; Montoya, Julio] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Inst Invest Sanitaria Aragon, E-50013 Zaragoza, Spain.
   [Ruiz-Pesini, Eduardo; Emperador, Sonia; Lopez-Gallardo, Ester; Bayona-Bafaluy, Pilar; Montoya, Julio] Univ Zaragoza, CIBERER ISCIII, E-50013 Zaragoza, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Zaragoza
RP Yubero, D (corresponding author), Inst Recerca St Joan de Deu, Clin Biochem Dept, Esplugues 08950, Spain.; Yubero, D (corresponding author), Inst Recerca St Joan de Deu, Pathol Dept, Esplugues 08950, Spain.; Yubero, D (corresponding author), Inst Recerca St Joan de Deu, Paediat Neurol Dept, Esplugues 08950, Spain.; Yubero, D (corresponding author), Inst Recerca St Joan de Deu, Mol Med Dept, Esplugues 08950, Spain.; Yubero, D (corresponding author), CIBERER ISCIII, Esplugues 08950, Spain.
EM cjou@sjdhospitalbarcelona.org; jortigoza@sjdhospitalbarcelona.org; mocallaghan@sjdhospitalbarcelona.org; anascimento@sjdhospitalbarcelona.org; adarling@sjdhospitalbarcelona.org; lpias@sjdhospitalbarcelona.org; belen.perez@vhir.org; pineda@sjdhospitalbarcelona.org; acodina@fsjd.org; carjona@fsjd.org; jarmstrong@sjdhospitalbarcelona.org; fpalau@sjdhospitalbarcelona.org; ARIBES@clinic.cat; LGORT@clinic.cat; FTORT@ciberer.es; pnavas@upo.es; eduruiz@unizar.es; seortiz@unizar.es; esterlop@unizar.es; pbayona@unizar.es; rmontero@sjdhospitalbarcelona.org; cjimenezm@fsjd.org; agarcia@sjdhospitalbarcelona.org; jmontoya@unizar.es; dyubero@sjdhospitalbarcelona.org; rartuch@sjdhospitalbarcelona.org
FU Instituto de Salud Carlos III [ISCIII-FIS PI17/00109, PI17/00021, PI17/01286, PI15/01082, PI16/01048]; Fundacion Mutua Madrilena [MMA17/01]; AEPMI; FEDER Funding Program from the European Union; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2014: SGR 393]; CERCA Programme/Generalitat de Catalunya; CIBERER-ISCIII
CR Abicht A, 2018, MOL GENET GENOM MED, V6, P1188, DOI 10.1002/mgg3.500
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Asencio C, 2016, EUR J HUM GENET, V24, P367, DOI 10.1038/ejhg.2015.112
   Batllori M, 2018, J INHERIT METAB DIS, V41, P1147, DOI 10.1007/s10545-018-0224-x
   Brito S, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00102
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Couser N, 2017, CLIN ASPECTS LAB DET, V2, P167, DOI 10.1016/B978-0-12-802896-4.00008-0
   Cruz S, 2017, MUSCLE NERVE, V56, P868, DOI 10.1002/mus.25593
   DaRe JT, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-118
   Ortigoza-Escobar JD, 2016, EXPERT REV NEUROTHER, V16, P755, DOI 10.1080/14737175.2016.1187562
   Ortigoza-Escobar JD, 2016, MITOCHONDRION, V28, P73, DOI 10.1016/j.mito.2016.04.001
   DÃ­ez H, 2017, MOVEMENT DISORD, V32, P1108, DOI 10.1002/mds.27021
   Ferrer-CortÃ¨s X, 2013, J INHERIT METAB DIS, V36, P841, DOI 10.1007/s10545-012-9565-z
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Goldstein AC, 2013, NEUROTHERAPEUTICS, V10, P212, DOI 10.1007/s13311-013-0185-6
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Menezes MJ, 2014, BBA-GEN SUBJECTS, V1840, P1368, DOI 10.1016/j.bbagen.2013.12.025
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   OCallaghan MM, 2015, MITOCHONDRION, V22, P17, DOI 10.1016/j.mito.2015.03.001
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   Palculict ME, 2016, METHODS MOL BIOL, V1351, P3, DOI 10.1007/978-1-4939-3040-1_1
   Phadke R, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6070064
   Plutino M, 2018, BMC MED GENET, V19, P0, DOI 10.1186/s12881-018-0568-y
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Serrano M, 2010, MITOCHONDRION, V10, P429, DOI 10.1016/j.mito.2010.04.001
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Thompson K, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809060
   Tulinius M, 2011, SEMIN FETAL NEONAT M, V16, P229, DOI 10.1016/j.siny.2011.04.001
   Vasta V, 2012, PEDIATR INT, V54, P585, DOI 10.1111/j.1442-200X.2012.03644.x
   Witters P, 2018, GENET MED, V20, P444, DOI 10.1038/gim.2017.125
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Yubero D, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0156359
NR 39
TC 13
Z9 13
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD JAN 15
PY 2019
VL 8
IS 1
BP 
EP 
DI 10.3390/jcm8010068
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA HJ4JU
UT WOS:000457141100067
PM 30634555
DA 2024-11-01
ER

PT J
AU Wagner, M
   Berutti, R
   Lorenz-Depiereux, B
   Graf, E
   Eckstein, G
   Mayr, JA
   Meitinger, T
   Ahting, U
   Prokisch, H
   Strom, TM
   Wortmann, SB
AF Wagner, Matias
   Berutti, Riccardo
   Lorenz-Depiereux, Bettina
   Graf, Elisabeth
   Eckstein, Gertrud
   Mayr, Johannes A.
   Meitinger, Thomas
   Ahting, Uwe
   Prokisch, Holger
   Strom, Tim M.
   Wortmann, Saskia B.
TI Mitochondrial DNA mutation analysis from exome sequencing-A more holistic approach in diagnostics of suspected mitochondrial disease
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
DE bioinformatics; diagnostics; mitochondrial disorders; muscle biopsy; nuclear DNA
ID genome; identify
AB Diagnostics for suspected mitochondrial disease (MD) can be challenging and necessitate invasive procedures like muscle biopsy. This is due to the extremely broad genetic and phenotypic spectrum, disease genes on both nuclear and mitochondrial DNA (mtDNA), and the tissue specificity of mtDNA variants. Exome sequencing (ES) has revolutionized the diagnostics for MD. However, the nuclear and mtDNA are investigated with separate tests, increasing costs and duration of diagnostics. The full potential of ES is often not exploited as the additional analysis of "off-target reads" deriving from the mtDNA can be used to analyze both genomes. We performed mtDNA analysis by ES of 2111 cases in a clinical setting. We further assessed the recall rate and precision as well as the estimation of heteroplasmy by ES data by comparison with targeted mtDNA next generation sequencing in 49 cases. ES identified known pathogenic mtDNA point mutations in 38 individuals, increasing the diagnostic yield by nearly 2%. Analysis of mtDNA variants by ES had a high recall rate (96.2 +/- 5.6%) and an excellent precision (99.5 +/- 2.2%) when compared to the gold standard of targeted mtDNA next generation sequencing. ES estimated heteroplasmy levels with an average difference of 6.6 +/- 3.8%, sufficient for clinical decision making. Taken together, the mtDNA analysis from ES is of sufficient quality for clinical diagnostics. We therefore propose ES, investigating both nuclear and mtDNA, as first line test in individuals with suspected MD. One should be aware, that a negative result does not exclude MD and necessitates further test (in additional tissues).
C1 [Wagner, Matias; Berutti, Riccardo; Meitinger, Thomas; Ahting, Uwe; Prokisch, Holger; Strom, Tim M.; Wortmann, Saskia B.] Tech Univ Munich, Inst Human Genet, Munich, Germany.
   [Wagner, Matias; Berutti, Riccardo; Lorenz-Depiereux, Bettina; Graf, Elisabeth; Eckstein, Gertrud; Meitinger, Thomas; Prokisch, Holger; Strom, Tim M.; Wortmann, Saskia B.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany.
   [Wagner, Matias] Helmholtz Zentrum Munchen, Inst Neurogen, Neuherberg, Germany.
   [Mayr, Johannes A.; Wortmann, Saskia B.] PMU, Univ Childrens Hosp, Salzburg, Austria.
C3 Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Paracelsus Private Medical University
RP Wortmann, SB (corresponding author), Tech Univ Munich, Inst Human Genet, Munich, Germany.
EM wortmann-hagemann@helmholtz-muenchen.de
CR Bergant G, 2018, GENET MED, V20, P303, DOI 10.1038/gim.2017.142
   Chinnery PF, 1993, GENEREVIEWS R, V0, P0
   Griffin HR, 2014, GENET MED, V16, P962, DOI 10.1038/gim.2014.66
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   King JL, 2014, FORENSIC SCI INT-GEN, V12, P128, DOI 10.1016/j.fsigen.2014.06.001
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pfundt R, 2017, GENET MED, V19, P667, DOI 10.1038/gim.2016.163
   Picardi E, 2012, NAT METHODS, V9, P523, DOI 10.1038/nmeth.2029
   Samuels DC, 2013, TRENDS GENET, V29, P593, DOI 10.1016/j.tig.2013.07.006
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   Witters P, 2018, GENET MED, V20, P444, DOI 10.1038/gim.2017.125
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 16
TC 52
Z9 52
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD SEP 15
PY 2019
VL 42
IS 5
BP 909
EP 917
DI 10.1002/jimd.12109
PG 9
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA IX9US
UT WOS:000486036500018
PM 31059585
DA 2024-11-01
ER

PT J
AU van Tienen, F
   Zelissen, R
   Timmer, E
   van Gisbergen, M
   Lindsey, P
   Quattrocelli, M
   Sampaolesi, M
   Mulder-den Hartog, E
   de Coo, I
   Smeets, H
AF van Tienen, Florence
   Zelissen, Ruby
   Timmer, Erika
   van Gisbergen, Marike
   Lindsey, Patrick
   Quattrocelli, Mattia
   Sampaolesi, Maurilio
   Mulder-den Hartog, Elvira
   de Coo, Irenaeus
   Smeets, Hubert
TI Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE mtDNA mutation; Mesoangioblasts; Muscle regeneration
ID ragged-red fibers; skeletal-muscle; point mutation; mitochondrial encephalomyopathy; satellite cells; stem-cells; young; prevalence; deletions; spectrum
AB Background Myopathy and exercise intolerance are prominent clinical features in carriers of a point-mutation or large-scale deletion in the mitochondrial DNA (mtDNA). In the majority of patients, the mtDNA mutation is heteroplasmic with varying mutation loads between tissues of an individual. Exercise-induced muscle regeneration has been shown to be beneficial in some mtDNA mutation carriers, but is often not feasible for this patient group. In this study, we performed in vitro analysis of mesoangioblasts from mtDNA mutation carriers to assess their potential to be used as source for autologous myogenic cell therapy. Methods We assessed the heteroplasmy level of patient-derived mesoangioblasts, isolated from skeletal muscle of multiple carriers of different mtDNA point-mutations (n = 25). Mesoangioblast cultures with < 10% mtDNA mutation were further analyzed with respect to immunophenotype, proliferation capacity, in vitro myogenic differentiation potential, mitochondrial function, and mtDNA quantity. Results This study demonstrated that mesoangioblasts in half of the patients contained no or a very low mutation load (< 10%), despite a much higher mutation load in their skeletal muscle. Moreover, none of the large-scale mtDNA deletion carriers displayed the deletion in mesoangioblasts, despite high percentages in skeletal muscle. The mesoangioblasts with no or a very low mutation load (< 10%) displayed normal mitochondrial function, proliferative capacity, and myogenic differentiation capacity. Conclusions Our data demonstrates that in half of the mtDNA mutation carriers, their mesoangioblasts are (nearly) mutation free and can potentially be used as source for autologous cell therapy for generation of new muscle fibers without mtDNA mutation and normal mitochondrial function.
C1 [van Tienen, Florence] Maastricht Univ, Dept Clin Genet, Med Ctr, Maastricht, Netherlands.
   [van Tienen, Florence; Zelissen, Ruby; Timmer, Erika; van Gisbergen, Marike; Smeets, Hubert] Maastricht Univ, Sch Dev Biol & Oncol GROW, Med Ctr, POB 616, NL-6200 MD Maastricht, Netherlands.
   [van Tienen, Florence; de Coo, Irenaeus; Smeets, Hubert] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Med Ctr, Maastricht, Netherlands.
   [van Tienen, Florence; Zelissen, Ruby; Timmer, Erika; Lindsey, Patrick; de Coo, Irenaeus; Smeets, Hubert] Maastricht Univ, Dept Genet & Cell Biol, Med Ctr, Div Clin Genom, Maastricht, Netherlands.
   [van Gisbergen, Marike] Maastricht Univ, Dept Radiat Oncol, Med Ctr, MaastRO Lab, Maastricht, Netherlands.
   [Quattrocelli, Mattia; Sampaolesi, Maurilio] Katholieke Univ Leuven, Translat Cardiomyol, Dept Dev & Regenerat, Leuven, Belgium.
   [Quattrocelli, Mattia] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA.
   [Sampaolesi, Maurilio] Univ Pavia, Human Anat Unit, Dept Publ Hlth Expt & Forens Med, Pavia, Italy.
   [Mulder-den Hartog, Elvira] Erasmus MC, Dept Pediat Surg, Rotterdam, Netherlands.
   [Mulder-den Hartog, Elvira; de Coo, Irenaeus] Neuromuscular & Mitochondrial Res Ctr NeMo, Rotterdam, Netherlands.
C3 Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; KU Leuven; Northwestern University; University of Pavia; Erasmus University Rotterdam; Erasmus MC
RP Smeets, H (corresponding author), Maastricht Univ, Sch Dev Biol & Oncol GROW, Med Ctr, POB 616, NL-6200 MD Maastricht, Netherlands.; Smeets, H (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Med Ctr, Maastricht, Netherlands.
EM Bert.smeets@maastrichtuniversity.nl
FU ZonMw "translational adult stem cell program" [116005007]; Ride4Kids Foundation [191213]; Metakids "ING goede doelen fonds" [2014-055]; Prinses Beatrix Spierfonds [PBS W.0R15 09]
CR Akaike H, 1973, 2 INT S INFORM THEOR, V0, PP267, DOI 10.1007/978-1-4612-1694-0
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Chen CW, 2009, CYTOKINE GROWTH F R, V20, P429, DOI 10.1016/j.cytogfr.2009.10.014
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Cossu G, 2015, EMBO MOL MED, V7, P1513, DOI 10.15252/emmm.201505636
   Dellavalle A, 2011, NAT COMMUN, V2, P0, DOI 10.1038/ncomms1508
   Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542
   Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461
   Farup J, 2015, J APPL PHYSIOL, V119, P1053, DOI 10.1152/japplphysiol.01108.2014
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085
   Gorman GS, 2015, NEUROMUSCULAR DISORD, V25, P563, DOI 10.1016/j.nmd.2015.03.001
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Ihaka Ross, 1996, JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS, V5, P3, DOI 10.2307/1390807
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   KÃ¤rppÃ¤ M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Lindsey J, 1999, MODELS REPEATED MEAS, V0, P536
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Meng JH, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0017454
   Morosetti R, 2011, ACTA MYOL, V30, P24
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Nederveen JP, 2018, J PHYSIOL-LONDON, V596, P1063, DOI 10.1113/JP275155
   Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Quattrocelli M, 2012, METHODS MOL BIOL, V798, P65, DOI 10.1007/978-1-61779-343-1_4
   Roobrouck VD, 2011, STEM CELLS, V29, P871, DOI 10.1002/stem.633
   Rotini A, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12714
   Sallevelt SCEH, 2013, J MED GENET, V50, P125, DOI 10.1136/jmedgenet-2012-101172
   Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254
   Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282
   Sancricca Cristina, 2010, WORLD J STEM CELLS, V2, P39, DOI 10.4252/wjsc.v2.i3.39
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tedesco FS, 2012, CURR OPIN NEUROL, V25, P597, DOI 10.1097/WCO.0b013e328357f288
   Tonlorenzi R, 2007, CURR PROTOC STEM CEL, V3, P1, DOI 10.1002/9780470151808.SC02B01S3
   Valero MC, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0029760
   Walker DK, 2012, MUSCLE NERVE, V46, P51, DOI 10.1002/mus.23266
NR 39
TC 10
Z9 10
U1 2
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD DEC 21
PY 2019
VL 10
IS 1
BP 
EP 
DI 10.1186/s13287-019-1510-8
PG 10
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA JY2YV
UT WOS:000504287000001
PM 31864395
DA 2024-11-01
ER

PT J
AU Magner, M
AF Magner, Martin
TI Clinical Manifestation of Mitochondrial Disorders in Childhood
SO HANDBOOK OF MITOCHONDRIAL DYSFUNCTION
LA English
DT Article; Book Chapter
ID cytochrome-c-oxidase; progressive external ophthalmoplegia; leigh-syndrome; neurogastrointestinal encephalomyopathy; cardiac manifestations; myoclonic epilepsy; presenting feature; deafness syndrome; natural-history; dna mutations
C1 [Magner, Martin] Charles Univ Prague, Gen Univ Hosp, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Magner, Martin] Charles Univ Prague, Fac Med 1, Ke Karlovu 2, Prague 12808 2, Czech Republic.
C3 General University Hospital Prague; Charles University Prague; Charles University Prague
RP Magner, M (corresponding author), Charles Univ Prague, Gen Univ Hosp, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.; Magner, M (corresponding author), Charles Univ Prague, Fac Med 1, Ke Karlovu 2, Prague 12808 2, Czech Republic.
FU Charles University in Prague [UNCE 204064, AZV 17-30965A, RVO-VFN 64165/2012]
CR Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Astuti D, 2004, BRIT J CANCER, V91, P1835, DOI 10.1038/sj.bjc.6602202
   Bachmann-Gagescu R, 2009, J INHERIT METAB D S1, V0, P1101
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bargiela David, 2015, CEREBELLUM ATAXIAS, V2, P16, DOI 10.1186/s40673-015-0035-x
   BarragÃ¡n-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Barrett TG, 1997, J MED GENET, V34, P838, DOI 10.1136/jmg.34.10.838
   BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Bates MGD, 2012, INT J CARDIOL, V155, P305, DOI 10.1016/j.ijcard.2011.11.063
   Berio A, 2013, PEDIATR MED CHIR, V35, P137
   Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   BÃ¶hm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Braczynski AK, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/462592
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Burki F, 2016, CURR BIOL, V26, PR410, DOI 10.1016/j.cub.2016.04.032
   Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012
   Cameron JM, 2004, AM J MED GENET A, V131A, P59, DOI 10.1002/ajmg.a.30287
   Carrozzo R, 2007, BRAIN 3, V130, P862
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   CHARLES R, 1981, CIRCULATION, V63, P214, DOI 10.1161/01.CIR.63.1.214
   Chi CS, 2015, PEDIATR NEONATOL, V56, P7, DOI 10.1016/j.pedneo.2014.03.009
   Chiang S, 2016, CLIN SCI, V130, P853, DOI 10.1042/CS20160072
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   CizkovÃ¡ A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Debray FG, 2006, EUR J PEDIATR, V165, P462, DOI 10.1007/s00431-006-0104-5
   Desguerre I, 2014, REV NEUROL-FRANCE, V170, P375, DOI 10.1016/j.neurol.2014.03.010
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2002, ADV NEUROL, V89, P217
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   DiMauro S, 2015, GENEREVIEWS R, V0, P0
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Emma F, 2017, NEPHROL THER, V13, PS23, DOI 10.1016/j.nephro.2017.01.014
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Filosto M, 2008, NEUROMUSCULAR DISORD, V18, P204
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Finsterer J, 2006, NETH J MED, V64, P61
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2007, ACTA HAEMATOL-BASEL, V118, P88, DOI 10.1159/000105676
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Finsterer J, 2017, BIOMED REP, V6, P487, DOI 10.3892/br.2017.892
   Finsterer J, 2015, SINGAP MED J, V56, P412, DOI 10.11622/smedj.2015112
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Finsterer J, 2012, SEIZURE-EUR J EPILEP, V21, P316, DOI 10.1016/j.seizure.2012.03.003
   Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606
   Gano LB, 2014, J LIPID RES, V55, P2211, DOI 10.1194/jlr.R048975
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gebhart SSP, 1996, METABOLISM, V45, P526, DOI 10.1016/S0026-0495(96)90231-0
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Graham BR, 2014, BMC NEPHROL, V15, P0, DOI 10.1186/1471-2369-15-10
   Gueyen N, 2015, REDOX BIOL, V4, P289, DOI 10.1016/j.redox.2015.01.009
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hirano M, 2016, GENEREVIEWS R, V0, P0
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Honzik T, 2006, CAS LEK CESK, V145, P665
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Huntsman RJ, 2005, PEDIATR NEUROL, V32, P334, DOI 10.1016/j.pediatrneurol.2004.12.009
   Ichida F, 2001, CIRCULATION, V103, P1256
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Kaufman KR, 2010, EPILEPSY BEHAV, V18, P494, DOI 10.1016/j.yebeh.2010.05.020
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kozak Igor, 2018, RETIN CASES BRIEF REP, V12, P349, DOI 10.1097/ICB.0000000000000503
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lamont PJ, 1998, ARCH DIS CHILD, V79, P22, DOI 10.1136/adc.79.1.22
   Lax NZ, 2017, NEUROPATH APPL NEURO, V43, P102, DOI 10.1111/nan.12333
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197
   Lee K T, 2001, KAOHSIUNG J MED SCI, V17, P336
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Li YY, 2018, GENE, V674, P15, DOI 10.1016/j.gene.2018.06.058
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Listernick R, 2007, PEDIATR ANN, V36, P254, DOI 10.3928/0090-4481-20070501-04
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Magner M, 2011, PRAGUE MED REP, V112, P18
   Magner M, 2010, CESK SLOV NEUROL N, V106, P73
   Magner M, 2015, J INHERIT METAB DIS, V38, P417, DOI 10.1007/s10545-014-9774-8
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Marin SE, 2013, GENE, V516, P162, DOI 10.1016/j.gene.2012.12.024
   MartÃ­ R, 2005, ANN NEUROL, V58, P649, DOI 10.1002/ana.20615
   Mignarri A, 2015, J NEUROL SCI, V349, P254, DOI 10.1016/j.jns.2014.12.040
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   MOHR JAN, 1960, ACTA GENET ET STATIST MED, V10, P54
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Mozzillo E, 2014, BMC MED GENET, V15, P0, DOI 10.1186/1471-2350-15-88
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Niaudet P, 1997, KIDNEY INT, V51, P1000, DOI 10.1038/ki.1997.140
   Nye JS, 2000, TERATOLOGY, V61, P165, DOI 10.1002/(SICI)1096-9926(200003)61:3<165::AID-TERA3>3.3.CO;2-5
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Piekutowska-Abramczuk D, 2009, CLIN GENET, V76, P195, DOI 10.1111/j.1399-0004.2009.01195.x
   POULTON J, 1989, LANCET, V1, P236
   Pronicka E, 2013, MITOCHONDRION, V13, P810, DOI 10.1016/j.mito.2013.05.007
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   RÃ¶tig A, 2003, J NEPHROL, V16, P286
   Saneto RP, 2013, NEUROTHERAPEUTICS, V10, P199, DOI 10.1007/s13311-012-0167-0
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Shigemoto M, 1998, INTERNAL MED, V37, P265, DOI 10.2169/internalmedicine.37.265
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sperl W, 2015, J INHERIT METAB DIS, V38, P391, DOI 10.1007/s10545-014-9787-3
   Subramanian VS, 2006, AM J PHYSIOL-CELL PH, V291, P0
   Taanman JW, 2009, NEUROMUSCULAR DISORD, V19, P151, DOI 10.1016/j.nmd.2008.11.002
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tay SKH, 2004, ARCH NEUROL-CHICAGO, V61, P950, DOI 10.1001/archneur.61.6.950
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Tesarova M, 2019, PEDIATR BLOOD CANCER, V66, P0, DOI 10.1002/pbc.28007
   Thorburn DR, 2017, GENEREVIEWS R, V0, P0
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Tranebjaerg L, 2001, OPHTHALMIC GENET, V22, P207
   TRANEBJAERG L, 1995, J MED GENET, V32, P257, DOI 10.1136/jmg.32.4.257
   Turconi AC, 1999, J NEUROL SCI, V170, P57, DOI 10.1016/S0022-510X(99)00199-9
   Ujike H, 2001, ARCH NEUROL-CHICAGO, V58, P1004, DOI 10.1001/archneur.58.6.1004
   Urano F, 2016, CURR DIABETES REP, V16, P0, DOI 10.1007/s11892-015-0702-6
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   van Adel Brian A, 2009, J CLIN NEUROMUSCUL DIS, V10, P97, DOI 10.1097/CND.0b013e3181903126
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vissing J, 2002, NEUROLOGY, V59, P926, DOI 10.1212/WNL.59.6.926
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Wallace DC, 1999, P NATL ACAD SCI USA, V96, P1817, DOI 10.1073/pnas.96.5.1817
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-96
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Yaplito-Lee J, 2007, J PEDIATR-US, V150, P407, DOI 10.1016/j.jpeds.2006.12.047
   Yu-Wai-Man P, 2016, GENEREVIEWS R, V0, P0
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 155
TC 0
Z9 0
U1 0
U2 0
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
SN 
EI 
J9 
PD JUN 15
PY 2019
VL 0
IS 
BP 243
EP 263
DI 
PG 21
WC Cell Biology; Genetics & Heredity; Pathology
SC Cell Biology; Genetics & Heredity; Pathology
GA BQ1CL
UT WOS:000575159400022
DA 2024-11-01
ER

PT J
AU Terburgh, K
   Lindeque, Z
   Mason, S
   van der Westhuizen, F
   Louw, R
AF Terburgh, Karin
   Lindeque, Zander
   Mason, Shayne
   van der Westhuizen, Francois
   Louw, Roan
TI Metabolomics of <i>Ndufs4</i><SUP>-/-</SUP> skeletal muscle: Adaptive mechanisms converge at the ubiquinone-cycle
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Ndufs4 knockout mice; Skeletal muscle; Metabolomics; Mitochondrial disease; Complex I deficiency; Ubiquinone-cycle
ID complex-i deficiency; clinical-features; mitochondrial-dna; mice display; mouse model; samples; mutations; gene
AB Leigh syndrome is one of the most common childhood-onset neurometabolic disorders resulting from a primary oxidative phosphorylation dysfunction and affecting mostly brain tissues. Ndufs4(-/-) mice have been widely used to study the neurological responses in this syndrome, however the reason why these animals do not display strong muscle involvement remains elusive. We combined biochemical strategies and multi-platform metabolomics to gain insight into the metabolism of both glycolytic (white quadriceps) and oxidative (soleus) skeletal muscles from Ndufs4(-/-) mice. Enzyme assays confirmed severely reduced (80%) CI activity in both Ndufs4(-/-) muscle types, compared to WTs. No significant alterations were evident in other respiratory chain enzyme activities; however, Ndufs4(-/-) solei displayed moderate decreases in citrate synthase (12%) and CIII (18%) activities. Through hypothesis-generating metabolic profiling, we provide the first evidence of adaptive responses to Cl dysfunction involving non-classical pathways fueling the ubiquinone (Q) cycle. We report a respective 48 and 34 discriminatory metabolites between Ndufs4(-/-) and WT white quadriceps and soleus muscles, among which the most prominent alterations indicate the involvement of the glycerol-3-phosphate shuttle, electron transfer flavoprotein system, CII, and proline cycle in fueling the Q cycle. By restoring the electron flux to CIII via the Q cycle, these adaptive mechanisms could maintain adequate oxidative ATP production, despite CI deficiency. Taken together, our results shed light on the underlying pathogenic mechanisms of CI dysfunction in skeletal muscle. Upon further investigation, these pathways could provide novel targets for therapeutic intervention in Cl deficiency and potentially lead to the development of new treatment strategies.
C1 [Terburgh, Karin; Lindeque, Zander; Mason, Shayne; van der Westhuizen, Francois; Louw, Roan] North West Univ Potchefstroom Campus, Fac Nat & Agr Sci, Human Metabol, Private Bag X6001, Potchefstroom, South Africa.
C3 North West University - South Africa
RP Louw, R (corresponding author), North West Univ Potchefstroom Campus, Fac Nat & Agr Sci, Human Metabol, Private Bag X6001, Potchefstroom, South Africa.
EM Roan.Louw@nwu.ac.za
FU National Research Foundation of South Africa (NRF) [92736, 111247]; Technological Innovation Agency of the Department of Science and Technology, Republic of South Africa (TIA) [Metabol. 01]
CR Alam MT, 2015, BBA-BIOENERGETICS, V1847, P526, DOI 10.1016/j.bbabio.2015.02.006
   Bogner-Strauss JG, 2017, FRONT ENDOCRINOL, V8, P0, DOI 10.3389/fendo.2017.00240
   Breuer ME, 2013, IUBMB LIFE, V65, P202, DOI 10.1002/iub.1127
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Budde SMS, 2003, J INHERIT METAB DIS, V26, P813, DOI 10.1023/B:BOLI.0000010003.14113.af
   Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446
   Cherry AD, 2015, ANTIOXID REDOX SIGN, V22, P965, DOI 10.1089/ars.2014.6200
   de Haas R, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-09417-5
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Ellis SM, 2003, MANAGEMENT DYNAMICS, V12, P51, DOI 10.10520/EJC69666
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Foriel S, 2018, DIS MODEL MECH, V11, P0, DOI 10.1242/dmm.032482
   Goody MF, 2018, SKELET MUSCLE, V8, P0, DOI 10.1186/s13395-018-0154-1
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   Leong DW, 2012, J BIOL CHEM, V287, P20652, DOI 10.1074/jbc.M111.327601
   Lindeque JZ, 2013, METABOLOMICS, V9, P418, DOI 10.1007/s11306-012-0459-8
   Mason S, 2018, METABOLOMICS, V14, P0, DOI 10.1007/s11306-018-1372-6
   McDonald AE, 2018, COMP BIOCHEM PHYS B, V224, P185, DOI 10.1016/j.cbpb.2017.11.006
   Mels Catharina M C, 2011, ISRN PHARMACOL, V2011, P851870, DOI 10.5402/2011/851870
   Phang JM, 2019, ANTIOXID REDOX SIGN, V30, P635, DOI 10.1089/ars.2017.7350
   QURESHI GA, 1986, J CHROMATOGR, V374, P363, DOI 10.1016/S0378-4347(00)83293-4
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Russell AP, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00314
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105
   Shaughnessy DT, 2014, ENVIRON HEALTH PERSP, V122, P1271, DOI 10.1289/ehp.1408418
   SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597
   Shokolenko IN, 2015, BBA-MOL BASIS DIS, V1852, P1805, DOI 10.1016/j.bbadis.2015.05.016
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   Terburgh K, 2018, MULTIPLATFORM METABO, V0, P0
   Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071
   Valsecchi F, 2012, BBA-BIOENERGETICS, V1817, P1925, DOI 10.1016/j.bbabio.2012.03.006
   Valsecchi F, 2010, DEV DISABIL RES REV, V16, P175, DOI 10.1002/ddrr.107
   Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007
   Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475
   Wu GY, 2011, AMINO ACIDS, V40, P1053, DOI 10.1007/s00726-010-0715-z
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, PW251, DOI 10.1093/nar/gkv380
NR 43
TC 20
Z9 21
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JAN 15
PY 2019
VL 1865
IS 1
BP 98
EP 106
DI 10.1016/j.bbadis.2018.10.034
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA HC0MM
UT WOS:000451492500010
PM 30391276
DA 2024-11-01
ER

PT J
AU Vita, G
   Vita, GL
   Musumeci, O
   Rodolico, C
   Messina, S
AF Vita, Giuseppe
   Vita, Gian Luca
   Musumeci, Olimpia
   Rodolico, Carmelo
   Messina, Sonia
TI Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle
SO NEUROLOGICAL SCIENCES
LA English
DT Review
DE Spinal muscular atrophy; Nusinersen; SMN1 gene replacement; Duchenne muscular dystrophy; Ataluren; Exon skipping
ID duchenne muscular-dystrophy; double-blind; nondystrophic myotonias; isoflavone genistein; sham control; sma type; diagnosis; atrophy; care; management
AB This is the second part of a two-part document intended to discuss recent therapeutic progresses in genetic neuromuscular disorders. The present review is for diseases of motor neuron and skeletal muscle, some of which reached recently the most innovative therapeutic approaches. Nusinersen, an SMN2 mRNA splicing modifier, was approved as first-ever therapy of spinal muscular atrophy (SMA) by FDA in 2016 and by EMA in 2017. The orally administered small-molecule risdiplam, which increases SMN protein levels similarly but also in peripheral organs, is tested in ongoing phase 2 and 3 trials. After positive results with phase 1 treatment with AAV9-SMN, the first gene therapy for SMA, a phase 3 clinical trial is ongoing. Ataluren is the first approved drug for Duchenne muscular dystrophy (DMD) patients with premature stop codon mutations and its indication has been recently extended since the age of 2years. Exon skipping technology was and is currently tested in many phase 3 trials, and eteplirsen received a conditional approval by FDA for patients amenable to exon 51 skipping, but not by EMA. Many other compounds with different mechanisms of action are now tested in DMD by phase 2 and 3 trials, including phase 1 gene therapy. Other innovative approaches are under investigation, i.e., gene therapy in X-linked myotubular myopathy and Pompe disease, and antisense oligonucleotides in myotonic dystrophy type 1. Positive evidences are discussed about lamotrigine and ranolazine in non-dystrophic myotonias, chaperons in Pompe disease, and nucleosides in mitochondrial DNA depletion induced by thymidine kinase 2 deficiency.
C1 [Vita, Giuseppe; Musumeci, Olimpia; Rodolico, Carmelo; Messina, Sonia] Univ Messina, Dept Clin & Expt Med, Unit Neurol & Neuromuscular Dis, Messina, Italy.
   [Vita, Giuseppe; Vita, Gian Luca; Messina, Sonia] Nemo Sud Clin Ctr Neuromuscular Disorders, Messina, Italy.
C3 University of Messina
RP Vita, G (corresponding author), Univ Messina, Dept Clin & Expt Med, Unit Neurol & Neuromuscular Dis, Messina, Italy.; Vita, G (corresponding author), Nemo Sud Clin Ctr Neuromuscular Disorders, Messina, Italy.
EM vitag@unime.it
CR Aartsma-Rus A, 2019, NUCLEIC ACID THER, V29, P13, DOI 10.1089/nat.2018.0756
   Al-Zaidy S, 2019, PEDIATR PULM, V54, P179, DOI 10.1002/ppul.24203
   Amoasii L, 2018, SCIENCE, V362, P86, DOI 10.1126/science.aau1549
   Andersen G, 2017, BRAIN, V140, P2295, DOI 10.1093/brain/awx192
   Angelini C, 2012, J NEUROL, V259, P952, DOI 10.1007/s00415-011-6293-5
   Arnold WD, 2017, NEUROLOGY, V89, P710, DOI 10.1212/WNL.0000000000004229
   Bach JR, 2011, RESP CARE, V56, P744, DOI 10.4187/respcare.00831
   BarthÃ©lÃ©my F, 2018, NEUROMUSCULAR DISORD, V28, P803, DOI 10.1016/j.nmd.2018.06.009
   Bassez G, 2018, BRAIN, V141, P2855, DOI 10.1093/brain/awy231
   Bertini E, 2017, LANCET NEUROL, V16, P513, DOI 10.1016/S1474-4422(17)30085-6
   Bettica P, 2016, NEUROMUSCULAR DISORD, V26, P643, DOI 10.1016/j.nmd.2016.07.002
   Biogen, 2018, REACTIONS WEEKLY, V1714, P3, DOI 10.1007/S40278-018-50183-2
   Birnkrant DJ, 2018, LANCET NEUROL, V17, P347, DOI 10.1016/S1474-4422(18)30025-5
   Birnkrant DJ, 2018, LANCET NEUROL, V17, P445, DOI 10.1016/S1474-4422(18)30026-7
   Birnkrant DJ, 2018, LANCET NEUROL, V17, P251, DOI 10.1016/S1474-4422(18)30024-3
   Calucho M, 2018, NEUROMUSCULAR DISORD, V28, P208, DOI 10.1016/j.nmd.2018.01.003
   Cassandrini D, 2017, ITAL J PEDIATR, V43, P0, DOI 10.1186/s13052-017-0419-z
   Corti M, 2017, HUM GENE THER CL DEV, V28, P208, DOI 10.1089/humc.2017.146
   DAmico A, 2017, NEUROMUSCULAR DISORD, V27, P447, DOI 10.1016/j.nmd.2017.02.006
   De Antonio M, 2016, REV NEUROL-FRANCE, V172, P572, DOI 10.1016/j.neurol.2016.08.003
   Elverman M, 2017, MUSCLE NERVE, V56, P943, DOI 10.1002/mus.25658
   Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752
   Finkel RS, 2018, NEUROMUSCULAR DISORD, V28, P197, DOI 10.1016/j.nmd.2017.11.004
   Finkel RS, 2017, NEUROMUSCULAR DISORD, V27, P596, DOI 10.1016/j.nmd.2017.02.014
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Guglieri M, 2017, CONTEMP CLIN TRIALS, V58, P34, DOI 10.1016/j.cct.2017.04.008
   Han SO, 2017, MOL THER-METH CLIN D, V4, P126, DOI 10.1016/j.omtm.2016.12.010
   Hoffman EP, 2018, STEROIDS, V134, P43, DOI 10.1016/j.steroids.2018.02.010
   Iwamoto N, 2017, NAT BIOTECHNOL, V35, P845, DOI 10.1038/nbt.3948
   Jauvin D, 2017, MOL THER-NUCL ACIDS, V7, P465, DOI 10.1016/j.omtn.2017.05.007
   Kinane T Bernard, 2018, J NEUROMUSCUL DIS, V5, P47, DOI 10.3233/JND-170272
   Klug C, 2016, ORPHANET J RARE DIS, V11, P0, DOI 10.1186/s13023-016-0424-0
   Koeberl DD, 2011, MOL GENET METAB, V103, P107, DOI 10.1016/j.ymgme.2011.02.006
   Kuntz N, 2018, NEUROMUSCULAR DISORD, V28, PS91, DOI 10.1016/j.nmd.2018.06.240
   La Foresta S, 2018, NEUROL SCI, V39, P1961, DOI 10.1007/s10072-018-3506-z
   Laustriat D, 2015, MOL THER-NUCL ACIDS, V4, P0, DOI 10.1038/mtna.2015.35
   Li DH, 2018, TRENDS PHARMACOL SCI, V39, P982, DOI 10.1016/j.tips.2018.09.001
   LÃ³pez-Bastida J, 2017, ORPHANET J RARE DIS, V12, P0, DOI 10.1186/s13023-017-0695-0
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   LoRusso S, 2019, MUSCLE NERVE, V59, P240, DOI 10.1002/mus.26372
   Maga JA, 2013, J BIOL CHEM, V288, P1428, DOI 10.1074/jbc.M112.438663
   Mah JK, 2018, METHODS MOL BIOL, V1687, P3, DOI 10.1007/978-1-4939-7374-3_1
   Matthews E, 2010, BRAIN, V133, P9, DOI 10.1093/brain/awp294
   Matthews E, 2016, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD003725.pub4
   McDonald CM, 2017, LANCET, V390, P1489, DOI 10.1016/S0140-6736(17)31611-2
   Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198
   Mendell JR, 2016, ANN NEUROL, V79, P257, DOI 10.1002/ana.24555
   Mercuri E, 2018, NEW ENGL J MED, V378, P625, DOI 10.1056/NEJMoa1710504
   Mercuri E, 2018, NEUROMUSCULAR DISORD, V28, P103, DOI 10.1016/j.nmd.2017.11.005
   Messina S, 2018, NEUROL SCI, V39, P1837, DOI 10.1007/s10072-018-3555-3
   Messina S, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7090251
   Messina S, 2017, NEUROMUSCULAR DISORD, V27, P1084, DOI 10.1016/j.nmd.2017.09.006
   Messina S, 2015, BIOFACTORS, V41, P324, DOI 10.1002/biof.1226
   Messina S, 2011, NEUROMUSCULAR DISORD, V21, P579, DOI 10.1016/j.nmd.2011.04.014
   Messina S, 2009, EXP NEUROL, V220, P349, DOI 10.1016/j.expneurol.2009.09.015
   Meyer K, 2015, MOL THER, V23, P477, DOI 10.1038/mt.2014.210
   Pacione M, 2019, J NEUROMUSCULAR DIS, V6, P119, DOI 10.3233/JND-180330
   Pane M, 2018, NEUROMUSCULAR DISORD, V28, P582, DOI 10.1016/j.nmd.2018.05.010
   Parenti G, 2014, MOL THER, V22, P2004, DOI 10.1038/mt.2014.138
   Parenti G, 2014, FUTURE MED CHEM, V6, P1031, DOI 10.4155/fmc.14.40
   Pena LDM, 2019, NEUROMUSCULAR DISORD, V29, P167, DOI 10.1016/j.nmd.2018.12.004
   Portaro S, 2016, PEDIATRICS, V137, P0, DOI 10.1542/peds.2015-3289
   Puzzo F, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aam6375
   Quinlivan R, 2014, CURR OPIN NEUROL, V27, P607, DOI 10.1097/WCO.0000000000000132
   Rahbek J, 2015, NEUROMUSCULAR DISORD, V25, P727, DOI 10.1016/j.nmd.2015.05.005
   Ratni H, 2018, J MED CHEM, V61, P6501, DOI 10.1021/acs.jmedchem.8b00741
   Schoser B, 2017, J NEUROL, V264, P621, DOI 10.1007/s00415-016-8219-8
   Smith BK, 2017, EXP NEUROL, V287, P216, DOI 10.1016/j.expneurol.2016.07.013
   Statland JM, 2012, JAMA-J AM MED ASSOC, V308, P1357, DOI 10.1001/jama.2012.12607
   Stein CA, 2017, MOL THER, V25, P1069, DOI 10.1016/j.ymthe.2017.03.023
   Sturm S, 2019, BRIT J CLIN PHARMACO, V85, P181, DOI 10.1111/bcp.13786
   Terracciano C, 2018, J NEUROL NEUROSUR PS, V89, P1232, DOI 10.1136/jnnp-2017-317615
   Tizzano EF, 2018, EUR J PAEDIATR NEURO, V22, P944, DOI 10.1016/j.ejpn.2018.08.009
   Trivedi JR, 2013, BRAIN, V136, P2189, DOI 10.1093/brain/awt133
   van Agtmaal EL, 2017, MOL THER, V25, P24, DOI 10.1016/j.ymthe.2016.10.014
   van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X
   Vita GL, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0205514
   Zuluaga-Sanchez S, 2019, PHARMACOECONOMICS, V37, P845, DOI 10.1007/s40273-019-00769-6
NR 79
TC 21
Z9 23
U1 1
U2 31
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD APR 15
PY 2019
VL 40
IS 4
BP 671
EP 681
DI 10.1007/s10072-019-03764-z
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HT7TG
UT WOS:000464766700002
PM 30805745
DA 2024-11-01
ER

PT J
AU Hannah-Shmouni, F
   MacNeil, L
   Brady, L
   Nilsson, MI
   Tarnopolsky, M
AF Hannah-Shmouni, Fady
   MacNeil, Lauren
   Brady, Lauren
   Nilsson, Mats, I
   Tarnopolsky, Mark
TI Expanding the Clinical Spectrum of <i>LONP1</i>-Related Mitochondrial Cytopathy
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE LONP1; mitochondrial cytopathy; granular bodies; whole exome sequencing; electron microscopy
ID skeletal-muscle mitochondria; diagnostic-criteria; consensus statement; aaa proteases; disease; lonp1; deficiency; mutations
AB Pathogenic variants in the LONP1 gene have been associated with CODAS syndrome (Cerebral, Ocular, Dental, Auricular, and Skeletal Anomalies Syndrome). A recent report identified the first newborn case with LONP1-related mitochondrial cytopathy due to a compound heterozygous pathogenic variant in LONP1 without features of CODAS. The proband had manifested with severe congenital lactic acidosis and profound multiple respiratory chain complex activity deficiencies associated with the quantitative loss of mtDNA copy number in muscle. A subsequent report identified two siblings with regression during infancy, profound hypotonia and muscle weakness, severe intellectual disability, progressive cerebellar atrophy, where muscle biopsy showed an electron dense mitochondrial inclusions without ragged-red fibers and normal electron transport chain enzyme activities. Here, we report an additional case of autosomal recessive mitochondrial cytopathy due to a homozygous missense variant in LONP1 that was identified on whole exome sequencing (c.810G > A; p.D463N). The proband, a 20-year-old male born to consanguineous parents, presented with global developmental delay, emotional outbursts, speech and swallowing difficulties, hypotonia, and ataxia since childhood. Muscle biopsy showed massive granular bodies, increased oxidative stress, and autophagic block and reduced mitochondrial state 3 respiration. We have identified another case of LONP1-related mitochondrial cytopathy further confirming a neurological phenotype without CODAS features.
C1 [Hannah-Shmouni, Fady] Univ Toronto, Hosp Sick Children, Clin Biochem Genet, Toronto, ON, Canada.
   [Hannah-Shmouni, Fady] NICHHD, Sect Endocrinol & Genet, NIH, Bethesda, MD 20892 USA.
   [MacNeil, Lauren] Univ Toronto, Hosp Sick Children, Div Pediat Lab Med, Toronto, ON, Canada.
   [MacNeil, Lauren] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.
   [Brady, Lauren; Nilsson, Mats, I; Tarnopolsky, Mark] McMaster Univ, Dept Pediat, Hamilton, ON, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; McMaster University
RP Tarnopolsky, M (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON, Canada.
EM tarnopol@mcmaster.ca
FU Mr. Dan Wright and family; Warren Lammert and family
CR Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7
   Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   COGSWELL AM, 1993, AM J PHYSIOL, V264, PC383, DOI 10.1152/ajpcell.1993.264.2.C383
   Devries MC, 2013, J CLIN ENDOCR METAB, V98, P4852, DOI 10.1210/jc.2013-2044
   Dikoglu E, 2015, AM J MED GENET A, V167, P1501, DOI 10.1002/ajmg.a.37029
   Gerdes F, 2012, BBA-MOL CELL RES, V1823, P49, DOI 10.1016/j.bbamcr.2011.09.015
   Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002
   GLERUM DM, 1988, FEBS LETT, V236, P100, DOI 10.1016/0014-5793(88)80293-X
   Inui T, 2017, J HUM GENET, V62, P653, DOI 10.1038/jhg.2017.11
   Khan AO, 2018, J AAPOS, V22, P229, DOI 10.1016/j.jaapos.2017.10.012
   KRIEGER DA, 1980, J APPL PHYSIOL, V48, P23, DOI 10.1152/jappl.1980.48.1.23
   Maj MC, 2005, J CLIN ENDOCR METAB, V90, P4101, DOI 10.1210/jc.2005-0123
   Monaco CMF, 2018, DIABETOLOGIA, V61, P1411, DOI 10.1007/s00125-018-4602-6
   MOREADITH RW, 1984, J CLIN INVEST, V74, P685, DOI 10.1172/JCI111484
   Nimmo GAM, 2019, HUM MOL GENET, V28, P290, DOI 10.1093/hmg/ddy351
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Peter B, 2018, HUM MOL GENET, V27, P1743, DOI 10.1093/hmg/ddy080
   QuirÃ³s PM, 2014, CELL REP, V8, P541, DOI 10.1016/j.celrep.2014.06.018
   RendÃ³n OZ, 2018, MOL CELL BIOL, V38, P0, DOI 10.1128/MCB.00412-17
   Robinson B H, 1996, METHODS ENZYMOL, V264, P454, DOI 10.1016/S0076-6879(96)64041-5
   SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597
   Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   Witters P, 2018, GENET MED, V20, P444, DOI 10.1038/gim.2017.125
NR 26
TC 9
Z9 9
U1 0
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD OCT 4
PY 2019
VL 10
IS 
BP 
EP 
DI 10.3389/fneur.2019.00981
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA JO5ZI
UT WOS:000497656100001
PM 31636596
DA 2024-11-01
ER

PT J
AU Bastian, AE
   Jugulete, G
   Manole, E
   Oprisan, LA
AF Bastian, Alexandra Eugenia
   Jugulete, Gheorghita
   Manole, Emilia
   Oprisan, Luminita Alexandra
TI A rare case of mitochondriopathy with autosomal dominant progressive external ophthalmoplegia diagnosed through skeletal muscle biopsy
SO ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY
LA English
DT Article
DE mitochondriopathy; progressive external ophthalmoplegia; nuclear DNA mutation; electron microscopy
ID membrane topology; dna; mutations
AB Mitochondriopathies are a heterogeneous group of genetic diseases of all ages, with a very diverse clinical presentation related to genetic heteroplasmy. The clinical symptoms display a large variability and generally, the more severe phenotypes have an early onset, even from the neonatal period, while milder ones are manifested later in the adulthood. Most publications have already demonstrated deletions or point mutations in mitochondrial deoxyribonucleic acid (DNA), but in recent years, the field of investigation has expanded to syndromes caused by mutations in the nuclear DNA (nDNA), with a Mendelian inheritance. We present the case of a male patient with a mitochondriopathy with phenotype of chronic progressive external ophthalmoplegia (PEO), due to an autosomal dominant mutation in nDNA, in the DNA polymerase subunit gamma (POLG) gene, the pathogenic variant c.2864A>G (p.Tyr955Cys), morphologically investigated and diagnosed using a skeletal muscle biopsy. The aim of this presentation is to emphasize the diagnostic value of the muscle biopsy both in cases of clinical suspicion and in more challenging cases of mitochondrial diseases with atypical or unusual features. Although genetic testing may be the initial test of choice in cases with suggestive clinical presentation, muscle biopsy is an alternative diagnostic aid with high value even in our molecular era. We present pathological and ultrastructural data to confirm the diagnosis.
C1 [Bastian, Alexandra Eugenia] Carol Davila Univ Med & Pharm, Fac Dent Med, Dept Pathol, Bucharest, Romania.
   [Bastian, Alexandra Eugenia] Colentina Clin Hosp, Dept Pathol, 19-21 Stefan Cel Mare Highway,Sect 2, Bucharest 020125, Romania.
   [Jugulete, Gheorghita] Carol Davila Univ Med & Pharm, Dept Infect Dis, Bucharest, Romania.
   [Jugulete, Gheorghita] Prof Dr Matei Bais Natl Inst Infect Dis, Clin Sect 9 Pediat, Bucharest, Romania.
   [Manole, Emilia] Colentina Clin Hosp, Colentina Res Ctr, Dept Pathol, Bucharest, Romania.
   [Manole, Emilia] Victor Babes Natl Inst Res & Dev Pathol & Biomed, Dept Mol Biol, 99-101 Independentei Ave,Sect 5, Bucharest 050096, Romania.
   [Oprisan, Luminita Alexandra] Colentina Clin Hosp, Dept Neurol, Bucharest, Romania.
   [Oprisan, Luminita Alexandra] Carol Davila Univ Med & Pharm, Dept Neurol, Bucharest, Romania.
C3 Carol Davila University of Medicine & Pharmacy; National Institute for Infectious Diseases "Matei Bals"; Carol Davila University of Medicine & Pharmacy; Victor Babes National Institute of Pathology; Carol Davila University of Medicine & Pharmacy
RP Manole, E (corresponding author), Colentina Clin Hosp, Dept Pathol, 19-21 Stefan Cel Mare Highway,Sect 2, Bucharest 020125, Romania.; Manole, E (corresponding author), Victor Babes Natl Inst Res & Dev Pathol & Biomed, Dept Mol Biol, 99-101 Independentei Ave,Sect 5, Bucharest 050096, Romania.
EM emilia_manole@yahoo.com
CR Angelini C, 2009, ACTA MYOL, V28, P16
   [Anonymous], 2000, GENEREVIEWS, V0, P0
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   COLLINS S, 1995, ACTA NEUROL SCAND, V91, P287, DOI 10.1111/j.1600-0404.1995.tb07007.x
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   DiMauro S, 1993, GENEREVIEWS, V0, P0
   Gonzalez-Moron D, 2013, BMJ CASE REP, V2013, P0
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Jackson S, 2015, EUR J NEUROL, V22, P1429, DOI 10.1111/ene.12814
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001
   Mannella CA, 2013, J MOL CELL CARDIOL, V62, P51, DOI 10.1016/j.yjmcc.2013.05.001
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Nascimento A, 2016, SEMIN PEDIATR NEUROL, V23, P290, DOI 10.1016/j.spen.2016.11.004
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011
   Phadke R, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6070064
   Sleigh K, 2011, MUSCLE NERVE, V43, P795, DOI 10.1002/mus.21962
   Sommerville Ewen W, 2014, J NEUROMUSCUL DIS, V1, P119
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vincent AE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30610
NR 25
TC 2
Z9 2
U1 0
U2 5
PU EDITURA ACAD ROMANE
PI BUCURESTI
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCURESTI 050711, ROMANIA
SN 1220-0522
EI 
J9 ROM J MORPHOL EMBRYO
JI Rom. J. Morphol. Embryol.
PD JUN 15
PY 2019
VL 60
IS 1
BP 273
EP 279
DI 
PG 7
WC Developmental Biology
SC Developmental Biology
GA IJ1VT
UT WOS:000475687700033
PM 31263856
DA 2024-11-01
ER

PT J
AU CarreÃ±o-Gago, L
   BlÃ¡zquez-Bermejo, C
   DÃ­az-Manera, J
   CÃ¡mara, Y
   Gallardo, E
   MartÃ­, R
   Torres-Torronteras, J
   GarcÃ­a-ArumÃ­, E
AF Carreno-Gago, Lidia
   Blazquez-Bermejo, Cora
   Diaz-Manera, Jordi
   Camara, Yolanda
   Gallardo, Eduard
   Marti, Ramon
   Torres-Torronteras, Javier
   Garcia-Arumi, Elena
TI Identification and Characterization of New <i>RNASEH1</i> Mutations Associated With PEO Syndrome and Multiple Mitochondrial DNA Deletions
SO FRONTIERS IN GENETICS
LA English
DT Article
DE mtDNA; mitochondrial disease; PEO; multiple mtDNA deletions; RNASEH1
ID impair mtdna replication; diseases; h1; sequence
AB Mitochondrial DNA (mtDNA) depletion and deletion syndrome encompasses a group of disorders caused by mutations in genes involved in mtDNA replication and maintenance. The clinical phenotype ranges from fatal infantile hepatocerebral forms to mild adult onset progressive external ophthalmoplegia (PEO). We report the case of a patient with PEO and multiple mtDNA deletions, with two new homozygous mutations in RNASEH1. The first mutation (c.487>C) is located in the same catalytic domain as the four previously reported mutations, and the second (c.258_260del) is located in the connection domain, where no mutations have been reported. In silico study of the mutations predicted only the first mutation as pathogenic, but functional studies showed that both mutations cause loss of ribonuclease H1 activity. mtDNA replication dysfunction was demonstrated in patient fibroblasts, which were unable to recover normal mtDNA copy number after ethidium bromide-induced mtDNA depletion. Our results demonstrate the pathogenicity of two new RNASEH1 variants found in a patient with PEO syndrome, multiple deletions, and mild mitochondrial myopathy.
C1 [Carreno-Gago, Lidia; Blazquez-Bermejo, Cora; Camara, Yolanda; Marti, Ramon; Torres-Torronteras, Javier; Garcia-Arumi, Elena] Univ Autonoma Barcelona, Hosp Univ Vail dHebron, Inst Recerca VHIR, Dept Patol Mitocondnal & Neuromuscular, Barcelona, Spain.
   [Carreno-Gago, Lidia; Blazquez-Bermejo, Cora; Diaz-Manera, Jordi; Camara, Yolanda; Gallardo, Eduard; Marti, Ramon; Torres-Torronteras, Javier; Garcia-Arumi, Elena] Inst Salud Carlos III, CIBERER, Barcelona, Spain.
   [Diaz-Manera, Jordi; Gallardo, Eduard] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Serv Neurol Malalties Neuromusculars, Barcelona, Spain.
   [Diaz-Manera, Jordi; Gallardo, Eduard] Univ Autonoma Barcelona, Inst Recerca, HSCSP, Barcelona, Spain.
   [Garcia-Arumi, Elena] Hosp Univ Vall dHebron, Area Genet Clin & Mol, Barcelona, Spain.
C3 Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron
RP Torres-Torronteras, J; GarcÃ­a-ArumÃ­, E (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vail dHebron, Inst Recerca VHIR, Dept Patol Mitocondnal & Neuromuscular, Barcelona, Spain.; Torres-Torronteras, J; GarcÃ­a-ArumÃ­, E (corresponding author), Inst Salud Carlos III, CIBERER, Barcelona, Spain.; GarcÃ­a-ArumÃ­, E (corresponding author), Hosp Univ Vall dHebron, Area Genet Clin & Mol, Barcelona, Spain.
EM javier.torres@vhir.org; elena.garcia@vhir.org
FU Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias; ERDF funds [FIS PI15/01428, FIS PI18/01574]; Spanish Ministry of Industry, Economy and Competitiveness [SAF2017-87506-R]; Generalitat de Catalunya (URDCat project PERIS); Generalitat de Catalunya (PERIS program) [SLT002/16/00370]
CR Al-Behadili A, 2018, NUCLEIC ACIDS RES, V46, P9471, DOI 10.1093/nar/gky708
   Alla NR, 2012, FEBS J, V279, P4492, DOI 10.1111/febs.12035
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Bugiardini E, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000149
   Cerritelli SM, 1998, GENOMICS, V53, P300, DOI 10.1006/geno.1998.5497
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Dubowitz C, 2007, MUSCLE BIOPSY PRACTI, V3rd, P0
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Herrmann JM, 2012, ADV EXP MED BIOL, V748, P41, DOI 10.1007/978-1-4614-3573-0_3
   Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Landsverk ML, 2012, GENET MED, V14, P877, DOI 10.1038/gim.2012.58
   Martins Raisa da Silva, 2014, BMC RES NOTES, V7, P583, DOI 10.1186/1756-0500-7-583
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Ruhanen H, 2011, BBA-MOL CELL RES, V1813, P2000, DOI 10.1016/j.bbamcr.2011.08.008
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Sachdev A, 2018, CAN J OPHTHALMOL, V53, PE203, DOI 10.1016/j.jcjo.2018.01.005
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Shibata A, 2015, J DERMATOL SCI, V80, P196, DOI 10.1016/j.jdermsci.2015.10.003
   Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wu HJ, 2001, J BIOL CHEM, V276, P23547, DOI 10.1074/jbc.M009676200
NR 31
TC 11
Z9 11
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-8021
EI 
J9 FRONT GENET
JI Front. Genet.
PD JUN 14
PY 2019
VL 10
IS 
BP 
EP 
DI 10.3389/fgene.2019.00576
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA IE0DP
UT WOS:000472057300001
PM 31258551
DA 2024-11-01
ER

PT J
AU Mahjoub, G
   Habibzadeh, P
   Dastsooz, H
   Mirzaei, M
   Kavosi, A
   Jamali, L
   Javanmardi, H
   Katibeh, P
   Faghihi, MA
   Dastgheib, SA
AF Mahjoub, Ghazale
   Habibzadeh, Parham
   Dastsooz, Hassan
   Mirzaei, Malihe
   Kavosi, Arghavan
   Jamali, Laila
   Javanmardi, Haniyeh
   Katibeh, Pegah
   Faghihi, Mohammad Ali
   Dastgheib, Seyed Alireza
TI Clinical and molecular characterization of three patients with Hepatocerebral form of mitochondrial DNA depletion syndrome: a case series
SO BMC MEDICAL GENETICS
LA English
DT Article
DE Mitochondrial DNA depletion syndrome; DGUOK; MPV17; Mitochondrial disorders
ID deoxyguanosine kinase gene; mutations; mtdna; dguok; protein; prediction; features; diseases
AB Background: Mitochondrial DNA depletion syndromes (MDS) are clinically and phenotypically heterogeneous disorders resulting from nuclear gene mutations. The affected individuals represent a notable reduction in mitochondrial DNA (mtDNA) content, which leads to malfunction of the components of the respiratory chain. MDS is classified according to the type of affected tissue; the most common type is hepatocerebral form, which is attributed to mutations in nuclear genes such as DGUOK and MPV17. These two genes encode mitochondrial proteins and play major roles in mtDNA synthesis. Case presentation: In this investigation patients in three families affected by hepatocerebral form of MDS who were initially diagnosed with tyrosinemia underwent full clinical evaluation. Furthermore, the causative mutations were identified using next generation sequencing and were subsequently validated using sanger sequencing. The effect of the mutations on the gene expression was also studied using real-time PCR. A pathogenic heterozygous frameshift deletion mutation in DGUOK gene was identified in parents of two affected patients (c.706- 707 + 2 del: p.k236 fs) presenting with jaundice, impaired fetal growth, low-birth weight, and failure to thrive who died at the age of 3 and 6 months in family I. Moreover, a novel splice site mutation in MPV17 gene (c.461 + 1G > C) was identified in a patient with jaundice, muscle weakness, and failure to thrive who died due to hepatic failure at the age of 4 months. A 5-month-old infant presenting with jaundice, dark urine, poor sucking, and feeding problems was also identified to have another novel mutation in MPV17 gene leading to stop gain mutation (c.277C > T: p.(Gln93*)). Conclusions: These patients had overlapping clinical features with tyrosinemia. MDS should be considered a differential diagnosis in patients presenting with signs and symptoms of tyrosinemia.
C1 [Mahjoub, Ghazale; Habibzadeh, Parham; Dastsooz, Hassan; Mirzaei, Malihe; Kavosi, Arghavan; Jamali, Laila; Faghihi, Mohammad Ali] Shiraz Univ Med Sci, Persian BayanGene Res & Training Ctr, Shiraz, Iran.
   [Habibzadeh, Parham; Javanmardi, Haniyeh] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran.
   [Dastsooz, Hassan] Univ Turin, IIGM, Turin, Italy.
   [Katibeh, Pegah] Shiraz Univ Med Sci, Dept Pediat, Shiraz, Iran.
   [Faghihi, Mohammad Ali] Univ Miami, Miller Sch Med, Ctr Therapeut Innovat, Dept Psychiat & Behav Sci, Miami, FL 33136 USA.
   [Dastgheib, Seyed Alireza] Shiraz Univ Med Sci, Sch Med, Dept Med Genet, Shiraz, Iran.
C3 Shiraz University of Medical Science; Shiraz University of Medical Science; University of Turin; Italian Institute for Genomic Medicine (IIGM); Shiraz University of Medical Science; University of Miami; Shiraz University of Medical Science
RP Dastgheib, SA (corresponding author), Shiraz Univ Med Sci, Sch Med, Dept Med Genet, Shiraz, Iran.
EM Dastgheib@sums.ac.ir
FU NIMAD research grant [940714]
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Brahimi N, 2009, MOL GENET METAB, V97, P221, DOI 10.1016/j.ymgme.2009.03.007
   CarreÃ±o-Gago L, 2017, BBA-MOL BASIS DIS, V1863, P182, DOI 10.1016/j.bbadis.2016.09.002
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   ENDO F, 1983, PEDIATR RES, V17, P92, DOI 10.1203/00006450-198302000-00002
   Fang WY, 2017, ONCOTARGET, V8, P84309, DOI 10.18632/oncotarget.20905
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Habibzadeh P, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00944
   Johansson K, 2001, NAT STRUCT BIOL, V8, P616, DOI 10.1038/89661
   Johansson M, 1996, GENOMICS, V38, P450, DOI 10.1006/geno.1996.0654
   Kim J, 2016, MOL GENET METAB REP, V8, P74, DOI 10.1016/j.ymgmr.2016.06.006
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Nobre S, 2012, BMJ CASE REP, V2012, P0
   Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Sezer T, 2015, J CHILD NEUROL, V30, P124, DOI 10.1177/0883073813517000
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Strachan T, 2014, GENETICS AND GENOMICS IN MEDICINE, V1st, P0
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang K, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkq603
   Wang LY, 2003, FEBS LETT, V554, P319, DOI 10.1016/S0014-5793(03)01181-5
   Wang LY, 1996, FEBS LETT, V390, P39, DOI 10.1016/0014-5793(96)00623-0
   Yang JY, 2015, NUCLEIC ACIDS RES, V43, PW174, DOI 10.1093/nar/gkv342
   Zhang CX, 2017, NUCLEIC ACIDS RES, V45, PW291, DOI 10.1093/nar/gkx366
NR 41
TC 9
Z9 12
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2350
J9 BMC MED GENET
JI BMC Med. Genet.
PD OCT 29
PY 2019
VL 20
IS 1
BP 
EP 
DI 10.1186/s12881-019-0893-9
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA JZ2HC
UT WOS:000504923600001
PM 31664948
DA 2024-11-01
ER

PT J
AU Bugiardini, E
   Pope, S
   Feichtinger, RG
   Poole, OV
   Pittman, AM
   Woodward, CE
   Heales, S
   Quinlivan, R
   Houlden, H
   Mayr, JA
   Hanna, MG
   Pitceathly, RDS
AF Bugiardini, Enrico
   Pope, Simon
   Feichtinger, Rene G.
   Poole, Olivia, V
   Pittman, Alan M.
   Woodward, Cathy E.
   Heales, Simon
   Quinlivan, Rosaline
   Houlden, Henry
   Mayr, Johannes A.
   Hanna, Michael G.
   Pitceathly, Robert D. S.
TI Utility of Whole Blood Thiamine Pyrophosphate Evaluation in TPK1-Related Diseases
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE mitochondrial diseases; TPK1; thiamine pyrophosphate; Leigh syndrome; thiamine deficiency
ID chromosomal ndufa1 gene; heterozygous mutation; phosphate-esters; deficiency; vitamin-b1; childhood; defects; girl
AB TPK1 mutations are a rare, but potentially treatable, cause of thiamine deficiency. Diagnosis is challenging given the phenotypic overlap that exists with other metabolic and neurological disorders. We report a case of TPK1-related disease presenting with Leigh-like syndrome and review the diagnostic utility of thiamine pyrophosphate (TPP) blood measurement. The proband, a 35-year-old male, presented at four months of age with recurrent episodes of post-infectious encephalopathy. He subsequently developed epilepsy, learning difficulties, sensorineural hearing loss, spasticity, and dysphagia. There was a positive family history for Leigh syndrome in an older brother. Plasma lactate was elevated (3.51 mmol/L) and brain MRI showed bilateral basal ganglia hyperintensities, indicative of Leigh syndrome. Histochemical and spectrophotometric analysis of mitochondrial respiratory chain complexes I, II+III, and IV was normal. Genetic analysis of muscle mitochondrial DNA was negative. Whole exome sequencing of the proband confirmed compound heterozygous variants in TPK1: c. 426G>C (p. Leu142Phe) and c. 258+1G>A (p.?). Blood TPP levels were reduced, providing functional evidence for the deleterious effects of the variants. We highlight the clinical and bioinformatics challenges to diagnosing rare genetic disorders and the continued utility of biochemical analyses, despite major advances in DNA sequencing technology, when investigating novel, potentially disease-causing, genetic variants. Blood TPP measurement represents a fast and cost-effective diagnostic tool in TPK1-related diseases.
C1 [Bugiardini, Enrico; Poole, Olivia, V; Quinlivan, Rosaline; Houlden, Henry; Hanna, Michael G.; Pitceathly, Robert D. S.] UCL Queen Sq Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Bugiardini, Enrico; Poole, Olivia, V; Quinlivan, Rosaline; Houlden, Henry; Hanna, Michael G.; Pitceathly, Robert D. S.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Bugiardini, Enrico; Poole, Olivia, V; Pittman, Alan M.; Quinlivan, Rosaline; Houlden, Henry; Hanna, Michael G.; Pitceathly, Robert D. S.] UCL Queen Sq Inst Neurol, Dept Neuromuscular Dis, London WC1N 3BG, England.
   [Pope, Simon; Heales, Simon] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Feichtinger, Rene G.; Mayr, Johannes A.] Paracelsus Med Univ, Univ Hosp Salzburg, Dept Pediat, A-5020 Salzburg, Austria.
   [Woodward, Cathy E.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
   [Quinlivan, Rosaline] Great Ormond St Hosp Sick Children, Dubowitz Neuromuscular Ctr, London WC1N 3JH, England.
C3 University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Paracelsus Private Medical University; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust
RP Pitceathly, RDS (corresponding author), UCL Queen Sq Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.; Pitceathly, RDS (corresponding author), Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.; Pitceathly, RDS (corresponding author), UCL Queen Sq Inst Neurol, Dept Neuromuscular Dis, London WC1N 3BG, England.
EM r.pitceathly@ucl.ac.uk
FU Medical Research Council Centre grant [G0601943]; European Community [2012-305121]; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Medical Research Council Clinician Scientist Fellowship [MR/S002065/1]; Lily Foundation; E-Rare project GENOMIT FWF I [2741-B26]; Austrian Science Fund (FWF) [I2741] Funding Source: Austrian Science Fund (FWF); MRC [G0601943, MR/S002065/1, MR/S005021/1, MR/K000608/1, MR/S01165X/1] Funding Source: UKRI
CR Banka S, 2014, MOL GENET METAB, V113, P301, DOI 10.1016/j.ymgme.2014.09.010
   Brown G, 2014, J INHERIT METAB DIS, V37, P577, DOI 10.1007/s10545-014-9712-9
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Cheng XQ, 2018, J CHROMATOGR B, V1095, P103, DOI 10.1016/j.jchromb.2018.07.030
   Collie JTB, 2017, CLIN CHEM LAB MED, V55, P1652, DOI 10.1515/cclm-2017-0054
   Ortigoza-Escobar JD, 2016, BRAIN, V139, P31, DOI 10.1093/brain/awv342
   Desvignes JP, 2018, NUCLEIC ACIDS RES, V46, PW545, DOI 10.1093/nar/gky471
   Edwards KA, 2017, CHEMISTRYOPEN, V6, P178, DOI 10.1002/open.201600160
   Fraser JL, 2014, MOLEC GENET METAB RE, V1, P66, DOI 10.1016/j.ymgmr.2013.12.007
   Invernizzi F, 2017, NEUROLOGY, V89, P870, DOI 10.1212/WNL.0000000000004270
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lu J, 2008, CLIN CHEM, V54, P901, DOI 10.1373/clinchem.2007.099077
   Mahajan A, 2017, J NEUROL SCI, V376, P42, DOI 10.1016/j.jns.2017.02.063
   Mayr JA, 2011, AM J HUM GENET, V89, P806, DOI 10.1016/j.ajhg.2011.11.007
   Mayr JA, 2011, MOL GENET METAB, V103, P358, DOI 10.1016/j.ymgme.2011.04.010
   Ortigoza-Escobar JD, 2017, ANN NEUROL, V82, P317, DOI 10.1002/ana.24998
   Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004
   Roelofsen-de Beer RJAC, 2017, J CHROMATOGR B, V1063, P67, DOI 10.1016/j.jchromb.2017.08.011
   Xu JJ, 2017, MOL GENET METAB REP, V13, P30, DOI 10.1016/j.ymgmr.2017.07.008
NR 19
TC 14
Z9 15
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2077-0383
EI 
J9 J CLIN MED
JI J. Clin. Med.
PD JUL 15
PY 2019
VL 8
IS 7
BP 
EP 
DI 10.3390/jcm8070991
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA IN9MO
UT WOS:000479003300076
PM 31288420
DA 2024-11-01
ER

PT J
AU Herbers, E
   KekÃ¤lÃ¤inen, NJ
   Hangas, A
   PohjoismÃ¤ki, JL
   Goffart, S
AF Herbers, Elena
   Kekalainen, Nina J.
   Hangas, Anu
   Pohjoismaki, Jaakko L.
   Goffart, Steffi
TI Tissue specific differences in mitochondrial DNA maintenance and expression
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA; mtDNA replication; mtDNA maintenance; mtDNA recombination
ID transcription factor-a; twinkle-helicase; reference genes; rna-polymerase; copy number; rt-qpcr; replication; deletions; protein; origin
AB The different cell types of multicellular organisms have specialized physiological requirements, affecting also their mitochondrial energy production and metabolism. The genome of mitochondria is essential for mitochondrial oxidative phosphorylation (OXHPOS) and thus plays a central role in many human mitochondrial pathologies. Disorders affecting mitochondrial DNA (mtDNA) maintenance are typically resulting in a tissue specific pattern of mtDNA deletions and rearrangements. Despite this role in disease as well as a biomarker of mitochondrial biogenesis, the tissue-specific parameters of mitochondrial DNA maintenance have been virtually unexplored. In the presented study, we investigated mtDNA replication, topology, gene expression and damage in six different tissues of adult mice and sought to correlate these with the levels of known protein factors involved in mtDNA replication and transcription. Our results show that while liver and kidney cells replicate their mtDNA using the asynchronous mechanism known from cultured cells, tissues with high OXPHOS activity, such as heart, brain, skeletal muscle and brown fat, employ a strand-coupled replication mode, combined with increased levels of recombination. The strand-coupled replication mode correlated also with mtDNA damage levels, indicating that the replication mechanism represents a tissue-specific strategy to deal with intrinsic oxidative stress. While the preferred replication mode did not correlate with mtDNA transcription or the levels of most known mtDNA maintenance proteins, mtSSB was most abundant in tissues using strand-asynchronous mechanism. Although mitochondrial transcripts were most abundant in tissues with high metabolic rate, the mtDNA copy number per tissue mass was remarkably similar in all tissues. We propose that the tissue-specific features of mtDNA maintenance are primarily driven by the intrinsic reactive oxygen species exposure, mediated by DNA repair factors, whose identity remains to be elucidated.
C1 [Herbers, Elena; Kekalainen, Nina J.; Hangas, Anu; Pohjoismaki, Jaakko L.; Goffart, Steffi] Univ Eastern Finland, Dept Environm & Biol Sci, POB 111, FI-80101 Joensuu, Finland.
C3 University of Eastern Finland
RP Goffart, S (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, POB 111, FI-80101 Joensuu, Finland.
EM steffi.goffart@uef.fi
FU Academy of Finland [292822, 265314]; Finnish Cultural Foundation, North Carelia Regional fund [55172179]; Jane and Aatos Erkko Foundation; Academy of Finland (AKA) [265314, 292822] Funding Source: Academy of Finland (AKA)
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Ciesielski GL, 2016, ENZYMES, V39, P255, DOI 10.1016/bs.enz.2016.03.006
   CREWS S, 1979, NATURE, V277, P192, DOI 10.1038/277192a0
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   FernÃ¡ndez-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Fukuoh A, 2009, GENES CELLS, V14, P1029, DOI 10.1111/j.1365-2443.2009.01328.x
   FustÃ© JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gong H, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep38513
   Han LH, 2015, AM J PHYSIOL-GASTR L, V309, PG112, DOI 10.1152/ajpgi.00435.2014
   Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881
   Jayashankar V, 2016, CURR OPIN CELL BIOL, V38, P45, DOI 10.1016/j.ceb.2016.02.006
   Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, PC698, DOI 10.1152/ajpcell.00109.2006
   Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, PC689, DOI 10.1152/ajpcell.00108.2006
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, P0, DOI 10.1093/nar/gks1324
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kunz WS, 2003, EXP PHYSIOL, V88, P149, DOI 10.1113/eph8802512
   Lehle S, 2014, NUCLEIC ACIDS RES, V42, P0, DOI 10.1093/nar/gkt1349
   Lindsay AK, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004567
   Lopez-Fabuel I, 2016, P NATL ACAD SCI USA, V113, P13063, DOI 10.1073/pnas.1613701113
   Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107
   Mruk Dolores D, 2011, SPERMATOGENESIS, V1, P121
   Neuhaus JFG, 2014, BRAIN, V137, P354, DOI 10.1093/brain/awt291
   Neuhaus JFG, 2017, NEUROENDOCRINOLOGY, V104, P72, DOI 10.1159/000444680
   Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200
   PohjoismÃ¤ki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   PohjoismÃ¤ki JLO, 2013, MOL BIOSYST, V9, P1210, DOI 10.1039/c3mb25556e
   PohjoismÃ¤ki JLO, 2012, NUCLEIC ACIDS RES, V40, P6595, DOI 10.1093/nar/gks301
   PohjoismÃ¤ki JLO, 2012, CIRC-HEART FAIL, V5, PE15, DOI 10.1161/CIRCHEARTFAILURE.111.964502
   PohjoismÃ¤ki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137
   PohjoismÃ¤ki JL, 2017, FREE RADICAL BIO MED, V106, P345, DOI 10.1016/j.freeradbiomed.2017.02.032
   PohjoismÃ¤ki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703
   PohjoismÃ¤ki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   PohjoismÃ¤ki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Rinkevich Y, 2014, CELL REP, V7, P1270, DOI 10.1016/j.celrep.2014.04.018
   Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160
   Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008
   Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006
   Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022
   Sen D, 2016, NUCLEIC ACIDS RES, V44, P4200, DOI 10.1093/nar/gkw098
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stefanatos R, 2018, FEBS LETT, V592, P743, DOI 10.1002/1873-3468.12902
   Svingen T, 2015, PEERJ, V3, P0, DOI 10.7717/peerj.855
   Torregrosa-MuÃ±umer R, 2017, P NATL ACAD SCI USA, V114, P11398, DOI 10.1073/pnas.1705367114
   Torregrosa-MuÃ±umer R, 2015, MOL BIOL CELL, V26, P4197, DOI 10.1091/mbc.E15-06-0390
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Voos W, 2016, ESSAYS BIOCHEM, V60, P213, DOI 10.1042/EBC20160009
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
NR 57
TC 76
Z9 79
U1 0
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN 15
PY 2019
VL 44
IS 
BP 85
EP 92
DI 10.1016/j.mito.2018.01.004
PG 8
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA HJ3JT
UT WOS:000457067900012
PM 29339192
DA 2024-11-01
ER

PT J
AU de Laat, P
   van Engelen, N
   Wetzels, JF
   Smeitink, JAM
   Janssen, MCH
AF de Laat, Paul
   van Engelen, Nienke
   Wetzels, Jack F.
   Smeitink, Jan A. M.
   Janssen, Mirian C. H.
TI Five non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype adult patients with m.3243A>G mutation after kidney transplantation: follow-up and review of the literature
SO CLINICAL KIDNEY JOURNAL
LA English
DT Review
DE encephalomyopathy; kidney transplantation; mitochondrial encephalomyopathy; lactic acidosis and stroke-like episodes (MELAS) syndrome; m.3243A>G mutation; maternally inherited diabetes deafness (MIDD); mitochondrial disease; mitochondrial myopathy
ID transfer rnaleu(uur) gene; mitochondrial myopathy; m.3243a-greater-than-g mutation; melas; dna; complications; involvement; disorders; cytopathy; children
AB Background. Renal involvement in patients with the m.3243A>G mutation may result in end-stage renal disease (ESRD) requiring renal replacement therapy. Although kidney transplantations have been performed in a small number of patients, short- and long-term follow-up data are lacking. Methods. We describe five patients with the m.3243A<G mutation who received a kidney transplant, including follow-up data up to 13years. We also summarize all cases (n = 13) of kidney transplantation in m.3243A>G carriers described in the literature. Results. Proteinuria with or without renal failure was the first clinical presentation of renal involvement in 13 of 18 (72%) patients. Focal segmental glomerulosclerosis (FSGS) was found in 9 of 13 (69%) biopsies. Sixteen of 18 (84%) patients developed hearing loss. All patients were diagnosed with diabetes mellitus, of whom eight (44%) developed the disease after transplantation. All patients with reported follow-up data (13/18) had stable kidney function from 6 months to 13 years of follow-up after transplantation. Conclusions. Renal involvement in carriers of the m.3243A>G mutation most commonly leads to proteinuria and FSGS and may lead to ESRD. Proper recognition of the mitochondrial origin of the renal disease in these patients is important for adequate treatment selection and suitable supportive care. This case series and review of the available literature on long-term follow-up after kidney transplantation shows it is feasible for non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype carriers of the m.3243A>G mutation to be considered for kidney transplantation in case of ESRD. These patients should not be excluded from transplant solely for their mitochondrial diagnosis.
C1 [de Laat, Paul; van Engelen, Nienke; Smeitink, Jan A. M.; Janssen, Mirian C. H.] Radboud Univ Nijmegen, Amalia Childrens Hosp, Med Ctr, Dept Pediat,Radboud Ctr Mitochondrial Med, Nijmegen, Netherlands.
   [Wetzels, Jack F.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands.
   [Janssen, Mirian C. H.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Mitochondrial Med, Dept Internal Med, Nijmegen, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen
RP Janssen, MCH (corresponding author), Radboud Univ Nijmegen, Amalia Childrens Hosp, Med Ctr, Dept Pediat,Radboud Ctr Mitochondrial Med, Nijmegen, Netherlands.; Janssen, MCH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Mitochondrial Med, Dept Internal Med, Nijmegen, Netherlands.
EM mirian.janssen@radboudumc.nl
FU ZonMW PMRare Grant [40-41900-98-033]
CR Cheong HI, 1999, PEDIATR NEPHROL, V13, P477, DOI 10.1007/s004670050641
   de Laat P, 2015, NETH J MED, V73, P30
   de Laat P, 2015, MITOCHONDRION, V25, P98, DOI 10.1016/j.mito.2015.10.005
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   de Laat P, 2013, JIMD REP, V8, P47, DOI 10.1007/8904_2012_159
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Doleris LM, 2000, KIDNEY INT, V58, P1851, DOI 10.1046/j.1523-1755.2000.00356.x
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GÃ¼Ã§er S, 2005, PEDIATR DEVEL PATHOL, V8, P710, DOI 10.1007/s10024-005-0058-z
   GuÃ©ry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060
   Hirano M, 2002, INTERNAL MED, V41, P113, DOI 10.2169/internalmedicine.41.113
   Humeidan ML, 2016, J CLIN ANESTH, V34, P344, DOI 10.1016/j.jclinane.2016.05.025
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Koopman WJH, 2016, EMBO MOL MED, V8, P311, DOI 10.15252/emmm.201506131
   Lederer SR, 2010, WIEN KLIN WOCHENSCHR, V122, P363, DOI 10.1007/s00508-010-1388-z
   Lev D, 2004, PEDIATR CARDIOL, V25, P443, DOI 10.1007/s00246-003-0490-7
   Liu CH, 2012, J FORMOS MED ASSOC, V111, P489, DOI 10.1016/j.jfma.2011.06.014
   LÃ¶wik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   MartÃ­n-HernÃ¡ndez E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Niaudet P, 1998, ARCH DIS CHILD, V78, P387, DOI 10.1136/adc.78.4.387
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Piccoli GB, 2012, BMC NEPHROL, V13, P0, DOI 10.1186/1471-2369-13-9
   Sasano N, 2007, J ANESTH, V21, P72, DOI 10.1007/s00540-006-0449-y
   Seidowsky A, 2013, CLIN NEPHROL, V80, P456, DOI 10.5414/CN107063
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Yamagata K, 2002, J AM SOC NEPHROL, V13, P0, DOI 10.1097/01.ASN.0000019772.17954.F8
   Yanagihara C, 2001, INTERNAL MED, V40, P662, DOI 10.2169/internalmedicine.40.662
NR 33
TC 12
Z9 12
U1 1
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2048-8505
EI 2048-8513
J9 CLIN KIDNEY J
JI Clin. Kidney J.
PD DEC 15
PY 2019
VL 12
IS 6
BP 840
EP 846
DI 10.1093/ckj/sfz020
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA KI2HX
UT WOS:000511169700014
PM 31807297
DA 2024-11-01
ER

PT J
AU Nissanka, N
   Minczuk, M
   Moraes, CT
AF Nissanka, Nadee
   Minczuk, Michal
   Moraes, Carlos T.
TI Mechanisms of Mitochondrial DNA Deletion Formation
SO TRENDS IN GENETICS
LA English
DT Review
ID progressive external ophthalmoplegia; multiple mtdna deletions; resolving enzyme cce1; human skeletal-muscle; large-scale deletions; strand break repair; point mutations; direct repeats; replication; genm
AB Mitochondrial DNA (mtDNA) encodes a subset of genes which are essential for oxidative phosphorylation. Deletions in the mtDNA can ablate a number of these genes and result in mitochondrial dysfunction, which is associated with bona fide mitochondrial disorders. Although mtDNA deletions are thought to occur as a result of replication errors or following double-strand breaks, the exact mechanism(s) behind deletion formation have yet to be determined. In this review we discuss the current knowledge about the fate of mtDNA following double-strand breaks, including the molecular players which mediate the degradation of linear mtDNA fragments and possible mechanisms of recircularization. We propose that mtDNA deletions formed from replication errors versus following double-strand breaks can be mediated by separate pathways.
C1 [Nissanka, Nadee; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Minczuk, Michal] Univ Cambridge, MRC, Mitochondrial Biol Unit, Cambridge, England.
C3 University of Miami; University of Cambridge
RP Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
FU National Institutes of Health [1R01AG036871, 5R01EY010804, 1R01NS079965]; Muscular Dystrophy Association; Champ Foundation; Medical Research Council [MC_UU_00015/4]; MRC [MC_UU_00015/4] Funding Source: UKRI
CR Abnet CC, 2004, BMC CANCER, V4, P0, DOI 10.1186/1471-2407-4-30
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bruni F, 2017, FEBS J, V284, P1767, DOI 10.1111/febs.13981
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Coffey G, 1999, NUCLEIC ACIDS RES, V27, P3348, DOI 10.1093/nar/27.16.3348
   Coffey G, 2000, NUCLEIC ACIDS RES, V28, P3793, DOI 10.1093/nar/28.19.3793
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   Dmitrieva NI, 2011, AM J PHYSIOL-REG I, V301, PR632, DOI 10.1152/ajpregu.00853.2010
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   Fogg JM, 2000, BIOCHEMISTRY-US, V39, P4082, DOI 10.1021/bi992785v
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467
   Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lee DY, 1998, J BIOL CHEM, V273, P30614, DOI 10.1074/jbc.273.46.30614
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Matic S, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03552-x
   Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250
   Medeiros TC, 2018, J CELL BIOL, V217, P1601, DOI 10.1083/jcb.201801168
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   Moretton A, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0176795
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Nissanka N, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04895-1
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   Peeva V, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04131-w
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x
   ROBBERSODL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stumpf JD, 2013, GENETICS, V194, P519, DOI 10.1534/genetics.113.150920
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   White MF, 1996, J MOL BIOL, V257, P330, DOI 10.1006/jmbi.1996.0166
   WIESNER RJ, 1992, BIOCHEM BIOPH RES CO, V183, P553, DOI 10.1016/0006-291X(92)90517-O
   Wisnovsky S, 2016, NAT CHEM BIOL, V12, P567, DOI 10.1038/nchembio.2102
   Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   Zinovkina LA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P233, DOI 10.1134/S0006297918030045
NR 84
TC 59
Z9 64
U1 1
U2 14
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0168-9525
EI 1362-4555
J9 TRENDS GENET
JI Trends Genet.
PD MAR 15
PY 2019
VL 35
IS 3
BP 235
EP 244
DI 10.1016/j.tig.2019.01.001
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA HL1CE
UT WOS:000458430700007
PM 30691869
DA 2024-11-01
ER

PT J
AU Galera-Monge, T
   Zurita-DÃ­az, F
   Garesse, R
   Gallardo, ME
AF Galera-Monge, Teresa
   Zurita-Diaz, Francisco
   Garesse, Rafael
   Esther Gallardo, Maria
TI The mutation m.13513G&gt;A impairs cardiac function, favoring a neuroectoderm commitment, in a mutant-load dependent way
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
DE cardiomyocytes; heteroplasmy; iPSc; Leigh syndrome; neuroectoderm
ID pluripotent stem-cells; human ipsc line; leigh-syndrome; mitochondrial; generation; patient
AB Mitochondrial disorders (MDs) arise as a result of a respiratory chain dysfunction. While some MDs can affect a single organ, many involve several organs, the brain being the most affected, followed by heart and/or muscle. Many of these diseases are associated with heteroplasmic mutations in the mitochondrial DNA (mtDNA). The proportion of mutated mtDNA must exceed a critical threshold to produce disease. Therefore, understanding how embryonic development determines the heteroplasmy level in each tissue could explain the organ susceptibility and the clinical heterogeneity observed in these patients. In this report, the dynamics of heteroplasmy and the influence in cardiac commitment of the mutational load of the m.13513G>A mutation has been analyzed. This mutation has been reported as a frequent cause of Leigh syndrome (LS) and is commonly associated with cardiac problems. In this report, induced pluripotent stem cell (iPSc) technology has been used to delve into the molecular mechanisms underlying cardiac disease in LS. When mutation m.13513G>A is above a threshold, iPSc-derived cardiomyocytes (iPSc-CMs) could not be obtained due to an inefficient epithelial-mesenchymal transition. Surprisingly, these cells are redirected toward neuroectodermal lineages that would give rise to the brain. However, when mutation is below that threshold, dysfunctional CM are generated in a mutant-load dependent way. We suggest that distribution of the m.13513G>A mutation during cardiac differentiation is not at random. We propose a possible explanation of why neuropathology is a frequent feature of MD, but cardiac involvement is not always present.
C1 [Galera-Monge, Teresa; Zurita-Diaz, Francisco; Garesse, Rafael; Esther Gallardo, Maria] Univ Autonoma Madrid, Fac Med, Dept Bioquim, Madrid, Spain.
   [Galera-Monge, Teresa; Zurita-Diaz, Francisco] UAM, CSIC, Inst Invest Biomed Alberto Sols, Dept Bioquim, Madrid, Spain.
   [Galera-Monge, Teresa; Zurita-Diaz, Francisco] Ctr Invest Biomed Red, Madrid, Spain.
   [Galera-Monge, Teresa; Zurita-Diaz, Francisco; Esther Gallardo, Maria] Inst Invest Sanitaria Hosp 12 Octubre, I 12 Ctr Actividades Ambulatorias, Ave Cordoba S-N, Madrid, Spain.
C3 Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; Hospital Universitario 12 de Octubre
RP Garesse, R; Gallardo, ME (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Bioquim, Madrid, Spain.
EM rafael.garesse@uam.es; egallardo.imas12@h12o.es
FU Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria and Regional Development Fund [ERDF/FEDER]) [PI16/00489, PI18/00151, PI10/00703, PI13/00556, PI15/00484]; Centro de Investigacion Biomedica en Red en Enfermedades Raras (CIBERER) [ER16P3AC717, 13-717/132.05]; Miguel Servet Program [CP16/00046]
CR Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503
   Burridge PW, 2015, CURR PROTOC HUM GENE, V87, P21
   Chou SJ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep23661
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2
   Galera T, 2016, STEM CELL RES, V16, P88, DOI 10.1016/j.scr.2015.12.010
   Galera T, 2016, STEM CELL RES, V16, P63, DOI 10.1016/j.scr.2015.12.005
   Galera-Monge T, 2016, STEM CELL RES, V16, P766, DOI 10.1016/j.scr.2016.04.012
   HÃ¤mÃ¤lÃ¤inen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150
   Lorenz C, 2017, CELL STEM CELL, V20, P659, DOI 10.1016/j.stem.2016.12.013
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   Monlleo-Neila L, 2013, J CHILD NEUROL, V28, P1531, DOI 10.1177/0883073812460580
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Sudo A, 2004, J HUM GENET, V49, P92, DOI 10.1007/s10038-003-0116-1
   Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001
   Zheng XD, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.13378
NR 21
TC 15
Z9 17
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD NOV 15
PY 2019
VL 234
IS 11
BP 19511
EP 19522
DI 10.1002/jcp.28549
PG 12
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA IM5EX
UT WOS:000478018200035
PM 30950033
DA 2024-11-01
ER

PT J
AU Lim, AZ
   Blakely, EL
   Baty, K
   He, LP
   Hopton, S
   Falkous, G
   McWilliam, K
   Cozens, A
   McFarland, R
   Taylor, RW
AF Lim, Albert Z.
   Blakely, Emma L.
   Baty, Karen
   He, Langping
   Hopton, Sila
   Falkous, Gavin
   McWilliam, Kenneth
   Cozens, Alison
   McFarland, Robert
   Taylor, Robert W.
TI A novel pathogenic m.4412G &gt; A <i>MT</i>-<i>TM</i> mitochondrial DNA variant associated with childhood-onset seizures, myopathy and bilateral basal ganglia changes
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial disease; Myopathy; Seizures; mtDNA variant; Basal ganglia changes; MTTM
ID mutation; features; muscle
AB Mitochondrial DNA variants in the MT-TM (mt-tRNA(Met)) gene are rare, typically associated with myopathic phenotypes. We identified a novel MT-TM variant resulting in prolonged seizures with childhood-onset myopathy, retinopathy, short stature and elevated CSF lactate associated with bilateral basal ganglia changes on neuroimaging. Muscle biopsy confirmed multiple respiratory chain deficiencies and focal cytochrome c oxidase (COX) histochemical abnormalities. Next-generation sequencing of the mitochondrial genome revealed a novel m.4412G > A variant at high heteroplasmy levels in muscle that fulfils all accepted criteria for pathogenicity including segregation within single muscle fibres, thus broadening the genotypic and phenotypic landscape of mitochondrial tRNA-related disease.
C1 [Lim, Albert Z.; Blakely, Emma L.; Baty, Karen; He, Langping; Hopton, Sila; Falkous, Gavin; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Blakely, Emma L.; Baty, Karen; He, Langping; Hopton, Sila; Falkous, Gavin; Taylor, Robert W.] Newcastle Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [McWilliam, Kenneth] Royal Hosp Sick Children, Dept Paediat Neurol, Edinburgh EH9 1LF, Midlothian, Scotland.
   [Cozens, Alison] NHS Natl Serv Scotland, Inherited Metab Disorders Scotland, Glasgow G2 6QE, Lanark, Scotland.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; NHS National Services Scotland
RP Taylor, RW (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Taylor, RW (corresponding author), Newcastle Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease; MRC Mitochondrial Disease Patient Cohort: A Natural History Study and Patient Registry [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre for Ageing; Newcastle upon Tyne Foundation Hospitals NHS Trust; MRC/EPSRC Molecular Pathology Node; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Born AP, 2015, EUR J PAEDIATR NEURO, V19, P69, DOI 10.1016/j.ejpn.2014.10.006
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kuwajima M, 2019, BRAIN DEV-JPN, V41, P465, DOI 10.1016/j.braindev.2019.01.006
   Lombes A, 1998, HUM MUTAT, V0, PS175
   Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1
   Peverelli L, 2014, MUSCLE NERVE, V50, P292, DOI 10.1002/mus.24262
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Scarpelli M, 2018, NEUROMUSCULAR DISORD, V28, P137, DOI 10.1016/j.nmd.2017.10.006
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
NR 21
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2019
VL 47
IS 
BP 18
EP 23
DI 10.1016/j.mito.2019.04.007
PG 6
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA II9VD
UT WOS:000475547200003
PM 31022467
DA 2024-11-01
ER

PT J
AU Tang, Y
   Qin, Q
   Xing, Y
   Guo, DM
   Di, L
   Jia, JP
AF Tang, Yi
   Qin, Qi
   Xing, Yi
   Guo, Dongmei
   Di, Li
   Jia, Jianping
TI <i>AARS2</i> leukoencephalopathy: A new variant of mitochondrial encephalomyopathy
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE AARS2 leukoencephalopathy; alanyl-transfer (t)RNA synthetase 2; leukoencephalopathies; mitochondrial encephalomyopathy
ID leukodystrophy; mutations; muscle; dna
AB Background Mutations in the mitochondrial alanyl-transfer (t)RNA synthetase 2 (AARS2,OMIM:612035) have been linked to leukoencephalopathy recently. Till now, there have been 19 cases reported so far. However, the clinical and genetic characteristics of this disease are not fully understood. We reported an adult-onset male leukoencephalopathy patient related to novel AARS2 gene mutations and reviewed all previous cases regarding the clinical and genetic features of AARS2 leukoencephalopathy. Methods The spectrum of clinical symptoms and the genetic analysis of the presented patient were identified and investigated. Besides this case, we assessed previously reported cases with AARS2 gene mutations. Results Here, we present a 30-year-old man with progressive motor deficits in the right lower limb and severe cerebellar ataxia for one year. MRI revealed extensive white matter lesions in periventricular regions and along the corticospinal tract. Genetic analysis revealed two new heterogeneous missense mutations in AARS2: c.179C>A and c.1703_1704del. We described the ragged red fiber (RRF) for the first time, suggesting that AARS2-related leukoencephalopathy be a new variant of mitochondrial encephalomyopathy. Gradual improvement in motor function was observed with intravenous coenzyme complex treatment. We also summarized our case and all previously reported cases to provide an overview of AARS2-related late-onset leukoencephalopathy. Then, we compared clinical and neuroimaging features of AARS2-related leukoencephalopathy with three other frequently diagnosed types of adult-onset leukoencephalopathy to provide insight into diagnostic strategies. Conclusion The characteristic MRI abnormalities and clinical symptoms described here may help to distinguish AARS2-related leukoencephalopathy from other adult-onset leukoencephalopathies. The combination of encephalopathy and myopathy strongly suggest that AARS2-related leukoencephalopathy is a new variant of mitochondrial encephalomyopathy. The response to coenzyme complex will shed light on future therapy investigation.
C1 [Tang, Yi; Qin, Qi; Xing, Yi; Guo, Dongmei; Di, Li; Jia, Jianping] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Innovat Ctr Neurol Disorders, Beijing, Peoples R China.
   [Jia, Jianping] Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing Key Lab Geriatr Cognit Disorders, Neurodegenerat Lab,Minist Educ Peoples, Beijing, Peoples R China.
C3 Capital Medical University
RP Tang, Y; Qin, Q (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Innovat Ctr Neurol Disorders, Beijing, Peoples R China.; Tang, Y; Qin, Q (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China.; Tang, Y; Qin, Q (corresponding author), Capital Med Univ, Xuan Wu Hosp, Innovat Ctr Neurol Disorders, Beijing, Peoples R China.
EM tangyixw@163.com; qinqibao@126.com
FU National Key R&D Program of China [2017YFC1310102]; National Natural Science Foundation of China [81671040]
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   Diodato Daria, 2014, INT J CELL BIOL, V2014, P787956, DOI 10.1155/2014/787956
   Dong Q, 2018, J HUM GENET, V63, P841, DOI 10.1038/s10038-018-0446-7
   Euro L, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00021
   GÃ¶tz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343
   Hamatani M, 2016, J HUM GENET, V61, P899, DOI 10.1038/jhg.2016.64
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kaye EM, 2004, NEUROLOGY, V62, P1464, DOI 10.1212/WNL.62.9.1464
   Lakshmanan R, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000135
   Lee JM, 2017, EUR J NEUROL, V24, PE21, DOI 10.1111/ene.13245
   Lynch DS, 2017, BRAIN, V140, P1204, DOI 10.1093/brain/awx045
   Lynch DS, 2016, JAMA NEUROL, V73, P1433, DOI 10.1001/jamaneurol.2016.2229
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   Moulinier L, 2017, HUM MUTAT, V38, P1316, DOI 10.1002/humu.23277
   Peragallo JH, 2018, OPHTHALMIC GENET, V39, P99, DOI 10.1080/13816810.2017.1350723
   Renaud DL, 2012, SEMIN NEUROL, V32, P3, DOI 10.1055/s-0032-1306380
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8
   Shoubridge EA, 1998, CURR OPIN NEUROL, V11, P491, DOI 10.1097/00019052-199810000-00012
   SHY GMILTON, 1964, REV NEURO PSIQUIAT, V27, P238
   Szpisjak L, 2017, J HUM GENET, V62, P329, DOI 10.1038/jhg.2016.126
   Taglia I, 2018, ACTA NEUROL SCAND, V138, P278, DOI 10.1111/ane.12954
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   van der Knaap MS, 1999, RADIOLOGY, V213, P121, DOI 10.1148/radiology.213.1.r99se01121
NR 29
TC 20
Z9 23
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
EI 
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD APR 15
PY 2019
VL 7
IS 4
BP 
EP 
DI 10.1002/mgg3.582
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA HU2LJ
UT WOS:000465102200006
PM 30706699
DA 2024-11-01
ER

PT J
AU Lehmann, D
   Tuppen, HAL
   Campbell, GE
   Alston, CL
   Lawless, C
   Rosa, HS
   Rocha, MC
   Reeve, AK
   Nicholls, TJ
   Deschauer, M
   Zierz, S
   Taylor, RW
   Turnbull, DM
   Vincent, AE
AF Lehmann, Diana
   Tuppen, Helen A. L.
   Campbell, Georgia E.
   Alston, Charlotte L.
   Lawless, Conor
   Rosa, Hannah S.
   Rocha, Mariana C.
   Reeve, Amy K.
   Nicholls, Thomas J.
   Deschauer, Marcus
   Zierz, Stephan
   Taylor, Robert W.
   Turnbull, Doug M.
   Vincent, Amy E.
TI Understanding mitochondrial DNA maintenance disorders at the single muscle fibre level
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID progressive external ophthalmoplegia; real-time pcr; mtdna replication; individual cells; skeletal-muscle; deletions; mutations; deficiency; mechanisms; quantification
AB Clonal expansion of mitochondrial DNA (mtDNA) deletions is an important pathological mechanism in adults with mtDNA maintenance disorders, leading to a mosaic mitochondrial respiratory chain deficiency in skeletal muscle. This study had two aims: (i) to determine if different Mendelian mtDNA maintenance disorders showed similar pattern of mtDNA deletions and respiratory chain deficiency and (ii) to investigate the correlation between the mitochondrial genetic defect and corresponding respiratory chain deficiency. We performed a quantitative analysis of respiratory chain deficiency, at a single cell level, in a cohort of patients with mutations in mtDNA maintenance genes. Using the same tissue section, we performed laser microdissection and single cell genetic analysis to investigate the relationship between mtDNA deletion characteristics and the respiratory chain deficiency. The pattern of respiratory chain deficiency is similar with different genetic defects. We demonstrate a clear correlation between the level of mtDNA deletion and extent of respiratory chain deficiency within a single cell. Long-range and single molecule PCR shows the presence of multiple mtDNA deletions in approximately one-third of all muscle fibres. We did not detect evidence of a replicative advantage for smaller mtDNA molecules in the majority of fibres, but further analysis is needed to provide conclusive evidence.
C1 [Lehmann, Diana] Univ Ulm, Dept Neurol, D-89075 Ulm, Germany.
   [Lehmann, Diana; Zierz, Stephan] Univ Halle Wittenberg, Dept Neurol, D-06120 Halle, Germany.
   [Tuppen, Helen A. L.; Campbell, Georgia E.; Alston, Charlotte L.; Lawless, Conor; Rosa, Hannah S.; Rocha, Mariana C.; Reeve, Amy K.; Nicholls, Thomas J.; Taylor, Robert W.; Turnbull, Doug M.; Vincent, Amy E.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Alston, Charlotte L.; Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Reeve, Amy K.; Turnbull, Doug M.; Vincent, Amy E.] Newcastle Univ, Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Deschauer, Marcus] Tech Univ Munich, Dept Neurol, D-81675 Munich, Germany.
C3 Ulm University; Martin Luther University Halle Wittenberg; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Technical University of Munich
RP Vincent, AE (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Vincent, AE (corresponding author), Newcastle Univ, Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM amy.vincent@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council Centre for Ageing and Vitality [L016354]; Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort [G0800674]; UK National Institute for Health Research Biomedical Research Centre in Age and Age Related Diseases; MRC/Engineering and Physical Sciences Research Council Molecular Pathology Node; UK NHS Specialist Commissioners Rare Mitochondrial Disorders of Adults and Children Service; European Academy of Neurology (EAN); MRC, Centre for Ageing and Vitality [MR/L016354/1]; National Institute for Health Research (NIHR) [NIHR-HCS-D12-03-04]; Parkinson's UK Fellowship [F-1401]; Wellcome Trust [213464/Z/18/Z]; Royal Society [213464/Z/18/Z]; Rosetrees and Stoneygate Trust Research Fellowship; RCUK (Gold Access funding) through MRC Centre for Ageing and Vitality; Lily Foundation; MRC [G0800674, MR/L016354/1] Funding Source: UKRI; Wellcome Trust [213464/Z/18/Z] Funding Source: Wellcome Trust
CR Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Gouspillou G, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0103044
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Kraytsberg Y, 2009, METHODS MOL BIOL, V554, P329, DOI 10.1007/978-1-59745-521-3_21
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   MULLERHOCKER J, 1983, VIRCHOWS ARCH A, V402, P61, DOI 10.1007/BF00695049
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Persson Ã, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Rygiel KA, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09906
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Tesarova M, 2004, NEUROPEDIATRICS, V35, P217, DOI 10.1055/s-2004-821081
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vincent AE, 2018, J PATHOL, V246, P261, DOI 10.1002/path.5146
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
NR 31
TC 11
Z9 13
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD AUG 22
PY 2019
VL 47
IS 14
BP 7430
EP 7443
DI 10.1093/nar/gkz472
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA IU8EP
UT WOS:000483815100027
PM 31147703
DA 2024-11-01
ER

PT J
AU Almutawa, W
   Smith, C
   Sabouny, R
   Smit, RB
   Zhao, T
   Wong, R
   Lee-Glover, L
   Desrochers-Goyette, J
   Ilamathi, HS
   Suchowersky, O
   Germain, M
   Mains, PE
   Parboosingh, JS
   Pfeffer, G
   Innes, AM
   Shutt, TE
AF Almutawa, Walaa
   Smith, Christopher
   Sabouny, Rasha
   Smit, Ryan B.
   Zhao, Tian
   Wong, Rachel
   Lee-Glover, Laurie
   Desrochers-Goyette, Justine
   Ilamathi, Hema Saranya
   Suchowersky, Oksana
   Germain, Marc
   Mains, Paul E.
   Parboosingh, Jillian S.
   Pfeffer, Gerald
   Innes, A. Micheil
   Shutt, Timothy E.
TI The R941L mutation in <i>MYH14</i> disrupts mitochondrial fission and associates with peripheral neuropathy
SO EBIOMEDICINE
LA English
DT Article
DE Mitochondria; Mitochondrial fission; Peripheral neuropathy; Non-muscle myosin; mtDNA; Caenorhabditis elegans
ID myosin-ii; hearing-loss; dynamics; disease; actin; gene; fusion; contributes; expression; phenotype
AB Background: Peripheral neuropathies are often caused by disruption of genes responsible for myelination or axonal transport. In particular, impairment inmitochondrial fission and fusion are known causes of peripheral neuropathies. However, the causal mechanisms for peripheral neuropathy gene mutations are not always known. While loss of function mutations in MYH14 typically cause non-syndromic hearing loss, the recently described R941L mutation in MYH14, encoding the non-muscle myosin protein isoform NMIIC, leads to a complex clinical presentation with an unexplained peripheral neuropathy phenotype. Methods: Confocal microscopywas used to examine mitochondrial dynamics in MYH14 patient fibroblast cells, as well as U2OS and M17 cells overexpressing NMIIC. The consequence of the R941L mutation on myosin activity was modeled in C. elegans. Findings: We describe the third family carrying the R941L mutation in MYH14, and demonstrate that the R941L mutation impairs non-muscle myosin protein function. To better understand the molecular basis of the peripheral neuropathy phenotype associatedwith the R941Lmutation, which has been hindered by the fact that NMIIC is largely uncharacterized, we have established a previously unrecognized biological role for NMIIC inmediating mitochondrial fission in human cells. Notably, the R941L mutation acts in a dominant-negative fashion to inhibit mitochondrial fission, especially in the cell periphery. In addition, we observed alterations to the organization of the mitochondrial genome. Interpretation: As impairments in mitochondrial fission cause peripheral neuropathy, this insight into the function of NMIIC likely explains the peripheral neuropathy phenotype associated with the R941L mutation.
C1 [Almutawa, Walaa; Smith, Christopher; Sabouny, Rasha; Smit, Ryan B.; Zhao, Tian; Wong, Rachel; Lee-Glover, Laurie; Mains, Paul E.; Parboosingh, Jillian S.; Pfeffer, Gerald; Innes, A. Micheil; Shutt, Timothy E.] Univ Calgary, Alberta Childrens Hosp Res Inst, Dept Med Genet, Cumming Sch Med, Calgary, AB, Canada.
   [Almutawa, Walaa; Sabouny, Rasha; Smit, Ryan B.; Zhao, Tian; Wong, Rachel; Lee-Glover, Laurie; Mains, Paul E.; Pfeffer, Gerald; Shutt, Timothy E.] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada.
   [Desrochers-Goyette, Justine; Ilamathi, Hema Saranya; Germain, Marc] Univ Quebec Trois Rivieres, Grp Rech Signalisat Cellulaire, Trois Rivieres, PQ, Canada.
   [Desrochers-Goyette, Justine; Ilamathi, Hema Saranya; Germain, Marc] Univ Quebec Trois Rivieres, Dept Biol Med, Trois Rivieres, PQ, Canada.
   [Desrochers-Goyette, Justine; Ilamathi, Hema Saranya; Germain, Marc] Univ Quebec Trois Rivieres, Ctr Rech Biomed, Trois Rivieres, PQ, Canada.
   [Suchowersky, Oksana] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada.
   [Suchowersky, Oksana] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.
   [Suchowersky, Oksana] Univ Alberta, Dept Pediat, Edmonton, AB, Canada.
   [Innes, A. Micheil; Shutt, Timothy E.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada.
C3 University of Calgary; University of Calgary; University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres; University of Alberta; University of Alberta; University of Alberta; University of Calgary
RP Innes, AM; Shutt, TE (corresponding author), Univ Calgary, Alberta Childrens Hosp Res Inst, Dept Med Genet, Cumming Sch Med, Calgary, AB, Canada.
EM micheil.innes@ahs.ca; timothy.shutt@ucalgary.ca
FU Alberta Children's Hospital Research Institute; UQTR Foundation; Canadian Institutes of Health Research; Saudi Cultural Bureau; QEII Graduate Scholarship; FRQ-NT scholarship; Genome Canada; Ontario Genomics Institute; Ontario Research Fund; Genome Alberta; Genome BC; Genome Quebec; Children's Hospital of Eastern Ontario Foundation
CR Andres D, 2013, BMC NEUROSCI, V14, P0, DOI 10.1186/1471-2202-14-49
   Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Ashrafi G, 2014, J CELL BIOL, V206, P655, DOI 10.1083/jcb.201401070
   Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110
   Beach JR, 2014, CURR BIOL, V24, P1160, DOI 10.1016/j.cub.2014.03.071
   Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, PW252, DOI 10.1093/nar/gku340
   Bobylev I, 2018, MOL NEUROBIOL, V55, P1227, DOI 10.1007/s12035-016-0364-7
   Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122
   BRENNER S, 1974, GENETICS, V77, P71
   Canta A, 2015, TOXICS, V3, P198, DOI 10.3390/toxics3020198
   Cassereau J, 2014, REV NEUROL-FRANCE, V170, P366, DOI 10.1016/j.neurol.2013.11.005
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Choi BO, 2011, HUM MUTAT, V32, P669, DOI 10.1002/humu.21488
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285
   Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Fu XL, 2016, NEURAL PLAST, V2016, P0, DOI 10.1155/2016/6720420
   Fukuoh A, 2014, MOL SYST BIOL, V10, P0, DOI 10.15252/msb.20145117
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200
   Gonzaga-Jauregui C, 2015, CELL REP, V12, P1169, DOI 10.1016/j.celrep.2015.07.023
   Hartley T, 2018, CLIN GENET, V93, P301, DOI 10.1111/cge.13101
   Hatch AL, 2016, MOL BIOL CELL, V27, P3109, DOI 10.1091/mbc.E16-03-0193
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   Iborra FJ, 2004, BMC BIOL, V2, P0, DOI 10.1186/1741-7007-2-9
   Iyadurai S, 2017, MUSCLE NERVE, V56, P341, DOI 10.1002/mus.25491
   Ji WK, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.11553.001
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kim B, 2017, J NEUROENG REHABIL, V14, P0, DOI 10.1186/s12984-017-0223-4
   Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200
   Kim SJ, 2016, GENE, V591, P177, DOI 10.1016/j.gene.2016.07.011
   Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445
   Koch J, 2016, J MED GENET, V53, P270, DOI 10.1136/jmedgenet-2015-103500
   Korobova F, 2014, CURR BIOL, V24, P409, DOI 10.1016/j.cub.2013.12.032
   Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360
   Kraus F, 2017, J CELL SCI, V130, P2953, DOI 10.1242/jcs.199562
   Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lewis SC, 2016, SCIENCE, V353, P0, DOI 10.1126/science.aaf5549
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Macias MP, 2014, J NEUROSCI METH, V223, P114, DOI 10.1016/j.jneumeth.2013.11.024
   Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120
   Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Ouellet M, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005612
   Pareyson D, 2015, NEUROSCI LETT, V596, P66, DOI 10.1016/j.neulet.2015.04.001
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Piekny AJ, 2003, DEVELOPMENT, V130, P5695, DOI 10.1242/dev.00807
   Prudent J, 2016, CURR BIOL, V26, PR207, DOI 10.1016/j.cub.2016.01.009
   Reyes A, 2011, NUCLEIC ACIDS RES, V39, P5098, DOI 10.1093/nar/gkr052
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI 10.1038/nmeth.2019
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098
   Yang Rong, 2010, ZHONGHUA YIXUE YICHUANXUE ZAZHI, V27, P259, DOI 10.3760/cma.j.issn.1003-940.2010.03.005
   Yang T, 2005, AM J MED GENET A, V139A, P9, DOI 10.1002/ajmg.a.30989
   Zhao T, 2019, LIFE SCI ALLIANCE, V2, P0, DOI 10.26508/lsa.201900353
NR 59
TC 30
Z9 31
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
EI 
J9 EBIOMEDICINE
JI EBioMedicine
PD JUL 15
PY 2019
VL 45
IS 
BP 379
EP 392
DI 10.1016/j.ebiom.2019.06.018
PG 14
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA IJ4FN
UT WOS:000475860000040
PM 31231018
DA 2024-11-01
ER

PT J
AU Storoni, M
   Robert, MP
   Plant, GT
AF Storoni, Mithu
   Robert, Matthieu P.
   Plant, Gordon T.
TI The therapeutic potential of a calorie-restricted ketogenic diet for the management of Leber hereditary optic neuropathy
SO NUTRITIONAL NEUROSCIENCE
LA English
DT Review
DE Ketogenic diet; Neurodegeneration; Leber hereditary optic neuropathy; Mitochondrial disorders; Complex I
ID beta-hydroxybutyrate; mitochondrial-dna; oxidative stress; clinical expression; skeletal-muscle; atkins diet; sirt1; biogenesis; ampk; progression
AB Leber hereditary optic neuropathy (LHON) is a maternally inherited, bilateral, sequential optic neuropathy that usually affects young males. LHON arises from a defect in complex I of the oxidative phosphorylation chain that generates increased reactive oxygen species and causes a decline in cellular ATP production. There exists no cure at present for LHON. Asymptomatic LHON mutation carriers show signs of increased mitochondrial biogenesis that may compensate for the compromise in complex I activity. Partial recovery in LHON is associated with a wider optic disc diameter and a younger age at disease onset, which may allow for greater mitochondrial bioenergetic capacity. Rescuing a mitochondrial bioenergetic deficit soon after disease onset may improve the chances of recovery and reduce visual loss in the second eye. We here propose that a calorie-restricted ketogenic diet has the potential to enhance mitochondrial bioenergetic capacity and should be explored as a potential therapeutic option for treating LHON.
C1 [Storoni, Mithu; Robert, Matthieu P.; Plant, Gordon T.] Natl Hosp Neurol & Neurosurg, Dept Neuroophthalmol, Box 93,Queen Sq, London WC1N 3BG, England.
   [Robert, Matthieu P.] Hop Univ Necker Enfants Malades, AP HP, Serv Ophtalmol, Rue Sevres, F-75015 Paris, France.
   [Plant, Gordon T.] St Thomas Hosp, London, England.
C3 University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Guy's & St Thomas' NHS Foundation Trust
RP Plant, GT (corresponding author), Natl Hosp Neurol & Neurosurg, Dept Neuroophthalmol, Box 93,Queen Sq, London WC1N 3BG, England.; Plant, GT (corresponding author), St Thomas Hosp, London, England.
EM gplant7@icloud.com
CR Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Ahola-ErkkilÃ¤ S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899
   CantÃ³ C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4
   Carta A, 2005, BRIT J OPHTHALMOL, V89, P825, DOI 10.1136/bjo.2004.060590
   Charach G, 2005, NEPHRON CLIN PRACT, V100, PC120, DOI 10.1159/000085291
   Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608
   Chuenkongkaew WL, 2005, J NEURO-OPHTHALMOL, V25, P173, DOI 10.1097/01.wno.0000176631.87234.49
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Clarke K, 2012, REGUL TOXICOL PHARM, V63, P401, DOI 10.1016/j.yrtph.2012.04.008
   DEVIVO DC, 1978, ANN NEUROL, V3, P331, DOI 10.1002/ana.410030410
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Frey S, 2016, BIOCHIM BIOPHYS ACTA, V1863, P284
   Fuehrlein BS, 2004, J CLIN ENDOCR METAB, V89, P1641, DOI 10.1210/jc.2003-031796
   Fung TT, 2010, ANN INTERN MED, V153, P289, DOI 10.7326/0003-4819-153-5-201009070-00003
   Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Giordano L, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.364
   Gonzalez AA, 2004, AM J PHYSIOL-ENDOC M, V287, PE1032, DOI 10.1152/ajpendo.00172.2004
   Guo XL, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep33950
   HARDING AE, 1995, AM J HUM GENET, V57, P77
   Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.02745
   Hwang J M, 1996, KOREAN J OPHTHALMOL, V10, P122
   JÃ¤ger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x
   Jenkins DJA, 2009, ARCH INTERN MED, V169, P1046, DOI 10.1001/archinternmed.2009.115
   JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440
   Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x
   Kim DY, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0119316
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klopstock T, 2013, BRAIN, V136, P0, DOI 10.1093/brain/aws279
   Kovac S, 2013, NEUROPHARMACOLOGY, V69, P96, DOI 10.1016/j.neuropharm.2012.05.012
   Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200
   La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155
   Lascaratos G, 2015, NEUROBIOL DIS, V82, P78, DOI 10.1016/j.nbd.2015.05.012
   Lauritzen KH, 2016, NEUROBIOL AGING, V48, P34, DOI 10.1016/j.neurobiolaging.2016.08.005
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065
   Mackey DA, 2003, EYE, V17, P312, DOI 10.1038/sj.eye.6700362
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   MARANGOS PJ, 1990, EPILEPSIA, V31, P239, DOI 10.1111/j.1528-1157.1990.tb05371.x
   Mitchell SE, 2015, ONCOTARGET, V6, P23213, DOI 10.18632/oncotarget.4003
   Moura ALA, 2013, INVEST OPHTH VIS SCI, V54, P4471, DOI 10.1167/iovs.12-11137
   Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200
   Newman NJ, 2006, AM J OPHTHALMOL, V141, P1061, DOI 10.1016/j.ajo.2005.12.045
   Newman NJ, 2005, AM J OPHTHALMOL, V140, P517, DOI 10.1016/j.ajo.2005.03.017
   Newman NJ, 2005, AM J OPHTHALMOL, V140, P407, DOI 10.1016/j.ajo.2005.03.058
   Nishioka T, 2004, J HUM GENET, V49, P701, DOI 10.1007/s10038-004-0209-5
   OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650
   Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021
   PÃ©rez-Guisado J, 2011, J MED FOOD, V14, P681, DOI 10.1089/jmf.2010.0137
   Peterman MG, 1925, J AMER MED ASSOC, V84, P1979, DOI 10.1001/jama.1925.02660520007003
   Pisano A, 2015, HUM MOL GENET, V24, P6921, DOI 10.1093/hmg/ddv396
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Rudolph G, 2013, J NEURO-OPHTHALMOL, V33, P30, DOI 10.1097/WNO.0b013e318272c643
   Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004
   Sadun A, 1998, TRANS AM OPHTHALMOL SOC, V96, P881
   Sadun A A, 2000, TRANS AM OPHTHALMOL SOC, V98, P223
   Sadun AA, 2000, T AM OPHTHAL SOC, V98, P232
   SADUN AA, 1994, CLIN NEUROSCI, V2, P165
   Sadun AA, 2012, ARCH NEUROL-CHICAGO, V69, P331, DOI 10.1001/archneurol.2011.2972
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Seo JH, 2010, CLIN EXP OPHTHALMOL, V38, P363, DOI 10.1111/j.1442-9071.2010.02240.x
   Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166
   Spruijt L, 2006, AM J OPHTHALMOL, V141, P676, DOI 10.1016/j.ajo.2005.11.007
   Stafstrom Carl E, 2004, EPILEPSY CURR, V4, P215, DOI 10.1111/j.1535-7597.2004.46001.x
   Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062
   Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19
   Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143
   Thouin A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0063446
   Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Van Bergen NJ, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0140919
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang Y, 2011, AM J DENT, V24, P3
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Wu JY, 2009, EUR J CLIN PHARMACOL, V65, P1169, DOI 10.1007/s00228-009-0723-7
   Yamada ES, 2001, VISION RES, V41, P119, DOI 10.1016/S0042-6989(00)00244-3
   Yang Q, 2008, TOXICOL SCI, V101, P132, DOI 10.1093/toxsci/kfm206
   Yen MY, 1996, BRIT J OPHTHALMOL, V80, P78, DOI 10.1136/bjo.80.1.78
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
NR 90
TC 6
Z9 7
U1 1
U2 20
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1028-415X
EI 1476-8305
J9 NUTR NEUROSCI
JI Nutr. Neurosci.
PD MAR 4
PY 2019
VL 22
IS 3
BP 156
EP 164
DI 10.1080/1028415X.2017.1368170
PG 9
WC Neurosciences; Nutrition & Dietetics
SC Neurosciences & Neurology; Nutrition & Dietetics
GA HJ4JK
UT WOS:000457140100002
PM 28994349
DA 2024-11-01
ER

PT J
AU O'Hara, R
   Tedone, E
   Ludlow, A
   Huang, E
   Arosio, B
   Mari, D
   Shay, JW
AF O'Hara, Ryan
   Tedone, Enzo
   Ludlow, Andrew
   Huang, Ejun
   Arosio, Beatrice
   Mari, Daniela
   Shay, Jerry W.
TI Quantitative mitochondrial DNA copy number determination using droplet digital PCR with single-cell resolution
SO GENOME RESEARCH
LA English
DT Article
ID leukocyte telomere length; real-time pcr; gene-expression; quantification; biogenesis; deletion; association; activation; depletion; muscle
AB Mitochondria are involved in a number of diverse cellular functions, including energy production, metabolic regulation, apoptosis, calcium homeostasis, cell proliferation, and motility, as well as free radical generation. Mitochondrial DNA (mtDNA) is present at hundreds to thousands of copies per cell in a tissue-specific manner. mtDNA copy number also varies during aging and disease progression and therefore might be considered as a biomarker that mirrors alterations within the human body. Here, we present a new quantitative, highly sensitive droplet digital PCR (ddPCR) method, droplet digital mitochondrial DNA measurement (ddMDM), to measure mtDNA copy number not only from cell populations but also from single cells. Our developed assay can generate data in as little as 3 h, is optimized for 96-well plates, and also allows the direct use of cell lysates without the need for DNA purification or nuclear reference genes. We show that ddMDM is able to detect differences between samples whose mtDNA copy number was close enough as to be indistinguishable by other commonly used mtDNA quantitation methods. By utilizing ddMDM, we show quantitative changes in mtDNA content per cell across a wide variety of physiological contexts including cancer progression, cell cycle progression, human T cell activation, and human aging.
C1 [O'Hara, Ryan; Tedone, Enzo; Ludlow, Andrew; Huang, Ejun; Shay, Jerry W.] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.
   [Arosio, Beatrice; Mari, Daniela] Univ Milan, Dept Med Sci & Community Hlth, Geriatr Unit, I-20122 Milan, Italy.
   [Arosio, Beatrice; Mari, Daniela] IRCCS Osped Maggiore Policlin, Fdn Ca Granda, I-20122 Milan, Italy.
C3 University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico
RP Shay, JW (corresponding author), UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.
EM Jerry.Shay@UTSouthwestern.edu
FU National Institutes of Health [AG01228, C06RR30414]; Harold Simmons National Cancer Institute Designated Comprehensive Cancer Center Support Grant [CA142543]; Southland Financial Corporation Distinguished Chair in Geriatric Research
CR Afrifa J, 2019, MITOCHONDRION, V47, P238, DOI 10.1016/j.mito.2018.12.003
   Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010
   Chen N, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep37404
   Chen T, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-8
   Cohen T, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1006407
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   DSouza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001
   Dimeloe S, 2017, IMMUNOLOGY, V150, P35, DOI 10.1111/imm.12655
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Eskiocak U, 2011, CANCER RES, V71, P4359, DOI 10.1158/0008-5472.CAN-11-0794
   Gammage PA, 2019, BMC BIOL, V17, P0, DOI 10.1186/s12915-019-0668-y
   Guantes R, 2015, GENOME RES, V25, P633, DOI 10.1101/gr.178426.114
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Hu LW, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep35859
   Huang E, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-05174-7
   Hurtado-Roca Y, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0163770
   Ibrahim-Hashim A, 2017, CANCER RES, V77, P2242, DOI 10.1158/0008-5472.CAN-16-2844
   Januszyk Michael, 2015, MICROARRAYS (BASEL), V4, P540, DOI 10.3390/microarrays4040540
   KABELITZ D, 1993, IMMUNOL TODAY, V14, P338, DOI 10.1016/0167-5699(93)90231-9
   Kawada K, 2017, INT J CLIN ONCOL, V22, P651, DOI 10.1007/s10147-017-1156-4
   Kim JH, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067227
   Kiselinova M, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0085999
   Klingbeil MM, 2009, MOL CELL, V35, P398, DOI 10.1016/j.molcel.2009.08.007
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lakshmanan LN, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12814
   Lee W, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.34
   Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005
   Ludlow AT, 2014, NUCLEIC ACIDS RES, V42, P0, DOI 10.1093/nar/gku439
   Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067
   Malik Afshan N, 2009, DIABETES RES CLIN PRACT, V86, Pe22, DOI 10.1016/j.diabres.2009.07.002
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mendenhall A, 2016, AGING CELL, V15, P4, DOI 10.1111/acel.12424
   Menendez JA, 2015, CELL CYCLE, V14, P3801, DOI 10.1080/15384101.2015.1022697
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Monickaraj F, 2012, MOL CELL BIOCHEM, V365, P343, DOI 10.1007/s11010-012-1276-0
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Morandi A, 2017, BBA-REV CANCER, V1868, P1, DOI 10.1016/j.bbcan.2016.12.004
   PIERCE DJ, 1990, BIOTECHNIQUES, V9, P724
   Pieters N, 2015, MECH AGEING DEV, V145, P51, DOI 10.1016/j.mad.2015.02.003
   Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x
   Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Qian Y, 2017, BIOINFORMATICS, V33, P1399, DOI 10.1093/bioinformatics/btw835
   Qiu CF, 2015, CLIN LAB, V61, P363, DOI 10.7754/Clin.Lab.2014.140313
   Ramirez RD, 2003, ONCOGENE, V22, P433, DOI 10.1038/sj.onc.1206046
   Regier N, 2010, BMC MOL BIOL, V11, P0, DOI 10.1186/1471-2199-11-57
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Robin JD, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep24067
   Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743
   SHAY JW, 1990, J BIOL CHEM, V265, P14802
   Tedone E, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.12859
   Tedone E, 2015, J ALZHEIMERS DIS, V46, P761, DOI 10.3233/JAD-142808
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyrka AR, 2015, EXP GERONTOL, V66, P17, DOI 10.1016/j.exger.2015.04.002
   Van Peer G, 2012, SCI REP-UK, V2, P0, DOI 10.1038/srep00222
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014
   Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103
   Yue P, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0206003
   Zhang L, 2015, BMC GENOMICS, V16, P0, DOI 10.1186/1471-2164-16-S1-S8
   Zhao SR, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0078644
   Zhao Y, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0159004
NR 69
TC 74
Z9 80
U1 6
U2 27
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD NOV 15
PY 2019
VL 29
IS 11
BP 1878
EP 1888
DI 10.1101/gr.250480.119
PG 11
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity
GA JJ1WN
UT WOS:000493952800011
PM 31548359
DA 2024-11-01
ER

PT J
AU Lam, J
   McKeague, M
AF Lam, Juwela
   McKeague, Maureen
TI Dietary modulation of mitochondrial DNA damage: implications in aging and associated diseases
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Review
DE Mitochondria; Dietary restriction; DNA damage; Aging; Lifespan
ID caloric restriction mimetics; foxo transcription factors; heavy-strand promoter; fatty-acid oxidation; base-excision-repair; life-span extension; copy number; skeletal-muscle; stress; mutations
AB Mammalian mitochondria contain small genomes [mitochondrial DNA (mtDNA)], which encode several of the proteins that are crucial for respiration. As such, maintaining the integrity of mtDNA is essential for healthy life. Nutritional strategies such as "Calorie Restriction" may play an important role in regulating mtDNA integrity and prolonging lifespan. In this review, we compare mtDNA with nuclear DNA damage and discuss how the resulting cell fates relate to human health. We provide a description of the mechanisms behind Calorie Restriction as an approach to induce mitochondrial processes contributing to a longer lifespan. We make connections between the current repertoire of studies to propose that how nutrition may mitigate mitochondrial dysfunction and potentially reduce DNA damage. Finally, we describe nutritional based approaches to prevent mitochondrial dysfunction with a focus on mimetics of dietary and calorie restriction. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Lam, Juwela; McKeague, Maureen] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Inst Food Nutr & Hlth, Schmelzbergstr 9, CH-8092 Zurich, Switzerland.
C3 Swiss Federal Institutes of Technology Domain; ETH Zurich
RP McKeague, M (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Inst Food Nutr & Hlth, Schmelzbergstr 9, CH-8092 Zurich, Switzerland.
EM maureen.mckeague@mcgill.ca
FU Swiss National Foundation
CR Adarme-Vega TC, 2012, MICROB CELL FACT, V11, P0, DOI 10.1186/1475-2859-11-96
   Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002
   Bankoglu EE, 2016, FREE RADICAL BIO MED, V94, P208, DOI 10.1016/j.freeradbiomed.2016.02.033
   Bess AS, 2012, NUCLEIC ACIDS RES, V40, P7916, DOI 10.1093/nar/gks532
   Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616
   Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012
   Busch C, 2015, CLIN EPIGENETICS, V7, P0, DOI 10.1186/s13148-015-0095-z
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Cedikova M, 2016, PHYSIOL RES, V65, PS519, DOI 10.33549/physiolres.933538
   Cook CC, 2012, CELL DEATH DIS, V3, P0, DOI 10.1038/cddis.2011.141
   Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005
   Diot A, 2016, MAMM GENOME, V27, P381, DOI 10.1007/s00335-016-9651-x
   Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884
   Eisenberg T, 2017, AUTOPHAGY, V13, P767, DOI 10.1080/15548627.2017.1280225
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Fogg Vanessa C, 2011, CHIN J CANCER, V30, P526, DOI 10.5732/cjc.011.10018
   Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086
   Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002
   Hayashi JI, 2016, CURR OPIN GENET DEV, V38, P63, DOI 10.1016/j.gde.2016.03.004
   He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004
   Horio Y, 2011, CLIN SCI, V121, P191, DOI 10.1042/CS20100587
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Kaeberlein M, 2009, SCIENCE, V326, P55, DOI 10.1126/science.1181034
   Kakimoto M, 2002, DIABETES, V51, P1588, DOI 10.2337/diabetes.51.5.1588
   Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014
   Kauppila JHK, 2015, BBA-BIOENERGETICS, V1847, P1354, DOI 10.1016/j.bbabio.2015.06.001
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kim DH, 2014, AGE, V36, P0, DOI 10.1007/s11357-014-9679-3
   Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501
   Kisby GE, 2010, EXP GERONTOL, V45, P208, DOI 10.1016/j.exger.2009.12.003
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091
   Lee HC, 2014, WORLD J GASTROENTERO, V20, P3950, DOI 10.3748/wjg.v20.i14.3950
   Lee SH, 2013, BMB REP, V46, P181, DOI 10.5483/BMBRep.2013.46.4.033
   Li WT, 2017, P NATL ACAD SCI USA, V114, P6752, DOI 10.1073/pnas.1706021114
   Li Y, 2009, HUM MOL GENET, V18, P4897, DOI 10.1093/hmg/ddp459
   Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023
   Lodeiro MF, 2012, P NATL ACAD SCI USA, V109, P6513, DOI 10.1073/pnas.1118710109
   Lujan SA, 2016, TRENDS CELL BIOL, V26, P640, DOI 10.1016/j.tcb.2016.04.012
   Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788
   Madeo F, 2014, NAT REV DRUG DISCOV, V13, P727, DOI 10.1038/nrd4391
   Madreiter-Sokolowski CT, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9030165
   Mao PZ, 2012, BBA-MOL BASIS DIS, V1822, P111, DOI 10.1016/j.bbadis.2011.10.014
   Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250
   MCCAY CM, 1989, NUTRITION, V5, P155
   Meeran SM, 2010, CLIN EPIGENETICS, V1, P0, DOI 10.1007/s13148-010-0011-5
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mikhed Y, 2015, INT J MOL SCI, V16, P15918, DOI 10.3390/ijms160715918
   Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x
   Molz P, 2016, AN ACAD BRAS CIENC, V88, P1863, DOI 10.1590/0001-3765201620150608
   Moro L, 2009, CELL DEATH DIFFER, V16, P571, DOI 10.1038/cdd.2008.178
   Mukherjee S, 2010, DOSE-RESPONSE, V8, P478, DOI 10.2203/dose-response.09-015.Mukherjee
   Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133
   OFlanagan CH, 2017, BMC MED, V15, P0, DOI 10.1186/s12916-017-0873-x
   Pamplona R, 2006, BBA-BIOENERGETICS, V1757, P496, DOI 10.1016/j.bbabio.2006.01.009
   Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100
   Picca A, 2017, CLIN INTERV AGING, V12, P1887, DOI 10.2147/CIA.S126458
   Picca A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074644
   Piper MDW, 2005, J GERONTOL A-BIOL, V60, P549, DOI 10.1093/gerona/60.5.549
   Qi WB, 2017, AGING CELL, V16, P1125, DOI 10.1111/acel.12651
   Qiu GH, 2015, MUTAT RES-REV MUTAT, V764, P108, DOI 10.1016/j.mrrev.2015.04.001
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Quarrie Jason K, 2004, SCI AGING KNOWLEDGE ENVIRON, V2004, Pre5, DOI 10.1126/sageke.2004.31.re5
   Reuter S, 2011, GENES NUTR, V6, P93, DOI 10.1007/s12263-011-0222-1
   Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow
   Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007
   Rubio-Cosials A, 2013, CURR OPIN STRUC BIOL, V23, P116, DOI 10.1016/j.sbi.2012.12.004
   Ruetenik A, 2015, BBA-BIOENERGETICS, V1847, P1434, DOI 10.1016/j.bbabio.2015.05.005
   Sanz A, 2004, J BIOENERG BIOMEMBR, V36, P545, DOI 10.1007/s10863-004-9001-7
   Satoh A, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5211
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schiavi A, 2014, EXP GERONTOL, V56, P147, DOI 10.1016/j.exger.2014.02.015
   Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009
   Shintani T, 2017, BIOCHEM BIOPH RES CO, V493, P1528, DOI 10.1016/j.bbrc.2017.09.147
   Shokolenko IN, 2013, DNA REPAIR, V12, P488, DOI 10.1016/j.dnarep.2013.04.023
   Singh KP, 2011, CHEM RES TOXICOL, V24, P340, DOI 10.1021/tx1003112
   Smieszek A, 2017, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, V18, P0
   Soda Kuniyasu, 2012, GLOB J HEALTH SCI, V4, P170, DOI 10.5539/gjhs.v4n6p170
   Sohal RS, 2014, FREE RADICAL BIO MED, V73, P366, DOI 10.1016/j.freeradbiomed.2014.05.015
   Sohl CD, 2013, HUM MOL GENET, V22, P1074, DOI 10.1093/hmg/dds509
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Trantakis IA, 2016, J AM CHEM SOC, V138, P8497, DOI 10.1021/jacs.6b03599
   Tu HK, 2015, ONCOTARGET, V6, P41988, DOI 10.18632/oncotarget.5889
   Van Houten B, 2016, FRONT BIOSCI-LANDMRK, V21, P42, DOI 10.2741/4375
   Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069
   Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377
   Webb AE, 2016, AGING CELL, V15, P673, DOI 10.1111/acel.12479
   Wegman MP, 2015, REJUV RES, V18, P162, DOI 10.1089/rej.2014.1624
   Wei M, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aai8700
   Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003
   Wullschleger S, 2006, CELL, V127, P5
   Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011
   Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013
   Zhu ZH, 2017, ADV EXP MED BIOL, V1038, P219, DOI 10.1007/978-981-10-6674-0_15
   Zollo O, 2012, P NATL ACAD SCI USA, V109, P6508, DOI 10.1073/pnas.1118594109
NR 110
TC 15
Z9 17
U1 0
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD JAN 15
PY 2019
VL 63
IS 
BP 1
EP 10
DI 10.1016/j.jnutbio.2018.07.003
PG 10
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA HF9NZ
UT WOS:000454570000001
PM 30071405
DA 2024-11-01
ER

PT J
AU Hoitzing, H
   Gammage, PA
   van Haute, L
   Minczuk, M
   Johnston, IG
   Jones, NS
AF Hoitzing, Hanne
   Gammage, Payam A.
   van Haute, Lindsey
   Minczuk, Michal
   Johnston, Iain G.
   Jones, Nick S.
TI Energetic costs of cellular and therapeutic control of stochastic mitochondrial DNA populations
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID oxidative-phosphorylation; deletion mutants; skeletal-muscle; wild-type; selective degradation; respiratory-chain; clonal expansion; copy number; mtdna; dynamics
AB The dynamics of the cellular proportion of mutant mtDNA molecules is crucial for mitochondrial diseases. Cellular populations of mitochondria are under homeostatic control, but the details of the control mechanisms involved remain elusive. Here, we use stochastic modelling to derive general results for the impact of cellular control on mtDNA populations, the cost to the cell of different mtDNA states, and the optimisation of therapeutic control of mtDNA populations. This formalism yields a wealth of biological results, including that an increasing mtDNA variance can increase the energetic cost of maintaining a tissue, that intermediate levels of heteroplasmy can be more detrimental than homoplasmy even for a dysfunctional mutant, that heteroplasmy distribution (not mean alone) is crucial for the success of gene therapies, and that long-term rather than short intense gene therapies are more likely to beneficially impact mtDNA populations. Author summary Mitochondria, best known for their role in energy production, are crucial to the survival of most of our cells. To respond to energetic demands and mitigate against mutational damage, cells control the mitochondrial populations within them, however the character of these control mechanisms remains open. As experimental elucidation of these mechanisms is challenging, theoretical approaches can help us understand the general principles of cellular control of mitochondria in physiology and disease. We use stochastic modelling to compare control strategies by studying their impact on the dynamics of mitochondrial DNA (mtDNA) populations as well as their energetic burden to the cell. We identify optimal strategies for the cell to control against mtDNA damage and preserve energy production and use this theory to explore the action of recently developed mitochondrial gene therapies, which reduce the fraction of mutant mtDNA molecules inside cells. We show how treatment efficiency might depend on pre-treatment distributions of mutant and wildtype mtDNA molecules: treatments are less effective for tissues consisting of cells with highly varying mutant levels, and long-term, rather than short intense, gene therapies should be favoured.
C1 [Hoitzing, Hanne; Jones, Nick S.] Imperial Coll London, Dept Math, London SW7 2AZ, England.
   [Gammage, Payam A.; van Haute, Lindsey; Minczuk, Michal] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Johnston, Iain G.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
C3 Imperial College London; University of Cambridge; University of Birmingham
RP Jones, NS (corresponding author), Imperial Coll London, Dept Math, London SW7 2AZ, England.; Johnston, IG (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
EM i.johnston.1@bham.ac.uk; nick.jones@imperial.ac.uk
FU Medical Research Council [MC_UU_00015/4] Funding Source: Medline; EPSRC [EP/N014529/1] Funding Source: UKRI; MRC [MC_UU_00015/4] Funding Source: UKRI
CR Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954
   Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   ANGULOBROWN F, 1995, NUOVO CIMENTO D, V17, P87, DOI 10.1007/BF02451604
   ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2
   Bacman SR, 2014, METHOD ENZYMOL, V547, P373, DOI 10.1016/B978-0-12-801415-8.00018-7
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004
   Bibikova M, 2002, GENETICS, V161, P1169
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   BRAND MD, 1993, BIOCHEM J, V291, P739, DOI 10.1042/bj2910739
   Burgstaller JP, 2015, MOL HUM REPROD, V21, P11, DOI 10.1093/molehr/gau090
   Busch KB, 2014, PHILOS T R SOC B, V369, P0, DOI 10.1098/rstb.2013.0442
   Capps GJ, 2003, J THEOR BIOL, V221, P565, DOI 10.1006/jtbi.2003.3207
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Gammage PA, 2016, METHODS MOL BIOL, V1351, P145, DOI 10.1007/978-1-4939-3040-1_11
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gitschlag BL, 2016, BIORXIV, V0, P0
   Grandemange S, 2009, SEMIN CANCER BIOL, V19, P50, DOI 10.1016/j.semcancer.2008.12.001
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934
   Jajoo R, 2016, SCIENCE, V351, P169, DOI 10.1126/science.aaa8714
   Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Johnston IG, 2016, AM J HUM GENET, V99, P1150, DOI 10.1016/j.ajhg.2016.09.016
   Johnston IG, 2015, P ROY SOC A-MATH PHY, V471, P0, DOI 10.1098/rspa.2015.0050
   Johnston IG, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.07464
   Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486
   Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208
   Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156
   KORZENIEWSKI B, 1995, BBA-BIOENERGETICS, V1229, P315, DOI 10.1016/0005-2728(95)00008-7
   Kowald A, 2000, J THEOR BIOL, V202, P145, DOI 10.1006/jtbi.1999.1046
   Kowald A, 2014, PROG MOL BIOL TRANSL, V127, P63, DOI 10.1016/B978-0-12-394625-6.00003-9
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009
   Majamaa-Voltti Kirsi, 2002, BMC CARDIOVASC DISORD, V2, P12
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Monternier PA, 2014, J EXP BIOL, V217, P2691, DOI 10.1242/jeb.104505
   Moraes C T, 1996, METHODS ENZYMOL, V264, P522, DOI 10.1016/S0076-6879(96)64046-4
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   MorÃ¡n M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029
   NOBES CD, 1990, J BIOL CHEM, V265, P12910
   Otten ABC, 2016, CELL REP, V16, P622, DOI 10.1016/j.celrep.2016.06.023
   Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079
   Pfleger J, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.202
   Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916
   Poovathingal SK, 2009, PLOS COMPUT BIOL, V5, P0, DOI 10.1371/journal.pcbi.1000572
   POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Royrvik EC, 2016, MOL HUM REPROD, V22, P809, DOI 10.1093/molehr/gaw062
   Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012
   Salin K, 2012, J EXP ZOOL PART A, V317A, P283, DOI 10.1002/jez.1722
   Salvatier J, 2016, PEERJ COMPUT SCI, V0, P0, DOI DOI 10.7717/peerj-cs.55
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Sriskanthadevan S, 2015, BLOOD, V125, P2120, DOI 10.1182/blood-2014-08-594408
   Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556
   Van Laar VS, 2009, EXP NEUROL, V218, P247, DOI 10.1016/j.expneurol.2009.03.019
   VANDIJKEN JP, 1993, ANTON LEEUW INT J G, V63, P343, DOI 10.1007/BF00871229
   Waddell TG, 1999, BIOCHEM EDUC, V27, P12, DOI 10.1016/S0307-4412(98)00266-0
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Zhu XW, 2013, J ALZHEIMERS DIS, V33, PS253, DOI 10.3233/JAD-2012-129005
NR 94
TC 17
Z9 17
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-734X
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD JUN 15
PY 2019
VL 15
IS 6
BP 
EP 
DI 10.1371/journal.pcbi.1007023
PG 27
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA IH7RZ
UT WOS:000474703000016
PM 31242175
DA 2024-11-01
ER

PT J
AU Peter, B
   Farge, G
   Pardo-Hernandez, C
   TÃ¥ngefjord, S
   Falkenberg, M
AF Peter, Bradley
   Farge, Geraldine
   Pardo-Hernandez, Carlos
   Tangefjord, Stefan
   Falkenberg, Maria
TI Structural basis for adPEO-causing mutations in the mitochondrial TWINKLE helicase
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID progressive external ophthalmoplegia; structure-function defects; image-processing package; stranded-dna-binding; crystal-structure; linker region; multiple deletions; primase-helicase; ul8 subunit; protein
AB TWINKLE is the helicase involved in replication and maintenance of mitochondrial DNA (mtDNA) in mammalian cells. Structurally, TWINKLE is closely related to the bacteriophage T7 gp4 protein and comprises a helicase and primase domain joined by a flexible linker region. Mutations in and around this linker region are responsible for autosomal dominant progressive external ophthalmoplegia (adPEO), a neuromuscular disorder associated with deletions in mtDNA. The underlying molecular basis of adPEO-causing mutations remains unclear, but defects in TWINKLE oligomerization are thought to play a major role. In this study, we have characterized these disease variants by single-particle electron microscopy and can link the diminished activities of the TWINKLE variants to altered oligomeric properties. Our results suggest that the mutations can be divided into those that (i) destroy the flexibility of the linker region, (ii) inhibit ring closure and (iii) change the number of subunits within a helicase ring. Furthermore, we demonstrate that wild-type TWINKLE undergoes large-scale conformational changes upon nucleoside triphosphate binding and that this ability is lost in the disease-causing variants. This represents a substantial advancement in the understanding of the molecular basis of adPEO and related pathologies and may aid in the development of future therapeutic strategies.
C1 [Peter, Bradley; Pardo-Hernandez, Carlos; Falkenberg, Maria] Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.
   [Farge, Geraldine] Univ Clermont Auvergne, Inst Natl Phys Nucl & Particules, Ctr Nacl Rech Sci, Lab Phys Clermont, BP 10448, F-63000 Clermont Ferrand, France.
   [Tangefjord, Stefan] AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden.
C3 University of Gothenburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite Clermont Auvergne (UCA); AstraZeneca
RP Peter, B (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.
EM peter.bradley@gu.se
FU Swedish Research Council [VR521-2013-3621]; Swedish Cancer Foundation [CAN 2016/816]; European Research Council [683191]; Inga Britt and Arne Lundberg Foundation; Knut and Alice Wallenbergs Foundation [KAW 2011, KAW 2014]; Association Francaise Contre les Myopathies Telethon [21411]; European Research Council (ERC) [683191] Funding Source: European Research Council (ERC)
CR Ariza A, 2005, NUCLEIC ACIDS RES, V33, P1465, DOI 10.1093/nar/gki288
   Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353
   Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101
   Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037
   Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Falkenberg M, 1997, J BIOL CHEM, V272, P22766, DOI 10.1074/jbc.272.36.22766
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   FernÃ¡ndez-MillÃ¡n P, 2015, NUCLEIC ACIDS RES, V43, P4284, DOI 10.1093/nar/gkv189
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303
   Hirano M, 2001, CURR OPIN CARDIOL, V16, P201, DOI 10.1097/00001573-200105000-00008
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kulczyk AW, 2017, P NATL ACAD SCI USA, V114, PE1848, DOI 10.1073/pnas.1701252114
   Lee SJ, 2005, J BIOL CHEM, V280, P26984, DOI 10.1074/jbc.M504817200
   Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200
   LeGac NT, 1996, J BIOL CHEM, V271, P21645
   Leipe DD, 2000, GENOME RES, V10, P5
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   OShea VL, 2014, CURR OPIN STRUC BIOL, V25, P16, DOI 10.1016/j.sbi.2013.11.006
   PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824
   Ramanagoudr-Bhojappa R, 2013, NUCLEIC ACIDS RES, V41, P1029, DOI 10.1093/nar/gks1088
   RICHARDSON JS, 1988, PROTEINS, V4, P229, DOI 10.1002/prot.340040402
   Sagermann M, 2002, PROTEIN SCI, V11, P516, DOI 10.1110/ps.39802
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7
   Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62
   Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992
   Scheres SHW, 2009, J STRUCT BIOL, V166, P234, DOI 10.1016/j.jsb.2009.02.007
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5
   Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wallen JR, 2017, STRUCTURE, V25, P157, DOI 10.1016/j.str.2016.11.019
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang Y, 2013, J PHYS-CONDENS MAT, V25, P0, DOI 10.1088/0953-8984/25/37/374101
NR 50
TC 15
Z9 18
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD APR 1
PY 2019
VL 28
IS 7
BP 1090
EP 1099
DI 10.1093/hmg/ddy415
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA HR6FL
UT WOS:000463244700004
PM 30496414
DA 2024-11-01
ER

PT J
AU Nesti, C
   Rubegni, A
   Tolomeo, D
   Baldacci, J
   Cassandrini, D
   D'Amore, F
   Santorelli, FM
AF Nesti, Claudia
   Rubegni, Anna
   Tolomeo, Deborah
   Baldacci, Jacopo
   Cassandrini, Denise
   D'Amore, Francesca
   Santorelli, Filippo M.
TI Complex multisystem phenotype associated with the mitochondrial DNA m.5522G&gt;A mutation
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE mtDNA mutation; Heteroplasmy; tRNA(Trp); Multisystem disorder; Massive parallel sequencing
AB Mitochondrial tRNAs are responsible for more than half of pathogenic point mutations in the mitochondrial genome (mtDNA). Different mutations give rise to widely differing phenotypes, ranging from isolated organ-specific diseases to multisystem conditions. Herein, we report a 40-year-old woman presenting with a complex multisystem phenotype including sensorineural hearing loss, retinopathy, severe dilated cardiomyopathy, non-insulin dependent diabetes mellitus, and renal failure. Sequence analysis of mtDNA identified the m.5522G>A mutation in MT-TW, the gene encoding mitochondrial tRNA for tryptophan. The heteroplasmic variant, thus far described once, was almost exclusively confined to skeletal muscle tissue, as shown by massive parallel sequencing and corroborated by an ad hoc designed PCR-based strategy. This patient, presenting a severe, multisystem involvement apparently sparing the brain, contributes to the genetic heterogeneity of mitochondrial diseases caused by mutations in mitochondrial tRNAs.
C1 [Nesti, Claudia; Rubegni, Anna; Baldacci, Jacopo; Cassandrini, Denise; D'Amore, Francesca; Santorelli, Filippo M.] IRCCS Stella Maris Fdn, Mol Med Neurodegenerat & Neuromuscular Dis Unit, Via Giacinti 2, I-56128 Pisa, Italy.
   [Tolomeo, Deborah] Univ Pisa, Dept Clin & Expt Med, Via Giacinti 2, I-56128 Pisa, Italy.
C3 IRCCS Fondazione Stella Maris; University of Pisa
RP Nesti, C; Santorelli, FM (corresponding author), IRCCS Stella Maris Fdn, Mol Med Neurodegenerat & Neuromuscular Dis Unit, Via Giacinti 2, I-56128 Pisa, Italy.
EM cla_nesti@yahoo.it; filippo3364@gmail.com
FU Italian Ministry of Health
CR Baric I, 2013, EUR J HUM GENET, V21, P871, DOI 10.1038/ejhg.2012.272
   Cardaioli E, 2018, BIOCHEM BIOPH RES CO, V500, P158, DOI 10.1016/j.bbrc.2018.04.009
   Cassandrini D, 2006, J CHILD NEUROL, V21, P983, DOI 10.1177/08830738060210111001
   De Michele G, 2018, FRONT NEUROL, V9, P0, DOI 10.3389/fneur.2018.00728
   Rubegni A, 2018, PEDIATR NEUROL, V89, P63, DOI 10.1016/j.pediatrneurol.2018.08.021
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 8
TC 10
Z9 10
U1 0
U2 3
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD AUG 15
PY 2019
VL 40
IS 8
BP 1705
EP 1708
DI 10.1007/s10072-019-03864-w
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA IJ2CO
UT WOS:000475706000024
PM 30937556
DA 2024-11-01
ER

PT J
AU Hjelm, BE
   Rollins, B
   Morgan, L
   Sequeira, A
   Mamdani, F
   Pereira, F
   Damas, J
   Webb, MG
   Weber, MD
   Schatzberg, A
   Barchas, JD
   Lee, FS
   Akil, H
   Watson, SJ
   Myers, RM
   Chao, EC
   Kimonis, V
   Thompson, PM
   Bunney, WE
   Vawter, MP
AF Hjelm, Brooke E.
   Rollins, Brandi
   Morgan, Ling
   Sequeira, Adolfo
   Mamdani, Firoza
   Pereira, Filipe
   Damas, Joana
   Webb, Michelle G.
   Weber, Matthieu D.
   Schatzberg, AlanF
   Barchas, Jack D.
   Lee, Francis S.
   Akil, Huda
   Watson, Stanley J.
   Myers, Richard M.
   Chao, Elizabeth C.
   Kimonis, Virginia
   Thompson, Peter M.
   Bunney, William E.
   Vawter, Marquis P.
TI Splice-Break: exploiting an RNA-seq splice junction algorithm to discover mitochondrial DNA deletion breakpoints and analyses of psychiatric disorders
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID progressive external ophthalmoplegia; real-time pcr; mutations; gene; single; accurate; genome
AB Deletions in the 16.6kb mitochondrial genome have been implicated in numerous disorders that often display muscular and/or neurological symptoms due to the high-energy demands of these tissues. We describe a catalogue of 4489 putative mitochondrial DNA (mtDNA) deletions, including their frequency and relative read rate, using a combinatorial approach of mitochondria-targeted PCR, next-generation sequencing, bioinformatics, post-hoc filtering, annotation, and validation steps. Our bioinformatics pipeline uses MapSplice, an RNA-seq splice junction detection algorithm, to detect and quantify mtDNA deletion breakpoints rather than mRNA splices. Analyses of 93 samples from postmortem brain and blood found (i) the 4977bp common deletion' was neither the most frequent deletion nor the most abundant; (ii) brain contained significantly more deletions than blood; (iii) many high frequency deletions were previously reported in MitoBreak, suggesting they are present at low levels in metabolically active tissues and are not exclusive to individuals with diagnosed mitochondrial pathologies; (iv) many individual deletions (and cumulative metrics) had significant and positive correlations with age and (v) the highest deletion burdens were observed in major depressive disorder brain, at levels greater than Kearns-Sayre Syndrome muscle. Collectively, these data suggest the Splice-Break pipeline can detect and quantify mtDNA deletions at a high level of resolution.
C1 [Hjelm, Brooke E.; Rollins, Brandi; Morgan, Ling; Sequeira, Adolfo; Mamdani, Firoza; Weber, Matthieu D.; Bunney, William E.; Vawter, Marquis P.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA.
   [Hjelm, Brooke E.; Webb, Michelle G.] Univ Southern Calif, Keck Sch Med, Dept Translat Genom, Los Angeles, CA 90033 USA.
   [Pereira, Filipe] Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, P-4050123 Matosinhos, Portugal.
   [Damas, Joana] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.
   [Schatzberg, AlanF] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.
   [Barchas, Jack D.; Lee, Francis S.] Cornell Univ, Weill Cornell Med Coll, Dept Psychiat, New York, NY 10065 USA.
   [Akil, Huda; Watson, Stanley J.] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.
   [Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA.
   [Chao, Elizabeth C.; Kimonis, Virginia] UCI, Div Genet & Genom Med, Dept Pediat, Irvine, CA USA.
   [Thompson, Peter M.] Texas Tech Univ, Hlth Sci Ctr, Southwest Brain Bank, Dept Psychiat, El Paso, TX 79905 USA.
C3 University of California System; University of California Irvine; University of Southern California; Universidade do Porto; University of California System; University of California Davis; Stanford University; Cornell University; Weill Cornell Medicine; University of Michigan System; University of Michigan; HudsonAlpha Institute for Biotechnology; University of California System; University of California Irvine; Texas Tech University System; Texas Tech University
RP Hjelm, BE; Vawter, MP (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA.; Hjelm, BE (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Translat Genom, Los Angeles, CA 90033 USA.
EM bhjelm@usc.edu; mvawter@uci.edu
FU Della Martin Foundation; National Institute of Mental Health (NIMH), National Institutes of Health [R01MH08580, R21MH099440, R01MH097082]; Portuguese Foundation for Science and Technology [IF/01356/2012]; McKee Foundation; TTUHSC-E1 Paso; Pritzker Neuropsychiatric Disorders Research Consortium; National Institute of Mental Health
CR BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Belmonte FR, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25186
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1821-7
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   Damas J, 2014, NUCLEIC ACIDS RES, V42, PD1261, DOI 10.1093/nar/gkt982
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   DiMauro S, 1993, GENEREVIEWS, V0, P0
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dong DW, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-677
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   GoudenÃ¨ge D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Grady JP, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114462
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Guo Y, 2013, BIOINFORMATICS, V29, P1210, DOI 10.1093/bioinformatics/btt118
   Harbottle A, 2004, J INVEST DERMATOL, V122, P1518, DOI 10.1111/j.0022-202X.2004.22608.x
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kasahara T, 2016, MOL PSYCHIATR, V21, P39, DOI 10.1038/mp.2015.156
   Koene S, 2009, J AFFECT DISORDERS, V114, P327, DOI 10.1016/j.jad.2008.06.023
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Leshinsky-Silver E, 2011, EUR J HUM GENET, V19, P287, DOI 10.1038/ejhg.2010.213
   LESTIENNE P, 1988, LANCET, V1, P885
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li JZ, 2013, P NATL ACAD SCI USA, V110, P9950, DOI 10.1073/pnas.1305814110
   Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229
   Milone M, 2013, MITOCHONDRIAL DISORD, V0, P123
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   Morava Ã, 2013, NEUROSCI BIOBEHAV R, V37, P668, DOI 10.1016/j.neubiorev.2013.02.005
   Newsholme P, 2012, ADV EXP MED BIOL, V942, P235, DOI 10.1007/978-94-007-2869-1_10
   Parada GE, 2014, NUCLEIC ACIDS RES, V42, P10564, DOI 10.1093/nar/gku744
   Paramasivam A, 2016, MITOCHONDRION, V26, P81, DOI 10.1016/j.mito.2015.12.006
   Peters SK, 2016, FRONT SYST NEUROSCI, V10, P0, DOI 10.3389/fnsys.2016.00104
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5
   ROTIG A, 1991, GENOMICS, V10, P502, DOI 10.1016/0888-7543(91)90342-C
   Seneca S, 2015, EUR J HUM GENET, V23, P41, DOI 10.1038/ejhg.2014.49
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Soleimanpour SA, 2014, CELL, V157, P1577, DOI 10.1016/j.cell.2014.05.016
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Wang K, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkq622
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Zambelli F, 2017, EUR J HUM GENET, V25, P1229, DOI 10.1038/ejhg.2017.129
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 56
TC 16
Z9 17
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUN 4
PY 2019
VL 47
IS 10
BP 
EP 
DI 10.1093/nar/gkz164
PG 19
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA IC8RE
UT WOS:000471248400005
PM 30869147
DA 2024-11-01
ER

PT J
AU Set, KK
   Sen, K
   Huq, AHM
   Agarwal, R
AF Set, Kallol K.
   Sen, Kuntal
   Huq, A. H. M.
   Agarwal, Rajkumar
TI Mitochondrial Disorders of the Nervous System: A Review
SO CLINICAL PEDIATRICS
LA English
DT Review
ID myoclonic epilepsy; cofactor treatment; lactic-acidosis; dna; diagnosis; disease; melas; mutation; myopathy; deficiency
C1 [Set, Kallol K.; Agarwal, Rajkumar] Dayton Childrens Hosp, Dayton, OH USA.
   [Set, Kallol K.; Agarwal, Rajkumar] Wright State Univ, Boonshoft Sch Med, Dayton, OH 45435 USA.
   [Sen, Kuntal; Huq, A. H. M.] Childrens Hosp Michigan, Detroit, MI 48201 USA.
   [Sen, Kuntal; Huq, A. H. M.] Wayne State Univ, Sch Med, Detroit, MI USA.
C3 University System of Ohio; Wright State University Dayton; Children's Hospital of Michigan; Wayne State University
RP Set, KK (corresponding author), Wright State Univ, Boonshoft Sch Med, Dayton Childrens Hosp, Div Neurol, 1 Childrens Plaza, Dayton, OH 45404 USA.
EM setk@childrensdayton.org
CR Ackrell BAC, 2002, MOL ASPECTS MED, V23, P369, DOI 10.1016/S0098-2997(02)00012-2
   Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Aniello MS, 2008, MOVEMENT DISORD, V23, P114, DOI 10.1002/mds.21760
   Babu S, 2015, J NEUROL SCI, V351, P13, DOI 10.1016/j.jns.2015.02.042
   BARDOSI A, 1987, ACTA NEUROPATHOL, V74, P248, DOI 10.1007/BF00688189
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Borisov VB, 2002, MOL ASPECTS MED, V23, P385, DOI 10.1016/S0098-2997(02)00013-4
   Bouillot S, 2002, J PERIPHER NERV SYST, V7, P213, DOI 10.1046/j.1529-8027.2002.02027.x
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Cannino G, 2007, MITOCHONDRION, V7, P359, DOI 10.1016/j.mito.2007.07.001
   CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
   Chinnery P, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub2
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Danhauser K, 2015, J INHERIT METAB DIS, V38, P467, DOI 10.1007/s10545-014-9796-2
   De Meirleir L, 2002, J CHILD NEUROL, V17, P0
   Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Dougherty MP, 2018, CURR OPIN OBSTET GYN, V30, P217, DOI 10.1097/GCO.0000000000000467
   Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009
   Feuer WJ, 2016, OPHTHALMOLOGY, V123, P558, DOI 10.1016/j.ophtha.2015.10.025
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Fogel BL, 2006, NAT CLIN PRACT NEURO, V2, P629, DOI 10.1038/ncpneuro0319
   Fogel BL, 2012, J CHILD NEUROL, V27, P1138, DOI 10.1177/0883073812448231
   FUKUHARA N, 1995, MUSCLE NERVE, V0, PS90
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gobu P, 2010, INDIAN PACING ELECTR, V10, P547
   Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2
   GrÃ¶nlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187
   Gropman AL, 2013, NEUROTHERAPEUTICS, V10, P273, DOI 10.1007/s13311-012-0161-6
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   Hynynen J, 2014, LIVER TRANSPLANT, V20, P1402, DOI 10.1002/lt.23965
   Ito S, 2008, AM J NEURORADIOL, V29, P392, DOI 10.3174/ajnr.A0865
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Caballero PEJ, 2007, NEUROLOGIST, V13, P33, DOI 10.1097/01.nrl.0000252953.49721.f5
   KEARNS THOMAS P, 1965, TRANS AMER OPHTHALMOL SOC, V63, P559
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351
   Leber T, 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Lee WS, 2007, SEMIN LIVER DIS, V27, P259, DOI 10.1055/s-2007-985071
   LEHNINGER A, 1961, SCI AM, V205, P62, DOI 10.1038/scientificamerican0961-62
   LINDAL S, 1992, ULTRASTRUCT PATHOL, V16, P263, DOI 10.3109/01913129209061355
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Mahoney DJ, 2002, CURR OPIN CLIN NUTR, V5, P619, DOI 10.1097/00075197-200211000-00004
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   MEDINA L, 1990, AM J ROENTGENOL, V154, P1269, DOI 10.2214/ajr.154.6.2159689
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   MITCHELL P, 1967, NATURE, V213, P137, DOI 10.1038/213137a0
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Noble P, 1998, PSYCHIAT B, V22, P648
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Robinson BH, 1996, J INHERIT METAB DIS, V19, P452, DOI 10.1007/BF01799106
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   SANTORELLI FM, 1994, NEUROLOGY, V44, P972, DOI 10.1212/WNL.44.5.972
   Set KK, 2018, NEUROLOGY, V90, PE625, DOI 10.1212/WNL.0000000000004973
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Tarnopolsky MA, 2001, ANN NEUROL, V49, P561, DOI 10.1002/ana.1028.abs
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Vento JM, 2013, NEUROTHERAPEUTICS, V10, P243, DOI 10.1007/s13311-012-0173-2
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
NR 96
TC 9
Z9 9
U1 0
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0009-9228
EI 1938-2707
J9 CLIN PEDIATR
JI Clin. Pediatr.
PD APR 15
PY 2019
VL 58
IS 4
BP 381
EP 394
DI 10.1177/0009922818821890
PG 14
WC Pediatrics
SC Pediatrics
GA HN2WD
UT WOS:000460044700001
PM 30607979
DA 2024-11-01
ER

PT J
AU Kojer, K
   Hering, T
   Bazenet, C
   Weiss, A
   Herrmann, F
   Taanman, JW
   Orth, M
AF Kojer, Kerstin
   Hering, Tanja
   Bazenet, Chantal
   Weiss, Andreas
   Herrmann, Frank
   Taanman, Jan-Willem
   Orth, Michael
TI Huntingtin Aggregates and Mitochondrial Pathology in Skeletal Muscle but not Heart of Late-Stage R6/2 Mice
SO JOURNAL OF HUNTINGTONS DISEASE
LA English
DT Article
DE Huntingtin; mitochondria; fission and fusion; respiratory chain; skeletal muscle
ID mutant huntingtin; polyglutamine inclusions; mouse models; disease; protein; fission; nuclear; gene; dna; quantification
AB Background: Cell or tissue specific background may influence the consequences of expressing the Huntington's disease (HD) mutation. Aggregate formation is known to occur in skeletal muscle, but not heart, of the R6/2 fragment HD model. Objective: We asked whether aggregate formation and the expression and subcellular localization of huntingtin species was associated with mitochondrial dysfunction. Methods: We analyzed levels of soluble HTT and HTT aggregates, as well as important fission and fusion proteins and mitochondrial respiratory chain activities, in quadriceps and heart of the R6/2 N-terminal fragment mouse model (12 weeks, 160 +/- 10 CAG repeats). Results: Soluble mutant HTT was present in both tissues with expression higher in cytoplasmic/mitochondrial than nuclear fractions. HTT aggregates were only detectable in R6/2 quadriceps, in association with increased levels of the pro-fission factor DRP1 and its phosphorylated active form, and decreased levels of the pro-fusion factor MFN2. In addition, respiratory chain complex activities were decreased. In heart that was without detectable HTT aggregates, we found no evidence for mitochondrial dysfunction. Conclusion: Tissue specific factors may exist that protect the R6/2 heart from HTT aggregate formation and mitochondrial pathology.
C1 [Kojer, Kerstin; Hering, Tanja; Orth, Michael] Ulm Univ, Dept Neurol, Ulm, Germany.
   [Bazenet, Chantal; Weiss, Andreas; Herrmann, Frank] Evotec AG, Hamburg, Germany.
   [Taanman, Jan-Willem] UCL Inst Neurol, Dept Clin Neurosci, London, England.
C3 Ulm University; Evotec; University of London; University College London
RP Orth, M (corresponding author), Ulm Univ Hosp, Dept Neurol, Oberer Eselsberg 45-1, D-89081 Ulm, Germany.
EM michael.orth@uni-ulm.de
FU CHDI Foundation [A-7328]
CR Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020
   Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1
   Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340
   Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   COORE HG, 1971, BIOCHEM J, V125, P115, DOI 10.1042/bj1250115
   Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503
   Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102
   DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990
   Dimauro Ivan, 2012, BMC RES NOTES, V5, P513, DOI 10.1186/1756-0500-5-513
   DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Gasset-Rosa F, 2017, NEURON, V94, P48, DOI 10.1016/j.neuron.2017.03.027
   Giorgetti E, 2016, CELL REP, V17, P125, DOI 10.1016/j.celrep.2016.08.084
   Greenbaum D, 2003, GENOME BIOL, V4, P0, DOI 10.1186/gb-2003-4-9-117
   Grima JC, 2017, NEURON, V94, P93, DOI 10.1016/j.neuron.2017.03.023
   Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911
   Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083
   Hellemans J, 2007, GENOME BIOL, V8, P0, DOI 10.1186/gb-2007-8-2-r19
   Hering T, 2017, EXP NEUROL, V288, P167, DOI 10.1016/j.expneurol.2016.10.017
   Hering T, 2015, EXP NEUROL, V266, P22, DOI 10.1016/j.expneurol.2015.02.004
   HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069
   Jovaisaite V, 2014, J EXP BIOL, V217, P137, DOI 10.1242/jeb.090738
   Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306
   KING TE, 1967, J BIOL CHEM, V242, P819
   Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8
   Kohler C, 2009, MOL CANCER, V8, P0, DOI 10.1186/1476-4598-8-105
   Kurosawa M, 2015, HUM MOL GENET, V24, P1092, DOI 10.1093/hmg/ddu522
   Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028
   Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003
   Lee JM, 2012, AM J HUM GENET, V90, P434, DOI 10.1016/j.ajhg.2012.01.005
   Li W, 2006, J BIOL CHEM, V281, P15916, DOI 10.1074/jbc.M511007200
   Liu R, 2015, MOL BIOL CELL, V26, P4466, DOI 10.1091/mbc.E15-08-0591
   Magnusson-Lind A, 2014, J HUNTINGTONS DIS, V3, P13, DOI 10.3233/JHD-130075
   Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0
   Mielcarek M, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005021
   Mielcarek M, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004550
   Moffitt H, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0008025
   MOREADITH RW, 1987, J CLIN INVEST, V79, P463, DOI 10.1172/JCI112834
   Neueder A, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-01510-z
   Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400
   Orth M, 2003, J NEUROCHEM, V87, P1, DOI 10.1046/j.1471-4159.2003.02009.x
   Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002
   Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54
   Perdiz D, 2017, CELL SIGNAL, V39, P32, DOI 10.1016/j.cellsig.2017.07.020
   Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24
   Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813
   Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425
   Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110
   Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604
   Shahni R, 2015, BRAIN, V138, P2834, DOI 10.1093/brain/awv182
   Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024
   Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475
   Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313
   TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0
   van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001
   Weiss A, 2009, MOL NEURODEGENER, V4, P0, DOI 10.1186/1750-1326-4-11
   Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101
   Wharton DC, 1967, METHODS ENZYMOL, V10, P245, DOI 10.1016/0076-6879(67)10048-7
   Wild EJ, 2015, J CLIN INVEST, V125, P1979, DOI 10.1172/JCI80743
   Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033
   Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156
NR 71
TC 18
Z9 18
U1 0
U2 0
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1879-6397
EI 1879-6400
J9 J HUNTINGTONS DIS
JI J. Huntingtons Dis.
PD JUN 15
PY 2019
VL 8
IS 2
BP 145
EP 159
DI 10.3233/JHD-180324
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA HW3QE
UT WOS:000466607000002
PM 30814364
DA 2024-11-01
ER

PT J
AU Hougaard, DD
   Hestoy, DH
   Hojland, AT
   Gaihede, M
   Petersen, MB
AF Hougaard, Dan Dupont
   Hestoy, Danjal Hofgaard
   Hojland, Allan Thomas
   Gaihede, Michael
   Petersen, Michael Bjorn
TI Audiological and Vestibular Findings in Subjects with MELAS Syndrome
SO JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY
LA English
DT Article; Proceedings Paper
DE MELAS syndrome; mitochondrial diseases; sensorineural hearing loss; vestibular disease; inner ear disease
ID inherited diabetes-mellitus; transfer rnaleu(uur) gene; stroke-like episodes; lactic-acidosis; point mutation; mitochondrial myopathy; clinical-applications; a3243g; deafness; encephalomyopathy
AB OBJECTIVES: The mitochondrial DNA (mtDNA) point mutation m.3243A>G is known to express the following two syndromes among others: maternally inherited diabetes and deafness (MIDD) and mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Sensorineural hearing loss (SNHL) is the most frequent symptom in individuals harboring the m.3243A>G mutation. However, dysfunction of the vestibular organs has been scarcely examined. Therefore, the present study aimed to study the impact of the m.3243A>G mutation on the inner ear. MATERIALS and METHODS: A total of 8 subjects harboring the blood-verified m.3243A>G mutation underwent thorough audiological and vestibular examinations, including tone and speech audiometry, video head impulse test (vHIT), ocular and cervical vestibular-evoked myogenic potential (oVEMP and cVEMP), and full otoneurological examination. The subjects also answered a Dizziness Handicap Inventory (DHI) questionnaire. RESULTS: SNHL was identified in all the 8 subjects, with a mean pure-tone average-4 (PTA-4) of 59 dB. Speech discrimination score (n=7) ranged from 24% to 100% (mean 74%), and vHIT (n=42) detected pathology in nine lateral semicircular canals (SCCs), five posterior SCCs, and one anterior SCC, whereas three measurements were inconclusive. All oVEMPs (n=14 ears) were absent, nine cVEMPs were absent, and two were inconclusive. Based on the DHI scores, 6 subjects reported none to mild dizziness, 1 reported moderate, and 1 reported severe dizziness. CONCLUSION: Our study population had pathological findings from every audiological and vestibular end organs. The results indicated that the pathological findings originated from within the end organs themselves and not within the superior and inferior vestibular or cochlear nerve.
C1 [Hougaard, Dan Dupont; Gaihede, Michael] Aalborg Univ Hosp, Head & Neck Surg & Audiol, Dept Otolaryngol, Aalborg, Denmark.
   [Hougaard, Dan Dupont; Hojland, Allan Thomas; Gaihede, Michael; Petersen, Michael Bjorn] Aalborg Univ, Dept Clin Med, Sch Med, Aalborg, Denmark.
   [Hestoy, Danjal Hofgaard] Aalborg Univ, Sch Hlth Sci, Aalborg, Denmark.
   [Hojland, Allan Thomas; Petersen, Michael Bjorn] Aalborg Univ Hosp, Dept Clin Genet, Aalborg, Denmark.
   [Hougaard, Dan Dupont; Hestoy, Danjal Hofgaard; Hojland, Allan Thomas; Gaihede, Michael; Petersen, Michael Bjorn] Aalborg Univ Hosp, Res & Knowledge Ctr Sensory Genet, Aalborg, Denmark.
C3 Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital
RP Gaihede, M (corresponding author), Aalborg Univ Hosp, Head & Neck Surg & Audiol, Dept Otolaryngol, Aalborg, Denmark.; Gaihede, M (corresponding author), Aalborg Univ, Dept Clin Med, Sch Med, Aalborg, Denmark.; Gaihede, M (corresponding author), Aalborg Univ Hosp, Res & Knowledge Ctr Sensory Genet, Aalborg, Denmark.
EM michael.petersen@rn.dk
FU Obelske Familiefond; Aalborg University
CR BlÃ¶dow A, 2013, AURIS NASUS LARYNX, V40, P348, DOI 10.1016/j.anl.2012.11.002
   Cardenas-Robledo S, 2016, J NEURO-OPHTHALMOL, V36, P134, DOI 10.1097/WNO.0000000000000340
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hendrickx JJ, 2006, OTOL NEUROTOL, V27, P802, DOI 10.1097/01.mao.0000224091.02506.a0
   Iwasaki S, 2011, LARYNGOSCOPE, V121, P1821, DOI 10.1002/lary.21879
   JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424
   Kantner C, 2012, HEARING RES, V294, P55, DOI 10.1016/j.heares.2012.10.008
   Kim SH, 2016, NEUROL SCI, V37, P1159, DOI 10.1007/s10072-016-2577-y
   Kirkwood BR, 2010, ESSENTIAL MEDICAL STATISTICS, V0, P0
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mossman B, 2015, J OTOLARYNGOL-HEAD N, V44, P0, DOI 10.1186/s40463-015-0081-7
   Murofushi T, 2002, CLIN NEUROPHYSIOL, V113, P305, DOI 10.1016/S1388-2457(01)00738-6
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Nguyen KD, 2010, OTOL NEUROTOL, V31, P793, DOI 10.1097/MAO.0b013e3181e3d60e
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Shin BS, 2012, CLIN NEUROPHYSIOL, V123, P369, DOI 10.1016/j.clinph.2011.05.029
   Vandana VP, 2016, CLIN NEUROL NEUROSUR, V148, P17, DOI 10.1016/j.clineuro.2016.04.024
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Vivero RJ, 2013, GENET TEST MOL BIOMA, V17, P383, DOI 10.1089/gtmb.2012.0403
   Watson SRD, 1998, ELECTROMYOGR MOTOR C, V109, P471, DOI 10.1016/S0924-980X(98)00033-2
   Welgampola MS, 2005, NEUROLOGY, V64, P1682, DOI 10.1212/01.WNL.0000161876.20552.AA
   Yamasoba T, 1996, LARYNGOSCOPE, V106, P49, DOI 10.1097/00005537-199601000-00010
NR 27
TC 9
Z9 10
U1 0
U2 5
PU AVES
PI SISLI
PA BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY
SN 1308-7649
EI 2148-3817
J9 J INT ADV OTOL
JI J. Int. Adv. Otol.
PD AUG 15
PY 2019
VL 15
IS 2
BP 296
EP 303
DI 10.5152/iao.2019.5913
PG 8
WC Otorhinolaryngology
SC Otorhinolaryngology
GA IT6ZW
UT WOS:000483026300020
PM 31347509
DA 2024-11-01
ER

PT J
AU Lahiri, D
   Sawale, VM
   Banerjee, S
   Dubey, S
   Roy, BK
   Das, SK
AF Lahiri, Durjoy
   Sawale, Vishal Madhukar
   Banerjee, Subhadeep
   Dubey, Souvik
   Roy, Biman Kanti
   Das, Shyamal Kumar
TI Chorea-ballism as a dominant clinical manifestation in heteroplasmic mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome with A3251G mutation in mitochondrial genome: a case report
SO JOURNAL OF MEDICAL CASE REPORTS
LA English
DT Article
DE Mitochondrial encephalopathy; lactic acidosis; and stroke-like episodes (MELAS); Chorea; Ballism; A3251G mutation
ID melas; dna
AB Background Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes, the most common maternally inherited mitochondrial disease, can present with a wide range of neurological manifestations including both central and peripheral nervous system involvement. The most frequent genetic mutation reported in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome is A3243G in MT-TL1 gene. Stroke-like episodes, dementia, epilepsy, lactic acidemia, myopathy, recurrent headaches, hearing impairment, diabetes, and short stature constitute the known presentations in this syndrome. Among the abnormal involuntary movements in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome, myoclonus is the commonest. Other movement disorders, including chorea, are rarely reported in this disorder. Case presentation A 14-year-old South Asian boy from rural Bengal (India), born of a second degree consanguineous marriage, with normal birth and development history, presented with abnormal brief jerky movements involving his trunk and limbs, with recurrent falls for 10 months. We present here a case of heteroplasmic mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome with A3251G mutation, in which the clinical picture was dominated by a host of involuntary abnormal movements including chorea-ballism, myoclonus, and oromandibular dystonia in a backdrop of cognitive decline, seizure, and stroke-like episode. A final diagnosis was established by muscle biopsy and genetic study. Haloperidol was administered to control the involuntary movements along with introduction of co-enzyme Q, besides symptomatic management for his focal seizures. Six months into follow-up his seizures and abnormal movements were controlled significantly with slight improvement of cognitive abilities. Conclusion The dominance of hyperkinetic movements in the clinical scenario and the finding of a point mutation A3251G in MT-TL1 gene make this a rare presentation.
C1 [Lahiri, Durjoy; Sawale, Vishal Madhukar; Banerjee, Subhadeep; Dubey, Souvik; Roy, Biman Kanti; Das, Shyamal Kumar] IPGMER & SSKM Hosp, Bangur Inst Neurosci, Dept Neurol, Kolkata 700025, India.
C3 Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata
RP Lahiri, D (corresponding author), IPGMER & SSKM Hosp, Bangur Inst Neurosci, Dept Neurol, Kolkata 700025, India.
EM dlahiri1998@gmail.com
CR De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HAMMANS SR, 1995, BRAIN, V118, P721, DOI 10.1093/brain/118.3.721
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Kang JH, 2005, J NEUROL, V252, P103, DOI 10.1007/s00415-005-0600-y
   Nakagaki Hideaki, 2005, RINSHO SHINKEIGAKU, V45, P502
   Singmaneesakulchai S, 2012, MOVEMENT DISORD, V27, P1495, DOI 10.1002/mds.24912
   Sudarsky L, 1999, MOVEMENT DISORD, V14, P488, DOI 10.1002/1531-8257(199905)14:3<488::AID-MDS1017>3.0.CO;2-4
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 10
TC 8
Z9 8
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1752-1947
J9 J MED CASE REP
JI J. Med. Case Rep.
PD MAR 6
PY 2019
VL 13
IS 1
BP 
EP 
DI 10.1186/s13256-018-1936-0
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA WD3GO
UT WOS:000704833800002
PM 30837005
DA 2024-11-01
ER

PT J
AU De la Casa-Fages, B
   FernÃ¡ndez-Eulate, G
   Gamez, J
   Barahona-Hernando, R
   MorÃ­s, G
   GarcÃ­a-Barcina, M
   Infante, J
   Zulaica, M
   FernÃ¡ndez-Pelayo, U
   MuÃ±oz-Oreja, M
   Urtasun, M
   Olaskoaga, A
   Zelaya, V
   JericÃ³, I
   Saez-Villaverde, R
   Catalina, I
   Sola, E
   MartÃ­nez-SÃ¡ez, E
   Pujol, A
   Ruiz, M
   SchlÃ¼ter, A
   Spinazzola, A
   MuÃ±oz-Blanco, JL
   Grandas, F
   Holt, I
   Alvarez, V
   de MunaÃ­n, AL
AF De la Casa-Fages, Beatriz
   Fernandez-Eulate, Gorka
   Gamez, Josep
   Barahona-Hernando, Raul
   Moris, German
   Garcia-Barcina, Maria
   Infante, Jon
   Zulaica, Miren
   Fernandez-Pelayo, Uxoa
   Munoz-Oreja, Mikel
   Urtasun, Miguel
   Olaskoaga, Ander
   Zelaya, Victoria
   Jerico, Ivonne
   Saez-Villaverde, Raquel
   Catalina, Irene
   Sola, Emma
   Martinez-Saez, Elena
   Pujol, Aurora
   Ruiz, Montserrat
   Schluter, Agatha
   Spinazzola, Antonella
   Luis Munoz-Blanco, Jose
   Grandas, Francisco
   Holt, Ian
   Alvarez, Victoria
   Lopez de Munain, Adolfo
TI Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism
SO MOVEMENT DISORDERS
LA English
DT Article
DE hereditary spastic paraplegia; mitochondria; parkinsonism; pathogenic genetic variants; SPG7 gene
ID spg7 mutations; substantia-nigra; dna deletions; gene; disease; homeostasis; impairment; protein
AB Background Pathogenic variants in the spastic paraplegia type 7 gene cause a complicated hereditary spastic paraplegia phenotype associated with classical features of mitochondrial diseases, including ataxia, progressive external ophthalmoplegia, and deletions of mitochondrial DNA. Objectives To better characterize spastic paraplegia type 7 disease with a clinical, genetic, and functional analysis of a Spanish cohort of spastic paraplegia type 7 patients. Methods Genetic analysis was performed in patients suspecting hereditary spastic paraplegia and in 1 patient with parkinsonism and Pisa syndrome, through next-generation sequencing, whole-exome sequencing, targeted Sanger sequencing, and multiplex ligation-dependent probe analysis, and blood mitochondrial DNA levels determined by quantitative polymerase chain reaction. Results Thirty-five patients were found to carry homozygous or compound heterozygous pathogenic variants in the spastic paraplegia type 7 gene. Mean age at onset was 40 years (range, 12-63); 63% of spastic paraplegia type 7 patients were male, and three-quarters of all patients had at least one allele with the c.1529C>T (p.Ala510Val) mutation. Eighty percent of the cohort showed a complicated phenotype, combining ataxia and progressive external ophthalmoplegia (65% and 26%, respectively). Parkinsonism was observed in 21% of cases. Analysis of blood mitochondrial DNA indicated that both patients and carriers of spastic paraplegia type 7 pathogenic variants had markedly lower levels of mitochondrial DNA than control subjects (228 per haploid nuclear DNA vs. 176 vs. 573, respectively; P < 0.001). Conclusions Parkinsonism is a frequent finding in spastic paraplegia type 7 patients. Spastic paraplegia type 7 pathogenic variants impair mitochondrial DNA homeostasis irrespective of the number of mutant alleles, type of variant, and patient or carrier status. Thus, spastic paraplegia type 7 supports mitochondrial DNA maintenance, and variants in the gene may cause parkinsonism owing to mitochondrial DNA abnormalities. Moreover, mitochondrial DNA blood analysis could be a useful biomarker to detect at risk families. (c) 2019 International Parkinson and Movement Disorder Society
C1 [De la Casa-Fages, Beatriz; Barahona-Hernando, Raul; Catalina, Irene; Luis Munoz-Blanco, Jose; Grandas, Francisco] Hosp Gen Univ Gregorio Maranon, Dept Neurol, Madrid, Spain.
   [De la Casa-Fages, Beatriz; Grandas, Francisco] Hosp Gen Univ Gregorio Maranon, Natl Referral Ctr Rare Dis Movement Disorders CSU, Movement Disorders Unit, Madrid, Spain.
   [De la Casa-Fages, Beatriz; Luis Munoz-Blanco, Jose; Grandas, Francisco] Inst Invest Sanitaria Gregorio Maranon, Neurosci Area, Madrid, Spain.
   [Fernandez-Eulate, Gorka; Urtasun, Miguel; Lopez de Munain, Adolfo] Hosp Univ Donostia, Dept Neurol, San Sebastian, Spain.
   [Fernandez-Eulate, Gorka; Fernandez-Pelayo, Uxoa; Munoz-Oreja, Mikel; Holt, Ian; Lopez de Munain, Adolfo] Inst Biodonostia, Dept Neurosci, San Sebastian, Spain.
   [Gamez, Josep] Hosp Gen Univ Vall dHebron UAB VHIR, Dept Neurol, Barcelona, Spain.
   [Gamez, Josep] Hosp Gen Univ Vall dHebron UAB, ERN RND, Barcelona, Spain.
   [Barahona-Hernando, Raul; Catalina, Irene; Luis Munoz-Blanco, Jose] Hosp Gen Univ Gregorio Maranon, ALS Neuromuscular Unit, Madrid, Spain.
   [Barahona-Hernando, Raul] Hosp Ruber Juan Bravo, Grp Quironsalud, Dept Neurol, Madrid, Spain.
   [Moris, German; Alvarez, Victoria] Inst Invest Biosanitaria Principado Asturias ISPA, Oviedo, Spain.
   [Moris, German] Hosp Univ Cent Asturias, Dept Neurol, Oviedo, Spain.
   [Garcia-Barcina, Maria] Hosp Univ Basurto, Genet Unit, Bilbao, Spain.
   [Infante, Jon] Univ Cantabria, Hosp Univ Marques Valdecilla IDIVAL, Dept Neurol, Santander, Spain.
   [Infante, Jon; Zulaica, Miren] Inst Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.
   [Olaskoaga, Ander] Hosp Zumarraga, Zumarraga, Spain.
   [Zelaya, Victoria] Complejo Hosp Navarra, Dept Pathol, Pamplona, Spain.
   [Jerico, Ivonne] Complejo Hosp Navarra, Dept Neurol, Pamplona, Spain.
   [Saez-Villaverde, Raquel] Hosp Univ Donostia, Dept Genet, San Sebastian, Spain.
   [Sola, Emma] Hosp Gen Univ Gregorio Maranon, Dept Pathol, Madrid, Spain.
   [Martinez-Saez, Elena] Hosp Gen Univ Vall dHebron UAB VHIR, Dept Pathol, Barcelona, Spain.
   [Martinez-Saez, Elena] UAB, Dept Med, Barcelona, Spain.
   [Pujol, Aurora; Ruiz, Montserrat; Schluter, Agatha] Bellvitge Biomed Res Inst IDIBELL, Neurometabol Dis Lab, Barcelona, Spain.
   [Pujol, Aurora] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain.
   [Pujol, Aurora; Ruiz, Montserrat; Schluter, Agatha] Inst Carlos III, Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain.
   [Spinazzola, Antonella] UCL Queen Sq Inst Neurol, Dept Clin Movement Neurosci, Royal Free Campus, London, England.
   [Spinazzola, Antonella] UCL Queen Sq Inst Neurol, MRC Ctr Neuromuscular Dis, London, England.
   [Spinazzola, Antonella] Natl Hosp Neurol & Neurosurg, London, England.
   [Holt, Ian] Basque Fdn Sci, Ikerbasque, Bilbao, Spain.
   [Alvarez, Victoria] Hosp Univ Cent Asturias, AGC Med Lab, Genet Lab, Oviedo, Spain.
   [Lopez de Munain, Adolfo] Univ Basque Country, Dept Neurosci, San Sebastian, Spain.
   [Lopez de Munain, Adolfo] Minist Sci Innovat & Univ, Ciberned, Madrid, Spain.
C3 General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; Instituto de Investigacion Sanitaria Biogipuzkoa; General University Gregorio Maranon Hospital; quironsalud Group; Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA); Central University Hospital Asturias; Basurto Hospital; Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); CIBERNED; Servicio Navarro de Salud - Osasunbidea; Servicio Navarro de Salud - Osasunbidea; General University Gregorio Maranon Hospital; Autonomous University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); ICREA; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Basque Foundation for Science; Central University Hospital Asturias; University of Basque Country; CIBERNED
RP Alvarez, V (corresponding author), Hosp Univ Cent Asturias, Genet Lab, Avda Roma S-N, Oviedo 30011, Spain.
EM victoria.alvarez@sespa.es
FU MRC [MC_PC_13029/2] Funding Source: UKRI
CR Arnoldi A, 2008, HUM MUTAT, V29, P522, DOI 10.1002/humu.20682
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bernardi P, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00320
   Caporali L, 2018, BRAIN, V141, P0, DOI 10.1093/brain/awx301
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Choquet K, 2016, EUR J HUM GENET, V24, P1016, DOI 10.1038/ejhg.2015.240
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   Denora PS, 2013, HAND CLINIC, V113, P1899, DOI 10.1016/B978-0-444-59565-2.00060-5
   DÃ¶lle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15
   FernÃ¡ndez A, 2015, J MOL NEUROSCI, V56, P613, DOI 10.1007/s12031-015-0560-3
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   GÃ³mez J, 2014, CIRC J, V78, P2963, DOI 10.1253/circj.CJ-14-0628
   GrÃ¼newald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   HARDING AE, 1983, LANCET, V1, P1151
   Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240
   Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lewis SC, 2016, SCIENCE, V353, P0, DOI 10.1126/science.aaf5549
   Magri S, 2018, HUM MUTAT, V39, P2060, DOI 10.1002/humu.23658
   Mancini C, 2019, EUR J NEUROL, V26, P80, DOI 10.1111/ene.13768
   Mancuso Michelangelo, 2008, HUMAN GENOMICS, V3, P71
   McDermott CJ, 2001, NEUROLOGY, V56, P467, DOI 10.1212/WNL.56.4.467
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Moss CF, 2017, NUCLEIC ACIDS RES, V45, P0, DOI 10.1093/nar/gkx1009
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Patron M, 2018, CELL RES, V28, P296, DOI 10.1038/cr.2018.17
   Pedroso JL, 2018, PARKINSONISM RELAT D, V47, P88, DOI 10.1016/j.parkreldis.2017.12.004
   Pfeffer G, 2015, NEUROLOGY, V84, P1174, DOI 10.1212/WNL.0000000000001369
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Roxburgh RH, 2013, J NEUROL, V260, P1286, DOI 10.1007/s00415-012-6792-z
   Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8
   Settasatian C, 1999, HUM GENET, V105, P139, DOI 10.1007/s004390051076
   Shanmughapriya S, 2015, MOL CELL, V60, P47, DOI 10.1016/j.molcel.2015.08.009
   SPATAX Network, 2009, DIAGN SPIN DEG AT SP, V0, P1
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Trinh J, 2019, MOVEMENT DISORD, V34, P133, DOI 10.1002/mds.27559
   van Gassen KLI, 2012, BRAIN, V135, P2994, DOI 10.1093/brain/aws224
   Venegas V, 2012, METHODS MOL BIOL, V837, P327, DOI 10.1007/978-1-61779-504-6_22
   Wedding IM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0086340
   Wilkinson PA, 2004, BRAIN, V127, P973, DOI 10.1093/brain/awh125
NR 45
TC 37
Z9 40
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD OCT 15
PY 2019
VL 34
IS 10
BP 1547
EP 1561
DI 10.1002/mds.27812
EA AUG 2019
PG 15
WC Clinical Neurology
SC Neurosciences & Neurology
GA JF1DQ
UT WOS:000482168600001
PM 31433872
DA 2024-11-01
ER

PT J
AU Hellebrekers, DMEI
   Blakely, EL
   Hendrickx, ATM
   Hardy, SA
   Hopton, S
   Falkous, G
   de Coo, IFM
   Smeets, HJM
   van der Beek, NME
   Taylor, RW
AF Hellebrekers, Debby M. E. I.
   Blakely, Emma L.
   Hendrickx, Alexandra T. M.
   Hardy, Steven A.
   Hopton, Sila
   Falkous, Gavin
   de Coo, Irenaeus F. M.
   Smeets, Hubert J. M.
   van der Beek, Nadine M. E.
   Taylor, Robert W.
TI A novel mitochondrial m.4414T&gt;C <i>MT-TM</i> gene variant causing progressive external ophthalmoplegia and myopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial disease; Chronic progressive external ophthalmoplegia; Myopathy; mtDNA variant; m.4414T > C; MTTM
ID mutation; assay
AB We report a novel mitochondrial m.4414T>C variant in the mt-tRNA(Met) (MT-TM) gene in an adult patient with chronic progressive external ophthalmoplegia and myopathy whose muscle biopsy revealed focal cytochrome c oxidase (COX)-deficient and ragged red fibres. The m.4414T>C variant occurs at a strongly evolutionary conserved sequence position, disturbing a canonical base pair and disrupting the secondary and tertiary structure of the mt-tRNA(Met). Definitive evidence of pathogenicity is provided by clear segregation of m.4414T>C mutant levels with COX deficiency in single muscle fibres. Interestingly, the variant is present in skeletal muscle at relatively low levels (30%) and undetectable in accessible, non-muscle tissues from the patient and her asymptomatic brother, emphasizing the continuing requirement for a diagnostic muscle biopsy as the preferred tissue for mtDNA genetic investigations of mt-tRNA variants leading to mitochondrial myopathy. (C) 2019 The Author(s). Published by Elsevier B.V.
C1 [Hellebrekers, Debby M. E. I.; Hendrickx, Alexandra T. M.] MUMC, Dept Clin Genet, P Debyelaan 25,POB 5800, NL-6202 AZ Maastricht, Netherlands.
   [Blakely, Emma L.; Hardy, Steven A.; Hopton, Sila; Falkous, Gavin; Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
   [Blakely, Emma L.; Hardy, Steven A.; Hopton, Sila; Falkous, Gavin; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [de Coo, Irenaeus F. M.; van der Beek, Nadine M. E.] Erasmus MC, Dept Neurol, Doctor Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.
   [de Coo, Irenaeus F. M.; van der Beek, Nadine M. E.] Erasmus MC, Dept Pediat, Doctor Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.
   [de Coo, Irenaeus F. M.; Smeets, Hubert J. M.] Maastricht Univ, Dept Genet & Cell Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
   [de Coo, Irenaeus F. M.] Med Spectrum Twente, Dept Neurol, Koningspl 1, NL-7512 KZ Enschede, Netherlands.
   [Smeets, Hubert J. M.] Maastricht Univ, MHeNs Sch Mental Hlth & Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.
C3 Maastricht University; Maastricht University Medical Centre (MUMC); Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Maastricht University; Medical Spectrum Twente; Maastricht University
RP Hellebrekers, DMEI (corresponding author), MUMC, Dept Clin Genet, P Debyelaan 25,POB 5800, NL-6202 AZ Maastricht, Netherlands.
EM debby.hellebrekers@mumc.nl
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease; Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; MRC/EPSRC Molecular Pathology Node; UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children; NeMO; MRC [MR/L016354/1, G0800674] Funding Source: UKRI
CR Alston CL, 2010, J NEUROL SCI, V298, P140, DOI 10.1016/j.jns.2010.08.014
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Cardaioli E, 2005, BIOCHEM BIOPH RES CO, V327, P675, DOI 10.1016/j.bbrc.2004.11.170
   Cardaioli E, 2007, NEUROMUSCULAR DISORD, V17, P681, DOI 10.1016/j.nmd.2007.05.001
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Hardy SA, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000082
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Jackson CB, 2014, BRIT J OPHTHALMOL, V98, P1453, DOI 10.1136/bjophthalmol-2014-305300
   Lim AZ, 2019, MITOCHONDRION, V47, P18, DOI 10.1016/j.mito.2019.04.007
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   PinÃ³s T, 2011, MITOCHONDRION, V11, P228, DOI 10.1016/j.mito.2010.08.008
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   Yarham JW, 2012, MITOCHONDRION, V12, P533, DOI 10.1016/j.mito.2012.06.009
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
NR 21
TC 1
Z9 1
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD SEP 15
PY 2019
VL 29
IS 9
BP 693
EP 697
DI 10.1016/j.nmd.2019.08.005
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA JC5WA
UT WOS:000489352400006
PM 31488384
DA 2024-11-01
ER

PT J
AU Navarro-Hortal, MD
   RamÃ­rez-Tortosa, CL
   Varela-LÃ³pez, A
   Romero-MÃ¡rquez, JM
   Ochoa, JJ
   RamÃ­rez-Tortosa, M
   Forbes-HernÃ¡ndez, TY
   Granados-Principal, S
   Battino, M
   Quiles, JL
AF Navarro-Hortal, Maria D.
   Ramirez-Tortosa, Cesar L.
   Varela-Lopez, Alfonso
   Romero-Marquez, Jose M.
   Ochoa, Julio J.
   Ramirez-Tortosa, MCarmen
   Forbes-Hernandez, Tamara Y.
   Granados-Principal, Sergio
   Battino, Maurizio
   Quiles, Jose L.
TI Heart Histopathology and Mitochondrial Ultrastructure in Aged Rats Fed for 24 Months on Different Unsaturated Fats (Virgin Olive Oil, Sunflower Oil or Fish Oil) and Affected by Different Longevity
SO NUTRIENTS
LA English
DT Article
DE aging; histology; inflammation; fibrosis; mitochondrial morphology; MUFA; PUFA; n-3; n-6
ID oxidative stress; cardiovascular-disease; antioxidant capacity; skeletal-muscle; dna deletion; liver; acids; supplementation; lifelong; exercise
AB Diet plays a decisive role in heart physiology, with lipids having especial importance in pathology prevention and development. This study aimed to investigate how dietary lipids varying in lipid profile (virgin olive oil, sunflower oil or fish oil) affected the heart of rats during aging. Heart histopathology, mitochondrial morphometry, and oxidative status were assessed. Typical histopathological features associated with aging, such as valvular lesions, endomyocardical hyperplasia, or papillary muscle calcification, were found at a low extent in all the experimental groups. The most relevant finding was that inflammation registered by fish oil group was lower compared to the other treatments. At the ultrastructural level, heart mitochondrial area, perimeter, and aspect ratio were higher in fish oil-fed rats than in those fed on sunflower oil. Concerning oxidative stress markers, there were differences only in coenzyme Q levels and catalase activity, lower in sunflower oil-fed animals compared with those fed on fish oil. In summary, dietary intake for a long period on dietary fats with different fatty acids profile led to differences in some aspects associated with the aging process at the heart. Fish oil seems to be the fat most protective of heart during aging.
C1 [Navarro-Hortal, Maria D.; Varela-Lopez, Alfonso; Romero-Marquez, Jose M.; Ochoa, Julio J.; Quiles, Jose L.] Univ Granada, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix Verdu, Dept Physiol, Avda Conocimiento Sn, Granada 18100, Spain.
   [Ramirez-Tortosa, Cesar L.] Hosp San Cecilio Granada, UGC Anat Patol, Avda Conocimiento S-N, Granada 18100, Spain.
   [Ramirez-Tortosa, MCarmen] Univ Granada, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix Verdu, Dept Biochem & Mol Biol 2, Avda Conocimiento Sn, Granada 18100, Spain.
   [Forbes-Hernandez, Tamara Y.; Battino, Maurizio] Univ Vigo, Dept Analyt & Food Chem, Nutr & Food Sci Grp, CITACA,CACTI, Vigo 36310, Spain.
   [Granados-Principal, Sergio] Hosp Univ Jaen, UGC Oncol Med, Ave Ejercito Espanol 10, Jaen 23007, Spain.
   [Granados-Principal, Sergio] Univ Granada, Ctr Genom & Oncol Res, Genyo, Pfizer,Andalusian Reg Govt, PTS Granada Ave Ilustrac 114, Granada 18016, Spain.
   [Battino, Maurizio] Univ Politecn Marche, Dipartimento Sci Clin Specialist Odontostomatol S, I-60131 Ancona, Italy.
   [Battino, Maurizio] Jiangsu Univ, Int Res Ctr Food Nutr & Safety, Zhenjiang 212013, Jiangsu, Peoples R China.
C3 University of Granada; University of Granada; Universidade de Vigo; Pfizer; University of Granada; Marche Polytechnic University; Jiangsu University
RP Quiles, JL (corresponding author), Univ Granada, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix Verdu, Dept Physiol, Avda Conocimiento Sn, Granada 18100, Spain.
EM mdnavarro@ugr.es; cesarl.ramirez.sspa@juntadeandalucia.es; alvarela@ugr.es; josemanuelromeromarquez@gmail.com; jjoh@ugr.es; mramirez@ugr.es; tamaraforbe@gmail.com; sgranados@fibao.es; maurizio.battino@uvigo.es; jlquiles@ugr.es
FU Spanish Ministry of Education and Science [AGL2008-01057]; Government of Andalusia [AGR832]
CR Aboulhoda BE, 2017, ANN ANAT, V214, P21, DOI 10.1016/j.aanat.2017.07.003
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Al-Okbi SY, 2018, J OLEO SCI, V67, P1551, DOI 10.5650/jos.ess18064
   Alvarado Garcia AM, 2014, GEROKOMOS, V25, P57, DOI 10.4321/S1134-928X2014000200002
   RincÃ³n-Cervera MA, 2016, NUTRITION, V32, P1254, DOI 10.1016/j.nut.2016.04.006
   [Anonymous], 2005, DIET, V0, P0
   Beliveau P, 2015, COMPUT BIOL MED, V65, P103, DOI 10.1016/j.compbiomed.2015.07.027
   Chalmers S, 2016, J PHYSIOL-LONDON, V594, P4283, DOI 10.1113/JP271942
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Pedroza AAD, 2015, LIFE SCI, V137, P133, DOI 10.1016/j.lfs.2015.07.021
   Desnoyers M, 2018, CAN J PHYSIOL PHARM, V96, P916, DOI 10.1139/cjpp-2018-0043
   Eilat-Adar S, 2013, NUTRIENTS, V5, P3646, DOI 10.3390/nu5093646
   Eldarov CM, 2015, BIOCHEMISTRY-MOSCOW+, V80, P604, DOI 10.1134/S0006297915050132
   Fleischer S, 1979, METHODS ENZYMOL, V55, P32
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   FRENZEL H, 1984, MECH AGEING DEV, V27, P29, DOI 10.1016/0047-6374(84)90080-0
   Halade GV, 2011, PHARMACOL RES, V63, P300, DOI 10.1016/j.phrs.2010.12.012
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Huet E, 2015, J PHYSIOL PHARMACOL, V66, P355
   Jahangir A, 2007, J APPL PHYSIOL, V103, P2120, DOI 10.1152/japplphysiol.00647.2007
   Kain V, 2018, AM J PHYSIOL-HEART C, V314, PH160, DOI 10.1152/ajpheart.00297.2017
   Kang Jing X, 2008, V49, V0, PP133, DOI 10.1007/978-1-4020-8831-5_5
   Kim EJ, 2011, CARDIOL RES, V2, P127, DOI 10.4021/cr29w
   Kurz FT, 2017, ADV EXP MED BIOL, V982, P1, DOI 10.1007/978-3-319-55330-6_1
   LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   LEPAGE G, 1986, J LIPID RES, V27, P114
   Lewis DJ, 1992, PATHOBIOLOGY AGING R, V1, P0
   Linton PJ, 2015, J MOL CELL CARDIOL, V83, P44, DOI 10.1016/j.yjmcc.2014.12.017
   Liu MY, 2016, HYPERTENSION, V68, P1245, DOI 10.1161/HYPERTENSIONAHA.116.07974
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mayyas F, 2018, NUTR METAB CARDIOVAS, V28, P592, DOI 10.1016/j.numecd.2018.02.012
   Naderi-Boldaji V, 2018, LIFE SCI, V209, P202, DOI 10.1016/j.lfs.2018.08.015
   Niccoli T, 2012, CURR BIOL, V22, PR741, DOI 10.1016/j.cub.2012.07.024
   OConnell TD, 2017, J MOL CELL CARDIOL, V103, P74, DOI 10.1016/j.yjmcc.2016.12.003
   Ochoa JJ, 2005, J GERONTOL A-BIOL, V60, P970, DOI 10.1093/gerona/60.8.970
   Ochoa JJ, 2003, J BIOENERG BIOMEMBR, V35, P267, DOI 10.1023/A:1024615816839
   Ochoa JJ, 2007, J GERONTOL A-BIOL, V62, P1211, DOI 10.1093/gerona/62.11.1211
   Ochoa JJ, 2011, FREE RADICAL BIO MED, V50, P1053, DOI 10.1016/j.freeradbiomed.2011.02.004
   Olgar Y, 2018, EXP GERONTOL, V110, P172, DOI 10.1016/j.exger.2018.06.012
   Orsavova J, 2015, INT J MOL SCI, V16, P12871, DOI 10.3390/ijms160612871
   Quiles JL, 2006, J GERONTOL A-BIOL, V61, P107, DOI 10.1093/gerona/61.2.107
   Quiles JL, 2006, FREE RADICAL RES, V40, P199, DOI 10.1080/10715760500404805
   Quiles JL, 2004, EXP GERONTOL, V39, P1189, DOI 10.1016/j.exger.2004.05.002
   Quiles JL, 2001, J BIOENERG BIOMEMBR, V33, P127, DOI 10.1023/A:1010700515071
   Quiles JL, 2010, MECH AGEING DEV, V131, P38, DOI 10.1016/j.mad.2009.11.004
   Raclot T, 2003, PROG LIPID RES, V42, P257, DOI 10.1016/S0163-7827(02)00066-8
   Ramirez-Tortosa CL, 2020, J GERONTOL A-BIOL, V75, P442, DOI 10.1093/gerona/glz091
   Rasband WS, 2012, IMAGEJ, V0, P0
   Reeves PG, 1997, J NUTR, V127, P0
   Richard D, 2009, CELL MOL LIFE SCI, V66, P3277, DOI 10.1007/s00018-009-0085-4
   Roche E, 2014, J GERONTOL A-BIOL, V69, P934, DOI 10.1093/gerona/glt157
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Schwender F T, 2001, HEART, V86, PE8, DOI 10.1136/heart.86.3.e8
   Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311
   Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496
   Varela-Lopez A, 2018, J NUTR BIOCHEM, V52, P36, DOI 10.1016/j.jnutbio.2017.09.007
   Veno SK, 2019, NUTRIENTS, V11, P0, DOI 10.3390/nu11071467
   Wang DD, 2016, JAMA INTERN MED, V176, P1134, DOI 10.1001/jamainternmed.2016.2417
   Wang YH, 2019, BBA-MOL BASIS DIS, V1865, P1853, DOI 10.1016/j.bbadis.2018.12.008
   Westrate LM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0095265
NR 62
TC 10
Z9 10
U1 0
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT 15
PY 2019
VL 11
IS 10
BP 
EP 
DI 10.3390/nu11102390
PG 16
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA JP4HG
UT WOS:000498227300131
PM 31591312
DA 2024-11-01
ER

PT J
AU De Paepe, B
AF De Paepe, Boel
TI Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras
SO BIOMOLECULES
LA English
DT Review
DE mitochondrial dysfunction; myositis; sporadic inclusion body myositis
ID skeletal-muscle; dna; abnormality; pathology; autoantibody; inflammation; maintenance; dysfunction; mitophagy; cytokines
AB The sporadic form of inclusion body myositis (IBM) is the most common late-onset myopathy. Its complex pathogenesis includes degenerative, inflammatory and mitochondrial aspects. However, which of those mechanisms are cause and which effect, as well as their interrelations, remain partly obscured to this day. In this review the nature of the mitochondrial dysregulation in IBM muscle is explored and comparison is made with other muscle disorders. Mitochondrial alterations in IBM are evidenced by histological and serum biomarkers. Muscular mitochondrial dynamics is disturbed, with deregulated organelle fusion leading to subsequent morphological alterations and muscle displays abnormal mitophagy. The tissue increases mitochondrial content in an attempt to compensate dysfunction, yet mitochondrial DNA (mtDNA) alterations and mild mtDNA depletion are also present. Oxidative phosphorylation defects have repeatedly been shown, most notably a reduction in complex IV activities and levels of mitokines and regulatory RNAs are perturbed. Based on the cumulating evidence of mitochondrial abnormality as a disease contributor, it is therefore warranted to regard IBM as a mitochondrial disease, offering a feasible therapeutic target to be developed for this yet untreatable condition.
C1 [De Paepe, Boel] Ghent Univ Hosp, Neuromuscular Reference Ctr, Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
C3 Ghent University; Ghent University Hospital
RP De Paepe, B (corresponding author), Ghent Univ Hosp, Neuromuscular Reference Ctr, Corneel Heymanslaan 10, B-9000 Ghent, Belgium.
EM boel.depaepe@ugent.be
FU Association Belge contre les Maladies neuro-Musculaires (ABMM) aides a la recherche [2018]
CR Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200
   Amato AA, 2017, NEUROLOGY, V88, P1
   Askanas V, 2015, BBA-MOL BASIS DIS, V1852, P633, DOI 10.1016/j.bbadis.201409.005
   Askanas V, 2012, J NEUROPATH EXP NEUR, V71, P680, DOI 10.1097/NEN.0b013e31826183c8
   Brady S, 2018, NEUROMUSCULAR DISORD, V28, PS30, DOI 10.1016/S0960-8966(18)30380-8
   Breithaupt M, 2013, CURR RHEUMATOL REP, V15, P0, DOI 10.1007/s11926-013-0329-z
   Buzkova J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809091
   CatalÃ¡n-GarcÃ­a M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Chung HK, 2017, J CELL BIOL, V216, P149, DOI 10.1083/jcb.201607110
   Dahlbom K, 2002, NEUROMUSCULAR DISORD, V12, P853, DOI 10.1016/S0960-8966(02)00098-6
   De Paepe B, 2018, CURR GENET, V64, P163, DOI 10.1007/s00294-017-0744-1
   Dimachkie MM, 2012, SEMIN NEUROL, V32, P237, DOI 10.1055/s-0032-1329197
   Enns GM, 2014, J CHILD NEUROL, V29, P1235, DOI 10.1177/0883073814538509
   Gambelli S, 2004, JOURNAL OF SUBMICROSCOPIC CYTOLOGY AND PATHOLOGY, V36, P85
   Georgantas RW, 2014, ARTHRITIS RHEUMATOL, V66, P1022, DOI 10.1002/art.38292
   Gidlund EK, 2016, PHYSIOL REP, V4, P0, DOI 10.14814/phy2.13063
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Hamann PD, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-08603-9
   Ivanidze J, 2011, AM J PATHOL, V179, P1347, DOI 10.1016/j.ajpath.2011.05.055
   Johnson Liam G, 2009, J CLIN NEUROMUSCUL DIS, V10, P178, DOI 10.1097/CND.0b013e3181a23c86
   Joshi PR, 2014, J CLIN NEUROSCI, V21, P1959, DOI 10.1016/j.jocn.2014.05.051
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Mariappan N, 2007, AM J PHYSIOL-HEART C, V293, PH2726, DOI 10.1152/ajpheart.00376.2007
   Matsubara S, 2018, NEUROMUSCULAR DISORD, V28, P283, DOI 10.1016/j.nmd.2018.01.004
   Meyer A, 2017, ACTA NEUROPATHOL, V134, P655, DOI 10.1007/s00401-017-1731-9
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Nie YH, 2016, FASEB J, V30, P3745, DOI 10.1096/fj.201600529R
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   PÃ¤ivÃ¤ H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006
   Pluk H, 2013, ANN NEUROL, V73, P397, DOI 10.1002/ana.23822
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Rojana-Udomsart A, 2012, J NEUROIMMUNOL, V250, P77, DOI 10.1016/j.jneuroim.2012.05.003
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Shabrokh E, 2014, OPEN J MOL INTEGR PHYSIOL, V04, P11, DOI 10.4236/ojmip.2014.42002
   Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023
   Sunitha B, 2016, J NEUROCHEM, V138, P174, DOI 10.1111/jnc.13626
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Temiz P, 2009, J NEUROL SCI, V278, P25, DOI 10.1016/j.jns.2008.11.010
   Vaamonde-GarcÃ­a C, 2012, ARTHRITIS RHEUM-US, V64, P2927, DOI 10.1002/art.34508
   Wang Y, 2018, NAT CELL BIOL, V20, P1145, DOI 10.1038/s41556-018-0204-2
   WOO M, 1988, J NEUROL SCI, V88, P133, DOI 10.1016/0022-510X(88)90211-0
   Xie T, 2017, AM J PHYSIOL-ENDOC M, V313, PE292, DOI 10.1152/ajpendo.00101.2017
   Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047
NR 50
TC 23
Z9 23
U1 1
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2218-273X
EI 
J9 BIOMOLECULES
JI Biomolecules
PD JAN 15
PY 2019
VL 9
IS 1
BP 
EP 
DI 10.3390/biom9010015
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA HK6AT
UT WOS:000458051700015
PM 30621041
DA 2024-11-01
ER

PT J
AU Elfawy, HA
   Das, B
AF Elfawy, Hasnaa A.
   Das, Biswadeep
TI Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies
SO LIFE SCIENCES
LA English
DT Review
DE Mitochondrial dysfunction; Oxidative stress; Neurodegenerative disease; Mitochondrial heteroplasmy; Therapeutic strategies
ID activated-receptor-gamma; dynamin-related gtpase; life-span; targeted antioxidant; caloric restriction; parkinsons-disease; skeletal-muscle; amyloid-beta; ppar-gamma; alzheimers-disease
AB Mitochondrial function is vital for normal cellular processes. Mitochondrial damage and oxidative stress have been greatly implicated in the progression of aging, along with the pathogenesis of age-related neurodegenerative diseases (NDs), such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. Although antioxidant therapy has been proposed for the prevention and treatment of age-related NDs, unraveling the molecular mechanisms of mitochondrial dysfunction can lead to significant progress in the development of effective treatments against such diseases. Aging is associated with the generation and accumulation of reactive oxygen species (ROS) that are the major contributors to oxidative stress. Oxidative stress is caused because of the imbalance between the production of ROS and their oxidation, which can affect the mitochondrial respiratory chain function, thereby altering the membrane permeability and calcium homeostasis, along with increasing the heteroplasmic mtDNA and weakening the mitochondrial defense systems. Mitochondrial dysfunction mainly affects mitochondrial biogenesis and dynamics that are prominent in several age-related NDs. Mitochondrial dysfunction has a crucial role in the pathophysiology of age-related NDs. Several mitochondria targeted strategies, such as enhancing the antioxidant bioavailability via novel delivery systems, identifying unique mitochondrial proteins as specific drug targets, investigating the signaling pathways of mitochondrial biogenesis and dynamics, and identifying effective natural products are potentially effective to counteract mitochondrial dysfunction-related NDs.
C1 [Elfawy, Hasnaa A.; Das, Biswadeep] KIIT, Sch Biotechnol, Campus 11, Bhubaneswar 751024, Odisha, India.
C3 Kalinga Institute of Industrial Technology (KIIT)
RP Das, B (corresponding author), KIIT Univ, Sch Biotechnol, Campus 11, Bhubaneswar 751024, India.
EM biswadeep.das@kiitbiotech.ac.in
CR Ahola-ErkkilÃ¤ S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Aiken CT, 2011, MOL CELL PROTEOMICS, V10, P0, DOI 10.1074/mcp.M110.006924
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168
   Andersen JK, 2004, NAT MED, V10, PS18, DOI 10.1038/nrn1434
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Barbieri E, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/917085
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138
   Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x
   Benedusi V, 2012, J BIOL CHEM, V287, P35899, DOI 10.1074/jbc.M112.366419
   Berg JM, 2002, BIOCHEMISTRY, V5th ed., P0
   Blesa J, 2015, FRONT NEUROANAT, V9, P0, DOI 10.3389/fnana.2015.00091
   Brazier MW, 2014, ANTIOXIDANTS-BASEL, V3, P288, DOI 10.3390/antiox3020288
   Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029
   Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474
   Calabrese V, 2007, NEUROCHEM RES, V32, P757, DOI 10.1007/s11064-006-9203-y
   CantÃ³ C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Cardinali DP, 2013, HORM BEHAV, V63, P322, DOI 10.1016/j.yhbeh.2012.02.020
   Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Corona JC, 2015, NEUROCHEM RES, V40, P308, DOI 10.1007/s11064-014-1377-0
   Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015
   Cummings JL, 2014, ALZHEIMERS RES THER, V6, P0, DOI 10.1186/alzrt269
   Danta CC, 2014, EXPERT OPIN DRUG DIS, V9, P1205, DOI 10.1517/17460441.2014.942218
   de Oliveira MR, 2016, BIOTECHNOL ADV, V34, P532, DOI 10.1016/j.biotechadv.2015.12.014
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Dhingra R, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.310
   Elbaz A, 2016, REV NEUROL-FRANCE, V172, P14, DOI 10.1016/j.neurol.2015.09.012
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   FAHN S, 1992, ANN NEUROL, V32, PS128, DOI 10.1002/ana.410320722
   Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5
   Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001
   Flis VV, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a013235
   Forbes JM, 2018, NAT REV NEPHROL, V14, P291, DOI 10.1038/nrneph.2018.9
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Gao AW, 2014, EMBO MOL MED, V6, P580, DOI 10.1002/emmm.201303782
   Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI 10.1038/nchembio.2287
   Goldstein AC, 2013, NEUROTHERAPEUTICS, V10, P212, DOI 10.1007/s13311-013-0185-6
   Gomes CM, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/487534
   Gott JM, 2016, GENES-BASEL, V7, P0, DOI 10.3390/genes7120128
   Gottlieb RA, 2016, CELL CALCIUM, V60, P88, DOI 10.1016/j.ceca.2016.04.006
   Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Heneka MT, 2007, NAT CLIN PRACT NEURO, V3, P496, DOI 10.1038/ncpneuro0586
   Herskovits AZ, 2014, NEURON, V81, P471, DOI 10.1016/j.neuron.2014.01.028
   Horvath TL, 2003, ENDOCRINOLOGY, V144, P2757, DOI 10.1210/en.2003-0163
   Hsieh Tze-chen, 2006, MED CHEM, V2, P275, DOI 10.2174/157340606776930709
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   JÃ¤ger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008
   Johnson ME, 2015, NEUROTOXICOLOGY, V46, P101, DOI 10.1016/j.neuro.2014.12.002
   Kandimalla R, 2018, HUM MOL GENET, V27, P30, DOI 10.1093/hmg/ddx381
   Karaaslan C, 2015, CURR TOP MED CHEM, V15, P894, DOI 10.2174/1568026615666150220120946
   Karunakaran S, 2007, FASEB J, V21, P2226, DOI 10.1096/fj.06-7580com
   Keeney PM, 2009, HUM GENE THER, V20, P897, DOI 10.1089/hum.2009.023
   Kiaei M, 2008, PPAR RES, V2008, P0, DOI 10.1155/2008/418765
   Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477
   Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758
   Klopstock T, 2016, GENOME MED, V8, P0, DOI 10.1186/s13073-016-0380-2
   Kobayashi I, 1998, TRENDS GENET, V14, P368, DOI 10.1016/S0168-9525(98)01532-7
   Komen JC, 2014, BRIT J PHARMACOL, V171, P1818, DOI 10.1111/bph.12413
   Kowaltowski AJ, 2011, REDOX REP, V16, P237, DOI 10.1179/1351000211Y.0000000014
   Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252
   Kwon HJ, 2016, ACS NANO, V10, P2860, DOI 10.1021/acsnano.5b08045
   Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010
   Lane N, 2011, BIOL DIRECT, V6, P0, DOI 10.1186/1745-6150-6-35
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lee M, 2007, J DRUG TARGET, V15, P115, DOI 10.1080/10611860600953555
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Lightowlers RN, 2014, EMBO MOL MED, V6, P705, DOI 10.15252/emmm.201404179
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lowes DA, 2008, FREE RADICAL BIO MED, V45, P1559, DOI 10.1016/j.freeradbiomed.2008.09.003
   Campo ML, 2017, J BIOENERG BIOMEMBR, V49, P75, DOI 10.1007/s10863-016-9662-z
   Luo Y, 2015, INT J MOL SCI, V16, P20704, DOI 10.3390/ijms160920704
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002
   Madamanchi NR, 2001, ARTERIOSCL THROM VAS, V21, P321, DOI 10.1161/01.ATV.21.3.321
   MagranÃ© J, 2009, ANTIOXID REDOX SIGN, V11, P1615, DOI 10.1089/ars.2009.2604
   Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754
   Manczak M, 2019, HUM MOL GENET, V28, P177, DOI 10.1093/hmg/ddy335
   Manczak M, 2015, HUM MOL GENET, V24, P7308, DOI 10.1093/hmg/ddv429
   Manfredi G, 2000, BRAIN PATHOL, V10, P462
   Masino SA, 2008, TRENDS NEUROSCI, V31, P273, DOI 10.1016/j.tins.2008.02.009
   Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012
   Matthews RT, 1999, EXP NEUROL, V157, P142, DOI 10.1006/exnr.1999.7049
   McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023
   McLachlan J, 2014, J HYPERTENS, V32, P555, DOI 10.1097/HJH.0000000000000054
   Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Mercer JR, 2012, FREE RADICAL BIO MED, V52, P841, DOI 10.1016/j.freeradbiomed.2011.11.026
   Mhyre Timothy R, 2012, SUBCELL BIOCHEM, V65, P389, DOI 10.1007/978-94-007-5416-4_16
   Miwa S, 2004, ANN NY ACAD SCI, V1019, P388, DOI 10.1196/annals.1297.069
   Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3
   Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Moussaoui S, 2000, EXP NEUROL, V166, P235, DOI 10.1006/exnr.2000.7516
   Muller M, 2014, J NEUROCHEM, V130, P328, DOI 10.1111/jnc.12739
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   Multhaup G, 1997, BIOCHEM PHARMACOL, V54, P533, DOI 10.1016/S0006-2952(97)00062-2
   Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110
   NAKASHIMA RA, 1989, J BIOENERG BIOMEMBR, V21, P461, DOI 10.1007/BF00762518
   Nieman DC, 2010, MED SCI SPORT EXER, V42, P338, DOI 10.1249/MSS.0b013e3181b18fa3
   Niforou K, 2014, REDOX BIOL, V2, P323, DOI 10.1016/j.redox.2014.01.017
   Onyango IG, 2010, BBA-MOL BASIS DIS, V1802, P228, DOI 10.1016/j.bbadis.2009.07.014
   Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152
   Ozden O, 2011, AGING-US, V3, P102, DOI 10.18632/aging.100291
   Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018
   Perera ND, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0090449
   Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006
   Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Pollari E, 2014, FRONT CELL NEUROSCI, V8, P0, DOI 10.3389/fncel.2014.00131
   Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007
   Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439
   Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629
   Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200
   Quintanilla RA, 2013, MOL NEURODEGENER, V8, P0, DOI 10.1186/1750-1326-8-45
   Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108
   Ramis MR, 2015, CURR MED CHEM, V22, P2690, DOI 10.2174/0929867322666150619104143
   Rappold PM, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6244
   Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882
   Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007
   Rawlins MD, 2016, NEUROEPIDEMIOLOGY, V46, P144, DOI 10.1159/000443738
   Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393
   Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002
   Reddy PH, 2018, HUM MOL GENET, V27, P2502, DOI 10.1093/hmg/ddy154
   Reddy PH, 2017, HUM MOL GENET, V26, P1597, DOI 10.1093/hmg/ddx129
   Reddy PH, 2011, BRAIN RES, V1415, P136, DOI 10.1016/j.brainres.2011.07.052
   Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001
   Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x
   Reddy PH, 2005, BRAIN RES REV, V49, P618, DOI 10.1016/j.brainresrev.2005.03.004
   Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510
   REMACLE J, 1995, MUTAT RES-DNAGING G, V316, P103, DOI 10.1016/0921-8734(95)90004-7
   Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Roberts DJ, 2015, CELL DEATH DIFFER, V22, P248, DOI 10.1038/cdd.2014.173
   RÃ³na-VÃ¶rÃ¶s K, 2010, CURR DRUG TARGETS, V11, P1262, DOI 10.2174/1389450111007011262
   Rosas HD, 2012, ARCH NEUROL-CHICAGO, V69, P887, DOI 10.1001/archneurol.2011.2945
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015
   Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Sekar S, 2015, NEUROBIOL AGING, V36, P583, DOI 10.1016/j.neurobiolaging.2014.09.027
   Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1299, DOI 10.1038/sj.cdd.4401974
   Shao J, 2007, HUM MOL GENET, V16, PR115, DOI 10.1093/hmg/ddm213
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Smilansky A, 2015, J BIOL CHEM, V290, P30670, DOI 10.1074/jbc.M115.691493
   Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Suliman HB, 2016, PHARMACOL REV, V68, P20, DOI 10.1124/pr.115.011502
   Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200
   Suzuki Y, 2012, SENSORS-BASEL, V12, P549, DOI 10.3390/s120100549
   Sweeney G, 2016, ANAT CELL BIOL, V49, P1, DOI 10.5115/acb.2016.49.1.1
   Szeto HH, 2014, CLIN PHARMACOL THER, V96, P672, DOI 10.1038/clpt.2014.174
   Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461
   Talbott EO, 2016, HAND CLINIC, V138, P225, DOI 10.1016/B978-0-12-802973-2.00013-6
   Tan WZ, 2014, BBA-MOL BASIS DIS, V1842, P1295, DOI 10.1016/j.bbadis.2014.02.009
   Tanaka AJ, 2013, NAT MED, V19, P1578, DOI 10.1038/nm.3422
   Taylor R W, 2000, HUM REPROD, V15 Suppl 2, P79
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, P0
   Thomas RR, 2012, AGING-US, V4, P620, DOI 10.18632/aging.100488
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Ungvari Z, 2008, CIRC RES, V102, P519, DOI 10.1161/CIRCRESAHA.107.168369
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011072
   Van Raamsdonk JM, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000361
   Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065
   Walker FO, 2007, SEMIN NEUROL, V27, P143, DOI 10.1055/s-2007-971176
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015
   Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13
   Ward MS, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-10209-0
   Weissig V, 2001, J CONTROL RELEASE, V75, P401, DOI 10.1016/S0168-3659(01)00392-3
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Wesselink E, 2019, CLIN NUTR, V38, P982, DOI 10.1016/j.clnu.2018.08.032
   Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200
   Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001
   Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789
   Woods LC, 2016, FRONT CELL DEV BIOL, V4, P0, DOI 10.3389/fcell.2016.00019
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xu SZ, 2009, FREE RADICAL BIO MED, V47, P167, DOI 10.1016/j.freeradbiomed.2009.04.021
   Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x
   Yasuzaki Y, 2010, BIOCHEM BIOPH RES CO, V397, P181, DOI 10.1016/j.bbrc.2010.05.070
   Yin XL, 2016, HUM MOL GENET, V25, P1739, DOI 10.1093/hmg/ddw045
   Yun JS, 2005, TOXICOLOGY, V216, P140, DOI 10.1016/j.tox.2005.08.017
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhang SM, 2002, NEUROLOGY, V59, P1161, DOI 10.1212/01.WNL.0000028688.75881.12
   Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599
   ZÃ¼chner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 210
TC 227
Z9 237
U1 11
U2 172
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD FEB 1
PY 2019
VL 218
IS 
BP 165
EP 184
DI 10.1016/j.lfs.2018.12.029
PG 20
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA HH4WO
UT WOS:000455727100018
PM 30578866
DA 2024-11-01
ER

PT J
AU Donkervoort, S
   Sabouny, R
   Yun, P
   Gauquelin, L
   Chao, KR
   Hu, Y
   Al Khatib, I
   Topf, A
   Mohassel, P
   Cummings, BB
   Kaur, R
   Saade, D
   Moore, SA
   Waddell, LB
   Farrar, MA
   Goodrich, JK
   Uapinyoying, P
   Chan, SHS
   Javed, A
   Leach, ME
   Karachunski, P
   Dalton, J
   Medne, L
   Harper, A
   Thompson, C
   Thiffault, I
   Specht, S
   Lamont, RE
   Saunders, C
   Racher, H
   Bernier, FP
   Mowat, D
   Witting, N
   Vissing, J
   Hanson, R
   Coffman, KA
   Hainlen, M
   Parboosingh, JS
   Carnevale, A
   Yoon, G
   Schnur, RE
   Boycott, KM
   Mah, JK
   Straub, V
   Foley, AR
   Innes, AM
   Bonnemann, CG
   Shutt, TE
AF Donkervoort, S.
   Sabouny, R.
   Yun, P.
   Gauquelin, L.
   Chao, K. R.
   Hu, Y.
   Al Khatib, I
   Topf, A.
   Mohassel, P.
   Cummings, B. B.
   Kaur, R.
   Saade, D.
   Moore, S. A.
   Waddell, L. B.
   Farrar, M. A.
   Goodrich, J. K.
   Uapinyoying, P.
   Chan, S. H. S.
   Javed, A.
   Leach, M. E.
   Karachunski, P.
   Dalton, J.
   Medne, L.
   Harper, A.
   Thompson, C.
   Thiffault, I
   Specht, S.
   Lamont, R. E.
   Saunders, C.
   Racher, H.
   Bernier, F. P.
   Mowat, D.
   Witting, N.
   Vissing, J.
   Hanson, R.
   Coffman, K. A.
   Hainlen, M.
   Parboosingh, J. S.
   Carnevale, A.
   Yoon, G.
   Schnur, R. E.
   Boycott, K. M.
   Mah, J. K.
   Straub, V
   Foley, A. Reghan
   Innes, A. M.
   Bonnemann, C. G.
   Shutt, T. E.
TI <i>MSTO1</i> mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE MSTO1; Mitochondrial fusion; Cerebellar atrophy; Muscular dystrophy; MtDNA depletion
ID mitochondrial-dna depletion; optic atrophy; recessive mutations; protein; expression; fusion; ataxia; dynamics; myopathy; binding
AB MSTO1 encodes a cytosolic mitochondrial fusion protein, misato homolog 1 or MSTO1. While the full genotype-phenotype spectrum remains to be explored, pathogenic variants in MSTO1 have recently been reported in a small number of patients presenting with a phenotype of cerebellar ataxia, congenital muscle involvement with histologic findings ranging from myopathic to dystrophic and pigmentary retinopathy. The proposed underlying pathogenic mechanism of MSTO1-related disease is suggestive of impaired mitochondrial fusion secondary to a loss of function of MSTO1. Disorders of mitochondrial fusion and fission have been shown to also lead to mitochondrial DNA (mtDNA) depletion, linking them to the mtDNA depletion syndromes, a clinically and genetically diverse class of mitochondrial diseases characterized by a reduction of cellular mtDNA content. However, the consequences of pathogenic variants in MSTO1 on mtDNA maintenance remain poorly understood. We present extensive phenotypic and genetic data from 12 independent families, including 15 new patients harbouring a broad array of bi-allelic MSTO1 pathogenic variants, and we provide functional characterization from seven MSTO1-related disease patient fibroblasts. Bi-allelic loss-of-function variants in MSTO1 manifest clinically with a remarkably consistent phenotype of childhood-onset muscular dystrophy, corticospinal tract dysfunction and early-onset non-progressive cerebellar atrophy. MSTO1 protein was not detectable in the cultured fibroblasts of all seven patients evaluated, suggesting that pathogenic variants result in a loss of protein expression and/or affect protein stability. Consistent with impaired mitochondrial fusion, mitochondrial networks in fibroblasts were found to be fragmented. Furthermore, all fibroblasts were found to have depletion of mtDNA ranging from 30 to 70% along with alterations to mtDNA nucleoids. Our data corroborate the role of MSTO1 as a mitochondrial fusion protein and highlight a previously unrecognized link to mtDNA regulation. As impaired mitochondrial fusion is a recognized cause of mtDNA depletion syndromes, this novel link to mtDNA depletion in patient fibroblasts suggests that MSTO1-deficiency should also be considered a mtDNA depletion syndrome. Thus, we provide mechanistic insight into the disease pathogenesis associated with MSTO1 mutations and further define the clinical spectrum and the natural history of MSTO1-related disease.
C1 [Donkervoort, S.; Yun, P.; Hu, Y.; Mohassel, P.; Kaur, R.; Saade, D.; Uapinyoying, P.; Leach, M. E.; Foley, A. Reghan; Bonnemann, C. G.] NINDS, Neuromuscular & Neurogenet Disorders Childhood Se, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
   [Sabouny, R.; Al Khatib, I; Shutt, T. E.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.
   [Gauquelin, L.; Carnevale, A.; Yoon, G.] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Clin & Metab Genet, Toronto, ON, Canada.
   [Gauquelin, L.; Yoon, G.] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Neurol, Toronto, ON, Canada.
   [Chao, K. R.; Cummings, B. B.; Goodrich, J. K.] Broad Inst MIT & Harvard, Ctr Mendelian Genom, Program Med & Populat Genet, Boston, MA USA.
   [Topf, A.; Specht, S.; Straub, V] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.
   [Moore, S. A.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA.
   [Waddell, L. B.] Childrens Hosp Westmead, Kids Neurosci Ctr, Kids Res, Sydney, NSW 2145, Australia.
   [Waddell, L. B.] Univ Sydney, Fac Med & Hlth, Discipline Child & Adolescent Hlth, Westmead, NSW 2145, Australia.
   [Farrar, M. A.] Sydney Childrens Hosp, Dept Neurol, Sydney, NSW, Australia.
   [Farrar, M. A.; Mowat, D.] UNSW Sydney, Sch Womens & Childrens Hlth, Sydney, NSW, Australia.
   [Chan, S. H. S.] Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China.
   [Javed, A.] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China.
   [Leach, M. E.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Neuromuscular Program, Portland, OR 97201 USA.
   [Karachunski, P.; Dalton, J.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA.
   [Medne, L.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA.
   [Harper, A.] Virginia Commonwealth Univ, Childrens Hosp Richmond VCU, Dept Neurol, Richmond, VA USA.
   [Thompson, C.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA.
   [Thiffault, I; Saunders, C.] Childrens Mercy Hosp, Dept Pathol & Lab Med, Kansas City, MO 64108 USA.
   [Thiffault, I; Saunders, C.] Childrens Mercy Hosp, Ctr Pediat Genom Med, Kansas City, MO 64108 USA.
   [Thiffault, I; Saunders, C.; Hanson, R.] Univ Missouri Kansas City, Sch Med, Kansas City, MO USA.
   [Lamont, R. E.; Racher, H.; Bernier, F. P.; Parboosingh, J. S.; Innes, A. M.] Univ Calgary, Cumming Sch Med, Dept Med Genet, Calgary, AB, Canada.
   [Lamont, R. E.; Racher, H.; Bernier, F. P.; Parboosingh, J. S.; Innes, A. M.] Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada.
   [Mowat, D.] Sydney Childrens Hosp, Dept Med Genet, Sydney, NSW, Australia.
   [Witting, N.; Vissing, J.] Univ Hosp, Dept Neurol, Rigshosp, Copenhagen, Denmark.
   [Hanson, R.; Coffman, K. A.; Hainlen, M.] Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA.
   [Coffman, K. A.; Hainlen, M.] Childrens Mercy Hosp, Div Neurol, Kansas City, MO 64108 USA.
   [Schnur, R. E.] GeneDx, Gaithersburg, MD USA.
   [Boycott, K. M.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada.
   [Boycott, K. M.; Care4Rare Canada Consortium] Care4Rare Res Consortium, Ottawa, ON, Canada.
   [Mah, J. K.] Univ Calgary, Dept Pediat, Sect Neurol, Calgary, AB, Canada.
   [Straub, V] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England.
   [Shutt, T. E.] Univ Calgary, Alberta Childrens Hosp, Hotchkiss Brain Inst, Dept Med Genet,Res Inst, Calgary, AB, Canada.
   [Uapinyoying, P.] Childrens Natl Med Ctr, Res Genet Med, Washington, DC 20010 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Calgary; University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Newcastle University - UK; University of Iowa; University of Sydney; NSW Health; The Children's Hospital at Westmead; University of Sydney; University of Sydney; NSW Health; Sydney Childrens Hospitals Network; University of New South Wales Sydney; University of Hong Kong; University of Hong Kong; Oregon Health & Science University; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Virginia Commonwealth University; University of California System; University of California San Diego; Children's Mercy Hospital; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of Calgary; Alberta Childrens Hospital; University of Calgary; NSW Health; Sydney Childrens Hospitals Network; University of Sydney; Rigshospitalet; University of Copenhagen; Children's Mercy Hospital; Children's Mercy Hospital; University of Ottawa; Children's Hospital of Eastern Ontario; University of Calgary; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Alberta Childrens Hospital; University of Calgary; Children's National Health System
RP Bonnemann, CG (corresponding author), NINDS, Neuromuscular & Neurogenet Disorders Childhood Se, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.; Shutt, TE (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.; Shutt, TE (corresponding author), Univ Calgary, Alberta Childrens Hosp, Hotchkiss Brain Inst, Dept Med Genet,Res Inst, Calgary, AB, Canada.
EM Carsten.bonnemann@nih.gov; timothy.shutt@ucalgary.ca
FU NHGRI NIH HHS [UM1 HG008900] Funding Source: Medline; NINDS NIH HHS [U54 NS053672] Funding Source: Medline; Ontario Genomics Institute [OGI-147] Funding Source: Medline
CR Adle-Biassette H, 2018, HAND CLINIC, V145, P51, DOI 10.1016/B978-0-12-802395-2.00006-7
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amberger JS, 2015, NUCLEIC ACIDS RES, V43, PD789, DOI 10.1093/nar/gku1205
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Ardicli D, 2019, NEUROMUSCULAR DISORD, V0, P0
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110
   Carss KJ, 2013, AM J HUM GENET, V93, P29, DOI 10.1016/j.ajhg.2013.05.009
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Cirak S, 2013, BRAIN, V136, P269, DOI 10.1093/brain/aws312
   Demers-Lamarche J, 2016, J BIOL CHEM, V291, P10263, DOI 10.1074/jbc.M115.695825
   Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Foley ARD, 2015, NEXT GENERATION SEQU, V1, P2376
   Gal A, 2017, EMBO MOL MED, V9, P967, DOI 10.15252/emmm.201607058
   Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Harding BN, 2008, GREENFIELDS NEUROPAT, V0, P365
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Iwama K, 2018, J HUM GENET, V63, P263, DOI 10.1038/s10038-017-0405-8
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1
   Krieger M, 2013, BRAIN, V136, P3634, DOI 10.1093/brain/awt283
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kuryshev VY, 2006, GENOMICS, V88, P143, DOI 10.1016/j.ygeno.2006.02.002
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lewis SC, 2016, SCIENCE, V353, P0, DOI 10.1126/science.aaf5549
   Li K, 2020, EUR J MED GENET, V63, P0, DOI 10.1016/j.ejmg.2019.01.013
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Nasca A, 2017, HUM MUTAT, V38, P970, DOI 10.1002/humu.23262
   Nasca A, 2016, HUM MUTAT, V37, P898, DOI 10.1002/humu.23033
   Nickolls AR, 2018, DIS MODEL MECH, V11, P0, DOI 10.1242/dmm.035931
   Nogueira C, 2014, ITAL J PEDIATR, V40, P0, DOI 10.1186/1824-7288-40-34
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Potorac I, 2016, J ENDOCRINOL, V231, P197, DOI 10.1530/JOE-16-0384
   Ramos ES, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1008085
   Renaldo F, 2012, BRAIN, V135, P0, DOI 10.1093/brain/aws111
   Sabouny R, 2017, ANTIOXID REDOX SIGN, V27, P1447, DOI 10.1089/ars.2016.6855
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI 10.1038/nmeth.2019
   Sobreira Nara, 2015, HUM MUTAT, V36, P928, DOI 10.1002/humu.22844
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Suarez-Rivero Juan M, 2016, DISEASES, V5, P0, DOI 10.3390/diseases5010001
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
NR 48
TC 24
Z9 28
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD DEC 15
PY 2019
VL 138
IS 6
BP 1013
EP 1031
DI 10.1007/s00401-019-02059-z
PG 19
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA JM3NF
UT WOS:000496124600007
PM 31463572
DA 2024-11-01
ER

PT J
AU Kumari, S
   Braun, RK
   Tetri, LH
   Barton, GP
   Hacker, TA
   Goss, KN
AF Kumari, Santosh
   Braun, Rudolf K.
   Tetri, Laura H.
   Barton, Gregory P.
   Hacker, Timothy A.
   Goss, Kara N.
TI Bimodal right ventricular dysfunction after postnatal hyperoxia exposure: implications for the preterm heart
SO AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
LA English
DT Article
DE heart failure; mitochondria; pediatric; prematurity; pulmonary hypertension
ID pulmonary-hypertension; bronchopulmonary dysplasia; neonatal hyperoxia; muscle-fibers; mitochondrial; infants; birth; hypertrophy; children; failure
AB Rats exposed to postnatal hyperoxia develop right ventricular (RV) dysfunction, mild pulmonary hypertension, and dysregulated cardiac mitochondrial biogenesis when aged to one year, with the degree of cardiac dysfunction and pulmonary hypertension similar to that previously described in young adults born preterm. Here, we sought to understand the impact of postnatal hyperoxia exposure on RV hemodynamic and mitochondrial function across the life span. In Methods, pups from timed-pregnant Sprague-Dawley rats were randomized to normoxia or hyperoxia [fraction of inspired oxygen (FIO2), 0.85] exposure for the first 14 days of life, a commonly used model of chronic lung disease of prematurity. RV hemodynamic and mitochondrial function were assessed by invasive measurement of RV pressure-volume loops and by high-resolution respirometry at postnatal day 21 (P21), P90, and P365. In Results, at P21, hyperoxia-exposed rats demonstrated severe pulmonary hypertension and RV dysfunction, accompanied by depressed mitochondrial oxidative capacity. However, significant upregulation of mitochondrial biogenesis at P21 as well as improved afterload led to complete RV hemodynamic and mitochondrial recovery at P90. Mitochondrial DNA mutations were significantly higher by P90 and associated with significant late RV mitochondrial and hemodynamic dysfunction at P365. In conclusion, there appears to be a "honeymoon period" where cardiac hemodynamic and mitochondrial function normalizes following postnatal hyperoxia exposure, only to decline again with ongoing aging. This finding may have significant implications if a long-term pulmonary vascular screening program were to be developed for children or adults with a history of severe prematurity. Further investigation into the mechanisms of recovery are warranted. NEW & NOTEWORTHY Premature birth is associated with increased risk for cardiac dysfunction and failure throughout life. Here, we identify bimodal right ventricular dysfunction after postnatal hyperoxia exposure. Mitochondrial biogenesis serves as an early adaptive feature promoting recovery of cardiac hemodynamic and mitochondrial function. However, the accumulation of mitochondrial DNA mutations results in late mitochondrial and right ventricular dysfunction. This bimodal right ventricular dysfunction may have important implications for the development of screening programs in the preterm population.
C1 [Kumari, Santosh; Goss, Kara N.] Univ Madison Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA.
   [Braun, Rudolf K.; Tetri, Laura H.; Barton, Gregory P.; Goss, Kara N.] Univ Madison Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA.
   [Hacker, Timothy A.] Univ Wisconsin, Sch Med & Publ Hlth, Cardiovasc Res Ctr, Univ Madison Wisconsin, Madison, WI USA.
C3 University of Wisconsin System; University of Wisconsin Madison
RP Goss, KN (corresponding author), Univ Wisconsin, Div Allergy Pulm & Crit Care, 600 Highland Ave,CSC H4-616 MC9988, Madison, WI 53792 USA.
EM kngoss@medicine.wisc.edu
FU University of Wisconsin Clinical and Translational Science Award program, through National Center for Advancing Translational Sciences Grant [UL1-TR-000427, 4KL2-TR-000428-10]; Joel Belt Pediatric Pulmonary Hypertension Research and Mentoring Grant through the Pulmonary Hypertension Association (Barst Award)
CR An Hyo Soon, 2010, KOREAN CIRC J, V40, P131, DOI 10.4070/kcj.2010.40.3.131
   Aye CYL, 2017, PEDIATR RES, V82, P36, DOI 10.1038/pr.2017.96
   Berenz A, 2017, AM J PERINAT, V34, P801, DOI 10.1055/s-0037-1598246
   Bhat R, 2012, PEDIATRICS, V129, PE682, DOI 10.1542/peds.2011-1827
   Carr H, 2017, J AM COLL CARDIOL, V69, P2634, DOI 10.1016/j.jacc.2017.03.572
   Cheng TC, 2018, AM J PHYSIOL-HEART C, V315, PH699, DOI 10.1152/ajpheart.00047.2018
   FerrÃ© C, 2016, MMWR-MORBID MORTAL W, V65, P1181, DOI 10.15585/mmwr.mm6543a1
   FOURON JC, 1980, PEDIATRICS, V65, P529
   Girard-Bock C, 2018, PHYSIOL REP, V6, P0, DOI 10.14814/phy2.13922
   Goss KN, 2018, AM J RESP CRIT CARE, V198, P1549, DOI 10.1164/rccm.201710-2016OC
   Goss KN, 2017, AM J RESP CELL MOL, V56, P609, DOI 10.1165/rcmb.2016-0256OC
   Goss KN, 2015, AM J RESP CELL MOL, V53, P902, DOI 10.1165/rcmb.2015-0100LE
   Goss KN, 2015, AM J PHYSIOL-LUNG C, V308, PL797, DOI 10.1152/ajplung.00276.2014
   Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herbst A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059006
   Huckstep OJ, 2018, J AM COLL CARDIOL, V71, P1347, DOI 10.1016/j.jacc.2018.01.046
   HUGHEY CC, 2011, JOVE J VIS EXP FEB, V0, P0, DOI DOI 10.3791/2431
   Joshi S, 2014, ARCH DIS CHILD-FETAL, V99, PF373, DOI 10.1136/archdischild-2013-305185
   Kadmon G, 2017, PEDIATR PULM, V52, P77, DOI 10.1002/ppul.23508
   Karamanlidis G, 2011, CIRC-HEART FAIL, V4, P707, DOI 10.1161/CIRCHEARTFAILURE.111.961474
   Khemani E, 2007, PEDIATRICS, V120, P1260, DOI 10.1542/peds.2007-0971
   Koroglu OA, 2013, NEONATOLOGY, V104, P283, DOI 10.1159/000354542
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Kowalski RR, 2016, J PEDIATR-US, V172, P75, DOI 10.1016/j.jpeds.2016.01.020
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Levy PT, 2018, J PEDIATR-US, V197, P48, DOI 10.1016/j.jpeds.2018.02.006
   Lewandowski AJ, 2013, CIRCULATION, V128, P713, DOI 10.1161/CIRCULATIONAHA.113.002583
   Lewandowski AJ, 2013, CIRCULATION, V127, P197, DOI 10.1161/CIRCULATIONAHA.112.126920
   Mirza H, 2018, J PEDIATR-US, V198, P187, DOI 10.1016/j.jpeds.2018.02.034
   Mohlkert LA, 2018, J AM HEART ASSOC, V7, P0, DOI 10.1161/JAHA.117.007742
   Mourani PM, 2015, CLIN PERINATOL, V42, P839, DOI 10.1016/j.clp.2015.08.010
   Mourani PM, 2015, AM J RESP CRIT CARE, V191, P87, DOI 10.1164/rccm.201409-1594OC
   OReilly M, 2014, AM J PHYSIOL-LUNG C, V307, PL948, DOI 10.1152/ajplung.00160.2014
   Patel JR, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.00840
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005
   Tetri LH, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.00326
   Yee M, 2018, AM J PHYSIOL-LUNG C, V314, PL846, DOI 10.1152/ajplung.00409.2017
   Zivanovic S, 2017, J PEDIATR-US, V191, P42, DOI 10.1016/j.jpeds.2017.08.034
NR 40
TC 13
Z9 13
U1 0
U2 3
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6135
EI 1522-1539
J9 AM J PHYSIOL-HEART C
JI Am. J. Physiol.-Heart Circul. Physiol.
PD DEC 15
PY 2019
VL 317
IS 6
BP H1272
EP H1281
DI 10.1152/ajpheart.00383.2019
PG 10
WC Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology; Physiology
GA JR5VE
UT WOS:000499691600011
PM 31702968
DA 2024-11-01
ER

PT J
AU MÃ¼ller-Nedebock, AC
   Brennan, RR
   Venter, M
   Pienaar, IS
   van der Westhuizen, FH
   Elson, JL
   Ross, OA
   Bardien, S
AF Mueller-Nedebock, Arnica C.
   Brennan, Rebecca R.
   Venter, Marianne
   Pienaar, Ilse S.
   van der Westhuizen, Francois H.
   Elson, Joanna L.
   Ross, Owen A.
   Bardien, Soraya
TI The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects
SO NEUROCHEMISTRY INTERNATIONAL
LA English
DT Article
DE Parkinson's disease; Mitochondrial DNA; Mitochondrial haplogroups; Somatic mtDNA variation; Homoplasmic mtDNA variation; mtDNA depletion
ID transfer-rna genes; complex-i; substantia-nigra; point mutations; alzheimers-disease; copy number; skeletal-muscle; mtdna mutations; cell-lines; 1-methyl-4-phenylpyridinium ion
AB Parkinson's disease (PD), a progressive neurodegenerative disorder, has long been associated with mitochondrial dysfunction in both sporadic and familial forms of the disease. Mitochondria are crucial for maintaining cellular homeostasis, and their dysfunction is detrimental to dopaminergic neurons. These neurons are highly dependent on mitochondrial adenosine triphosphate (ATP) and degenerate in PD. Mitochondria contain their own genomes (mtDNA). The role of mtDNA has been investigated in PD on the premise that it encodes vital components of the ATP-generating oxidative phosphorylation (OXPHOS) complexes and accumulates somatic variation with age. However, the association between mtDNA variation and PD remains controversial. Herein, we provide an overview of previously published studies on the role of inherited as well as somatic (acquired) mtDNA changes in PD including point mutations, deletions and depletion. We outline limitations of previous investigations and the difficulties associated with studying mtDNA, which have left its role unresolved in the context of PD. Lastly, we highlight the potential for further research in this field and provide suggestions for future studies. Overall, the mitochondrial genome is indispensable for proper cellular function and its contribution to PD requires further, more extensive investigation.
C1 [Mueller-Nedebock, Arnica C.; Bardien, Soraya] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Div Mol Biol & Human Genet, Cape Town, South Africa.
   [Brennan, Rebecca R.; Ross, Owen A.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.
   [Venter, Marianne; van der Westhuizen, Francois H.; Elson, Joanna L.] North West Univ, Human Metab, Potchefstroom, South Africa.
   [Pienaar, Ilse S.] Univ Sussex, Sch Life Sci, Falmer BN1 9PH, England.
   [Pienaar, Ilse S.] Imperial Coll London, Ctr Neuroinflammat & Neurodegenerat, London, England.
   [Elson, Joanna L.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.
   [Ross, Owen A.] Mayo Clin, Dept Clin Genom, Jacksonville, FL 32224 USA.
   [Ross, Owen A.] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland.
C3 Stellenbosch University; Mayo Clinic; North West University - South Africa; University of Sussex; Imperial College London; Newcastle University - UK; Mayo Clinic; University College Dublin
RP Bardien, S (corresponding author), Stellenbosch Univ, Div Mol Biol & Human Genet, Dept Biomed Sci, POB 241, ZA-8000 Cape Town, South Africa.
EM sbardien@sun.ac.za
FU National Research Foundation of South Africa [106052]; South African Medical Research Council; Stellenbosch University; NIH [P50NS072187]; DOD award [W81XWH-17.1-0249]; Lewy Body Dementia Association (LBDA) Research Center of Excellence; American Parkinson Disease Association Center for Advanced Research; Michael J. Fox Foundation; NRF-DST Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Bandmann O, 1997, J NEUROL, V244, P262, DOI 10.1007/s004150050082
   BARBEAU A, 1984, CAN J NEUROL SCI, V11, P24, DOI 10.1017/S0317167100045273
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Borland MK, 2009, BBA-MOL BASIS DIS, V1792, P68, DOI 10.1016/j.bbadis.2008.09.014
   Brichta L, 2014, FRONT NEUROANAT, V8, P0, DOI 10.3389/fnana.2014.00152
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049
   BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546
   Bury AG, 2017, ANN NEUROL, V82, P1016, DOI 10.1002/ana.25099
   Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475
   Calabrese C, 2014, BIOINFORMATICS, V30, P3115, DOI 10.1093/bioinformatics/btu483
   Cantuti-Castelvetria I, 2005, NEUROBIOL AGING, V26, P1343, DOI 10.1016/j.neurobiolaging.2004.11.008
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Castellana S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005628
   Chen CM, 2007, J NEURAL TRANSM, V114, P1017, DOI 10.1007/s00702-007-0658-z
   Chen YF, 2015, CHINESE MED J-PEKING, V128, P1748, DOI 10.4103/0366-6999.159348
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chu QH, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep17170
   Collier TJ, 2017, MOVEMENT DISORD, V32, P983, DOI 10.1002/mds.27037
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437
   DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4
   Dominy JE, 1900, V5, V0, P0
   Done C, 2016, NAT COMMUN, V7, P13548, DOI 10.1038/ncomms13548
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elbaz A, 1999, NEUROLOGY, V52, P1876, DOI 10.1212/WNL.52.9.1876
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Esteves AR, 2010, FRONT AGING NEUROSCI, V1, P0, DOI 10.3389/neuro.24.005.2009
   Esteves AR, 2010, J NEUROCHEM, V113, P674, DOI 10.1111/j.1471-4159.2010.06631.x
   Esteves AR, 2010, NEUROBIOL DIS, V37, P723, DOI 10.1016/j.nbd.2009.12.011
   Esteves AR, 2009, ANTIOXID REDOX SIGN, V11, P439, DOI 10.1089/ars.2008.2247
   Esteves ARF, 2008, MITOCHONDRION, V8, P219, DOI 10.1016/j.mito.2008.03.004
   Fachal L, 2015, AM J MED GENET B, V168, P54, DOI 10.1002/ajmg.b.32276
   Gaweda-Walerych K, 2008, J NEURAL TRANSM, V115, P1521, DOI 10.1007/s00702-008-0121-9
   Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   Ghosh SS, 1999, ANN NY ACAD SCI, V893, P176, DOI 10.1111/j.1749-6632.1999.tb07825.x
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   Goudenege D, 1407, GENET MED, V21, P0
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   GrÃ¼newald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Gui YX, 2015, PARKINSONISM RELAT D, V21, P282, DOI 10.1016/j.parkreldis.2014.12.030
   Guyatt AL, 2019, HUM GENOMICS, V13, P0, DOI 10.1186/s40246-018-0190-2
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   HALLIWELL B, 1984, METHOD ENZYMOL, V105, P47
   HEIKKILA RE, 1984, SCIENCE, V224, P1451, DOI 10.1126/science.6610213
   HEIKKILA RE, 1985, NEUROSCI LETT, V62, P389, DOI 10.1016/0304-3940(85)90580-4
   Hellwege JN, 2017, CURRENT PROTOCOLS HU, V95, P1
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041
   Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Jandova J, 2012, EXP CELL RES, V318, P2215, DOI 10.1016/j.yexcr.2012.06.006
   JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7
   Keeney PM, 2009, EXP NEUROL, V220, P374, DOI 10.1016/j.expneurol.2009.09.025
   Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Kim KH, 2018, CELL METAB, V28, P516, DOI 10.1016/j.cmet.2018.06.008
   Kim SJ, 2017, J PHYSIOL-LONDON, V595, P6613, DOI 10.1113/JP274472
   Kirchner SC, 2000, NEUROTOXICOLOGY, V21, P441
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   Kosel S, 1997, MOVEMENT DISORD, V12, P639, DOI 10.1002/mds.870120504
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   Kumar KR, 2011, SEMIN NEUROL, V31, P433, DOI 10.1055/s-0031-1299782
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Latsoudis H, 2008, J HUM GENET, V53, P349, DOI 10.1007/s10038-008-0259-1
   Lee C, 2019, MOL CELL ONCOL, V6, P0, DOI 10.1080/23723556.2018.1549464
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee CH, 2013, TRENDS ENDOCRIN MET, V24, P222, DOI 10.1016/j.tem.2013.01.005
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liou CW, 2016, EUR J NEUROL, V23, P1289, DOI 10.1111/ene.13020
   Liu WC, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0004597
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   MANN VM, 1992, FEBS LETT, V299, P218, DOI 10.1016/0014-5793(92)80118-Z
   Mayr-Wohlfart U, 1997, EUR J MED RES, V2, P111
   Mehta P, 2009, MOVEMENT DISORD, V24, P290, DOI 10.1002/mds.22389
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   MIZUNO Y, 1987, NEUROSCI LETT, V81, P204, DOI 10.1016/0304-3940(87)90366-1
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   NAKAGAWAHATTORI Y, 1992, J NEUROL SCI, V107, P29, DOI 10.1016/0022-510X(92)90205-Y
   Neuhaus JFG, 2014, BRAIN, V137, P354, DOI 10.1093/brain/awt291
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Onyango IG, 2005, MOL CELL NEUROSCI, V28, P452, DOI 10.1016/j.mcn.2004.10.006
   Onyango IG, 2005, NEUROBIOL DIS, V20, P141, DOI 10.1016/j.nbd.2005.02.009
   Otaegui D, 2004, NEUROSCI LETT, V370, P171, DOI 10.1016/j.neulet.2004.08.012
   OZAWA T, 1991, BIOCHEM BIOPH RES CO, V176, P938, DOI 10.1016/S0006-291X(05)80276-1
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   Pardo-Seco J, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0073567
   Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x
   Park JS, 2018, CURR NEUROL NEUROSCI, V18, P0, DOI 10.1007/s11910-018-0829-3
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Peeva V, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04131-w
   Pienaar IS, 2017, MITOCHONDRION, V34, P141, DOI 10.1016/j.mito.2017.04.002
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515
   Pyle A, 2010, INTENS CARE MED, V36, P956, DOI 10.1007/s00134-010-1823-7
   QuirÃ³s PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23
   Raule N, 2007, MITOCHONDRION, V7, P29, DOI 10.1016/j.mito.2006.11.013
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   Salas A, 2015, J GENET GENOMICS, V42, P169, DOI 10.1016/j.jgg.2015.03.002
   Salas A, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0008347
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Sekhar GN, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0173474
   Sheehan JP, 1997, J NEUROCHEM, V68, P1221
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Simon DK, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-017-0433-9
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092
   Strobbe D, 2018, NEUROBIOL DIS, V114, P129, DOI 10.1016/j.nbd.2018.02.010
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Swerdlow RH, 2012, ANTIOXID REDOX SIGN, V16, P950, DOI 10.1089/ars.2011.3948
   Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333
   Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x
   Trinh J, 2013, NAT REV NEUROL, V9, P445, DOI 10.1038/nrneurol.2013.132
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Venter M, 2019, MITOCHONDRIAL DNA A, V30, P440, DOI 10.1080/24701394.2018.1544248
   Venter M, 2017, J GENET GENOMICS, V44, P139, DOI 10.1016/j.jgg.2016.12.003
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vivian CJ, 2017, CANCER RES, V77, P6202, DOI 10.1158/0008-5472.CAN-17-1473
   WALLACE RA, 1984, LIFE SCI, V35, P285
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-016-0404-6
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, PW64, DOI 10.1093/nar/gkw247
   West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973
   Wilkins HM, 2014, REDOX BIOL, V2, P619, DOI 10.1016/j.redox.2014.03.006
   Wu HM, 2018, NEUROBIOL DIS, V114, P17, DOI 10.1016/j.nbd.2018.02.015
   Yasukawa T, 2018, J BIOCHEM, V164, P183, DOI 10.1093/jb/mvy058
   Ye F, 2014, MITOCHONDRION, V17, P157, DOI 10.1016/j.mito.2014.05.004
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Zhang J, 2002, PARKINSONISM RELAT D, V8, P165, DOI 10.1016/S1353-8020(01)00041-4
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 172
TC 22
Z9 24
U1 1
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0197-0186
EI 1872-9754
J9 NEUROCHEM INT
JI Neurochem. Int.
PD OCT 15
PY 2019
VL 129
IS 
BP 
EP 
DI 10.1016/j.neuint.2019.104495
PG 14
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA IU9NS
UT WOS:000483908300014
PM 31233840
DA 2024-11-01
ER

PT J
AU Esterhuizen, K
   Lindeque, JZ
   Mason, S
   van der Westhuizen, FH
   Suomalainen, A
   Hakonen, AH
   Carroll, CJ
   Rodenburg, RJ
   de Laat, PB
   Janssen, MCH
   Smeitink, JAM
   Louw, R
AF Esterhuizen, Karien
   Lindeque, J. Zander
   Mason, Shayne
   van der Westhuizen, Francois H.
   Suomalainen, Anu
   Hakonen, Anna H.
   Carroll, Christopher J.
   Rodenburg, Richard J.
   de Laat, Paul B.
   Janssen, Mirian C. H.
   Smeitink, Jan A. M.
   Louw, Roan
TI A urinary biosignature for mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS)
SO MITOCHONDRION
LA English
DT Article
DE MELAS; m.3243A > G; Metabolomics; Mutation; Metabolism; mtDNA
ID metabolomics; prevalence; features; defects
AB We used a comprehensive metabolomics approach to study the altered urinary metabolome of two mitochondrial myopathy, encephalopathy lactic acidosis and stroke like episodes (MELAS) cohorts carrying the m.3243A > G mutation. The first cohort were used in an exploratory phase, identifying 36 metabolites that were significantly perturbed by the disease. During the second phase, the 36 selected metabolites were able to separate a validation cohort of MELAS patients completely from their respective control group, suggesting usefulness of these 36 markers as a diagnostic set. Many of the 36 perturbed metabolites could be linked to an altered redox state, fatty acid catabolism and one-carbon metabolism. However, our evidence indicates that, of all the metabolic perturbations caused by MELAS, stalled fatty acid oxidation prevailed as being particularly disturbed. The strength of our study was the utilization of five different analytical platforms to generate the robust metabolomics data reported here. We show that urine may be a useful source for disease-specific metabolomics data, linking, amongst others, altered one-carbon metabolism to MELAS. The results reported here are important in our understanding of MELAS and might lead to better treatment options for the disease.
C1 [Esterhuizen, Karien; Lindeque, J. Zander; Mason, Shayne; van der Westhuizen, Francois H.; Louw, Roan] North West Univ, Ctr Human Metabol, Mitochondria Res Lab, Potchefstroom, South Africa.
   [Suomalainen, Anu; Hakonen, Anna H.; Carroll, Christopher J.] Univ Helsinki, Res Programs Unit, Biomed Helsinki, Mol Neurol, Helsinki, Finland.
   [Rodenburg, Richard J.; de Laat, Paul B.; Janssen, Mirian C. H.; Smeitink, Jan A. M.] Radboud Univ Nijmegen, Dept Pediat, Radboud Ctr Mitochondria Med, Med Ctr, Nijmegen, Netherlands.
C3 North West University - South Africa; University of Helsinki; Radboud University Nijmegen
RP Louw, R (corresponding author), North West Univ, Potchefstroom Campus,Private Bag X6001, ZA-2520 Potchefstroom, South Africa.
EM Roan.Louw@nwu.ac.za
FU Technology Innovation Agency (TIA), South Africa [Metabol. 01]
CR Bao XR, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10575
   BriÃ¨re JJ, 2004, BBA-BIOENERGETICS, V1659, P172, DOI 10.1016/j.bbabio.2004.07.002
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Elshaghabee FMF, 2016, FRONT MICROBIOL, V7, P0, DOI 10.3389/fmicb.2016.00047
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Fiehn O, 2007, METABOLOMICS, V3, P175, DOI 10.1007/s11306-007-0070-6
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Kami K, 2012, MITOCHONDRION, V12, P644, DOI 10.1016/j.mito.2012.07.113
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Munnich A, 1996, EUR J PEDIATR, V155, P262
   Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Reinecke CJ, 2012, METABOLOMICS, V8, P264, DOI 10.1007/s11306-011-0309-0
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Venkataraman A, 2014, ISME J, V8, P1210, DOI 10.1038/ismej.2013.232
NR 22
TC 13
Z9 15
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2019
VL 45
IS 
BP 38
EP 45
DI 10.1016/j.mito.2018.02.003
PG 8
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA HO3WI
UT WOS:000460853300006
PM 29471047
DA 2024-11-01
ER

PT J
AU DomÃ­nguez-GonzÃ¡lez, C
   Madruga-Garrido, M
   Mavillard, F
   Garone, C
   Aguirre-RodrÃ­guez, FJ
   Donati, MA
   Kleinsteuber, K
   MartÃ­, I
   MartÃ­n-HernÃ¡ndez, E
   Morealejo-Aycinena, JP
   Munell, F
   Nascimento, A
   Kalko, SG
   Sardina, MD
   del Vayo, CA
   Serrano, O
   Long, YL
   Tu, YQ
   Levin, B
   Thompson, JLP
   Engelstad, K
   Uddin, J
   Torres-Torronteras, J
   Jimenez-Mallebrera, C
   MartÃ­, R
   Paradas, C
   Hirano, M
AF Dominguez-Gonzalez, Cristina
   Madruga-Garrido, Marcos
   Mavillard, Fabiola
   Garone, Caterina
   Javier Aguirre-Rodriguez, Francisco
   Donati, M. Alice
   Kleinsteuber, Karin
   Marti, Itxaso
   Martin-Hernandez, Elena
   Morealejo-Aycinena, Juan P.
   Munell, Francina
   Nascimento, Andres
   Kalko, Susana G.
   Dolores Sardina, M.
   Alvarez del Vayo, Concepcion
   Serrano, Olga
   Long, Yuelin
   Tu, Yuqi
   Levin, Bruce
   Thompson, John L. P.
   Engelstad, Kristen
   Uddin, Jasim
   Torres-Torronteras, Javier
   Jimenez-Mallebrera, Cecilia
   Marti, Ramon
   Paradas, Carmen
   Hirano, Michio
TI Deoxynucleoside Therapy for Thymidine Kinase 2-Deficient Myopathy
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID mitochondrial-dna depletion; differentiation factor 15; enzyme-activity; mutations; gene; biomarker
AB Objective Thymidine kinase 2, encoded by the nuclear gene TK2, is required for mitochondrial DNA maintenance. Autosomal recessive TK2 mutations cause depletion and multiple deletions of mtDNA that manifest predominantly as a myopathy usually beginning in childhood and progressing relentlessly. We investigated the safety and efficacy of deoxynucleoside monophosphate and deoxynucleoside therapies. Methods We administered deoxynucleoside monophosphates and deoxynucleoside to 16 TK2-deficient patients under a compassionate use program. Results In 5 patients with early onset and severe disease, survival and motor functions were better than historically untreated patients. In 11 childhood and adult onset patients, clinical measures stabilized or improved. Three of 8 patients who were nonambulatory at baseline gained the ability to walk on therapy; 4 of 5 patients who required enteric nutrition were able to discontinue feeding tube use; and 1 of 9 patients who required mechanical ventilation became able to breathe independently. In motor functional scales, improvements were observed in the 6-minute walk test performance in 7 of 8 subjects, Egen Klassifikation in 2 of 3, and North Star Ambulatory Assessment in all 5 tested. Baseline elevated serum growth differentiation factor 15 levels decreased with treatment in all 7 patients tested. A side effect observed in 8 of the 16 patients was dose-dependent diarrhea, which did not require withdrawal of treatment. Among 12 other TK2 patients treated with deoxynucleoside, 2 adults developed elevated liver enzymes that normalized following discontinuation of therapy. Interpretation This open-label study indicates favorable side effect profiles and clinical efficacy of deoxynucleoside monophosphate and deoxynucleoside therapies for TK2 deficiency. ANN NEUROL 2019;86:293-303
C1 [Dominguez-Gonzalez, Cristina] Hosp 12 Octubre, Neurol Dept, Neuromuscular Disorders Unit, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina; Martin-Hernandez, Elena] Hosp 12 Octubre, Inst Invest I 12, Madrid, Spain.
   [Dominguez-Gonzalez, Cristina; Martin-Hernandez, Elena; Nascimento, Andres; Kalko, Susana G.; Torres-Torronteras, Javier; Jimenez-Mallebrera, Cecilia; Marti, Ramon] Inst Salud Carlos III, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain.
   [Madruga-Garrido, Marcos] Univ Seville, Hosp Univ Virgen Rocio, Neuromuscular Disorders Unit, Pediat Neurol Dept,CSIC,Inst Biomed Sevilla, Seville, Spain.
   [Mavillard, Fabiola; Paradas, Carmen] Univ Seville, Hosp Univ Virgen Rocio, Neuromuscular Disorders Unit, Neurol Dept,CSIC,Inst Biomed Sevilla, Seville, Spain.
   [Mavillard, Fabiola; Alvarez del Vayo, Concepcion; Paradas, Carmen] Inst Salud Carlos III, Ctr Biomed Network Res Neurodegenerat Dis, Madrid, Spain.
   [Garone, Caterina] Cambridge Biomed Campus, Med Res Council, Mitochondrial Biol Unit, Cambridge, England.
   [Javier Aguirre-Rodriguez, Francisco] Torrecardenas Hosp Complex, Dept Pediat Neurol, Almeria, Spain.
   [Donati, M. Alice] Meyer Hosp, Metab & Neuromuscular Unit, Florence, Italy.
   [Kleinsteuber, Karin] Univ Chile, Pediat Neurol Dept, Las Condes Clin, Fac Med, Santiago, Chile.
   [Marti, Itxaso] Donostia Univ Hosp, Pediat Neurol Dept, San Sebastian, Spain.
   [Martin-Hernandez, Elena] October 12 Hosp, Pediat Dept, Hereditary Metab & Mitochondrial Disorders Unit, Madrid, Spain.
   [Morealejo-Aycinena, Juan P.] Hosp Guatemala, Guatemala City, Guatemala.
   [Munell, Francina] Vall dHebron Hosp, Pediat Dept, Barcelona, Spain.
   [Nascimento, Andres; Kalko, Susana G.; Jimenez-Mallebrera, Cecilia] St Joan Deu Hosp, St Joan Deu Res Inst, Neurol Dept, Neuromuscular Unit, Barcelona, Spain.
   [Dolores Sardina, M.] Badajoz Hosp Complex, Pediat Neurol Dept, Badajoz, Spain.
   [Alvarez del Vayo, Concepcion] Virgin Rocio Univ Hosp, Pharm Dept, Seville, Spain.
   [Serrano, Olga] October 12 Hosp, Pharm Dept, Madrid, Spain.
   [Long, Yuelin; Tu, Yuqi; Levin, Bruce; Thompson, John L. P.] Columbia Univ, Med Ctr, Dept Biostat, Mailman Sch Publ Hlth, New York, NY USA.
   [Engelstad, Kristen; Uddin, Jasim; Hirano, Michio] Columbia Univ, Med Ctr, Neurol Dept, H Houston Merritt Ctr, 630 West 168th St,P&S 4-423, New York, NY 10032 USA.
   [Torres-Torronteras, Javier; Marti, Ramon] Autonomous Univ Barcelona, Vall dHebron Res Inst, Res Grp Neuromuscular & Mitochondrial Dis, Barcelona, Spain.
C3 Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Instituto de Salud Carlos III; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Hospital Torrecardenas; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Universidad de Chile; University Hospital Donostia; Hospital Universitari Vall d'Hebron; Columbia University; Columbia University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)
RP Paradas, C (corresponding author), Univ Seville, Hosp Univ Virgen Rocio, Neuromuscular Disorders Unit, Neurol Dept,CSIC,Inst Biomed Sevilla, Seville, Spain.; Hirano, M (corresponding author), Columbia Univ, Med Ctr, Neurol Dept, H Houston Merritt Ctr, 630 West 168th St,P&S 4-423, New York, NY 10032 USA.
EM cparadas@us.es; mh29@columbia.edu
FU Carlos III Health Institute Funding Source: Medline; European Regional Development Fund Funding Source: Medline; Instituto de Salud Carlos III Funding Source: Medline; Muscular Dystrophy Association [577391] Funding Source: Medline; NICHD NIH HHS [P01 HD080642] Funding Source: Medline; NINDS NIH HHS [U54 NS078059] Funding Source: Medline; Spanish Carlos III Health Institute [CP09/00011, PMP15/00025, PI16/00579] Funding Source: Medline; Arturo Estopinan TK2 Research Fund Funding Source: Medline; Generalitat de Catalunya PERIS program [SLT002/16/00370] Funding Source: Medline
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   BÃ©hin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   BERK AJ, 1973, J BIOL CHEM, V248, P2722
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   CÃ¡mara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   CÃ¡mara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Carrozzo R, 2003, HUM MUTAT, V21, P0, DOI 10.1002/humu.9135
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   Fagoaga J, 2015, REV NEUROLOGIA, V61, P344, DOI 10.33588/rn.6108.2015319
   Galbiati S, 2006, PEDIATR NEUROL, V34, P177, DOI 10.1016/j.pediatrneurol.2005.07.013
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   GÃ¶tz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Ji XB, 2017, MOL NEUROBIOL, V54, P8110, DOI 10.1007/s12035-016-0283-7
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mayhew AG, 2013, DEV MED CHILD NEUROL, V55, P1046, DOI 10.1111/dmcn.12220
   McDonald CM, 2013, MUSCLE NERVE, V48, P357, DOI 10.1002/mus.23905
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Scott E, 2012, PHYSIOTHER RES INT, V17, P0, DOI 10.1002/pri.520
   Steffensen B, 2001, PHYSIOTHER RES INT, V6, P119, DOI 10.1002/pri.221
   Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   USFood and Drug Administration, 2017, GUID IND EXP ACC INV, V0, P0
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Zhang SL, 2010, MOL GENET METAB, V99, P53, DOI 10.1016/j.ymgme.2009.09.003
NR 36
TC 67
Z9 74
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD AUG 15
PY 2019
VL 86
IS 2
BP 293
EP 303
DI 10.1002/ana.25506
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA IJ1PL
UT WOS:000475670500013
PM 31125140
DA 2024-11-01
ER

PT J
AU Seo, GH
   Oh, A
   Kim, EN
   Lee, Y
   Park, J
   Kim, T
   Lim, YM
   Kim, GH
   Kim, CJ
   Yoo, HW
   Kang, E
   Lee, BH
AF Seo, Go Hun
   Oh, Arum
   Kim, Eun Na
   Lee, Yeonmi
   Park, Jumi
   Kim, Taeho
   Lim, Young-Min
   Kim, Gu-Hwan
   Kim, Chong Jai
   Yoo, Han-Wook
   Kang, Eunju
   Lee, Beom Hee
TI Identification of extremely rare mitochondrial disorders by whole exome sequencing
SO JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID translation; spectrum; mutation; disease
AB Whole exome sequencing (WES) is an effective tool for the genetic diagnosis of mitochondrial disorders due to various nuclear genetic defects. In this study, three patients affected by extremely rare mitochondrial disorders caused by nuclear genetic defects are described. The medical records of each patient were reviewed to obtain clinical symptoms, results of biochemical and imaging studies, and muscle biopsies. WES and massive parallel sequencing of whole mtDNA were performed for each patient. The oxygen consumption rate (OCR) and complex activity I and IV was measured. Patients 1 and 2 had exhibited global developmental delay and seizure since early infancy. Blood lactate, the lactate-to-pyruvate ratio, and urinary excretion of Krebs cycle intermediates were markedly elevated. Patient 1 also was noted for ophthalmoplegia. Patient 2 had left ventricular hypertrophy and ataxia. Patient 3 developed dysarthria, gait disturbance, and right-side weakness at age 29. Brain magnetic resonance imaging demonstrated abnormal signal intensity involving the bilateral thalami, midbrain, or pons. Based on WES, patient 1 had p.Glu415Gly and p.Arg484Trp variants in MTO1 . In patient 2, p.Gln111ThrfsTer5 and RNA mis-splicing were identified in TSFM. Patient 3 carried p.Met151Thr and p.Met246Lys variants in AARS2. Skin fibroblasts of three patients exhibited decreased OCRs and complex 1 activity, and mitochondrial DNA was normal. These results demonstrate the utility of WES for identifying the genetic cause of extremely rare mitochondrial disorders, which has implications for genetic counseling.
C1 [Seo, Go Hun; Oh, Arum; Yoo, Han-Wook; Lee, Beom Hee] Univ Ulsan, Coll Med, Dept Pediat, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
   [Kim, Eun Na; Kim, Chong Jai] Univ Ulsan, Coll Med, Dept Pathol, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
   [Lee, Yeonmi; Park, Jumi; Kang, Eunju] Univ Ulsan, Coll Med, Asan Med Ctr Childrens Hosp, Stem Cell Ctr,ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
   [Kim, Taeho] Univ Ulsan, Coll Med, Biomed Res Ctr, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
   [Lim, Young-Min] Univ Ulsan, Coll Med, Dept Neurol, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
   [Kim, Gu-Hwan; Yoo, Han-Wook; Lee, Beom Hee] Univ Ulsan, Coll Med, Ctr Med Genet, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
C3 University of Ulsan; University of Ulsan; University of Ulsan; University of Ulsan; University of Ulsan; University of Ulsan
RP Lee, BH (corresponding author), Univ Ulsan, Coll Med, Dept Pediat, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.; Kang, E (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr Childrens Hosp, Stem Cell Ctr,ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.; Lee, BH (corresponding author), Univ Ulsan, Coll Med, Ctr Med Genet, ASAN Inst Life Sci,Asan Med Ctr, Seoul, South Korea.
EM kangeun@amc.seoul.kr; bhlee@amc.seoul.kr
FU National Research Foundation of Korea - Ministry of Education, Science, and Technology [NRF-2018M3A9H1078335]; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [2017-756, 2018-756]
CR Ahola S, 2014, NEUROLOGY, V83, P743, DOI 10.1212/WNL.0000000000000716
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   Emperador S, 2017, EUR J HUM GENET, V25, P153, DOI 10.1038/ejhg.2016.124
   GÃ¶tz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Lee JM, 2017, EUR J NEUROL, V24, PE21, DOI 10.1111/ene.13245
   Lynch DS, 2016, JAMA NEUROL, V73, P1433, DOI 10.1001/jamaneurol.2016.2229
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Merz TM, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0178946
   Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Murayama K, 2019, J HUM GENET, V64, P113, DOI 10.1038/s10038-018-0528-6
   Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450
   OByrne JJ, 2018, MOL GENET METAB, V123, P28, DOI 10.1016/j.ymgme.2017.11.003
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Powell CA, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00079
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   TraschÃ¼tz A, 2019, PARKINSONISM RELAT D, V60, P176, DOI 10.1016/j.parkreldis.2018.09.031
   Vedrenne V, 2012, J HEPATOL, V56, P294, DOI 10.1016/j.jhep.2011.06.014
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
NR 26
TC 12
Z9 12
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD NOV 15
PY 2019
VL 64
IS 11
BP 1117
EP 1125
DI 10.1038/s10038-019-0660-y
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA JI2KB
UT WOS:000493291400008
PM 31451716
DA 2024-11-01
ER

